Citrus Sinensis ID: 008285
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 571 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.374 | 0.351 | 0.504 | 5e-52 | |
| Q99759 | 626 | Mitogen-activated protein | yes | no | 0.357 | 0.325 | 0.450 | 5e-51 | |
| Q61084 | 626 | Mitogen-activated protein | yes | no | 0.362 | 0.330 | 0.447 | 1e-50 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.422 | 0.361 | 0.433 | 2e-50 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.411 | 0.360 | 0.431 | 3e-50 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | no | no | 0.373 | 0.344 | 0.448 | 7e-50 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.353 | 0.214 | 0.441 | 1e-49 | |
| Q61083 | 619 | Mitogen-activated protein | no | no | 0.373 | 0.344 | 0.435 | 7e-48 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.355 | 0.311 | 0.456 | 4e-47 | |
| Q10407 | 1116 | MAP kinase kinase kinase | yes | no | 0.364 | 0.186 | 0.424 | 9e-46 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 206 bits (523), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 113/224 (50%), Positives = 151/224 (67%), Gaps = 10/224 (4%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
P + WQKG+L+GRG+FGSVY G + + G A+KEV ++ ++ ECI+QLE E
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRH 465
IK+L L+H+NIV+Y G+ +LYI+LE V GS+ + Y R RD S+V +TR
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQ 439
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525
IL+GL YLH IHRDIK AN+LVDA+G VKLADFG+AK ++ + S KG+P WMAP
Sbjct: 440 ILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAP 498
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
EVI +KD + + A DIWSLGCTV+EM TG+ P+S+ E V
Sbjct: 499 EVIN---RKDSDGYGSPA-DIWSLGCTVLEMCTGQIPYSDLEPV 538
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 101/224 (45%), Positives = 149/224 (66%), Gaps = 20/224 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
E IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 526
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVTGTPYWMSPE 537
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
VI +G + A D+WSLGCTV+EMLT KPPW+E+E ++
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMA 574
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 99/221 (44%), Positives = 147/221 (66%), Gaps = 14/221 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
E IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEVIK 529
HS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+P WM+PEVI
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 540
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+G + A D+WSLGCTV+EMLT KPPW+E+E ++
Sbjct: 541 G----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMA 574
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 201 bits (510), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 118/272 (43%), Positives = 161/272 (59%), Gaps = 31/272 (11%)
Query: 311 ESNNHLNAHPLPLPPGALSPPKSSVTSAVMP-HIMEKPSASPKK----------SQWQKG 359
+ +N N P P G L+ +TS + I KPS SP W+KG
Sbjct: 19 DDDNQENQPPFP---GVLA---DKITSCIRKSKIFIKPSFSPPPPANTVDMAPPISWRKG 72
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHE 416
+LIGRG FG+VY+G N ++G A+K+V I + K+ I++LE+E+K+L +L H
Sbjct: 73 QLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHP 132
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NIV+Y G+ DD L I LE+V GSI+ + E ES+VR +TR +L GL YLH+
Sbjct: 133 NIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEYLHNH 191
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HRDIKGAN+LVD G +KLADFG +K L ++ S+KG+P WMAPEVI
Sbjct: 192 AIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQTGH 251
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + DIWS+GCTVIEM+TGK PWS+
Sbjct: 252 -------SFSADIWSVGCTVIEMVTGKAPWSQ 276
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (508), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 113/262 (43%), Positives = 157/262 (59%), Gaps = 27/262 (10%)
Query: 319 HPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS---------QWQKGKLIGRGTFGS 369
HP P P S +TS + ++ S SP + +W+KG+LIGRG FG+
Sbjct: 26 HPPPFP----SLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGT 81
Query: 370 VYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
VY+G N ++G A+K+V I + K+ I++LE+E+K+L +L H NIV+Y G+
Sbjct: 82 VYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVR 141
Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486
D+ L I LE+V GSI+ + E ES+VR +T +L GL YLH+ +HRDIKGA
Sbjct: 142 EDETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGA 200
Query: 487 NLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 543
N+LVD G +KLADFG +K L +S S+KG+P WMAPEVI + +
Sbjct: 201 NILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVILQTGH-------SFS 253
Query: 544 VDIWSLGCTVIEMLTGKPPWSE 565
DIWS+GCTVIEM+TGK PWS+
Sbjct: 254 ADIWSVGCTVIEMVTGKAPWSQ 275
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 105/234 (44%), Positives = 152/234 (64%), Gaps = 21/234 (8%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 516
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+
Sbjct: 465 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMK---SV 521
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
G+P WM+PEVI +G + A DIWS+ CTV+EMLT KPPW+EFE ++
Sbjct: 522 TGTPYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMA 568
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 94/213 (44%), Positives = 149/213 (69%), Gaps = 11/213 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGH 412
+WQKG+++GRG +GSVY+G N++TG A+K+++I I DPK I +EI+V+
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L+H+NIV+Y G+ + L ++LEY+ GSI+ + + +E++++ +T+ IL GL++
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 287
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 531
LH+ + IHRDIKGAN+L+D G+VKL+DFG +K +G+ + S++G+P WMAPEVIK
Sbjct: 288 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 345
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ G+ + + DIWSLGC ++EM T +PPWS
Sbjct: 346 --QTGHGR---SSDIWSLGCVIVEMATAQPPWS 373
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 7e-48, Method: Compositional matrix adjust.
Identities = 102/234 (43%), Positives = 150/234 (64%), Gaps = 21/234 (8%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V P+ P++++ + LE
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPESPETSKEVNALEC 405
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++E GSI ++ + +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMELSPGGSIKDQLKAYGA-LTENVTRKYT 464
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 516
R IL G+ YLHS +HRDIKGAN+L D++G +KL DFG +K L TG+ S+
Sbjct: 465 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNIKLGDFGASKRLQTICLSGTGMK---SV 521
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
G+P WM+PEVI +G + A DIWS+ CTV+EMLT KPPW+EFE ++
Sbjct: 522 TGTPYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMA 568
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 99/217 (45%), Positives = 138/217 (63%), Gaps = 14/217 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLG 411
+W+KG+LIG G FG VY+G N ++G AIK+V I P K+ I++LE+E+++L
Sbjct: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+L H NIV+Y G+ D L I +E+V GSI+ + E E ++ +T+ +L GL
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLE 185
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVI 528
YLH+ +HRDIKGAN+LVD G ++LADFG +K + L+ S+KG+P WMAPEVI
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI 245
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + DIWS+GCTVIEM TGKPPWSE
Sbjct: 246 LQTGH-------SFSADIWSVGCTVIEMATGKPPWSE 275
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 95/224 (42%), Positives = 133/224 (59%), Gaps = 16/224 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQEIK 408
+W KG+LIG GT+G V++ N TG A+K+V+I P D + + + EI
Sbjct: 824 KWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEI-PQTINGRHDQLRKDIVDSINAEIS 882
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
++ L H NIVQY G E + + I+LEYV GSI R +R + E +VR +R +L
Sbjct: 883 MIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYG-PFEEQLVRFVSRQVLY 941
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAP 525
GL+YLHS IHRD+K NLL+D GV K++DFG++KH + LS++GS WMAP
Sbjct: 942 GLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAP 1001
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
EVI + + + VD+WSLGC V+EML G+ PWS E +
Sbjct: 1002 EVI-----HNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDEAI 1040
|
May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 571 | ||||||
| 255538424 | 692 | conserved hypothetical protein [Ricinus | 0.924 | 0.763 | 0.565 | 1e-144 | |
| 225470467 | 707 | PREDICTED: uncharacterized protein LOC10 | 0.891 | 0.719 | 0.516 | 1e-134 | |
| 225458499 | 782 | PREDICTED: uncharacterized protein LOC10 | 0.656 | 0.479 | 0.631 | 1e-129 | |
| 449470172 | 709 | PREDICTED: uncharacterized protein LOC10 | 0.908 | 0.732 | 0.524 | 1e-128 | |
| 255562635 | 709 | conserved hypothetical protein [Ricinus | 0.646 | 0.520 | 0.609 | 1e-121 | |
| 449448516 | 760 | PREDICTED: uncharacterized protein LOC10 | 0.917 | 0.689 | 0.450 | 1e-118 | |
| 356565641 | 637 | PREDICTED: uncharacterized protein LOC10 | 0.605 | 0.543 | 0.597 | 1e-117 | |
| 357465415 | 700 | Mitogen-activated protein kinase kinase | 0.845 | 0.69 | 0.458 | 1e-115 | |
| 449521088 | 604 | PREDICTED: uncharacterized protein LOC10 | 0.639 | 0.604 | 0.568 | 1e-115 | |
| 356514005 | 634 | PREDICTED: mitogen-activated protein kin | 0.439 | 0.395 | 0.735 | 1e-112 |
| >gi|255538424|ref|XP_002510277.1| conserved hypothetical protein [Ricinus communis] gi|223550978|gb|EEF52464.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 320/566 (56%), Positives = 380/566 (67%), Gaps = 38/566 (6%)
Query: 21 NNRKLTRVRKLRHVPDDELGLLMT-DRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLP 79
N ++LTR RK+RH +LGL + DR SP ASPDSAR SP S SS A+P+PLP
Sbjct: 21 NTKRLTRQRKIRHETQQDLGLQFSQDRLNSPPASPDSARKPRSPPCSSSSSSPALPQPLP 80
Query: 80 LPDLASLFRKPES----SGHGF-ESPEGRPHR--GRKSTNQ----TAKGSAGFLSHFHKG 128
LP+ + R+ E GH SPE RP R S +Q +A GS+ F F
Sbjct: 81 LPE-SHFTRRLEPFGFIPGHAVPASPEERPIYLLRRNSADQVDINSATGSSNFQWRFSPQ 139
Query: 129 DSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNP----KSISTRR 184
D N+++ + LR ++ RS P SS VSP+RSN + N K T
Sbjct: 140 DP---NVDTANHGLRLNIAPRSAP----SSPLVSPRRSNAGEFSTTFNAADSTKCSKTCC 192
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+G +DLNIEC NY P+SAPTS FSSP VSPQ S T + SF A
Sbjct: 193 KGQLNDLNIECVNYKLSWIDSPRSAPTSGFSSPNVSPQRSYTIDFLPSFVA--------- 243
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
EVPDLGR G TS S K D S + P +QS N + P K F L +K
Sbjct: 244 REVPDLGRHAGHTSRKSLVKTG-NGLDRSAI-YPSQQSPTPNKKPPHKFSFQLHNKMFVG 301
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
SKE E+N+ +AHPLPLPPGA SP +S + S A++ H +EKP+ S +K+QW KGKLI
Sbjct: 302 KSKEWPETNSQFSAHPLPLPPGAASP-QSFIPSPPAILHHTIEKPNVSLRKTQWLKGKLI 360
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRGT+GSVY+GTNRETGA CA+KEVDIIP D KS ECIKQLEQEI++L HL+H NIVQYY
Sbjct: 361 GRGTYGSVYVGTNRETGALCAMKEVDIIPGDSKSVECIKQLEQEIRLLQHLEHPNIVQYY 420
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
E+VDDH YIYLEYV+PGSI++YVREHC +TESIVRNFTRHIL+GLAYLHS TIHRD
Sbjct: 421 SCEIVDDHFYIYLEYVYPGSISKYVREHCGAMTESIVRNFTRHILSGLAYLHSKKTIHRD 480
Query: 483 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
IKGANLLV++SG+VKLADFGMAKHL+GLSYELSLKGSP+WMAPEVI+AVMQ + NP LAL
Sbjct: 481 IKGANLLVNSSGIVKLADFGMAKHLSGLSYELSLKGSPHWMAPEVIQAVMQNNANPDLAL 540
Query: 543 AVDIWSLGCTVIEMLTGKPPWSEFEG 568
AVDIWSLGCT+IEM TGKPPW E EG
Sbjct: 541 AVDIWSLGCTIIEMFTGKPPWGELEG 566
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1247), Expect = e-134, Method: Compositional matrix adjust.
Identities = 287/556 (51%), Positives = 350/556 (62%), Gaps = 47/556 (8%)
Query: 25 LTRVRKLRHVPDDELGLLMTDRACS-PSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
LTR RKLRHV + + L+ R+ + P S S S SS VP PLP P+L
Sbjct: 25 LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84
Query: 84 ASLFRKPESSGHGF--ESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKND 141
A LFR+ S + P P G S GF KG+S V D
Sbjct: 85 ALLFRRNGGSNSNLNCDRPLPSPKEGL---------SRGFEDR-DKGNSFV-------GD 127
Query: 142 LRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPL------HNPKSISTRRRGFSHDLNIEC 195
V V ST T S + R +++ L S+ R F
Sbjct: 128 GNGEVAVSSTATG--SKVGYNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNF-------- 177
Query: 196 ANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF-SSFWAPKEIQDWSTAEVPDLGRFV 254
+ D+ +SAPTS SSPAVSPQ + GN+F S +P+ Q WS E+P
Sbjct: 178 -----KLDVPTRSAPTSSLSSPAVSPQRTSPGNLFLSQNVSPQVFQGWSAPEMPVFDMVT 232
Query: 255 GCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNN 314
G T +SP ++ ++S D+SPL SP +S N RSP PL K + S E+N+
Sbjct: 233 GFTPQMSP-EQTMFSTDNSPLHSPTVKSPHVNPRSPSGPASPLHPKISLETSTARRENNS 291
Query: 315 HLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
H N H LPLPPG ++PP++S ++ P ++ K + P +QWQKGKLIGRGTFGSVY+ T
Sbjct: 292 HANVHRLPLPPGVVAPPQAS---SIHP-VIAKTESFPMTTQWQKGKLIGRGTFGSVYVAT 347
Query: 375 NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434
NRETGA CA+KEV+++PDDPKSAE IKQLEQEIK+L LKH NIVQY+GSE V+D LYIY
Sbjct: 348 NRETGALCAMKEVELLPDDPKSAESIKQLEQEIKILSQLKHPNIVQYFGSETVEDRLYIY 407
Query: 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494
LEYVHPGSIN+YVREHC ITES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVDASG
Sbjct: 408 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDASG 467
Query: 495 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
VVKLADFGM+KHLTG + +LSLKGSP WMAPE+++AVMQKD + LA AVDIWSLGCT+I
Sbjct: 468 VVKLADFGMSKHLTGAAADLSLKGSPYWMAPELMQAVMQKDHSSDLAFAVDIWSLGCTII 527
Query: 555 EMLTGKPPWSEFEGVS 570
EML GKPPWSE+EG +
Sbjct: 528 EMLNGKPPWSEYEGAA 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458499|ref|XP_002282240.1| PREDICTED: uncharacterized protein LOC100257467 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1204), Expect = e-129, Method: Compositional matrix adjust.
Identities = 249/394 (63%), Positives = 291/394 (73%), Gaps = 19/394 (4%)
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
RGFS DLN E Y+ R +I +SAPTS FSSPA+SPQ G S +A IQD+ +
Sbjct: 228 RGFSQDLNDEACPYNLRVNIPARSAPTSGFSSPALSPQRFSPGERLPSSYA--AIQDFQS 285
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNL----RSPRKVYFPLRHK 300
P R GC+S +SP K ++ D+SPL SP QS + +SP + F L K
Sbjct: 286 ---PGFDRLPGCSSQMSPLK-TPHTPDYSPLHSPTVQSPCISPCLSPKSPTGIAFSLYPK 341
Query: 301 SLPQNSKELLESNNHLNAHPLPLPPGALSP-----PKSSVT---SAVMPHIMEKPSASPK 352
LP + E N H+ HPLPLPP AL P P ++T SA+ H EKP+
Sbjct: 342 LLPGSHVTWPEKNGHVTVHPLPLPPIALMPSELPLPPKALTPSESAISHHTAEKPNVPSM 401
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
KSQWQKGKLIGRGTFGSVY+ TNRETGA CA+KEVDIIPDDPKS+ECIKQLEQEIKVL H
Sbjct: 402 KSQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVDIIPDDPKSSECIKQLEQEIKVLHH 461
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIVQYYGSE+VDDH YIYLEYVHPGSIN+YV +H +TE++VRNFTRHIL+GLAY
Sbjct: 462 LKHPNIVQYYGSEIVDDHFYIYLEYVHPGSINKYV-DHFGAMTENVVRNFTRHILSGLAY 520
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LHST TIHRDIKGANLLVD+ GVVKLADFG+AK LTG + +LSLKGSP+WMAPEV++AV+
Sbjct: 521 LHSTKTIHRDIKGANLLVDSFGVVKLADFGLAKFLTGQACDLSLKGSPHWMAPEVMQAVL 580
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
+KD NP LA AVDIWSLGCT+IEML G+PPWSEF
Sbjct: 581 RKDANPDLAFAVDIWSLGCTIIEMLNGRPPWSEF 614
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470172|ref|XP_004152792.1| PREDICTED: uncharacterized protein LOC101219854 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1192), Expect = e-128, Method: Compositional matrix adjust.
Identities = 297/566 (52%), Positives = 360/566 (63%), Gaps = 47/566 (8%)
Query: 20 FNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSP----GTSDHWSSSAVP 75
F R+LTR RKLRH+ D ++G P + PDS +S P G S+ WSSS P
Sbjct: 38 FIQRRLTRQRKLRHLTDQDVGFEH------PRSLPDSPDISAKPKSPLGGSERWSSSPSP 91
Query: 76 KPLPLPDLASLFRKPESSGHGFESPEGRPHRG--RKSTNQTAKGSAGFLSHFHKGDSQVL 133
+PLPLP+L + R PE + + G P RK ++ + H + + L
Sbjct: 92 QPLPLPELFPV-RSPEFGSNYGQGRVGSPVETSVRKCSDHATTNVSRSFGHNQRRVATDL 150
Query: 134 NIESVKNDLRPSVPVRSTPTSLSS-SHAVSPQRSNL---QNPTPLHNPKSISTRRRGFSH 189
+E V + R ++P SLS+ S ++P + L + TP + + RG
Sbjct: 151 TLEVVDGNSRTGATAFTSPQSLSANSGKLNPNKEFLFGCSDQTP-------NNKGRGSPT 203
Query: 190 DLNIECANYSSRADIIPK-----SAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+ E NY ++ PK SAPTS+ SP VSP+ S GN F + E Q+ +
Sbjct: 204 HPSAERGNY----NLTPKKSSSKSAPTSILPSPVVSPRKSYNGNHFVPGLSHHEHQESPS 259
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
SP P + S+ PL SP +SS SN RS + FPL K
Sbjct: 260 N-----------NSPKVPPLKTALSSQPFPLHSPTARSSISNSRSHNDMTFPLHTKLQKD 308
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
NS + ES+ H+NAHPLPLPP ++ ++S S + + H++EKP S K QWQKGKLI
Sbjct: 309 NSIDRSESHAHVNAHPLPLPPPLVASSQASAQSLPSNVHHVIEKPFISSMKGQWQKGKLI 368
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRGTFGSVY+ TNRETGA CA+KEVD+IPDDPKSAECIKQLEQEI+VL HLKH NIVQYY
Sbjct: 369 GRGTFGSVYLATNRETGALCAMKEVDLIPDDPKSAECIKQLEQEIEVLSHLKHPNIVQYY 428
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
GSE++ D YIYLEYV+PGSIN+YVRE C ITESIVRNFTRHIL+GLAYLHST TIHRD
Sbjct: 429 GSEIIGDCFYIYLEYVYPGSINKYVRERCGAITESIVRNFTRHILSGLAYLHSTKTIHRD 488
Query: 483 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
IKGANLLVD+SGVVKLADFGMAKHLTG Y+LSLKGSP WMAPEVIKA M KD NP LAL
Sbjct: 489 IKGANLLVDSSGVVKLADFGMAKHLTG-QYDLSLKGSPYWMAPEVIKAAMLKDANPDLAL 547
Query: 543 AVDIWSLGCTVIEMLTGKPPWSEFEG 568
AVDIWSLGCT+IEML GKPPW EFEG
Sbjct: 548 AVDIWSLGCTIIEMLNGKPPWCEFEG 573
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1136), Expect = e-121, Method: Compositional matrix adjust.
Identities = 234/384 (60%), Positives = 279/384 (72%), Gaps = 15/384 (3%)
Query: 190 DLNIE-CANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWA--PKEIQDWSTAE 246
D +++ CA+YS R + +SAPTS FSSP Q T F ++ K Q WS E
Sbjct: 216 DFSVDHCADYS-RINAPIRSAPTSPFSSP----QKLTTAADFLPYYQMIAKGNQVWSAPE 270
Query: 247 VPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNS 306
+ L + P + F +S D SPL SPP +S + N +SP L + + S
Sbjct: 271 MATLD--IPGLPPPAFFDYTAFSTDTSPLHSPPSRSPRRNPKSPTGGPASLNARLSIETS 328
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 366
+E N +L HPLPLPPGA S S+ +P ++ K + P KSQWQKGKLIGRGT
Sbjct: 329 REC---NANLEVHPLPLPPGASS--SRPSISSSVPQVISKAESIPLKSQWQKGKLIGRGT 383
Query: 367 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
FGSVY+ +NRETGA CA+KEVD+ PDDPKSAE IKQLEQEIKVL HLKH NIVQYYGSE+
Sbjct: 384 FGSVYVASNRETGALCAMKEVDMFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI 443
Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486
V DH YIYLEYVHPGSIN+YVREHC ITE++VR+F+RHIL+GLAYLHS TIHRDIKGA
Sbjct: 444 VGDHFYIYLEYVHPGSINKYVREHCGAITENVVRSFSRHILSGLAYLHSMKTIHRDIKGA 503
Query: 487 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546
NLLVDASGVVKLADFGM+KHLTG + ELSLKGSP WMAPE+++AVMQKD + LALAVDI
Sbjct: 504 NLLVDASGVVKLADFGMSKHLTGQAAELSLKGSPYWMAPELMQAVMQKDTSSDLALAVDI 563
Query: 547 WSLGCTVIEMLTGKPPWSEFEGVS 570
WSLGCT+IEM TGKPPWS++EG +
Sbjct: 564 WSLGCTIIEMFTGKPPWSDYEGAA 587
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1108), Expect = e-118, Method: Compositional matrix adjust.
Identities = 271/601 (45%), Positives = 350/601 (58%), Gaps = 77/601 (12%)
Query: 5 GKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPG 64
G A N ++ V F + +R RKLR++ E + + A +P+ +S SP
Sbjct: 36 GSAENNYRGIVWR--FGASRYSRHRKLRNLSGREH--VDSSLAKWSDTAPEPVSLSRSPS 91
Query: 65 TSDHWSSSAVPKPLPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGF--- 121
TSDH AVP LPLP+++ LF+ R R ST+ +A G
Sbjct: 92 TSDH---PAVP--LPLPEVSPLFQP----------------RERISTSNSAGGEGDCPLP 130
Query: 122 ---LSHFHKGDSQVLNI------ESVKNDLRPSVPVRSTPTSLSSSH----AVSPQRSNL 168
S GD + ++ + + + P+ ++S S+ H + + S
Sbjct: 131 SPKGSRGRAGDERDVDRDRNAPPQKIGGGISPNASIKSVSDSVGERHKKEGQIEARLSGR 190
Query: 169 QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGN 228
N P++ R GF D+ +SAPTS ++SP SPQ + +GN
Sbjct: 191 ANQDARRYPEN---SRNGF-------------WIDVPSRSAPTSPYTSPTPSPQRNISGN 234
Query: 229 VFS-SFWAPKEIQDWSTAEVPD-------LGRFVGCTS--PVSPFKRNV---------YS 269
+ + + +P Q WS E+P+ +G V P S R V S
Sbjct: 235 ISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLS 294
Query: 270 ADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALS 329
+ SP+ SP +S + RSP PL K + E + H++ HPLPLPPG
Sbjct: 295 TESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPM 354
Query: 330 PPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI 389
P SS ++ + + S S K+QWQKGKLIGRGTFGSVY+ +NR+ GA CA+KEV++
Sbjct: 355 PSASSPSTPISQANTKSESIS-MKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVEL 413
Query: 390 IPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE 449
DDPKSAE IKQLEQEIK+L LKH NIVQYYGS+++DD LYIYLEYVHPGSIN+YVRE
Sbjct: 414 FHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVRE 473
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVD+ GVVKLADFGMAKHLTG
Sbjct: 474 HCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDSCGVVKLADFGMAKHLTG 533
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
+LSLKGSP WMAPE++ +VMQKD P LALAVDIWSLGCT+IEM TGKPPWSE+EG
Sbjct: 534 QVADLSLKGSPYWMAPELLLSVMQKDNTPDLALAVDIWSLGCTIIEMFTGKPPWSEYEGA 593
Query: 570 S 570
+
Sbjct: 594 A 594
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 223/373 (59%), Positives = 268/373 (71%), Gaps = 27/373 (7%)
Query: 212 SVFSSPAVSPQSSKTGNVFSSFWA-PKEIQDWSTAEVP--DLGRFVGCTSPVSPFKRNVY 268
S+ SP++SPQ ++ G+ ++A PK Q WST E+P D G P + F +
Sbjct: 161 SISGSPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDAGLL-----PPAFFDLSAL 215
Query: 269 SADHSPLP----SPPRQSSQSNLRS---PRKVYFPLRHKSLPQNSKELLESNNH--LNAH 319
S + S P SP R+S Q + R+ P P+ +P E NN + H
Sbjct: 216 STETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHE----NNAPPVAVH 271
Query: 320 PLPLPP--GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRE 377
PLPLPP G SPP +A H M K + P KSQW+KGKLIGRGTFGSVY+ TNRE
Sbjct: 272 PLPLPPRAGLTSPP----AAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRE 327
Query: 378 TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437
TGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D YIYLEY
Sbjct: 328 TGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEY 387
Query: 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 497
VHPGSIN+YVR+HC ITES++RNFTRHIL+GLAYLHS TIHRDIKGANLLVD++GVVK
Sbjct: 388 VHPGSINKYVRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVK 447
Query: 498 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
LADFGMAKHLTG LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+IEM
Sbjct: 448 LADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMF 507
Query: 558 TGKPPWSEFEGVS 570
TGKPPWSE+EG +
Sbjct: 508 TGKPPWSEYEGAA 520
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465415|ref|XP_003602992.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355492040|gb|AES73243.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-115, Method: Compositional matrix adjust.
Identities = 258/563 (45%), Positives = 331/563 (58%), Gaps = 80/563 (14%)
Query: 20 FNNRKLTRVRKLRHVPDDELG--LLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKP 77
R+LTR ++L + D ++G TD A S S SP +SDHWS+SAVP+P
Sbjct: 23 IQQRRLTRQKRLCYPNDQDVGESFHSTDVAVSFSLP-----TSPYRTSSDHWSTSAVPQP 77
Query: 78 LPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIES 137
LPLP+ R+P+ H P R T ++ + S+ HF + +
Sbjct: 78 LPLPESPLTTRRPDH--HAAALPFSRK-SADHDTVRSLRSSSNLGRHFFNTVTG-----N 129
Query: 138 VKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECAN 197
K+DLR ++P P R L + S R SHD + E +
Sbjct: 130 AKSDLRVNIP---------------PTRG-------LVSSNSSCKDTRKHSHDNDCEGIS 167
Query: 198 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDW------STAEVPDL 250
+S+ KSAP S+FSSP SP+ + ++ S P++ D TA PDL
Sbjct: 168 -NSKLQFAAKSAPNSIFSSPVTSPRRLSSVDLLDPSIILPQDFNDMFRVLPAKTAHSPDL 226
Query: 251 G--RFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKE 308
R G SP + + + SQ + + +V+
Sbjct: 227 SPRRSFGNHSPANHHRHTIQGG------------SQQHSKFCTRVW-------------- 260
Query: 309 LLESNNHLNAHPLPLPPGALSPPKSS---VTSAVMPHIMEKPSASPKKSQWQKGKLIGRG 365
NNHL+AHPLPLPP A P+ S +S M H E + K WQKGKLIGRG
Sbjct: 261 --PENNHLDAHPLPLPPRASPQPQQSPAHQSSVTMNHSTENIHS--MKGHWQKGKLIGRG 316
Query: 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425
+FGSVY TN ETGASCA+KEVD++PDDPKS +CIKQL+QEI++LG L H NIV+YYGSE
Sbjct: 317 SFGSVYHATNLETGASCALKEVDLVPDDPKSTDCIKQLDQEIRILGQLHHPNIVEYYGSE 376
Query: 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485
VV D L IY+EYVHPGS+ +++++HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKG
Sbjct: 377 VVGDRLCIYMEYVHPGSLQKFMQDHCGVMTESVVRNFTRHILSGLAYLHSTKTIHRDIKG 436
Query: 486 ANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
ANLLVDASG+VKLADFG++K LT SYELSLKGSP WMAPE++ A M+ + NP +A+AVD
Sbjct: 437 ANLLVDASGIVKLADFGVSKILTEKSYELSLKGSPYWMAPELMMAAMKNETNPTVAMAVD 496
Query: 546 IWSLGCTVIEMLTGKPPWSEFEG 568
IWSLGCT+IEMLTGKPPWSEF G
Sbjct: 497 IWSLGCTIIEMLTGKPPWSEFPG 519
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-115, Method: Compositional matrix adjust.
Identities = 221/389 (56%), Positives = 266/389 (68%), Gaps = 24/389 (6%)
Query: 203 DIIPKSAPTSVFSSPAVSPQSSKTGNV---------------------FSSFWAPKEIQD 241
D+ +SAPTS ++SP SPQ + +GN+ F AP
Sbjct: 53 DVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHV 112
Query: 242 WSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKS 301
WS E+P G P + F + S + SP+ SP +S + RSP PL K
Sbjct: 113 WSAPELPSSAMMRGV--PPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKI 170
Query: 302 LPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKL 361
+ E + H++ HPLPLPPG P SS ++ + + S S K+QWQKGKL
Sbjct: 171 SHETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESIS-MKNQWQKGKL 229
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IGRGTFGSVY+ +NR+ GA CA+KEV++ DDPKSAE IKQLEQEIK+L LKH NIVQY
Sbjct: 230 IGRGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQY 289
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS+++DD LYIYLEYVHPGSIN+YVREHC +TES+VRNFTRHIL+GLAYLHST TIHR
Sbjct: 290 YGSDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHR 349
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541
DIKGANLLVD+ GVVKLADFGMAKHLTG +LSLKGSP WMAPE++ +VMQKD P LA
Sbjct: 350 DIKGANLLVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWMAPELLLSVMQKDNTPDLA 409
Query: 542 LAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
LAVDIWSLGCT+IEM TGKPPWSE+EG +
Sbjct: 410 LAVDIWSLGCTIIEMFTGKPPWSEYEGAA 438
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514005|ref|XP_003525698.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1062), Expect = e-112, Method: Compositional matrix adjust.
Identities = 189/257 (73%), Positives = 217/257 (84%), Gaps = 6/257 (2%)
Query: 316 LNAHPLPLPPGA--LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIG 373
+ HPLPLPPGA SPP +A H + K + P KSQW+KGKLIGRGTFGSVY+
Sbjct: 265 VGVHPLPLPPGAALTSPP----AAATFSHAVAKSESFPMKSQWKKGKLIGRGTFGSVYVA 320
Query: 374 TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
TNRETGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D YI
Sbjct: 321 TNRETGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYI 380
Query: 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493
YLEYVHPGSIN+YVREHC ITES++RNFTRHIL+GLAYLHS TIHRDIKGANLLVD++
Sbjct: 381 YLEYVHPGSINKYVREHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSA 440
Query: 494 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
GVVKLADFGMAKHLTG LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+
Sbjct: 441 GVVKLADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTI 500
Query: 554 IEMLTGKPPWSEFEGVS 570
IEM TGKPPWSE+EG +
Sbjct: 501 IEMFTGKPPWSEYEGAA 517
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 571 | ||||||
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.416 | 0.332 | 0.735 | 9e-111 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.402 | 0.260 | 0.588 | 5.2e-77 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.367 | 0.344 | 0.603 | 6e-72 | |
| ZFIN|ZDB-GENE-120215-96 | 623 | si:dkey-32h20.5 "si:dkey-32h20 | 0.397 | 0.364 | 0.434 | 2.3e-53 | |
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.362 | 0.340 | 0.516 | 1.4e-50 | |
| UNIPROTKB|E2RN16 | 620 | MAP3K2 "Uncharacterized protei | 0.378 | 0.348 | 0.450 | 1.8e-50 | |
| UNIPROTKB|F1MH06 | 626 | MAP3K3 "Uncharacterized protei | 0.378 | 0.345 | 0.441 | 2.3e-50 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.364 | 0.371 | 0.458 | 2.4e-50 | |
| UNIPROTKB|F1M9D0 | 618 | Map3k2 "Protein Map3k2" [Rattu | 0.378 | 0.349 | 0.441 | 3.7e-50 | |
| UNIPROTKB|I3LNQ4 | 620 | MAP3K2 "Uncharacterized protei | 0.378 | 0.348 | 0.450 | 6e-50 |
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 9.0e-111, Sum P(2) = 9.0e-111
Identities = 175/238 (73%), Positives = 202/238 (84%)
Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
SS S P K + P SQW+KGKLIGRGTFGSVY+ +N ETGA CA+KEV++ PD
Sbjct: 323 SSAASVPSPQAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPD 382
Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
DPKSAECIKQLEQEIK+L +L+H NIVQY+GSE V+D +IYLEYVHPGSIN+Y+R+HC
Sbjct: 383 DPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCG 442
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+TES+VRNFTRHIL+GLAYLH+ T+HRDIKGANLLVDASGVVKLADFGMAKHLTG
Sbjct: 443 TMTESVVRNFTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRA 502
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+LSLKGSP WMAPE+++AVMQKD NP LA AVDIWSLGCT+IEM TGKPPWSEFEG +
Sbjct: 503 DLSLKGSPYWMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAA 560
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 5.2e-77, Sum P(2) = 5.2e-77
Identities = 140/238 (58%), Positives = 176/238 (73%)
Query: 333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
S+ TS +P + A+ S+W+KG+L+G G+FG VY+G N E+G CA+KEV +
Sbjct: 376 SAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCS 435
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
DDPKS E +QL QEI VL L+H+NIVQYYGSE VDD LYIYLEYV GSI + ++E+
Sbjct: 436 DDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYG 495
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
+ E+ +RN+T+ IL+GLAYLH+ NT+HRDIKGAN+LVD G VK+ADFGMAKH+T S
Sbjct: 496 Q-FGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQS 554
Query: 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
LS KGSP WMAPEVIK +G+ LAVDIWSLGCTV+EM T KPPWS++EGV
Sbjct: 555 GPLSFKGSPYWMAPEVIK---NSNGSN---LAVDIWSLGCTVLEMATTKPPWSQYEGV 606
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 6.0e-72, Sum P(2) = 6.0e-72
Identities = 131/217 (60%), Positives = 162/217 (74%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S W+KGK +G GTFG VY+G N E G CAIKEV +I DD S EC+KQL QEI +L L
Sbjct: 212 STWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQL 271
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H NIVQYYGSE+ ++ L +YLEYV GSI++ ++++ TE +++N+TR IL GLAYL
Sbjct: 272 CHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYL 330
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H NT+HRDIKGAN+LVD +G +KLADFGMAKH+T S LS KGSP WMAPEV VM
Sbjct: 331 HGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEV---VMS 387
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
++G AVDIWSLGCT++EM T KPPWS+FEGV+
Sbjct: 388 QNGYTH---AVDIWSLGCTILEMATSKPPWSQFEGVA 421
|
|
| ZFIN|ZDB-GENE-120215-96 si:dkey-32h20.5 "si:dkey-32h20.5" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.3e-53, Sum P(3) = 2.3e-53
Identities = 107/246 (43%), Positives = 159/246 (64%)
Query: 333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
S+ T +VM + PS SP+ + W+ GKL+G+G FG V++ + +TG A+K+V P
Sbjct: 340 SNPTLSVMD--ISPPSRSPRAPTNWRLGKLLGQGAFGRVFLCYDADTGRELAVKQVQFDP 397
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH---LYIYLEYVHPGSINRYVR 448
D P++++ + LE EI++L +L HE IVQYYG + D H L I++EY+ GSI ++
Sbjct: 398 DSPETSKEVSALECEIQLLKNLFHERIVQYYGC-LRDTHEKTLSIFMEYMPGGSIKDQLK 456
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+ +TE++ R +TR IL G+ YLHS +HRDIKGAN+L D++G VKL DFG ++ L
Sbjct: 457 SYGA-LTENVTRKYTRQILEGVCYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASRRLQ 515
Query: 509 GLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ S+ G+P WM+PEVI +G + A DIWS+GCTV+EMLT +PPW+
Sbjct: 516 TICLSGTGIKSVTGTPYWMSPEVISG----EGYGRKA---DIWSIGCTVVEMLTQRPPWA 568
Query: 565 EFEGVS 570
EFE ++
Sbjct: 569 EFEAMA 574
|
|
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.4e-50, Sum P(2) = 1.4e-50
Identities = 112/217 (51%), Positives = 147/217 (67%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ WQKG+L+GRG+FGSVY G + + G A+KEV ++ ++ ECI+QLE EIK+L L
Sbjct: 331 TSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAY 472
+H+NIV+Y G+ +LYI+LE V GS+ + Y R RD S+V +TR IL+GL Y
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQILDGLKY 446
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LH IHRDIK AN+LVDA+G VKLADFG+AK ++ + S KG+P WMAPEVI
Sbjct: 447 LHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINR-K 504
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
DG A DIWSLGCTV+EM TG+ P+S+ E V
Sbjct: 505 DSDGYGSPA---DIWSLGCTVLEMCTGQIPYSDLEPV 538
|
|
| UNIPROTKB|E2RN16 MAP3K2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 1.8e-50, Sum P(2) = 1.8e-50
Identities = 104/231 (45%), Positives = 151/231 (65%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 347 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 406
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 407 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 465
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+
Sbjct: 466 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGT 525
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
P WM+PEVI +G + A DIWS+GCTV+EMLT KPPW+EFE ++
Sbjct: 526 PYWMSPEVISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMA 569
|
|
| UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.3e-50, Sum P(2) = 2.3e-50
Identities = 102/231 (44%), Positives = 151/231 (65%)
Query: 347 PSASPKKS-QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
P+ SP W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE
Sbjct: 352 PTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L+HE IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +T
Sbjct: 412 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 470
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G++YLHS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+
Sbjct: 471 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGT 530
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
P WM+PEVI +G + A D+WSLGCTV+EMLT KPPW+E+E ++
Sbjct: 531 PYWMSPEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMA 574
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 2.4e-50, Sum P(3) = 2.4e-50
Identities = 99/216 (45%), Positives = 140/216 (64%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ W KG+L+GRG++ SVY + E G A+KEV ++ ++ ECI+QLE EI +L L
Sbjct: 301 TSWLKGQLLGRGSYASVYEAIS-EDGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQL 359
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+H+NIV+Y G+ LYI+LE V GS+ + + ++ ++V +TR IL GL YL
Sbjct: 360 QHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERY--QLSYTVVSLYTRQILAGLNYL 417
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H +HRDIK AN+LVDA+G VKLADFG+A+ + + +S KG+ WMAPEVI
Sbjct: 418 HDKGFVHRDIKCANMLVDANGTVKLADFGLAE-ASKFNDIMSCKGTLFWMAPEVINR-KD 475
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
DGN A DIWSLGCTV+EM TG+ P+S+ + +
Sbjct: 476 SDGNGSPA---DIWSLGCTVLEMCTGQIPYSDLKPI 508
|
|
| UNIPROTKB|F1M9D0 Map3k2 "Protein Map3k2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 3.7e-50, Sum P(2) = 3.7e-50
Identities = 102/231 (44%), Positives = 150/231 (64%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 345 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFNPDSPETSKEVNALEC 404
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 405 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 463
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G+ YLHS +HRDIKGAN+L D++G +KL DFG +K L + S+ G+
Sbjct: 464 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNIKLGDFGASKRLQTICLSGTGMKSVTGT 523
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
P WM+PEVI +G + A DIWS+ CTV+EMLT KPPW+EFE ++
Sbjct: 524 PYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMA 567
|
|
| UNIPROTKB|I3LNQ4 MAP3K2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 6.0e-50, Sum P(2) = 6.0e-50
Identities = 104/231 (45%), Positives = 151/231 (65%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 347 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 406
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 407 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 465
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+
Sbjct: 466 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGT 525
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
P WM+PEVI +G + A DIWS+GCTV+EMLT KPPW+EFE ++
Sbjct: 526 PYWMSPEVISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMA 569
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 571 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-105 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-94 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-76 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-73 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-73 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-71 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-69 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-66 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-65 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-60 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-59 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-57 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-57 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-57 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-56 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-56 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-56 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-52 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-50 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-49 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-48 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-43 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-43 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-41 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-37 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-37 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-36 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-36 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-36 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-36 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-36 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-36 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-36 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-36 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-35 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-35 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-35 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-34 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-34 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-34 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-33 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-33 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-33 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-32 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-32 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-31 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-31 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-31 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-31 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-30 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-29 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-28 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-28 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-28 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-25 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-25 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-24 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-23 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-22 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-15 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-09 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-105
Identities = 120/214 (56%), Positives = 151/214 (70%), Gaps = 7/214 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+KG+L+G G+FGSVY G N + G A+KEV + D E +KQLEQEI +L L+H
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIVQY G+E +D+LYI+LE V GS+ + ++++ E ++R +TR IL GL YLH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
NT+HRDIKGAN+LVD +GVVKLADFGMAK + S+ S KGSP WMAPEVI Q+
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI---AQQG 177
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
G LA DIWSLGCTV+EM TGKPPWS+ EGV
Sbjct: 178 GY---GLAADIWSLGCTVLEMATGKPPWSQLEGV 208
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 287 bits (736), Expect = 9e-94
Identities = 109/218 (50%), Positives = 146/218 (66%), Gaps = 16/218 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+W +G+L+GRG+FGSVY+ +++TG A+K V++ D + E LE+EI++L L+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57
Query: 415 HENIVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H NIV+YYGSE + L I+LEYV GS+ + + + E ++R +TR IL GLAY
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 529
LHS +HRDIKGAN+LVD+ GVVKLADFG AK L + S++G+P WMAPEVI+
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
++ G A DIWSLGCTVIEM TGKPPWSE
Sbjct: 177 G--EEYG-----RAADIWSLGCTVIEMATGKPPWSELG 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 9e-76
Identities = 78/209 (37%), Positives = 119/209 (56%), Gaps = 12/209 (5%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG VY+ +++TG AIK + + +++ +EIK+L LKH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK----KDRERILREIKILKKLKH 56
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ Y +D LY+ +EY G + +++ R ++E R + R IL+ L YLHS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHS 115
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+L+D G VKLADFG+A+ L + G+P +MAPEV+
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL------ 169
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
AVDIWSLG + E+LTGKPP+
Sbjct: 170 -GKGYGKAVDIWSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 3e-73
Identities = 102/212 (48%), Positives = 131/212 (61%), Gaps = 12/212 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+Q G LIGRG FG VY G N ETG AIK++ + + A +K + QEI +L +LK
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEA--LKSIMQEIDLLKNLK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NIV+Y GS D LYI LEY GS+ + +++ ES+V + +L GLAYLH
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLH 116
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQ 533
IHRDIK AN+L GVVKLADFG+A L +S + S+ G+P WMAPEVI +
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI----E 172
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
G + A DIWSLGCTVIE+LTG PP+ +
Sbjct: 173 MSG---ASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (595), Expect = 8e-73
Identities = 101/219 (46%), Positives = 146/219 (66%), Gaps = 18/219 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A+K+V PD P++ + + LE EI++L +L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
E IVQYYG D+ L I++EY+ GS+ ++ + +TE++ R +TR IL G+ YLHS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS 122
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPEVI 528
+HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PEVI
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVI 179
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+G + A D+WS+GCTV+EMLT KPPW+EFE
Sbjct: 180 SG----EGYGRKA---DVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 5e-71
Identities = 102/218 (46%), Positives = 135/218 (61%), Gaps = 13/218 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+WQ+G IG GTFG VY N +TG A+KE+ I +DPK+ IK++ E+KVL LK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H N+V+YYG EV + +YI++EY G++ + EH R + E ++R +T +L GLAYLH
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWMAPEVIK 529
S +HRDIK AN+ +D +GV+KL DFG A L T SL G+P +MAPEVI
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
A DIWSLGC V+EM TGK PWSE +
Sbjct: 177 ----GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 9e-69
Identities = 80/211 (37%), Positives = 117/211 (55%), Gaps = 11/211 (5%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG+VY ++ TG A+K + KS + +EI++L L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTAR-REIRILRRLSH 57
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + DHLY+ +EY G + Y+ ++E + IL GL YLHS
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHS 116
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+D +GVVK+ADFG+AK L S L + G+P +MAPEV+
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL----- 171
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
G VD+WSLG + E+LTGKPP+S
Sbjct: 172 -GGNGYGPKVDVWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-66
Identities = 99/222 (44%), Positives = 136/222 (61%), Gaps = 14/222 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQEIKVL 410
W KG+LIG+GT+G VY+ N TG A+K+V++ D + + +K L EI+ L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L H NIVQY G E +++L I+LEYV GSI +R + R E +VR FT +L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGL 121
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEV 527
AYLHS +HRD+K NLLVDA G+ K++DFG++K + +S++GS WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
I + Q + VDIWSLGC V+EM G+ PWS+ E +
Sbjct: 182 IHSYSQ-----GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 1e-65
Identities = 85/211 (40%), Positives = 124/211 (58%), Gaps = 12/211 (5%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + IG+G FG VY ++ TG AIK + + +S E +++ EI++L KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+YYGS + D L+I +E+ GS+ ++ + +TES + + +L GL YLHS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
IHRDIK AN+L+ + G VKL DFG++ L+ ++ G+P WMAPEVI K
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---GKP 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
+ K DIWSLG T IE+ GKPP+SE
Sbjct: 174 YDYK----ADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 7e-62
Identities = 102/220 (46%), Positives = 133/220 (60%), Gaps = 19/220 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDDPKSAECIKQLEQEIKVL 410
+W KG LIG G+FGSVY+G N +G A+K+V++ + + L +EI +L
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L+HENIVQY GS + DHL I+LEYV GS+ + + E++VRNF R IL GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWM 523
YLH+ IHRDIKGAN+LVD G +K++DFG++K L S SL+GS WM
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
APEV+K K DIWSLGC V+EMLTGK P+
Sbjct: 180 APEVVKQTSY---TRK----ADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 6e-60
Identities = 75/197 (38%), Positives = 116/197 (58%), Gaps = 12/197 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G FG+VY+ +++TG AIK + S+ +++L +EI++L L H NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YG ++HLY+ +EY GS+ ++E+ ++E + IL GL YLHS IHR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 482 DIKGANLLVDA-SGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPK 539
D+K N+L+D+ +G VKLADFG++K LT L ++ G+P +MAPEV+ G
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL------GKGY 170
Query: 540 LALAVDIWSLGCTVIEM 556
+ DIWSLG + E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 9e-59
Identities = 81/217 (37%), Positives = 116/217 (53%), Gaps = 22/217 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + IG+G+FG VY ++ T AIK +D+ ++ + I+ ++QEI+ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ I +YYGS + L+I +EY GS ++ + E+ + R +L GL YL
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVI 528
H IHRDIK AN+L+ G VKLADFG++ LT K G+P WMAPEVI
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMAPEVI 170
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
K Q + K DIWSLG T IE+ G+PP S+
Sbjct: 171 K---QSGYDEK----ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 81/207 (39%), Positives = 117/207 (56%), Gaps = 15/207 (7%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
+G G++GSVY ++ETG AIK V + D ++++ +EI +L IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVK 62
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
YYGS + L+I +EY GS++ ++ + +TE + L GL YLHS IH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
RDIK N+L++ G KLADFG++ LT ++ ++ G+P WMAPEVI + N K
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYNNK 179
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEF 566
DIWSLG T IEM GKPP+S+
Sbjct: 180 ----ADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 3e-57
Identities = 101/226 (44%), Positives = 149/226 (65%), Gaps = 24/226 (10%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V P+ P++++ + LE EI++L +L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 416 ENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
E IVQYYG + D L I++EY+ GS+ ++ + +TES+ R +TR IL G++
Sbjct: 64 ERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMS 120
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMA 524
YLHS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMS 177
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
PEVI +G + A D+WSLGCTV+EMLT KPPW+E+E ++
Sbjct: 178 PEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 4e-57
Identities = 98/223 (43%), Positives = 147/223 (65%), Gaps = 14/223 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ W+ GKL+G+G FG VY+ + +TG A+K+V P+ P++++ + LE EI++L +L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 414 KHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
HE IVQYYG + ++ L I++E++ GSI ++ + +TE++ R +TR IL G++
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVS 120
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEV 527
YLHS +HRDIKGAN+L D+ G VKL DFG +K L + S+ G+P WM+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
I +G + A DIWS+GCTV+EMLT KPPW+EFE ++
Sbjct: 181 ISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 89/212 (41%), Positives = 118/212 (55%), Gaps = 17/212 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+K IG G G VY T+R TG AIK++ + + + + EI ++ KH
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV YY S +V D L++ +EY+ GS+ + ++ + E + R +L GL YLHS
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQK 534
N IHRDIK N+L+ G VKLADFG A LT S S+ G+P WMAPEVIK +K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK---RK 191
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
D PK VDIWSLG IEM G+PP+
Sbjct: 192 DYGPK----VDIWSLGIMCIEMAEGEPPYLRE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 2e-56
Identities = 97/224 (43%), Positives = 147/224 (65%), Gaps = 20/224 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ GKL+GRG FG VY+ + +TG A+K+V PD ++++ + LE EI++L +L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ IVQYYG + + L I++EY+ GSI ++ + +TE++ R +TR IL G++YL
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYL 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 526
HS +HRDIKGAN+L D++G VKL DFG +K + TG+ S+ G+P WM+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPYWMSPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
VI +G + A D+WS+ CTV+EMLT KPPW+E+E ++
Sbjct: 180 VISG----EGYGRKA---DVWSVACTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 85/205 (41%), Positives = 115/205 (56%), Gaps = 10/205 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY + TG AIK + + P D + ++QEI +L +H NIV Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAY 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + D L+I +EY GS+ + ++E + R L GLAYLH T IHR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ G VKLADFG++ LT ++ S G+P WMAPEV AV +K G
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-AVERKGGYDGK 184
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSE 565
DIW+LG T IE+ +PP +
Sbjct: 185 C---DIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 2e-52
Identities = 86/225 (38%), Positives = 140/225 (62%), Gaps = 19/225 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIG-TNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGH 412
+W KG+++G+G +G+VY G TN G A+K+V++ + +AE ++L++E+ +L
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIVQY G+ + D+ + I++E+V GSI+ + + E + +T+ IL+G+AY
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWMAP 525
LH+ +HRDIKG N+++ +G++KL DFG A+ L + S+ G+P WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
EVI + G + + DIWS+GCTV EM TGKPP + + ++
Sbjct: 178 EVIN----ESGYGRKS---DIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 82/218 (37%), Positives = 119/218 (54%), Gaps = 16/218 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S +Q+ +LIGRG +G+VY G + TG A+K +++ D ++ +++E+ +L L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD----IQREVALLSQL 56
Query: 414 KH---ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
+ NI +YYGS + L+I +EY GS+ ++ I E + R +L L
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVAL 114
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIK 529
Y+H IHRDIK AN+LV +G VKL DFG+A L S + G+P WMAPEVI
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
D DIWSLG T+ EM TG PP+S+ +
Sbjct: 175 EGKYYD------TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-49
Identities = 84/209 (40%), Positives = 123/209 (58%), Gaps = 14/209 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G+GT+G VY + T AIKE+ + + ++ L +EI + +LKH NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYLHSTNT 478
Y GS+ + I++E V GS++ +R + E + +T+ IL GL YLH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 479 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 536
+HRDIKG N+LV+ SGVVK++DFG +K L G++ + G+ +MAPEVI + G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
P DIWSLGCT++EM TGKPP+ E
Sbjct: 190 AP-----ADIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 9e-49
Identities = 70/217 (32%), Positives = 116/217 (53%), Gaps = 25/217 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG+G+FG VY+ + G +KE+D+ K + E+K+L L H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK---EREDALNEVKILKKLNHPNII 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHST 476
+YY S L I +EY G +++ +++ ++ E + ++ + L YLHS
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQK 534
+HRDIK N+ + ++G+VKL DFG++K L+ + +L ++ G+P +++PE+ +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYYLSPELCQ----- 176
Query: 535 DGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
P K DIWSLGC + E+ T K P FEG
Sbjct: 177 -NKPYNYK----SDIWSLGCVLYELCTLKHP---FEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 75/216 (34%), Positives = 128/216 (59%), Gaps = 15/216 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHL 413
+W KG+ +G G F S Y + +TG A+K+V + + E + + L +EI+++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H +I++ G+ D H +++E++ GS++ + ++ E+++ N+T +L GL+YL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119
Query: 474 HSTNTIHRDIKGANLLVDASG-VVKLADFG----MAKHLTGLS-YELSLKGSPNWMAPEV 527
H IHRD+KGANLL+D++G +++ADFG +A TG ++ L G+ +MAPEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
++ G + D+WS+GC +IEM T KPPW
Sbjct: 180 LR------GEQ-YGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 8e-48
Identities = 78/221 (35%), Positives = 116/221 (52%), Gaps = 19/221 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
++ ++IG GT+G VY +++TG AIK +DII D+ +++++E +L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRKYSN 61
Query: 415 HENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRH 465
H NI +YG DD L++ +E GS+ V R+ + + E + R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMA 524
L GLAYLH IHRDIKG N+L+ + VKL DFG++ L + G+P WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
PEVI A ++ + D+WSLG T IE+ GKPP +
Sbjct: 182 PEVI-ACDEQP-DASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-47
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ GK +G G FG VY GT T A+K + + + E +E ++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKK 57
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H NIV+ G + LYI EY+ G + ++R+H +T + I G+ Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIK 529
L S N +HRD+ N LV + VVK++DFG+++ + Y G WMAPE +K
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
+ K D+WS G + E+ T G+ P+
Sbjct: 178 -------DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
GK +G G FG VY G + A+K + + S + I++ +E +++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H N+V+ G ++ LYI +EY+ G + Y+R++ ++ S + +F I G+ Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVI 528
L S N IHRD+ N LV + VVK++DFG+++ L + K WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY--DDDYYRKRGGKLPIRWMAPESL 175
Query: 529 KAVMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K+G K D+WS G + E+ T G+ P+
Sbjct: 176 -----KEGKFTSK----SDVWSFGVLLWEIFTLGEQPYPG 206
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 23/218 (10%)
Query: 358 KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK +G G FG VY GT A+K + + S + I++ +E +++ L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKL 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAY 472
H NIV+ G ++ L I +EY+ G + Y+R++ ++++ S + +F I G+ Y
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 530
L S N IHRD+ N LV + VVK++DFG+++ L Y G P WMAPE +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL-- 176
Query: 531 VMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K+G K D+WS G + E+ T G+ P+
Sbjct: 177 ---KEGKFTSK----SDVWSFGVLLWEIFTLGEEPYPG 207
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 73/213 (34%), Positives = 118/213 (55%), Gaps = 14/213 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S ++ K++G+G+ G VY ++ TG A+K++ + D E KQL +E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDE---EFRKQLLRELKTLRSC 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ +V+ YG+ + + I LEY+ GS+ +++ I E ++ R IL GL YL
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115
Query: 474 HST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAV 531
H+ + IHRDIK +NLL+++ G VK+ADFG++K L L + G+ +M+PE I+
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ DIWSLG T++E GK P+
Sbjct: 175 -ESYSYAA-----DIWSLGLTLLECALGKFPFL 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 68/216 (31%), Positives = 122/216 (56%), Gaps = 31/216 (14%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHL 413
+K + +G GT+G VY +++TG A+K++ + ++ P + ++ EI +L L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALR----EISLLKEL 55
Query: 414 KHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
KH NIV+ +V+ + LY+ EY + +Y+ + ++ +++++ +L GLA
Sbjct: 56 KHPNIVKLL--DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM------AP 525
Y HS +HRD+K N+L++ GV+KLADFG+A+ ++ + L+ + + AP
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAP 167
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
E++ G+ + AVDIWS+GC EM+TGKP
Sbjct: 168 EILL------GSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 82/211 (38%), Positives = 117/211 (55%), Gaps = 8/211 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY ++ETG A K + I +S E ++ EI +L KH
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV Y + ++ L+I +E+ G+++ + E R +TE +R R +L L +LHS
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+ G VKLADFG+ AK+ + L + G+P WMAPEV+ K
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
D NP A DIWSLG T+IE+ +PP E
Sbjct: 182 D-NPYDYKA-DIWSLGITLIELAQMEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 75/213 (35%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G VY AIK +D+ K + +L +E++ + H N+V+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTI 479
Y S VV D L++ + Y+ GS+ ++ + E+I+ + +L GL YLHS I
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLK---GSPNWMAPEVIKAVMQK 534
HRDIK N+L+ G VK+ADFG++ L G K G+P WMAPEV++ Q
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME---QV 181
Query: 535 DG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
G + K DIWS G T IE+ TG P+S++
Sbjct: 182 HGYDFK----ADIWSFGITAIELATGAAPYSKY 210
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G FG VY G A+K + + + K +E +V+ L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------ITESIVRNFTRHILN 468
N+V+ G ++ LY+ LEY+ G + Y+R+ ++ + +F I
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAP 525
G+ YL S +HRD+ N LV VVK++DFG+++ + Y G WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGVSP 571
E +K + D+WS G + E+ T G P + G+S
Sbjct: 177 ESLK-------DGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSN 213
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 5e-41
Identities = 87/214 (40%), Positives = 117/214 (54%), Gaps = 16/214 (7%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
PKK ++ + + IG+G G+VY + TG AIK++++ PK I EI V+
Sbjct: 17 PKK-KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII----NEILVM 70
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
KH NIV Y S +V D L++ +EY+ GS+ V E C D E + R L L
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQAL 128
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 529
+LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-- 186
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
V +K PK VDIWSLG IEM+ G+PP+
Sbjct: 187 -VTRKAYGPK----VDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY N++TG A+K+ I ++ K I + EIK+L L+H NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 422 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
E+V +Y+ EY+ + + TES ++ + + +L GL YLHS
Sbjct: 64 K--EIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WM-APEVIKAVM 532
+HRDIKG+N+L++ GV+KLADFG+A+ T S + W PE++
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTK---RNSADYTNRVITLWYRPPELLL--- 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G + VD+WS+GC + E+ GKP
Sbjct: 175 ---GATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
IG G G V+ +RETG + A+K+V + + I Q +EIK L +H +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ +EY+ P ++ +R+ R + E+ V+++ R +L G+AY+H+ +H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW-MAPEVIKAVMQKDGNP 538
RD+K ANLL+ A GV+K+ADFG+A+ S + + W APE++ G
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY------GAR 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKP 561
K VD+W++GC E+L G P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 71/215 (33%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ IG+G+FG+V + G KE+D K E +QL E+ +L LKH NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EK-QQLVSEVNILRELKHPNIV 62
Query: 420 QYYGSEVVDDH--LYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 473
+YY + + LYI +EY G I + +E I E + +L L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYEC 121
Query: 474 H-----STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEV 527
H +HRD+K AN+ +DA+ VKL DFG+AK L S+ + G+P +M+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
+ + K DIWSLGC + E+ PP
Sbjct: 182 L---NHMSYDEK----SDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G G +G V N+ TG AIK+ DD + + E+KVL L+HENIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ LY+ EYV ++ + + VR++ +L +AY HS N IH
Sbjct: 65 LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--------WM-APEVIKAV 531
RDIK N+LV SGV+KL DFG A+ L + + W APE++
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRA-------RPASPLTDYVATRWYRAPELLV-- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ VD+W++GC + E+L G+P +
Sbjct: 175 ----GDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G G V +R TG A+K I + A KQ+ +E+ +L IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK---TIRLEINEAI-QKQILRELDILHKCNSPYIVGF 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIH 480
YG+ + + I +EY+ GS+++ ++E I E I+ +L GL YLH IH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K +N+LV++ G +KL DFG++ L S + G+ ++MAPE I+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQG-------NDY 176
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWS 564
++ DIWSLG ++IE+ TG+ P+
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 142 bits (357), Expect = 2e-37
Identities = 75/227 (33%), Positives = 117/227 (51%), Gaps = 20/227 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG VY+ +R+ A+K + ++ +++ +EI++L L H
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKV--LAKKLESKSKEVERFLREIQILASLNH 56
Query: 416 E-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 472
NIV+ Y + LY+ +EYV GS+ +++ ++ES IL+ L Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 473 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYEL-------SLKGSPNWMA 524
LHS IHRDIK N+L+D G VVKL DFG+AK L + G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
PEV+ + + DIWSLG T+ E+LTG PP+ + S
Sbjct: 177 PEVLLGLSLAYASSS----SDIWSLGITLYELLTGLPPFEGEKNSSA 219
|
Length = 384 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 83/206 (40%), Positives = 113/206 (54%), Gaps = 14/206 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG VY G + T AIK +D+ ++ + I+ ++QEI VL I +Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + L+I +EY+ GS ++ + E+ + R IL GL YLHS IHR
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-------QSAY 178
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEF 566
DIWSLG T IE+ G+PP S+
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 73/206 (35%), Positives = 115/206 (55%), Gaps = 18/206 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
K +G G+FG V + ++ +G A+K I K + +KQ+E E ++L ++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALK----ILSKAKIVK-LKQVEHVLNEKRILQSIRHP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V YGS D +LY+ +EYV G + ++R+ E + R + ++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ ++RD+K NLL+D+ G +K+ DFG AK + G +Y L G+P ++APE+I G
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEII----LSKG 174
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPP 562
K AVD W+LG + EML G PP
Sbjct: 175 YGK---AVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 81/212 (38%), Positives = 114/212 (53%), Gaps = 8/212 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ETGA A K ++ KS E ++ EI++L H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNH 68
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
IV+ G+ D L+I +E+ G+++ + E R +TE ++ R +L L YLHS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+ G +KLADFG+ AK++ L S G+P WMAPEV+ K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
D DIWSLG T+IEM +PP E
Sbjct: 189 DT--PYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 83/202 (41%), Positives = 117/202 (57%), Gaps = 11/202 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY N TG AIK + + P E ++QEI ++ KH NIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + D L+I +E+ GS+ + ++ES + +R L GL YLHS +HR
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ +G VKLADFG++ +T ++ S G+P WMAPEV AV +K G +L
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV-AAVERKGGYNQL 189
Query: 541 ALAVDIWSLGCTVIEMLTGKPP 562
DIW++G T IE+ +PP
Sbjct: 190 C---DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 86/206 (41%), Positives = 116/206 (56%), Gaps = 14/206 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG V+ G + T AIK +D+ ++ + I+ ++QEI VL + +Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + D L+I +EY+ GS + D E+ + R IL GL YLHS IHR
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK Q + K
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK- 181
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEF 566
DIWSLG T IE+ G+PP SE
Sbjct: 182 ---ADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 25/208 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIKVLGHLKHE 416
IG G+ G V I T++ TG A+K++D+ KQ L E+ ++ +H
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLR----------KQQRRELLFNEVVIMRDYQHP 76
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NIV+ Y S +V D L++ +E++ G++ V H R + E + +L L++LH+
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQ 134
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKD 535
IHRDIK ++L+ + G VKL+DFG ++ + SL G+P WMAPEVI +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL---- 190
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VDIWSLG VIEM+ G+PP+
Sbjct: 191 ---PYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 83/205 (40%), Positives = 115/205 (56%), Gaps = 14/205 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG V+ G + T AIK +D+ ++ + I+ ++QEI VL + +Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + L+I +EY+ GS +R D E + + IL GL YLHS IHR
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVI+ Q + K
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSK- 181
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSE 565
DIWSLG T IE+ G+PP S+
Sbjct: 182 ---ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 6e-36
Identities = 78/203 (38%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + T AIK++ +S E + + +E++ L L+H N ++Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + L GLAYLHS IHR
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + +S S G+P WMAPEVI A+ Q DG
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGK-- 194
Query: 540 LALAVDIWSLGCTVIEMLTGKPP 562
VD+WSLG T IE+ KPP
Sbjct: 195 ----VDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 82/202 (40%), Positives = 116/202 (57%), Gaps = 11/202 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+G VY N TG A+K + + P D S ++QEI ++ KH NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVAY 71
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + + L+I +EY GS+ + ++E + R L GLAYLHS +HR
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ +G VKLADFG+A +T ++ S G+P WMAPEV AV + G +L
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGGYNQL 189
Query: 541 ALAVDIWSLGCTVIEMLTGKPP 562
DIW++G T IE+ +PP
Sbjct: 190 C---DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHEN 417
+G G FG V + + + A+K V K + + E ++L H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ Y + ++Y+ +EY G + +R+ E R + ++ YLH+
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRG 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
I+RD+K NLL+D++G VKL DFG AK L + G+P ++APE+I K +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL---NKGYD 170
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+VD WSLG + E+LTG+PP+ E
Sbjct: 171 ----FSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 87/226 (38%), Positives = 122/226 (53%), Gaps = 19/226 (8%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
IMEK S K ++ + + IG+G G+V+ + TG AIK++++ PK
Sbjct: 4 IMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKEL 62
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
I EI V+ LK+ NIV + S +V D L++ +EY+ GS+ V E C D E+
Sbjct: 63 II----NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQ 116
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517
+ R L L +LH+ IHRDIK N+L+ G VKL DFG +T S ++
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+P WMAPEV V +K PK VDIWSLG IEM+ G+PP+
Sbjct: 177 GTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ K +G GTFG V++ +R + A+K + I + + + + E +VL +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI--PEVIRLKQEQHVHNEKRVLKEV 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H I++ + +E LY+ +EYV G + Y+R + S + I+ L YL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYL 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS ++RD+K N+L+D G +KL DFG AK L ++ +L G+P ++APEVI Q
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVI----Q 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ K AVD W+LG + EML G PP+
Sbjct: 172 SKGHNK---AVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 69/217 (31%), Positives = 114/217 (52%), Gaps = 32/217 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG G +G V ++ TG AIK++ + DD A K++ +EIK+L HL+HENI+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA---KRILREIKLLRHLRHENII 62
Query: 420 Q-----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
S + +YI E + +++ ++ + +T+ ++ F IL GL YLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------A 524
S N IHRD+K +N+LV+++ +K+ DFG+A+ + E ++ A
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE------KGFLTEYVVTRWYRA 174
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
PE++ + + A+DIWS+GC E+LT KP
Sbjct: 175 PELLLSSSRYT------KAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 84/217 (38%), Positives = 116/217 (53%), Gaps = 15/217 (6%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S K ++ + + IG+G G+VY + TG AI+++++ PK I EI
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII----NEI 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E + R L
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 126
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPE 526
L +LHS IHRDIK N+L+ G VKL DFG +T + S + G+P WMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
V V +K PK VDIWSLG IEM+ G+PP+
Sbjct: 187 V---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 85/217 (39%), Positives = 116/217 (53%), Gaps = 15/217 (6%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S K ++ + + IG+G G+VY + TG AIK++++ PK I EI
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII----NEI 67
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E + R L
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 125
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPE 526
L +LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPE
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
V V +K PK VDIWSLG IEM+ G+PP+
Sbjct: 186 V---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLGHLKHEN 417
+G+G+FG V + ++TG A+K + K ++ + E +L + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ + + ++ LY+ LEY G + ++ + +E R + I+ L YLHS
Sbjct: 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
I+RD+K N+L+DA G +KL DFG+AK L + S + G+P ++APEV+ K
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL---GKGY 170
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPP 562
AVD WSLG + EMLTGKPP
Sbjct: 171 GK----AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 72/215 (33%), Positives = 111/215 (51%), Gaps = 20/215 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAE-CIKQLEQEIKVLGHLKHEN 417
K IG+G F VY G A+K+V I D K+ + C+K EI +L L H N
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLLKQLDHPN 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINR---YVREHCRDITESIVRNFTRHILNGLAYLH 474
+++Y S + ++ L I LE G ++R + ++ R I E + + + + L ++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 533
S +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
++G DIWSLGC + EM + P F G
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 15/211 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK IG GT+G VY ++ TG AIK++ + + K +EIK+L L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57
Query: 416 ENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
NI++ +V LY+ E++ + + +++ R + ES+++++ +L GLA+
Sbjct: 58 PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 532
HS +HRD+K NLL++ GV+KLADFG+A+ + W APE++
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VDIWS+GC E+L+ +P +
Sbjct: 175 GYSTP------VDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 81/203 (39%), Positives = 112/203 (55%), Gaps = 14/203 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY TN T A+K++ ++ E + + +E+K L LKH N ++Y
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q DG
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 200
Query: 540 LALAVDIWSLGCTVIEMLTGKPP 562
VD+WSLG T IE+ KPP
Sbjct: 201 ----VDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 77/212 (36%), Positives = 110/212 (51%), Gaps = 8/212 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ETG A K +D KS E ++ EI +L H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + +++L+I +E+ G+++ + E R +TE +R + L L YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L G +KLADFG+ AK+ + S G+P WMAPEV+ K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
D D+WSLG T+IEM +PP E
Sbjct: 182 D--RPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 80/214 (37%), Positives = 115/214 (53%), Gaps = 21/214 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 418
+++G GT+G VY G + +TG AIK +D+ D+ + +++ EI +L + H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75
Query: 419 VQYYGSEVV------DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
YYG+ + DD L++ +E+ GS+ V+ + E + R IL GLA
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 530
+LH+ IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 531 VMQKDGNPKLALAV--DIWSLGCTVIEMLTGKPP 562
D NP DIWSLG T IEM G PP
Sbjct: 196 ----DENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 77/218 (35%), Positives = 114/218 (52%), Gaps = 41/218 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQEIKVLGHLK 414
K +G GTFGSVY+ N+ETG AIK++ K EC+ +E+K L L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMN--LREVKSLRKLN 55
Query: 415 -HENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 470
H NIV+ EV +D LY EY+ G++ + +++ + +ES++R+ IL GL
Sbjct: 56 EHPNIVKLK--EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSLKGSPNWM- 523
A++H HRD+K NLLV VVK+ADFG+A+ + T Y S W
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--DYV-----STRWYR 165
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ + + VDIW+LGC + E+ T +P
Sbjct: 166 APEILLR------STSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 79/214 (36%), Positives = 116/214 (54%), Gaps = 21/214 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 418
+L+G GT+G VY G + +TG AIK +D+ D+ + +++QEI +L + H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 65
Query: 419 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
YYG+ + +DD L++ +E+ GS+ ++ + E + R IL GL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 530
+LH IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 531 VMQKDGNPKLA--LAVDIWSLGCTVIEMLTGKPP 562
D NP D+WSLG T IEM G PP
Sbjct: 186 ----DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 77/244 (31%), Positives = 115/244 (47%), Gaps = 55/244 (22%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV--------- 409
GK+IG G+F +V + +ET AIK +D +QL +E KV
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDK-----------RQLIKEKKVKYVKIEKEV 54
Query: 410 LGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHIL 467
L L H I++ Y + +++LY LEY G + +Y+R++ D E R + IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD--EKCTRFYAAEIL 112
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---------- 517
L YLHS IHRD+K N+L+D +K+ DFG AK L S S K
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 518 -----------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
G+ +++PE++ +K + D+W+LGC + +MLTGKPP F
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLN---EKPAGK----SSDLWALGCIIYQMLTGKPP---F 222
Query: 567 EGVS 570
G +
Sbjct: 223 RGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQ 420
I +G +G V++ + TG AIK +I + + Q+ E +L + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y S +LY+ +EY+ G + + E+ + E + R + I+ L YLHS IH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 481 RDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLK--------GSPNWMAPEVIKAV 531
RD+K N+L+D++G +KL DFG++K L L+ G+P+++APEVI
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
+ + VD WSLGC + E L G PP
Sbjct: 176 --QGHSK----TVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQ 420
IG+G+FG V+ + A+K++D+ + + E I E +VL L I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTI 479
YY S + L I +EY G +++ ++ R + E V F IL GLA+LHS +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
HRDIK NL +DA VK+ D G+AK L ++ ++ G+P +++PE+ + K N
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE---DKPYNE 180
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
K D+W+LG + E TGK P+
Sbjct: 181 K----SDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 74/229 (32%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
GKL G GTFG VY +TG A+K+ I+ + K I L +EIK+L LKH N+
Sbjct: 14 GKL-GEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITAL-REIKILKKLKHPNV 69
Query: 419 VQY------YGSEVVDDHLYIYLEYVHP-------GSI-NRYVREHCRDITESIVRNFTR 464
V + +Y+ V P G + N V+ +TES ++ +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVK-----LTESQIKCYML 122
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 521
+L G+ YLH + +HRDIK AN+L+D G++K+ADFG+A+ G G
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 522 --------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W PE++ G + AVDIW +GC EM T +P
Sbjct: 183 YTNLVVTRWYRPPELLL------GERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
L+G G++G V ++ETG AIK + K +EI++L L+HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
EV LY+ E+V ++ + ++ + ES VR + IL G+ + HS N
Sbjct: 65 LI--EVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 537
IHRDIK N+LV SGVVKL DFG A+ L + + W APE++ G+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV------GD 175
Query: 538 PKLALAVDIWSLGCTVIEMLTGKP 561
K AVDIW++GC V EMLTG+P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 42/225 (18%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC------IKQLEQEIK 408
+++KGK +G GT+ VY ++ETG AIK+ I + K A+ ++ EIK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALR----EIK 54
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+L LKH NI+ ++ + E++ + + +++ +T + ++++ L
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEV 527
GL YLHS +HRD+K NLL+ + GV+KLADFG+A+ S+ GSPN M +V
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----SF-----GSPNRKMTHQV 163
Query: 528 I----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
+ +A P+L VD+WS+GC E+L P
Sbjct: 164 VTRWYRA-------PELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKE---VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IG+G FG V I R+T A+K + ++ + E ++L L H +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFL 62
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + S ++++Y+ ++ + G + RY +E V+ + I+ L YLHS
Sbjct: 63 VNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
IHRDIK N+L+D G V + DF +A +T + S G+P +MAPEV+ Q
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--QGYS-- 177
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
+AVD WSLG T E L GK P+
Sbjct: 178 ---VAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHE-- 416
K I +G FGSVY+ R TG AIK ++ D + + ++ E ++ ++ E
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIK---VLKKSDMIAKNQVTNVKAERAIM-MIQGESP 57
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + Y S D+LY+ +EY++ G ++ + E + + ++ G+ LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
IHRDIK NLL+D +G +KL DFG+++ GL + G+P+++APE I +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLENK-KFVGTPDYLAPETI---LGVGD 170
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+ D WSLGC + E L G PP F +P
Sbjct: 171 DK----MSDWWSLGCVIFEFLFGYPP---FHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 78/224 (34%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
W+ + IG+GT+G VY TN++ G+ A+K +D I D +++E E +L L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSLPN 77
Query: 415 HENIVQYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHI 466
H N+V++YG D L++ LE + GS+ V+ + E+++
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 525
L GL +LH+ IHRD+KG N+L+ G VKL DFG++ LT + G+P WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
EVI Q D + D+WSLG T IE+ G PP + V
Sbjct: 198 EVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPV 239
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHENI 418
K +G+G++GSVY A+KEVD+ + + + EI++L + H NI
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASVNHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHS 475
+ Y + + + L I +EY G +++ + + + I E + +L GL LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRD+K AN+L+ A+ +VK+ D G++K L + + G+P++MAPEV K
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK------ 174
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
G P + DIWSLGC + EM T PP FE S
Sbjct: 175 GRP-YSYKSDIWSLGCLLYEMATFAPP---FEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 81/211 (38%), Positives = 113/211 (53%), Gaps = 14/211 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + T AIK++ +S E + + +E+K L +KH N ++Y
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 91 KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q DG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 204
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
VD+WSLG T IE+ KPP +S
Sbjct: 205 ----VDVWSLGITCIELAERKPPLFNMNAMS 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 18/221 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
W+ + IG+GT+G V+ N++ G+ A+K +D I D +++E E +L L
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKALSD 73
Query: 415 HENIVQYYG-----SEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHI 466
H N+V++YG D L++ LE + GS+ V+ + + E I+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 525
L GL +LH TIHRD+KG N+L+ G VKL DFG++ LT + G+P WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
EVI Q D D+WSLG T IE+ G PP ++
Sbjct: 194 EVIACEQQLDST--YDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 72/206 (34%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENIVQ 420
IG G++G V+ NRETG AIK+ DDP IK++ +EI++L LKH N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVN 64
Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
EV L++ EY +N + + R + E +++ L + + H N
Sbjct: 65 LI--EVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 537
IHRD+K N+L+ G +KL DFG A+ LTG + + + W APE++ Q G
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY-GP 180
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPW 563
P VD+W++GC E+LTG+P W
Sbjct: 181 P-----VDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 76/203 (37%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + AIK++ +S E + + +E++ L L+H N +QY
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
D+K N+L+ G+VKL DFG A + + G+P WMAPEVI A+ Q DG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK-- 194
Query: 540 LALAVDIWSLGCTVIEMLTGKPP 562
VD+WSLG T IE+ KPP
Sbjct: 195 ----VDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 23/214 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLKHEN 417
+G+G +G V++ ++TG A+K + KS ++ + E +L K E
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V+ + D++LY+ +EYV PG R + + ++E R + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
IHRD+K N L+DASG +KL DFG++K ++Y S+ GSP++MAPEV++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRG------- 172
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
VD WSLGC + E L G PP F G +P
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPP---FSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-31
Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I + +G A+K +D+ + + + L E+ ++ +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V + L++ +E++ G++ V + + E + +L L YLHS IHR
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ G VKL+DFG ++ + SL G+P WMAPEVI
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-------Y 194
Query: 541 ALAVDIWSLGCTVIEMLTGKPPW 563
VDIWSLG VIEM+ G+PP+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 77/216 (35%), Positives = 113/216 (52%), Gaps = 31/216 (14%)
Query: 357 QKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----QEIK 408
+K +++G G FG V Y N TG A+K + EC +Q +EI
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEIN 58
Query: 409 VLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+L L HENIV+Y G SE L + +EYV GS+ Y+ +H ++ + ++ F + I
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQI 116
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG-LSYELSLKG-SPN-W 522
G+AYLHS + IHRD+ N+L+D +VK+ DFG+AK + G Y + G SP W
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
A E +K K + A D+WS G T+ E+LT
Sbjct: 177 YAVECLKEN-------KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 72/203 (35%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I T + TG A+K++D+ + + + L E+ ++ HEN+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V D L++ +E++ G++ V H R + E + +L L+YLH+ IHR
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ + G +KL+DFG ++ + SL G+P WMAPEVI +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-------PY 195
Query: 541 ALAVDIWSLGCTVIEMLTGKPPW 563
VDIWSLG VIEM+ G+PP+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/218 (31%), Positives = 119/218 (54%), Gaps = 32/218 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
+QK + IG GT+G VY ++ TG A+K++ + +D P +A I+ EI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IR----EISLLKE 54
Query: 413 LKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNG 469
L H NIV+ +VV ++ LY+ E++ + +Y+ + +++++ +L G
Sbjct: 55 LNHPNIVRLL--DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WM- 523
+AY HS +HRD+K NLL+D G +KLADFG+A+ ++ + ++ + W
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYR 166
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ G+ + + VDIWS+GC EM+ +P
Sbjct: 167 APEILL------GSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 65/214 (30%), Positives = 115/214 (53%), Gaps = 15/214 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG + E + KEV++ K + EI +L L+H NI+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
YY + D+ L I +EY + G++ ++ VR+ + E +V + I++ ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
+HRDIK N+ + +G++KL DFG++K L + S ++ G+P +M+PE+ + V
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV------ 176
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
K DIW+LGC + E+LT K F+ +P
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLK---RTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 12/208 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++K +++GRG FG V++ + IK+ IP + + + + E +VL L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLS 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
H NI++YY + + D L I +EY G++ Y+++ C + E + +F IL L ++
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 474 HSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
H+ +HRD+K N+L+D VVK+ DFG++K L+ S ++ G+P +++PE+ +
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-- 175
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGK 560
K N K DIW+LGC + E+ + K
Sbjct: 176 -KPYNQK----SDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 76/226 (33%), Positives = 119/226 (52%), Gaps = 23/226 (10%)
Query: 344 MEKPSASP-KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-- 400
KP S K S ++ G+ +G G+FG V I ++ TG AIK + K E +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKM 59
Query: 401 KQLE---QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
KQ++ QE +L L H IV S ++ +Y LE+V G + ++R+ R
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPND 118
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
+ + + ++ YLHS + I+RD+K NLL+D G VK+ DFG AK + ++ +L
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLC 176
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+P ++APEVI Q G+ K AVD W++G + E + G PP+
Sbjct: 177 GTPEYLAPEVI----QSKGHGK---AVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 35/215 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G GSV + TG A+K + P+ + KQ+ +E+++ K IV+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKY 64
Query: 422 YGSEVVDDH---LYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS 475
YG+ +D+ + I +EY GS++ V++ I E ++ +L GL+YLHS
Sbjct: 65 YGA-FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSLKGSPNWMAPEV 527
IHRDIK +N+L+ G VKL DFG +A TG S+ +MAPE
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---------YMAPER 174
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
I+ G P ++ D+WSLG T++E+ + P
Sbjct: 175 IQ------GKP-YSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 76/210 (36%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K IGRG F VY T G A+K+V I + D A+CIK EI +L L H N
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLH 474
+++YY S + D+ L I LE G ++R ++ + R I E V + + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 533
S +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
++G DIWSLGC + EM + P+
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 66/210 (31%), Positives = 116/210 (55%), Gaps = 14/210 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ + +G GT+ +VY G NR TG A+KE+ + ++ + I+ EI ++ LK
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELK 56
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAY 472
HENIV+ + ++ L + EY+ + +Y+ + + V++FT +L G+A+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAV 531
H +HRD+K NLL++ G +KLADFG+A+ S + W AP+V+
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL-- 173
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G+ + ++DIWS+GC + EM+TG+P
Sbjct: 174 ----GSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 7e-29
Identities = 73/213 (34%), Positives = 113/213 (53%), Gaps = 18/213 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG G+FG +Y+ + C IKE+D+ K E K +E+ +L +KH NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
++ S + L+I +EY G + R R+ +E + ++ I GL ++H
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 479 IHRDIKGANLLVDASGVV-KLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQKD 535
+HRDIK N+ + +G+V KL DFG+A+ L S EL+ G+P +++PE+ + +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQ---NRP 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
N K DIWSLGC + E+ T K P FEG
Sbjct: 179 YNNK----TDIWSLGCVLYELCTLKHP---FEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 22/212 (10%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK + IG GT+G VY N+ TG A+K++ + D ++ +EI +L L H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLH 474
NIV+ ++ LY+ E++H + +++ I +++++ +L GLA+ H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------WMAPEVI 528
S +HRD+K NLL++ G +KLADFG+A+ ++ + ++ + + APE++
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
G + AVDIWSLGC EM+T +
Sbjct: 173 L------GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG V++G + E + V + + S + K E+E ++L + +HENIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------------ITESIVRNFTRHI 466
++YG D + EY+ G +N+++R H D +T S + I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NW 522
+G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y + G W
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRW 190
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
M PE ++M + K D+WS G + E+ T GK PW
Sbjct: 191 MPPE---SIMYR----KFTTESDVWSFGVVLWEIFTYGKQPWYG 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 49/221 (22%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
I GT+G VY +++TG A+K++ + + K I L +EI +L L+H NIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTV 69
Query: 422 YGSEVV----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFT--------RHILN 468
EVV D +Y+ +EYV EH + + E++ + F +L+
Sbjct: 70 --KEVVVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGLSYELSLKGSPN 521
G+A+LH +HRD+K +NLL++ G++K+ DFG+A K T L L
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL------- 170
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W APE++ G + + A+D+WS+GC E+LT KP
Sbjct: 171 WYRAPELLL------GAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 360 KLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V + GTN K+V + DD EC +E+ + L +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VEC-TMVERRVLALA-WEH 55
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + +HL+ +EY++ G + +++ E+ R + I+ GL +LH
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK 114
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
I+RD+K N+L+D G +K+ADFGM K ++ G + G+P+++APE++K
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ--- 171
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
K +VD WS G + EML G+ P+
Sbjct: 172 ----KYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 70/203 (34%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I T + +G A+K++D+ + + + L E+ ++ +HEN+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V D L++ +E++ G++ V H R + E + +L L+ LH+ IHR
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ G VKL+DFG ++ + SL G+P WMAPE+I +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-------PY 193
Query: 541 ALAVDIWSLGCTVIEMLTGKPPW 563
VDIWSLG VIEM+ G+PP+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 62/198 (31%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ G IG+G FG V +G R G A+K + DD +A+ E V+ L+H
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQ---AFLAEASVMTTLRHP 60
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHS 475
N+VQ G + + LYI EY+ GS+ Y+R R IT + F + G+ YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVM 532
N +HRD+ N+LV V K++DFG+AK W APE ++
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR--- 172
Query: 533 QKDGNPKLALAVDIWSLG 550
K + D+WS G
Sbjct: 173 ----EKKFSTKSDVWSFG 186
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 39/216 (18%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENI 418
IG GT+G VY G N++TG A+K++ + ++ P +A +EI +L L+H NI
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLKELQHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 476
V + + LY+ E++ + +Y+ + + +V+++ IL G+ + HS
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-----------HLTGLSYELSLKGSPNWMAP 525
+HRD+K NLL+D GV+KLADFG+A+ + L Y AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR----------AP 170
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
EV+ G+P+ + VDIWS+G EM T KP
Sbjct: 171 EVLL------GSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K++G+G+FG V + + T A+K + I+ DD EC E+ + L KH
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECT-MTEKRVLALAG-KHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D L+ +EYV+ G + +++ E R + I+ GL +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 533
I+RD+K N+L+D+ G +K+ADFGM K G+ ++ G+P+++APE++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE--GILGGVTTSTFCGTPDYIAPEILSYQ-- 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
AVD W+LG + EML G+ P FEG
Sbjct: 172 -----PYGPAVDWWALGVLLYEMLAGQSP---FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 69/205 (33%), Positives = 116/205 (56%), Gaps = 9/205 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G +GSVY +R TG + A+KE+ + D+ K + I +L+ +L IV +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST-NT 478
YG+ ++ +Y+ +EY+ GS+++ I E ++R T ++ GL +L N
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
IHRD+K N+LV+ +G VKL DFG++ +L S + G ++MAPE IK + NP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIK-SGGPNQNP 182
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
+ D+WSLG +++EM G+ P+
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ K K IG G+FG + ++E G IKE++I PK E + +E+ VL ++K
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAY 472
H NIVQY S + +LYI ++Y G + + + R + E + ++ I L +
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKH 116
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKA 530
+H +HRDIK N+ + G +KL DFG+A+ L + EL+ G+P +++PE+ +
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICE- 174
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
+ N K DIW+LGC + EM T K
Sbjct: 175 --NRPYNNK----SDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 47/233 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+++K IG+GTFG V+ +++T A+K+ ++ ++ K I L +EIK+L L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITAL-REIKILQLL 68
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY------VREHCR------------DIT 455
KHEN+V +L I + NRY V E C T
Sbjct: 69 KHENVV----------NL-IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
S ++ + +LNGL Y+H +HRD+K AN+L+ G++KLADFG+A+ ++ LS
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-----AFSLS 172
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
PN V+ + P+L L +D+W GC + EM T P
Sbjct: 173 KNSKPNRYTNRVVTLWYRP---PELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 360 KLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K +G G FG V + TG A+K ++ ++ ++ E+EI++L L H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLDH 65
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
ENIV+Y G + L + +EY+ GS+ Y++ H I + F+ I G+ YL
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSYELSLKGSP-NWMAPEVIK 529
S IHRD+ N+LV++ +VK++DFG+AK L Y SP W APE ++
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
K + A D+WS G T+ E+ T
Sbjct: 186 -------TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 72/216 (33%), Positives = 111/216 (51%), Gaps = 17/216 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLG 411
+ +Q K IGRG F VY T A+K+V I D +C+K EI +L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLLK 57
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN---RYVREHCRDITESIVRNFTRHILN 468
L H N+++Y S + D+ L I LE G ++ +Y ++ R I E V + + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEV 527
+ ++HS +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
I ++G DIWSLGC + EM + P+
Sbjct: 178 I----HENG---YNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 92/295 (31%), Positives = 147/295 (49%), Gaps = 33/295 (11%)
Query: 273 SPLPSPPRQSSQSNLRS-PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 331
P P +++ +S PR+ P LPQ L A PLPLPP + S
Sbjct: 6 PPPGVPLPSTARHTTKSRPRRR--PDLTLPLPQRDPSL--------AVPLPLPPPSSSSS 55
Query: 332 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
SS +SA PSA+ S+ ++ IG G G+VY +R TG A+K +
Sbjct: 56 SSSSSSA----SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
+D +Q+ +EI++L + H N+V+ + + + + LE++ GS+ E
Sbjct: 112 ED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGT 162
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GL 510
E + + R IL+G+AYLH + +HRDIK +NLL++++ VK+ADFG+++ L +
Sbjct: 163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222
Query: 511 SYELSLKGSPNWMAPEVIKAVMQK---DGNPKLALAVDIWSLGCTVIEMLTGKPP 562
S G+ +M+PE I + DG A DIWSLG +++E G+ P
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDG-----YAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 74/213 (34%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
+++K + IG GT+G+V+ NRET A+K V + DD P SA +EI +L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLK 54
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
LKH+NIV+ Y D L + EY + +Y + C DI IV++F +L GL
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF-DSCNGDIDPEIVKSFMFQLLKGL 112
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIK 529
A+ HS N +HRD+K NLL++ +G +KLADFG+A+ S + W P+V+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G + ++D+WS GC E+ P
Sbjct: 173 ------GAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 58/251 (23%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-------LEQE 406
++ K+IGRG FG V++ +++TG A+K + + ++ IK+ E++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERD 53
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDITESIVRNFTR 464
I IV+ Y S ++HLY+ +EY+ PG +N +R+ E R +
Sbjct: 54 ILA--DADSPWIVKLYYSFQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIA 108
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLK--- 517
++ L +H IHRDIK N+L+DA G +KLADFG+ K + Y
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 518 -----------------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
G+P+++APEV++ L D WSLG +
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-------PYGLECDWWSLGVILY 221
Query: 555 EMLTGKPPWSE 565
EML G PP+
Sbjct: 222 EMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 38/224 (16%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
+++ IG G +G+VY + TG A+K+V + + P S +EI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 413 LK---HENIVQYYG-SEVVDDH----LYIYLEYVHPGSINRYVREHC--RDITESIVRNF 462
L+ H NIV+ L + E+V + Y+ C + +++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDL 112
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN- 521
R +L G+ +LHS +HRD+K N+LV + G VK+ADFG+A+ S+E++L +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMAL--TSVV 167
Query: 522 ---WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W APEV+ +Q A VD+WS+GC E+ +P
Sbjct: 168 VTLWYRAPEVL---LQS----SYATPVDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 32/211 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
IG G +G V + +G AIK++ D P A K+ +E+K+L H KH+NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNIIAI 69
Query: 420 -QYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHST 476
D +Y+ ++ + ++ + H +TE +R F +L GL Y+HS
Sbjct: 70 RDILRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------APE 526
N IHRD+K +NLLV+ +++ DFGMA+ L+ E +M APE
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-----YFMTEYVATRWYRAPE 181
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
++ ++ P+ A+D+WS+GC EML
Sbjct: 182 LLLSL------PEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 74/232 (31%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQ-- 402
S S + QKG +G GT+G V + TG AIK+V II D K + +
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 403 ----LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
+E+K++ +KHENI+ V D + + ++ + + + V R +TES
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQ 120
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
V+ ILNGL LH +HRD+ AN+ +++ G+ K+ADFG+A+ Y +L
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 519 SPNW-----MAPEVI----KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
M +V+ +A G K AVD+WS+GC E+LTGKP
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 27/218 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++++K IG GT+G VY + +G A+K+V + D+ + I L +EI +L +L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNL 63
Query: 414 KHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+H NIV+ EVV D +++ +EY + + +ES V+ +L G
Sbjct: 64 RHPNIVEL--KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SPN----WM- 523
L YLH IHRD+K +NLL+ G +K+ADFG+A+ +Y L K +P W
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMTPKVVTLWYR 175
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ G A+D+W++GC + E+L KP
Sbjct: 176 APELLL------GCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 65/216 (30%), Positives = 113/216 (52%), Gaps = 26/216 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +G V + +TG AIK++ P +SA K+ +E+++L H+
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71
Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHI 466
HEN++ + + ++D +YL V +N V+ C+ +++ ++ I
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK--CQKLSDDHIQFLVYQI 127
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAP 525
L GL Y+HS IHRD+K +N+ V+ +K+ DFG+A+H E++ + W AP
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAP 184
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
E++ M + VDIWS+GC + E+LTGK
Sbjct: 185 EIMLNWMHYNQ------TVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 23/227 (10%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQE 406
K+++ +K K++G G FG+VY G G AIK + + S + K++ E
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
V+ + H ++V+ G + I + + G + YVR H +I + N+ I
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWM 523
G++YL +HRD+ N+LV VK+ DFG+AK L E +G WM
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGV 569
A E I + D+WS G TV E++T G P +EG+
Sbjct: 179 ALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKP---YEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 36/219 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY +++TG A+K+V + D+ K I + +EIK+L L H NIV
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71
Query: 422 YGSEVVDDH------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
E+V D Y+ EY+ + + +E +++F + +L G
Sbjct: 72 K--EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFMKQLLEG 128
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
L Y H N +HRDIK +N+L++ G +KLADFG+A+ L +VI
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--------LYNSEESRPYTNKVIT 180
Query: 530 AVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
+ P+L L A+D+WS GC + E+ T KP
Sbjct: 181 LWYRP---PELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/223 (29%), Positives = 114/223 (51%), Gaps = 33/223 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ K +G+G +G V N ET + AIK++ + K + L +E+K+L H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRAL-RELKLLRHF 58
Query: 414 K-HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ H+NI Y ++V + LY+Y E + +++ +R +T++ ++F IL
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP-LTDAHFQSFIYQILC 116
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 523
GL Y+HS N +HRD+K NLLV+A +K+ DFG+A+ + + + +M
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAGFMTEYVA 171
Query: 524 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ + A+D+WS+GC + E+L KP
Sbjct: 172 TRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G G+FG + + + A+KE+ + PKS+ ++ +E +L +KH NIV
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ S D HLYI +EY G + + ++ + + E + + + G+ ++H
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGN 537
+HRDIK N+ + +G VKL DFG A+ LT +Y + G+P ++ PE+ + + + +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS 181
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPW 563
DIWSLGC + E+ T K P+
Sbjct: 182 -------DIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 14/210 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G GSV + TG A K V I KS KQ+ +E++++ + IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKS-SVRKQILRELQIMHECRSPYIVSF 68
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-H 480
YG+ + ++++ + +E++ GS++R ++ I I+ ++ GL YL++ + I H
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RDIK +N+LV++ G +KL DFG++ L S + G+ +M+PE I+ K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQG-------GKY 179
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ D+WSLG ++IE+ GK P++
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV 419
IGRG FG+V ++ +G A+K + D+ K K+L ++ V+ IV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQ---KRLLMDLDVVMRSSDCPYIV 66
Query: 420 QYYGS-----------EVVD---DHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
++YG+ E++D D Y +YV E + I E I+
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFY------------KYVYEVLKSVIPEEILGKIAV 114
Query: 465 HILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ L YL IHRD+K +N+L+D +G +KL DFG++ L + G +M
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
APE I + D+WSLG T+ E+ TGK P+ ++ V
Sbjct: 175 APERI----DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE------VAHTLTESRVLQNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS 113
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
+ ++RD+K NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE--- 168
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD W LG + EM+ G+ P+
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/228 (31%), Positives = 116/228 (50%), Gaps = 35/228 (15%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S++ + +G G+ G V+ + + A+K+ I+ DP+S +K +EIK++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQS---VKHALREIKIIRRL 59
Query: 414 KHENIVQYY------GSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITESIV 459
H+NIV+ Y GS++ +D +YI EY+ V E ++E
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL--ANVLEQGP-LSEEHA 116
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAK----HLTGLSYEL 514
R F +L GL Y+HS N +HRD+K AN+ ++ V+K+ DFG+A+ H + Y L
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY-L 175
Query: 515 SLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
S W +P + ++ + K A+D+W+ GC EMLTGKP
Sbjct: 176 SEGLVTKWYRSPRL---LLSPNNYTK---AIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 361 LIGRGTFG--SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
LIG+ V++ ++ T A+K++++ D S E +K L+QEI L+H NI
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
+ Y S +VD LY+ + GS ++ H + + E + + +LN L Y+HS
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----------KGSP------- 520
IHR +K +++L+ G V L+GL Y +S+ P
Sbjct: 122 FIHRSVKASHILLSGDGKV---------VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 521 NWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
W++PEV++ +Q G N K DI+S+G T E+ G P+ +
Sbjct: 173 PWLSPEVLQQNLQ--GYNEK----SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHE 416
L+GRG FG V + + TG A+K + KS E + E+E +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMK------KSVLLAQETVSFFEEERDILSISNSP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS-----INRYVREHCRDITESIVRNFTRHILNGLA 471
I Q + D+LY+ +EY PG +NRY + E + + + ++ +
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEY-QPGGDLLSLLNRYEDQ----FDEDMAQFYLAELVLAIH 116
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIK 529
+H +HRDIK N+L+D +G +KLADFG A LT + G+P+++APEV+
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
M DG + D WSLG EM+ G+ P+ E
Sbjct: 177 T-MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 51/225 (22%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IGRG +G V N ET AIK++ D+ A K+ +EIK+L HL HEN++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVI 67
Query: 420 Q----------------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
Y E++D L+ + S +HC+ F
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS-----DDHCQ--------YFL 114
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+L GL Y+HS N +HRD+K +NLL++A+ +K+ DFG+A+ + ++M
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDFM 165
Query: 524 APEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
V V + P+L L A+D+WS+GC E+L KP
Sbjct: 166 TEYV---VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K++G+G+FG V + + T AIK + I+ DD +C E+ I L KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDC-TMTEKRILALAA-KHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + D L+ +EYV+ G + + + R E R + + L +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G KLADFGM K + + G+P+++APE+++ +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL---- 171
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +VD W+LG + EM+ G+PP+
Sbjct: 172 ---EYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 77/230 (33%), Positives = 110/230 (47%), Gaps = 51/230 (22%)
Query: 362 IGRGTFGSVY--IGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENI 418
IGRGT+G VY N + G AIK+ D + I Q +EI +L LKHEN+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 419 VQYYGSEVVDDH----LYIYLEYV-HP-GSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
V EV +H +Y+ +Y H I ++ R+ R I S+V++ ILNG+
Sbjct: 65 VSL--VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 472 YLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLHS +HRD+K AN+LV GVVK+ D G+A+ + AP
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL---------------FNAP-- 165
Query: 528 IKAVMQKDG--------NPKLAL-------AVDIWSLGCTVIEMLTGKPP 562
+K + D P+L L A+DIW++GC E+LT +P
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+ IG+G FG VY G + A+K + PD K L QE ++L H N
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK-----RKFL-QEAEILKQYDHPN 53
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ G V +YI +E V GS+ ++R+ +T + + G+ YL S N
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQK 534
IHRD+ N LV + V+K++DFGM++ G Y +S LK P W APE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY---- 169
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
+ D+WS G + E + G P+
Sbjct: 170 ---GRYTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/212 (30%), Positives = 116/212 (54%), Gaps = 24/212 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V + + G A+K +V +I DD EC E +VL L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMV---EKRVLA-LAW 53
Query: 416 EN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAY 472
EN + Y + +HL+ +E+++ G + ++++ R D+ + + I+ GL +
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQF 111
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 531
LHS I+RD+K N+++D G +K+ADFGM K ++ G + + G+P+++APE+++ +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
K +VD WS G + EML G+ P+
Sbjct: 172 -------KYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
Q++K + IG GT+G VY +R T + A+K++ + +D P +A +EI +L
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYV------HPGSINRYVREHCRDITESIVRNFTRH 465
++H NIV+ + LY+ EY+ H S + + +++ +
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQ 110
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM- 523
IL G+AY HS +HRD+K NLL+D +KLADFG+A+ + + W
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ G+ + VDIWS+GC EM+ KP
Sbjct: 171 APEILL------GSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLG 411
+++ K +G G +G+V +R TGA AIK++ P +E K+ +E+++L
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69
Query: 412 HLKHENIVQ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
H+KHEN++ + +D YL G+ + +H + ++E ++ +L
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APE 526
GL Y+H+ IHRD+K NL V+ +K+ DFG+A+ E++ W APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---EMTGYVVTRWYRAPE 185
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
VI M VDIWS+GC + EMLTGKP
Sbjct: 186 VILNWMH------YTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 38/225 (16%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q IG G +G V T++ TG AIK+ I P + C + L +EIK+L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-HQTFCQRTL-REIKILRRF 60
Query: 414 KHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
KHENI+ +YI E + + + ++ + ++ ++ F IL
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKT--QHLSNDHIQYFLYQILR 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------- 521
GL Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++ +
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR--------IADPEHDHTGFLTEY 169
Query: 522 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W APE++ + G K A+DIWS+GC + EML+ +P
Sbjct: 170 VATRWYRAPEIM---LNSKGYTK---AIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV---DIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
+GRG FG V + ++TG AIK + DII D+ +S C K++ + +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHPF 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V + +DH+ +EY G + ++ H +E + ++ GL YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDG 536
++RD+K NLL+D G VK+ADFG+ K G S G+P ++APEV+
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT------- 174
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWS 564
AVD W LG + EML G+ P+
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 13/211 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ +G G++ +VY G +R G A+K + + ++ I+ E +L LKH NIV
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + L EY+H + +Y+ +H + VR F +L GLAY+H + +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+K NLL+ G +KLADFG+A+ + S S + W P ++ G
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP--DVLL---GATD 180
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ A+DIW GC IEML G+P F GVS
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPA---FPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
+ + D L +EY + G + ++ RE R TE R + I++ L YLH
Sbjct: 55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 531
S + ++RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-- 168
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD W LG + EM+ G+ P+
Sbjct: 169 -----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 17/214 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
Q +++G G G+VY + T A+K +IP D + E KQ+ E+++L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVK---VIPLD-ITVELQKQIMSELEILYKCD 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
I+ +YG+ V++ + I E++ GS++ Y R I E ++ ++ GL YL
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S +HRD+K +N+LV+ G VKL DFG++ L S + G+ +MAPE I
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISG---- 167
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ + D+WSLG + +E+ G+ P+ + +
Sbjct: 168 ---EQYGIHSDVWSLGISFMELALGRFPYPQIQK 198
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++G+G+FG V + + T AIK + II DD EC +E+ + L K
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECT-MVEKRVLALPG-KPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + ++++ + E + I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+++DA G +K+ADFGM K ++ G + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPY 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
G +VD W+ G + EML G+PP F+G
Sbjct: 179 GK-----SVDWWAFGVLLYEMLAGQPP---FDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
K+IGRG FG V + ++ + A+K + E IK+ + +E ++ H
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAHAN 101
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
E IVQ + + D +LY+ +EY+ G + + + DI E R +T ++ L +H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH 159
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
S IHRD+K N+L+D SG +KLADFG M G+ + G+P++++PEV+K+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS-- 217
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ G+ D WS+G + EML G P+
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++G R AIK ++ + A + +E KV+ L H +V
Sbjct: 10 KELGSGQFGVVHLGKWRAQ-IKVAIKAIN------EGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
Q YG LYI E++ G + Y+R+ +++ ++ + + + G+ YL + I
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 537
HRD+ N LV ++GVVK++DFGM +++ Y S K W PEV
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF------- 175
Query: 538 PKLALAVDIWSLGCTVIEMLT-GKPPW 563
K + D+WS G + E+ T GK P+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 7e-23
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V G R A IKE + D+ +E KV+ L HE
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEK 60
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+VQ YG +YI EY+ G + Y+REH + S + + + G+AYL S
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKD 535
IHRD+ N LVD G VK++DFG+++++ Y S+ K W PEV+
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS---- 176
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
K + D+W+ G + E+ + GK P+ F
Sbjct: 177 ---KFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G+FG V G +G V + D K ++ + +E ++ L HEN++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNT 478
+ YG V+ L + E GS+ +R+ S + ++ I NG+ YL S
Sbjct: 60 RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSY--ELSLKGSPNWMAPEVIKAVMQK 534
IHRD+ N+L+ + VK+ DFG+ + L Y E LK W APE ++
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR--- 175
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ A D+W G T+ EM T G+ PW
Sbjct: 176 ----TFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-23
Identities = 63/210 (30%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V++ + T AIK +V ++ DD EC +E+ + L +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VEC-TMVEKRVLSLA-WEH 55
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLH 474
+ Y + ++L+ +EY++ G + +++ H D+ + + I+ GL +LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLH 113
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
S ++RD+K N+L+D G +K+ADFGM K ++ G + + G+P+++APE++ + Q
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL--LGQ 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
K +VD WS G + EML G+ P+
Sbjct: 172 KYNT-----SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+++G+G+FG V + +E+G A+K + D+I D EC E+ I L H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 57
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Q Y D L+ +E+V+ G + ++++ R E+ R + I + L +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D G KLADFGM K G + + G+P+++APE+++ ++
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEML--- 172
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+VD W++G + EML G P+
Sbjct: 173 ----YGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 360 KLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHL 413
+ +G G+FG V + T + E AIK + ++ IKQ + E K+L ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKILNYI 88
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H V YGS + +LY+ LE+V G ++R + R + + I+ YL
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYL 147
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
S N ++RD+K NLL+D G +K+ DFG AK + +Y +L G+P ++APE++ V
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNV-- 203
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ K A D W+LG + E+L G PP+
Sbjct: 204 --GHGK---AADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
K+IG+G+FG V + ++ G A+K + K A K+ ++ I +L ++K
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVK 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
H +V + S D LY L+YV+ G + ++ RE R E R + I + L YL
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYL 112
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVM 532
HS N I+RD+K N+L+D+ G V L DFG+ K + + G+P ++APEV++
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR--- 169
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
K + VD W LG + EML G PP+
Sbjct: 170 -KQPYDR---TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGHLKHE 416
+G G FG V Y TG A+K + P+S I L++EI++L +L HE
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 66
Query: 417 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
NIV+Y G +E + + + +E++ GS+ Y+ + I + I G+ YL
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN-WMAPEVIKA 530
S +HRD+ N+LV++ VK+ DFG+ K + ++K SP W APE +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL-- 184
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT 558
+Q K +A D+WS G T+ E+LT
Sbjct: 185 -IQS----KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 29/227 (12%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
SP KS ++ G +IG G+FG VY +T AIK+V DP+ +E+ +
Sbjct: 63 SPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKN------RELLI 112
Query: 410 LGHLKHENIV---QYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCRD---ITESI 458
+ +L H NI+ YY +E + L + +E++ P ++++Y++ + R+ + +
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFL 171
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLK 517
V+ ++ + LAY+HS HRD+K NLL+D + +KL DFG AK+L +S
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
S + APE++ G +D+WSLGC + EM+ G P +S
Sbjct: 232 CSRFYRAPELML------GATNYTTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 362 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G G FG V++ + A+K + D+ + K +E ++L +L+HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQHE 67
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 464
+IV++YG V D L + EY+ G +N+++R H D +T+S + + +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 520
I G+ YL S + +HRD+ N LV + +VK+ DFGM++ + Y + G
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 186
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
WM PE ++M + K D+WSLG + E+ T GK PW +
Sbjct: 187 RWMPPE---SIMYR----KFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 38/225 (16%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLGHLKHE-- 416
IG GT G VY ++TG A+K++ ++ E K++ ++ V+ H+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQM------RRTGNKEENKRILMDLDVV-LKSHDCP 74
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRHIL 467
IV+ YG + D ++I +E + C D I E I+ T I+
Sbjct: 75 YIVKCYGYFITDSDVFICME----------LMSTCLDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 468 NGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L YL IHRD+K +N+L+DASG VKL DFG++ L + G +MAPE
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFE 567
I D NPK + D+WSLG +++E+ TG+ P+ +EFE
Sbjct: 185 RIDP---PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 12/211 (5%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G++ +VY G ++ TG A+KE+ + ++ I+ E +L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + L + EY+ + +Y+ + ++ VR F +L GLA
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 530
Y H +HRD+K NLL+ G +KLADFG+A+ + S S + W P+V+
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G+ + + ++D+W +GC EM TG+P
Sbjct: 177 -----GSTEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 359 GKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G FG V++G + A I+E + DD +E KV+ L H
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59
Query: 417 NIVQYYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
N+VQ YG V ++I EY+ G + Y+RE + + + + + YL
Sbjct: 60 NLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVM 532
S IHRD+ N LV VVK++DFG+A+++ Y S K W PEV
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD--- 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
+ + D+WS G + E+ + GK P+ F
Sbjct: 175 ----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 45/216 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 420
+G G FG V ++ TG + AIK+ I + K+ +E+K+L HL+HENI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKK---IMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 421 -----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
Y+ +E++ L+ L R + + ++ F IL G
Sbjct: 75 SDIFISPLEDIYFVTELLGTDLHRLLT--------------SRPLEKQFIQYFLYQILRG 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLKGSPNWMAP 525
L Y+HS +HRD+K +N+L++ + +K+ DFG+A+ +TG + + AP
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV------STRYYRAP 174
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
E++ QK + VDIWS GC EML GKP
Sbjct: 175 EIM-LTWQKYD-----VEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 362 IGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEI----KVLGHLK 414
+G G FGSV G A+K + E I ++E V+ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H IV+ G + L + +E G + +Y+++ R+I S ++ + G+AYL
Sbjct: 55 HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGS--P-NWMAPEVIKA 530
S + +HRD+ N+L+ K++DFGM++ L G Y + P W APE I
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGV 569
K + D+WS G T+ E + G P+ E +G
Sbjct: 173 G-------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-22
Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENI 418
K +G G +GSV ++ TG AIK++ P +E K+ +E+ +L H++HEN+
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 419 V---QYYGSEVVDDHLY-IYLEYVHPGSINRYVREHCRDI-----TESIVRNFTRHILNG 469
+ + S V D YL V P Y++ + I +E V+ +L G
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYL--VMP-----YMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVI 528
L Y+HS IHRD+K NL V+ +K+ DFG+A+H E++ W APEVI
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVI 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
M + VDIWS+GC + EMLTGK
Sbjct: 187 LNWMHYNQ------TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G++G V + +R G IK++++ S K EQE ++L LKH NIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 420 QYYGS-EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
Y S E D LYI + + G + ++E + + E+ V + I L YLH +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+ + + ++K+ D G+A+ L ++ +L G+P +M+PE+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFS------ 175
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGK 560
N D+W+LGC V EM T K
Sbjct: 176 -NKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 49/235 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
+G G FG V++ A C +++P+ K +K L ++E ++L
Sbjct: 13 LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--------------CRDITE 456
L+H++IV++YG L + EY+ G +NR++R H +T
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ I +G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y +
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 180
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
G WM PE +++ + K DIWS G + E+ T GK PW +
Sbjct: 181 GGRTMLPIRWMPPE---SILYR----KFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 65/213 (30%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + +TG A+K++ P +S K+ +E+++L H+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHM 73
Query: 414 KHENIVQ----YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
KHEN++ + + +++ +YL ++ +N V+ C+ +T+ V+ IL
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 131
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 527
GL Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEI 188
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
+ M + VDIWS+GC + E+LTG+
Sbjct: 189 MLNWMHYN------QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLEQEIK 408
++K + IG GT+G VY ++ TG A+K+ + D+ P +A ++ L + I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRH 465
++ L E++ + G LY+ EY+ ++ R R + +++F
Sbjct: 63 IVRLLDVEHVEEKNGKPS----LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 521
+L G+A+ H +HRD+K NLLVD G++K+AD G+ + + + +K +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIV 173
Query: 522 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ APEV+ G+ + VDIWS+GC EM +P
Sbjct: 174 TLWYRAPEVLL------GSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 360 KLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ +G+G FGSV Y TG A+K++ +AE ++ E+EI++L L+H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+NIV+Y G +L + +EY+ GS+ Y+++H + + + I G+ YL
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP-NWMAPEVIK 529
S +HRD+ N+LV++ VK+ DFG+ K L Y++ G SP W APE +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF 566
K ++A D+WS G + E+ T P +EF
Sbjct: 185 -------ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + +G A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE------VAHTLTESRVLKNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EYV+ G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS 113
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQK 534
++RD+K NL++D G +K+ DFG+ K +T + + G+P ++APEV++
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE----- 168
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD W LG + EM+ G+ P+
Sbjct: 169 --DNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 18/209 (8%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
+K +G G G V +R +G A K + +I P Q+ +E+KVL
Sbjct: 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECN 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV +YG+ D + I +E++ GS+++ +++ R I E+I+ + +L GL YL
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLR 116
Query: 475 STNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ---- 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G + DIWSLG +++EM G+ P
Sbjct: 172 --GT-HYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+ IG G FG VY G + A+K P E + QE ++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVRE---KFLQEAYIMRQFDH 66
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+IV+ G + ++ ++I +E G + Y++ + + + + ++ + LAYL S
Sbjct: 67 PHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQ 533
+HRDI N+LV + VKL DFG++++L SY + KG P WMAPE I
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--- 182
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ A D+W G + E+L G P+
Sbjct: 183 ----RRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+ +V+ G ++ T A+KE+ + ++ I+ E+ +L +LKH NIV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIH 480
+ + L + EY+ + +Y+ ++C ++ + V+ F +L GL+Y H +H
Sbjct: 69 HDIIHTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K NLL++ G +KLADFG+A+ + + S + W P + G+ +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-----GSTEY 181
Query: 541 ALAVDIWSLGCTVIEMLTGKP 561
+ +D+W +GC + EM TG+P
Sbjct: 182 STPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 70/239 (29%), Positives = 113/239 (47%), Gaps = 51/239 (21%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQ---EIKVLGHLKH 415
KLI G +G+VY+ ++ET A+K+++ K ++ Q++Q E +L ++
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-------VRNFTRHILN 468
+V + S HL + +EYV G C + ++I R + +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGD--------CATLLKNIGALPVDMARMYFAETVL 112
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLK------- 517
L YLH+ +HRD+K NLL+ + G +KL DFG++K LT YE ++
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 518 -----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
G+P ++APEVI + Q G P VD W++G + E L G P F G +P
Sbjct: 173 DKQVCGTPEYIAPEVI--LRQGYGKP-----VDWWAMGIILYEFLVGCVP---FFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+ +VY G ++ T A+KE+ + ++ I+ E+ +L LKH NIV
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+ + L + EY+ + +Y+ + I V+ F +L GL Y H +HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541
D+K NLL++ G +KLADFG+A+ + + S + W P I G+ +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-----GSTDYS 183
Query: 542 LAVDIWSLGCTVIEMLTGKP--PWSEFE 567
+D+W +GC EM TG+P P S E
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 419
+G+G +G V+ +R T A+K++ D + + + EI L L H NIV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70
Query: 420 QYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLHST 476
+ ++ IYL EY+ ++ +R +I E + + + +L L Y+HS
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMET-DLHAVIR---ANILEDVHKRYIMYQLLKALKYIHSG 126
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--------NWM-APEV 527
N IHRD+K +N+L+++ VKLADFG+A+ L+ L +P W APE+
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP---ENPVLTDYVATRWYRAPEI 183
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ G+ + VD+WS+GC + EML GKP F G S
Sbjct: 184 LL------GSTRYTKGVDMWSVGCILGEMLLGKP---LFPGTS 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 10/208 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K + +G G++ +VY G ++ G A+K + + ++ I+ E +L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + + L + EYVH + +Y+ +H + V+ F +L GL+
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y+H +HRD+K NLL+ +G +KLADFG+A+ + S+ S + W P +
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL- 176
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTG 559
G+ + + +D+W +GC +EM+ G
Sbjct: 177 ----GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLK 414
K K+IG G FG V+ G + G KEV + K KQ + E ++G
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NI++ G I EY+ G++++Y+R+H + + + R I G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSP-NWMAPEVIKA 530
N +HRD+ N+LV+++ K++DFG+++ L +Y S P W APE I
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI-- 182
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K A D+WS G + E+++ G+ P+ +
Sbjct: 183 -----AYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG V++ N + V + D +A K ++E ++L +L+HE+IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 464
++YG D L + EY+ G +N+++R H D + S + +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 520
I +G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y + G
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 189
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WM PE ++M + K D+WS G + E+ T GK PW
Sbjct: 190 RWMPPE---SIMYR----KFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----EIKVL-GHL 413
K+IG+G+FG V + + G+ A+K + + +K+ EQ E VL +L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVL-------QKKTILKKKEQNHIMAERNVLLKNL 53
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 472
KH +V + S + LY L+YV+ G + ++ RE C E R + + + + Y
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGY 111
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 529
LHS N I+RD+K N+L+D+ G V L DFG+ K G+ E + G+P ++APEV++
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLR 169
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VD W LG + EML G PP+
Sbjct: 170 -------KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 10/210 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K + K + +G GT+ +V+ G ++ T A+KE+ + ++ I+ E+ +L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLK 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + D L + EY+ + +Y+ + ++ V+ F IL GLA
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y H +HRD+K NLL++ G +KLADFG+A+ + + S + W P +
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL- 177
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G+ + + +D+W +GC EM +G+P
Sbjct: 178 ----GSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G FG V +G R G A+K I +D + + E V+ L+H N+VQ
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLA----EASVMTQLRHSNLVQL 64
Query: 422 YGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTI 479
G V + LYI EY+ GS+ Y+R R + + F+ + + YL + N +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+ N+LV V K++DFG+ K + S + + K W APE ++ K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKK 175
Query: 540 LALAVDIWSLGCTVIEMLT-GKPPW 563
+ D+WS G + E+ + G+ P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQ 420
+GRG +G V + TG A+K I S E K+L ++ + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKR---IRATVNSQE-QKRLLMDLDISMRSVDCPYTVT 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 476
+YG+ + ++I +E V S++++ V + I E I+ I+ L YLHS
Sbjct: 65 FYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ IHRD+K +N+L++ +G VKL DFG++ +L + G +MAPE I +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP----EL 179
Query: 537 NPK-LALAVDIWSLGCTVIEMLTGKPPW 563
N K + D+WSLG T+IE+ TG+ P+
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V + TG A K++D + E + E++I + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ D L + + ++ G + ++ E+ + I+ GL +LH ++
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+D G V+++D G+A L G G+P +MAPEV++
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-------GEVY 171
Query: 541 ALAVDIWSLGCTVIEMLTGKPPW 563
+VD ++LGCT+ EM+ G+ P+
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
K+IGRG FG V + ++ + A+K + E IK+ + +E ++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+VQ + + D +LY+ +EY+ G + + + D+ E + +T ++ L +H
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH 159
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
S IHRD+K N+L+D G +KLADFG M TG+ + G+P++++PEV+K+
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS-- 217
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ G+ D WS+G + EML G P+
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLG 411
+ + + +G G FG V++GT T A+K + K + QE +++
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL-------KPGTMSPEAFLQEAQIMK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGL 470
L+H+ +VQ Y ++ +YI EY+ GS+ +++ + + + + I G+
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 528
AYL S N IHRD+ N+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + D+WS G + E++T G+ P+
Sbjct: 177 NY-------GRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVL-GHLKHE 416
K+IG+G+FG V + + G A+K + I+ + + K + E VL ++KH
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ----KHIMAERNVLLKNVKHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + S + LY L++V+ G + +++ R E R + I + L YLHS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKD 535
N ++RD+K N+L+D+ G V L DFG+ K S + G+P ++APEVI+ Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--QPY 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
N VD W LG + EML G PP+
Sbjct: 174 DN-----TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QE 406
K ++ K+IGRG FG V + ++ T A+K + E IK+ + +E
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 93
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
++ +VQ + + D +LY+ +EY+ G + + + D+ E R +T +
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 151
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMA 524
+ L +HS IHRD+K N+L+D SG +KLADFG M + G+ + G+P++++
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
PEV+K+ + G+ D WS+G + EML G P+
Sbjct: 212 PEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G+G+FG VY G + E AIK V+ ++ E I+ L E V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL-NEASVMKEFNCH 69
Query: 417 NIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRH 465
++V+ G VV + +E + G + Y+R + T
Sbjct: 70 HVVRLLG--VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS-P-NW 522
I +G+AYL + +HRD+ N +V VK+ DFGM + + Y KG P W
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
MAPE + KDG D+WS G + EM T
Sbjct: 188 MAPESL-----KDG--VFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 16/201 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
+G+G+FG+VY+ +++ A +K + IP + E + Q QE ++L L H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKLDHPAIVK 66
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTN 477
++ S + D I EY ++ + E ++E+ V + +L G+ Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+ + + ++K+ DFG+++ L G S +L + G+P +M+PE +K +
Sbjct: 127 ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALK---HQG 181
Query: 536 GNPKLALAVDIWSLGCTVIEM 556
+ K DIWSLGC + EM
Sbjct: 182 YDSK----SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 56/225 (24%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G FG V+ T+ G A+K++ + + S K++ +E+K+L KH+N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE--------SIVRN----------FT 463
L+ + P I+ + E +TE IV F
Sbjct: 65 -------------LDILQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA--------KHLTGLSYELS 515
IL GL YLHS +HRDIK NLLV+++ V+K+ DFG+A KH+T E+
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT---QEVV 166
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
+ + APE++ G+ AVDIWS+GC E+L +
Sbjct: 167 ---TQYYRAPEILM------GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
K+IG+G+FG V + ++ A+K + K A K+ E+ I +L ++K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQ------KKAILKKKEEKHIMSERNVLLKNVK 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
H +V + S D LY L+Y++ G + ++ RE C E R + I + L YL
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 112
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVM 532
HS N ++RD+K N+L+D+ G + L DFG+ K ++ + G+P ++APEV+
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH--- 169
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VD W LG + EML G PP+
Sbjct: 170 ----KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVL 410
+ ++ + +G G FG V+ G + AIK I+ KS + +KQ ++E++ L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNR-VRVAIK---IL----KSDDLLKQQDFQKEVQAL 56
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNG 469
L+H++++ + V + +YI E + GS+ ++R + + + + + + G
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP-NWMAPEVI 528
+AYL N+IHRD+ N+LV V K+ADFG+A+ + Y S K P W APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGVS 570
+ + D+WS G + EM T G+ P + G++
Sbjct: 177 -------SHGTFSTKSDVWSFGILLYEMFTYGQVP---YPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++G+G+FG V + + T AIK + +I DD EC +E+ + L K
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVEC-TMVEKRVLALSG-KPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + +++ R E + I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQK 534
I+RD+K N+++D+ G +K+ADFGM K G++ + + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIA--YQP 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
G +VD W+ G + EML G+ P FEG
Sbjct: 178 YGK-----SVDWWAFGVLLYEMLAGQAP---FEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 20/217 (9%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P++S + KL G+G FG V++GT T AIK + P++ QE +V+
Sbjct: 4 PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVM 55
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNG 469
L+HE +VQ Y + V ++ +YI EY+ GS+ +++ E + + + + I +G
Sbjct: 56 KKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEV 527
+AY+ N +HRD++ AN+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE- 173
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A + + + D+WS G + E+ T G+ P+
Sbjct: 174 --AALYG----RFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLK 414
+++G G +G V++ + G A+K + I K+AE + E +VL ++
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVR 62
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLA 471
+V + + D L++ L+YV+ G + + Y REH TES VR + I+ L
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALD 119
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIK 529
+LH I+RDIK N+L+D+ G V L DFG++K E S G+ +MAPEVI+
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ AVD WSLG E+LTG P++
Sbjct: 180 G-----GSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ G++IG G FG+V G TG A+K + K + +E V+ L
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKL 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAY 472
H+N+V+ G ++ + LYI +E + G++ ++R R + I + F+ + G+ Y
Sbjct: 57 HHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGL-SYELSLKGSPNWMAPEVIKA 530
L S +HRD+ N+LV GV K++DFG+A+ G+ + +L +K W APE +K
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALK- 170
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ K + D+WS G + E+ + G+ P+
Sbjct: 171 ------HKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGAS-CAIKEVDII-PDDPKSA----ECIKQLEQEIKVLG-HL 413
+G G FG VY + G + A+KE+++ P K + I + E+ ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
+H NIV+YY + + +D LYI ++ + + + ++E + TE + N ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 471 AYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
YLH I HRD+ N+++ V + DFG+AK S S+ G+ + PE++K
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
N D+W+ GC + +M T +PP+
Sbjct: 187 -------NEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K KL G G +G VY G ++ + A+K + D + +++ +E V+ +KH
Sbjct: 11 KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLH 474
N+VQ G + YI E++ G++ Y+RE R ++V + I + + YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVM 532
N IHRD+ N LV + +VK+ADFG+++ +TG +Y K W APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL---- 177
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
K ++ D+W+ G + E+ T G P+
Sbjct: 178 ---AYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV + D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRVLQNSRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS 113
Query: 476 T-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 531
N ++RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLE-- 169
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD W LG + EM+ G+ P+
Sbjct: 170 -----DNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+L+G+G FG V+ GT ++ A+K + +P + K IK L E ++L H NI
Sbjct: 1 ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELK----IKFL-SEARILKQYDHPNI 54
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G +YI +E V G ++R+ ++ + F G+AYL S N
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSP-NWMAPEVIKAVMQKDG 536
IHRD+ N LV + V+K++DFGM++ Y S LK P W APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY------ 168
Query: 537 NPKLALAVDIWSLGCTVIEMLT 558
+ + D+WS G + E +
Sbjct: 169 -GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G FG V++G E AIK + + A + +E +V+ L H +VQ
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YG + + E++ G ++ Y+R ++ + + G+AYL S+N IHR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPK 539
D+ N LV + VVK++DFGM + + Y S K W +PEV K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-------SK 177
Query: 540 LALAVDIWSLGCTVIEMLT-GKPPW 563
+ D+WS G + E+ + GK P+
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASC---AIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHL 413
K+IG G FG V G + G AIK + K+ KQ E ++G
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-------KAGSSDKQRLDFLTEASIMGQF 62
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H NI++ G + I EY+ GS+++++RE+ T + R I +G+ YL
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG--SP-NWMAPEVIKA 530
N +HRD+ N+LV+++ V K++DFG+++ L + KG P W APE I
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI-- 180
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWS 564
K A D+WS G + E+++ +P W
Sbjct: 181 -----AYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++G+G+FG V + + T AIK + +I DD EC E +VL K
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMV---EKRVLALQDKPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + ++++ + E + I GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRR 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+++D+ G +K+ADFGM K H+ + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPY 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G +VD W+ G + EML G+PP+
Sbjct: 179 G-----KSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 72/257 (28%), Positives = 114/257 (44%), Gaps = 79/257 (30%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 417
K+IGRG FG V + ++TG A+K++ + +E +++ EQ + H++ E
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEK-EQ----VAHVRAERDI 54
Query: 418 --------IVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDI-TESIVRNFTRHI 466
+V+ Y S +++LY+ +EY+ PG + ++ +D TE R +
Sbjct: 55 LAEADNPWVVKLYYSFQDENYLYLIMEYL-PGGDMMTLLMK---KDTFTEEETRFYIAET 110
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-----HLT------------- 508
+ + +H IHRDIK NLL+DA G +KL+DFG+ H T
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 509 -----------------------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
L+Y S G+P+++APEV +Q N D
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAY--STVGTPDYIAPEVF---LQTGYNK----ECD 221
Query: 546 IWSLGCTVIEMLTGKPP 562
WSLG + EML G PP
Sbjct: 222 WWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 36/235 (15%)
Query: 359 GKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPK-----------SAECIKQLEQE 406
+ +G G FG V++ S + D P S + +E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----------CRDITE 456
+K+L L NI + G VD L + +EY+ G +N+++++H + ++
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
S + I +G+ YL S N +HRD+ N LV + +K+ADFGM+++L Y +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRV 188
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE 565
+G WMA E +V+ K D+W+ G T+ E+LT + P+
Sbjct: 189 QGRAPLPIRWMAWE---SVLLG----KFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G G +G V ++ET AIK+ D ++ E + +E+K+L LK ENIV+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ LY+ EYV + + E + VR++ ++ + + H + +H
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWM-APEVIKAVMQKDGNP 538
RDIK NLL+ + V+KL DFG A++L+ G + + + W +PE++ G P
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL------GAP 177
Query: 539 KLALAVDIWSLGCTVIEMLTGKP 561
AVD+WS+GC + E+ G+P
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V+ G N T A+K + DPK E +++ L+H +
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPK------DFLAEAQIMKKLRHPKL 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
+Q Y +++ +YI E + GS+ Y++ R + + + + +G+AYL + N
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKD 535
IHRD+ N+LV + + K+ADFG+A+ + YE K W APE
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY----- 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
+ ++ D+WS G + E++T G+ P+
Sbjct: 179 --NRFSIKSDVWSFGILLTEIVTYGRMPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 43/239 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
+ + GK +G G FG V N ++ A+K + + ++ + ++E
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM- 68
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------CRDIT 455
+K++G KH+NI+ G + LY+ +EY G++ ++R R
Sbjct: 69 MKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 456 ESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
E++ + +F + G+ +L S IHRD+ N+LV V+K+ADFG+A+ + +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 512 Y-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561
Y L +K WMAPE + + D+WS G + E+ T G P
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
E P + + GK +G G FG V +G +++ V ++ DD +
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
+ + ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R E+
Sbjct: 66 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 451 CRDITE--------SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
DI + + T + G+ YL S IHRD+ N+LV + V+K+ADFG
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 503 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
+A+ + + Y K + N WMAPE + + + D+WS G + E+
Sbjct: 183 LARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 232
Query: 557 LT-GKPPW 563
T G P+
Sbjct: 233 FTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQ 420
IG GTF V +R+TG AIK + KS E + L +EI+ L L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKC---MKKHFKSLEQVNNL-REIQALRRLSPHPNILR 62
Query: 421 YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
EV+ D L V ++ ++ R + E V+++ +L L ++H
Sbjct: 63 LI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM-APEVIKAVMQKD 535
HRDIK N+L+ ++KLADFG + + Y + S W APE + D
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYI--STRWYRAPE----CLLTD 173
Query: 536 G--NPKLALAVDIWSLGCTVIEMLTGKP 561
G PK +DIW++GC E+L+ P
Sbjct: 174 GYYGPK----MDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G+G +G V+ T +TG A+K + I+ + +A + E +L +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA----HTKAERNILEAV 57
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 472
KH IV + LY+ LEY+ G + ++ RE E + I L +
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEH 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 531
LH I+RD+K N+L+DA G VKL DFG+ K + + + G+ +MAPE++
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL--- 172
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ G+ K AVD WSLG + +MLTG PP++
Sbjct: 173 -MRSGHGK---AVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++IGRG++ V + ++T A+K V +++ DD E I ++ E V H
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D+ G +KL D+GM K L + G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+VD W+LG + EM+ G+ P+
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 38/235 (16%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYI------------GTNRETGASCAIKEVDIIPDDPKSAE 398
P++ K KL G G FG V++ G G + + D K+A
Sbjct: 3 PRQQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--RE------H 450
+EIK++ LK+ NI++ G V DD L + EY+ G +N+++ RE H
Sbjct: 62 --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 451 CRDITESIVRNF---TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
+I + N I +G+ YL S N +HRD+ N LV +K+ADFGM+++L
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 508 TGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
Y ++G WMA E I K A D+W+ G T+ EM T
Sbjct: 180 YSGDY-YRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 13/215 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ ++ K++G G FG+VY G G + I I ++ + + E ++
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ H ++V+ G + + + + + G + YV EH +I ++ N+ I G+
Sbjct: 65 SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV + VK+ DFG+A+ L G E + G WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561
K D+WS G T+ E++T GKP
Sbjct: 184 HY-------RKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
++IG+G++G V + TG AIK+++ + + A I + EIK+L L+H +IV
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIV 62
Query: 420 QYYG-------SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+ E D +Y+ E + S V + D+T + F +L L Y
Sbjct: 63 EIKHIMLPPSRREFKD--IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------- 521
+H+ N HRD+K N+L +A +K+ DFG+A+ ++ +P
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--------VAFNDTPTAIFWTDYVATR 170
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ APE+ + K A+DIWS+GC E+LTGKP
Sbjct: 171 WYRAPELCGSFFSK-----YTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 50/239 (20%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+G G V++ + TG A+K +D +I + +K++ E ++L L H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEILATLDHP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 473
+ Y S + +L + ++Y G + R ++ C ++E + R + +L L YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYL 119
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPN--------- 521
H ++RD+K N+L+ SG + L+DF ++K + KGS
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 522 ------------------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
++APEVI DG+ AVD W+LG + EML G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISG----DGH---GSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 24/216 (11%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G G +G V++ T +TG A+K + ++ + A+ ++ E VL H+
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHV 61
Query: 414 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 470
+ +V + + + L++ L+YV G + + Y R++ +E VR ++ I+ L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILAL 118
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 528
+LH ++RDIK N+L+D+ G V L DFG++K E S G+ +MAPE+I
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ K G+ K AVD WSLG + E+LTG P++
Sbjct: 179 RG---KGGHGK---AVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 360 KLIGRGTFGSVYIGTNRE-----TGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+G G FG VY GT + +G A+K + D + E +K E ++ +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK----EAHLMSNF 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR------HIL 467
H NIV+ G ++++ YI +E + G + Y+R+ + + +
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 468 NGLAYLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSY---ELSLKGS 519
G YL + IHRD+ N LV DA VVK+ DFG+A+ + Y E
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WMAPE + DG K D+WS G + E+LT G+ P+
Sbjct: 177 VRWMAPESL-----LDG--KFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 61/214 (28%), Positives = 114/214 (53%), Gaps = 19/214 (8%)
Query: 360 KLIGRGTFGSVYIG---TNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G G +G V++ + ++G A +K+ I+ + A+ + E +VL H+
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHI 61
Query: 414 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+ +V + + D L++ L+Y++ G + ++ + R E V+ ++ I+ L +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEH 120
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKA 530
LH I+RDIK N+L+D++G V L DFG++K E S G+ +MAP++++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ K AVD WS+G + E+LTG P++
Sbjct: 181 --GDGGHDK---AVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++GT A+K + P+S +E +++ L+H+ +V
Sbjct: 12 KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPES------FLEEAQIMKKLRHDKLV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 478
Q Y + V ++ +YI EY+ GS+ ++++ R + + + + G+AY+ N
Sbjct: 65 QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDG 536
IHRD++ AN+LV V K+ADFG+A+ + Y K W APE A +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG-- 178
Query: 537 NPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + D+WS G + E++T G+ P+
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 23/232 (9%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
P+ P +W GK +G G FG V T S A+ +V + P +
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 400 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITE 456
++ L E+K++ HL HENIV G+ + + + EY G + ++R +T
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ +F+ + G+A+L S N IHRD+ N+L+ +VK+ DFG+A+ + S +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV- 199
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
KG+ WMAPE I N D+WS G + E+ + G P+
Sbjct: 200 KGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 43/247 (17%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLE-- 404
P+K K KL G G FG V++ G + + +D+ + P +K L
Sbjct: 3 PRKRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFS---LDVSGNQPVLV-AVKMLRED 57
Query: 405 ----------QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---- 450
+EIK++ LK NI++ + D L + EY+ G +N+++ H
Sbjct: 58 ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 451 ------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504
I+ S + I +G+ YL S N +HRD+ N LV + +K+ADFGM+
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 505 KHL-TGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--G 559
++L +G Y + + WM+ E I K A D+W+ G T+ E+LT
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCK 230
Query: 560 KPPWSEF 566
+ P+S+
Sbjct: 231 EQPYSQL 237
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++G + A+K + P + ++ +E ++ L+H+ +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y ++ +YI EY+ GS+ +++ E + + ++ +F+ I G+AY+ N
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 123
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
IHRD++ AN+LV S + K+ADFG+A+ + Y K W APE I
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF----- 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ D+WS G + E++T GK P+
Sbjct: 179 --GSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLKHE 416
IG+G+FG V R+T A+K + + A + + E E VL +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI-------RKAHIVSRSEVTHTLAERTVLAQVNCP 53
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHS 475
IV S + LY+ L +++ G + ++ RE D++ + R +T +L L LH
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
N I+RD+K N+L+D G + L DFG+ K ++ + G+P ++APE++
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH--- 168
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G K AVD W+LG + EMLTG PP+
Sbjct: 169 -GYTK---AVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 52/162 (32%), Positives = 94/162 (58%), Gaps = 10/162 (6%)
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
Q+ +E++VL IV +YG+ D + I +E++ GS+++ ++E + I E I+
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGK 107
Query: 462 FTRHILNGLAYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+ +L GLAYL + I HRD+K +N+LV++ G +KL DFG++ L S S G+
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTR 166
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
++M+PE ++ ++ DIWS+G +++E+ G+ P
Sbjct: 167 SYMSPERLQGT-------HYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 59/208 (28%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + T A+K ++ + K AE C ++ E+ + V G +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKW-EMLKRAETACFRE-ERNVLVNGDCQWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H +
Sbjct: 65 TLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG + G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G K D WSLG + EML G+ P+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHL 413
++IG+G FG VY GT + CA+K ++ I D ++++EQ +K ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------LEEVEQFLKEGIIMKDF 53
Query: 414 KHENIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H N++ G + + + L Y+ G + ++R + T + F + G+ Y
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---------ELSLKGSPNWM 523
L S +HRD+ N ++D S VK+ADFG+A+ + Y +L +K WM
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
A E ++ K D+WS G + E++T G PP+ +
Sbjct: 170 ALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G +G+VY + +G A+K V + ++ + +K L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 422 YGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E VD L YL+ V P + +++ R
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-----------PAETIKDLMRQ 116
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNW 522
L GL +LH+ +HRD+K N+LV + G VKLADFG+A+ S +++L + +
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWY 173
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APEV+ +Q A VD+WS+GC EM KP
Sbjct: 174 RAPEVL---LQS----TYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
++IGRG++ V + ++ A+K V +++ DD E I ++ E V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNP 56
Query: 418 -IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + L++ +EYV+ G + +++ R + E R + I L +LH
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G +KL D+GM K G S G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +VD W+LG + EM+ G+ P+
Sbjct: 171 --EEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 59/208 (28%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + A+K ++ + K AE C ++ E+++ V G +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKRAETACFRE-ERDVLVNGDNQWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H +
Sbjct: 65 TLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G K D WSLG + EML G+ P+
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 60/208 (28%), Positives = 111/208 (53%), Gaps = 10/208 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + TG A+K ++ + K AE C ++ E+++ V G +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-EMLKRAETACFRE-ERDVLVNGDRRWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H
Sbjct: 65 NLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G + D WSLG + EML G+ P+
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V + TG A K++D KS E + LE+EI L + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ HL + + ++ G + ++ R + V +++ I G+ +LHS + ++
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+D G +L+D G+A L G+ +MAPE++K
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK-------EEPY 171
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+ VD +++GC++ EM+ G+ P+ + +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-17
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V++GT T AIK + P++ QE +++ L+H+ +V
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y + V ++ +YI E++ GS+ +++E + + + + I +G+AY+ N IH
Sbjct: 67 Y-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 538
RD++ AN+LV + V K+ADFG+A+ + Y K W APE A +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG---- 178
Query: 539 KLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + D+WS G + E++T G+ P+
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++IGRG++ V + ++T A+K + +++ DD E I ++ E V H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + + L+ +E+V G + +++ R + E R ++ I L +LH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G +KL D+GM K S G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+VD W+LG + EM+ G+ P+
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 22/213 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + A+K++ P +S ++ +E+++L H+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS----RPFQSLIHARRTYRELRLLKHM 71
Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILN 468
KHEN++ + + +++ +YL G+ +N V+ C+ +++ V+ +L
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLR 129
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 527
GL Y+HS IHRD+K +N+ V+ +++ DFG+A+ E++ + W APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEI 186
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
+ M + VDIWS+GC + E+L GK
Sbjct: 187 MLNWMHYNQ------TVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 49/249 (19%)
Query: 351 PKKSQWQK-------GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS--- 396
P+ +W+ GK +G G FG V IG ++E V ++ D
Sbjct: 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67
Query: 397 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------E 449
++ I ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R E
Sbjct: 68 SDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124
Query: 450 HCRDITESIVRNFT--------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501
+C + T+ + + G+ YL S IHRD+ N+LV V+K+ADF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184
Query: 502 GMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
G+A+ + + Y K + N WMAPE + + + D+WS G + E
Sbjct: 185 GLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWE 234
Query: 556 MLT-GKPPW 563
+ T G P+
Sbjct: 235 IFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V++G A ++K+ + P+ E ++ L+H
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------AFLAEANLMKQLQHPR 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHST 476
+V+ Y + V + +YI EY+ GS+ +++ +T + + + I G+A++
Sbjct: 63 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQ 533
N IHRD++ AN+LV + K+ADFG+A+ + Y + +G+ W APE I
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--- 177
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ D+WS G + E++T G+ P+
Sbjct: 178 ----GTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 63/212 (29%), Positives = 115/212 (54%), Gaps = 14/212 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K +I + K A Q+ +E++VL
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARK---LIHLEIKPA-IRNQIIRELQVLH 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 117
Query: 472 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL + I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
++ DIWS+G +++EM G+ P
Sbjct: 177 T-------HYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLKHEN-I 418
IG+GTFG VY ++T A+K + I + A I E+ I V L I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG--ERNILVRTLLDESPFI 58
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V S D LY+ +Y+ G + ++++ R +E + + ++ L +LH +
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDI 117
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
++RD+K N+L+DA+G + L DFG++K +LT + G+ ++APEV+ + + G
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL---LDEKGY 174
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
K VD WSLG V EM G WS F
Sbjct: 175 TKH---VDFWSLGVLVFEMCCG---WSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 360 KLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIK---QLEQEIKVLGHL 413
K++G+G+FG V++ T + G A+K + K+ ++ + + E +L +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK------KATLKVRDRVRTKMERDILAEV 55
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAY 472
H IV+ + + + LY+ L+++ G + R +E TE V+ + + L +
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDH 113
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAV 531
LHS I+RD+K N+L+D G +KL DFG++K + S G+ +MAPEV+
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--- 170
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ G+ + D WS G + EMLTG P F+G
Sbjct: 171 -NRRGH---TQSADWWSFGVLMFEMLTGSLP---FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 67/248 (27%), Positives = 115/248 (46%), Gaps = 46/248 (18%)
Query: 349 ASPK----KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
A PK +++ GK +G G FG V IG +++ V ++ DD +
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
+ + ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 63 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 449 --EHCRDITESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
+ C+ E + + + + G+ YL S IHRD+ N+LV V+K+ADFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 503 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
+A+ + + Y K + N WMAPE + + + D+WS G + E+
Sbjct: 180 LARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEI 229
Query: 557 LT-GKPPW 563
T G P+
Sbjct: 230 FTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
K +G G FG V++ T N+ T A+K + P S ++ E V+ L+H+ +
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSMS-VEAFLAEANVMKTLQHDKL 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
V+ + + V + +YI E++ GS+ +++ + + +F+ I G+A++ N
Sbjct: 64 VKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQK 534
IHRD++ AN+LV AS V K+ADFG+A+ + Y + +G+ W APE I
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF---- 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ D+WS G ++E++T G+ P+
Sbjct: 178 ---GSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 42/234 (17%)
Query: 359 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLG 411
GK +G G FG V G ++ V ++ D D A+ I ++E +K++G
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIG 75
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFT- 463
KH+NI+ G + LY+ +EY G++ ++R ++ DIT+ +
Sbjct: 76 --KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 464 -------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ G+ YL S IHRD+ N+LV V+K+ADFG+A+ + + Y
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY---Y 190
Query: 517 KGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
K + N WMAPE + + + D+WS G + E+ T G P+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-16
Identities = 61/238 (25%), Positives = 112/238 (47%), Gaps = 21/238 (8%)
Query: 340 MPHIMEKP-SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
+P E P S +P++ + L+GR + ++ T + + ++ D+ ++A
Sbjct: 52 LPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAY 111
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---IT 455
E+ L H IV+++ DD L + +EY G +N+ +++ ++
Sbjct: 112 A----RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSY 512
E V I+ L +HS +HRD+K AN+ + +G++KL DFG +K + L
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
S G+P ++APE+ + + + D+WSLG + E+LT P F+G S
Sbjct: 228 ASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRP---FKGPS 275
|
Length = 478 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
IGRG FG V+ G R A+K + +P D K+ + QE ++L H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPNIVR 57
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
G +YI +E V G ++R + + + G+ YL S + IH
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKDGN 537
RD+ N LV V+K++DFGM++ Y + +K P W APE +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY------- 170
Query: 538 PKLALAVDIWSLGCTVIEMLT-GKPPWS 564
+ + D+WS G + E + G P++
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYA 198
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ +K KL+G G FG+V+ G G S I D + +++ + +G
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
L H IV+ G L + + GS+ +VR+H + + N+ I G+
Sbjct: 65 SLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 528
YL +HR++ N+L+ + +V++ADFG+A L + K WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
+ D+WS G TV EM++ G P++
Sbjct: 184 LF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 32/189 (16%)
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
PD K+A +E+K+L LK NI++ G V +D L + EY+ G +N+++ H
Sbjct: 56 PDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH 113
Query: 451 CRD------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
D I+ S + + I +G+ YL S N +HRD+ N LV
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
Query: 493 SGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+ +K+ADFGM+++L Y ++G WMA E I +M K A D+W+
Sbjct: 174 NLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECI--LMG-----KFTTASDVWA 225
Query: 549 LGCTVIEML 557
G T+ E+L
Sbjct: 226 FGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K ++ + E + E++I L + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + IL GL LH NT
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEV+ N
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-------NQ 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
+ L+ D W LGC + EM+ G+ P+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++++K K++G G FG+VY G G I + S + K++ E V+
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + ++ + G + + + + + G + YVREH +I + N+ I G+
Sbjct: 65 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV VK+ DFG+AK L E +G WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGV 569
+ + D+WS G TV E++T KP P SE +
Sbjct: 184 LHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
++IG G FG V G + G +E+ + KS KQ E ++G H
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NI+ G + I E++ G+++ ++R++ T + R I G+ YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS-P-NWMAPEVIKA 530
N +HRD+ N+LV+++ V K++DFG+++ L + +Y SL G P W APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPW 563
K A D+WS G + E+++ +P W
Sbjct: 186 -------RKFTSASDVWSYGIVMWEVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 59/213 (27%), Positives = 86/213 (40%), Gaps = 32/213 (15%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
+ +G G FG VY G R +V + +P+ + L E ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFN 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------ITESIVRNFTRHIL 467
H+NIV+ G +I LE + G + ++RE R +T + R +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVA 126
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYE-------LSLK 517
G YL + IHRDI N L+ G V K+ADFGMA+ + SY L +K
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 550
WM PE A + K D+WS G
Sbjct: 187 ----WMPPE---AFLDGIFTSK----TDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
K+IG G FG V G + G +E+ + K+ KQ E ++G H
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGK----REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NI+ G + I EY+ GS++ ++R+H T + R I +G+ YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 532
+HRD+ N+LV+++ V K++DFG+++ L +Y P W APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-- 183
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K A D+WS G + E+++ G+ P+ E
Sbjct: 184 -----RKFTSASDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 49/231 (21%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDD---PKSAECIKQLEQEIKVL 410
Q++ IG G +G V+ + + G A+K V + + P S +E+ VL
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAVL 55
Query: 411 GHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPGSINRYVREH 450
HL+ H N+V+ + E VD L YL+ V PG
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------- 106
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
+ +++ +L GL +LHS +HRD+K N+LV +SG +KLADFG+A+ +
Sbjct: 107 ---VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163
Query: 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
S+ + + APEV+ +Q A VD+WS+GC EM KP
Sbjct: 164 MALTSVVVTLWYRAPEVL---LQS----SYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 70/265 (26%), Positives = 109/265 (41%), Gaps = 76/265 (28%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIK 408
S + K K IG G FG V + +T A A+K + + A+ + + ++ E
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-------RKADVLMRNQAAHVKAERD 53
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS------INRYVREHCRDITESIVRNF 462
+L +E +V+ Y S D+LY ++Y+ PG I + E E + R +
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRLGIFE------EDLARFY 106
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHL 507
+ + +H IHRDIK N+L+D G +KL DFG+ H
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 508 TGLSYEL-----------------------------SLKGSPNWMAPEVIKAVMQKDGNP 538
S E SL G+PN++APEV+ + G
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL----LRTGYT 222
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
+L D WS+G + EML G+PP+
Sbjct: 223 QLC---DWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 56/197 (28%), Positives = 82/197 (41%), Gaps = 22/197 (11%)
Query: 377 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDHLYIYL 435
TG AIK + D P+ + +E + L H NIV S E L+
Sbjct: 1 MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58
Query: 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
EYV PG R V + +L+ LA H+ +HRD+K N++V +GV
Sbjct: 59 EYV-PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 496 ---VKLADFGMAKHLTG--------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 544
K+ DFG+ L G L+ + G+P + APE Q G P
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE------QLRGEPVTP-NS 170
Query: 545 DIWSLGCTVIEMLTGKP 561
D+++ G +E LTG+
Sbjct: 171 DLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E++I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + I GL LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEV+K N
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK-------NE 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW 563
+ + D W LGC + EM+ GK P+
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E++I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTN 477
+ D L + L ++ G + ++ H + E + I GL LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
++RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K N
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-------N 175
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + D W+LGC + EM+ G+ P+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-14
Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 41/235 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K IG G FG V++ ++ T K + + + KS QL E+ V+ LKH+N
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRELKHKN 73
Query: 418 IVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAY 472
IV+Y + + LYI +E+ G ++R +++ + I E + + TR +L+ LAY
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 473 LHS-------TNTIHRDIKGANLLV-----------------DASGVVKLADFGMAKHLT 508
H+ +HRD+K N+ + + + K+ DFG++K++
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
S S G+P + +PE++ + + D+W+LGC + E+ +GK P+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKS-----DMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 40/226 (17%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
IG+G FG V+ + V ++ ++ SA+ ++E ++ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIV 71
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR--------------- 464
+ G V + + EY+ G +N ++R S+ + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 465 ------HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
+ G+AYL +HRD+ N LV + VVK+ADFG+++++ Y K
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKA 188
Query: 519 SPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
S N WM PE I + D+W+ G + E+ +
Sbjct: 189 SENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 419
+IGRG FG VY +TG A+K +D K E + E+ + ++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ D L L+ ++ G ++ ++ +H +E +R + I+ GL ++H+ +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS--- 175
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSE 565
+ D +SLGC + ++L G P+ +
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 48/248 (19%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
GK +G G FG V T V + + ++ S+E ++ L E +L +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVN 61
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------------------C 451
H ++++ YG+ D L + +EY GS+ ++RE
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
R +T + +F I G+ YL +HRD+ N+LV +K++DFG+++ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV---- 177
Query: 512 YELS--LKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
YE +K S WMA E + + + D+WS G + E++T G P
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNP- 229
Query: 564 SEFEGVSP 571
+ G++P
Sbjct: 230 --YPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 12/221 (5%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ +K K++G G FG+VY G G + I + + S + K++ E V+
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + + G + + + + + G + YVRE+ I + N+ I G++
Sbjct: 65 GVGSPYVCRLLGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV + VK+ DFG+A+ L E G WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
+ + D+WS G TV E++T G P+
Sbjct: 184 L-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K+IGRG FG V + ++TG A+K + D E + + E +L +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILR--KADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + S +LY+ +E++ PG + ++E + + + + +H I
Sbjct: 65 KMFYSFQDKRNLYLIMEFL-PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-----------------TGLSYE--------- 513
HRDIK NLL+DA G VKL+DFG+ L + S++
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 514 ----------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
S G+P+++APEV MQ G KL D WSLG + EML G PP+
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVF---MQT-GYNKLC---DWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 67/240 (27%), Positives = 104/240 (43%), Gaps = 46/240 (19%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K+IGRG FG V + ++TG A+K + D E + + E +L +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILR--KADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + S +LY+ +E++ PG + +TE + + + + +H I
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLT---------GLSYEL---------------- 514
HRDIK NLL+D+ G VKL+DFG+ L L++ L
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 515 -----------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
S G+P+++APE V + G KL D WSLG + EML G PP+
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPE----VFMQTGYNKLC---DWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V R TG A K+++ K + + E ++L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLN--KKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 422 -YGSEVVDDHLYIYLEYVHPGSINRY----VREHCRDITESIVRNFTRHILNGLAYLHST 476
Y + D L + + ++ G + RY V E E +T I++GL +LH
Sbjct: 59 AYAFQTKTD-LCLVMTIMNGGDL-RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D G V+++D G+A L G S G+P +MAPE+++
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ------ 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +VD ++LG T+ EM+ + P+
Sbjct: 171 -GEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 66/258 (25%), Positives = 105/258 (40%), Gaps = 58/258 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + K K +G G FG V + +T A A+K + D + ++ E +L
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR--KKDVLLRNQVAHVKAERDILAEA 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+E +V+ Y S D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYEL---- 514
H IHRDIK N+L+D G +KL DFG+ H+ S +
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 515 -----------------------------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
SL G+PN++APE V+ + G +L D
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTGYTQLC---D 230
Query: 546 IWSLGCTVIEMLTGKPPW 563
WS+G + EML G+PP+
Sbjct: 231 WWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 67/258 (25%), Positives = 106/258 (41%), Gaps = 58/258 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + K K +G G FG V + +T A A+K + D + + ++ E +L
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEA 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+E +V+ Y S D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYE----- 513
H IHRDIK N+L+D G +KL DFG+ H+ S E
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 514 ----------------------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
SL G+PN++APE V+ + G +L D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKGYTQLC---D 230
Query: 546 IWSLGCTVIEMLTGKPPW 563
WS+G + EML G+PP+
Sbjct: 231 WWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 419
+G+GTF ++ G RE G + + +++ D + + ++ L H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
YG V D + EYV GS++ Y++++ I S + + L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 480 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
H ++ N+L+ +G +KL+D G++ +T L E+ L+ P W+ PE I+
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECIE-- 177
Query: 532 MQKDGNPK-LALAVDIWSLGCTVIEMLTG 559
NP+ L+LA D WS G T+ E+ +G
Sbjct: 178 -----NPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 361 LIGRGTFGSVYIGT--NRETGASCA--IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
L+ GTFG ++ G + + G +K V D S + L QE +L L H+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQ 68
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHP--GSINRYVREHCRDITESIVRNFTRH--------I 466
NI+ ++D ++ Y + G++ ++++ CR + + + I
Sbjct: 69 NILPILHV-CIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQI 126
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----W 522
G++YLH IH+DI N ++D VK+ D +++ L + Y L + N W
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CLGDNENRPVKW 185
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
MA E + N + + A D+WS G + E++T G+ P+ E
Sbjct: 186 MALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 9/206 (4%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 419
+IGRG FG VY +TG A+K +D K E + E+ + ++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ D L L+ ++ G ++ ++ +H +E+ +R + I+ GL ++H+ +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS--- 175
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSE 565
+ D +SLGC + ++L G P+ +
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCA---IKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKHE 416
IG G FG V +G G S A +KE+ SA +QL QE++ L H
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELR------ASATPDEQLLFLQEVQPYRELNHP 55
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRH-ILNGLAY 472
N++Q G + + LE+ G + Y+R + + V + +GL +
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIK 529
LH + IH D+ N + A VK+ D+G+A Y ++ P W+APE+++
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
Q +IWSLG T+ E+ T P+ +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 38/245 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
E + K W +++G G G+V G A+K VD+ + S + +
Sbjct: 24 EATAKEQAKKYWIS-RVLGSGATGTVLCAKRVSDGEPFAVKVVDM---EGMSEADKNRAQ 79
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITE 456
E+ L + +IV+ + D + + L+Y + G + + ++ +
Sbjct: 80 AEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK---- 135
Query: 457 SIVRNFTRH--------ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
R F H +L + ++HS + IHRDIK AN+L+ ++G+VKL DFG +K
Sbjct: 136 -TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194
Query: 509 G-LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+S ++ + G+P ++APE+ + +K + K D++SLG + E+LT K P
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKK----ADMFSLGVLLYELLTLKRP--- 244
Query: 566 FEGVS 570
F+G +
Sbjct: 245 FDGEN 249
|
Length = 496 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 362 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G G FG VY G R + S AIK + ++AE Q E QE +++ L+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQQEFRQEAELMSDLQ 66
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILN---- 468
H NIV G + + EY+ G ++ ++ + D+ + L+
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 469 ---------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
G+ YL S + +HRD+ N LV VK++DFG+++ + Y S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 520 P---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
WM PE A++ K DIWS G + E+
Sbjct: 187 LLPVRWMPPE---AILYG----KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAI---KEVDIIPDDPKSAECIKQLEQE-IKVLGHLKHEN 417
+G+GTF ++Y G R + +EV ++ S E ++ L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V+ YG V D+++ + EYV G ++ ++ +++ + + + + L YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 478 TIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
+H ++ G N+LV G+ +KL+D G+ +T LS E ++ P W+APE I
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP-WIAPECI-- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEM 556
++G L +A D WS G T++E+
Sbjct: 177 ---RNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 408
+G +GRGT+G VY R+ G DD A +KQ+E +EI
Sbjct: 5 EGCKVGRGTYGHVY-KAKRKDGK-----------DDRDYA--LKQIEGTGISMSACREIA 50
Query: 409 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCRDIT--ESIV 459
+L LKH N++ Q D +++ +Y H +R + + + + +V
Sbjct: 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 110
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 515
++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD G A+ L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 516 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ + + APE++ G A+DIW++GC E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 46/230 (20%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 408
+G +GRGT+G VY R+ G D+ + A +KQ+E +EI
Sbjct: 5 EGCKVGRGTYGHVY-KAKRKDGK-----------DEKEYA--LKQIEGTGISMSACREIA 50
Query: 409 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCR--DITESIV 459
+L LKH N++ Q D +++ +Y H +R + + + + S+V
Sbjct: 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMV 110
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 515
++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD G A+ L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 516 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ + + APE++ G A+DIW++GC E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG+V G +++ + A+K I+ +D +L +E V+ L + IV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ G + + +E G +N++++++ + +TE + + G+ YL TN +
Sbjct: 60 RMIGI-CEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKD 535
HRD+ N+L+ K++DFG++K L K W APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY---- 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G + E + G+ P+ +G
Sbjct: 174 ---KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E+ I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + + GL L
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEVI N
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN-------NE 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
K + D W LGC + EM+ G+ P+ + +
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 53/216 (24%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 362 IGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
IGRG SVY+ + TG ++ D+ + + E +K L+ E+ + +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 478
+ L++ ++ GS N ++ + + ++E+++ N L GL YLH
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 479 IHRDIKGANLLVDASGVVKLAD----FGMAKH--LTGLSYE---LSLKGSPNWMAPEVIK 529
IHR+IK +++L+ G+V L+ + + ++ + Y+ S P W++PE+++
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLR 181
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + DI+S+G T E+ TG+ P+ +
Sbjct: 182 QDLY-----GYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 33/94 (35%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ IL GL YLH+ IHRD+K N+ ++ V + D G A+ L L G+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
APEV+ K DIWS G + EML
Sbjct: 224 APEVL-------ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IG G FG V ++ G + AIK + + + +LE K LGH H NI
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK-LGH--HPNI 65
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------------EH--CRDITESIVRNFT 463
+ G+ +LYI +EY G++ ++R EH +T + F
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ G+ YL IHRD+ N+LV + K+ADFG+++ + + WM
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWM 185
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A E + + + D+WS G + E+++ G P+
Sbjct: 186 AIESLNYSVYTTKS-------DVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 78/262 (29%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 417
K+IG+G FG V + ++TG A+K + +E K+ +Q L H+K E
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTL-------LKSEMFKK-DQ----LAHVKAERDV 54
Query: 418 --------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+V Y S +LY+ +E++ G + + ++ +E + R + +
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLA 113
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTG------- 509
+ +H IHRDIK N+L+D G +KL+DFG++ K L G
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 510 ----------LSYELSLK------------------GSPNWMAPEVIKAVMQKDGNPKLA 541
++ +S K G+P+++APE+ + Q G
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQ---- 227
Query: 542 LAVDIWSLGCTVIEMLTGKPPW 563
D WSLG + E L G PP+
Sbjct: 228 -ECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 46/233 (19%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKH 415
K IG G FG V +G + T A +KE+ + SA +Q++ +E + L+H
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRV------SASVQEQMKFLEEAQPYRSLQH 54
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI------VRNFTRHIL 467
N++Q G +EV + +E+ G + Y+R CR E + ++ I
Sbjct: 55 SNLLQCLGQCTEVTP--YLLVMEFCPLGDLKGYLRS-CR-KAELMTPDPTTLQRMACEIA 110
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 521
GL +LH N IH D+ N L+ A VK+ D+G++ Y+ +P+
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH----NKYKEDYYVTPDQLWVPL 166
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVD------IWSLGCTVIEMLT-GKPPWSEF 566
W+APE++ V GN L VD +WSLG T+ E+ G P+
Sbjct: 167 RWIAPELVDEV---HGN---LLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 17/100 (17%)
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM----TPYVVTR 181
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
+ APEVI + K+ VDIWS+GC + EM+ G
Sbjct: 182 YYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+LIG+G G VY+ + A+K+ I D ++ K+ +E K+ L H IV
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKK--IREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 420 QYYGSEVVDDHLYIYLEYVHP---GSINRYVRE--------HCRDITESIVRNFTRHILN 468
Y D +Y + Y+ S+ + V + + + + F + I
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-ICA 124
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS------------- 515
+ Y+HS +HRD+K N+L+ G V + D+G A +L
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 516 ------LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ G+P++MAPE + G P + + DI++LG + +MLT P+
Sbjct: 185 MTIPGKIVGTPDYMAPERLL------GVPA-SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IG G FG V ++ G AIK + + +LE K LGH H NI
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 58
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-------------NRYVREH--CRDITESIVRNFT 463
+ G+ +LY+ +EY G++ + + ++ + +F
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ G+ YL IHRD+ N+LV + V K+ADFG+++ + + WM
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A E + + + D+WS G + E+++ G P+
Sbjct: 179 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS-----CAIKEVDIIPDDPKSAECIKQLEQEI 407
+S Q+ +GRG FG V++ + +K + D+ + +E+
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRREL 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHI 466
+ L H+N+V+ G + Y+ LEY G + +++R + T+
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 467 LN-------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 517
+ G+ +L + +HRD+ N LV + VK++ ++K + Y +
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
W+APE AV + D + K D+WS G + E+ T G+ P+
Sbjct: 180 IPLRWLAPE---AVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++Q+ K IG G G V + G + A+K++ + A K+ +E+ +L +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVN 78
Query: 415 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
H+NI+ Q E D +L + L + + +H R + +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQM 132
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ + + APE
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559
VI + K+ VDIWS+GC + E++ G
Sbjct: 193 VILGMGYKEN-------VDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 361 LIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IGRG +V + + TG ++ +++ + + E + L+ E+ V H NI
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
V Y + + D+ L++ ++ GS + H D ++E + + +L L Y+H
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121
Query: 478 TIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVI 528
+HR +K +++L+ G V L ++ M H L + S+K P W++PEV+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVL 180
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ +Q DI+S+G T E+ G P+ +
Sbjct: 181 QQNLQGYDAKS-----DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 9/97 (9%)
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM- 523
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ +
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 192
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
APEVI + K+ VDIWS+GC + EM+ G
Sbjct: 193 APEVILGMGYKEN-------VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGHLKHENI 418
+G G FG V G + K++D+ K+ ++ +E +++ L + I
Sbjct: 3 LGSGNFGCVKKGVYKMRK-----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G + L + +E G +N+++ +IT S V + G+ YL N
Sbjct: 58 VRMIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP---NWMAPEVIKAVMQK 534
+HRD+ N+L+ K++DFG++K L SY + W APE I
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF---- 172
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G T+ E + G+ P+ + +G
Sbjct: 173 ---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 359 GKLIGRGTFGSVYIG--TNRETGASCAIKEVDI-------IPDDPKSAECIKQLEQE--I 407
GK +G G FGSV G ++ A+K + I + D A C+K+ + +
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 408 KVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+++G + Y S VV L+ +L Y G +Y+ T+ +V+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLP------TQMLVK- 116
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS---LKG 518
F I +G+ YL S + IHRD+ N +++ + V +ADFG++K + Y K
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567
W+A E + + D+WS G T+ E+ T G+ P+ E
Sbjct: 177 PVKWIAIESL-------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
YY + H+ I ++Y+ G + +++ ++E+ V+ R ++ L LH N IH
Sbjct: 75 YYSVTTLKGHVLI-MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 481 RDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
DIK N+L D A + L D+G+ K + T Y+ G+ ++ +PE IK
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIK----GHNY- 183
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
++ D W++G E+LTGK P+ E E
Sbjct: 184 --DVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G+G+FG VY G + E AIK V+ ++A +++E E V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERIEFLNEASVMKEFN 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 465
++V+ G + +E + G + Y+R ++ + V+
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
WM+PE + KDG D+WS G + E+ T
Sbjct: 186 RWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 355 QWQKGK---LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
+W K +IG G FG V ++ G AIK + + S + + E++V
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEV 60
Query: 410 LGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRD 453
L L H NI+ G+ +LY+ +EY G++ ++R+
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
++ + +F + G+ YL IHRD+ N+LV + V K+ADFG+++ +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ WMA E + + + D+WS G + E+++ G P+
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQEIKVLGHLK 414
K I RG FG VY+G + A+K V K A+ I Q++ E L K
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVV-------KKADMINKNMVHQVQAERDALALSK 62
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV Y S +++Y+ +EY+ G + + + E + + + L YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH 121
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAK 505
IHRD+K N+L+ G +KL DFG++K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
F+ + G+ +L S N IHRD+ N+L+ V K+ DFG+A+ + S +KG+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNAR 275
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WMAPE I + + D+WS G + E+ + GK P+
Sbjct: 276 LPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 9/97 (9%)
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 523
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + +
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560
APEVI + K+ VDIWS+GC + EM+ K
Sbjct: 186 APEVILGMGYKEN-------VDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
F+ + NG+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
WMAPE I N D+WS G + E+ T G P+ E
Sbjct: 303 LPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 54/231 (23%), Positives = 106/231 (45%), Gaps = 36/231 (15%)
Query: 359 GKLIGRGTFGSV---YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+++G+G FGSV + + + A+K ++ D S+ I++ +E + H
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVK---MLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 416 ENIVQYYGSEV---VDDHLYI---YLEYVHPGSINRY-----VREHCRDITESIVRNFTR 464
N+++ G + L I L ++ G ++ + + E + + F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLK 517
I +G+ YL S N IHRD+ N +++ + V +ADFG++K + G + +L +K
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567
W+A E + + D+W+ G T+ E++T G+ P++ E
Sbjct: 181 ----WLALESL-------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 24/230 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIK----------Q 402
+W+ KLIG G FG VY + A+ +++ + ++ E +
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESI 458
L + I + HL I +YYG + +I LE + + + R C++ + +
Sbjct: 73 LWKNIHNIDHL---GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN--KKL 127
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSL 516
++N + +L L Y+H H DIK N++VD + + D+G+A H + G E S
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS- 186
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
K + + A + + D+ SLG +++ K PW F
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236
|
Length = 294 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 44/231 (19%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGAS--CAIK--EVDI-----IPDDPKSAECIKQLEQE-- 406
GK++G G FGSV G +++ G+ A+K ++DI I + A C+K +
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 407 IKVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
+K++G + +Q +V L+ +L Y G + + +++++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP------LQTLLK 117
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-------E 513
F I G+ YL + N IHRD+ N ++ V +ADFG++K + Y +
Sbjct: 118 -FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ +K W+A I+++ + K D+W+ G T+ E+ T G+ P+
Sbjct: 177 MPVK----WIA---IESLADRVYTSK----SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 41/232 (17%)
Query: 362 IGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+G FG +Y G + AIK + D + + + +QE ++ L H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK----DINNPQQWGEFQQEASLMAELHHPN 68
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYV---REH----CRDITESIVRNFTRH----- 465
IV G + + + EY++ G ++ ++ H C + V++ H
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 466 ----ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 521
I G+ YL S +H+D+ N+L+ VK++D G+++ + Y + P
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YRVQPK 185
Query: 522 ------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
WM PE I K + DIWS G + E+ + G P+ F
Sbjct: 186 SLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY-LEYVHPGSINRYVREHCRDITESIVR 460
QLE EI LG L HENI++ E++ Y + + + ++ + D + +
Sbjct: 209 QLENEILALGRLNHENILKI--EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 461 NFTRHILNGL----AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYEL 514
TR I+ L Y+H IHRDIK N+ ++ G + L DFG A +++
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
G+ +PE ++ DG ++ DIWS G +++ML+
Sbjct: 327 GWVGTVATNSPE----ILAGDGYCEIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G+G+FG VY G R E A+K V+ +SA +++E E V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 465
++V+ G + +E + G + Y+R + + R
Sbjct: 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----- 520
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
WMAPE + KDG + D+WS G + E+ +
Sbjct: 186 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E LG H NIV+ G + + I EY+ G+++ ++R+H + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWM 523
+ +G+ YL +H+ + +LV++ V K++ F + + +S K W
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPW 563
APE I+ + A D+WS G + E+++ +P W
Sbjct: 176 APEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 362 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK 414
+GRGT +Y G + E KE+ +I DP + + ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H++IV YG V D + E+V G ++ ++ +T + + + L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 475 STNTIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
+ +H ++ N+L+ G+ +KL+D G+ +T LS + ++ P W+APE
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPEC 179
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
++ + L++A D WS G T+ E+
Sbjct: 180 VE------DSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 35/108 (32%), Positives = 48/108 (44%), Gaps = 9/108 (8%)
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPN 521
R +L + YLH IHRDIK N+ ++ G V L DFG A ++ G+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
APE++ AVDIWS G + EM T E +G+
Sbjct: 249 TNAPELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 400 IKQLEQEIKVLGHLKHENIVQYYG--SEVVDD--HLYIYLEYVHPGSINRYVREHCRDIT 455
I E EIK L + NI++ YG ++VDD L + LEY G + + + +D++
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLS 120
Query: 456 ESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514
+ GL L+ TN ++++ + LV + +K+ G+ K L+ ++
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK- 179
Query: 515 SLKGSPNWMA---PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ N+M +++ + + + DI+SLG + E+ TGK P FE ++
Sbjct: 180 ----NVNFMVYFSYKMLNDIFSE-----YTIKDDIYSLGVVLWEIFTGKIP---FENLT 226
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+F+ + G+++L S N IHRD+ N+L+ + K+ DFG+A+ + S +KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNA 276
Query: 521 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WMAPE I N D+WS G + E+ + G P+
Sbjct: 277 RLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 19/217 (8%)
Query: 362 IGRGTFGSV-----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
IG G FG V Y T A +KE+ + E ++Q + L+H
Sbjct: 3 IGNGWFGKVLLSEIYTDT---GVARVVVKELKANASSKEQNEFLQQGDPYRI----LQHP 55
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 473
NI+Q G V + EY G + Y+ H R+ +++ I G+ ++
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKA 530
H N +H D+ N + + VK+ D+G+ Y E W+APE++
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEF 566
+ ++W+LG T+ E+ P+S
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+FT + G+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGST 299
Query: 521 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
WMAPE I N L+ D+WS G + E+ +
Sbjct: 300 FLPVKWMAPESIF------DNLYTTLS-DVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGL 510
RDI ++++ R +L GL LH +HRDIK NLLV G VK+ DFG A + TG+
Sbjct: 306 RDI--NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI 363
Query: 511 SYELSLKG--SPNWMAPE 526
++ L G P + PE
Sbjct: 364 NFN-PLYGMLDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 44/178 (24%), Positives = 63/178 (35%), Gaps = 38/178 (21%)
Query: 401 KQLEQEIKVLGHLKHENIVQY-----YGSEV--VDDH----LYIYLEYVHPGSINRYVRE 449
K +EI +L + H I+ + S V V L+ Y++ P + + +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI-- 188
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
R +L LAYLH IHRD+K N+ +D L DFG A L
Sbjct: 189 -----------TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-----AVDIWSLGCTVIEMLTGKPP 562
G W ++ + LAL DIWS G + EM
Sbjct: 238 HPDTPQCYG---WS------GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 16/147 (10%)
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
N+V + V +D +++ L++ G + ++ + I E V+ + ++ L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDALHRE 104
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNWMAPEVIKAVMQ 533
+ RD+ N+L+D G ++L F + E S G + APEV
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENMYCAPEV------ 153
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGK 560
G + A D WSLG + E+LTGK
Sbjct: 154 -GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 23/112 (20%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 514
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ S L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 515 SLKGSPNWMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
LK WMAPE I K + D+WS G + E+ + G P+
Sbjct: 239 PLK----WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 362 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G FG VY G E + AIK + D ++ + E + L+H
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDI----TESIVRN--------- 461
NIV G + L + Y ++ ++ R D+ + V++
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
I G+ +L S + +H+D+ N+LV VK++D G+ + + Y L G+
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSL 187
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
WM+PE A+M K ++ DIWS G + E+ +
Sbjct: 188 LPIRWMSPE---AIMYG----KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 22/119 (18%)
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSY--- 512
I++ R IL L LHST +HRD+K N++ SG K+ D G A L G++Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV---------------DIWSLGCTVIEM 556
E L P + APE Q P +A DI+S G ++M
Sbjct: 316 EFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 19/110 (17%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 514
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
LK WMAPE I + + D+WS G + E+ + G P+
Sbjct: 244 PLK----WMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 23/105 (21%)
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYELSLKGSPN 521
G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L LK
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 240
Query: 522 WMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WMAPE I K + D+WS G + E+ + G P+
Sbjct: 241 WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 24/99 (24%), Positives = 35/99 (35%), Gaps = 19/99 (19%)
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L L LH + + L+ G V + P +MAPE
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKLDGSV------------AFKTPEQSRPDPYFMAPE 74
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
VI+ DI+SLG T+ E L + P++E
Sbjct: 75 VIQGQSY-------TEKADIYSLGITLYEALDYELPYNE 106
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505
Y+ R + + V R +L+ + Y+H IHRDIK N+LV+ + L DFG A
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308
Query: 506 HLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
G + + G+ + APEV+ G+P +VDIWS G + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLA------GDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 16/128 (12%)
Query: 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
E+V G ++ +R+ + + + + + L+YL N +H ++ N+L+ G+
Sbjct: 96 EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155
Query: 496 -------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+KL+D G++ T LS E ++ P W+APE + GN L+ A D WS
Sbjct: 156 AEGTSPFIKLSDPGVS--FTALSREERVERIP-WIAPECV-----PGGN-SLSTAADKWS 206
Query: 549 LGCTVIEM 556
G T++E+
Sbjct: 207 FGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 9e-04
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 10/74 (13%)
Query: 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
I +EY+ G + V E +VR + A LH +H D+ +N +V
Sbjct: 413 IVMEYIG-GKDLKDVLEG----NPELVRKVGEIV----AKLHKAGIVHGDLTTSNFIVRD 463
Query: 493 SGVVKLADFGMAKH 506
+ L DFG+ K+
Sbjct: 464 DRLY-LIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
+I P P S+W+ G+++G G FG V GT S + +V + P
Sbjct: 18 YIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKP 77
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
+ KQ L E+K++ HL H NIV G+ +YI EY G + Y+ ++
Sbjct: 78 TARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 20/86 (23%)
Query: 427 VDDHLY-IYLEYVHPG-----SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
VD I +EY+ G I E R+I + + LH +H
Sbjct: 67 VDPDNKTIVMEYIE-GKPLKDVIEEGNDELLREIGRLVGK------------LHKAGIVH 113
Query: 481 RDIKGANLLVDASGVVKLADFGMAKH 506
D+ +N++V + L DFG+ K+
Sbjct: 114 GDLTTSNIIVRDDKLY-LIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 571 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.67 | |
| PLN02236 | 344 | choline kinase | 96.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.44 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.13 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.69 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.62 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.61 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.49 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.41 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.37 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.14 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.19 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.16 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=385.71 Aligned_cols=202 Identities=36% Similarity=0.648 Sum_probs=185.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|.+.+.||+|+||+||+|+++.++..||||.+..... .....+.+..|+.||+.++|+|||.+++++..++.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 34589999999999999999999999999999999864321 345677789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------CcEEEEecCCcc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS------GVVKLADFGMAK 505 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~------g~vKLiDFGlA~ 505 (571)
|||||||+||+|.+||+.+ +.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999886 479999999999999999999999999999999999999754 469999999999
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.+.......+.+|++.|||||+++. ..|+.|+|+||+|+|||+|++|+.||.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~-------~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMS-------QQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHh-------ccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998888889999999999999973 368889999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=367.98 Aligned_cols=206 Identities=32% Similarity=0.534 Sum_probs=185.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.++||+|+||+||+++.+.+++.+|+|+++...- ......+....|..||..++||.||.++..|.+.+.+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i--v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI--VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh--hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45699999999999999999999999999999999864221 1223467789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc-cCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l-~~~ 510 (571)
|+|+||+.||+|+.+|++. +.++|..++.++..|+.||.|||++|||||||||+|||||++|+++|+|||+++.. ...
T Consensus 101 ylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999999876 56999999999999999999999999999999999999999999999999999954 444
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....+++||+.|||||++.. ..|+..+|+||||+++|||++|.+||.+-+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CccccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 55667899999999999983 478999999999999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=377.15 Aligned_cols=212 Identities=34% Similarity=0.539 Sum_probs=187.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcH--HHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~--~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++.|.+.+.||+|+||.|.+|..+.+|+.||||++.......... .....+.+|++||++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5678999999999999999999999999999999997544333221 12334679999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKH 506 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~ 506 (571)
..|+||||++||+|++++..+ +.+.|...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999999875 679999999999999999999999999999999999999644 7899999999999
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
........++|||+.|.|||++... +...+..++||||||||||-+|+|.+||.+--+
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~k----g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASK----GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred cccceehhhhcCCccccChhheecC----CeecccchheeeeccceEEEEeccCCCcccccC
Confidence 9888888899999999999999742 233455689999999999999999999987544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=366.18 Aligned_cols=203 Identities=31% Similarity=0.548 Sum_probs=186.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~- 429 (571)
....+.+.++.||+|..|+||+|+++.+++.+|+|++... ......+++.+|+++++..+||+||.+||+|..++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 3445888899999999999999999999999999998543 23567789999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.++|+||||+||+|++++.+. +.++|..+..|+.++++||.|||+ ++||||||||+||||+..|.|||||||.+..+.
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 599999999999999999875 679999999999999999999995 999999999999999999999999999999887
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+. ...+++||..|||||.++ +..|+.++||||||++|+||++|+.||...
T Consensus 231 nS-~a~tfvGT~~YMsPERi~-------g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERIS-------GESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hh-hcccccccccccChhhhc-------CCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 76 667899999999999998 457899999999999999999999999763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=379.79 Aligned_cols=203 Identities=36% Similarity=0.644 Sum_probs=185.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|..+++||+|||+.||.+++..+|+.||+|++....- ......+++.+||+|-+.|+|||||+++++|++.+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 689999999999999999999999999999999864211 123446788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~ 512 (571)
|+|+|..++|..+++ ..+.++|.+++.+++||+.||.|||+++|||||||..||||+++.+|||+|||||..+... ..
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999997 4578999999999999999999999999999999999999999999999999999998754 66
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..+.+|||.|+|||++. ...+++.+||||+|||||.||+|++||...
T Consensus 175 k~TlCGTPNYIAPEVl~-------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLN-------KSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cceecCCCcccChhHhc-------cCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 67899999999999997 446889999999999999999999999753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.10 Aligned_cols=210 Identities=30% Similarity=0.540 Sum_probs=185.0
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~ 429 (571)
.....|.+++.||+|+||+|++|.+..+|..||+|+++............+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456999999999999999999999999999999976543211111234566779999999999 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCcccc-
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL- 507 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA~~l- 507 (571)
.+|+|||||.||+|+++|.+ .+.+.|.+++.+++||++||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999998 5789999999999999999999999999999999999999999 99999999999988
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.........+||+.|+|||++.... .+.+.++||||+||+||.|++|+.||++.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~-----~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKG-----TYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCC-----CcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 4556667899999999999998521 13368999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.78 Aligned_cols=204 Identities=33% Similarity=0.605 Sum_probs=185.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||.|+||+|.+++.+.+|..+|+|+++.. +-.....++...+|..+|+.+.||+++++++.|.+.+.+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~--~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ--KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH--HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 345899999999999999999999999999999988632 222344567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.||.|+.++++. +++++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.+.+.
T Consensus 120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999999874 77999999999999999999999999999999999999999999999999999998776
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..+.||||.|+|||+++ ...|..++|+|+|||++|||+.|.+||.+..
T Consensus 198 -T~TlCGTPeYLAPEii~-------sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQ-------SKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred -EEEecCCccccChHHhh-------cCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 44689999999999998 4578899999999999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.58 Aligned_cols=204 Identities=36% Similarity=0.568 Sum_probs=180.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEee-eEEeCCe-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-SEVVDDH- 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g-~~~~~~~- 430 (571)
..+|++.++||+|.||.||++.+..+|..+|.|.+.... -.......+..|+.+|++|+|||||++++ .+.++.+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 348999999999999999999999999999999886322 33455677889999999999999999998 5655555
Q ss_pred EEEEEeecCCCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 431 LYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHS--TN--TIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~---~~~~~Lse~~i~~I~~QIa~gL~yLHs--~G--IVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
++||||||++|+|..+|+ +..+.++|..++.++.|++.||.++|. .. |+||||||.||+|+.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999999999999986 345679999999999999999999998 44 99999999999999999999999999
Q ss_pred cccccCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++.+..... ..+++|||+||+||+++ ...|+.++||||+||++|||+.-+.||.+.
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~-------~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIH-------ESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHh-------cCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 998876443 34789999999999998 457999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=358.79 Aligned_cols=206 Identities=31% Similarity=0.590 Sum_probs=182.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
.-.+|..++.||+|+|++||+|+++.+++.||||++.... -..+..++.+..|-++|.+| .||.|++||..|.++..
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~--Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY--IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH--HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3469999999999999999999999999999999875311 12233456678899999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+|+||+.+|+|.++|.+. +.|++..++.++.+|+.||+|||++|||||||||+|||||+++++||+|||.|+.+...
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999887 67999999999999999999999999999999999999999999999999999877542
Q ss_pred ccc--------------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYE--------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~--------------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... .+++||-.|.+||+|. ....+..+|||+||||||.|+.|.+||.+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 111 3589999999999997 3467889999999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=341.23 Aligned_cols=207 Identities=30% Similarity=0.521 Sum_probs=184.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
+.|+.+..+|+|+||+||+|++++||+.||||.+.-..+ .....+...+||++|++|+|+|+|.++++|.-...+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed---d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED---DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc---cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 368889999999999999999999999999998864332 24555667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-CCcc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-~~~~ 512 (571)
|+|||+..-| +-|......++.+.++.+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+. +...
T Consensus 79 VFE~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9999985444 4455666779999999999999999999999999999999999999999999999999999887 5566
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
.+..+.|..|.|||.+.+ ...|+..+||||+||++.||++|.+-|.+...||
T Consensus 158 YTDYVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred hhhhhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 667889999999999985 5678999999999999999999999998877665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.97 Aligned_cols=207 Identities=30% Similarity=0.521 Sum_probs=182.1
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++++.||+|+||.||+|+.+.||..||+|+++.. +-.....++.++.|-+||...+.++||+||..|.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS--~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS--EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH--HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 34567999999999999999999999999999999998642 2233456788999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+||||||++||++..+|... +.|++..++.++.+++.||..||++|||||||||+|+|||..|++||+||||+..+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999999999875 6799999999999999999999999999999999999999999999999999853211
Q ss_pred ----------------------Cc-c-------------------------ccccCCCCcccChHHHHHhhhcCCCCCCC
Q 008285 510 ----------------------LS-Y-------------------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541 (571)
Q Consensus 510 ----------------------~~-~-------------------------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s 541 (571)
.. . ..+.+|||.|||||++. +..|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-------~kgY~ 366 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-------GKGYG 366 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-------cCCCC
Confidence 00 0 01267999999999998 44688
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 542 LAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 542 ~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...|+|||||||||||.|.+||...
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.41 Aligned_cols=210 Identities=32% Similarity=0.561 Sum_probs=181.4
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcE-EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~-VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
......+..+.+.||+|+||+||+|.++ |+. ||+|.+.....+. ...+.+.+|+.+|.+++|||||+++|++..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~---~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDD---ESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3334456667777999999999999997 455 9999987433322 227889999999999999999999999988
Q ss_pred CC-eEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCCC-cEEEEecCC
Q 008285 428 DD-HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVDASG-VVKLADFGM 503 (571)
Q Consensus 428 ~~-~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~G-IVHRDIKPsNILLd~~g-~vKLiDFGl 503 (571)
.. .++|||||+.+|+|.++++. ....++...+..|+.||++||.|||+++ |||||||++||||+.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 87 79999999999999999988 3678999999999999999999999999 99999999999999997 999999999
Q ss_pred cccccCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 504 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 504 A~~l~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
++..... .......||+.|||||++... ...|+.++||||||++||||++|+.||.+...
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9877653 233347899999999999742 35799999999999999999999999998763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.23 Aligned_cols=203 Identities=30% Similarity=0.481 Sum_probs=177.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||+|.++.+|+.||||++.... .........+.+|+.++.+++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 37999999999999999999999999999999986321 1123345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
|||||.||+|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999999765 579999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH
Q 008285 512 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (571)
Q Consensus 512 ----------------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL 557 (571)
.....+||+.|+|||++. +..++.++|||||||++|||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-------CCCCCCchhhhhhHHHHHHHH
Confidence 012357999999999986 335788999999999999999
Q ss_pred cCCCCCCCC
Q 008285 558 TGKPPWSEF 566 (571)
Q Consensus 558 tGr~PF~~~ 566 (571)
+|+.||.+.
T Consensus 231 ~G~~Pf~~~ 239 (363)
T cd05628 231 IGYPPFCSE 239 (363)
T ss_pred hCCCCCCCC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=355.49 Aligned_cols=207 Identities=32% Similarity=0.541 Sum_probs=183.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--Ce
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~ 430 (571)
...|+.++.||+|+||.||+|++..+|+.||+|.+.....+ .....-..+||.||++|.||||++|.+...+. ..
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 45799999999999999999999999999999998764433 33456677999999999999999999988776 68
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+|+|||+ -+|.-++...+-.|++.+++.+++||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999999997 8888888876778999999999999999999999999999999999999999999999999999977654
Q ss_pred c--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 008285 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569 (571)
Q Consensus 511 ~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egv 569 (571)
. ..+..+-|..|.|||.|.+ ...|+.++||||.||||.||+.|++.|.+-..+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred CCcccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 3 3456678999999999985 567999999999999999999999999875543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.84 Aligned_cols=199 Identities=35% Similarity=0.632 Sum_probs=181.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|.+.++||+|.||+||+|+.+.+.+.||||.+.... .....++.+.+|++|++.++|||||.++++|+...++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 47899999999999999999999999999999987544 334567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
|.|||.| +|+.+|... +.++|+.++.|+.|++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+.....
T Consensus 79 Vte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999986 999999775 6799999999999999999999999999999999999999999999999999998765443
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.....|||.|||||.+. ...|+..+|+||||||+|||+.|++||-
T Consensus 157 ltsikGtPlYmAPElv~-------e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVE-------EQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeeccCcccccCHHHHc-------CCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 34578999999999987 4578999999999999999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=342.76 Aligned_cols=203 Identities=53% Similarity=0.920 Sum_probs=177.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC--e
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--H 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--~ 430 (571)
...|..++.||+|+||.||++.+..+|..+|||.+..... ...+.+.+|+.+|.+++|+|||+++|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 4479999999999999999999999999999999875411 11677899999999999999999999755554 6
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~ 509 (571)
++|+|||+.||+|.+++...++.|+|..++.+++||+.||+|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999999999987668999999999999999999999999999999999999999 79999999999987764
Q ss_pred ----CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 ----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ----~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........||+.|||||++.. +.....++|||||||+++||+||+.||.++
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 223445789999999999973 112235899999999999999999999984
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.32 Aligned_cols=203 Identities=31% Similarity=0.515 Sum_probs=176.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+.+|+++|+.++|+||+++++.+.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 379999999999999999999999999999999864211 122345667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999999765 569999999999999999999999999999999999999999999999999987543211
Q ss_pred -------------------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHH
Q 008285 512 -------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554 (571)
Q Consensus 512 -------------------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLy 554 (571)
.....+||+.|+|||++. ...++.++|||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-------QTGYNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-------CCCCCCeeeeecchhHHH
Confidence 011246999999999986 335788999999999999
Q ss_pred HHHcCCCCCCCC
Q 008285 555 EMLTGKPPWSEF 566 (571)
Q Consensus 555 ELLtGr~PF~~~ 566 (571)
||++|+.||.+.
T Consensus 231 el~~G~~Pf~~~ 242 (364)
T cd05599 231 EMLVGYPPFCSD 242 (364)
T ss_pred HhhcCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=352.85 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=182.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~ 428 (571)
.....+|.++++||+|.||+|+++..+.+++.+|||+++... --..+.++.++.|..|+.... ||.++.++..|...
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~--Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGD--ILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccc--eeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 445679999999999999999999999999999999987422 223344677888888888775 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+++|+||||+.||++..+++ .+.+++..++.++..|+.||.|||++|||+||||.+|||+|.+|++||+||||++..-
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999999555443 3679999999999999999999999999999999999999999999999999999764
Q ss_pred -CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 -GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 -~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.+....+++||+.|||||++. ...|+.++|+|+|||+|||||.|..||.+.+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~-------e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLT-------EQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred CCCCccccccCChhhcChhhhc-------cCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 455667899999999999998 4478999999999999999999999998554
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=337.81 Aligned_cols=202 Identities=29% Similarity=0.485 Sum_probs=175.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++++.||+|+||+||+|+++.+++.||||++.... .......+.+.+|+++++.++|+||+++++++.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 6899999999999999999999999999999986321 11234456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC----
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~---- 510 (571)
||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999999765 56899999999999999999999999999999999999999999999999997533100
Q ss_pred --------------------------------------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhH
Q 008285 511 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546 (571)
Q Consensus 511 --------------------------------------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDV 546 (571)
......+||+.|+|||++. +..++.++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~Di 231 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-------RKGYTQLCDW 231 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-------CCCCCCccce
Confidence 0012357999999999986 2357889999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 008285 547 WSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 547 WSLGvVLyELLtGr~PF~~~ 566 (571)
|||||++|||++|+.||...
T Consensus 232 wSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred eehhhHHHHHHhCCCCCcCC
Confidence 99999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.44 Aligned_cols=203 Identities=27% Similarity=0.471 Sum_probs=175.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|++++++++|+||+++++++.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 379999999999999999999999999999998753211 123345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999764 569999999999999999999999999999999999999999999999999986321100
Q ss_pred ----------------------------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhh
Q 008285 512 ----------------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545 (571)
Q Consensus 512 ----------------------------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksD 545 (571)
.....+||+.|+|||++. +..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~D 230 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-------QQGYGQECD 230 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-------cCCCCCcee
Confidence 001246999999999986 335788999
Q ss_pred HHHHHHHHHHHHcCCCCCCCC
Q 008285 546 IWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 546 VWSLGvVLyELLtGr~PF~~~ 566 (571)
||||||++|||++|+.||...
T Consensus 231 iwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred eEecchhhhhhhcCCCCCCCC
Confidence 999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.27 Aligned_cols=204 Identities=34% Similarity=0.576 Sum_probs=187.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.-|++++-||.|+-|.|.+|++.+||+..|||++..... ........+++||-||+.+.||||+++|++|+.+.++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~--~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE--LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccc--cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 469999999999999999999999999999999865322 233445778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|.||++||.|++|+..+ +.|++.+++.+++||+.|+.|+|..+|+||||||+|+|||..+++||+|||||....++...
T Consensus 90 vlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999999886 56999999999999999999999999999999999999999999999999999988888888
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.+.||++.|.|||++++ ..+.+.++||||.|||||.||+|++||++.
T Consensus 169 eTSCGSPHYA~PEIV~G------~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSG------RPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred cccCCCcccCCchhhcC------CCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 88999999999999985 456678999999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.05 Aligned_cols=208 Identities=29% Similarity=0.484 Sum_probs=187.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD- 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~- 429 (571)
..++|++++.||.|+||.||+|+.+++|..||||.++..... -.+ -.-.+|+..|++|. |+|||++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 346899999999999999999999999999999987643221 111 12358999999998 999999999999988
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||+ .+|+++++...+.+++..++.|+.||++||+|+|++|++||||||+|||+.....+||+|||+|+.+..
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 9999999997 899999998888999999999999999999999999999999999999999899999999999999988
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
....+..+.|..|+|||+|.+ ...|+.+.|||++|||++|+++-++-|.+...+|
T Consensus 163 kpPYTeYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred CCCcchhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 888888899999999999986 6689999999999999999999999999887665
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=337.72 Aligned_cols=204 Identities=30% Similarity=0.472 Sum_probs=175.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||.||+|++..+|+.||||++.... .........+.+|+++|+.++|+||+++++.+.+++.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 37999999999999999999999999999999875321 1112334667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC---
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~--- 510 (571)
|||||.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 79 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 79 VMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999999775 56899999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHH
Q 008285 511 -----------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549 (571)
Q Consensus 511 -----------------------------------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSL 549 (571)
......+||+.|||||++. +..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSl 230 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCDWWSV 230 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-------CCCCCcceeeeec
Confidence 0011347999999999986 3357889999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 008285 550 GCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 550 GvVLyELLtGr~PF~~~e 567 (571)
||++|||++|+.||.+..
T Consensus 231 Gvilyell~G~~Pf~~~~ 248 (376)
T cd05598 231 GVILYEMLVGQPPFLADT 248 (376)
T ss_pred cceeeehhhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=323.88 Aligned_cols=201 Identities=33% Similarity=0.550 Sum_probs=176.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+++++.++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 379999999999999999999999999999999863211 112345668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 99999999999999765 569999999999999999999999999999999999999999999999999998764422
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|++.|+|||++. +..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 156 WTLCGTPEYLAPEVIQ-------SKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ccccCChhhcCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2456999999999986 335688999999999999999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.47 Aligned_cols=203 Identities=24% Similarity=0.405 Sum_probs=176.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|++++++++|+||+++++.+.+++.+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 378999999999999999999999999999987632211 122234577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 9999999999888653 246899999999999999999999999999999999999999999999999999876544444
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 159 RGRVGTVGYMAPEVIN-------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred cCCCCCCCccCHhhhc-------CCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 4567999999999986 346788999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=336.90 Aligned_cols=202 Identities=29% Similarity=0.481 Sum_probs=175.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++++.||+|+||+||+|++..+++.||||++.... .......+.+.+|++++++++|+||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 6999999999999999999999999999999886321 12234456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC----
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~---- 510 (571)
||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999999765 56899999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhH
Q 008285 511 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546 (571)
Q Consensus 511 --------------------------------------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDV 546 (571)
......+||+.|+|||++. +..++.++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~Di 231 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCDW 231 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-------CCCCCCeeeE
Confidence 0012356999999999986 3357889999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 008285 547 WSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 547 WSLGvVLyELLtGr~PF~~~ 566 (571)
|||||+||||++|+.||...
T Consensus 232 wSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EechHHHHHHHhCCCCCCCC
Confidence 99999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.93 Aligned_cols=205 Identities=31% Similarity=0.485 Sum_probs=173.6
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.....+|++++.||+|+||.||+|++..+|+.||||++... ......+.+.+|+++++.++|+||+++++++...+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 33456899999999999999999999999999999998532 22345577889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+++++|... ..+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 146 ~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred eEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999999999998653 3467788889999999999999999999999999999999999999999999987643
Q ss_pred C-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 510 L-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 510 ~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
. .......||..|+|||++...... +...+.++|||||||++|||++|+.||..
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNH--GAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccccccccCccccCcccccccccc--CcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2 222346799999999987532211 23456789999999999999999999973
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.63 Aligned_cols=203 Identities=32% Similarity=0.552 Sum_probs=178.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|++++|+||+++++++..++.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 45689999999999999999999999999999999863211 1123456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999999775 568999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.
T Consensus 173 --~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred --ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 24579999999999863 35678999999999999999999999654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.61 Aligned_cols=201 Identities=32% Similarity=0.569 Sum_probs=177.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+.+|++++..++|+||+++++++...+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 379999999999999999999999999999999864211 112345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 79 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 79 AMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 99999999999999764 5699999999999999999999999999999999999999999999999999986644 23
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred CCcccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 35679999999999863 36788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.59 Aligned_cols=197 Identities=30% Similarity=0.491 Sum_probs=171.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
+.||+|+||.||+|.++.+|+.||||++..... ........+.+|+.+++.++|+||+++++.+...+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999863211 122345667789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccCC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG 518 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~G 518 (571)
||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999999764 5799999999999999999999999999999999999999999999999999876432 222334679
Q ss_pred CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 519 T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CccccChhhhc-------CCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 99999999986 345788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.73 Aligned_cols=207 Identities=28% Similarity=0.555 Sum_probs=190.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.+-+|++.+.||+|+||+|-++.....|+.||||.++.. .-++++.+-.+.+||+||..|.||||+++|++|+..+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd--kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD--KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh--hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 355899999999999999999999999999999988642 234556677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
.|||||..+|+|++||.+. +.|+|.+++.|++||++|+.|+|+++++|||||.+|||+|.++++||+|||++..+....
T Consensus 129 vivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999999875 779999999999999999999999999999999999999999999999999999888888
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...+++|++-|.+||++.+ ..+-+..+|-|||||+||.|+.|..||++.+
T Consensus 208 fLqTFCGSPLYASPEIvNG------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNG------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred HHHHhcCCcccCCccccCC------CCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 8889999999999999974 3445678999999999999999999998765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.68 Aligned_cols=204 Identities=27% Similarity=0.503 Sum_probs=175.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||.||+|.++.+|+.||||++...... .....+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 35899999999999999999999999999999998643221 11234668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 9999995 78888887766779999999999999999999999999999999999999999999999999987543322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......|++.|+|||++.+ ...++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred cCCCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2234568999999999863 3357889999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.30 Aligned_cols=209 Identities=26% Similarity=0.426 Sum_probs=179.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||++++..+++.||||++.... .......+.+.+|+.++..++|+||+++++++.+++.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 37999999999999999999999999999999986311 1112234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.||+|.+++.+....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999999876677999999999999999999999999999999999999999999999999998765443221
Q ss_pred --cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 --~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|||||++..... +...++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMED--GKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cccceeccccccCHHHHhhccc--cccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 23469999999999864211 1235778999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.02 Aligned_cols=203 Identities=30% Similarity=0.490 Sum_probs=176.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.++.+|+.||||++.... .........+..|+.++..++|+||+++++.+.+.+.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 37999999999999999999999999999999986321 1123345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
|||||.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999999764 569999999999999999999999999999999999999999999999999987543210
Q ss_pred ----------------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH
Q 008285 512 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (571)
Q Consensus 512 ----------------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL 557 (571)
.....+||+.|+|||++. +..++.++|||||||++|||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-------CCCCCCcceeccccceeeecc
Confidence 012357999999999986 345788999999999999999
Q ss_pred cCCCCCCCC
Q 008285 558 TGKPPWSEF 566 (571)
Q Consensus 558 tGr~PF~~~ 566 (571)
+|+.||.+.
T Consensus 231 tG~~Pf~~~ 239 (360)
T cd05627 231 IGYPPFCSE 239 (360)
T ss_pred cCCCCCCCC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.93 Aligned_cols=204 Identities=32% Similarity=0.543 Sum_probs=179.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||+|.+..+|+.||||++..... ........+.+|++++..++|+||+++++.+.+++.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 379999999999999999999999999999999863211 112345668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+.|++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999999876 679999999999999999999999999999999999999999999999999998665432
Q ss_pred ----------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 512 ----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 512 ----------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCC
Confidence 2234569999999999873 36788999999999999999999999
Q ss_pred CCCC
Q 008285 564 SEFE 567 (571)
Q Consensus 564 ~~~e 567 (571)
....
T Consensus 231 ~~~~ 234 (350)
T cd05573 231 YSDT 234 (350)
T ss_pred CCCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.01 Aligned_cols=211 Identities=31% Similarity=0.567 Sum_probs=186.7
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
......++|++.+.||.|..++||+|++..+++.||||++.... ....++.+.+|+..|..++||||+.++..|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk----c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK----CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh----hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 45667789999999999999999999999999999999987533 23347889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+..+|+||.||.+|++.++|... ...+.|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+-.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999999764 34599999999999999999999999999999999999999999999999998765
Q ss_pred ccCCc----cc-cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLS----YE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~----~~-~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+.... .. ..++||+.|||||+++... -.|+.|+||||||++..||.+|..||.++.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~-----~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL-----HGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcc-----cCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 53321 11 4578999999999976532 248999999999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.22 Aligned_cols=203 Identities=27% Similarity=0.480 Sum_probs=175.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||.||+|.+..++..||+|+++..... .....+.+|+.+++.++|+||+++++++..++..|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 45799999999999999999999999999999998643221 11245678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9999997 58999998766668999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2234568999999998853 345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=345.26 Aligned_cols=199 Identities=38% Similarity=0.667 Sum_probs=181.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|...+.||+|+.|.||.+....+++.||||.+.+.... ..+-+.+|+.+|+.++|+|||.+++.|...+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-----chhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 45799999999999999999999999999999999864432 2355789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+|||||+||+|.+.+.+. .++|.+++.|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+....
T Consensus 347 VVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999999999774 49999999999999999999999999999999999999999999999999998876644
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
...+.+||++|||||++.. ..|+.++||||||++++||+-|++||-.
T Consensus 425 KR~TmVGTPYWMAPEVvtr-------k~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTR-------KPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccccccCCCCccchhhhhh-------cccCccccchhhhhHHHHHhcCCCCccC
Confidence 4456889999999999983 4689999999999999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.46 Aligned_cols=207 Identities=27% Similarity=0.481 Sum_probs=183.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|...+.||+|.||+||+|++.++|+.||||.++...... ..-....+||+.|+.++|+||+.++++|...+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 47889999999999999999999999999999998643221 122446789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
|+|||+ .+|...|++....|+..+++.++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+++.+.....
T Consensus 79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 999996 999999998888899999999999999999999999999999999999999999999999999998765332
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
....+-|..|.|||.+.+ ...|+..+||||.|||+.||+.|.+-|.+...+|
T Consensus 158 ~~~~V~TRWYRAPELLfG------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFG------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred cccceeeeeccChHHhcc------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 233478899999999986 5568889999999999999999998887766543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=322.62 Aligned_cols=197 Identities=30% Similarity=0.492 Sum_probs=170.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
+.||+|+||.||++.+..+|..||+|++..... ........+.+|+.+++.++|+||+++++.+...+.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 479999999999999999999999999864211 122345667789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-ccccccCC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKG 518 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~~~~~G 518 (571)
||+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......|
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99999988764 56999999999999999999999999999999999999999999999999998754322 22234679
Q ss_pred CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 519 T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 t~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CcCcCCccccc-------CCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 99999999986 335788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.34 Aligned_cols=205 Identities=30% Similarity=0.502 Sum_probs=177.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCC-cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG-~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....+|++.+.||+|+||.||+|.++.++ ..||+|.+..... ......+.+.+|+.+++.++|+||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 34568999999999999999999876654 6899998863211 11234566889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999999765 5699999999999999999999999999999999999999999999999999987643
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .....||+.|||||++.. ..++.++|||||||++|||++|+.||.+.+
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C--cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 2 234679999999999863 356789999999999999999999997643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=323.50 Aligned_cols=209 Identities=25% Similarity=0.391 Sum_probs=178.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+++++.+++.||+|++.... .........+.+|+.++..++|+||+++++++...+..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999886321 1112234557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999999876667999999999999999999999999999999999999999999999999999866543221
Q ss_pred --cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 --~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|++.|||||++...... ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDG--MGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeccccCCcccCCHHHHhccccC--CCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 235699999999998642211 235778999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.18 Aligned_cols=203 Identities=28% Similarity=0.433 Sum_probs=174.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyL 433 (571)
+|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+..|..++..+ +|++|+++++++...+.+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 58999999999999999999999999999999864211 1223345567788888777 58999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Ccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~ 512 (571)
||||+.||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999999999765 5699999999999999999999999999999999999999999999999999975432 222
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 158 TKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred cccCCCChhhcCHHHhc-------CCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 33567999999999986 3457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.90 Aligned_cols=197 Identities=30% Similarity=0.492 Sum_probs=171.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
+.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.+|+.++|+||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 469999999999999999999999999864221 123345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccCC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG 518 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~G 518 (571)
+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ........|
T Consensus 79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99999998764 5699999999999999999999999999999999999999999999999999876432 222234679
Q ss_pred CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 519 T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 158 t~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred CcCccChhhhc-------CCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 99999999986 335788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.54 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=181.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+..+.+.+|+.+++.++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 379999999999999999999999999999999874211 123345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999999887677999999999999999999999999999999999999999999999999999876543322
Q ss_pred --cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 --~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++...... ....++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 234699999999998643221 2345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.30 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=173.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIVkl~g~~~~~~~lyL 433 (571)
+|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+..|++++..+.| ++|+++++++...+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 58999999999999999999999999999999863211 112335667789999999975 568889999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-CCcc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-~~~~ 512 (571)
||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999999765 568999999999999999999999999999999999999999999999999987532 2223
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 158 TRTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred eeeecCCccccChhhhc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 33467999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.79 Aligned_cols=209 Identities=25% Similarity=0.407 Sum_probs=178.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+++++.+++.||+|++.... .........+..|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 37999999999999999999999999999999985311 1112234457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.||+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999987666799999999999999999999999999999999999999999999999999876543222
Q ss_pred -ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 -~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|||||++...... ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDG--KGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred eecccccCccccCHHHHhccccC--CCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 2235699999999998643211 345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.09 Aligned_cols=208 Identities=27% Similarity=0.457 Sum_probs=178.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||++.++.+++.||+|++..... ......+.+.+|+.+++.++|+||+++++.+..++.+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 45689999999999999999999999999999999863211 1122345577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999999999999753 58999999999999999999999999999999999999999999999999998764322
Q ss_pred c--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. .....||+.|||||++... .....++.++|||||||++|||++|+.||...
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ceecccCCCCcccCCHHHHhcc---CCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 1 2356799999999998642 11234788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.67 Aligned_cols=195 Identities=31% Similarity=0.454 Sum_probs=170.1
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|+||.||+|.+..+++.||||++..... ........+.+|+.+|++++|+||+++++.+...+.+|+||||+.||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 7999999999999999999999999863211 12234567788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccCCCC
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP 520 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~GT~ 520 (571)
+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999999764 5699999999999999999999999999999999999999999999999999875432 22233467999
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 ~y~aPE~~~-------~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 158 EYLAPELLL-------GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccCCHHHHc-------CCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 999999986 335788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.29 Aligned_cols=206 Identities=32% Similarity=0.535 Sum_probs=184.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~ 429 (571)
.....|++.+.||+|.||+||+|+.+.+|+.+|+|.+...... .....+.+.+|+.||+++. |+|||++++.|++.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3456899999999999999999999999999999998653322 1224577889999999998 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----CCcEEEEecCCcc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFGMAK 505 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~----~g~vKLiDFGlA~ 505 (571)
.+++|||+|.||+|++.|.+. .++|..+..+++||+.++.|||+.||+||||||+|||+.. ++.+|++|||++.
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999999876 3999999999999999999999999999999999999952 3579999999999
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........+||++|+|||++. ...|+..+||||+||++|.|++|..||.+..
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~-------~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLG-------GRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred EccCCceEeeecCCccccCchhhc-------CCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 988766667889999999999997 3578999999999999999999999998654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.09 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=173.6
Q ss_pred CeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ 430 (571)
+|++++.||+|+||+||++++. .+|+.||+|++...... ......+.+..|+.++++++ |+||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 5899999999999999998864 57899999998632111 12234566788999999995 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+||||+.||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999999764 56999999999999999999999999999999999999999999999999999865332
Q ss_pred c--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ......||+.|||||++.. ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 2 2234679999999999863 234678899999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.29 Aligned_cols=210 Identities=29% Similarity=0.440 Sum_probs=179.3
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.....+|++.+.||+|+||.||+|.++.+++.||+|++..... ......+.+.+|+.+++.++|+||+++++.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3345799999999999999999999999999999999863211 11223455778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999999999753 589999999999999999999999999999999999999999999999999987654
Q ss_pred Cc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ......||+.|||||++.... ....++.++|||||||++|||++|+.||...
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCcccccCcccCccccCHHHHhccC---CCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 32 223467999999999986421 1234788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.70 Aligned_cols=203 Identities=28% Similarity=0.523 Sum_probs=171.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----C
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~-----~ 429 (571)
+|++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+++++.++|+||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 58999999999999999999999999999998763221 122345678999999999999999999987643 2
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 4899999995 7899988764 5699999999999999999999999999999999999999999999999999986532
Q ss_pred Cc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. ......|+..|+|||++... ...++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 21 11245799999999998631 2357889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.59 Aligned_cols=207 Identities=29% Similarity=0.470 Sum_probs=181.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~l 431 (571)
++|+++..|++|+||+||+|+++.|++.||+|.++....... .---..+||.+|.+++|+|||.+.++.+- -+.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G---FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG---FPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC---CcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 489999999999999999999999999999999986543221 11234689999999999999999887654 4679
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|||||||+ -+|..++..-...+...+++.++.|+++||+|||.+.|+|||||++|+|+...|.+||+|||+|+.+...
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999997 8999999887778999999999999999999999999999999999999999999999999999988664
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
...+..+-|..|.|||.+.+ ...|+.++||||+|||+.||+++++-|.+...+|
T Consensus 232 k~~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred ccCcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 33456778999999999985 6689999999999999999999999998765543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.90 Aligned_cols=200 Identities=30% Similarity=0.514 Sum_probs=170.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHH---hhcCCCCeeEEeeeEEeCCeEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL---GHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL---~~L~HpNIVkl~g~~~~~~~ly 432 (571)
|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.++ +.++|+||+++++++...+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 7889999999999999999999999999999864211 1122345566666554 5667999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Cc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~ 511 (571)
+||||+.|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999999998865 4699999999999999999999999999999999999999999999999999875433 22
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|||||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLT-------ETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred cccccccCccccCHhHhc-------CCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 233567999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.87 Aligned_cols=210 Identities=30% Similarity=0.445 Sum_probs=178.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
....+|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 345689999999999999999999999999999999863211 112234557789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998753 5899999999999999999999999999999999999999999999999999876432
Q ss_pred c--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ......||+.|||||++.... ....++.++|||||||++|||++|+.||.+..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 2 123467999999999986421 12347889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.08 Aligned_cols=202 Identities=28% Similarity=0.477 Sum_probs=174.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|+++.+++.||||++...... ....+.+.+|+++++.++|+||+++++++..++.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 3799999999999999999999999999999998643221 2334667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+.++.|..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 78 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99999987766554 334579999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 157 NYTEYVATRWYRSPELLL-------GAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccccccccccCCcHHHc-------CCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 122356899999999986 235788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.74 Aligned_cols=206 Identities=27% Similarity=0.479 Sum_probs=170.1
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g 423 (571)
....++|++.+.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.+|..+ +|+||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence 345578999999999999999999752 44578999987532 1233456788999999999 8999999999
Q ss_pred eEEeC-CeEEEEEeecCCCCHHHHHHHhc---------------------------------------------------
Q 008285 424 SEVVD-DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (571)
Q Consensus 424 ~~~~~-~~lyLVmEy~~GGsL~d~L~~~~--------------------------------------------------- 451 (571)
++... +.+++||||+.+|+|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 87764 46899999999999999997531
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCC
Q 008285 452 ----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKG 518 (571)
Q Consensus 452 ----------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~G 518 (571)
..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... .....+
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 2377888999999999999999999999999999999999999999999999986543221 112345
Q ss_pred CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 519 T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+..|||||++. ...++.++|||||||+||||++ |..||.+.
T Consensus 239 ~~~y~aPE~~~-------~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 239 PLKWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred CccccCcHHhh-------cCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 67899999986 3357889999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.01 Aligned_cols=197 Identities=30% Similarity=0.489 Sum_probs=170.3
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
+.||+|+||.||+|.+..+|+.||+|++..... ........+..|+++++.++|+||+++++.+...+.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999864221 122345667789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.... ........
T Consensus 79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99999998764 569999999999999999999997 7999999999999999999999999999875432 22223457
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|||||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 158 GTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCcccCCHHHHc-------cCCCCCccccccccceeeeeccCCCCCCCC
Confidence 999999999986 335788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.53 Aligned_cols=196 Identities=28% Similarity=0.496 Sum_probs=170.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.++.+++.||||+++.... ......+.+..|+.++..+ +|+||+++++++.+.+.+|+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 479999999999999999999999999874221 1233456678899999988 6999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc-cCCccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l-~~~~~~~~~~ 517 (571)
.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. ..........
T Consensus 79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999999998765 57999999999999999999999999999999999999999999999999998753 2223334567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 158 GTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHc-------CCCCCCccceechHHHHHHHHHCCCCccc
Confidence 999999999986 33578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.35 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=176.1
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||+|+||.||++.+..+++.||||++..... ........+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 48899999999999999999999999999998863211 1122345567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 9999999999988654 346899999999999999999999999999999999999999999999999999876544433
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~y~aPE~~~-------~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 159 RGRVGTVGYMAPEVVK-------NERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred ccccCCCCccCcHHhc-------CCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 4567999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.57 Aligned_cols=211 Identities=30% Similarity=0.486 Sum_probs=174.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---------CcHHHHHHHHHHHHHHhhcCCCCeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------KSAECIKQLEQEIKVLGHLKHENIVQYY 422 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---------~~~~~~k~l~~Ei~IL~~L~HpNIVkl~ 422 (571)
..++|++++.||+|.||.|.+|.+..+++.||||++....... ....-++++.+||.||++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3468999999999999999999999999999999986433210 1111246889999999999999999999
Q ss_pred eeEEe--CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEe
Q 008285 423 GSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (571)
Q Consensus 423 g~~~~--~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiD 500 (571)
++..+ .+.+|||+|||..|.+...=.. ...|++.+++.++++++.||+|||.+|||||||||+|+||+++|+|||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 98765 3679999999999987553222 22399999999999999999999999999999999999999999999999
Q ss_pred cCCcccccC------CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 501 FGMAKHLTG------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 501 FGlA~~l~~------~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||.+..... .......+|||.|||||.+.... .....+++.||||+||+||.|+.|+.||-+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~---~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN---SFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCC---CccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999886622 22223478999999999887421 1345678999999999999999999999654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.94 Aligned_cols=201 Identities=29% Similarity=0.520 Sum_probs=178.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||++++..+|..+|+|.+.... .....+.+.+|+++|+.++|+||+++++++..++.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3568999999999999999999999999999999986421 234457789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
++||||++|++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999999764 5699999999999999999999986 6999999999999999999999999999766432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -ccccCCCCcCcCCHhHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 223457999999999986 33578899999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.00 Aligned_cols=197 Identities=31% Similarity=0.514 Sum_probs=166.2
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHH-HHHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei-~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|++..+|+.||||++..... ........+..|+ .+++.++|+||+++++.+.+.+.+|+|||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999999863211 1112233444554 4678899999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.|++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999999988764 5689999999999999999999999999999999999999999999999999875322 22233467
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 158 GTPEYLAPEVLR-------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CCcccCCHHHhc-------CCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=314.66 Aligned_cols=197 Identities=29% Similarity=0.511 Sum_probs=167.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.+..+++.||||+++..... .....+.+..|..++..+ +|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4799999999999999999999999998642111 112234455666677654 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........
T Consensus 79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999999765 5699999999999999999999999999999999999999999999999999986533 22333567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 158 GTPDYIAPEILK-------GQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCccccCHHHHc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.30 Aligned_cols=197 Identities=31% Similarity=0.499 Sum_probs=165.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHH-HHHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei-~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|++..+++.||+|++...... .......+..|. .+++.++|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 4799999999999999999999999998632111 111223344444 4568889999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.|++|.+++... ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999999764 5688999999999999999999999999999999999999999999999999975432 22233567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 158 GTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred CCccccCHHHHc-------CCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 999999999986 335778999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.70 Aligned_cols=197 Identities=28% Similarity=0.487 Sum_probs=169.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|+++.+++.||||++..... ......+.+..|+.++..+ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999999863211 1122345667888888876 6999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999999999765 5699999999999999999999999999999999999999999999999999875432 22333467
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 158 GTPDYIAPEILQ-------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cCccccCHHHHc-------CCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.25 Aligned_cols=197 Identities=33% Similarity=0.533 Sum_probs=166.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHH-HHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~-IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|.+..+|+.||||++..... ......+.+..|.. +++.++|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 479999999999999999999999999863211 11122344445544 567899999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999999764 5699999999999999999999999999999999999999999999999999875432 22333467
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 158 GTPEYLAPEVLR-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred CChhhcChhhhc-------CCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.34 Aligned_cols=197 Identities=29% Similarity=0.481 Sum_probs=169.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
++||+|+||.||+|+++.+|+.||||++..... ......+.+..|++++..+ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 469999999999999999999999999863211 1123345667888888866 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999999999765 5699999999999999999999999999999999999999999999999999875432 22233467
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 158 GTPDYIAPEILQ-------ELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cCccccCHHHHc-------CCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.38 Aligned_cols=198 Identities=30% Similarity=0.458 Sum_probs=168.7
Q ss_pred eEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|+||.||+|.+. .+++.||||++...... ........+.+|+++|+.++|+||+++++.+..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 68999999999999864 57889999998642111 112234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Cccccc
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELS 515 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~ 515 (571)
|+.|++|.+++... ..+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 99999999999765 5689999999999999999999999999999999999999999999999999875432 222334
Q ss_pred cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 516 ~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..|++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 160 FCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred cCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 679999999999863 34678999999999999999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.78 Aligned_cols=203 Identities=30% Similarity=0.504 Sum_probs=167.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECC-CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEe--
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV-- 427 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~-tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~-- 427 (571)
.+|++.+.||+|+||+||+|++.. +|..||+|.+......... ...+.+|+.+++.+ +|+||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 379999999999999999999854 4688999988754332211 23344566666655 69999999998753
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 428 ---~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
...+++||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 6899998754 34589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+.............|++.|+|||++. ...++.++|||||||++|||++|++||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred eEeccCCcccccccccccccChHHHh-------CCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 98765544444567999999999986 2357889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.94 Aligned_cols=206 Identities=32% Similarity=0.571 Sum_probs=180.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeCC--
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDD-- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~~-- 429 (571)
...|+.+++||+|+||+||+|+.+.+|+.||+|++....++.. .-....+|+.+|+.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 3468888899999999999999999999999999987554311 2244678999999999999 999999988877
Q ss_pred ----eEEEEEeecCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 430 ----HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 430 ----~lyLVmEy~~GGsL~d~L~~~~---~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.+++|+||++ .+|.+|+.... ..++...++.+++||+.||+|||++||+||||||.||||+..|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 8999999997 99999998765 358888999999999999999999999999999999999999999999999
Q ss_pred Cccccc-CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 503 MAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 503 lA~~l~-~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
+|+... +.......++|..|+|||++.+ ...|+...||||+|||+.||++++.-|.+...
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 999766 4444556789999999999985 45689999999999999999999999987543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.36 Aligned_cols=196 Identities=29% Similarity=0.508 Sum_probs=169.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.+..+++.||+|++..... ......+.+..|+.++.++ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 479999999999999999999999999874321 1234456678899888777 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999999988764 5699999999999999999999999999999999999999999999999999875422 22233467
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 158 GTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHc-------CCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 999999999986 33578899999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=316.01 Aligned_cols=197 Identities=32% Similarity=0.521 Sum_probs=166.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHH-HHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~-IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|.++.+|+.||||++..... ......+.+..|.. +++.++|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 469999999999999999999999999863211 11122344555554 567789999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|..++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999999998764 5799999999999999999999999999999999999999999999999999875432 23334567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++.|||||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 158 GTPEYLAPEVIR-------KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CChhhCCHHHHc-------CCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 999999999986 335778999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.22 Aligned_cols=202 Identities=28% Similarity=0.438 Sum_probs=172.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyL 433 (571)
+|+..+.||+|+||.||+|.++.+|+.||||++..... ......+.+..|+.++..+. |++|+++++++...+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 47889999999999999999999999999999863211 11233456778888888886 5778889999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+.||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999999999765 569999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 158 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 158 TRTFCGTPDYIAPEIIA-------YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred ccCccCCccccCHHHHc-------CCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 33456999999999986 335788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.97 Aligned_cols=196 Identities=28% Similarity=0.496 Sum_probs=170.5
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.+..+++.||+|++.... .......+.+.+|+.++.++ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 47999999999999999999999999987421 11233456688899999888 5999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-CCccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-~~~~~~~~~ 517 (571)
.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999999998764 569999999999999999999999999999999999999999999999999987532 223334567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 158 GTPNYIAPEILR-------GEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCcccCCHHHHC-------CCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 999999999986 34578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.81 Aligned_cols=201 Identities=35% Similarity=0.536 Sum_probs=177.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
-.|...+++|.|.||+||.|...++++.||||.+-.... .-.+|+++|+.++|||||+++.+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 368899999999999999999999999999998743221 2237999999999999999998776532
Q ss_pred -eEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCc
Q 008285 430 -HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA 504 (571)
Q Consensus 430 -~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA 504 (571)
...+|||||+ .+|.++++.. +..++...++-+++||++||+|||+.||+||||||.|||||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 2458999995 8999999753 5678999999999999999999999999999999999999955 99999999999
Q ss_pred ccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 505 ~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
+.+..+....+...|.+|+|||.+.+ ...|+.+.||||.|||+.||+.|++-|.+..++|
T Consensus 174 K~L~~~epniSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d 233 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD 233 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH
Confidence 99988888888889999999999985 6679999999999999999999999999877754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.83 Aligned_cols=205 Identities=30% Similarity=0.495 Sum_probs=177.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++..+++.||+|.||+||+|.+.. .||||++.... ...+.++.|++|+.++++.+|.||+-++|++...
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~---pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD---PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC---CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 33444567788999999999999999975 49999987533 3345889999999999999999999999998876
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.. .||..||+|.+|+.+|+.....|....++.|++||++||.|||.++|||||||..||++.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 66 99999999999999998777789999999999999999999999999999999999999999999999999987532
Q ss_pred ---CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 509 ---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 509 ---~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
+......-.|..-|||||+++. + | ...|++.+||||||||+|||++|..||.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRm--q-d-~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRM--Q-D-DNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhh--c-c-cCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 2222234457888999999983 2 2 4579999999999999999999999998
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=304.17 Aligned_cols=196 Identities=26% Similarity=0.419 Sum_probs=168.8
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|+||+||+|.++.+|+.||||.+..... ......+.+..|+++++.++|+||+++++++..++.+|+||||+.||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 7999999999999999999999998763211 12223456778999999999999999999999999999999999999
Q ss_pred CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-ccccC
Q 008285 442 SINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-ELSLK 517 (571)
Q Consensus 442 sL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~-~~~~~ 517 (571)
+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 99988753 234689999999999999999999999999999999999999999999999999976644322 23457
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 159 g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 159 GTPGFMAPELLQ-------GEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCcCccCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999986 335778999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.39 Aligned_cols=197 Identities=27% Similarity=0.481 Sum_probs=167.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.++.+|+.||+|+++..... .....+.+..|..++..+ +|+||+++++.+.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4799999999999999999999999998642110 112234566777787754 8999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999999764 5689999999999999999999999999999999999999999999999999875322 22234567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 158 GTPDYIAPEILQ-------GLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred CCcCccCHHHHc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999986 345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.94 Aligned_cols=197 Identities=25% Similarity=0.363 Sum_probs=172.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
....+|++.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++++|+||+++++++...+.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 34568999999999999999999999999999999643 1346789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.++|||++. ++|..++... ..+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999999995 7898888764 56899999999999999999999999999999999999999999999999999754322
Q ss_pred --ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 --SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 --~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||-+.+
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltg~~p~~~~~ 287 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLA-------RDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287 (391)
T ss_pred cccccccccCccCCCChhhhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcc
Confidence 1223467999999999986 3457889999999999999999998875443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.16 Aligned_cols=202 Identities=28% Similarity=0.495 Sum_probs=174.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|+++.+++.||||.++...... ....+.+|+++++.++|+||+++++++..++..|+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 57999999999999999999999999999999987533221 12346689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 999997 58888887766678999999999999999999999999999999999999999999999999987653322 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+++.|+|||++.. ...++.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred cccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223568899999999863 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.56 Aligned_cols=207 Identities=29% Similarity=0.532 Sum_probs=179.6
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.+....+.++.++.||+|-||.||+|.+.. ...||+|.++... ...+.+.+|+++|++|+|+|||++++++..
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 345556677788999999999999999975 3589999987432 223567799999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++.+|||||||..|+|.+||+. .+..+...+.+.++.||++||+||+++++|||||...||||+++..+||+|||||+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 8999999999999999999987 567799999999999999999999999999999999999999999999999999996
Q ss_pred ccCCccccccC--CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 008285 507 LTGLSYELSLK--GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (571)
Q Consensus 507 l~~~~~~~~~~--GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~eg 568 (571)
+.++.+....- -...|.|||.+. ...++.++|||||||+||||+| |+.||.++..
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 66655544332 345799999998 4579999999999999999999 9999987653
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=295.53 Aligned_cols=206 Identities=47% Similarity=0.890 Sum_probs=179.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
+.|++.+.||+|++|.||.|.+..+++.||+|.+.............+.+.+|++++++++|+||+++++++..++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 36899999999999999999999999999999987543333334445778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999999765 56899999999999999999999999999999999999999999999999998765432211
Q ss_pred ----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....|+..|+|||++.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred cccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 23457889999999863 347889999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=325.65 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=175.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCC-CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~t-G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++|+||+++++++..++.+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 34699999999999999999998887 788999976421 233446678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
||||||+.||+|.++|... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999999988642 3458999999999999999999999999999999999999999999999999998765
Q ss_pred CCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred CccccccccccCCCccccCHhHhC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 432 233467999999999886 346788999999999999999999999754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.45 Aligned_cols=201 Identities=29% Similarity=0.475 Sum_probs=173.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-eE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~-~l 431 (571)
.+.|....+||+|+||.||+|.... |..||||.+...... . .++|.+|+++|.+++|+|+|+++|+|.+.+ +.
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 3678888999999999999999765 589999976532211 1 355999999999999999999999999998 59
Q ss_pred EEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 432 YIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~G---IVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+||+|||.+|+|.++|..... .|+|....+|+.++|+||+|||... |||||||++|||+|++.+.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999999999999999987655 8999999999999999999999854 999999999999999999999999999765
Q ss_pred cC-Ccccccc-CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TG-LSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~-~~~~~~~-~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ....... .||.+|+|||++.. ..++.++|||||||+|+||++|+.+.+..
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~-------g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYAST-------GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccccceeeecCCCCccCChhhhcc-------CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 54 3322223 79999999999873 46889999999999999999999887643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.75 Aligned_cols=197 Identities=30% Similarity=0.479 Sum_probs=169.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|.+..+++.||||++..... ........+..|+++++.+ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999999864211 1123345667888999888 6999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999999998765 5699999999999999999999999999999999999999999999999999875322 22233456
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 158 g~~~y~aPE~~~-------~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 158 GTPDYIAPEILS-------YQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred cCccccCHHHhc-------CCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 999999999986 345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.74 Aligned_cols=196 Identities=27% Similarity=0.434 Sum_probs=168.5
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|+||.||++.++.+|+.||+|.+..... ......+.+..|++++++++|+||+++++.+..+..+|+||||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh--hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 7999999999999999999999998853211 11122344567999999999999999999999999999999999999
Q ss_pred CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCC
Q 008285 442 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (571)
Q Consensus 442 sL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~ 520 (571)
+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............|+.
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 9999886533 358899999999999999999999999999999999999999999999999998765544444567999
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 159 ~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 159 GYMAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CccCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999863 34788999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.66 Aligned_cols=201 Identities=29% Similarity=0.498 Sum_probs=166.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEe----
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV---- 427 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~---- 427 (571)
+|++.+.||+|+||+||+|.++.+|+.||+|.+......... ...+.+|+++++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 589999999999999999999999999999988653222111 12344566666554 79999999998764
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
...+++||||+. ++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 345899999997 58988887643 358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
............|+..|+|||++. +..++.++|||||||++|+|++|++||...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcccCCCccccccccCchHhh-------CCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 765444444567899999999986 335788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=312.35 Aligned_cols=201 Identities=24% Similarity=0.395 Sum_probs=171.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++|+||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 468999999999999999999999999999999886432 12334566778999999999999999999886543
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999974 56666643 488999999999999999999999999999999999999999999999999986
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccCccCCCCcccCCCCCchhcc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 65444444567899999999986 3357889999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.31 Aligned_cols=197 Identities=28% Similarity=0.494 Sum_probs=167.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||+||+|.+..+++.||||++...... .....+....|..++..+ +|+||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 4799999999999999999999999998642110 112234556677777764 8999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999999764 5689999999999999999999999999999999999999999999999999875422 22233567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 158 GTPDYIAPEILL-------GQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCccccCHHHHc-------CCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.80 Aligned_cols=210 Identities=28% Similarity=0.426 Sum_probs=181.6
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.......|++++.||.|.-|+||+|..+.++..+|+|++.... ......+.++..|-+||..++||.++.||..|+.+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~--l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES--LASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH--HhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3444568999999999999999999999999999999986422 22345567788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+..|++||||.||+|+.+++++ ++.+++..++.++..++.||+|||..|||+|||||+||||.++|++.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999865 567999999999999999999999999999999999999999999999999986432
Q ss_pred cC----------------------------------Cc-----------------------cccccCCCCcccChHHHHH
Q 008285 508 TG----------------------------------LS-----------------------YELSLKGSPNWMAPEVIKA 530 (571)
Q Consensus 508 ~~----------------------------------~~-----------------------~~~~~~GT~~YmAPEvl~~ 530 (571)
.- .. ...+++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 00 0124779999999999984
Q ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 531 ~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..++.++|+|+|||+|||||.|+.||.+..
T Consensus 310 -------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 310 -------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred -------CCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 457889999999999999999999998754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.59 Aligned_cols=196 Identities=29% Similarity=0.463 Sum_probs=169.2
Q ss_pred eEEeecCceEEEEEEE---CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~---k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|+||.||++.+ ..+|+.||+|++..... .......+..|+++|++++|+||+++++.+..++.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999999876 35789999999864221 11223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-ccccc
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELS 515 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~~~ 515 (571)
|+.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999999999764 56999999999999999999999999999999999999999999999999999865443 23335
Q ss_pred cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 516 ~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..|++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 158 FCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred ccCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCC
Confidence 679999999999862 34678999999999999999999999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.68 Aligned_cols=201 Identities=39% Similarity=0.621 Sum_probs=175.8
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|++++.||+|+||+||++.+..+++.||+|++.... ..........+|+.++++++|+||+++++++...+..++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999987432 11222334456999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc-cCCcccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYEL 514 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l-~~~~~~~ 514 (571)
||+.+++|.+++.. ...+++.++..++.||+.||++||++||+|+||||+|||++.++.++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999984 367999999999999999999999999999999999999999999999999999763 2233344
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...++..|+|||++.. ...++.++||||||+++|+|++|+.||.+.
T Consensus 157 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQ------GKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSGGGSCHHHHTT------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccc------cccccccccccccccccccccccccccccc
Confidence 5678999999999861 346788999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.93 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=175.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+.+|+.++++++|+||+.+++.+.+.+.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 37888999999999999999999999999998764221 1223345567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.|++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999986532 35899999999999999999999999999999999999999999999999998766543333
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 159 KGRVGTVGYMAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cCCCCCccccChHHHc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 3457999999999986 335788999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.90 Aligned_cols=203 Identities=42% Similarity=0.689 Sum_probs=183.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|...++||+|.||.||+|.+..+++.||||++.... ....++.+.+|+.+|.+++++||.++|+.|..+..+|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 447888899999999999999999999999999987532 2345678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
++||||.||++.+.++. +..+.|.++..++++++.||.|||.++.+|||||+.|||+..+|.|||+|||++..+.....
T Consensus 88 iiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999999976 35569999999999999999999999999999999999999999999999999988766433
Q ss_pred c-cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 E-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~-~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .+++||++|||||+++. ..|+.++||||||++.|||++|.+||.+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~-------~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQ-------SGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred ccccccccccccchhhhcc-------ccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 3 67899999999999983 358899999999999999999999998764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.13 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=175.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||+|+||+||+|.+..+|+.||+|.+..... ........+.+|+++|+.++|+||+.+++.+..++.+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 37889999999999999999999999999998863211 1122345567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 9999999999988654 246999999999999999999999999999999999999999999999999998765443333
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||.+. +..++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~g~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 159 RGRVGTVGYMAPEVLN-------NQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred cCCCCCcCccChHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 4567999999999986 335788999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.29 Aligned_cols=201 Identities=28% Similarity=0.523 Sum_probs=176.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||++.+..+|..+|+|.+.... .....+.+.+|+++++.++|+||+++++++.+++.+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 3568999999999999999999999999999999876422 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999999999764 5689999999999999999999975 7999999999999999999999999998765432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 223456899999999986 33578899999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.14 Aligned_cols=205 Identities=30% Similarity=0.510 Sum_probs=186.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe-E
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-L 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~-l 431 (571)
.+.|..++.+|+|+||.+++++++.++..+++|.+....... ...+...+|+.++.+++|||||.+++.|++++. +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 357999999999999999999999999999999987644332 223467899999999999999999999999999 9
Q ss_pred EEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|||+||+||+|.+.|.+.. ..++|+.+..++.||+.|+.|||+++|+|||||+.||+++.++.|||.|||+|+.+...
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999999997654 67999999999999999999999999999999999999999999999999999999876
Q ss_pred c-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ...+.+||+.||.||++. +..|..++|||||||++|||++=+.+|...+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhhhheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 6 666789999999999997 4579999999999999999999999998765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.35 Aligned_cols=203 Identities=30% Similarity=0.471 Sum_probs=169.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC----------------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~----------------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp 416 (571)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+++|..++|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCCC
Confidence 4689999999999999999998543 3457999987632 1234456788999999999999
Q ss_pred CeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 008285 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC------------------RDITESIVRNFTRHILNGLAYLHSTNT 478 (571)
Q Consensus 417 NIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~------------------~~Lse~~i~~I~~QIa~gL~yLHs~GI 478 (571)
||+++++++.+.+..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986531 236778899999999999999999999
Q ss_pred eecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHH
Q 008285 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555 (571)
Q Consensus 479 VHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyE 555 (571)
+||||||+|||++.++.+||+|||+++.+..... .....++..|||||++. ...++.++|||||||++||
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-------MGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-------cCCCCchhhhHHHHHHHHH
Confidence 9999999999999999999999999986643321 12334678899999986 2357889999999999999
Q ss_pred HHc--CCCCCCCC
Q 008285 556 MLT--GKPPWSEF 566 (571)
Q Consensus 556 LLt--Gr~PF~~~ 566 (571)
|++ +..||.+.
T Consensus 233 l~~~~~~~p~~~~ 245 (304)
T cd05096 233 ILMLCKEQPYGEL 245 (304)
T ss_pred HHHccCCCCCCcC
Confidence 986 66788754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.55 Aligned_cols=206 Identities=33% Similarity=0.544 Sum_probs=180.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-----C
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-----D 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-----~ 428 (571)
..|...+.||+|+||.|..+.++.+|+.||||.+..... .....++..+|+++|++++|+||+.+++.+.. -
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~---~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE---NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh---chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 366668999999999999999999999999998763332 34556888999999999999999999998766 3
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..+|+|+|+| +.+|...|+.. ..|++..+..+++||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+...
T Consensus 99 ~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 5689999999 49999999774 459999999999999999999999999999999999999999999999999999885
Q ss_pred C---CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 509 G---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 509 ~---~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
. ....+..+-|..|.|||++.. ...|+.+.||||+|||+.||++|++-|.+.+.++
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLN------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhc------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 4 333456778999999999964 4568999999999999999999999999877654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.79 Aligned_cols=199 Identities=30% Similarity=0.525 Sum_probs=167.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
...+|++++.||+|+||+||+|.+..+++.||||.+.... ....+|+.+|+.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 3458999999999999999999999999999999875211 2234799999999999999998876432
Q ss_pred -----CeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEE
Q 008285 429 -----DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLA 499 (571)
Q Consensus 429 -----~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLi 499 (571)
..+++||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 24679999997 567777653 346799999999999999999999999999999999999998654 79999
Q ss_pred ecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 500 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 500 DFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|||+++.+..........||+.|+|||++.+ ...++.++|||||||++|||++|++||.+.
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987765554556779999999999863 335788999999999999999999999764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=295.28 Aligned_cols=205 Identities=22% Similarity=0.416 Sum_probs=173.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
...+|++.+.||+|+||.||+|.++ ..+..||+|.++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 3458999999999999999999865 446789999876422 223456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+..++||||+.+|+|.+++......+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999998765679999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 509 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... ...++..|+|||.+.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 222111 2335678999998863 357889999999999999875 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=291.61 Aligned_cols=205 Identities=46% Similarity=0.843 Sum_probs=175.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~l 431 (571)
.+|++.+.||+|+||.||+|.+..+|..||||.+.............+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998864333333345567889999999999999999999987763 568
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
++||||+.|++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8999999999999999765 458999999999999999999999999999999999999999999999999987654311
Q ss_pred ----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|+..|+|||.+. +..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVIS-------GEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccCCCCccccChhhhc-------CCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 122345889999999886 234678999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.76 Aligned_cols=199 Identities=21% Similarity=0.403 Sum_probs=164.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC------CCeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH------ENIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H------pNIVkl~g~~ 425 (571)
...+|++.+.||+|+||+||+|.+..+++.||||+++... ...+....|+++++.++| .+|+.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3568999999999999999999999999999999986321 223345567777766654 4588888887
Q ss_pred EeC-CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC---------
Q 008285 426 VVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG--------- 494 (571)
Q Consensus 426 ~~~-~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g--------- 494 (571)
..+ +.+|||||++ |++|.+++.+. +.+++..++.|+.||+.||+|||. .|||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 764 5789999988 68899988765 579999999999999999999997 5999999999999998665
Q ss_pred -------cEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 495 -------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 495 -------~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.+||+|||++..... .....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL-------GLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhh-------cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864332 233567999999999987 3458889999999999999999999997644
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.70 Aligned_cols=202 Identities=24% Similarity=0.373 Sum_probs=172.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 3468999999999999999999999999999999876422 2234456778899999999999999999987654
Q ss_pred ---CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
...|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 92 ~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 92 EEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 35799999997 467666643 48899999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
............||..|+|||++. +..++.++|||||||++|+|++|+.||.+.+
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cCCCccccCCccccCCccCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 765544444567999999999986 3357889999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.49 Aligned_cols=196 Identities=28% Similarity=0.412 Sum_probs=165.3
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
||+|+||+||+|+++.+|+.||||++..... ...........|..++..+ +|+||+++++.+...+.+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999853211 1112234455666777655 6999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-CccccccC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~~~~~~ 517 (571)
.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999999764 5699999999999999999999999999999999999999999999999999875432 23334567
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||..|||||++.. ...++.++|||||||++|+|++|+.||...
T Consensus 158 gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 158 GTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 9999999999863 234678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.93 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=172.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 468999999999999999999999999999999876422 1233456678899999999999999999887543
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 35799999997 567777753 488999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........||..|+|||++. +..++.++|||||||++|+|++|+.||.+.+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHh-------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 65544444567999999999986 3457889999999999999999999997653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.38 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=172.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-----
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----- 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~----- 429 (571)
+|++++.||+|+||.||+|.+..+|+.||||.+.... ......+++.+|+++++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 4788999999999999999999999999999875322 12234567889999999999999999999988776
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 7899999996 6788888654 5699999999999999999999999999999999999999999999999999986543
Q ss_pred Cc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ......++..|+|||++.+ ...++.++|||||||++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 22 2223568899999999863 234788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=287.07 Aligned_cols=206 Identities=56% Similarity=0.975 Sum_probs=181.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||+||+|.+..++..|++|.+..........+..+.+.+|+++++.++|+||+++++++...+.+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999998999999999875444444456678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
|||+.+++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999999999775 468999999999999999999999999999999999999999999999999988765544334
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...|+..|++||.+.. ...++.++|+|||||++|+|++|+.||....
T Consensus 160 ~~~~~~~y~~pe~~~~------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 160 SFKGSPYWMAPEVIAQ------QGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ccCCCcceeCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 5668999999999853 1137889999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.84 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=176.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~- 429 (571)
....+|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 345699999999999999999999999999999999864322 2345567889999999999999999988765432
Q ss_pred -------eEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEE
Q 008285 430 -------HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (571)
Q Consensus 430 -------~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLi 499 (571)
.+++||||+.+|+|.++|... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999753 3468999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCC---ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 500 DFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 500 DFGlA~~l~~~---~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|||+++.+... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-------RKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999865432 2223467999999999986 345789999999999999999999999753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=285.89 Aligned_cols=202 Identities=31% Similarity=0.529 Sum_probs=177.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|.+.+.||+|++|.||+|.+..+|+.|++|.+..... .....+.+.+|+++++.++|+||+++++.+...+..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 58899999999999999999999999999998864321 234456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
|||+.|++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999999875 45789999999999999999999999999999999999999999999999999887654322
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 158 ANTIVGTPYYLSPELCE-------DKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred hhccccCccccCHHHhc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 23456889999999886 335678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.21 Aligned_cols=206 Identities=31% Similarity=0.538 Sum_probs=181.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
.-|...+.||+|+||.||+++++++|+.||||.++... ...-.+...+|+++|++|.|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 56888899999999999999999999999999886432 2233567789999999999999999998765543
Q ss_pred --eEEEEEeecCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--C--CCcEEEEec
Q 008285 430 --HLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--A--SGVVKLADF 501 (571)
Q Consensus 430 --~lyLVmEy~~GGsL~d~L~~--~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd--~--~g~vKLiDF 501 (571)
...+|||||.||+|+.++.+ +...|++.+++.++.++..||.|||++||+||||||.||++. + .-.-||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 45899999999999999973 556799999999999999999999999999999999999984 2 236899999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egv 569 (571)
|.|+.+.++....+++||..|++||++.. ...|+..+|.|||||++|++.||..||.-+.|.
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99999999888899999999999999874 457899999999999999999999999877764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.60 Aligned_cols=206 Identities=30% Similarity=0.502 Sum_probs=187.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..-|.+.+.||+|-|.+|.++++..+|+.||||+++....+. ..-..+.+|+.-|+.++|||||++|++......+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 346888999999999999999999999999999998655442 23466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~l~~~~ 511 (571)
||+|+-++|+|++||-++...+.|+.+++++.||+.||.|+|+..+|||||||+||+|. .-|-|||.|||++-.+..+.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999998888899999999999999999999999999999999999875 55899999999999888888
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...+.+|+..|-|||++.+ ..+...++||||||||||-|++|++||.+..
T Consensus 174 kL~TsCGSLAYSAPEILLG------DsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLG------DSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred hhhcccchhhccCchhhhc------CccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 8889999999999999985 3345678999999999999999999998754
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=286.88 Aligned_cols=205 Identities=39% Similarity=0.636 Sum_probs=179.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... ....+.+.+|+++++.++|+||+++++.+...+.+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 358999999999999999999999999999999987432 224577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
++|||+.+++|.+++......+++.++..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999999999998765779999999999999999999999999999999999999999999999999988665422
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......++..|+|||.+.... ...++.++|||||||++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~----~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVER----KGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred ccccccCCccccCchhhcccc----cCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 223456888999999886311 125678999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=296.55 Aligned_cols=203 Identities=28% Similarity=0.482 Sum_probs=175.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 458999999999999999999999999999999986433221 1234668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9999997 68999988766679999999999999999999999999999999999999999999999999987643322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......+++.|+|||++.. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred cccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2223457889999998863 335778999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.79 Aligned_cols=211 Identities=28% Similarity=0.514 Sum_probs=191.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---CcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~ 428 (571)
...|...+.||.|..++|.+|.++.+|+.+|+|++....... ...+..+...+|+.||+++. ||+|+++.+.|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346777789999999999999999999999999987654332 23445666788999999995 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..+++|+|+|.-|.|+|||.+. -.++|++.+.|++||+.|+.|||.++||||||||+|||++++-++||+|||+++.+.
T Consensus 96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999886 569999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.+......+|||+|+|||.+.+.+.. +...|+..+|+|++|||||.||-|-+||+.
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e-~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYE-NHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred CchhHHHhcCCCcccChhheeeeccc-CCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 88888889999999999999876654 477899999999999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=294.37 Aligned_cols=202 Identities=32% Similarity=0.589 Sum_probs=177.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||++.+..+++.||+|++..... ......+.+.+|+++|++++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 379999999999999999999999999999998863211 122345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||||+.++.+||+|||++...... .
T Consensus 79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 99999999999999775 57999999999999999999999999999999999999999999999999999876554 3
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....|++.|+|||.+.. ..++.++||||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 156 YTLCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCCCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 34568999999998852 246778999999999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.96 Aligned_cols=207 Identities=29% Similarity=0.488 Sum_probs=172.7
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG-----~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~ 422 (571)
+....++|++++.||+|+||.||+|++..+| ..||||.+.... .....+.+.+|+++++.+ +|+||++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3445668999999999999999999865443 579999886322 223456788999999999 899999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------------------------------------------
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~--------------------------------------------------- 451 (571)
+++...+.+|+|||||.+|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986431
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 452 ------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 452 ------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24788889999999999999999999999999999999999999999999999865432211
Q ss_pred ---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 514 ---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 514 ---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
....++..|||||++. ...++.++|||||||++|||++ |+.||...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 269 VVKGNARLPVKWMAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eeccCCCCccceeCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 1223556799999986 3457889999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.54 Aligned_cols=205 Identities=30% Similarity=0.555 Sum_probs=182.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.-++|.+++.||+|-||.||+|+.+.++-.||+|++.... -......+++.+|++|...|+||||+++|++|.++..+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3458999999999999999999999999999999975322 12233457789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|+++||...|+|+..|.+. ...+++...+.++.|++.||.|+|..+||||||||+|+|++..+.+||+|||.+.... .
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence 9999999999999999843 4569999999999999999999999999999999999999999999999999997765 3
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....+.+||..|++||+.. +..++..+|+|++|++.||++.|.+||...
T Consensus 177 ~kR~tlcgt~dyl~pEmv~-------~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVE-------GRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCceeeecccccCCHhhcC-------CCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 4445789999999999987 345778999999999999999999999754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.92 Aligned_cols=200 Identities=30% Similarity=0.520 Sum_probs=177.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-C-----CCeeEEeeeEEe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-H-----ENIVQYYGSEVV 427 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-H-----pNIVkl~g~~~~ 427 (571)
.+|.+.+.||+|+||.|.+|.+..|++.||||+++. ......+...|+.||.+|+ | -|||+++++|..
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 389999999999999999999999999999999873 3456677788999999996 4 489999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEEecCCc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMA 504 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~g~vKLiDFGlA 504 (571)
.+++|||+|++. .+|.++|+.+ ...|+...++.|+.||+.||.+||+.||||+|||||||||.. ...|||+|||.+
T Consensus 260 r~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999995 9999999864 455999999999999999999999999999999999999963 348999999999
Q ss_pred ccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 008285 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569 (571)
Q Consensus 505 ~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egv 569 (571)
+.....-+ ..+-+..|+|||++. +..|+.+.||||||||+.||++|.+-|.+....
T Consensus 339 c~~~q~vy--tYiQSRfYRAPEVIL-------GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 339 CFESQRVY--TYIQSRFYRAPEVIL-------GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cccCCcce--eeeeccccccchhhc-------cCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 98766544 567788999999998 457899999999999999999999889776543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.07 Aligned_cols=195 Identities=35% Similarity=0.629 Sum_probs=175.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.......++-||+|+.|-||+|+.+ ++.||||.++ +.-+.+|+-|++|+|+||+.+.|+|...-.+
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------------elkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------------ELKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc--CceehhHHHh------------hhhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 3334455677999999999999875 6889999765 2234688999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
+||||||..|-|..+|+.. ..++...+..+.++|+.||.|||.+.|||||||.-||||..+..|||+|||.++......
T Consensus 188 CIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred EEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 9999999999999999874 678889999999999999999999999999999999999999999999999999988877
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
..-.++||..|||||+++ +...++|+|||||||||||||||..||.+.+.
T Consensus 267 TkMSFaGTVaWMAPEvIr-------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIR-------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred hhhhhhhhHhhhCHHHhh-------cCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 777899999999999998 56789999999999999999999999998764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=289.01 Aligned_cols=205 Identities=38% Similarity=0.624 Sum_probs=176.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++++++|+||+++++.+..++.+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 3458999999999999999999999999999999986422 12235677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999999999999764 568999999999999999999999999999999999999999999999999998664322
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|+..|+|||.+... ....++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred cccCccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 22345688999999987531 1334678999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=290.81 Aligned_cols=203 Identities=32% Similarity=0.547 Sum_probs=172.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|++|.||+|++..+|+.||||.+.....+ ....+.+.+|+.+++.++|+||+++++++.+++.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 589999999999999999999999999999988643222 12235677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99997 68988886532 568999999999999999999999999999999999999999999999999987553321
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......+++.|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cccCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1223457889999998863 2346789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=285.37 Aligned_cols=201 Identities=30% Similarity=0.545 Sum_probs=176.1
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||++.+..+++.+|+|.++... .....+.+.+|+.+++.++|+||+++++.+..++.+|++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5899999999999999999999999999999986432 123456778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999999998653 4558999999999999999999999999999999999999999999999999997664422 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++.. ..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-------MPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred cccccCCccccCHHHHcc-------CCcCchhhhhhhchhheehhhccCCCCCC
Confidence 234568999999999863 35788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.11 Aligned_cols=204 Identities=32% Similarity=0.552 Sum_probs=175.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|++++++++|+||+++++.+...+..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 3799999999999999999999999999999988643221 1223557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||++++.|..++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... .
T Consensus 78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99999988888877543 469999999999999999999999999999999999999999999999999998765533 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++..|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 157 YTDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ccCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 234557889999999863 2356789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.55 Aligned_cols=204 Identities=29% Similarity=0.474 Sum_probs=183.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...+.|++-+.||+|.|++||+|.+..+|+.+|+|.+....-. ....+++.+|+.|.+.|+||||+++.+.+.+++.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---cccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 3456899999999999999999999999999999988654322 2256789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~l 507 (571)
.|||+|+|+|++|..-|-+. ..++|..+-.+++||+.+|.|+|.+||||||+||+|+|+. ....+||+|||+|..+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999999998777554 4589999999999999999999999999999999999994 4457999999999999
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.+......++|||.|||||+++ ...|+..+|||+-|||||-||.|.+||++
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvr-------kdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred CCccccccccCCCcccCHHHhh-------cCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 8777777899999999999998 55789999999999999999999999987
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=292.54 Aligned_cols=207 Identities=36% Similarity=0.610 Sum_probs=179.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+++++.++|+||+++++.+..++.+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 4799999999999999999999989999999998642 23445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+.+++|.+++.+....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999998766779999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....|+..|++||.+..... ....++.++|||||||++|||++|+.||.+.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred cceeecchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 233568999999999863211 12346789999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.19 Aligned_cols=203 Identities=31% Similarity=0.509 Sum_probs=172.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcE----EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~----VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||.||+|++..+|.. ||+|.+... ......+.+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 356899999999999999999998766664 888887521 223445678899999999999999999998876
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+..++|+||+.+|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4578999999999999999887667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcccc---ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~---~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
....... ...++..|+|||.+. ...++.++|||||||++|||++ |+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred cCCCcceeccCCccceeecChHHhc-------cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 5433221 223466799999986 3457889999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.90 Aligned_cols=200 Identities=39% Similarity=0.696 Sum_probs=183.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.-|.+++.||+|+||.||++.++++|+.+|||.+... ..++++..|+.||++++.+++|++||.|.....+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 4688899999999999999999999999999987642 236778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Ccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~ 512 (571)
|||||..|++.+.++.....|+|.++..+++..++||+|||...-||||||..|||++.+|..||+|||.|-.+.+ ...
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999987765 344
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.++..||+.|||||++... .|..++||||||++.+||..|++||.+..
T Consensus 186 RNTVIGTPFWMAPEVI~EI-------GY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEI-------GYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hCccccCcccccHHHHHHh-------ccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 4578899999999999854 47789999999999999999999998764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.73 Aligned_cols=205 Identities=47% Similarity=0.876 Sum_probs=175.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY 432 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~ly 432 (571)
.|++.+.||+|+||.||+|.+..+|..|++|.+.............+.+.+|+.+++.++|+||+++++.+.. .+.++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6899999999999999999999999999999887544333344556778999999999999999999998765 36789
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
++|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999764 458999999999999999999999999999999999999999999999999987653311
Q ss_pred ---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|+|||.+. +..++.++|||||||++|||++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVIS-------GEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred cCCccccCCccccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 112345888999999885 2356789999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=293.02 Aligned_cols=206 Identities=29% Similarity=0.491 Sum_probs=176.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|.+..+|+.||||.+...............+..|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 48899999999999999999999999999999875433222233456677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
|||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999997754479999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....++..|+|||.+.. ...++.++|||||||++|||++|.+||.+..
T Consensus 160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 160 THQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred cccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 23457888999998852 3356889999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.90 Aligned_cols=206 Identities=45% Similarity=0.842 Sum_probs=175.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~l 431 (571)
..|++.+.||+|+||.||+|.+..+|..||+|.+.............+.+.+|++++++++|+||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998754322222344567888999999999999999999988764 468
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999999999765 458999999999999999999999999999999999999999999999999998654311
Q ss_pred ----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 1123568899999998862 346788999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=284.96 Aligned_cols=203 Identities=33% Similarity=0.561 Sum_probs=175.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|++..+|+.||||.+..... ........+.+|+++++.++|+||+++++.+.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 479999999999999999999999999999998764221 223445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999998853 2345899999999999999999999999999999999999999999999999998876543
Q ss_pred cc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.. .....|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hHHHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 22 123568899999998863 3467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.02 Aligned_cols=201 Identities=25% Similarity=0.463 Sum_probs=171.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++.+.||+|+||+||+|.+..+++.||||.+.... ......+.+.+|+.+|++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 358999999999999999999999999999999875321 1223345677899999999999999999877543
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+|++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3579999998 7899888754 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||..|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred cCCC--cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 6542 234578999999999863 2357889999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=293.05 Aligned_cols=208 Identities=37% Similarity=0.610 Sum_probs=179.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.+.|++.+.||.|+||.||+|.+..+++.|++|.+.. ......+.+.+|+.+++.++|+||+++++.+..++.+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 4579999999999999999999999999999999763 22345677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+.|++|..++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999999999887766779999999999999999999999999999999999999999999999999987543322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|+|||++...... ...++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMK--DTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ccceecCCccccCceeecccccc--CCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 12345688999999987532111 2346789999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.37 Aligned_cols=196 Identities=28% Similarity=0.505 Sum_probs=167.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
+.||+|+||.||+|+++.+|+.||+|.+... ...+....+.+|+++++.++|+||+++++++...+.+|+||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 4699999999999999999999999986521 223455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc---cc
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL 516 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~---~~ 516 (571)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999999998766679999999999999999999999999999999999999999999999999987654322111 11
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.++..|+|||.+. +..++.++|||||||++|||++ |..||...
T Consensus 157 ~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 157 QIPVKWTAPEALN-------YGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCceeecCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 2345699999885 3357889999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=308.19 Aligned_cols=206 Identities=28% Similarity=0.473 Sum_probs=171.8
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g 423 (571)
.....+|++++.||+|+||+||+|++ ..++..||||+++... .....+.+.+|+.+|+.+ +|+||+++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 34456899999999999999999974 3457789999876322 123346788999999999 7999999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhc----------------------------------------------------
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------- 451 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------------------------------------------- 451 (571)
++...+..++|||||.||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 452 ----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 452 ----------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1477888999999999999999999999999999999999999999999999986644
Q ss_pred Cccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ....++..|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccccccCCCCCCcceeChhHhc-------CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 3211 1233556799999986 3457889999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.84 Aligned_cols=202 Identities=29% Similarity=0.484 Sum_probs=170.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcE----EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~----VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..+|++.+.||+|+||+||+|.+..+|.. +++|.+. .........++..|+.+++++.|+||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 45899999999999999999999887775 5566543 1222344567888999999999999999999875 4
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
...+++|||+.+|+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 56789999999999999998776789999999999999999999999999999999999999999999999999998654
Q ss_pred CCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... .....++..|++||.+. ...++.++|||||||++|||++ |+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESIL-------FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhc-------cCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 3221 12344677899999886 2357889999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.64 Aligned_cols=204 Identities=28% Similarity=0.487 Sum_probs=173.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|++|.||+|.++.+++.||||.+....... ....+.+|+++++.++|+||+++++++.+++..|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 358999999999999999999999999999999986432221 1233567999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9999997 5999999876667899999999999999999999999999999999999999999999999998754321 1
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122347888999998763 2346789999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.41 Aligned_cols=205 Identities=49% Similarity=0.851 Sum_probs=176.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC----cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~----~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+........ ..+..+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47888999999999999999999999999998864332211 22345678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.++||||+.+++|.+++... ..+++..+..++.||+.||+|||++|++||||+|+|||++.++.++|+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999998876531
Q ss_pred c-------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 S-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~-------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ......|+..|+|||.+. ...++.++|||||||++|+|++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVK-------QTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccCCccccccccCCCcCccChhHhc-------cCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 1 111345888999999886 3356788999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.09 Aligned_cols=200 Identities=31% Similarity=0.535 Sum_probs=170.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||++.++. +..+|+|.+.... ...+.+.+|+++|+.++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 579999999999999999998764 5689999865221 113567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999999865557899999999999999999999999999999999999999999999999998865433222
Q ss_pred --cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 514 --~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
....++..|+|||++. ...++.++||||||+++|||++ |+.||....
T Consensus 157 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFN-------FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred ccCCCCCchhhCChhhcc-------cCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 1233566899999985 2357789999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.62 Aligned_cols=205 Identities=29% Similarity=0.479 Sum_probs=176.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+..|+++++.++|+||+++++.+...+..|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 37999999999999999999999999999999986422 1223456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
||||+.|++|.+++... ...+++..+..++.||+.||+|||++|++|+||||+||||+.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999999753 3568999999999999999999999999999999999999999999999999987543211
Q ss_pred -----------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008285 512 -----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (571)
Q Consensus 512 -----------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P 562 (571)
......|+..|+|||++. +..++.++||||||+++|+|++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-------GDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 111346889999999986 33568899999999999999999999
Q ss_pred CCCCC
Q 008285 563 WSEFE 567 (571)
Q Consensus 563 F~~~e 567 (571)
|.+.+
T Consensus 232 f~~~~ 236 (316)
T cd05574 232 FKGSN 236 (316)
T ss_pred CCCCc
Confidence 97554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.79 Aligned_cols=196 Identities=31% Similarity=0.559 Sum_probs=171.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+++.||||.+.... .....+.+.+|++++++++|+||+++++.+...+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 36889999999999999999999999999999886321 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.+++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... .
T Consensus 77 v~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~ 150 (279)
T cd06619 77 CTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-A 150 (279)
T ss_pred EEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-c
Confidence 9999999999654 347888999999999999999999999999999999999999999999999998664432 2
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 151 ~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 151 KTYVGTNAYMAPERIS-------GEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred cCCCCChhhcCceeec-------CCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 3457999999999886 235788999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.11 Aligned_cols=206 Identities=36% Similarity=0.599 Sum_probs=177.1
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.++|+||+++++.+..++..|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 478889999999999999999999999999987532 234456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
|||+.+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99999999999887655679999999999999999999999999999999999999999999999999987653321 22
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....|+..|+|||++...... ...++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSK--DRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccccccccccCHhhccccCCC--CCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 345689999999998532211 3356789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=293.11 Aligned_cols=199 Identities=30% Similarity=0.512 Sum_probs=175.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||++.+..+|..+|+|.+.... .....+++.+|++++++++|+||+++++.+.+++.+|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 37999999999999999999999999999999876321 23445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
||||++|++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+|||++.++.+||+|||++.......
T Consensus 77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999999999765 668999999999999999999997 699999999999999999999999999987654322
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.....|+..|+|||.+. +..++.++|||||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ANSFVGTRSYMSPERLQ-------GTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cccCCCCcCccChhHhc-------CCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 23467899999999875 23477899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=288.25 Aligned_cols=204 Identities=38% Similarity=0.637 Sum_probs=176.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++|+||+++++.+...+.+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 458999999999999999999999999999999986432 123455778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+.+++|.+++... +.+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999999999765 569999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|+..|+|||++... ....++.++|||||||++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 12345689999999987421 1234678999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=281.48 Aligned_cols=202 Identities=29% Similarity=0.532 Sum_probs=177.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||.|+||.||.+++..+++.+++|.+...... ....+.+.+|++++++++|+||+++++++.+.+.++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 589999999999999999999999999999988643221 23456678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999999764 4568999999999999999999999999999999999999999999999999998664433 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred ccccCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 234568999999998762 34677899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=305.64 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=182.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|..+++||+|.||+|.+|+.+.+|+.||||+++... -...+.+..-..|-.+|+..+||.+..+...|...+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 4568999999999999999999999999999999876321 12234456677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc-ccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~-l~~~ 510 (571)
|+||||..||.|+.+|.. .+.++|..++.+...|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++. +...
T Consensus 244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999999999999965 46799999999999999999999999999999999999999999999999999985 4556
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++|||.|+|||++.. ..|+.++|+|.+|||||||++|++||.+-+
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-------nDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ceeccccCChhhcCchhhcc-------ccccceeehhhhhHHHHHHHhccCcccccc
Confidence 66678999999999999973 368899999999999999999999997543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.62 Aligned_cols=196 Identities=22% Similarity=0.322 Sum_probs=168.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----CCeEEEEE
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYL 435 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----~~~lyLVm 435 (571)
..||+|++|.||+|.+ +|+.||||.+.... .......+.+.+|+.+|++++|+||+++++++.+ ...+++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH--KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc--cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 5799999999999987 58999999886432 2334456778899999999999999999999876 34689999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
||+.||+|.+++.+. ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+.... .
T Consensus 102 Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~ 178 (283)
T PHA02988 102 EYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--F 178 (283)
T ss_pred EeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--c
Confidence 999999999999774 568999999999999999999998 499999999999999999999999999998664432 2
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...|+..|+|||++... ...++.++|||||||++|||++|+.||.+..
T Consensus 179 ~~~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred cccCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 45688999999998642 2467899999999999999999999998653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.86 Aligned_cols=202 Identities=27% Similarity=0.473 Sum_probs=172.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCC-----cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG-----~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 47999999999999999999876655 67999987532 2234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+..|++|||+.+++|.+++.... ..+++.++..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 99999999999999999997532 357889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+.++|+|||++....... ......+++.|+|||.+. ...++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-------YGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhc-------cCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999997653322 122345678899999885 3357889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.42 Aligned_cols=200 Identities=34% Similarity=0.542 Sum_probs=171.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|++..+|+.||+|.+...... ......+.+|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 588999999999999999999999999999998643221 12235567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
|||+. ++|.+++......+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 99997 58888887656679999999999999999999999999999999999999999999999999988654322 22
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
....++..|+|||++.+ ...++.++|||||||++|+|++|..||.
T Consensus 157 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 157 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 23567889999999863 3346789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.21 Aligned_cols=194 Identities=28% Similarity=0.499 Sum_probs=159.9
Q ss_pred eeEEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeEEEE
Q 008285 359 GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIY 434 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~lyLV 434 (571)
++.||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+++|++++|+||+++++.+.. +..+|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999976 4678999998753211 2346789999999999999999998864 4568999
Q ss_pred EeecCCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEEecC
Q 008285 435 LEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFG 502 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~--------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL----d~~g~vKLiDFG 502 (571)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99996 6888887532 1258999999999999999999999999999999999999 456799999999
Q ss_pred CcccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 503 MAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+++...... ......||+.|+|||++.+ ...++.++|||||||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 998664321 1234578999999999863 235788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=314.78 Aligned_cols=208 Identities=27% Similarity=0.411 Sum_probs=185.2
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....+.|...++||+||||.||-|+.+.||+.||+|.+..... +.........+|-.||.++..+.||.+-..|+..+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH--HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 4456789999999999999999999999999999998753211 11122344568999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.+++||..|.||+|.-+|.+.+ ..+++..++.++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999999997754 359999999999999999999999999999999999999999999999999999998
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........+||.+|||||+++ +..|++..|+|+|||+||||+-|+.||...
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~-------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQ-------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCccccccCcccccCHHHHc-------CCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 888887889999999999998 456999999999999999999999999743
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=285.47 Aligned_cols=202 Identities=28% Similarity=0.532 Sum_probs=173.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.++.+++.||+|.+... ....+.+.+|+++++.++|+||+++++.+..++.+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 445799999999999999999999999999999987521 12245688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999997643 45899999999999999999999999999999999999999999999999999876543
Q ss_pred cccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ...++..|+|||.+. ...++.++|||||||++|||++ |..||.+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred eeeccCCCCCccccCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 2221 223456799999886 3357789999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.71 Aligned_cols=192 Identities=23% Similarity=0.374 Sum_probs=168.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++++|+|||++++++...+..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457999999999999999999999999999999532 123568999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+|||++. ++|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999995 78999887765679999999999999999999999999999999999999999999999999998664322
Q ss_pred --cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 512 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 512 --~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
......||+.|||||++. +..++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~-------~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLA-------GDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122456999999999986 335788999999999999999987654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.91 Aligned_cols=206 Identities=36% Similarity=0.667 Sum_probs=174.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~--- 428 (571)
...|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +|+||+++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4578999999999999999999999999999999864321 135677899999998 699999999988753
Q ss_pred ---CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 429 ---DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
+.+|+||||+.+++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999864 346899999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...... .......|+..|+|||++..... ....++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 865432 22234668999999999863211 1345788999999999999999999999754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=330.60 Aligned_cols=205 Identities=24% Similarity=0.381 Sum_probs=175.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.++||+|+||.||+|.+..+|+.||||++.... .......+++.+|+++++.++|+||+++++++.+.+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 48999999999999999999999999999999986322 1223445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 434 YLEYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~----------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
||||++|++|.+++... ...++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999998642 12355677889999999999999999999999999999999999999999999
Q ss_pred cccccCCc-------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 504 AKHLTGLS-------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 504 A~~l~~~~-------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
++...... .....+||+.|||||++. +..++.++|||||||++|||++|+.||.
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-------g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-------GVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-------CCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 98652110 111256999999999886 3457889999999999999999999997
Q ss_pred CCC
Q 008285 565 EFE 567 (571)
Q Consensus 565 ~~e 567 (571)
..+
T Consensus 233 ~~~ 235 (932)
T PRK13184 233 RKK 235 (932)
T ss_pred Ccc
Confidence 643
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.99 Aligned_cols=203 Identities=31% Similarity=0.521 Sum_probs=179.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+.+|++++++++|+||+++++.+...+..|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999999999999999986422 12224567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
|||+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999999999775 579999999999999999999999999999999999999999999999999998765544444
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...|+..|+|||.+.. ..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 158 STSGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccCCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 5668899999999863 236789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=286.92 Aligned_cols=202 Identities=31% Similarity=0.549 Sum_probs=176.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|.+..+|..||+|++...... ....+.+.+|+.++++++|+||+++++++...+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 589999999999999999999999999999998753321 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--c
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--Y 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~--~ 512 (571)
|||+ +++|.+++......+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 999999998766779999999999999999999999999999999999999999999999999998765432 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++.. ...++.++|||||||++|||++|+++|...
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 157 YSHQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cccccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 224568999999998753 334678999999999999999998888653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=279.45 Aligned_cols=202 Identities=31% Similarity=0.537 Sum_probs=173.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-CCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-~~~lyL 433 (571)
.|++.+.||+|++|.||++.+..+++.||+|.+.... ......+.+.+|++++++++|+||+++++.+.. +..+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4899999999999999999999999999999986322 223345668899999999999999999988764 446899
Q ss_pred EEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+|||+.+++|.+++... ...+++.+++.++.||+.||++||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999999764 3458999999999999999999999999999999999999999999999999998664322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 158 MASTLIGTPYYMSPELFS-------NKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ccccccCCcCccChhHhc-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 223456899999999886 345778999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=281.32 Aligned_cols=199 Identities=40% Similarity=0.677 Sum_probs=177.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..++..+++|.+... ...+.+.+|+++++.++|+||+++++.+.+.+.+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 5899999999999999999999998999999988632 115778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
+|||+.+++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999999999998766789999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++.. ..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccccCCccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 233558889999999863 35788999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=290.60 Aligned_cols=202 Identities=36% Similarity=0.628 Sum_probs=175.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+..+++.|++|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 34589999999999999999999999999999998864221 2235678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.|++|.+++.+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999999999965 358999999999999999999999999999999999999999999999999987654332
Q ss_pred c-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .....|++.|+|||.+. ...++.++|||||||++|+|++|+.||...+
T Consensus 171 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cccCcccCCccccCHHHHc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22356899999999886 2356789999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.85 Aligned_cols=202 Identities=31% Similarity=0.508 Sum_probs=171.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|.+..+|..||||++....... ....+.+|+++++.++|+||+++++++..++..|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 58999999999999999999999999999999986433221 12345689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+. ++|.+++......+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++...... .
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 999996 77777776655668899999999999999999999999999999999999999999999999987643321 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....++..|+|||.+.. ...++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 223457889999998753 234677899999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=280.71 Aligned_cols=203 Identities=33% Similarity=0.564 Sum_probs=176.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|.+..+|+.||+|.++.... ......+.+.+|++++++++|+||+++++.+...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 479999999999999999999999999999998864222 222345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
||||+.+++|..++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999998642 345899999999999999999999999999999999999999999999999998765432
Q ss_pred c-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
. ......|+..|+|||.+. +..++.++|||||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CcccceecCCccccCHHHhc-------cCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 2 122356889999999886 23577899999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=280.67 Aligned_cols=204 Identities=34% Similarity=0.632 Sum_probs=177.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||.|+||+||+|.+..++..+++|++..... ......+.+|+++++.++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 479999999999999999999999999999998753221 2256778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~--~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
||||+.|++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||++++++.++|+|||++..+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999999764 2468999999999999999999999999999999999999999999999999988665432
Q ss_pred cc-----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~-----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. ....|+..|++||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQ------VHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cccccccccccCChhhcChHHHcc------ccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 22 34568999999999864 2256789999999999999999999997653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=284.61 Aligned_cols=201 Identities=32% Similarity=0.547 Sum_probs=171.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||+||+|.+.. +..+|||.+.... . ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---M---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---c---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 3579999999999999999998764 4569999875321 1 1356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+.+++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||+++.+.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999999999987655799999999999999999999999999999999999999999999999999886544322
Q ss_pred c--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 513 E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 513 ~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
. ....++..|++||.+. +..++.++|||||||++|+|++ |+.||....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLL-------YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred eecCCCccChhhCCHHHHh-------cCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 1 1233567799999986 2357889999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=286.50 Aligned_cols=203 Identities=25% Similarity=0.459 Sum_probs=171.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..+|++.+.||+|+||+||+|.+ ..++..|++|.+... ...+....+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35799999999999999999985 345678999987632 2234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~----------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~ 492 (571)
+..|+||||+.+++|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 99999999999999999985321 24788899999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 493 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 493 ~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++.+||+|||+++.+..... .....++..|+|||++. ...++.++|||||||++|||++ |..||.+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-------YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhc-------cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999986643221 22344667899999886 2357889999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=284.83 Aligned_cols=204 Identities=25% Similarity=0.427 Sum_probs=163.6
Q ss_pred eEEeecCceEEEEEEECC--CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~--tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 369999999999996533 3456777765421 2234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 438 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 438 ~~GGsL~d~L~~~~----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
+.+|+|.+++.... ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999999997643 2346778889999999999999999999999999999999999999999999875433221
Q ss_pred --ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 513 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 513 --~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.....++..|+|||++...........++.++|||||||++|||++ |..||....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1233466789999998643222223457889999999999999999 889997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=283.13 Aligned_cols=205 Identities=36% Similarity=0.749 Sum_probs=175.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc-CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~-~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.|+.++.||+|+||.||++.+..+|+.||+|++....... ......+.+.+|++++++++|+||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999986433221 222356788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccccCCcc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~~~~~ 512 (571)
||||+.|++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999765 5689999999999999999999999999999999999998775 699999999877654211
Q ss_pred -----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 -----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 -----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 123468889999999852 356789999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=292.87 Aligned_cols=203 Identities=26% Similarity=0.461 Sum_probs=169.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEE--EEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~V--AIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
-++|++.+.||+|+||.||+|.++.+|..+ ++|.+.. .......+.+.+|++++.++ +|+||+++++++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 458999999999999999999998887654 6665442 12234456788899999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 008285 430 HLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g 494 (571)
.+|+||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 2578999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 495 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 495 ~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.+||+|||++.............++..|+|||.+.. ..++.++|||||||++|||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999999864322211222334667999998853 346789999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.82 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=168.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|++++.||+|+||.||+|.+..++..||+|+... .....|+.++++++|+||+++++++...+..+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 4579999999999999999999999999999997431 11346899999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+. ++|.+++......+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9999995 789999877667899999999999999999999999999999999999999999999999999976544334
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCC-CCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSE 565 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr-~PF~~ 565 (571)
.....||..|+|||++. +..++.++|||||||++|||+++. .+|..
T Consensus 213 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 213 FLGLAGTVETNAPEVLA-------RDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccccCCeecC-------CCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 44567999999999986 335788999999999999999854 44443
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.74 Aligned_cols=202 Identities=27% Similarity=0.464 Sum_probs=168.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCc--EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~--~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
++|++.+.||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|++++.++ +|+||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 479999999999999999999887775 4688876532 1233456788999999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 431 LYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
+|+||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 999999999999999997532 24888999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 496 VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 496 vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+||+|||++..............+..|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN-------YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999986433221111222355799999885 3357889999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=285.76 Aligned_cols=200 Identities=40% Similarity=0.673 Sum_probs=176.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+++++.++|+||+++++.+.++..+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 37889999999999999999999999999999986422 12334667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~ 512 (571)
|+||+.+++|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+... ..
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999999999764 7899999999999999999999999999999999999999999999999999877543 22
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...
T Consensus 155 ~~~~~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred cccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 334568899999999863 34788999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=285.70 Aligned_cols=203 Identities=30% Similarity=0.469 Sum_probs=171.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||+||+|++..+|. .||+|.+... ......+.+.+|+.+++.+.|+||+.+++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 34689999999999999999999887776 4789987532 223445678899999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
...+++|||+.+|+|.+++.+....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999999999999876667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... ....++..|+|||.+. ...++.++|||||||++|||++ |..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESIL-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 433221 1223567899999985 2357889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=282.57 Aligned_cols=204 Identities=40% Similarity=0.791 Sum_probs=174.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-cCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
+|++.+.||+|+||.||+|.+ .+|+.+|+|.+...... .......+.+.+|++++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 47899999988643322 1223445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC---
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~--- 510 (571)
||||+.|++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999765 46899999999999999999999999999999999999999999999999998765321
Q ss_pred ----ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 ----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ----~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE-------SGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccccccCCCccccChhhhcC-------CCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11123568999999998863 356789999999999999999999997644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=282.51 Aligned_cols=202 Identities=28% Similarity=0.543 Sum_probs=172.2
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34568999999999999999999865 46789999865311 224678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.|++|||+.+++|.+++... ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999999999754 35688999999999999999999999999999999999999999999999999987644
Q ss_pred Cccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ....++..|+|||.+. ...++.++|||||||++|+|++ |+.||...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred CceeccCCCccceecCCHHHhc-------cCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 2211 2234567899999885 3357789999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.24 Aligned_cols=196 Identities=23% Similarity=0.326 Sum_probs=169.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
...+|++++.||+|+||.||+|... .++..||+|.+... +...+|+++|++++|+||+++++.+...+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 3458999999999999999999764 35678999976521 23457999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||++. ++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.+..
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9999999996 788888844 46799999999999999999999999999999999999999999999999999976644
Q ss_pred Ccc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLA-------LDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccccCccCHhHhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 322 22467999999999986 345788999999999999999999999654
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=284.98 Aligned_cols=205 Identities=24% Similarity=0.436 Sum_probs=170.0
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
...++|++.+.||+|+||.||+|.+. .++..||||.+... ........+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34568999999999999999999865 23567999986421 1223345688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~---------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
...+..++||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||++|++|+||||+|||+++++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 99999999999999999999997532 235778889999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 497 KLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+|+|||++..+...... ....++..|||||++. ...++.++|||||||++|||++ |..||.+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhh-------cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999998765432221 1234577899999986 3357889999999999999998 78898754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=294.70 Aligned_cols=201 Identities=22% Similarity=0.431 Sum_probs=169.2
Q ss_pred EeeEEeec--CceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 358 KGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 358 i~k~LG~G--~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
++++||+| +|++||++.++.+|+.||+|.+..... .....+.+.+|+++++.++|+||+++++++..++..|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 46789999 789999999999999999998864321 2344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc---
Q 008285 436 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--- 511 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~--- 511 (571)
||+.+|+|.+++..+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999999754 3458999999999999999999999999999999999999999999999998654432111
Q ss_pred -----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......++..|+|||++... ...++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 11123467789999998631 234788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=286.61 Aligned_cols=204 Identities=31% Similarity=0.573 Sum_probs=172.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
..+|.+.+.||+|+||.||+|.+.. ++..||||.+... ...+..+.+.+|+++|+.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 4578999999999999999998753 4678999987532 223345788899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~-------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g 494 (571)
.+..++||||+.|++|.++|...+ ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 999999999999999999997542 3478889999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 495 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 495 ~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.+||+|||++..+..... .....+++.|+|||++. ...++.++|||||||++|||++ |+.||.+..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhc-------cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999976533221 12334577899999986 3457889999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=282.80 Aligned_cols=203 Identities=30% Similarity=0.493 Sum_probs=173.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++|++.+.||+|+||+||+|.+..+ ...||||.+... ........+.+|+.+++.++|+||+++++.+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 35799999999999999999998654 457999987532 22344567888999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..++||||+.+++|.+++......+++..+..++.|++.||.|||++||+|+||||+|||+++++.++|+|||++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999999987666799999999999999999999999999999999999999999999999999987752
Q ss_pred Cccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ....++..|+|||.+. ...++.++||||||+++|+|++ |..||.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccceeccCCCCCccccChhhhc-------cCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 2111 1233567899999886 2357889999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=278.82 Aligned_cols=196 Identities=31% Similarity=0.542 Sum_probs=171.6
Q ss_pred eEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|+||.||+|.+... +..|++|.+...... ...+.+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 4699999999999999866 899999988643221 246778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 437 YVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 437 y~~GGsL~d~L~~~--------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
|+.+++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999999875 4679999999999999999999999999999999999999999999999999998765
Q ss_pred CCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
... ......++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 532 2234557889999998863 257889999999999999999 69999765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=289.00 Aligned_cols=201 Identities=37% Similarity=0.628 Sum_probs=176.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+..+|+.||||.+..... ...+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 34689999999999999999999999999999998864221 2235678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999999999975 358999999999999999999999999999999999999999999999999987664432
Q ss_pred c-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. .....+++.|+|||.+. ...++.++|||||||++|+|++|+.||...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cCcCcccCCccccCHHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 22356889999999886 335678999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.05 Aligned_cols=203 Identities=32% Similarity=0.605 Sum_probs=172.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
.+.+|.+.+.||+|+||.||++.+ ..++..+|+|.+.. ......+.+.+|++++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 356899999999999999999985 33456789997753 12344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g 494 (571)
..+.+++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999999997543 2489999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 495 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 495 ~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.+||+|||++..+..... .....++..|+|||++. +..++.++|||||||++|+|++ |..||...
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999986543221 12234577899999886 3457889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=284.10 Aligned_cols=203 Identities=35% Similarity=0.595 Sum_probs=175.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|.+..+|..+|||.+..... ........+.+|+.+++.++|+||+++++.+..++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 378899999999999999999999999999998764221 223345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|||+.|++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999999864 2345899999999999999999999999999999999999999999999999998766432
Q ss_pred cc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.. .....|+..|+|||.+. ...++.++||||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CcccccccCCcCccCHHHhc-------CCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 22 22456899999999886 23567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=283.15 Aligned_cols=203 Identities=28% Similarity=0.492 Sum_probs=172.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
.+|++.+.||+|+||.||+|.++.+|. .||||.+... ......+.+..|+.+++.++|+||+++++.+..++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 479999999999999999999887765 5999987532 124455778999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.++||||+.+++|.+++......+++.+++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999999876677999999999999999999999999999999999999999999999999998765432
Q ss_pred cccc----ccC--CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 511 SYEL----SLK--GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 511 ~~~~----~~~--GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... ... ++..|+|||.+. ...++.++|||||||++|||++ |..||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccccCCCcceeecCHhHhc-------cCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 2111 111 235799999886 3357889999999999999886 999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.19 Aligned_cols=207 Identities=29% Similarity=0.476 Sum_probs=172.9
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~ 422 (571)
.....++|+++++||+|+||.||+|++... +..||||++... ......+.+.+|+++|+++. ||||++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 445577999999999999999999987533 347999987532 12334567889999999996 99999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------------------------------------------
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~--------------------------------------------------- 451 (571)
+++...+.+|||||||.+|+|.++|.+..
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999986521
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008285 452 --------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487 (571)
Q Consensus 452 --------------------------------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsN 487 (571)
..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 247788889999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008285 488 LLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563 (571)
Q Consensus 488 ILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF 563 (571)
||++.++.+||+|||+++.+..... .....++..|+|||.+. ...++.++|||||||++|||++ |..||
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-------DNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999986543221 12344678899999886 3357889999999999999997 99999
Q ss_pred CCC
Q 008285 564 SEF 566 (571)
Q Consensus 564 ~~~ 566 (571)
...
T Consensus 341 ~~~ 343 (400)
T cd05105 341 PGM 343 (400)
T ss_pred ccc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.19 Aligned_cols=205 Identities=31% Similarity=0.552 Sum_probs=183.1
Q ss_pred eEE--eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 356 WQK--GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 356 y~i--~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
||+ .+.||+|-||+||-|+++.+|+.||||+++...-..+. ..++++|+.||+.++||.||.+.-.|+..+.+++
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 555 47999999999999999999999999999765433322 3678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~l~~~ 510 (571)
|||-+.|.-|.-.|....++|++...+.++.||+.||.|||-++|||+||||+|||+... -.+||||||+|+.+...
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999998666766676666889999999999999999999999999999999999999533 47999999999999888
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
....+.+||+.|+|||+++ +..|...-||||.|||+|--|+|..||.+.|.|+
T Consensus 721 sFRrsVVGTPAYLaPEVLr-------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR-------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hhhhhhcCCccccCHHHHh-------hccccccccceeeeEEEEEEecccccCCCccchh
Confidence 7778899999999999998 4568889999999999999999999999998774
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.03 Aligned_cols=206 Identities=30% Similarity=0.502 Sum_probs=186.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
......|.+.+.||+|.|++|.++++..+|..||||.++.... .......+.+|+++|..|.|||||+++.+.+...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l---n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL---NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc---ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3345689999999999999999999999999999998865332 2334455899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+.+|.|++||.+++ .+.+.+++.++.|++++++|||+++|||||||.+||||+.+-++||+|||++.++..
T Consensus 129 ~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999999999874 577799999999999999999999999999999999999999999999999999988
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.....+++|++.|.|||++.+ ....+..+|+||||++||.|++|.+||++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g------~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNG------KKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cccccccCCCCCccChHhhcC------cccCCcceehhhhhhhheeeeecccccCC
Confidence 888889999999999999985 33557889999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.94 Aligned_cols=210 Identities=30% Similarity=0.554 Sum_probs=179.2
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCc---E-EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---S-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS 424 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~---~-VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~ 424 (571)
+...-++-.+.+.||+|+||.||+|..+..+. . ||+|..+. ......+.++++.+|+++|++++|+|||++||+
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 44444556666999999999999998776433 3 89998763 122446778999999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 425 EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 425 ~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
...+..+|||||+|.||+|.+||++....++..+...++.+++.||+|||++++|||||-.+|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999998778999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccc-ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 505 KHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 505 ~~l~~~~~~~-~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+......... ...-...|+|||.+.. ..|+.++|||||||++||+++ |..||.+..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~-------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNT-------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred cCCcceeeccccccCcceecChhhhcc-------CccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 8654222222 1124578999999983 478999999999999999999 889998765
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=278.20 Aligned_cols=202 Identities=29% Similarity=0.530 Sum_probs=176.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+.+|+++++.++|+||+++++.+...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 58999999999999999999999999999999864321 223457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCcccccCCcc
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA~~l~~~~~ 512 (571)
|||+.|++|.+++.+. ...+++..+..++.||+.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999999764 3458999999999999999999999999999999999999754 5689999999987765444
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+. ...++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 158 AYTVVGTPCYISPELCE-------GKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred ccccccCCcccCchhcc-------CCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 44567899999999886 234678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=277.37 Aligned_cols=202 Identities=33% Similarity=0.555 Sum_probs=175.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY 432 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~ly 432 (571)
+|++.+.||.|+||.||++.+..+|+.||+|.+.... ......+++..|+++++.++|+||+++++.+.. ....|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5889999999999999999999999999999876422 223445778899999999999999999997764 45689
Q ss_pred EEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH-----STNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLH-----s~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999999754 457999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........ .....|+..|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLN-------HMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCcccccccccCCCccChhhhc-------CCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 87765443 33456899999999986 234778999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=284.23 Aligned_cols=208 Identities=36% Similarity=0.636 Sum_probs=173.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEE---
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV--- 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~--- 426 (571)
....+|++.+.||+|+||.||+|.+..+|+.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34569999999999999999999999999999999875321 1235577899999999 6999999999874
Q ss_pred --eCCeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 427 --VDDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 427 --~~~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
..+.+|+||||++|++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 34568999999999999998863 2346889999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 502 GMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++..+.... ......|+..|+|||++...... ...++.++|||||||++|||++|+.||.+.
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL--DSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhc--cccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9988664432 22235689999999998632211 235788999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=329.64 Aligned_cols=209 Identities=29% Similarity=0.538 Sum_probs=176.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-- 428 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~-- 428 (571)
....+|++++.||+|+||+||+|.++.++..||+|++..... .......+..|+.+|++|+|+|||+++++|...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 345699999999999999999999999999999999864322 234456788999999999999999999988653
Q ss_pred CeEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcC------
Q 008285 429 DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-------NTIHRDIKGANLLVDA------ 492 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~-------GIVHRDIKPsNILLd~------ 492 (571)
+.+|||||||.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999999753 35699999999999999999999985 4999999999999954
Q ss_pred -----------CCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 008285 493 -----------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (571)
Q Consensus 493 -----------~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~ 561 (571)
.+.+||+|||++..+..........||+.|+|||++... ...++.++||||||||||||++|+.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHHHCCC
Confidence 345999999999876554444456799999999998631 2347889999999999999999999
Q ss_pred CCCCCC
Q 008285 562 PWSEFE 567 (571)
Q Consensus 562 PF~~~e 567 (571)
||...+
T Consensus 242 PF~~~~ 247 (1021)
T PTZ00266 242 PFHKAN 247 (1021)
T ss_pred CCCcCC
Confidence 997544
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=282.97 Aligned_cols=204 Identities=29% Similarity=0.492 Sum_probs=173.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
..+|++.+.||+|+||.||+|.++.++. .+|+|.++... .....+.+.+|+.++++++|+||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3579999999999999999999875543 68999875321 2334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..|+||||+.|++|.+++......+++.++..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999999987666789999999999999999999999999999999999999999999999999987644
Q ss_pred Cccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 510 LSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 510 ~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... ....++..|+|||.+. ...++.++|||||||++|||++ |+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccceeeecCCCccceeecCHhHhc-------cCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 3211 1122356799999986 2357889999999999999886 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=279.09 Aligned_cols=204 Identities=48% Similarity=0.845 Sum_probs=177.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ....+.+.+|+++++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 589999999999999999999999999999998754322 45678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc-
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE- 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~- 513 (571)
+||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999999764 45899999999999999999999999999999999999999999999999998876543221
Q ss_pred ----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....++..|++||++.... ...++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 1245788999999986321 123778999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=283.58 Aligned_cols=203 Identities=31% Similarity=0.501 Sum_probs=172.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||.||+|.++.+|. .+|+|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34689999999999999999999877665 5888876532 224456778899999999999999999998877
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
...++||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7899999999999999999887677999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccc---cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~---~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
........ ..++..|+|||.+. ...++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred cCcccceecCCCcccccccCHHHhh-------cCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 54322211 22356799999875 2357789999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=280.80 Aligned_cols=206 Identities=36% Similarity=0.653 Sum_probs=175.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC--
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~-- 429 (571)
.++|++.+.||+|++|.||+|.++.+++.+++|++.... ...+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 468999999999999999999999999999999876422 1246688999999999 6999999999987644
Q ss_pred ----eEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 430 ----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 430 ----~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998653 3579999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 503 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++....... ......|+..|+|||++...... ...++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP--DASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccc--cCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 987654322 22235689999999998643222 345788999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=288.35 Aligned_cols=202 Identities=36% Similarity=0.629 Sum_probs=176.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
....|++.+.||.|+||.||+|.+..+|+.|+||.+.... ....+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 3457999999999999999999999999999999886422 12245678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.+++|..++... .+++.++..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999999998753 58999999999999999999999999999999999999999999999999988665433
Q ss_pred c-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .....|+..|+|||.+. ...++.++|||||||++|+|++|+.||...+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred ccCCCcCCCccccCcchhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22356889999999886 3356789999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.68 Aligned_cols=206 Identities=32% Similarity=0.592 Sum_probs=175.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|++++++++|+||+++++.+...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 36899999999999999999999999999999886421 22334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~--~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
||||+.|++|..++... ...+++..+..++.||+.||.|||. .||+|+||||+|||++.++.++|+|||++..+...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999998763 2368999999999999999999996 59999999999999999999999999998766432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
. .....|+..|+|||.+...... ....++.++|||||||++|+|++|+.||..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 L-AKTNIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred c-cccCCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 2 2234588899999988542211 133568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=282.76 Aligned_cols=199 Identities=31% Similarity=0.511 Sum_probs=169.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 47899999999999999999876 467899998752211 12456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.|++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999999876567899999999999999999999999999999999999999999999999998765432221
Q ss_pred c--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 514 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 514 ~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
. ...++..|+|||.+. ...++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFD-------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred ccCCCCCCccccCHHHhc-------cCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 1 122345799999886 3357789999999999999998 89999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=285.28 Aligned_cols=203 Identities=33% Similarity=0.542 Sum_probs=175.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.+|+++++.++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 379999999999999999999999999999998764322 22344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+.++.|..++.. ...+++.++..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9999998777666554 3569999999999999999999999999999999999999999999999999998765543
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......++..|+|||++.. ...++.++||||||+++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 157 PLTDYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccCcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2334568889999999863 225788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.79 Aligned_cols=194 Identities=29% Similarity=0.515 Sum_probs=159.0
Q ss_pred EeeEEeecCceEEEEEEECC--CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeEEE
Q 008285 358 KGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYI 433 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~--tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~lyL 433 (571)
.+..||+|+||.||+|+++. ++..||+|.+.... ....+.+|+++|+.++|+||+++++++.. +..+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 34689999999999999754 56889999875321 12346789999999999999999998854 467899
Q ss_pred EEeecCCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEEec
Q 008285 434 YLEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADF 501 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~--------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL----d~~g~vKLiDF 501 (571)
||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 999996 5787877532 1248899999999999999999999999999999999999 46679999999
Q ss_pred CCcccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 502 GMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 502 GlA~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
|+++...... ......||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9998664322 1223568999999999863 23578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.77 Aligned_cols=205 Identities=25% Similarity=0.428 Sum_probs=172.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
...++|++.+.||+|+||.||+|.++.. +..||+|.+... ........+.+|+.+|+.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 3456899999999999999999987643 478999986522 1223345678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~---------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
...+..|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 99999999999999999999996531 236788999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 497 KLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
||+|||+++.+..... .....++..|+|||.+. ...++.++|||||||++|||++ |+.||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHh-------cCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 9999999886644321 12344678899999886 2357889999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=286.19 Aligned_cols=208 Identities=26% Similarity=0.516 Sum_probs=174.9
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEE
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY 421 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl 421 (571)
.......+|++.+.||+|+||.||++.+... ...+|+|.+... ........+.+|+++++++ +|+||+++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 4556677999999999999999999987643 367999987632 1233456688999999999 79999999
Q ss_pred eeeEEeCCeEEEEEeecCCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 008285 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (571)
Q Consensus 422 ~g~~~~~~~lyLVmEy~~GGsL~d~L~~~---------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPs 486 (571)
++++..++.++++|||+.+|+|..++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999999642 346899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 008285 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562 (571)
Q Consensus 487 NILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~P 562 (571)
|||++.++.+||+|||+++.+..... .....++..|+|||++. +..++.++|||||||++|||++ |..|
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-------cCCcCcccceeehhhHHHHHhcCCCCC
Confidence 99999999999999999987654322 11233567799999875 3457889999999999999997 9999
Q ss_pred CCCC
Q 008285 563 WSEF 566 (571)
Q Consensus 563 F~~~ 566 (571)
|...
T Consensus 235 ~~~~ 238 (293)
T cd05053 235 YPGI 238 (293)
T ss_pred CCCC
Confidence 9754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=339.06 Aligned_cols=211 Identities=29% Similarity=0.436 Sum_probs=183.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.....+|.++++||+|+||.|.+++++.+++.||+|++.... --....-.-|..|-+||..-..+-|++++..|.++.
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e--MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE--MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH--HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 345679999999999999999999999999999999875310 000111245778899999888999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
++|+||||+.||+|..++.+.. .++++.++.++..|+-||.-||+.|+|||||||+|||||..|++||+|||.+-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999999999998876 899999999999999999999999999999999999999999999999999887764
Q ss_pred Cc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 510 ~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.. .....+|||.|++||+|+... ++.+.|+...|+||+||++||||.|..||..
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~--~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQG--DGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhc--CCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 33 234578999999999998753 3357899999999999999999999999964
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.04 Aligned_cols=203 Identities=28% Similarity=0.459 Sum_probs=170.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.+.|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4579999999999999999999987 77889999875322 22334567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEE
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKL 498 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g---~vKL 498 (571)
.+..++||||+.|++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 2589999999999999999999999999999999999998654 6999
Q ss_pred EecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 499 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 499 iDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+|||+++.+...... ....++..|+|||++. +..++.++|||||||++|||++ |+.||.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL-------DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHh-------cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999876432221 1222356799999986 3457899999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.65 Aligned_cols=203 Identities=29% Similarity=0.511 Sum_probs=172.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+..|++++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 3478899999999999999999876665 68998875321 2234567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..|+||||+.+++|.+++.+....+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999987667799999999999999999999999999999999999999999999999999876643
Q ss_pred Ccccc----ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYEL----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~~----~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
..... ....+..|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccccceeccCCCcCceecCHHHhh-------cCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 22111 122345799999886 3357889999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=280.62 Aligned_cols=207 Identities=46% Similarity=0.829 Sum_probs=176.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-----cCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-----~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
+|.+.+.||+|+||.||+|.+..+|+.+|||.++..... .......+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999999999999987642211 112234567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+++||||+.|++|.+++.+. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999876 5689999999999999999999999999999999999999999999999999876543
Q ss_pred Cc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. ......|+..|+|||.+... ...++.++||||||+++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 21 12235688999999998632 1236789999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=276.42 Aligned_cols=201 Identities=36% Similarity=0.596 Sum_probs=178.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|++|.||+|++..+|+.|++|.+..... ....+.+.+|+.++..++|+||+++++.+...+..++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 68999999999999999999999999999998864321 14457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999765 679999999999999999999999 99999999999999999999999999999876543332
Q ss_pred c-ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 L-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ~-~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ...++..|+|||.+.. ..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-------ESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2 4568899999998763 367889999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.16 Aligned_cols=205 Identities=28% Similarity=0.493 Sum_probs=169.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS 424 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~ 424 (571)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+... ......+.+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44568999999999999999999754 34578999987532 1233456678899999999 79999999998
Q ss_pred EEeC-CeEEEEEeecCCCCHHHHHHHhc----------------------------------------------------
Q 008285 425 EVVD-DHLYIYLEYVHPGSINRYVREHC---------------------------------------------------- 451 (571)
Q Consensus 425 ~~~~-~~lyLVmEy~~GGsL~d~L~~~~---------------------------------------------------- 451 (571)
+... ..++++|||+.+++|.++|....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 7654 56899999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCC
Q 008285 452 --------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSP 520 (571)
Q Consensus 452 --------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~ 520 (571)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... .....++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 2578999999999999999999999999999999999999999999999999987643221 12244677
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.|+|||++. +..++.++|||||||++|||++ |+.||.+.
T Consensus 240 ~y~aPE~~~-------~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 240 KWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred cccCcHHhc-------CCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 899999986 3468889999999999999997 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.08 Aligned_cols=200 Identities=30% Similarity=0.526 Sum_probs=167.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~- 427 (571)
..+|++.+.||+|+||.||+|.. ..++..||||.+... .....+.+.+|+++++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 35899999999999999999974 457889999987632 23445778899999999999999999997654
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...+++||||+.+++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 3468999999999999999987656799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 507 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 507 l~~~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
+...... ....++..|+|||++. +..++.++|||||||++|||++|..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLT-------ESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhc-------cCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 6442211 1122445699999885 3357889999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.70 Aligned_cols=200 Identities=41% Similarity=0.729 Sum_probs=178.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|.+.+.||+|++|.||++.+..+|+.+++|++..... ...+.+.+|+++++.++|+||+++++.+...+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 58889999999999999999998999999999864221 3457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
|||+.|++|.+++......+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 99999999999998765679999999999999999999999999999999999999999999999999998776543234
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...|+..|++||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 156 TMVGTPYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ceecCCcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 5668899999999863 24678999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.24 Aligned_cols=202 Identities=28% Similarity=0.461 Sum_probs=173.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||++.+..+++.|+||.+.... .......+.+.+|+++++.++|+||+++++.+..++.+|+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 6999999999999999999999999999999876421 11223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC----
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~---- 510 (571)
|||+.|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999765 56899999999999999999999999999999999999999999999999988632100
Q ss_pred ------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 ------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-------RQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhcc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0111245788899999875 235788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.02 Aligned_cols=199 Identities=40% Similarity=0.735 Sum_probs=178.2
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCC
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP 440 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~G 440 (571)
+||+|+||+||.|+++.+....|||.+.. ...+..+-+..||.+-++|+|.|||+++|.+.+++.+-|+||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 79999999999999999999999998752 2234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCcccccCCc-ccccc
Q 008285 441 GSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLS-YELSL 516 (571)
Q Consensus 441 GsL~d~L~~~~~~L--se~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~l~~~~-~~~~~ 516 (571)
|+|.++|+..-+++ .|..+..+.+||+.||.|||++.|||||||.+||||+ ..|.+||+|||.++.+.+-. ...++
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999999887888 8889999999999999999999999999999999996 67999999999999887744 34478
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egv 569 (571)
.||.-|||||++... -..|+.++|||||||++.||.||++||-+....
T Consensus 737 TGTLQYMAPEvIDqG-----~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp 784 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQG-----PRGYGKAADIWSFGCTMVEMATGRPPFVELGSP 784 (1226)
T ss_pred ccchhhhChHhhccC-----CcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence 899999999999742 345889999999999999999999999877653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=280.25 Aligned_cols=203 Identities=27% Similarity=0.509 Sum_probs=171.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
....+|++.+.||+|+||.||+|.+.. ++.||||.++... ...+.+.+|+.++++++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 345689999999999999999999754 5789999876321 123567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999999997643 4689999999999999999999999999999999999999999999999999987653
Q ss_pred Ccccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 510 LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 510 ~~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... ...++..|+|||.+. +..++.++||||||+++|||++ |+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAAL-------YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred CcccccCCCcCceeccCccccc-------cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 22111 122345799999875 3357889999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.48 Aligned_cols=202 Identities=41% Similarity=0.707 Sum_probs=171.4
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
+.....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 33445899999999999999999999999987632 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCcccccCCcc
Q 008285 436 EYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~L--se~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~~~~ 512 (571)
||+.+++|.+++......+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999999998754556 88889999999999999999999999999999999976 67999999999876543222
Q ss_pred -ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 -~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....|+..|+|||.+... ...++.++||||||+++|+|++|+.||.+.+
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKG-----PRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccccCCCCccccChhhhccc-----cccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 2234688999999998531 2246789999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.93 Aligned_cols=202 Identities=24% Similarity=0.436 Sum_probs=167.8
Q ss_pred eEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe--
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-- 430 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~-- 430 (571)
|++++.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+++++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 57889999999999999987654 4789999876322 223446778899999999999999999998766554
Q ss_pred ----EEEEEeecCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 431 ----LYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 431 ----lyLVmEy~~GGsL~d~L~~~-----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
.+++|||+.+++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 135899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 502 GMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 502 GlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
|+++.+...... ....++..|+|||.+. ...++.++|||||||++|||++ |..||.+.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999876443221 1223567899999875 3357889999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=320.07 Aligned_cols=209 Identities=26% Similarity=0.439 Sum_probs=176.1
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEee-eEE
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYG-SEV 426 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g-~~~ 426 (571)
.....-+++|.+.|.+|||+.||+|.+...|..||+|++... ++..++.+.+||++|++|+ |+|||.+++ ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 345566899999999999999999999998899999987642 3567888999999999997 999999999 322
Q ss_pred e------CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEE
Q 008285 427 V------DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVK 497 (571)
Q Consensus 427 ~------~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~vK 497 (571)
. .-+++|.||||.||.|-|++... ...|+|.++++|+.|+++|+++||... |||||||-|||||..+|..|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 2 13678999999999999999742 234999999999999999999999987 99999999999999999999
Q ss_pred EEecCCcccccCCc----------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 498 LADFGMAKHLTGLS----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 498 LiDFGlA~~l~~~~----------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|||||.++..-... ......-|+-|+|||++.-- .+..+++|+|||+|||+||.||....||++.
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly----sg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY----SGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh----cCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 99999987542211 11123468999999998642 2457899999999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=285.31 Aligned_cols=203 Identities=36% Similarity=0.570 Sum_probs=174.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+++++.++|+||+++++++..++..|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 3799999999999999999999999999999987542221 2344667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.++.|..++... ..+++.++..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 99999999998877553 4589999999999999999999999999999999999999999999999999887644322
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....++..|+|||++.. ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 157 YTDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred cCcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 223558889999999863 234678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.00 Aligned_cols=202 Identities=31% Similarity=0.581 Sum_probs=172.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||.|++|.||+|++..+|..||||++...... ...+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 589999999999999999999999999999998753322 1234566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 99998 58988887654 458999999999999999999999999999999999999999999999999997653321
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|++||.+.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999998863 2346789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=322.11 Aligned_cols=207 Identities=34% Similarity=0.586 Sum_probs=186.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.+.|.|+..||.|+||.||++..++++..-|.|++.. ...+.++.+.-||+||..++||+||++++.|..++.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 3479999999999999999999999999999998864 45677888999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Cc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~ 511 (571)
|++|||.||-.+..+-+.+..|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ..
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998765433 22
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...+++|||+|||||++++..-+ ...|.+++||||||++|+||..+.+|-.+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~K--D~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFK--DQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred hhccccCCcccccchheeecccc--CCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 23468899999999999865444 357999999999999999999999997764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.53 Aligned_cols=201 Identities=39% Similarity=0.710 Sum_probs=174.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC---CCCeeEEeeeEEeCCeE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHL 431 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~~~~~l 431 (571)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.... .....+.+.+|+.+++.++ |+||+++++++..+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 5788899999999999999999999999999876422 1233466788999999986 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.|++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999999999865 368999999999999999999999999999999999999999999999999998765433
Q ss_pred c-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .....|+..|+|||.+.. +..++.++|||||||++|+|++|+.||.+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred cccccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 234568999999998853 3346789999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=271.04 Aligned_cols=202 Identities=53% Similarity=0.982 Sum_probs=179.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLY 432 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~ly 432 (571)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|++++++++|+||+++++.+... +.++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 488999999999999999999999999999998643321 34567889999999999999999999999988 8999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
++|||+.+++|.+++.+.. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999999998754 799999999999999999999999999999999999999999999999999987766543
Q ss_pred ---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++..|++||.+.. ..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 345668999999998863 237889999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.52 Aligned_cols=209 Identities=28% Similarity=0.544 Sum_probs=173.6
Q ss_pred CCCCCCCCCeEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCe
Q 008285 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI 418 (571)
Q Consensus 347 p~~~~~~~~y~i~k~LG~G~fG~VYla~~k-------~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNI 418 (571)
+.+.....+|++.+.||+|+||.||+|++. .++..||+|.+... ......+.+.+|+.+++.+ +|+||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCc
Confidence 345566789999999999999999999753 23457999987521 1234457788999999999 79999
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDI 483 (571)
+++++.+...+..|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl 163 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 999999999999999999999999999997631 24778889999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-C
Q 008285 484 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (571)
Q Consensus 484 KPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-G 559 (571)
||+|||++.++.+||+|||+++.+..... .....++..|+|||++. +..++.++||||||+++|+|++ |
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc-------cCCCCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999987644221 12234567899999886 3357889999999999999998 8
Q ss_pred CCCCCCC
Q 008285 560 KPPWSEF 566 (571)
Q Consensus 560 r~PF~~~ 566 (571)
..||.+.
T Consensus 237 ~~p~~~~ 243 (304)
T cd05101 237 GSPYPGI 243 (304)
T ss_pred CCCcccC
Confidence 8888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=281.72 Aligned_cols=202 Identities=27% Similarity=0.501 Sum_probs=173.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||.|+||.||+|.+.. +..+++|.+... .......+..|+.+++.++|+||+++++++...+.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence 34579999999999999999999988 899999987632 122345688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
++||||+.+++|.+++.+. ...+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999999763 346899999999999999999999999999999999999999999999999999766432
Q ss_pred ccc-cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~-~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
... ....++..|++||.+. ...++.++||||||+++|+|++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAAS-------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred cccccCCCCceEecCHHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 211 1234567899999885 2357789999999999999998 89999754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.89 Aligned_cols=198 Identities=33% Similarity=0.521 Sum_probs=165.6
Q ss_pred CeEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--
Q 008285 355 QWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-- 428 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~-- 428 (571)
.|++.+.||+|+||+||++. ...++..||+|.+.... .....+.+.+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34999999999999998865 34568899999876321 123446678899999999999999999987653
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..+|+||||+.+++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 4589999999999999999763 59999999999999999999999999999999999999999999999999998664
Q ss_pred CCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 509 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 509 ~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.... .....++..|+|||.+.. ..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKE-------NKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcc-------cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 4221 112345667999998852 3567899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.95 Aligned_cols=213 Identities=28% Similarity=0.476 Sum_probs=180.5
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV 427 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~ 427 (571)
.......|++++.||+||.+.||++.... .+.||+|.+.... .+...+.-+.+|+.+|.+|+ |.+||++|++...
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 34556789999999999999999998554 5667777655333 33567788999999999996 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++.+|+||||-+ .+|..+|.+....+....++.+..||+.++.++|.+||||.||||.|+|| -.|.+||+|||+|..+
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 999999999864 79999999887777767899999999999999999999999999999999 6789999999999988
Q ss_pred cCCccc---cccCCCCcccChHHHHHhhhcCCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGN----PKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~----~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...... ...+||+.||+||.+......+.. -+.+.++||||||||||+|+.|++||..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 665433 357899999999999876443211 237889999999999999999999998764
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=281.58 Aligned_cols=200 Identities=32% Similarity=0.551 Sum_probs=177.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||+|.++.+++.+|+|.+..... ....+.+.+|+++++.++|+||+++++.+...+.++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 68888999999999999999999999999998864322 24456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.+++|.+++......+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999999998765779999999999999999999999 99999999999999999999999999998766433222
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 158 -~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 -TFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred -cccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2668899999999863 36788999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.70 Aligned_cols=208 Identities=27% Similarity=0.511 Sum_probs=171.8
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCee
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIV 419 (571)
.......+|.+++.||+|+||.||++.+.. ++..+|+|.+... ........+.+|+++++.+ +|+||+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 344455789999999999999999998643 2356999987632 1223456788899999999 799999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
++++++...+..|+||||+.+|+|.+++.... ..+++.+++.++.||+.||+|||++|++|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 99999999999999999999999999997642 248889999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr 560 (571)
|+|||++.++.+||+|||++......... ....++..|+|||++. +..++.++|||||||++|||++ |.
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc-------cCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999998765432211 1223456899999886 3357889999999999999998 88
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||...
T Consensus 241 ~p~~~~ 246 (307)
T cd05098 241 SPYPGV 246 (307)
T ss_pred CCCCcC
Confidence 998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.32 Aligned_cols=203 Identities=27% Similarity=0.415 Sum_probs=163.3
Q ss_pred eEEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
+.||+|+||.||+|.+. .++..+|+|.++... .......+.+|+.++++++|+||+++++.+.+...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 36999999999999865 345678999875322 123345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 438 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 438 ~~GGsL~d~L~~~~----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
+.+|+|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999999997532 2356778889999999999999999999999999999999999999999999875433221
Q ss_pred --ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 513 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 513 --~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.....|+..|+|||++...........++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 1234577889999998632111111246789999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.87 Aligned_cols=205 Identities=29% Similarity=0.522 Sum_probs=169.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHH-HhhcCCCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~I-L~~L~HpNIVkl~g~~~~~~~ly 432 (571)
++|++.+.||+|+||.||++.++.+|+.||||.+..... ... ...+..|+.+ ++.++|+||+++++++..++.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 379999999999999999999999999999998864321 112 2344455554 66678999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
++|||++ ++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999997 7888887642 34689999999999999999999997 99999999999999999999999999998765
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.........|+..|+|||.+..... ...++.++|||||||++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELN---QKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccccCCccccChhhcCCccc---ccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 4333334568899999998853211 134678999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=285.78 Aligned_cols=203 Identities=30% Similarity=0.501 Sum_probs=174.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~l 431 (571)
.+|++.+.||+|+||.||+|.+..+++.++||.++..... ......+.+|++++++++|+||+++++++... +..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 4799999999999999999999999999999998743322 22234567899999999999999999998877 889
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|+||||+. ++|.+++......+++.+++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999997 5999998776567999999999999999999999999999999999999999999999999999876553
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......++..|+|||.+.. ...++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cccccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22233557889999998863 233578999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.47 Aligned_cols=201 Identities=40% Similarity=0.677 Sum_probs=176.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|+..+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++++.|+||+++++.+.+++..|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46888999999999999999999999999999886421 23445778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 80 v~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 80 IMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999999999999875 4689999999999999999999999999999999999999999999999999977654332
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 158 ~~~~~~~~~y~apE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQ-------SAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cccccCcccccCHhHhcc-------CCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 223468889999998862 356889999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=344.45 Aligned_cols=207 Identities=44% Similarity=0.794 Sum_probs=184.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
-+|+.+..||.|.||.||-|.+.++|+..|+|.+.+...+ ....+.+.+|+.++..|.|||||++||+....+..+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 4799999999999999999999999999999998865544 4456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
.||||+||+|.++++. ++.+.|-....+..|++.||+|||++|||||||||+||+++.+|.+|++|||.|..+.+....
T Consensus 1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999854 577888888999999999999999999999999999999999999999999999988664311
Q ss_pred -----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 514 -----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 514 -----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
....||+.|||||++.+.. ......+.||||||||++||+||+.||.+++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTK----GKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccc----cCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 2477999999999997542 23356689999999999999999999998764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.46 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=172.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--Ce
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~ 430 (571)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++|+||+++++++... +.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 358999999999999999999999999999999986432221 1123456799999999999999999988765 56
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+||||+. ++|.+++......+++.++..++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 899999997 5898888765567999999999999999999999999999999999999999999999999999876543
Q ss_pred c-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ......++..|+|||.+.+ ...++.++|||||||++|||++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred cCCCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2223346788999998863 3357889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.97 Aligned_cols=200 Identities=26% Similarity=0.399 Sum_probs=169.9
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC--CeEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--DHLY 432 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~--~~ly 432 (571)
|++.+.||+|+||.||+|.+..++..||+|.+.....+. .. ....+|+.++.++. |+||+++++++.+. +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 678899999999999999999999999999876432221 11 23347888888885 99999999999987 8899
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+. ++|.+++......+++.++..++.||+.||+|||++|++||||||+||+++. +.+||+|||++..+.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9999997 5888888765567999999999999999999999999999999999999999 9999999999987755444
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++..|+|||.+.. +..++.++|||||||++|||++|..||.+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 155 YTEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred cCCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 445568899999998753 2346789999999999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=282.51 Aligned_cols=197 Identities=27% Similarity=0.432 Sum_probs=162.4
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHH---HHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI---KVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei---~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
.||+|+||.||++.+..+|+.+|||.+......... ......+|. .++...+|+||+.+++.+...+..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 489999999999999999999999988643222111 112223343 334445799999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccC
Q 008285 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517 (571)
Q Consensus 438 ~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~ 517 (571)
+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence 9999999999765 569999999999999999999999999999999999999999999999999987654322 22356
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|+..|+|||.+.. +..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 157 GTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 8999999998752 2346789999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=284.05 Aligned_cols=202 Identities=30% Similarity=0.567 Sum_probs=170.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
..+|.+.+.||+|+||.||+|.+. .++..+++|.+.. ......+.+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 457999999999999999999854 3456688887652 223344678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~ 492 (571)
.+..++||||+.+++|.+++..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997542 34789999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 493 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 493 ~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++.++|+|||++........ .....++..|+|||.+. ...++.++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999976543221 22345678899999886 3457889999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.64 Aligned_cols=200 Identities=30% Similarity=0.541 Sum_probs=167.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|++..+ ..||||.+..... ..+.+.+|++++++++|+||+++++.+. .+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 75 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence 345799999999999999999998765 4699998763211 1246788999999999999999998764 5668
Q ss_pred EEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|+||||+.+|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999764 345899999999999999999999999999999999999999999999999999766433
Q ss_pred ccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
... ....++..|+|||++. ...++.++|||||||++|||++ |+.||.+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ccccccCCcccceecCHhHhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 221 1234667899999875 3457889999999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.75 Aligned_cols=203 Identities=28% Similarity=0.529 Sum_probs=172.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+.. ++.+|||.+..... ..+.+.+|+.+++.++|+||+++++++.....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence 456799999999999999999999764 57899998763221 23567889999999999999999999998899
Q ss_pred EEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.++||||+.+++|.+++.+.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999999997643 4689999999999999999999999999999999999999999999999999886643
Q ss_pred Cccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 510 ~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... ....++..|+|||.+. +..++.++|||||||++|+|++ |+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAAN-------YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hhhhhhhccCCCccccCHHHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2211 1233566899999886 3357889999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=282.44 Aligned_cols=199 Identities=27% Similarity=0.424 Sum_probs=163.5
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCc-HHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~-~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
.||+|+||.||+|.+..+|+.||||.+......... .........++.+++...|+||+++++.+...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999988643221111 1111112223445555679999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT 519 (571)
|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.... .....|+
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 99999998764 569999999999999999999999999999999999999999999999999987654332 2345799
Q ss_pred CcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 520 ~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..|+|||.+.. +..++.++||||+||++|||++|+.||.+..
T Consensus 159 ~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 159 HGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred cCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999863 2347788999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=280.51 Aligned_cols=208 Identities=36% Similarity=0.620 Sum_probs=174.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD-- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~-- 428 (571)
...+|++.+.||+|+||.||+|.+..+|+.+|+|++.... .....+.+|+.+++.+ +|+||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3568999999999999999999999999999999875321 2235677899999998 799999999988754
Q ss_pred ---CeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 429 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
+.+|+||||+.|++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 358999999999999998863 34568999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++........ .....|+..|+|||.+...... ...++.++|||||||++|||++|+.||...+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY--DYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCc--ccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 9886544321 2235688999999998632111 2246789999999999999999999997654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.31 Aligned_cols=200 Identities=33% Similarity=0.578 Sum_probs=167.9
Q ss_pred EEeeEEeecCceEEEEEEEC----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 357 QKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.+.+.||.|.||.||+|.+. ..+..|+||.+.. ....+..+.+.+|++++++++|+||++++|++...+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence 46789999999999999988 4567899998853 233445788899999999999999999999999888899
Q ss_pred EEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
+|||||.+|+|.++|... ...+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999886 5679999999999999999999999999999999999999999999999999998763221
Q ss_pred c---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 512 Y---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 512 ~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
. .....+...|+|||.+... .++.++||||||+++|||++ |+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~-------~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDG-------EYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHS-------EESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccc-------cccccccccccccccccccccccccccccc
Confidence 1 1234467789999998742 37889999999999999999 789997653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=277.69 Aligned_cols=196 Identities=32% Similarity=0.516 Sum_probs=172.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||.|+||.||+|++..+++.||+|++..... ......+.+.+|+.+++.++|+||+++++.+.+++.+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 6999999999999999999999999864321 22234577889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCc
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 521 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~ 521 (571)
+|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.............|+..
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999999765 4589999999999999999999999999999999999999999999999999987765443344578999
Q ss_pred ccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 522 YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|++||.+. ...++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~PE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 158 YVAPEIIL-------NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccChhHhc-------CCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999875 2346789999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=280.46 Aligned_cols=196 Identities=27% Similarity=0.496 Sum_probs=162.6
Q ss_pred eEEeecCceEEEEEEECCCCcE--EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~--VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|+||.||+|.+..+|.. +++|.+... ......+.+.+|++++.++ +|+||+++++++...+.+|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 3689999999999999888764 577776521 1234456788999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 437 YVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 437 y~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
|+.+++|.+++.+.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997532 24789999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
|++..............+..|+|||++. ...++.++|||||||++|||++ |+.||.+.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9986432221112223456799999885 3357889999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.48 Aligned_cols=208 Identities=26% Similarity=0.493 Sum_probs=172.3
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCee
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIV 419 (571)
.+.....+|.+++.||+|+||.||+|.+.. .+..+|+|.+... ........+.+|+++++.+ +|+||+
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCee
Confidence 345556799999999999999999998642 3457899987532 1234456788999999999 599999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
++++++...+.+|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 99999999999999999999999999997632 348889999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr 560 (571)
|+|||++.++.+||+|||+++....... .....++..|||||++. +..++.++|||||||++|||++ |.
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~~g~ 234 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGILMWEIFTLGG 234 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-------cCCcCccchhhHHHHHHHHHHhCCC
Confidence 9999999999999999999986643221 11223456799999886 3357889999999999999999 89
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||...
T Consensus 235 ~p~~~~ 240 (314)
T cd05099 235 SPYPGI 240 (314)
T ss_pred CCCCCC
Confidence 999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=278.44 Aligned_cols=201 Identities=24% Similarity=0.448 Sum_probs=165.8
Q ss_pred eEEeeEEeecCceEEEEEEECCCCc--EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~--~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
|.+++.||+|+||.||+|.+..++. .+|+|.++... ......+.+.+|+++++.++|+||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 3567899999999999999887775 68999876422 2344567788999999999999999999976432
Q ss_pred -CeEEEEEeecCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 429 -DHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~-----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
...+++|||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2468999999999999988532 2347899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 503 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+++.+..... .....+++.|++||.+. ...++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLA-------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHcc-------CCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9987644321 11234667899999886 3457889999999999999999 89999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=281.58 Aligned_cols=197 Identities=28% Similarity=0.452 Sum_probs=169.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|+||+||+|.+..+|+.||+|.+..... ......+.+..|+++|+.++|+||+++++.+...+.+|+||||+.++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 6999999999999999999999998863211 11223455678999999999999999999999999999999999999
Q ss_pred CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCC
Q 008285 442 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (571)
Q Consensus 442 sL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~ 520 (571)
+|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++.............++.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 9999997653 368999999999999999999999999999999999999999999999999987665433334456888
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.|++||.+.. ..++.++|||||||++|+|++|+.||...+
T Consensus 159 ~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 159 GYMAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred CcCCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999863 247889999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=274.40 Aligned_cols=195 Identities=29% Similarity=0.507 Sum_probs=165.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+++++.++|+||+++++.+...+..++||||+.
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 46999999999999865 68899999875321 23344568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc--ccC
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 517 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~--~~~ 517 (571)
+++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... ...
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 999999998766678999999999999999999999999999999999999999999999999987544322111 123
Q ss_pred CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 518 GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++..|+|||++. ...++.++||||||+++|+|++ |..||...
T Consensus 156 ~~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 156 IPIKWTAPEALN-------YGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CcccccCHHHhc-------cCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 456799999886 3357889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=274.52 Aligned_cols=202 Identities=31% Similarity=0.520 Sum_probs=175.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 589999999999999999999999999999998643221 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+.+++|.+++.+. ...+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999999764 335899999999999999999999999999999999999999999999999999876543222
Q ss_pred -cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 -LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 -~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 158 ARTCIGTPYYLSPEICE-------NRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hhhccCCccccCHHHhC-------CCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 2345888999999876 235678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.56 Aligned_cols=203 Identities=28% Similarity=0.487 Sum_probs=171.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCC----------------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETG----------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG----------------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp 416 (571)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+++++.++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCC
Confidence 458999999999999999999876544 457999875321 224567788999999999999
Q ss_pred CeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 008285 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (571)
Q Consensus 417 NIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~----------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPs 486 (571)
||+++++++..++.++++|||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999997643 25899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc--CCC
Q 008285 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561 (571)
Q Consensus 487 NILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt--Gr~ 561 (571)
|||++.++.++|+|||++........ .....++..|+|||.+.. ..++.++|||||||++|||++ |..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCCC
Confidence 99999999999999999886543321 223446778999998863 357889999999999999998 778
Q ss_pred CCCCC
Q 008285 562 PWSEF 566 (571)
Q Consensus 562 PF~~~ 566 (571)
||...
T Consensus 233 p~~~~ 237 (296)
T cd05051 233 PYEHL 237 (296)
T ss_pred CCCCc
Confidence 88653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=284.20 Aligned_cols=203 Identities=23% Similarity=0.396 Sum_probs=170.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.+|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.++..++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 468888999999999999998754 35789999876321 233456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 429 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~---------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+..++++||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 1347888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+.+||+|||+++.+..... .....+++.|+|||.+. ...++.++|||||||++|||++ |..||.+..
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999886643322 12334577899999886 3357889999999999999998 888987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=284.69 Aligned_cols=204 Identities=31% Similarity=0.513 Sum_probs=170.5
Q ss_pred CeEEeeEEeecCceEEEEEEECC--CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--Ce
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~--tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~ 430 (571)
+|++.+.||+|+||.||+|.+.. ++..||||.+..... ......+.+.+|+.+++.++|+||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 48899999999999999999988 899999999874321 1122235577899999999999999999999988 88
Q ss_pred EEEEEeecCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----CCcEEEEecC
Q 008285 431 LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFG 502 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~----~g~vKLiDFG 502 (571)
+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999999997 56777765322 36899999999999999999999999999999999999998 9999999999
Q ss_pred CcccccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++........ .....++..|+|||++.+ ...++.++|||||||++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9886543222 223467889999998763 2346789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=277.91 Aligned_cols=195 Identities=27% Similarity=0.460 Sum_probs=162.6
Q ss_pred EEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 361 LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.++++++|+||+++++.+. .+..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence 3899999999999875 44567999987532 22344567889999999999999999999875 45789999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc----c
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----L 514 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~----~ 514 (571)
.+++|.+++......+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++......... .
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999999999876667999999999999999999999999999999999999999999999999999765432211 1
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...++..|+|||.+. ...++.++|||||||++|||++ |..||.+..
T Consensus 157 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 157 AGKWPLKWYAPECIN-------FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCcccCCHHHHc-------cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 122356899999886 2357889999999999999996 999997653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=291.77 Aligned_cols=201 Identities=25% Similarity=0.403 Sum_probs=172.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
..+|++.+.||+|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 468999999999999999999999999999999875322 1233445677899999999999999999987644
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...|+||||+. ++|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999996 5888887643 89999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........|+..|+|||.+. +..++.++|||||||++|+|++|+.||...+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHh-------CCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 65544344456889999999986 3357889999999999999999999997554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=282.19 Aligned_cols=201 Identities=27% Similarity=0.477 Sum_probs=167.9
Q ss_pred CeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
+|++.+.||+|+||.||+|.+.. ....+++|.+... ........+.+|+.+++.+.|+||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47889999999999999998753 2356888876532 12334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 008285 430 HLYIYLEYVHPGSINRYVREH-----------------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~-----------------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPs 486 (571)
..+++|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999999998642 134788999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 008285 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562 (571)
Q Consensus 487 NILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~P 562 (571)
|||+++++.+||+|||+++....... .....++..|+|||.+. +..++.++||||||+++|||++ |+.|
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-------cCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999976533221 12234567899999875 3357889999999999999998 9999
Q ss_pred CCCC
Q 008285 563 WSEF 566 (571)
Q Consensus 563 F~~~ 566 (571)
|.+.
T Consensus 230 ~~~~ 233 (290)
T cd05045 230 YPGI 233 (290)
T ss_pred CCCC
Confidence 9753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.19 Aligned_cols=206 Identities=37% Similarity=0.672 Sum_probs=173.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~---- 427 (571)
...|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 45899999999999999999999999999999987632 12335678899999998 69999999998853
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 --DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 --~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
.+.+|++|||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46789999999999999999763 345889999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...... .......|+..|+|||.+... ......++.++|||||||++|||++|+.||.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcc--cCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 765432 222345689999999987531 112345788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=281.24 Aligned_cols=205 Identities=24% Similarity=0.430 Sum_probs=168.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
....+|++.+.||+|+||.||+|.++. .+..||+|.+... ........+.+|+.+++.++|+||+++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 445689999999999999999997652 3557999986522 1222334577899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~---------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
.+.+..|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999997532 234667888999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 497 KLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+|+|||+++.+..... .....++..|+|||.+. ...++.++|||||||++|||++ |..||.+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-------~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhc-------cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876543221 11234567899999886 2357889999999999999998 88899653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=285.31 Aligned_cols=207 Identities=29% Similarity=0.493 Sum_probs=173.8
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~ 422 (571)
+....++|++.+.||+|+||.||++.+ ..++..||+|.++... .....+.+.+|+++++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 445566899999999999999999975 3345689999876322 123456788999999999 799999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
+.+...+..|+||||+.+|+|.+++.... ..+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999999997643 34899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 502 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
|++........ .....++..|+|||.+. ...++.++|||||||++|||++ |..||...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhc-------cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 99986543221 11234677899999886 3357889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.50 Aligned_cols=205 Identities=28% Similarity=0.473 Sum_probs=170.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~-- 429 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+.+|+++++.++|+||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 345899999999999999999999999999999988643221 112234568999999999999999999877654
Q ss_pred ------eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 430 ------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 430 ------~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
..|+||||+. ++|.+++......+++.+++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 588888876655799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+........ .....++..|+|||.+.. ...++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 976543221 123457888999998753 233577899999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=281.26 Aligned_cols=203 Identities=31% Similarity=0.559 Sum_probs=171.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
...+|++.+.||+|+||.||++... .++..+|+|.+.. ........+.+|+++++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 3458899999999999999999743 3567889997653 22344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~--------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~ 492 (571)
..+..+++|||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 9999999999999999999997643 24889999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 493 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 493 ~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++.+||+|||++........ .....+++.|+|||.+. +..++.++|||||||++|||++ |+.||.+.
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-------YRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc-------cCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 99999999999876543221 11233567899999886 3357889999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.25 Aligned_cols=204 Identities=37% Similarity=0.623 Sum_probs=182.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|.-++.||.|+||-||.+++..+.+.||||.+..... ...+....+..|+..|++|.|||++.+.|+|.-+...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 468888999999999999999999999999998764433 445666789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||||- |+-.|+|..+...|-+.++..|+.+.+.||+|||+++.||||||..|||+.+.|.|||+|||.|....+ .
T Consensus 104 VMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---A 179 (948)
T KOG0577|consen 104 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---A 179 (948)
T ss_pred HHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---h
Confidence 999997 778888887778899999999999999999999999999999999999999999999999999987654 3
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++++|||+|||||++..+. .+.|+-++||||||++.+||.-.++|+=++.
T Consensus 180 nsFvGTPywMAPEVILAMD----EGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred hcccCCccccchhHheecc----ccccCCccceeeccchhhhhhhcCCCccCch
Confidence 4789999999999998753 3468889999999999999999999975544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=273.55 Aligned_cols=200 Identities=33% Similarity=0.577 Sum_probs=172.2
Q ss_pred eEEeeEEeecCceEEEEEEECCCC----cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG----~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
+++.+.||.|+||.||+|.+...+ ..||+|.+.... .....+.+..|+++++.++|+||+++++.+.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 457789999999999999998766 899999885322 122557788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~-Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|++|||+.+++|.+++...... +++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999999999765444 999999999999999999999999999999999999999999999999999876544
Q ss_pred cccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ...++..|+|||.+. ...++.++||||||+++|+|++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2221 133678999999884 3457889999999999999998 89998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=276.75 Aligned_cols=195 Identities=25% Similarity=0.479 Sum_probs=163.7
Q ss_pred EEeecCceEEEEEEE--CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 361 LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 361 ~LG~G~fG~VYla~~--k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
.||+|+||.||+|.+ ..++..+|+|+++... ......+.+.+|+.+++.++|+||+++++.+. .+..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence 589999999999965 4567899999876322 23445677889999999999999999999875 56779999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc----cc
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----EL 514 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~----~~ 514 (571)
.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++..+..... ..
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999999764 5699999999999999999999999999999999999999999999999999986644321 11
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...++..|+|||.+. ...++.++|||||||++|||++ |+.||....
T Consensus 157 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 157 HGKWPVKWYAPECMN-------YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred CCCCCccccCHhHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 223457899999875 2357789999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.03 Aligned_cols=201 Identities=29% Similarity=0.507 Sum_probs=176.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||+||++.+..+|+.||+|++.... .....+.+.+|+++++.++|+||+++++.+...+.+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 458999999999999999999999999999999876422 2334577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
+||||+.+++|.+++.+. +.+++..+..++.+|+.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999999998764 568999999999999999999996 699999999999999999999999999987553322
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 159 -~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred -cCccccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 234578999999998852 35778999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=283.90 Aligned_cols=200 Identities=42% Similarity=0.706 Sum_probs=174.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|++.+.||+|+||.||+|.+..+|+.||+|.+.... .....+.+.+|+++++.++|+||+++++.+..++..|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 35778889999999999999999999999999876322 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 80 IMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999999999999865 4689999999999999999999999999999999999999999999999999986654321
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+.. ..++.++|||||||++|||++|+.||.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQ-------SAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred hhcccCcccccCHHHhCc-------CCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 223468889999999863 35788999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.31 Aligned_cols=200 Identities=31% Similarity=0.510 Sum_probs=169.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+.-|++.+.||+|+||.||+|.+ +.++..||+|.+.... .....+.+.+|+++++.+.|+||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34689999999999999999984 4568899999875321 233456788999999999999999999988775
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...++||||+.|++|.+++.+....+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 568999999999999999977656789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 507 LTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 507 l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
+..... .....++..|+|||.+. +..++.++|||||||++|||++++.|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLI-------QSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhc-------cCCCCccccchhhhhhhhhhhcCCCCC
Confidence 643221 12345677899999875 335778999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=275.45 Aligned_cols=197 Identities=30% Similarity=0.553 Sum_probs=166.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE-eCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~-~~~~ 430 (571)
...+|++.+.||+|+||.||++... |..+|+|.+... ...+.+.+|+.++++++|+||+++++++. ..+.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 3458999999999999999999764 788999987521 12356789999999999999999999764 4567
Q ss_pred EEEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.|+||||+.+++|.+++.+... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 8999999999999999976533 488999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.. ....++..|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 155 ~~--~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cC--CCCccceeecCHHHHc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 22 1233566899999885 3357889999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=279.22 Aligned_cols=203 Identities=29% Similarity=0.512 Sum_probs=169.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCe--
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH-- 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~-- 430 (571)
++|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 3699999999999999999999999999999987643221 123356778999999995 6999999999887766
Q ss_pred ---EEEEEeecCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecC
Q 008285 431 ---LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFG 502 (571)
Q Consensus 431 ---lyLVmEy~~GGsL~d~L~~~~----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFG 502 (571)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7988886532 35899999999999999999999999999999999999998 8999999999
Q ss_pred CcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 503 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++..+.... ......+++.|+|||++.. ...++.++||||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 987653321 1123457888999998853 335688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.24 Aligned_cols=209 Identities=28% Similarity=0.533 Sum_probs=173.4
Q ss_pred CCCCCCCCCeEEeeEEeecCceEEEEEEECCC-------CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCe
Q 008285 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI 418 (571)
Q Consensus 347 p~~~~~~~~y~i~k~LG~G~fG~VYla~~k~t-------G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNI 418 (571)
+.+.....+|++++.||+|+||.||+|.+... +..||+|.+... ......+.+.+|+++++++ +|+||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 35666777999999999999999999986432 236899976532 2234457788999999999 79999
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDI 483 (571)
+++++.+...+.+|++|||+.+|+|.++|.... ..+++.++..++.||+.||.|||++||+||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 999999999999999999999999999997532 24778888999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-C
Q 008285 484 KGANLLVDASGVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (571)
Q Consensus 484 KPsNILLd~~g~vKLiDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-G 559 (571)
||+|||++.++.+||+|||+++........ ....++..|+|||++. +..++.++|||||||++|||++ |
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g 233 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLG 233 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-------cCCcCchhhhHHHHHHHHHHHhcC
Confidence 999999999999999999999866443211 1233456799999986 3457889999999999999998 8
Q ss_pred CCCCCCC
Q 008285 560 KPPWSEF 566 (571)
Q Consensus 560 r~PF~~~ 566 (571)
..||.+.
T Consensus 234 ~~p~~~~ 240 (334)
T cd05100 234 GSPYPGI 240 (334)
T ss_pred CCCCCCC
Confidence 9999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.35 Aligned_cols=201 Identities=29% Similarity=0.552 Sum_probs=168.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... . .+.+.+|+.++++++|+||+++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 3458999999999999999999866 467799998764221 1 245789999999999999999998764 5668
Q ss_pred EEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|++|||+.+++|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999999764 345899999999999999999999999999999999999999999999999999866443
Q ss_pred ccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 511 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 511 ~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
... ....++..|+|||.+. ...++.++||||||+++|+|++ |+.||.+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred ccccccCCCCCccccChHHHh-------cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 221 1233566799999875 3357889999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=303.05 Aligned_cols=209 Identities=29% Similarity=0.451 Sum_probs=177.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~ 428 (571)
.....+|..+.+||+|+||+|.++..+.+.+.+|||+++.... .....++--+.|-++|... +-|.+++++.+|..-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVi--iQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhcccee--eecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3445689999999999999999999999999999998753110 0001122234566677666 468899999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc-
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL- 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l- 507 (571)
+++|+||||+.||+|.-.|++. +.+.|..+..++..|+-||-+||++|||.||||.+|||+|.+|++||+|||+++.-
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999999876 56999999999999999999999999999999999999999999999999999853
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
.+.....+++||+.|+|||++. ...|+.++|+||+||+|||||.|++||++.+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~-------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred cCCcceeeecCCCcccccceEE-------ecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 4455566899999999999987 34789999999999999999999999987653
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=276.64 Aligned_cols=202 Identities=27% Similarity=0.515 Sum_probs=169.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|+++++||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+ ..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 74 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEP 74 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCC
Confidence 34568999999999999999999865 578899998763221 135678899999999999999999876 4567
Q ss_pred EEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+++|||+.+++|.+++... ...+++.++..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 89999999999999998653 34689999999999999999999999999999999999999999999999999976653
Q ss_pred Cccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 510 ~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... ....++..|+|||++. ...++.++||||||+++|||++ |+.||.+..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAIN-------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred CCcccccCCcccccccCHHHhc-------cCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 2211 2234667899999886 3357789999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=273.80 Aligned_cols=198 Identities=32% Similarity=0.552 Sum_probs=171.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||.|+||.||+|... |+.||||.+.... ...+++.+|+.+++.++|+||+++++.+...+..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 3458999999999999999999875 7899999886321 1457788999999999999999999999989999
Q ss_pred EEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999999997653 26899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.. ...++..|+|||.+. ...++.++||||||+++|||++ |+.||...
T Consensus 156 ~~--~~~~~~~~~ape~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 156 QD--SGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cc--cCCCcccccCchhhc-------CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 22 234566799999885 2356789999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=275.01 Aligned_cols=195 Identities=30% Similarity=0.536 Sum_probs=166.1
Q ss_pred eEEeecCceEEEEEEECC-CCc--EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~-tG~--~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|++|.||+|.+.. .+. .||||.+..... ....+.+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 468999999999999865 333 689998764221 1566788999999999999999999999888 88999999
Q ss_pred ecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---
Q 008285 437 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--- 512 (571)
Q Consensus 437 y~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~--- 512 (571)
|+.+++|.+++.+.. ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++..+.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999999998754 5689999999999999999999999999999999999999999999999999987644221
Q ss_pred -ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 513 -~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.....++..|+|||.+. ...++.++|||||||++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLR-------TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhc-------ccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11245778899999886 3357889999999999999998 99999644
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=273.94 Aligned_cols=199 Identities=30% Similarity=0.515 Sum_probs=170.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+++++++.|+||+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 489999999999999999998764 67899998753221 12457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.+++|.+++......++++.++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999999876667899999999999999999999999999999999999999999999999998765432211
Q ss_pred --cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 514 --~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
....++..|+|||.+.. ..++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred ccCCCccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 12335678999998862 357889999999999999998 99999743
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=283.01 Aligned_cols=203 Identities=30% Similarity=0.474 Sum_probs=168.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCC--------------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG--------------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI 418 (571)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|++++++++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 458999999999999999999875432 35899987632 123345678899999999999999
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~-----------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsN 487 (571)
+++++++...+..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999996532 236888899999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 008285 488 LLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPP 562 (571)
Q Consensus 488 ILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt--Gr~P 562 (571)
||++.++.+||+|||++..+..... .....++..|+|||++. ...++.++|||||||++|+|++ |..|
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-------cCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999976543221 12234567899999886 3357889999999999999988 6778
Q ss_pred CCCC
Q 008285 563 WSEF 566 (571)
Q Consensus 563 F~~~ 566 (571)
|...
T Consensus 233 ~~~~ 236 (295)
T cd05097 233 YSLL 236 (295)
T ss_pred Cccc
Confidence 8653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=275.13 Aligned_cols=192 Identities=26% Similarity=0.473 Sum_probs=162.6
Q ss_pred eEEeecCceEEEEEEECCCC----------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 360 KLIGRGTFGSVYIGTNRETG----------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG----------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+|+.++|+||+++++.+.. +
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 46999999999999998776 347777654211 115678889999999999999999999888 7
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-------cEEEEecC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-------VVKLADFG 502 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-------~vKLiDFG 502 (571)
..++||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 88999999999999999987655799999999999999999999999999999999999999887 79999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++..... .....++..|+|||++... ...++.++|||||||++|||++ |..||...
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9987654 2234577889999998631 1357889999999999999999 68888665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.27 Aligned_cols=205 Identities=27% Similarity=0.489 Sum_probs=168.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS 424 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~ 424 (571)
...++|++++.||+|+||+||+|.+ ..+++.||||.++... .......+.+|+.+|.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 3456899999999999999999984 3467889999886321 233456788999999999 68999999998
Q ss_pred EEeC-CeEEEEEeecCCCCHHHHHHHhc----------------------------------------------------
Q 008285 425 EVVD-DHLYIYLEYVHPGSINRYVREHC---------------------------------------------------- 451 (571)
Q Consensus 425 ~~~~-~~lyLVmEy~~GGsL~d~L~~~~---------------------------------------------------- 451 (571)
+... ..+++|||||.+|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 46799999999999999986531
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---cc
Q 008285 452 --------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---EL 514 (571)
Q Consensus 452 --------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~ 514 (571)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 2367788889999999999999999999999999999999999999999999886533211 11
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...++..|+|||.+. ...++.++|||||||++|+|++ |..||...
T Consensus 240 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 240 DARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCCCcceECcHHhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 233567799999885 3457889999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=281.72 Aligned_cols=203 Identities=29% Similarity=0.468 Sum_probs=168.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC----------------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~----------------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp 416 (571)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+... ........+.+|+++|+.++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence 4579999999999999999986432 3456899987532 1234456788999999999999
Q ss_pred CeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 008285 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (571)
Q Consensus 417 NIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~----------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPs 486 (571)
||+++++++...+..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999999999999997642 23677889999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc--CCC
Q 008285 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561 (571)
Q Consensus 487 NILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt--Gr~ 561 (571)
|||++.++.++|+|||++..+..... .....++..|++||... ...++.++|||||||++|||++ |..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-------LGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-------cCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999986543221 11233467899999875 2357889999999999999998 788
Q ss_pred CCCCC
Q 008285 562 PWSEF 566 (571)
Q Consensus 562 PF~~~ 566 (571)
||...
T Consensus 233 p~~~~ 237 (296)
T cd05095 233 PYSQL 237 (296)
T ss_pred Ccccc
Confidence 98654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=277.18 Aligned_cols=201 Identities=31% Similarity=0.521 Sum_probs=172.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~l 431 (571)
++|++.+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++|+||+++++++.+. +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 36899999999999999999999999999999886422 124457788999999999999999999988654 478
Q ss_pred EEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
|+||||+.|++|.+++.. ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999998753 34568999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... .....++..|+|||.+. ...++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQ-------GKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc-cccccCCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 322 12355788999999886 345788999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=288.00 Aligned_cols=201 Identities=29% Similarity=0.527 Sum_probs=169.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 458999999999999999999999999999999886322 123446677899999999999999999876544
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 35799999996 588888754 46999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..... .....|+..|+|||.+.. ...++.++|||||||++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43221 123568999999998752 335788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=268.75 Aligned_cols=202 Identities=32% Similarity=0.590 Sum_probs=177.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||.|+||.||++.+..++..|++|++..... .....+.+.+|+++++.++|+|++++++.+...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 58999999999999999999999999999999864332 234556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||+++++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999999865 3679999999999999999999999999999999999999999999999999998765433
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred ceecceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 2234568899999998752 34678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=277.30 Aligned_cols=202 Identities=32% Similarity=0.567 Sum_probs=173.5
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--CeEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYI 433 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--~~lyL 433 (571)
|++.+.||+|+||.||+|++..+|+.+|+|.+.... ........+.+|+++++.++|+||+++++++... +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678999999999999999999999999999987533 1123345677899999999999999999999888 88999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+. ++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||+++++.++|+|||++.......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 999997 58998887655679999999999999999999999999999999999999999999999999998765543
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|+|||.+.+ ...++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 157 DYTNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cccccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457888999997653 2346789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=276.49 Aligned_cols=200 Identities=42% Similarity=0.705 Sum_probs=174.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
.-|++.+.||+|+||.||+|.+..++..||||.+... ......+.+.+|+.+++.++|+||+++++.+..++..|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 3588899999999999999999999999999987532 223345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 80 v~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 80 IMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 9999999999999865 4689999999999999999999999999999999999999999999999999876644321
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+.. ..++.++|||||||++|+|++|..||...
T Consensus 158 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred hccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 223568889999998862 34677899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=271.93 Aligned_cols=195 Identities=30% Similarity=0.534 Sum_probs=167.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecC
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~ 439 (571)
++||+|+||.||+|.+.. ++.||+|.+..... ....+.+.+|++++++++|+||+++++++...+..|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 469999999999999887 99999998764221 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc---cc
Q 008285 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL 516 (571)
Q Consensus 440 GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~---~~ 516 (571)
|++|.+++......+++..+..++.+++.||+|||++|++||||||+|||++.++.++|+|||++.......... ..
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999999998766678999999999999999999999999999999999999999999999999998654322111 12
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.++..|+|||.+.. ..++.++|||||||++|||++ |..||...
T Consensus 156 ~~~~~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 156 QIPIKWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred cceeccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 23567999998762 357889999999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=273.87 Aligned_cols=196 Identities=30% Similarity=0.505 Sum_probs=163.7
Q ss_pred eEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
++||+|+||.||+|++...+ ..+|+|.+..... ....+.+.+|+++++.+.|+||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 47999999999999876554 7899998763221 134567889999999999999999999765 556899999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc--
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-- 514 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~-- 514 (571)
|+.+++|.+++... ..+++..+..++.||+.||+|||.+|++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 76 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 76 LAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred eCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999999875 379999999999999999999999999999999999999999999999999998664332211
Q ss_pred --ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 008285 515 --SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (571)
Q Consensus 515 --~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~eg 568 (571)
...++..|+|||.+. ...++.++|||||||++|||++ |+.||....+
T Consensus 155 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 155 TTAGRWPLKWYAPECIN-------YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred ccCccccccccCHHHhc-------CCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 122346799999885 3457889999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=276.02 Aligned_cols=204 Identities=28% Similarity=0.493 Sum_probs=170.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
...+|++.+.||+|+||.||+|.+... ...|+||.+.... .....+.+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 456799999999999999999987654 3468889775322 13445678899999999999999999998765
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+..|+||||+.+++|.+++......+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 56789999999999999998765678999999999999999999999999999999999999999999999999998665
Q ss_pred CCcccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 509 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... ...++..|+|||.+. ...++.++|||||||++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cccceecCCCCccccccChhhhc-------cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 432211 223456799999875 3357889999999999999986 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=278.53 Aligned_cols=203 Identities=30% Similarity=0.508 Sum_probs=169.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|++|.||+|.++.+|+.||||.+...... ....+.+.+|+++++.++|+||+++++++...+..|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 4799999999999999999999999999999987543221 2234567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCcccccCCc
Q 008285 434 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~~~ 511 (571)
||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++. ++.+||+|||++.......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999996 57888775432 33688889999999999999999999999999999999985 5679999999997653321
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223457889999998853 235778999999999999999999999754
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=282.10 Aligned_cols=204 Identities=36% Similarity=0.614 Sum_probs=175.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+..+.+.+|+++++.++|+||+++++++...+..|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 356999999999999999999999999999999875332 223445567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+. |+|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999997 6777777665567999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++... ....++.++||||||+++|||++|+.||...
T Consensus 169 -~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred -CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 235688899999987531 1235778999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=274.39 Aligned_cols=199 Identities=29% Similarity=0.547 Sum_probs=166.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+++++.++|+||+++++++. .+..|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 45799999999999999999987664 469999765321 12356778999999999999999998774 56689
Q ss_pred EEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
++|||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997642 348899999999999999999999999999999999999999999999999997654322
Q ss_pred cc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 512 YE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 512 ~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.. ....++..|+|||.+. +..++.++|||||||++|||++ |+.||.+.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccccCCCccchhhCCHHHhc-------cCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1234667899999875 3457889999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=283.39 Aligned_cols=203 Identities=29% Similarity=0.523 Sum_probs=169.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++|+||+++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 45689999999999999999999887776 4677776421 123334567899999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
...++++||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4567999999999999999876667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... ....++..|+|||.+. +..++.++|||||||++|||++ |+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIH-------YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cCcccccccCCCccccccCCHHHhc-------cCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 443221 1233567899999875 3457889999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.03 Aligned_cols=199 Identities=35% Similarity=0.623 Sum_probs=172.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|.....||+|+||.||++.+..++..||||.+... .....+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3566667899999999999999999999999987532 23345668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+.+++|.+++.. ..+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 97 v~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 97 VMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 9999999999998854 458999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 175 RKSLVGTPYWMAPEVIS-------RLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred CceeecCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22356899999999885 335778999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=267.35 Aligned_cols=201 Identities=50% Similarity=0.847 Sum_probs=177.5
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|++|.||++++..+++.|++|.+.... ......+.+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 5889999999999999999999999999999986432 2234567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-c
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~-~ 513 (571)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999999999999765 5799999999999999999999999999999999999999999999999999987755332 2
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....++..|+|||.+.. ..++.++|||+||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred cccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 34568899999998863 23678999999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.73 Aligned_cols=205 Identities=24% Similarity=0.435 Sum_probs=172.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECC----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
...++|++.+.||+|+||.||+|.+.. ++..|++|.+.. .......+.+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 346789999999999999999999876 357889997652 123445677889999999999999999999876
Q ss_pred e-CCeEEEEEeecCCCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEE
Q 008285 427 V-DDHLYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (571)
Q Consensus 427 ~-~~~lyLVmEy~~GGsL~d~L~~~~-------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKL 498 (571)
. ....++++||+.+++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 6 467899999999999999997532 45899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 499 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 499 iDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+|||+++.+...... ....++..|+|||++. +..++.++|||||||++|||++ |+.||.+.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHh-------cCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 999999866433221 1234567899999886 3357889999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=291.05 Aligned_cols=204 Identities=27% Similarity=0.470 Sum_probs=176.1
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEEEee
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
.+.||+|+|+.|--|+...+|..||||++..... ....++.+|++++.+.+ |+||++++++|+++..+|||||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 3689999999999999999999999999876532 34578899999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCcccccCCc---
Q 008285 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGLS--- 511 (571)
Q Consensus 438 ~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~l~~~~--- 511 (571)
|.||.|..+|+++ ..++|.++..++++|+.||.+||.+||.||||||+|||.... .-||||||.+...+.-..
T Consensus 158 m~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred ccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999886 679999999999999999999999999999999999999544 369999999986543211
Q ss_pred -----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 512 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 512 -----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
...+-+|+..|||||++.... +....|..+.|.||||||||-||+|.+||-+..|-|
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv--~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFV--DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhc--cccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 123467889999999986432 225678999999999999999999999999877754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=279.41 Aligned_cols=204 Identities=27% Similarity=0.464 Sum_probs=171.9
Q ss_pred CeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
.|++.+.||.|+||.||+|.+. .+|..||+|++..... .......+.+.+|+.+++++ +|+||+.+++.+..++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 4889999999999999999875 4789999999863211 11123346678899999999 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999866442
Q ss_pred cc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.. .....|+..|+|||.+... ...++.++||||||+++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGG-----DGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccccccCCcccCChhhccCC-----CCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 21 2235689999999988531 22457789999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=281.41 Aligned_cols=201 Identities=37% Similarity=0.636 Sum_probs=174.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 468999999999999999999999899999999875321 122466788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+++++|.+++.+. .+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999999999763 588999999999999999999999999999999999999999999999998876544322
Q ss_pred -ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 -~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....|++.|++||.+.. ..++.++|||||||++|+|++|+.||....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ccccccCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223468889999998862 356789999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=279.37 Aligned_cols=202 Identities=31% Similarity=0.546 Sum_probs=171.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++.+.||.|++|.||+|++..+|+.||||.+..... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 48899999999999999999999999999998764321 122335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
|||+. ++|..++... ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 6898888653 3568999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....++..|+|||.+.+ ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 157 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223457889999998753 234678899999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.71 Aligned_cols=193 Identities=26% Similarity=0.454 Sum_probs=162.0
Q ss_pred eEEeecCceEEEEEEECCCCcE-------EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 360 KLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~-------VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
+.||+|+||.||+|.++.++.. +++|.+.. ......+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 3699999999999998765544 77776542 22344567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--------EEEEecCCc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--------VKLADFGMA 504 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~--------vKLiDFGlA 504 (571)
+||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999999876667899999999999999999999999999999999999987664 699999998
Q ss_pred ccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 008285 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG-r~PF~~~ 566 (571)
...... ....++..|+|||.+.. ...++.++|||||||++|||++| ..||...
T Consensus 156 ~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 156 ITVLPK---EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cccCCc---hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 765432 23458889999998863 23468899999999999999998 4666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=323.26 Aligned_cols=207 Identities=27% Similarity=0.501 Sum_probs=179.2
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~-----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
......+.++.||+|.||.||.|....... .||||.+... ...+....|.+|..+|..++|||||+++|++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 445678889999999999999998765333 3888877643 3356678899999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLi 499 (571)
.+....+|++|||+||+|..||++. ...|+..+++.|+.||++|+.||+++++|||||..+|+||++...|||+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999999986 5679999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCccccc-c--CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 008285 500 DFGMAKHLTGLSYELS-L--KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (571)
Q Consensus 500 DFGlA~~l~~~~~~~~-~--~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~eg 568 (571)
|||||+.+....+... . .-...|||||.++. ..++.|+|||||||+|||+|+ |..||.+...
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-------~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-------cccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 9999996655443321 1 23357999999983 478999999999999999999 9999987654
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=276.59 Aligned_cols=193 Identities=23% Similarity=0.415 Sum_probs=160.8
Q ss_pred eEEeecCceEEEEEEECCC------------CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 360 KLIGRGTFGSVYIGTNRET------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~t------------G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
+.||+|+||.||+|+.... ...|++|++... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4689999999999985422 235788876431 23344567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-------EEEEe
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------VKLAD 500 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~-------vKLiD 500 (571)
+...++||||+.+++|..++......+++..++.++.||+.||+|||++||+||||||+||||+.++. ++|+|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999999999876667999999999999999999999999999999999999976654 89999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEF 566 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL-tGr~PF~~~ 566 (571)
||++...... ....++..|+|||.+.. ...++.++|||||||++|||+ .|+.||...
T Consensus 156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 156 PGIPITVLSR---QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCccccCc---ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9998765432 23457888999998752 345788999999999999997 589998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=279.52 Aligned_cols=205 Identities=29% Similarity=0.504 Sum_probs=172.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
..+|++.+.||+|+||.||+|.++.+|+.||||.++..... ......+.+|+++++.++|+||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45899999999999999999999999999999998753221 122345678999999999999999999887654
Q ss_pred -------eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 430 -------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 430 -------~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.+|+||||+.+ +|.+++......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999975 7778777655679999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++........ .....++..|+|||.+.. ...++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987644321 122346788999998753 2346789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.06 Aligned_cols=199 Identities=35% Similarity=0.620 Sum_probs=172.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|.....||+|+||.||++.+..+++.||||++..... ...+.+.+|+.+++.++|+||+++++.+..++..|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 456666789999999999999999999999999864221 224567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 96 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 96 LMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9999999999998865 458999999999999999999999999999999999999999999999999987554322 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ccceecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234568999999999862 35788999999999999999999999644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.80 Aligned_cols=206 Identities=37% Similarity=0.604 Sum_probs=176.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
....|...+.||+|+||.||++++..+|..||+|.+..... ...+..+.+.+|+++++.++|+||+++++++..++..
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 34468899999999999999999999999999998864322 2344557788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 99999997 5788887666677999999999999999999999999999999999999999999999999998755432
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....|+..|+|||.+.... ...++.++|||||||++|||++|+.||...+
T Consensus 179 --~~~~~~~~y~aPE~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred --ccccCCccccChhhhhcCC----CCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 2356889999999975321 2346789999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=277.85 Aligned_cols=204 Identities=25% Similarity=0.477 Sum_probs=171.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
..++|++.+.||+|+||.||+|.+. .++..||+|.+... ......+.+.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 3568999999999999999999874 36788999987532 12344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHC---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~---------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKP 485 (571)
+++..++||||+.+++|.+++.... ..+++.++..++.||+.||+|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999999997532 2377888999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008285 486 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 561 (571)
Q Consensus 486 sNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~ 561 (571)
+|||++.++.++|+|||++..+..... .....++..|+|||.+. +..++.++|||||||++|||++ |..
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-------cCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999876543221 11233566799999876 3457889999999999999997 888
Q ss_pred CCCCC
Q 008285 562 PWSEF 566 (571)
Q Consensus 562 PF~~~ 566 (571)
||.+.
T Consensus 232 p~~~~ 236 (288)
T cd05050 232 PYYGM 236 (288)
T ss_pred CCCCC
Confidence 98643
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=269.47 Aligned_cols=202 Identities=33% Similarity=0.534 Sum_probs=176.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|++.+.||+|+||.||++++..+|+.+++|.+..... .......+.+|+++++.++|+||+++++.+...+..|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc---cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 58999999999999999999999999999999864322 123346677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||+.+++|.+++... ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999999998652 356899999999999999999999999999999999999999999999999999877554
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......|+..|++||.+. ...++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~-------~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWK-------GRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CcccccCCccccCHHHHC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 333456889999999986 3356789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.52 Aligned_cols=201 Identities=28% Similarity=0.524 Sum_probs=169.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
....+|++.+.||+|+||.||++.+. .+..+|+|.+... ....+.+.+|+++++.++|+||+++++.+.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP 74 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence 34678999999999999999999865 4667999986521 2234678889999999999999999998877 78
Q ss_pred EEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.|++|||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 89999999999999999763 34578889999999999999999999999999999999999999999999999976543
Q ss_pred Cccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ....++..|+|||++. ...++.++|||||||++|+|++ |+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred CCcccccCCcccccccCHhHhc-------cCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 2211 1234567799999886 2357789999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=272.33 Aligned_cols=196 Identities=29% Similarity=0.565 Sum_probs=160.9
Q ss_pred eEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE-eCCeEEEEE
Q 008285 360 KLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDHLYIYL 435 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~-~~~~lyLVm 435 (571)
+.||+|+||.||+|.+.. ++..||||.+... ......+.+.+|+.+++.++|+||+++++.+. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998653 3457999986422 22344577889999999999999999999765 455689999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc----
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 511 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~---- 511 (571)
||+.+++|.+++......+.+..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999999998765667888889999999999999999999999999999999999999999999997654321
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
......++..|+|||.+. ...++.++|||||||++|||++ |.+||...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred cccccCcCCccccChhHhc-------cCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 111334677899999886 2357889999999999999999 56677643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=278.51 Aligned_cols=208 Identities=22% Similarity=0.335 Sum_probs=159.8
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHH------HHHHHHHHHHHhhcCCCCeeE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAEC------IKQLEQEIKVLGHLKHENIVQ 420 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~------~k~l~~Ei~IL~~L~HpNIVk 420 (571)
....++|++.++||+|+||+||+|.+..+ +..+|+|+..........+.. ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557999999999999999999998887 667788765432221111110 011223344556678999999
Q ss_pred EeeeEEeCC----eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 421 YYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 421 l~g~~~~~~----~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
+++++.... ..+++||++. .++.+.+... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998766543 3477888874 5677766543 446888899999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 497 KLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+|+|||+++.+.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-------~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-------GACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999998653211 112356999999999876 346789999999999999999999999866
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=271.43 Aligned_cols=195 Identities=32% Similarity=0.568 Sum_probs=169.0
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||.|+||.||+|++..+|+.+++|++.... .......+.+.+|++++++++|+||+++++.+...+..|++|||+.|+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999999999999999875322 122345677889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc---------c
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---------Y 512 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~---------~ 512 (571)
+|.+++.... .+++..+..++.||+.||+|||++|++|+||+|+|||++.++.++|+|||++....... .
T Consensus 79 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 79 DLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 9999998754 79999999999999999999999999999999999999999999999999987653321 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....++..|++||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 158 DKRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 223568889999999863 23678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=317.61 Aligned_cols=205 Identities=27% Similarity=0.509 Sum_probs=177.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
...+.+..+.||+|.||+||+|+.. .+...||||.++. ....+...+|++|+++|..++|+|||+++|+|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3456788889999999999999754 3356799998763 234456788999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHh---------cCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREH---------CRD----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~---------~~~----Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+++.+|+|+|||..|||.+||... +.. |+..+...|+.||+.||.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 999999999999999999999643 122 8899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCccccc---cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~~~~---~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..|||+||||++.+...++... ..-.++||+||.++ ..+|+.++||||+||||||+++ |+.||.++.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999999998877655432 22466899999998 4579999999999999999999 999997653
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.70 Aligned_cols=208 Identities=29% Similarity=0.487 Sum_probs=172.5
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEE
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQY 421 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl 421 (571)
.+....++|.+++.||+|+||.||+|++. .++..||+|+++... .....+.+.+|+++|.++. |+||+++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 34555678999999999999999999864 345689999986422 1233456889999999997 9999999
Q ss_pred eeeEEeCCeEEEEEeecCCCCHHHHHHHhc--------------------------------------------------
Q 008285 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-------------------------------------------------- 451 (571)
Q Consensus 422 ~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~-------------------------------------------------- 451 (571)
++.+...+.+++|||||.+|+|.++|+...
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999996532
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 452 -----------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 452 -----------------------------------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
..+++..++.|+.||+.||+|||++||+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 135677788999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr 560 (571)
|+|||++.++.+||+|||+++...... ......++..|||||.+. ...++.++|||||||++|||++ |+
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGvil~e~l~~g~ 339 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGG 339 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-------CCCCCcHhHHHHHHHHHHHHHHcCC
Confidence 999999999999999999998653321 112345778899999886 3357889999999999999998 89
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||...
T Consensus 340 ~P~~~~ 345 (401)
T cd05107 340 TPYPEL 345 (401)
T ss_pred CCCCCC
Confidence 999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.43 Aligned_cols=203 Identities=41% Similarity=0.680 Sum_probs=177.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
....|++.+.||+|++|.||+|.+..++..|++|++..... ..+.+.+|+++++.++|+||+++++.+...+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 34578999999999999999999998899999999874321 456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.|++|.+++......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999999998865479999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......++..|++||++. +..++.++|||||||++|+|++|+.||....
T Consensus 171 ~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIK-------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hhhccccCCcccCCHhHhc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 112345788999999875 2356789999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.70 Aligned_cols=199 Identities=36% Similarity=0.619 Sum_probs=173.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|...+.||+|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 46777789999999999999999999999999875321 2334567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
+|||+.|++|.+++.. ..+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999999999999977 468999999999999999999999999999999999999999999999999887654322 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|+|||.+.. ..++.++|||||||++|||++|+.||.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred cccccCCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 223568999999998852 34778999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=273.75 Aligned_cols=203 Identities=34% Similarity=0.598 Sum_probs=176.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ly 432 (571)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+++++++. |+||+++++.+...+..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 379999999999999999999999999999998764221 12333467888999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999999875 4699999999999999999999999999999999999999999999999999886644221
Q ss_pred ---------------------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ---------------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ---------------------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|+..|++||++.. ..++.++||||||+++++|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-------KPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-------CCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 123457889999998763 34788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=270.90 Aligned_cols=194 Identities=31% Similarity=0.546 Sum_probs=162.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHH-hhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL-~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
+.||+|+||.||+|.+..+|+.||||.+..... ........+..|..++ ...+|+||+++++.+...+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 579999999999999999999999998753211 1122233444555444 4458999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCC
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~G 518 (571)
.|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++..... .....|
T Consensus 80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 999999999764 5689999999999999999999999999999999999999999999999999876543 223568
Q ss_pred CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 519 T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 156 TPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 889999999863 23678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=278.59 Aligned_cols=204 Identities=29% Similarity=0.485 Sum_probs=170.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ly 432 (571)
.+|+..+.||+|+||.||++.+..+|+.||||.+..... ......+.+|+.++.++. |+||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 367778899999999999999999999999998764221 134567889999999996 999999999999999999
Q ss_pred EEEeecCCCCHHHHH---HH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 433 IYLEYVHPGSINRYV---RE-HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 433 LVmEy~~GGsL~d~L---~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++|||+. ++|.++. .. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++..+
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9999986 4554443 22 235699999999999999999999974 9999999999999999999999999999876
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..........|+..|+|||++.... ...++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred ccCCccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 5544444456899999999986311 135788999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=271.34 Aligned_cols=201 Identities=29% Similarity=0.479 Sum_probs=169.8
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEeCCe--
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDH-- 430 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~~~~-- 430 (571)
|++.+.||+|+||.||+|+++.+|+.||+|.+...... ......+.+|+.+++++ .|+||+++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 68899999999999999999989999999998743322 12234456777777666 59999999999988776
Q ss_pred ---EEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 431 ---LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 431 ---lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++..
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999997 58998887643 3589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........++..|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCCcccccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 755444444568889999999863 357789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.73 Aligned_cols=204 Identities=30% Similarity=0.542 Sum_probs=169.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++.+.||+|+||.||+|.++.+++.+|||++........ ....+.+|+++++.++|+||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4699999999999999999999999999999998864322111 123456899999999999999999877543
Q ss_pred ----CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 429 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 429 ----~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
..+|+||||+. ++|..++......+++..+..++.||++||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 34699999997 5777777665567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccc------------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGLSYE------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~~~------------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......... ....|++.|+|||.+.. ...++.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 765432211 12356888999998763 234678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=277.55 Aligned_cols=192 Identities=22% Similarity=0.371 Sum_probs=159.2
Q ss_pred EEeecCceEEEEEEECCC------------------------CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC
Q 008285 361 LIGRGTFGSVYIGTNRET------------------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~t------------------------G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp 416 (571)
.||+|+||.||+|....+ ...|++|.+.. ........+.+|+.+++.++|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence 599999999999975322 23577887642 1233456678899999999999
Q ss_pred CeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--
Q 008285 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-- 494 (571)
Q Consensus 417 NIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-- 494 (571)
||+++++++...+..|+||||+++|+|..++......+++..+..++.||++||+|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999999987666799999999999999999999999999999999999997543
Q ss_pred -----cEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCC
Q 008285 495 -----VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEF 566 (571)
Q Consensus 495 -----~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL-tGr~PF~~~ 566 (571)
.+||+|||++....... ...++..|+|||.+.. ...++.++|||||||++|||+ +|+.||...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCcccccccccc---ccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 48999999886543221 2357888999998863 235788999999999999985 699999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.45 Aligned_cols=202 Identities=33% Similarity=0.535 Sum_probs=171.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~- 427 (571)
..+|++.+.||+|+||.||+|.+.. ++..||||.+...... ...+.+.+|+++++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 3578889999999999999998653 4889999988643221 456778999999999999999999998877
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
....++||||+.+++|.+++......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 5578999999999999999987655799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 507 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 507 l~~~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
....... ....++..|++||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCccc
Confidence 6532211 12234567999998862 3577899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=305.44 Aligned_cols=203 Identities=23% Similarity=0.359 Sum_probs=160.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCC-cEEEEEEeecC------------CCCcCcHHHHHHHHHHHHHHhhcCCCCee
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDII------------PDDPKSAECIKQLEQEIKVLGHLKHENIV 419 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG-~~VAIK~i~~~------------~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV 419 (571)
..+|++++.||+|+||+||+|..+... ..+++|.+... ............+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999765432 22222211100 00011223456688999999999999999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
++++++...+..|+|||++. ++|..++... .......+++.|+.||+.||.|||++|||||||||+||||+.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 6777777542 122446678889999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 496 VKLADFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 496 vKLiDFGlA~~l~~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
+||+|||+++.+.... ......||..|+|||++. +..++.++|||||||++|||++|..++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-------GDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999998765432 223467999999999986 335788999999999999999987643
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=271.56 Aligned_cols=205 Identities=26% Similarity=0.508 Sum_probs=174.1
Q ss_pred CeEEeeEEeecCceEEEEEEECC-CCcEEEEEEeecCCCC-----cCcHHHHHHHHHHHHHHhh-cCCCCeeEEeeeEEe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV 427 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~-tG~~VAIK~i~~~~~d-----~~~~~~~k~l~~Ei~IL~~-L~HpNIVkl~g~~~~ 427 (571)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+...... ........++.+|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999987 6789999987543211 1234455667788988865 789999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
++..++||||+.|++|.+++.. ....+++..++.++.||+.||.|||. .|++|+||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998853 34568999999999999999999995 7899999999999999999999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.............|+..|++||.+. ...++.++||||||+++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVK-------NEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred eeecccccccccccCcccCcChhhhc-------CCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 98765544334566899999999886 235788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=268.41 Aligned_cols=202 Identities=30% Similarity=0.572 Sum_probs=172.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|.+.+.||+|+||.||+|.++.+|..+|+|.+...... ....+.+.+|+++++.++|+||+++++.+...+..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP---VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc---chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 588999999999999999999999999999998653211 12345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccccCCcc
Q 008285 435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~~~~~ 512 (571)
|||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999999997643 3589999999999999999999999999999999999998775 569999999886654322
Q ss_pred c-cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 E-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~-~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ....|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQ-------NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cccccCCCccccCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 2245889999999875 235778999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=273.42 Aligned_cols=202 Identities=23% Similarity=0.355 Sum_probs=160.4
Q ss_pred EEeecCceEEEEEEECCC--CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeec
Q 008285 361 LIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~t--G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
.||+|+||.||+|..... ...+++|.+... ......+.+.+|+.+++.++|+||+++++.+......|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 699999999999975433 234566655432 12234577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc---c
Q 008285 439 HPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---Y 512 (571)
Q Consensus 439 ~GGsL~d~L~~~~---~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~---~ 512 (571)
.+|+|.+++.+.. ..+.+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999999997632 346677788999999999999999999999999999999999999999999986432211 1
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.....|+..|+|||++...........++.++|||||||++|||++ |..||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 2245688899999988532222223346789999999999999996 67788654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.83 Aligned_cols=202 Identities=32% Similarity=0.568 Sum_probs=174.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|++.+.||+|++|.||+|.+..+|+.+++|.+...... ......+.+|+++++.++|+||+++++.+...+.+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 56788999999999999999999999999987643222 133467788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-ccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 514 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~~ 514 (571)
||+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 78 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 9997 58888887765789999999999999999999999999999999999999999999999999988765433 222
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...++..|+|||.+.. ...++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 157 HYVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred CccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3558889999999863 2357889999999999999999999997644
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.12 Aligned_cols=201 Identities=30% Similarity=0.558 Sum_probs=170.4
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|++.+.||.|++|.||+|.+..+|..||||++...... ....+.+.+|+++++.++|+||+++++++.+.+..|++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 67889999999999999999999999999988643221 122355778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 436 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
||+. ++|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9995 78999987643 368999999999999999999999999999999999999999999999999987653221 11
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....++..|+|||++.. ...++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 157 THEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23456889999998753 234678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.54 Aligned_cols=196 Identities=30% Similarity=0.541 Sum_probs=163.4
Q ss_pred eEEeecCceEEEEEEECCCC------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 360 KLIGRGTFGSVYIGTNRETG------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
+.||+|+||.||+|+++... +.+|||.+... ........+.+|+++++.++|+||+++++++...+..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 36999999999999986544 68999986532 112335678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----cEEEEecC
Q 008285 434 YLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-----VVKLADFG 502 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-----~vKLiDFG 502 (571)
||||+.+++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+|||++.++ .++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999999753 23478899999999999999999999999999999999998877 89999999
Q ss_pred CcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 503 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++..+..... .....++..|+|||.+. ...++.++|||||||++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL-------DGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHc-------cCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9876543221 11234567899999886 3357889999999999999998 99999754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.90 Aligned_cols=203 Identities=23% Similarity=0.434 Sum_probs=170.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.++|++.+.||+|+||.||+|+.+.+ .+.|++|.+... ......+.+.+|++++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 46899999999999999999997643 467888876531 223356778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEE
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~--------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLi 499 (571)
.+..|+||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 899999999999999999997643 158999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 500 DFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 500 DFGlA~~l~~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
|||++....... ......++..|++||.+.. ..++.++||||||+++|+|++ |..||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999987543221 1123446778999998862 346788999999999999998 88899653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.84 Aligned_cols=206 Identities=31% Similarity=0.489 Sum_probs=179.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
..++-|.+++.||-|+||.|.++....|...||+|.++. .|......+..++.|-+||...+.+-||+||..|.+++.
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 345679999999999999999999999999999998763 233344566778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc--
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 508 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-- 508 (571)
+|+||+|+.||++..+|... +.+.|..++.++..+.+|+++.|+.|+|||||||+|||||.+|++||.||||+.-+.
T Consensus 704 LYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999999999875 568999999999999999999999999999999999999999999999999986420
Q ss_pred -------CCc----------------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHH
Q 008285 509 -------GLS----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547 (571)
Q Consensus 509 -------~~~----------------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVW 547 (571)
.++ ....++||+.|+|||++. ...|+--.|+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q~cdww 855 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQLCDWW 855 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccccchhh
Confidence 000 001267999999999997 45678889999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 008285 548 SLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 548 SLGvVLyELLtGr~PF~~~ 566 (571)
|.|||||||+.|++||.+.
T Consensus 856 s~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred HhhHHHHHHhhCCCCccCC
Confidence 9999999999999999754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=281.24 Aligned_cols=206 Identities=32% Similarity=0.500 Sum_probs=170.1
Q ss_pred CCeE-EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHH---------HHHHHHHHHHHHhhcCCCCeeEEee
Q 008285 354 SQWQ-KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLEQEIKVLGHLKHENIVQYYG 423 (571)
Q Consensus 354 ~~y~-i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~---------~~k~l~~Ei~IL~~L~HpNIVkl~g 423 (571)
++|. +.+.||+|+||+||+|.+..+|+.||||++........... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 56789999999999999999999999999864322211100 1124678999999999999999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
++..++..++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 9999999999999997 6899998654 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccCC---------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 504 AKHLTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 504 A~~l~~~---------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+...... .......++..|+|||.+.+ ...++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765411 11112346888999998853 2346889999999999999999999997554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=269.10 Aligned_cols=195 Identities=29% Similarity=0.552 Sum_probs=164.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||++.. +++.||+|.+... ...+.+.+|+.+++.++|+||+++++.+.. +..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 74 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLY 74 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcE
Confidence 35799999999999999999864 6788999987531 123567889999999999999999998865 4579
Q ss_pred EEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999999999997643 358999999999999999999999999999999999999999999999999987643321
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.....+..|+|||.+. ...++.++|||||||++|||++ |+.||.+.
T Consensus 155 --~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 --DNSKLPVKWTAPEALK-------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --CCCCCCceecCHHHhc-------cCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 1233456799999875 2357889999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=271.60 Aligned_cols=191 Identities=25% Similarity=0.405 Sum_probs=160.4
Q ss_pred CeEEeeEE--eecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeE
Q 008285 355 QWQKGKLI--GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 355 ~y~i~k~L--G~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~l 431 (571)
.|.+.+.+ |+|+||.||++.++.++..+|+|.+...... . .|+.+...+ +|+||+++++.+...+.+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 55555555 9999999999999999999999997632111 1 122222222 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~~~ 510 (571)
|+||||+.|++|.+++... ..+++.+++.++.||++||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999999775 4799999999999999999999999999999999999999888 9999999998766432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ---~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIK-------GHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ---ccCCCCCcccChhhhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2346899999999986 235678999999999999999999999744
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=282.78 Aligned_cols=203 Identities=31% Similarity=0.528 Sum_probs=172.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
.+|++.+.||+|+||+||+|.+..+|+.||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 479999999999999999999999999999998764321 122345677899999999999999999987654
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 34799999996 7899888764 569999999999999999999999999999999999999999999999999998664
Q ss_pred CC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. .......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred CCcccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 43 22334568889999998863 2347789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=281.23 Aligned_cols=202 Identities=30% Similarity=0.527 Sum_probs=172.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~-- 429 (571)
...+|++.+.||+|+||.||+|.+..+|..||||.+.... ......+.+.+|+++|++++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4568999999999999999999999999999999875321 22334456789999999999999999999887654
Q ss_pred ----eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 430 ----~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
.+++||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999999 7899988864 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....++..|+|||.+.. ...++.++|||||||++|+|++|+.||...+
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 223467889999999863 2347789999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.81 Aligned_cols=206 Identities=32% Similarity=0.472 Sum_probs=176.4
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.+..++...+.++||+|-||.|.+|.... +.+||+|.++... .....+.|.+|+++|.+|+||||++++|+|..+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 34456688999999999999999998543 7999999876422 234457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~L-se~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+++|||||++|+|.+||.++.... ..+....|+.||++||+||.+.++|||||.+.|+|+++++++||+|||+++.+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999999998864333 45566779999999999999999999999999999999999999999999977
Q ss_pred cCCcccc---ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH--cCCCCCCCC
Q 008285 508 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML--TGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~---~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL--tGr~PF~~~ 566 (571)
...++.. ..+-.+.|||+|.+. ..+++.++|||+||++|||++ +...||.+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsil-------lgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHH-------hccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 6654432 355678999999987 357899999999999999975 488899754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.93 Aligned_cols=203 Identities=30% Similarity=0.531 Sum_probs=171.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----CC
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DD 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----~~ 429 (571)
.+|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+|++++|+||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 589999999999999999999999999999998864322 12235667789999999999999999987753 35
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred eEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 6899999996 6899988654 4599999999999999999999999999999999999999999999999999976543
Q ss_pred Ccc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... .....|+..|+|||++.. ...++.++|||||||++|||++|+.||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cCcCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 221 123568899999999853 2346789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=273.08 Aligned_cols=200 Identities=34% Similarity=0.538 Sum_probs=171.8
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLV 434 (571)
|++.+.||+|++|+||+|+...+++.|+||.+...... .......+|+..++.++ |+||+++++.+..++..|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 67889999999999999999999999999987532211 11223456899999999 99999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+ +|+|.+++.... ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999 789999887653 46899999999999999999999999999999999999999999999999999877654444
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....++..|+|||++.. ...++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 156 TDYVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred CCCCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 45668899999998753 334678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=303.89 Aligned_cols=200 Identities=35% Similarity=0.627 Sum_probs=173.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe--EE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH--LY 432 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~--ly 432 (571)
..+...+||+|+|-+||+|.|..+|..||=-.+++ .+-....+.++++..|+.+|+.|+|+|||++|++|.+... +.
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~-~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhH-HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 34556789999999999999999999887543332 1223456677899999999999999999999999988765 88
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEcC-CCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~--GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~ 509 (571)
+|+|++..|+|+.|++++ +.++.+.++.|++||++||.|||++ -|||||||.+||+|+. .|.|||+|+|||.....
T Consensus 120 ~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999999887 5699999999999999999999988 5999999999999985 59999999999988765
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.... ..+|||.|||||+... .|...+||||||++|+||+|+..||.+
T Consensus 199 s~ak-svIGTPEFMAPEmYEE--------~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 199 SHAK-SVIGTPEFMAPEMYEE--------NYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cccc-eeccCccccChHHHhh--------hcchhhhhhhhhHHHHHHHhccCChhh
Confidence 4433 4789999999999863 578899999999999999999999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=281.48 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=171.4
Q ss_pred CCCCeEEe-eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe--
Q 008285 352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV-- 427 (571)
Q Consensus 352 ~~~~y~i~-k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~-- 427 (571)
..++|++. ++||-|-.|.|..|.++.+|+.+|+|++.. ..+.++|+++--.. .|+|||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 34567664 689999999999999999999999998752 13455777765544 59999999998764
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEec
Q 008285 428 --DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADF 501 (571)
Q Consensus 428 --~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDF 501 (571)
...+.+|||.|+||+|+..|++++ ..++|.++..|++||..|+.|||+.+|.||||||+|+|.. .+..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 356889999999999999998764 3599999999999999999999999999999999999996 4568999999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egv 569 (571)
|+|+.........+-+.|++|.|||++. ..+|+...|+||+||+||-||+|.+||-...|+
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg-------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhC-------chhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 9999877655556778999999999986 346888999999999999999999999877664
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=272.53 Aligned_cols=208 Identities=31% Similarity=0.514 Sum_probs=173.7
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~ 428 (571)
....++|++.+.||+|+||.||+|.+..+|+.||||.+..... ......+..|+.++.++. |+||+++++++.+.
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 4456789999999999999999999999999999999864321 223455666777676665 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
...|+||||+. +.|.+++......+++..+..++.||+.||+|||+ .||+||||+|+|||++.++.+||+|||++..+
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999985 67888877655679999999999999999999997 59999999999999999999999999999876
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
..........++..|+|||.+.... ....++.++||||||+++|+|++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPD---PNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCC---CccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 5444334456888999999986321 123477899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=273.90 Aligned_cols=203 Identities=38% Similarity=0.621 Sum_probs=173.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|...+.||+|+||.||+|++..+|+.|+||.+..... ......+.+.+|+++++.++|+||+++++++.+.+..|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 47777889999999999999999999999998864322 2234456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
|||+. ++|.+++......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... ..
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~ 175 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN 175 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence 99996 678888876666799999999999999999999999999999999999999999999999999865432 22
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...|+..|+|||++.... ...++.++|||||||++|+|++|+.||.+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~----~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 176 SFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred CccccccccChhhccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 456899999999975311 2346789999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=278.78 Aligned_cols=201 Identities=29% Similarity=0.500 Sum_probs=169.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|++++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 3468999999999999999999999999999999876321 1223345677899999999999999999987643
Q ss_pred ---CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
...|++++++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3468888887 7899888764 359999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..... .....|+..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 169 HTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ccccc--ccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65332 234568899999998753 234678999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=269.96 Aligned_cols=201 Identities=32% Similarity=0.563 Sum_probs=173.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|++.+.||+|+||.||+|++..+++.||+|.+..... .....+.+..|+++++.++|+||+++++++...+.+++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 6778899999999999999999999999999875331 1233456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-ccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 514 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~~ 514 (571)
||+. ++|.+++......+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 9997 58999998764579999999999999999999999999999999999999999999999999998764432 222
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...++..|+|||.+.. ...++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 157 HEVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 3456788999999863 235778999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=267.08 Aligned_cols=202 Identities=24% Similarity=0.453 Sum_probs=165.2
Q ss_pred eEEeeEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
|.+.+.||+|+||.||+|.+.. +++.||||++.... ......+.+.+|+++++.++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 6778899999999999998653 57899999886322 22344577889999999999999999999876532
Q ss_pred ---eEEEEEeecCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 430 ---HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~-----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
..++++||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 124788999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 502 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 502 GlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
|+++....... .....++..|++||.+. ...++.++|||||||++|||++ |+.||.+.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA-------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHh-------cCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 99886543221 12234567899999886 3356789999999999999999 899997553
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=281.76 Aligned_cols=203 Identities=30% Similarity=0.509 Sum_probs=170.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD-- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~-- 428 (571)
...+|++.+.||+|+||.||+|.+..+|+.+|+|.+...... ......+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 345899999999999999999999999999999987532211 22335577899999999 999999999987654
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..+|+||||+. ++|..++... .+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 36899999997 6999988764 68899999999999999999999999999999999999999999999999998664
Q ss_pred CCc------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... ......|+..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 322 1223568999999998753 335678899999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=278.22 Aligned_cols=199 Identities=26% Similarity=0.457 Sum_probs=164.9
Q ss_pred eEEeec--CceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 360 KLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 360 k~LG~G--~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
..||+| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 356666 999999999999999999998764321 234457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc----
Q 008285 438 VHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---- 512 (571)
Q Consensus 438 ~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---- 512 (571)
+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999999997642 3589999999999999999999999999999999999999999999999986533221110
Q ss_pred ----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....++..|+|||++... ...++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112356679999998631 234678999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=276.44 Aligned_cols=202 Identities=31% Similarity=0.555 Sum_probs=168.5
Q ss_pred CeEEeeEEeecCceEEEEEEECCC--CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC---
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--- 428 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~t--G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~--- 428 (571)
+|++.+.||+|+||.||++.+..+ +..||||.+..... .....+.+.+|+++++++ .|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 588999999999999999999988 89999998763221 123346678899999999 599999999875432
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+|++|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 45789999996 6899988653 56999999999999999999999999999999999999999999999999999865
Q ss_pred cCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....|+..|+|||.+.. ...++.++|||||||++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 43221 223568999999998753 2357789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=279.12 Aligned_cols=202 Identities=32% Similarity=0.562 Sum_probs=174.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-----
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----- 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~----- 429 (571)
+|++.+.||+|++|.||+|++..+|+.||||.+..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 58999999999999999999999999999998864322 1334567889999999999999999999988775
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred ceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 7899999997 5899988764 4799999999999999999999999999999999999999999999999999987655
Q ss_pred Cc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. ......++..|+|||++.. ...++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLS------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccCcCCceeeec------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 43 2234568889999999863 2257889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=279.73 Aligned_cols=200 Identities=29% Similarity=0.525 Sum_probs=167.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
..+|++.+.||.|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+++++.++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4689999999999999999999999999999998864322 3346688899999999999999999766543
Q ss_pred ----------CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEE
Q 008285 429 ----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVK 497 (571)
Q Consensus 429 ----------~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vK 497 (571)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 35799999997 689888864 4689999999999999999999999999999999999997 556799
Q ss_pred EEecCCcccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 498 LADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 498 LiDFGlA~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+|||++..+.... ......|+..|+|||.+.. ...++.++|||||||++|+|++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999997653321 1122457889999998753 234678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=273.71 Aligned_cols=198 Identities=34% Similarity=0.594 Sum_probs=170.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|.....||+|+||.||++..+.+|..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 445557899999999999999999999999987532 123456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
|||+.+++|.+++.. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999999999998754 358999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|++||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 174 ~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 174 KSLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cccccCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3356889999999875 235678999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=269.67 Aligned_cols=204 Identities=30% Similarity=0.460 Sum_probs=171.0
Q ss_pred CeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
+|++.+.||+|+||.||++.+. .++..||||.++.... .......+.+.+|++++.++ +|+||+++++.+...+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 4889999999999999999864 4678999998863211 11223346678899999999 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999998764 56899999999999999999999999999999999999999999999999998765433
Q ss_pred cc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.. .....|+..|+|||.+... ...++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 22 2234689999999987632 12357789999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=260.65 Aligned_cols=196 Identities=34% Similarity=0.559 Sum_probs=170.5
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|+||.||++.+..+++.+++|++..... ........+..|+++++.++|+||+++++.+..++..|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 6999999999999998999999998764321 22234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-ccccccCCCC
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKGSP 520 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~~~~~GT~ 520 (571)
+|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999999765 46899999999999999999999999999999999999999999999999999876543 2233456888
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.|++||.+.. ..++.++|+||||+++|+|++|+.||...+
T Consensus 158 ~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 158 EYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999998863 246788999999999999999999996543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=275.03 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=179.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ly 432 (571)
++.+.+..||.|+-|+|++++.+.+|...|||..... ...+..+++...++++...+ .|+||+++|+|..+..++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 4566778899999999999999999999999987643 23456678888888877665 899999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH-s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|.||.|. .-++.+++.-.+.++|..+-.+..-|++||.||. ++||+|||+||+|||+|+.|++||||||++-.+.+..
T Consensus 168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9999994 6677777766678999999999999999999997 5699999999999999999999999999999988888
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.+....|.+.|||||.+.- .....|...+||||||+.|+||.||+.||.+
T Consensus 247 AhtrsAGC~~YMaPERidp----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDP----PDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccccccCCccccCccccCC----CCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 8888889999999998863 2366899999999999999999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=265.14 Aligned_cols=203 Identities=28% Similarity=0.520 Sum_probs=170.1
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|.+.+.||+|+||.||++.+...+..+++|+++..............+..|+.+++.++|+||+++++.+.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999999988877787777654433222222334566789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 435 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 435 mEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|||+.+++|.+++.+ ....+++.+++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999999864 3456899999999999999999999999999999999999965 57999999998766432
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.......|+..|+|||.+.. ..++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKH-------QGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ccccCCCCCcCccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334568899999998752 3467789999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=264.04 Aligned_cols=204 Identities=32% Similarity=0.525 Sum_probs=179.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|...+.||+|+||+||+++++++++.||+|.++...++.. .-....+|+.+|+.++|.|||+++++...+..+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 57778899999999999999999999999999987655533 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
+|||+ -+|..|.....+.++.+.++.++.|+++||.++|++++.||||||.|+||+.+|++||+|||+++.+.-.- ..
T Consensus 80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 99996 88999998888899999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~eg 568 (571)
...+-|..|.+|.++.+ ..-|+...||||.|||+.||.. |++-|.+.+-
T Consensus 159 saevvtlwyrppdvlfg------akly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred eceeeeeeccCcceeee------eehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 24567889999999975 4568889999999999999988 8888877654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=300.06 Aligned_cols=208 Identities=28% Similarity=0.456 Sum_probs=186.5
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++++++..||-||||.|-++..+.....+|+|+++... -......+.+..|-.||...+.+.||++|-.|.++.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~h--IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKH--IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhh--ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 344567888899999999999999887766668888775432 223445677889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|++||-|-||+|+..|++. +.+.+..++.++..++.|++|||++|||+|||||+|+|++.+|-+||.|||+|+.+..
T Consensus 494 yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999999999886 6799999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+....+++||+.|.|||++. +..+..++|.||||+++||||+|++||.+.+
T Consensus 573 g~KTwTFcGTpEYVAPEIIL-------nKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIIL-------NKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred CCceeeecCCcccccchhhh-------ccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 88888999999999999997 4457889999999999999999999998765
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=270.03 Aligned_cols=193 Identities=27% Similarity=0.430 Sum_probs=161.7
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCCCHHH
Q 008285 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR 445 (571)
Q Consensus 366 ~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~d 445 (571)
++|.||.++...+|+.||||++.... ...+..+.+.+|+++++.++|+||+++++++...+..|++|||+.+++|.+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44556666667789999999987431 233456789999999999999999999999999999999999999999999
Q ss_pred HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc--------cccc
Q 008285 446 YVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--------ELSL 516 (571)
Q Consensus 446 ~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~--------~~~~ 516 (571)
++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..+..... ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 99864 34689999999999999999999999999999999999999999999999998875532211 1234
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.++..|+|||++... ...++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 169 VKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 577889999998631 124678999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=271.76 Aligned_cols=205 Identities=36% Similarity=0.612 Sum_probs=174.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|+..+.||+|+||.||+|+++.++..+|||.+..... ......+.+.+|+++++.++|+||+++++++...+..|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3468888999999999999999999999999998864221 22344566788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+. |+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9999996 6888877665567999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....|+..|+|||.+.... ...++.++|||||||++|+|++|+.||.+.+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred -ccccCCccccCHHHHhhcc----cCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 2356888999999985321 2346778999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=276.59 Aligned_cols=199 Identities=31% Similarity=0.506 Sum_probs=167.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
..+|.+.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3589999999999999999999999999999998764221 1223456788999999999999999999887543
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+|+||||+. .+|..++ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4699999996 5777665 24689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... .....++..|+|||++.. ...++.++|||||||++|||++|+.||.+.
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 167 ADAE--MTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCCC--CCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5332 223567889999999853 234678999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=274.49 Aligned_cols=202 Identities=30% Similarity=0.515 Sum_probs=170.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-CCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-~~~ 430 (571)
..++|++.+.||.|+||.||+|.+..+|+.||||++..... .....+.+..|+++++.++|+||+++++++.. .+.
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 45689999999999999999999999999999998753221 12234667789999999999999999998876 567
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++......
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 89999999 5789888864 35888889999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....++..|+|||.+.. ...++.++|||||||++|+|++|+.||...+
T Consensus 162 --~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred --cCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234567889999998752 2357889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=277.19 Aligned_cols=202 Identities=28% Similarity=0.491 Sum_probs=172.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH- 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~- 430 (571)
..++|++.+.||+|++|.||+|.+..+++.||||++.... ......+.+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3558999999999999999999999999999999875321 122344667789999999999999999988776654
Q ss_pred -----EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 431 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 431 -----lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6799999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....++..|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76433 223467889999999863 2256789999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=269.64 Aligned_cols=208 Identities=26% Similarity=0.389 Sum_probs=177.4
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD- 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~- 428 (571)
-...++|++.+.||+|||+.||+++...++..||+|.+... ..+..+...+|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34567999999999999999999999999999999988642 245678889999999999999999999876544
Q ss_pred ----CeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEE
Q 008285 429 ----DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLA 499 (571)
Q Consensus 429 ----~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~vKLi 499 (571)
...||++.|...|+|.+.|.. .+..++|.++.+|+.+|++||.+||+.. ++||||||.|||+.+.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 348999999999999999864 3457999999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccC----Cc------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 500 DFGMAKHLTG----LS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 500 DFGlA~~l~~----~~------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|||.++...- .. .......|..|.|||.+... .+...+.++|||||||+||+|+.|..||+..
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK----SHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc----cCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 9999875421 11 11234579999999988642 2457899999999999999999999999754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=298.08 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=136.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++++.||+|+||+||+|.+..+++.||||++.... .........+..|+.+++.++|+||+++++.+...+.+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 458999999999999999999999999999999986422 123445677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
|||||+.|++|.+++... ..+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999764 568999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=298.00 Aligned_cols=208 Identities=36% Similarity=0.643 Sum_probs=182.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV--- 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~--- 427 (571)
....|.+.+.||.|.+|.||+++.+.+|+..|+|+.....+. .++++.|.+||+.+ .|||++.+|++|.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345799999999999999999999999999999988754332 35677889999988 49999999998874
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 --DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 --~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
++++|||||||.||+..|+++.. +..+.|+.+..|++.++.||.|||++.++|||||-.|||++.++.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 57899999999999999999753 667999999999999999999999999999999999999999999999999998
Q ss_pred ccccC-CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 505 KHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 505 ~~l~~-~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..++. ....++.+||+.|||||++.+..+. ...|+..+|+||||++.+||--|.+|+.++.
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~--d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESP--DATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCC--CCCcccccchhhccceeehhcCCCCCccCcc
Confidence 87754 2334567899999999999876554 4678999999999999999999999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=276.76 Aligned_cols=209 Identities=27% Similarity=0.464 Sum_probs=182.9
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEE
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV 426 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~ 426 (571)
.+.....+|.++++||+|+|.+|.+++++.+.+.||+|+++..-- ...+.+..+..|-.+..+. .||.+|-+..+|.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 455566799999999999999999999999999999999864221 1223345566677777666 5999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+..+++|.||+.||+|.-+++.+ +.|+|+.++.+...|.-||.|||++|||.||||.+|||+|.+|++||.|+|+++.
T Consensus 322 tesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999999999988776 5699999999999999999999999999999999999999999999999999986
Q ss_pred c-cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 L-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l-~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
- ...+...+++||+.|+|||+++ +..|++.+|+|+|||+|+||+.|+.||+-.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilr-------geeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILR-------GEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCCCcccccccCCCcccchhhhc-------ccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 4 4566667899999999999998 457899999999999999999999999743
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=278.34 Aligned_cols=205 Identities=29% Similarity=0.490 Sum_probs=172.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~- 427 (571)
...|++++.||+|+||.||+|..+.+.. .+|||.++...+... ......+|+.+++.++|+||+.+..++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3479999999999999999996655433 689998875443221 22345689999999999999999999887
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CcEEEE
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLA 499 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~----g~vKLi 499 (571)
+..+++++||.+ -+|...|+-+ ...++...++.|++||+.|+.|||++-|+||||||.||||..+ |.|||+
T Consensus 100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 788999999997 7888888643 3568999999999999999999999999999999999999876 899999
Q ss_pred ecCCcccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 500 DFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 500 DFGlA~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|||+++.+.+.- .....+-|+.|.|||.+.+ ...|+.+.|||+.|||+.||++-++-|.+.|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999875532 2234667999999999985 5578999999999999999999999997654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=295.09 Aligned_cols=205 Identities=26% Similarity=0.426 Sum_probs=175.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC--CcC-cHHHHHHHHHHHHHHhhcC---CCCeeEEeeeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPK-SAECIKQLEQEIKVLGHLK---HENIVQYYGSEV 426 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~--d~~-~~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~ 426 (571)
..+|..++.||+|+||.|++|+++++...|+||.+....- +.+ ....+-.+-.||+||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3469999999999999999999999999999998753210 111 1111223457999999997 999999999999
Q ss_pred eCCeEEEEEeec-CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 427 VDDHLYIYLEYV-HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 427 ~~~~lyLVmEy~-~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
+++.+||+||-- +|.+|+++|.-+ ..++|.++..|++|++.|+++||++||||||||-+||+++.+|.+||+|||.+.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 999999999965 455999999765 679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
....+... .++||..|.|||++.+ ..+.+..-|||+||++||.++....||-+
T Consensus 719 ~~ksgpfd-~f~gtv~~aapevl~g------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSGPFD-VFVGTVDYAAPEVLGG------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCCCcc-eeeeeccccchhhhCC------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 77665544 6789999999999974 45667789999999999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=259.06 Aligned_cols=209 Identities=25% Similarity=0.460 Sum_probs=179.0
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV 427 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~ 427 (571)
.+...+....+..||+|+||.|-+.++..+|...|+|.+...-. .+..+++.+|+++..+. ..|.+|.+||.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 44455677778899999999999999999999999999875332 34567788888887665 68999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 428 DDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~---~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
+..+||.||.|+ .+|..+-. +++..++|..+-+|+.-++.||.|||++ .+||||+||+||||+.+|.|||||||+
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 999999999996 88887754 4578899999999999999999999976 899999999999999999999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
+-.+.+.-......|...|||||.+....+ ...|+.++||||||++++||.+++.||..
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n---~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELN---QKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccC---cccceeehhhhhhhhhhhhhhhccccccc
Confidence 988766544444678999999999875433 33689999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=245.26 Aligned_cols=200 Identities=38% Similarity=0.674 Sum_probs=174.5
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|.+.+.||+|++|.||+|.+..+++.+++|.+...... ...+.+.+|++.++.++|+||+++++.+...+..++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 56788999999999999999988999999998643211 24678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--cc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YE 513 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~--~~ 513 (571)
||+.+++|.+++......+++..+..++.+++.+|.+||++|++|+||++.||+++.++.++|+|||++....... ..
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999998754338999999999999999999999999999999999999999999999999998775543 33
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
....++..|++||.+. ....++.++|||+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3456888899999874 134567799999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=278.85 Aligned_cols=208 Identities=29% Similarity=0.454 Sum_probs=175.6
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~ 428 (571)
.......+.+..||.|+||+|++-.++.+|+..|||.++.... ....+++..|.+...+- ..+|||++||....+
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 3445577888899999999999999999999999999986543 23456777777765554 689999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 429 DHLYIYLEYVHPGSINRYVR----EHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~----~~~~~Lse~~i~~I~~QIa~gL~yLH-s~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
+..||.||+|+ .+|+.+-. .+...++|..+-.|...++.||.||- +..||||||||+|||++..|.|||||||+
T Consensus 136 GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 99999999996 77766542 23456999999999999999999997 45999999999999999999999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+-.+.+.-......|...|||||.+... ...|..++||||||++|||+.||+.||.+.+
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~-----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPS-----DKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCc-----cCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 9887766555567799999999998642 2358999999999999999999999998654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=256.35 Aligned_cols=181 Identities=22% Similarity=0.283 Sum_probs=153.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCCCHH
Q 008285 365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN 444 (571)
Q Consensus 365 G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~ 444 (571)
|.+|.||++.+..+|+.||+|.+.... ...+|...+....|+||+++++.+...+..|+||||+.||+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999886321 1223444445557999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccC
Q 008285 445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 524 (571)
Q Consensus 445 d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmA 524 (571)
+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+... .....++..|+|
T Consensus 74 ~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~a 150 (237)
T cd05576 74 SHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCA 150 (237)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccC
Confidence 999765 45999999999999999999999999999999999999999999999999987665432 223456778999
Q ss_pred hHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 525 PEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||.+. ...++.++||||+||++|||++|+.||..
T Consensus 151 PE~~~-------~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGG-------ISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccC-------CCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 99874 23467899999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.50 Aligned_cols=208 Identities=29% Similarity=0.499 Sum_probs=181.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
+..-+...|.++||.|.||.||.|..+..|+ .||||.++.. -.+.....|..|+.||.+.+||||++|.|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 4445678899999999999999999887764 5899988742 33455678999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
....+.||.|||++|+|+.||+++.+.++..++.-+++.|+.||.||-+.|+|||||...||||+.+..+|++||||++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 89999999999999999999999989999999999999999999999999999999999999999999999999999998
Q ss_pred ccCCccc-c-cc--CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 008285 507 LTGLSYE-L-SL--KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (571)
Q Consensus 507 l~~~~~~-~-~~--~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~eg 568 (571)
+.++... . +. .-..+|.|||.+. ..+++.++||||+||||||.++ |.-||+++.+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa-------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred cccCCCccccccCCccceeecChhHhh-------hcccCchhhccccceEEEEecccCCCcccccch
Confidence 7554311 1 11 2246899999997 4578999999999999999887 9999998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=305.06 Aligned_cols=198 Identities=32% Similarity=0.535 Sum_probs=163.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
..+|+++++||+||||.||+++++-+|+.||||.+.... ......++.+|+.+|.+|+|||||++|..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 458899999999999999999999999999999987543 345668899999999999999999987532110
Q ss_pred --------------------------------------------------------------------------------
Q 008285 429 -------------------------------------------------------------------------------- 428 (571)
Q Consensus 429 -------------------------------------------------------------------------------- 428 (571)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 008285 429 -----------------------------------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (571)
Q Consensus 429 -----------------------------------~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL 473 (571)
-.+||-||||+...|.++|..+...-....++.++++|+.||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 025899999998888888876422114667899999999999999
Q ss_pred HhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-------------------CCccccccCCCCcccChHHHHHhhhc
Q 008285 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------------GLSYELSLKGSPNWMAPEVIKAVMQK 534 (571)
Q Consensus 474 Hs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-------------------~~~~~~~~~GT~~YmAPEvl~~~~~~ 534 (571)
|++|||||||||.||++++.+.|||+|||+|+... +....+..+||--|+|||++....
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-- 791 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-- 791 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--
Confidence 99999999999999999999999999999998721 011234578999999999987431
Q ss_pred CCCCCCCchhhHHHHHHHHHHHHc
Q 008285 535 DGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 535 d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
...|+.|+||||||||++||+.
T Consensus 792 --~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 --SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred --cccccchhhhHHHHHHHHHHhc
Confidence 2368999999999999999993
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=283.22 Aligned_cols=207 Identities=27% Similarity=0.527 Sum_probs=183.4
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.++..+.+..+...||-|-||.||.|.|+.-...||||.++ ++...+++|..|+.+|+.++|||+|+|+|+|..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 46677778888899999999999999999988999999876 334567889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+-.+|||.|||..|+|.+||++-.+ .++.-.+.+++.||.+||.||..+++|||||...|+||.++..|||+||||++.
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999999987433 467777889999999999999999999999999999999999999999999999
Q ss_pred ccCCcccc--ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~--~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+.++.+.. ...-.+.|.|||-|. ..+++.++|||+|||+|||+.| |-.||.+++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred hcCCceecccCccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 98766543 233466799999986 4478999999999999999998 999998765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=300.44 Aligned_cols=188 Identities=24% Similarity=0.394 Sum_probs=159.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|...+.||+|+||.||+|+++.+|..||||.+..... ....|++++++++|||||++++++.+.+..|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 35566789999999999999999999999998753211 112468889999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH---s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||+++|+|.++++. +++..+..|+.||++||+||| +.+|+||||||+|||++.++..++. ||........
T Consensus 762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999999953 889999999999999999999 6799999999999999998888775 6665443221
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....|+..|||||++. ...++.++|||||||++|||++|+.||...
T Consensus 836 --~~~~~t~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 836 --TKCFISSAYVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred --CCccccccccCccccc-------CCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 2336889999999875 345788999999999999999999999643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=287.34 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=175.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++....++||+|.||+|+.|.|..-+ ..||||+++..... .....|.+|+.+|.+|+|+|+++|||+..+ .
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 346777889999999999999987543 35899988743322 256789999999999999999999998776 7
Q ss_pred eEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.+.+|||++.+|+|.+.|++ ....|....+..++.||+.||.||..+++|||||...|||+.....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999987 55678889999999999999999999999999999999999999999999999999887
Q ss_pred CCccccc----cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 008285 509 GLSYELS----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGV 569 (571)
Q Consensus 509 ~~~~~~~----~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~egv 569 (571)
.+..... ..-.+.|||||.|+ ..+++.++|||++||+|||||+ |+.||-+..|+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLr-------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~ 322 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLR-------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI 322 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhc-------cccccccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence 6543332 22456799999997 4578999999999999999999 99999877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=279.56 Aligned_cols=207 Identities=26% Similarity=0.431 Sum_probs=173.3
Q ss_pred CCcccCCCCCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCe
Q 008285 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI 418 (571)
Q Consensus 340 ~p~~~~~p~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNI 418 (571)
.+.+.+..........|.+...+|.|+|+.|..|.+..+++.+++|++.....+ ..+|+.++... .|+||
T Consensus 308 a~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---------~~~e~~~~~~~~~h~ni 378 (612)
T KOG0603|consen 308 APGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---------NQDEIPISLLVRDHPNI 378 (612)
T ss_pred ChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccc---------cccccchhhhhcCCCcc
Confidence 333444433445667899999999999999999999999999999998743222 33567666555 69999
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCcEE
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-DASGVVK 497 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL-d~~g~vK 497 (571)
+++.+.+.+..+.|+|||++.|+.|.+.|.... .+. .++..|+.+|+.++.|||++|+|||||||+|||+ +..|+++
T Consensus 379 v~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lr 456 (612)
T KOG0603|consen 379 VKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLR 456 (612)
T ss_pred eeecceecCCceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEE
Confidence 999999999999999999999999988887642 233 7888999999999999999999999999999999 5889999
Q ss_pred EEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 498 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 498 LiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+|||.++.+... ...-+-|..|.|||++. ...|+.++||||||++||+||+|+.||..-
T Consensus 457 ltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 457 LTYFGFWSELERS--CDTPALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred EEEechhhhCchh--hcccchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 9999999987665 33345788899999997 346899999999999999999999999743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=238.31 Aligned_cols=188 Identities=39% Similarity=0.683 Sum_probs=166.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCCCHHH
Q 008285 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR 445 (571)
Q Consensus 366 ~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~d 445 (571)
+||.||+|.+..+|+.+++|++...... ...+.+.+|++++++++|+||+++++.+......+++|||+.+++|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK----KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 5899999999999999999998643221 115778899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccCh
Q 008285 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525 (571)
Q Consensus 446 ~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAP 525 (571)
++.... .+++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.............++..|++|
T Consensus 77 ~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 77 LLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred HHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 997653 3899999999999999999999999999999999999999999999999999887665444556789999999
Q ss_pred HHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 526 Evl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
|.+. ...++.++|||+||+++|+|++|..||..
T Consensus 156 E~~~-------~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 156 EVLL-------GKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9886 33567799999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-31 Score=274.95 Aligned_cols=210 Identities=28% Similarity=0.471 Sum_probs=179.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC--cCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-CC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d--~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-~~ 429 (571)
.++|-++.+||+|||+.||++.+....+.||||+-....++ .+.+...+...+|.+|-+.|+|+.||++|++|.. .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45788899999999999999999998999999987655544 2334456778899999999999999999999865 56
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEc---CCCcEEEEecCCc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVD---ASGVVKLADFGMA 504 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~--GIVHRDIKPsNILLd---~~g~vKLiDFGlA 504 (571)
.+|-|+|||+|.+|+-||+.+ +-++|++++.|+.||+.||.||.+. -|||-||||.|||+- .-|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 789999999999999999876 6799999999999999999999866 699999999999993 4579999999999
Q ss_pred ccccCCccc--------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~~~--------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.+.+..+. ....||.+|++||.+.-. + .-.+++.++||||.|||+|.++.|+.||...
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg--k-ePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG--K-EPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecC--C-CCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 988765443 246799999999987531 1 1356889999999999999999999999754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=273.00 Aligned_cols=205 Identities=28% Similarity=0.517 Sum_probs=173.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCC--Cc--EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRET--GA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~t--G~--~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
......++||.|-||.||.|++..- |+ .||||..+... . .+..+.|..|.-+|+.++||||++++|++.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t-~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---T-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---C-hhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3445557899999999999986532 33 57888766322 1 2336789999999999999999999999865 5
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..|||||++.-|.|..||+.+...|+...+..++.||+.+|+|||+..+|||||...|||+.....|||+|||+++.+.+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 67999999999999999998888899999999999999999999999999999999999999999999999999998877
Q ss_pred CccccccC--CCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 008285 510 LSYELSLK--GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGVS 570 (571)
Q Consensus 510 ~~~~~~~~--GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~egvd 570 (571)
..+..... -.+.|||||.+. ...++.++|||-|||+|||+|. |..||.+.++-|
T Consensus 544 ~~yYkaS~~kLPIKWmaPESIN-------fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESIN-------FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred cchhhccccccceeecCccccc-------hhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 66544333 456799999986 4578999999999999999987 999998876543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=277.92 Aligned_cols=204 Identities=23% Similarity=0.301 Sum_probs=145.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCC----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRET----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS--- 424 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~t----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~--- 424 (571)
..++|++.+.||+|+||.||+|++..+ +..||||.+.... .. +....| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~----e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AV----EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hh----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 456899999999999999999999998 9999999865211 10 111111 1111122222221111
Q ss_pred ---EEeCCeEEEEEeecCCCCHHHHHHHhcCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008285 425 ---EVVDDHLYIYLEYVHPGSINRYVREHCRD-------------------ITESIVRNFTRHILNGLAYLHSTNTIHRD 482 (571)
Q Consensus 425 ---~~~~~~lyLVmEy~~GGsL~d~L~~~~~~-------------------Lse~~i~~I~~QIa~gL~yLHs~GIVHRD 482 (571)
...++.+++||||+.+++|.+++...... ..+..+..++.||+.||+|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 24567899999999999999998753211 12345668999999999999999999999
Q ss_pred CCCCcEEEcC-CCcEEEEecCCcccccCC--ccccccCCCCcccChHHHHHhhhcCC---------------CCCCCchh
Q 008285 483 IKGANLLVDA-SGVVKLADFGMAKHLTGL--SYELSLKGSPNWMAPEVIKAVMQKDG---------------NPKLALAV 544 (571)
Q Consensus 483 IKPsNILLd~-~g~vKLiDFGlA~~l~~~--~~~~~~~GT~~YmAPEvl~~~~~~d~---------------~~~~s~ks 544 (571)
|||+||||+. ++.+||+|||+++.+... .......|++.|||||.+....+... ...+..++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 589999999999865432 22235678999999997653221110 01245567
Q ss_pred hHHHHHHHHHHHHcCCCCCC
Q 008285 545 DIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 545 DVWSLGvVLyELLtGr~PF~ 564 (571)
||||||||||||+++..++.
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999877764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=264.55 Aligned_cols=193 Identities=27% Similarity=0.431 Sum_probs=162.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhh--cCCCCeeEEeeeEEeCC--
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~--L~HpNIVkl~g~~~~~~-- 429 (571)
...+..++||+|.||.||+|... ++.||||++.. +..+.+.+|-+|... ++|+||+++++...-..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 35677789999999999999875 59999999863 345667777777765 47999999998766555
Q ss_pred --eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCcEEEcCCCcEEE
Q 008285 430 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS---------TNTIHRDIKGANLLVDASGVVKL 498 (571)
Q Consensus 430 --~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs---------~GIVHRDIKPsNILLd~~g~vKL 498 (571)
+++||+||-+.|+|.+||..+ .+++.....|+.-|++||+|||+ ..|+|||||..||||..++..-|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 789999999999999999875 59999999999999999999995 37999999999999999999999
Q ss_pred EecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC
Q 008285 499 ADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (571)
Q Consensus 499 iDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG 559 (571)
+|||+|..+..... ....+||.+|||||+|.+..+-.+ ...-.+.||||+|+|||||++.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhh
Confidence 99999988764322 234789999999999987665432 3334579999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=262.38 Aligned_cols=201 Identities=30% Similarity=0.512 Sum_probs=169.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----C
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~-----~ 429 (571)
+.+-.+.||.|+||+||.+++-.+|+.||+|.+.... ......+++.+|+++|.-.+|.|++..++...-. .
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 4445568999999999999999999999999875332 2233457889999999999999999998865433 3
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
++|++.|+|. .+|++.|-. ...|+.+.++-+++||++||.|||+.||.||||||.|+|++.+..+||||||+++....
T Consensus 131 EiYV~TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 131 ELYVLTELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 5788999996 888888865 36799999999999999999999999999999999999999999999999999987654
Q ss_pred Cc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. .....+-|.+|.|||++++ ...|+.++||||.|||+.||+..+.-|...
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG------aRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG------ARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc------chhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 32 3345667889999999996 456888999999999999999998888653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=266.17 Aligned_cols=213 Identities=20% Similarity=0.285 Sum_probs=154.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC----------------CCCcEEEEEEeecCCCCcCcHHH----------HHHHHH
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR----------------ETGASCAIKEVDIIPDDPKSAEC----------IKQLEQ 405 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k----------------~tG~~VAIK~i~~~~~d~~~~~~----------~k~l~~ 405 (571)
..++|++.++||+|+||+||+|.+. ..++.||||.+...... ...+. .+....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhHH
Confidence 4669999999999999999999752 34567999998642211 11111 122334
Q ss_pred HHHHHhhcCCCCe-----eEEeeeEEe--------CCeEEEEEeecCCCCHHHHHHHhcC--------------------
Q 008285 406 EIKVLGHLKHENI-----VQYYGSEVV--------DDHLYIYLEYVHPGSINRYVREHCR-------------------- 452 (571)
Q Consensus 406 Ei~IL~~L~HpNI-----Vkl~g~~~~--------~~~lyLVmEy~~GGsL~d~L~~~~~-------------------- 452 (571)
|+.++.+++|.++ ++++++|.. .+..||||||+.+++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776554 566666543 3568999999999999999864211
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc--ccCCCCcccChHH
Q 008285 453 ---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEV 527 (571)
Q Consensus 453 ---~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~--~~~GT~~YmAPEv 527 (571)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ...+++.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 23566788899999999999999999999999999999999999999999997654332222 2335789999999
Q ss_pred HHHhhhcCCC---------------CCCCchhhHHHHHHHHHHHHcCCC-CCCC
Q 008285 528 IKAVMQKDGN---------------PKLALAVDIWSLGCTVIEMLTGKP-PWSE 565 (571)
Q Consensus 528 l~~~~~~d~~---------------~~~s~ksDVWSLGvVLyELLtGr~-PF~~ 565 (571)
+......... .....+.||||+|||+|+|++|.. ||.+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 8532111000 011234799999999999999886 7754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=246.97 Aligned_cols=194 Identities=25% Similarity=0.461 Sum_probs=169.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD-- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~-- 428 (571)
..++|++.+.+|+|.|+.||.|.+..+.++++||+++. ...+++.+|+.||+.|. |+||+++++...+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 35689999999999999999999999999999999874 33578999999999997 99999999987764
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~l 507 (571)
....+|+||+++.+...+. ..|+...++.++.+|+.||.|+|++||+|||+||.|++|| +...++|+|+|+|.+.
T Consensus 108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 4578999999988776654 4588889999999999999999999999999999999998 4568999999999988
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
-.....+..+.+.+|--||.+.. ...|.+.-|||||||++..|+..+-||
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVd------y~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred CCCceeeeeeehhhcCCchheee------chhccccHHHHHHHHHHHHHHhccCcc
Confidence 76655556678888999999874 335778899999999999999999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=276.36 Aligned_cols=202 Identities=32% Similarity=0.525 Sum_probs=173.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..+.+.+++||+|+||+||+|.+...|+ +||||++... .....-.++.+|+-+|..|+|+|++++++++...
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 4467778999999999999999877666 4677766432 3334457788999999999999999999998776
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
. +.||++|+++|.|.+|++.+...+-......|..||++||.|||++++|||||-..||||..-..+||.|||+++.+.
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 5 889999999999999999998999999999999999999999999999999999999999999999999999999887
Q ss_pred CCccccc---cCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~---~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.+..... ....+.|||-|.+. ...|+.++|||||||++|||+| |..||.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred cccccccccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 6554432 23355688888876 5579999999999999999998 99998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=272.22 Aligned_cols=208 Identities=31% Similarity=0.525 Sum_probs=174.0
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCee
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIV 419 (571)
.+....+..++.+.||+|.||.|++|.... ....||+|..+... .....+.+..|+++|+.+ +|+||+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~----~~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA----SSSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc----CcHHHHHHHHHHHHHHHhcCCcchh
Confidence 355556666788899999999999997431 14568999765322 225567899999999999 599999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
.++|++...+.+++|+||+..|+|..|++... ..|+..++..++.||+.||+||++.++|||||-
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999999999999999999999999998765 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCcccc--ccCC--CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-C
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~~~~--~~~G--T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-G 559 (571)
..|||+..+..+||+|||+++......... ...| ...|||||.+. ...|+.++||||+||+||||++ |
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCC
Confidence 999999999999999999999765543332 1222 34599999997 3478999999999999999999 9
Q ss_pred CCCCCCC
Q 008285 560 KPPWSEF 566 (571)
Q Consensus 560 r~PF~~~ 566 (571)
..||.+.
T Consensus 519 ~~PYp~~ 525 (609)
T KOG0200|consen 519 GTPYPGI 525 (609)
T ss_pred CCCCCCC
Confidence 9999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=255.34 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=167.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhh--cCCCCeeEEeeeEEeC-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVD- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~--L~HpNIVkl~g~~~~~- 428 (571)
...+.++.+.||+|-||.||+|.++ |+.||||++.... .+...+|.+|.+. |+|+||+.+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3458899999999999999999997 7999999986322 2445677777765 5899999999875543
Q ss_pred ---CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEE
Q 008285 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVK 497 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~--------GIVHRDIKPsNILLd~~g~vK 497 (571)
.++|||.+|-+.|+|+|||.. ..++.+...+++.-+++||+|||.. .|.|||||..||||..+|..-
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 368999999999999999987 4699999999999999999999943 599999999999999999999
Q ss_pred EEecCCcccccCCc-----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc----------CCCC
Q 008285 498 LADFGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------GKPP 562 (571)
Q Consensus 498 LiDFGlA~~l~~~~-----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt----------Gr~P 562 (571)
|+|+|||....... ..+..+||.+|||||+|....+..-... -..+||||||+|+||++. -++|
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes-yk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES-YKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhh-hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999998665432 2345789999999999976655332211 236999999999999873 2467
Q ss_pred CCCCCCCCC
Q 008285 563 WSEFEGVSP 571 (571)
Q Consensus 563 F~~~egvdp 571 (571)
|.+.---||
T Consensus 436 yyd~Vp~DP 444 (513)
T KOG2052|consen 436 YYDVVPSDP 444 (513)
T ss_pred cccCCCCCC
Confidence 777655554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=260.15 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=171.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC--CC----CeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HE----NIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~--Hp----NIVkl~g~~ 425 (571)
...+|++.+.||+|+||.|-.|.+.+++..||||+++... ...+..+-|+++|+++. .| -+|++.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~------kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD------KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH------HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 4679999999999999999999999999999999987432 33455667999999993 23 388888999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC------------
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA------------ 492 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~------------ 492 (571)
+..++.+||+|.+ |-+++++|.+ ....++...++.|++||++++++||+.+++|.||||+|||+..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 5799999986 4556899999999999999999999999999999999999921
Q ss_pred --------CCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 493 --------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 493 --------~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
+-.|+|+|||.|+...... ...+.|..|.|||++.+ -.++...||||+||||+||++|..-|.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccceecc
Confidence 2369999999998765543 45678999999999985 368889999999999999999999987
Q ss_pred CCC
Q 008285 565 EFE 567 (571)
Q Consensus 565 ~~e 567 (571)
.-+
T Consensus 311 tHe 313 (415)
T KOG0671|consen 311 THE 313 (415)
T ss_pred cCC
Confidence 544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-30 Score=255.80 Aligned_cols=204 Identities=28% Similarity=0.487 Sum_probs=170.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----- 427 (571)
.+.|.....||+|.||.||+|+.+.+|+.||+|.+-...... ..-....+|+++|..|+|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 457888889999999999999999999999998764322111 112345689999999999999999887654
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 ---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 ---~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
...+|+||.+|+ .+|.-+|.+....++..++..++.+++.||.|+|+..|+|||+|++|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 235899999997 8888888776677999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.+..... ....+-|..|+.||.+.+ ...|+.+.|||..|||+.||++|.+-|.+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG------~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLG------DREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhc------ccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 76543221 122446899999999985 557889999999999999999999888654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=214.60 Aligned_cols=185 Identities=39% Similarity=0.681 Sum_probs=159.9
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
||+|.+|.||++....+|+.+++|++....... ..+.+.+|+++++.+.|++|+++++.+...+..+++|||+.|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999998889999999987432211 4567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCcccccCCc-cccccCCC
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGS 519 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~~~-~~~~~~GT 519 (571)
+|.+++......+++..++.++.+++++|.+||++|++|+||+|.||+++. ++.++|+|||.+....... ......+.
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999999765356899999999999999999999999999999999999998 8999999999998765432 12335578
Q ss_pred CcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHH
Q 008285 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556 (571)
Q Consensus 520 ~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyEL 556 (571)
..|++||.+... ..++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhccc------CCCCchhhhHHHHHHHHHH
Confidence 889999988631 2567889999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=267.63 Aligned_cols=200 Identities=39% Similarity=0.656 Sum_probs=176.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
+.+|..+.++|.|+||.||+++++.+++..|+|+++....+ .++-+.+|+-+++..+|+|||.+++.|.-.+.+|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45899999999999999999999999999999999876544 3456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
|+||||.||+|++.-+.. +.++|.++....+..++||+|||++|-+|||||..|||+++.|.+||+|||.+-.+... .
T Consensus 89 icMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999999999976654 67999999999999999999999999999999999999999999999999998766542 2
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P 562 (571)
....+.||++|||||+..-. ....|....|||++|+..+|+-.-++|
T Consensus 168 KrksfiGtpywmapEvaave----rkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhcccCCccccchhHHHHH----hcccccccccccccccchhhhhhcCCc
Confidence 23468899999999987532 244688899999999999999877666
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=244.14 Aligned_cols=203 Identities=24% Similarity=0.393 Sum_probs=173.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
..+|.-++.+|.|.- .|-.+.+.-.++.||+|.+...... ....++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n---~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN---QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc---CccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 348999999999999 8888889999999999987543222 223466778999999999999999999886543
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++|+|||||+ .+|...+.. .++-+.+..|+.|++.|+.|||+.||+||||||+||++..++.+||.|||+++.
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 5799999996 899998873 478888999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~egvd 570 (571)
....-.....+.|.+|.|||++.+. .|...+||||+||++.||++|+.-|.+-+-+|
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id 224 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHID 224 (369)
T ss_pred cCcccccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHH
Confidence 6555445567889999999999853 37889999999999999999999998766544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=254.77 Aligned_cols=202 Identities=25% Similarity=0.390 Sum_probs=173.3
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC------CCCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK------HENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~------HpNIVkl~g 423 (571)
+....+|.+....|+|-|++|..|.+..-|..||||+|... +...+.-..|++||++|. -.++++++-
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 44556899999999999999999999999999999998732 233455678999999995 257899999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEe
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLAD 500 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~--Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiD 500 (571)
.|...+++|||+|-+. .+|.++|++.+.. |....++.++.|++-||..|-+-||+|.||||+||||++. ..+||||
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 9999999999999985 8999999987543 7788999999999999999999999999999999999866 5799999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||.|.......... +.-+-.|.|||++. +..|.+..|+||.||+||||+||+.-|.+-
T Consensus 581 fGSA~~~~eneitP-YLVSRFYRaPEIiL-------G~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 581 FGSASFASENEITP-YLVSRFYRAPEIIL-------GLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred CccccccccccccH-HHHHHhccCcceee-------cCcccCCccceeeceeeEEeeccceecCCC
Confidence 99998876655432 33455699999998 457889999999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=262.36 Aligned_cols=193 Identities=32% Similarity=0.543 Sum_probs=158.1
Q ss_pred eEEeeEEeecCce-EEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEE
Q 008285 356 WQKGKLIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 356 y~i~k~LG~G~fG-~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyL 433 (571)
|.-.+++|.|+.| .||+|... |+.||||.+- .+......+|+..|+.-+ |+|||++|+...+....||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 3344678999887 58999874 7899999764 345567789999999985 9999999999888999999
Q ss_pred EEeecCCCCHHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCcEEEEecCCcc
Q 008285 434 YLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMAK 505 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~---Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-----~g~vKLiDFGlA~ 505 (571)
..|.|. -+|.+++...... ......+.++.|+++||+|||+.+||||||||.||||.. ...++|+|||+++
T Consensus 581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999996 8999999763111 111456788999999999999999999999999999964 3579999999999
Q ss_pred cccCCcccc----ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 506 HLTGLSYEL----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~~~----~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.+..+.... ...||-+|+|||++... .-+.++||||||||+|+.++ |..||.+.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCch
Confidence 987755433 45699999999999853 23458999999999999998 58999753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-27 Score=234.23 Aligned_cols=205 Identities=25% Similarity=0.425 Sum_probs=166.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEee-eEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYG-SEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g-~~~~~~ 429 (571)
..+.|.|.+.||+|.||.+.+|.++.+.+.+++|.+.. ....++.|.+|...--.|. |.||+..|+ .|...+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 45689999999999999999999999999999998752 2234577888877666664 899999886 467778
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCcEEEEecCCcccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHL 507 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd--~~g~vKLiDFGlA~~l 507 (571)
.++++|||++-|+|..-+.. ..+-|...+.++.|+++||.|||++++||||||.+||||- +.-.|||||||+....
T Consensus 96 ~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 88999999999999887765 3488889999999999999999999999999999999993 3348999999998755
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
..- -.....+..|.+||++....+ ........+|||.||+|+|.+|+|.+||...--
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~~n--e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTVVN--EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhccc--cceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 321 112224556999999876532 244556789999999999999999999985433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-24 Score=207.19 Aligned_cols=203 Identities=36% Similarity=0.606 Sum_probs=171.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC-CeeEEeeeEEeCCeEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-NIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp-NIVkl~g~~~~~~~lyLV 434 (571)
|.+.+.||.|+||.||++.+. ..+++|.+...... .......+.+|+.+++.+.|+ +|+.+++.+......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES--KSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc--chhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 788999999999999999987 78899987643322 113567788999999999988 799999999777778999
Q ss_pred EeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccccCCc
Q 008285 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~~~~ 511 (571)
++++.+++|.+++.... ..+.+..+..++.|++.++.|+|+.|++||||||+|||++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999999997776643 2699999999999999999999999999999999999999888 79999999998665433
Q ss_pred -------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 -------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 -------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......|+..|++||.+.... ...+....|+|++|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234677999999999987310 0357789999999999999999999976554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=235.52 Aligned_cols=168 Identities=16% Similarity=0.151 Sum_probs=130.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECC-CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeE-EeeeEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ-YYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~-tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVk-l~g~~~~~~ 429 (571)
...+|++.+.||+|+||+||+|.++. +|+.||||++.............+.+.+|+++|++++|+||+. +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 44589999999999999999999876 6788899986422110012334567899999999999999985 443 25
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDI-KPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
..|||||||.|++|... .. .. ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 68999999999999632 11 11 1467899999999999999999999 9999999999999999999998664
Q ss_pred CCccc---------cccCCCCcccChHHHHHh
Q 008285 509 GLSYE---------LSLKGSPNWMAPEVIKAV 531 (571)
Q Consensus 509 ~~~~~---------~~~~GT~~YmAPEvl~~~ 531 (571)
..... ....+++.|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 42211 235688889999988643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=238.33 Aligned_cols=195 Identities=29% Similarity=0.489 Sum_probs=165.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~ 427 (571)
..+.|.++++||+|.|++||++++.. ....||+|.+.... ...++.+|+++|..+. +.||+.+.+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34589999999999999999999887 78899999886532 2356889999999996 8999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~ 506 (571)
++...+||||++...-.+++.. ++..+++.+++.++.||.++|.+|||||||||.|+|++ ..+.-.|+|||+|..
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999998888887754 67889999999999999999999999999999999997 568899999999872
Q ss_pred cc-----------------C-C----------------c-----------cccccCCCCcccChHHHHHhhhcCCCCCCC
Q 008285 507 LT-----------------G-L----------------S-----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541 (571)
Q Consensus 507 l~-----------------~-~----------------~-----------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s 541 (571)
.. . . . ......||++|.|||++.. ...-+
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k------~~~Qt 256 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR------CPRQT 256 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh------ccCcC
Confidence 10 0 0 0 0012459999999999985 34457
Q ss_pred chhhHHHHHHHHHHHHcCCCCC
Q 008285 542 LAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 542 ~ksDVWSLGvVLyELLtGr~PF 563 (571)
.++||||.|||++.+++++.||
T Consensus 257 taiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred Cccceeeccceeehhhcccccc
Confidence 7899999999999999999997
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=223.91 Aligned_cols=201 Identities=27% Similarity=0.380 Sum_probs=164.5
Q ss_pred CeEEeeEEeecCceEEEEEEECCCC-cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC----CCeeEEeeeE-EeC
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----ENIVQYYGSE-VVD 428 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG-~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H----pNIVkl~g~~-~~~ 428 (571)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.++..+.. .++..+++.+ ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999988775 6788887654322111 146678888888762 6889999888 477
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-----CcEEEEecC
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFG 502 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-----g~vKLiDFG 502 (571)
+..||||+.+ |.+|.++..... +.++...+..|+.|++.+|.+||+.|++||||||+|+++... ..+.|+|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 7889999998 799999886655 789999999999999999999999999999999999999754 469999999
Q ss_pred Ccc--cccCCc--------c-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 503 MAK--HLTGLS--------Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 503 lA~--~l~~~~--------~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
+++ ...... . ...+.||..|++++...+ ...+.+.|+|||+.++.||+.|..||...+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-------IEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-------CccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 321111 1 224569999999998873 4567899999999999999999999987654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=226.77 Aligned_cols=130 Identities=24% Similarity=0.443 Sum_probs=113.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-----C---CCeeEEeeeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----H---ENIVQYYGSE 425 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-----H---pNIVkl~g~~ 425 (571)
.+|.+.++||.|-|++||+|.+..+.+.||+|+++- .....+....||++|++++ | ..||+|++.|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 799999999999999999999999999999999872 2344566789999999984 2 3599999998
Q ss_pred EeC----CeEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 008285 426 VVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLV 490 (571)
Q Consensus 426 ~~~----~~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILL 490 (571)
... .++++|+|++ |.+|..+|.. ..+.++...+++|++||+.||.|||+. ||||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 864 4789999999 6788888864 456799999999999999999999976 99999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=219.09 Aligned_cols=207 Identities=25% Similarity=0.424 Sum_probs=170.2
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS 424 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~-----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~ 424 (571)
...+.+++...++-+|+||.||.|.+++... .|.+|.++ +..+.-.+..+..|..++..+.|+|++.+.++
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk----~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK----QHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH----hcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3445678888899999999999998875433 34444433 23445567778899999999999999999998
Q ss_pred EEeC-CeEEEEEeecCCCCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 425 EVVD-DHLYIYLEYVHPGSINRYVRE-------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 425 ~~~~-~~lyLVmEy~~GGsL~d~L~~-------~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
+.++ +..++++.++.-|+|..||.. ..+.++..++..++.|++.||+|||++||||.||...|++||+.-.|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 7665 567888899988999999972 23457888899999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCcccc---ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 497 KLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~~~---~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
||+|=.+++.+...+++. .......||++|.+. +..|+.++|||||||+||||++ |+.||.+.+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------NSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHh-------hhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 999999999887665542 233456799999998 4468899999999999999999 999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=208.95 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=168.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~ 429 (571)
.....|.+++.||+|+||.+|+|....+|+.||||+-...... -++..|..+.+.|+ ...|..+..++.+.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-------PQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-------cchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3456899999999999999999999999999999985432222 34677888999887 478888888888888
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~ 506 (571)
.-.+||+++ |-+|.+++.--.+.++..++..++.|++.-|+|+|.+++|||||||+|+|+. ....+.|+|||+++.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 889999998 6788888765556799999999999999999999999999999999999995 345799999999998
Q ss_pred ccCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+.+... ...+.||..|.+-....+.. -+...|+-|+|.+|+++.-|..||.+..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-------qSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-------QSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhh-------hhhhhhhhhhcceeeeeecCCCcccccc
Confidence 765332 23477999998877665433 3457899999999999999999998764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=210.07 Aligned_cols=201 Identities=25% Similarity=0.394 Sum_probs=169.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~l 431 (571)
.-.|.+++.||+|+||++++|++.-+++.||||.-....+ .-++..|....+.|. .++|.++|.+..+.-.-
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-------cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4489999999999999999999999999999997543221 245777888888885 69999999887777788
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-----CCCcEEEEecCCccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-----ASGVVKLADFGMAKH 506 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-----~~g~vKLiDFGlA~~ 506 (571)
.||||++ |-+|.|+..--++.++.+.+..++.|++.-|+|+|++.+|.|||||+|+||. ....+.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 6788888766667899999999999999999999999999999999999995 345799999999998
Q ss_pred ccCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 507 LTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 507 l~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
+-+... ..+..||..||+-....+ ..-+...|+-|||-|++++|-|.+||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc-------chhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 765432 235779999999877664 3446689999999999999999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-24 Score=246.31 Aligned_cols=145 Identities=18% Similarity=0.250 Sum_probs=111.6
Q ss_pred cCC-CCeeEEeeeE-------EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 413 LKH-ENIVQYYGSE-------VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 413 L~H-pNIVkl~g~~-------~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
++| .||+.+++++ ...+.++++|||+ +++|.++|......+++.+++.+++||++||+|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 4667777765 2334678888987 579999997655679999999999999999999999999999999
Q ss_pred CCcEEEcCCC-------------------cEEEEecCCcccccCCc-----------------cccccCCCCcccChHHH
Q 008285 485 GANLLVDASG-------------------VVKLADFGMAKHLTGLS-----------------YELSLKGSPNWMAPEVI 528 (571)
Q Consensus 485 PsNILLd~~g-------------------~vKLiDFGlA~~l~~~~-----------------~~~~~~GT~~YmAPEvl 528 (571)
|+||||+..+ .+||+|||+++...... ......||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 45556666654321100 00124588999999998
Q ss_pred HHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 529 ~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
. +..|+.++|||||||+||||++|..||..
T Consensus 188 ~-------~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 188 N-------GSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred c-------cCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 6 34578999999999999999999998764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=194.13 Aligned_cols=145 Identities=19% Similarity=0.168 Sum_probs=111.6
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcH---------------------HHHHHHHHHHHHHhhcCCCC
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------------ECIKQLEQEIKVLGHLKHEN 417 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~---------------------~~~k~l~~Ei~IL~~L~HpN 417 (571)
.+.||+|+||.||+|.+. +|+.||||+++......... ........|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999987532111100 01123456999999998777
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCcE
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL-Hs~GIVHRDIKPsNILLd~~g~v 496 (571)
|....... . ...+|||||+.|++|...+.+. ..+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.+
T Consensus 81 v~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEE-e-cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 64433222 2 2238999999988776654332 5689999999999999999999 799999999999999998 5789
Q ss_pred EEEecCCccccc
Q 008285 497 KLADFGMAKHLT 508 (571)
Q Consensus 497 KLiDFGlA~~l~ 508 (571)
+|+|||++....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-22 Score=194.34 Aligned_cols=192 Identities=17% Similarity=0.174 Sum_probs=144.5
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEEE
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLVm 435 (571)
.+...|++|+||+||++.. .+.+++.+.+........ .-....+.+|+++|++|. +++|++++++ +..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3567899999999997765 578888777654332211 111235789999999995 5889999875 4569999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCcEEEEecCCcccccCCcc--
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGLSY-- 512 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDI-KPsNILLd~~g~vKLiDFGlA~~l~~~~~-- 512 (571)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999999764421 1 1357889999999999999999999 79999999999999999999986543321
Q ss_pred ------------ccccCCCCcccChHHHHHhhhcCCCCCCC-chhhHHHHHHHHHHHHcCCCC-CCCCCCC
Q 008285 513 ------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLA-LAVDIWSLGCTVIEMLTGKPP-WSEFEGV 569 (571)
Q Consensus 513 ------------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s-~ksDVWSLGvVLyELLtGr~P-F~~~egv 569 (571)
.....+++.|+.|+...-.. ..+ ...++++.|+-+|.++|++.+ |.+.||-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~------~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~~ 214 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLK------RTSWIRELWFATGKPVYRFVTRRVLHWEDNEGQ 214 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc------cchhHHHHHHHhcchHHHHHhccCCccccCCCC
Confidence 01133788899999765321 122 467899999999999999988 5666664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=189.21 Aligned_cols=146 Identities=16% Similarity=0.150 Sum_probs=113.7
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCc---------------------HHHHHHHHHHHHHHhhcCCCC
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------------------AECIKQLEQEIKVLGHLKHEN 417 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~---------------------~~~~k~l~~Ei~IL~~L~HpN 417 (571)
.+.||+|++|.||+|.+. +|+.||||+++........ ......+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998754221000 111233468999999999988
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcE
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~v 496 (571)
|.....+... ..||||||+.|+++...+... ..+++.++..++.|++.+|.+||. +||+||||||+|||++ ++.+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 7544433322 248999999988654432222 458888999999999999999999 9999999999999998 8899
Q ss_pred EEEecCCcccccC
Q 008285 497 KLADFGMAKHLTG 509 (571)
Q Consensus 497 KLiDFGlA~~l~~ 509 (571)
+|+|||++..+..
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=196.78 Aligned_cols=174 Identities=13% Similarity=0.159 Sum_probs=132.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHH------HHHHHHHHhhcCCCCeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~------l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
..++|++.++||.|+||.||++.. ++..+|||++..... ........ +++|+..+.++.|++|..+.+++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~--~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK--RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC--chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 356899999999999999999655 477899999864322 22222233 67999999999999999999886
Q ss_pred EeC--------CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEE
Q 008285 426 VVD--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 497 (571)
Q Consensus 426 ~~~--------~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vK 497 (571)
.+. +..+|||||++|.+|.++. .+++ ..+.+|+.+|..||++|++||||||+|||++.+| ++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 644 3579999999999998873 2333 3456999999999999999999999999999888 99
Q ss_pred EEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH
Q 008285 498 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (571)
Q Consensus 498 LiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL 557 (571)
|+|||............ .++.. ..|..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d-----------~~vle-------r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD-----------RIDLE-------RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHH-----------HHHHH-------hHhcccccccceeEeehHHH
Confidence 99999887553221110 01111 12456899999999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=179.75 Aligned_cols=108 Identities=30% Similarity=0.382 Sum_probs=95.5
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCC
Q 008285 441 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (571)
Q Consensus 441 GsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~ 520 (571)
|+|.+++.+....+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 7899999876677999999999999999999999998 999999999999999 99988764432 36899
Q ss_pred cccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 521 ~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.|||||++. +..++.++|||||||++|||++|+.||....
T Consensus 69 ~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 69 YFMAPEVIQ-------GQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred cccChHHhc-------CCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 999999986 3457889999999999999999999997543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-22 Score=221.56 Aligned_cols=203 Identities=29% Similarity=0.429 Sum_probs=164.1
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeecCC-CCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~-~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
....++|.|.+|.|+.+........++.|.+.... ...........+..|..+-..++|+||+..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999999998888777777777654210 11122223333778888889999999998888777777767779
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc----
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 511 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~---- 511 (571)
|||++ +|+.++... ..++..++..+++||+.||.|||..||.|||||++|+|+..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99998 999999764 468999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....++|+-.|+|||++... .......||||.|++++.|.+|+.||....
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~------~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGK------EYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhcCcccCCcCcCccccccc------ccCcchhhhhhccceEEEEecCCCcccccc
Confidence 23457899999999998753 334567999999999999999999997544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=187.98 Aligned_cols=207 Identities=24% Similarity=0.331 Sum_probs=136.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC----------CCeeEEeee
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----------ENIVQYYGS 424 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H----------pNIVkl~g~ 424 (571)
.+..++.||.|+++.||.+++.++|+.+|+|++....+ ......+.+++|.-....+.+ -.++..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 57888999999999999999999999999999876553 223345666666544433222 223333332
Q ss_pred EEeC------------C-----eEEEEEeecCCCCHHHHHHH---hcCC---CCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008285 425 EVVD------------D-----HLYIYLEYVHPGSINRYVRE---HCRD---ITESIVRNFTRHILNGLAYLHSTNTIHR 481 (571)
Q Consensus 425 ~~~~------------~-----~lyLVmEy~~GGsL~d~L~~---~~~~---Lse~~i~~I~~QIa~gL~yLHs~GIVHR 481 (571)
.... . ..+++|+-+. ++|.+++.. .... +.......+..|+++.+++||..|+||+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 2211 1 2367777774 888888643 2111 2223334667999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhh-cCCCCCCCchhhHHHHHHHHHHHHcCC
Q 008285 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ-KDGNPKLALAVDIWSLGCTVIEMLTGK 560 (571)
Q Consensus 482 DIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~-~d~~~~~s~ksDVWSLGvVLyELLtGr 560 (571)
||||+|+|++.+|.++|+||+........... ...+..|.+||....... ......++.+.|.|+||++||.|+||+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999887655442222 334577999998765311 012346789999999999999999999
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||...
T Consensus 248 lPf~~~ 253 (288)
T PF14531_consen 248 LPFGLS 253 (288)
T ss_dssp -STCCC
T ss_pred CCCCCC
Confidence 999844
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-21 Score=212.12 Aligned_cols=189 Identities=25% Similarity=0.405 Sum_probs=161.1
Q ss_pred EEeecCceEEEEEE---ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEEEe
Q 008285 361 LIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 361 ~LG~G~fG~VYla~---~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLVmE 436 (571)
.+|+|.||.|+++. -...|..+|+|+.+.......... ....|..++..++ |+.+|++...+..+...+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999874 234577899998765443322222 4567888888887 9999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccccc
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~ 516 (571)
|..||+|...+.+. ..+++.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+.+........
T Consensus 78 ~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred hcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99999999988664 56888888888999999999999999999999999999999999999999999977654433
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
+||..|||||++++ +..+.|+||||++++||++|..||..
T Consensus 154 cgt~eymApEI~~g---------h~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---------HLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhhc---------cCCcccchhhhhhHHHHhhCCCCCch
Confidence 89999999999972 45679999999999999999999976
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=178.15 Aligned_cols=136 Identities=21% Similarity=0.321 Sum_probs=106.5
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-----CCCCeeEEeeeEEeCC---
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-----KHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-----~HpNIVkl~g~~~~~~--- 429 (571)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .|+||++++++++++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 346899999999995 6666665 6888764221 1346689999999999 5799999999998873
Q ss_pred eEE-EEEee--cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEcC----CCcEEEEec
Q 008285 430 HLY-IYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGL-AYLHSTNTIHRDIKGANLLVDA----SGVVKLADF 501 (571)
Q Consensus 430 ~ly-LVmEy--~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL-~yLHs~GIVHRDIKPsNILLd~----~g~vKLiDF 501 (571)
.++ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++. ++.++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 5579999999663 36655 35678888787 9999999999999999999973 348999995
Q ss_pred CCcc
Q 008285 502 GMAK 505 (571)
Q Consensus 502 GlA~ 505 (571)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 4443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=180.67 Aligned_cols=151 Identities=18% Similarity=0.142 Sum_probs=116.9
Q ss_pred CCCeEEeeEEeecCceEEEEEE-ECCCCcEEEEEEeecCCCCcC-------------------cHHHHHHHHHHHHHHhh
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGH 412 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~-~k~tG~~VAIK~i~~~~~d~~-------------------~~~~~k~l~~Ei~IL~~ 412 (571)
...|++.+.||+|+||.||+|. +..+|+.||||+++....... .......+..|++++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3468899999999999999999 677899999999875321100 01122346789999999
Q ss_pred cCCCC--eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEE
Q 008285 413 LKHEN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLL 489 (571)
Q Consensus 413 L~HpN--IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G-IVHRDIKPsNIL 489 (571)
+.+.+ +.++++. ...+|||||+.|++|..++... ..+.+.++..++.||+.+|.+||.+| |+||||||+|||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 97532 3444432 2358999999998887665332 34667778899999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccC
Q 008285 490 VDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 490 Ld~~g~vKLiDFGlA~~l~~ 509 (571)
++ ++.++|+|||++.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 98 88999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=208.00 Aligned_cols=199 Identities=24% Similarity=0.278 Sum_probs=158.2
Q ss_pred CCCCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC---CCCeeEEe
Q 008285 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYY 422 (571)
Q Consensus 346 ~p~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~---HpNIVkl~ 422 (571)
..........|.|.+.||+|+||+||+|.... |+.||||+-+....+ .-.... +++.+|+ -+.|+.+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~------q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICL------QVMERLKPQMLPSIMHIS 760 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehH------HHHHhhchhhhcchHHHH
Confidence 33445566789999999999999999999877 999999987643332 211122 2223332 24556666
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-------CCCc
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-------ASGV 495 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-------~~g~ 495 (571)
.++.-.+.-+||+||.+.|+|.+++. ..+.+++..+..|..||+..|++||..||||+||||+|+||. ...-
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 66667788899999999999999997 457799999999999999999999999999999999999993 3346
Q ss_pred EEEEecCCccccc---CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 008285 496 VKLADFGMAKHLT---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (571)
Q Consensus 496 vKLiDFGlA~~l~---~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~ 561 (571)
++|+|||.+..+. +.......++|-.+-.+|++. +..+++.+|.|.|+.+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-------grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-------GRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc-------CCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999987543 333344567888899999886 5679999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-19 Score=169.87 Aligned_cols=140 Identities=21% Similarity=0.296 Sum_probs=114.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
+.||+|++|.||+|.+ +|..+++|+........ .......++.+|++++..+.|++|.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 57889999754221111 111123467889999999999998877777777788899999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
|++|++|.+++.... . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++...
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999999986532 2 7788999999999999999999999999999998 789999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=166.77 Aligned_cols=136 Identities=22% Similarity=0.308 Sum_probs=108.9
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC---cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~---~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
.||+|+||.||+|.+ +|..+++|.......... .....+++.+|++++..+.|.+|.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 578899998643221111 122346678999999999988765555555667778999999
Q ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 438 ~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++|++|.+++..... .++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999998755311 7889999999999999999999999999998 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=166.04 Aligned_cols=143 Identities=18% Similarity=0.171 Sum_probs=110.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-----------------cHHHHHHHHHHHHHHhhcCCCC
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-----------------SAECIKQLEQEIKVLGHLKHEN 417 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-----------------~~~~~k~l~~Ei~IL~~L~HpN 417 (571)
.|.+.+.||+|+||.||+|.+. +|+.||||++........ ..........|+.++..+.+.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4778899999999999999875 799999998764221100 0011123567899999988774
Q ss_pred --eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 418 --IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 418 --IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
++..++ .+..++||||++|++|..++.. .....++.+|+.++.++|+.||+||||||+||++++++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 444443 3456899999999998765421 345678899999999999999999999999999999999
Q ss_pred EEEEecCCcccccC
Q 008285 496 VKLADFGMAKHLTG 509 (571)
Q Consensus 496 vKLiDFGlA~~l~~ 509 (571)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=6e-18 Score=188.13 Aligned_cols=142 Identities=19% Similarity=0.227 Sum_probs=113.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.|...+.||+|+||+||+|.+.. ..+++|+........ ......+++.+|+++++.++|++|+..+.++...+..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 45667899999999999998754 344444432111111 1122346688999999999999999887777777788
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
++||||++|++|.+++. ....++.+|+.+|.+||++||+||||||+|||+ .++.++|+|||+++...
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999999886 346789999999999999999999999999999 67899999999998654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=199.56 Aligned_cols=204 Identities=23% Similarity=0.317 Sum_probs=155.4
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|...+-||++-|=+|.+|++.+ |. |+||++....+. -.-...++...|++ ...+++||++.+.-+-+.+.-.|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~-~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPT-ISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCC-CCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78888999999999999999876 55 999998644333 33333334444555 5667899999988776677777899
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc--CC--
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GL-- 510 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~--~~-- 510 (571)
-+|+. -+|+|.|.-. ..|.+.+.++|+.||+.||.-+|+.||+|||||.+||||+..+-+.|+||...+-.. .+
T Consensus 100 Rqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99985 8899988543 557888999999999999999999999999999999999999999999998776331 11
Q ss_pred -ccccc---cCCCCcccChHHHHHhh----hcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008285 511 -SYELS---LKGSPNWMAPEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564 (571)
Q Consensus 511 -~~~~~---~~GT~~YmAPEvl~~~~----~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~ 564 (571)
++... -.--..|+|||.+.... .......++.+.||||+||++.||++ |+++|.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11111 11122499999986522 12223347889999999999999988 899996
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=153.80 Aligned_cols=142 Identities=21% Similarity=0.263 Sum_probs=100.6
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHH-------------------HHHHHHHHHHHhhcCCC--C
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC-------------------IKQLEQEIKVLGHLKHE--N 417 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~-------------------~k~l~~Ei~IL~~L~Hp--N 417 (571)
.+.||+|+||+||+|.+. +|+.||||++............ ......|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999976 7999999987643211110000 01114566666666543 2
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCc
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d-~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~ 495 (571)
+.++++. ...++||||+.|+.+.. .+... . . ..++..++.+++.++.++|. +||+|+||||+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-h-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4445543 34689999999854322 22221 1 1 15678899999999999999 9999999999999999 899
Q ss_pred EEEEecCCcccccC
Q 008285 496 VKLADFGMAKHLTG 509 (571)
Q Consensus 496 vKLiDFGlA~~l~~ 509 (571)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.5e-17 Score=171.79 Aligned_cols=210 Identities=26% Similarity=0.402 Sum_probs=146.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCc-----------------------------------EEEEEEeecCCCCcCc
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA-----------------------------------SCAIKEVDIIPDDPKS 396 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~-----------------------------------~VAIK~i~~~~~d~~~ 396 (571)
..++|++++.||+|+...||.+....+|. +.|||.+-...-+...
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 34689999999999999999987554221 1355544322223333
Q ss_pred HHHHHHHHHHH------HHH--------h-------h-cCCCCeeEEeeeEEeC--------------------------
Q 008285 397 AECIKQLEQEI------KVL--------G-------H-LKHENIVQYYGSEVVD-------------------------- 428 (571)
Q Consensus 397 ~~~~k~l~~Ei------~IL--------~-------~-L~HpNIVkl~g~~~~~-------------------------- 428 (571)
...++..-+|. .++ + + -+|||||+++..|.+.
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 33344433331 111 1 1 2599999998876542
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCC--cEEEEecCC
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASG--VVKLADFGM 503 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL--d~~g--~vKLiDFGl 503 (571)
..+|+||-... -+|+.|+-. ...+....+-|+.|+++|+.|||++||.|||+|.+|||| |+++ .+.|+|||+
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 24689998875 788888865 356777888899999999999999999999999999999 3443 688999997
Q ss_pred cccccC-------CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 504 AKHLTG-------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 504 A~~l~~-------~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
+-.-.. .......-|.-.-||||+....-... ...--.++|.|+.|.+.||++....||-.
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~-avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN-AVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCc-eeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 643221 22223345777789999986542221 11123489999999999999999999965
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-16 Score=158.30 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=107.2
Q ss_pred eeEEe-ecCceEEEEEEECCCCcEEEEEEeecCC-------CC-cCcHHHHHHHHHHHHHHhhcCCCCe--eEEeeeEEe
Q 008285 359 GKLIG-RGTFGSVYIGTNRETGASCAIKEVDIIP-------DD-PKSAECIKQLEQEIKVLGHLKHENI--VQYYGSEVV 427 (571)
Q Consensus 359 ~k~LG-~G~fG~VYla~~k~tG~~VAIK~i~~~~-------~d-~~~~~~~k~l~~Ei~IL~~L~HpNI--Vkl~g~~~~ 427 (571)
...|| .||.|+||.+... +..++||.+.... ++ ........++.+|++++.+|.|.+| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8889999988764 7889999875311 11 0112234667889999999998775 667765443
Q ss_pred CC----eEEEEEeecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 428 DD----HLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 428 ~~----~lyLVmEy~~G-GsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.. ..++||||++| .+|.+++.+ ..+++.. +.+|+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 32 23599999997 689998865 3456543 5789999999999999999999999999988999999999
Q ss_pred Ccccc
Q 008285 503 MAKHL 507 (571)
Q Consensus 503 lA~~l 507 (571)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 98764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-17 Score=188.62 Aligned_cols=166 Identities=30% Similarity=0.513 Sum_probs=123.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
+...+|..+|.|..|+||-||+++++.+.+.+|+|+-+ + ..+.+- |+.....+.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q--------~lilRn--ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---Q--------NLILRN--ILTFAGNPFVV----------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccc---c--------chhhhc--cccccCCccee-----------
Confidence 34569999999999999999999999999999996422 1 001110 22222223222
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc--
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 508 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-- 508 (571)
|+..+.++.- +.++.. ++.+++|||+.||+|||+||+|+||+.-|++|+.|||+.+...
T Consensus 136 ----------gDc~tllk~~-g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----------GDCATLLKNI-GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----------chhhhhcccC-CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 5555555432 345533 3788999999999999999999999999999999999987431
Q ss_pred ------CCc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 ------GLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ------~~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.+. .....+||+.|+|||++.. ..|+..+|+|++|+|+||++.|..||.+.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 111 1124689999999999873 35788999999999999999999998654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=140.18 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=110.6
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeeeEEeCCeEEEEE
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~~~~~~~lyLVm 435 (571)
+++.||+|.++.||++.... ..+++|.+..... ...+..|+.+++.+++ .++++++..+...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence 45789999999999999754 7899998753211 3567889999999976 58999998888778899999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~---GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
||+.|+.+..+ +......++.+++.+|++||.. +++|+||+++|||++..+.++|+|||++..
T Consensus 73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99998877654 4556677889999999999985 799999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.4e-16 Score=155.51 Aligned_cols=202 Identities=20% Similarity=0.319 Sum_probs=154.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++.....+|.+.-.|..|+|++.. ..++.|++.... ......+.|..|.-.|+-..||||+.+++.|.....+.
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 3456667788999999999999974 456667654322 22334466888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|..||+-|+|+.+|++... -.+..++..++.+|++|++|||+.. |.---|....|+||++-..+|. .+-.++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee-
Confidence 99999999999999987532 3677889999999999999999873 3344588899999998776664 22222111
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
........+.||+||.++..-.+ .--.+.|||||+++||||.|...||.+..
T Consensus 342 --qe~gr~y~pawmspealqrkped----~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPED----LNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred --eccccccCcccCCHHHHhcCchh----cchhhhhHHHHHHHHHHhhccccccccCC
Confidence 11233467889999999753221 23458999999999999999999998653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.7e-16 Score=169.11 Aligned_cols=119 Identities=24% Similarity=0.458 Sum_probs=105.1
Q ss_pred eEEEEEeecCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 430 HLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~--~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+||.|++|.-.+|.++|.. .....+......++.||+.|+.| +|.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 57999999999999999963 34457778889999999999999 99999999999999999999999999998877
Q ss_pred cCCc-------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc
Q 008285 508 TGLS-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 508 ~~~~-------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
.... .....+||..||+||.+.+ ..|+.++||||||+||+||+.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-------~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-------QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-------hhhhhhcchhhHHHHHHHHHH
Confidence 6554 4456789999999999984 468899999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-16 Score=180.59 Aligned_cols=205 Identities=31% Similarity=0.506 Sum_probs=168.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCC-CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~t-G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~l 431 (571)
..|.+.+.||+|.|+.|-++....+ ...+|.|.+.... ......+.+..|..+-..+. |.|++++++.....+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4677778899999999998876443 3456666655433 33455667777888888887 99999999999999999
Q ss_pred EEEEeecCCCCHHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCC-cEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASG-VVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L-~~~~~~Lse~~i~~I~~QIa~gL~yLH-s~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~ 508 (571)
++++||.+|+++++.+ .......+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999999 554436777888899999999999999 99999999999999999999 99999999998765
Q ss_pred C-Cc---cccccCC-CCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 G-LS---YELSLKG-SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~-~~---~~~~~~G-T~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. .. .....+| ++.|+|||...+. .......|+||.|+++..+++|..||....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccc
Confidence 5 22 2234668 9999999998742 234568999999999999999999997544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-14 Score=159.47 Aligned_cols=157 Identities=28% Similarity=0.478 Sum_probs=129.5
Q ss_pred HhhcCCCCeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcE
Q 008285 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-IHRDIKGANL 488 (571)
Q Consensus 410 L~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GI-VHRDIKPsNI 488 (571)
|+.+.|.|+.+++|.+.+....++|.+||.-|+|.+.+......+++.....++++|+.||+|||.--| .|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457889999999999999999999999999999999998877788988899999999999999997755 9999999999
Q ss_pred EEcCCCcEEEEecCCcccccCC---ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 489 LVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 489 LLd~~g~vKLiDFGlA~~l~~~---~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
++|....+||.|||+....... .......-..-|.|||.+............+.+.||||||++++|+++.+.||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998766420 1111112334599999998643222222357789999999999999999999975
Q ss_pred C
Q 008285 566 F 566 (571)
Q Consensus 566 ~ 566 (571)
.
T Consensus 161 ~ 161 (484)
T KOG1023|consen 161 R 161 (484)
T ss_pred c
Confidence 3
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=150.16 Aligned_cols=146 Identities=15% Similarity=0.151 Sum_probs=98.9
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-------------------------cHH----HHH------HHH
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------------------------SAE----CIK------QLE 404 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-------------------------~~~----~~k------~l~ 404 (571)
+.||.|++|.||+|+.+ +|+.||||+.+......- ... ..+ .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 699999999854221100 000 001 133
Q ss_pred HHHHHHhhcC----CCCeeEEeeeE-EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 008285 405 QEIKVLGHLK----HENIVQYYGSE-VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN-GLAYLHSTNT 478 (571)
Q Consensus 405 ~Ei~IL~~L~----HpNIVkl~g~~-~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~-gL~yLHs~GI 478 (571)
+|+..+.++. +.+-+.+-..+ ......+|||||++|++|.+++......+. ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555542 32223322222 224557999999999999988754322232 2345556655 4678999999
Q ss_pred eecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 479 VHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|+|+||.||+++.++.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-14 Score=156.06 Aligned_cols=147 Identities=16% Similarity=0.191 Sum_probs=96.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc-------------------------C----cHHHHHHHHH
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-------------------------K----SAECIKQLEQ 405 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~-------------------------~----~~~~~k~l~~ 405 (571)
.|.. +.||+|++|+||+|+.+.+|+.||||+++...... . ..+..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 5665 78999999999999999889999999986431100 0 0122233334
Q ss_pred HHHHHh------hcC----CCCeeEEeeeEE-eCCeEEEEEeecCCCCHHHHH--HHhcC---CCCHHHHHHHHHHHHHH
Q 008285 406 EIKVLG------HLK----HENIVQYYGSEV-VDDHLYIYLEYVHPGSINRYV--REHCR---DITESIVRNFTRHILNG 469 (571)
Q Consensus 406 Ei~IL~------~L~----HpNIVkl~g~~~-~~~~lyLVmEy~~GGsL~d~L--~~~~~---~Lse~~i~~I~~QIa~g 469 (571)
|+++++ ++. +.+.+.+-.++. .....+|||||++|+.|.++. ...+. .+.+..+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 444333 332 232233222222 244567999999999998753 22211 233444444555544
Q ss_pred HHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCcccccC
Q 008285 470 LAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLTG 509 (571)
Q Consensus 470 L~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~l~~ 509 (571)
..|++|+|+||.||+++.+| .++++|||+...+..
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999887 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.5e-13 Score=148.02 Aligned_cols=204 Identities=25% Similarity=0.338 Sum_probs=167.7
Q ss_pred CCCCCCCCeEEeeEEee--cCceEEEEEEE--CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEe
Q 008285 348 SASPKKSQWQKGKLIGR--GTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY 422 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~--G~fG~VYla~~--k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~ 422 (571)
........+.+.+.+|. |.+|.||.+.. ..++..+|+|.-++...... .-.+-.+|+..-+.++ |.|.++.+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc---ccccccchhhcccccCccccccccC
Confidence 34555668889999999 99999999988 89999999998554332211 1122335666666665 99999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEcCC-CcEE
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----GLAYLHSTNTIHRDIKGANLLVDAS-GVVK 497 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~----gL~yLHs~GIVHRDIKPsNILLd~~-g~vK 497 (571)
..++..+..|+-+|+|. .+|..+++..+..+++..++..+.++.+ ||.++|..+|+|-|+||.||++..+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999995 8999999988888999999999999999 9999999999999999999999988 8999
Q ss_pred EEecCCcccccCCcccc------ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 498 LADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 498 LiDFGlA~~l~~~~~~~------~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
++|||+...+....... ...|...|++||.++. -++...|||+||.++++..+|...+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccc
Confidence 99999998876654222 1247778999999864 4778999999999999988766554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-12 Score=128.35 Aligned_cols=143 Identities=16% Similarity=0.202 Sum_probs=104.2
Q ss_pred eeEEeecCceEEEEEEECC------CCcEEEEEEeecCCC-----------CcC----------cHHHHHHHHHHHHHHh
Q 008285 359 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPD-----------DPK----------SAECIKQLEQEIKVLG 411 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~------tG~~VAIK~i~~~~~-----------d~~----------~~~~~k~l~~Ei~IL~ 411 (571)
...||.|-.+.||.|.... .+..+|||+.+.... +.. ........++|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 357999999865321 100 1111122348999999
Q ss_pred hcC--CCCeeEEeeeEEeCCeEEEEEeecCCCCHHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCc
Q 008285 412 HLK--HENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGAN 487 (571)
Q Consensus 412 ~L~--HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~d-~L~~~~~~Lse~~i~~I~~QIa~gL~yL-Hs~GIVHRDIKPsN 487 (571)
++. .-++.+.++. ..-+|||||+.+..+.. .+++ ..+++.++..++.+++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 985 3566677754 45689999998654432 2322 2456667778899999999999 89999999999999
Q ss_pred EEEcCCCcEEEEecCCccccc
Q 008285 488 LLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 488 ILLd~~g~vKLiDFGlA~~l~ 508 (571)
||++ ++.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9996 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.4e-13 Score=124.77 Aligned_cols=128 Identities=16% Similarity=0.132 Sum_probs=95.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCCeEEEEEee
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~~lyLVmEy 437 (571)
++.|+.|.++.||++... |..|++|....... ....+..|+.+++.+.+.++ .+++... .+..++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence 467899999999999864 78899998642211 11235678888888865444 3555432 3345899999
Q ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 438 ~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GI-----VHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++|.++... . . ....++.+++.+|+.||..++ +|+|+++.|||++ ++.++|+|||.+..
T Consensus 73 i~G~~l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999887643 0 1 113456899999999999885 9999999999998 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=143.24 Aligned_cols=178 Identities=23% Similarity=0.358 Sum_probs=136.9
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCC
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GG 441 (571)
..-++.+..-.|..+.++..|.|..++.... +....+.+-++-|+.|+||||+++++.++.++.+|||+|.+.
T Consensus 20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-- 92 (690)
T KOG1243|consen 20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-- 92 (690)
T ss_pred ccCCCcccccccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--
Confidence 3333443333577788899999988875332 445667788899999999999999999999999999999995
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc-cccCCC
Q 008285 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE-LSLKGS 519 (571)
Q Consensus 442 sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH-s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~-~~~~GT 519 (571)
-|..++.+. ....+...+.||+.||.||| +.+++|++|.-.-|+|++.|.+||++|.++....+.... ....--
T Consensus 93 Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~ 168 (690)
T KOG1243|consen 93 PLETVLKEL----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLI 168 (690)
T ss_pred cHHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhh
Confidence 567777664 37778888999999999997 668999999999999999999999999988765443311 111122
Q ss_pred CcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC
Q 008285 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (571)
Q Consensus 520 ~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG 559 (571)
..|..|+.+.. . .-..|.|-|||+++|++.|
T Consensus 169 ~s~~~P~~~~~------s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDP------S---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCc------c---ccchhhhhHHHHHHHHhCc
Confidence 23667776531 1 1357999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.7e-11 Score=116.61 Aligned_cols=148 Identities=23% Similarity=0.277 Sum_probs=112.4
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-c--CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-P--KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-~--~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
...+|-+|+.+.|+++.+. |+.++||.-...... . ...-..++..+|+.+|.+++--.|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999874 888899864322111 1 1122346678899999998755555444456667777899
Q ss_pred EeecCC-CCHHHHHHHhcCCCCHHHH-HHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEEecCCcccc
Q 008285 435 LEYVHP-GSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHL 507 (571)
Q Consensus 435 mEy~~G-GsL~d~L~~~~~~Lse~~i-~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g---~vKLiDFGlA~~l 507 (571)
|||++| .++.+++......-.+.+. ..++++|-+.|.-||.++|+|+||..+|||+..++ .+.|+|||++..-
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 4899999877555555444 78999999999999999999999999999996544 4589999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.6e-11 Score=115.46 Aligned_cols=137 Identities=18% Similarity=0.289 Sum_probs=100.1
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCC-CcCc--HHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEe
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS--AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-d~~~--~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmE 436 (571)
..+++|+.+.+|.+.+. |..+++|.-..... .... .-..++..+|+.+|.+++--.|..-+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 36789999999999764 45577775322111 1111 1223556789999999875555444444567778889999
Q ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 437 y~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
|++|..|.++|... . ..+++.+-.-+.-||..||||+||.++||++..++ +.++||||+..-
T Consensus 80 ~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999999998764 1 35566677777889999999999999999996655 999999999754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.1e-11 Score=114.86 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=102.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeeeEEeC---CeEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVD---DHLYI 433 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~~~~~---~~lyL 433 (571)
.+.|+.|.++.||++.... |..+++|........ .....+..|+++++.+.+ .++.+++.+.... +..++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 3578999999999998754 688999986432110 123567889999999875 3456677665543 36789
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 475 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-------------------------------------- 475 (571)
||||++|.+|.+.+.. ..+++.....++.+++++|..||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999887665421 235666666666677777766663
Q ss_pred ------------------CCceecCCCCCcEEEcC--CCcEEEEecCCccc
Q 008285 476 ------------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKH 506 (571)
Q Consensus 476 ------------------~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~ 506 (571)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34689999999999988 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-11 Score=133.16 Aligned_cols=198 Identities=26% Similarity=0.227 Sum_probs=149.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
...+|..+..||.|.|+.|+.+..+ .++..|++|.+...-. .... ...-..|+-+...+ .|.+++..+..|...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHh-hhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3458999999999999999998866 7788999997643211 1111 12223566666655 4889999988888888
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA~~l~ 508 (571)
..||-.|||+++++...+. ....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999999998877763 23568888999999999999999999999999999999999765 889999999987522
Q ss_pred CCccccccCCCCccc-ChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 008285 509 GLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (571)
Q Consensus 509 ~~~~~~~~~GT~~Ym-APEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~ 561 (571)
-. .......-.++ ..|++.. ...+..+.|+++||+.+++.++|..
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ee--cccccccccccccchhhcc------ccccccccccccccccccccccCcc
Confidence 11 11122233344 3565553 4467789999999999999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-10 Score=107.69 Aligned_cols=131 Identities=21% Similarity=0.280 Sum_probs=86.5
Q ss_pred EEEEEEECCCCcEEEEEEeecCCCC---------------------cCcHHHHHHHHHHHHHHhhcCCC--CeeEEeeeE
Q 008285 369 SVYIGTNRETGASCAIKEVDIIPDD---------------------PKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSE 425 (571)
Q Consensus 369 ~VYla~~k~tG~~VAIK~i~~~~~d---------------------~~~~~~~k~l~~Ei~IL~~L~Hp--NIVkl~g~~ 425 (571)
.||.|... +|..+|+|+.+..... ...........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999864 5889999998642110 12222345577899999999755 566777542
Q ss_pred EeCCeEEEEEeecC--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 426 VVDDHLYIYLEYVH--PGSINRYVREHCRDITESIVRNFTRHILNGLAY-LHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 426 ~~~~~lyLVmEy~~--GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~y-LHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.-+|||||++ |..|..+.... ++.+....++.+++..+.. +|+.||||+||.+.|||++++ .+.|+|||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 3479999998 66665544322 2244556778888886555 579999999999999999877 89999999
Q ss_pred Cccccc
Q 008285 503 MAKHLT 508 (571)
Q Consensus 503 lA~~l~ 508 (571)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.9e-11 Score=139.57 Aligned_cols=205 Identities=21% Similarity=0.338 Sum_probs=158.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.-..+.+.+-+-+|.++.++.+.-..+|...++|+...... ......+.+..+-.++-..++|-++...-.+......
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~--i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK--IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchh--hccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 44578888899999999999999888887777776543221 1111233344454555555667777766666677889
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
+|+|+|..|++|...|+.- +.++++.++.++..+...++|||...++|+|++|.|+|+..+++.++.|||......-.
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999999999875 45777888888899999999999999999999999999999999999999843321100
Q ss_pred -------------------------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC
Q 008285 511 -------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (571)
Q Consensus 511 -------------------------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG 559 (571)
.......||+.|.+||.+.+ ......+|+|++|++++|.++|
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-------~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-------RRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-------ccCCCcchhhhhhhhhhhhhcC
Confidence 11223569999999999874 3456789999999999999999
Q ss_pred CCCCCCC
Q 008285 560 KPPWSEF 566 (571)
Q Consensus 560 r~PF~~~ 566 (571)
.+||...
T Consensus 1032 ~pp~na~ 1038 (1205)
T KOG0606|consen 1032 IPPFNAE 1038 (1205)
T ss_pred CCCCCCc
Confidence 9999753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.9e-09 Score=108.47 Aligned_cols=141 Identities=14% Similarity=0.103 Sum_probs=98.8
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHH----------HHHHHHHHHhhcCCCCe--eEEeeeEEe
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----------QLEQEIKVLGHLKHENI--VQYYGSEVV 427 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k----------~l~~Ei~IL~~L~HpNI--Vkl~g~~~~ 427 (571)
+.+-......|+.+.. .|+.|.||....... .+..+ ...+|...+.+|...+| +..+.+++.
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~----~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~ 101 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGW----GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER 101 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcH----HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence 4455445555666654 477899997632110 11111 36688888887753333 333444432
Q ss_pred -----CCeEEEEEeecCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------C
Q 008285 428 -----DDHLYIYLEYVHPG-SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------S 493 (571)
Q Consensus 428 -----~~~lyLVmEy~~GG-sL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-------~ 493 (571)
...-+||||+++|. +|.+++... .....+.....++.+|+..+.-||.+||+|+|+++.||||+. +
T Consensus 102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999976 899998642 234566777899999999999999999999999999999974 4
Q ss_pred CcEEEEecCCccc
Q 008285 494 GVVKLADFGMAKH 506 (571)
Q Consensus 494 g~vKLiDFGlA~~ 506 (571)
..+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.5e-09 Score=106.90 Aligned_cols=143 Identities=19% Similarity=0.227 Sum_probs=105.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC---------------C--cCcHHHHHHHHHHHHHHhhcCCC-
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---------------D--PKSAECIKQLEQEIKVLGHLKHE- 416 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~---------------d--~~~~~~~k~l~~Ei~IL~~L~Hp- 416 (571)
-+.++..||-|-.+.||.|.+. .|.++|||.=+.... . .+........++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3566789999999999999976 589999996543210 0 11122234467899999999643
Q ss_pred -CeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 417 -NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 417 -NIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
.|.+.+++ +.-.+||||++|..|... .++.+....++..|+.-+..+-..||||+|+..-|||++++|.
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 67777753 566899999998777442 1234555666777777777777899999999999999999999
Q ss_pred EEEEecCCccccc
Q 008285 496 VKLADFGMAKHLT 508 (571)
Q Consensus 496 vKLiDFGlA~~l~ 508 (571)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998765443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=98.48 Aligned_cols=106 Identities=18% Similarity=0.232 Sum_probs=82.7
Q ss_pred HHHHHHHHHHhhcCCC--CeeEEeeeEEeC----CeEEEEEeecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 008285 401 KQLEQEIKVLGHLKHE--NIVQYYGSEVVD----DHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (571)
Q Consensus 401 k~l~~Ei~IL~~L~Hp--NIVkl~g~~~~~----~~lyLVmEy~~GG-sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL 473 (571)
.+..+|...+..|... .+.+.+.+.+.. ...+||+|+++|. +|.+++..... ++......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3566777777777432 244455544442 2458999999985 89999976433 77777889999999999999
Q ss_pred HhCCceecCCCCCcEEEcCCC---cEEEEecCCcccc
Q 008285 474 HSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHL 507 (571)
Q Consensus 474 Hs~GIVHRDIKPsNILLd~~g---~vKLiDFGlA~~l 507 (571)
|.+||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999998877 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=4e-08 Score=107.43 Aligned_cols=173 Identities=16% Similarity=0.223 Sum_probs=130.7
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----CCeEEEEE
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYL 435 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----~~~lyLVm 435 (571)
+.++.=--.+.|+|....+|..|++|++....+... .+...-+++++++.|.|||.+.+++.. +..+++|+
T Consensus 282 ~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvY 356 (655)
T KOG3741|consen 282 ELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVY 356 (655)
T ss_pred ccccccccceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEE
Confidence 334333456889999999999999999853322211 123345788999999999999998773 45689999
Q ss_pred eecCCC-CHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEe
Q 008285 436 EYVHPG-SINRYVRE--------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (571)
Q Consensus 436 Ey~~GG-sL~d~L~~--------------~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiD 500 (571)
+|.++. +|.++--. .+..++|+.+|.++.||..||.++|+.|+..+-|.+.+||++++.+++|..
T Consensus 357 DYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 357 DYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred ecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEec
Confidence 999763 67665421 134478999999999999999999999999999999999999988999988
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr 560 (571)
.|+...+..+. ++ .-|..+ +-|.=.||.+++.|.+|.
T Consensus 437 C~i~Dvl~~d~------~~----~le~~Q-------------q~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 437 CGIMDVLQEDP------TE----PLESQQ-------------QNDLRDLGLLLLALATGT 473 (655)
T ss_pred ccceeeecCCC------Cc----chhHHh-------------hhhHHHHHHHHHHHhhcc
Confidence 88776665443 00 012222 468889999999999984
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-08 Score=105.17 Aligned_cols=198 Identities=16% Similarity=0.178 Sum_probs=135.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeE--------EeeeEEeCC
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ--------YYGSEVVDD 429 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVk--------l~g~~~~~~ 429 (571)
++.||+|+.+.+|..-.. ...+.|++....... ..+ .++.|... .||-+-. ++|- ....
T Consensus 16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-----~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~ 83 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-----QAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGK 83 (637)
T ss_pred CccccCCccceeeecchh---hchhheeecCCCchH-----HHH---HHHHhccCCCCcchhhhhcccHHHhhCC-Cccc
Confidence 357999999999975432 224457665322211 111 12223333 3543322 2221 1123
Q ss_pred eEEEEEeecCCCC-HHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 430 HLYIYLEYVHPGS-INRYVR-----EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 430 ~lyLVmEy~~GGs-L~d~L~-----~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
.+-++|..+.|.. +.+++. ..+....+..+...++.|+.+.+.||..|.+-+|++++|+|+.+++.|.|+|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 3678888887762 344332 2344578889999999999999999999999999999999999999999999776
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGVS 570 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG-r~PF~~~egvd 570 (571)
.....++.....-+|...|.+||...-..- .+..-+...|.|.||++|++||.| +.||.++-.+.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf--~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~ 229 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSF--VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS 229 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccc--cccCCCccccchhHHHHHHHHHhcCCCCCCcccccC
Confidence 666566666667889999999997641111 122345679999999999999885 99999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.7e-07 Score=93.38 Aligned_cols=143 Identities=14% Similarity=0.135 Sum_probs=100.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecCCCCcCc-HHHHHHHHHHHHHHhhcCCC--CeeEEeeeEEe----CCeEEEE
Q 008285 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-AECIKQLEQEIKVLGHLKHE--NIVQYYGSEVV----DDHLYIY 434 (571)
Q Consensus 362 LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~-~~~~k~l~~Ei~IL~~L~Hp--NIVkl~g~~~~----~~~lyLV 434 (571)
-|+||.+.|+..... |+.+-+|.-......... ..-...+.+|+..|.+|... .+.+.+..... ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999987654 446888875411111000 11235577898888888532 24444422111 1246899
Q ss_pred EeecCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEEecCCccc
Q 008285 435 LEYVHPG-SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKH 506 (571)
Q Consensus 435 mEy~~GG-sL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~--vKLiDFGlA~~ 506 (571)
+|-+.|- +|.+++.+.. ...++.....++.+|+..|+-||..|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9988654 8999986632 24577777899999999999999999999999999999986666 99999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-08 Score=103.41 Aligned_cols=147 Identities=20% Similarity=0.348 Sum_probs=109.9
Q ss_pred HHHhhcCCCCeeEEeeeEEeC-----CeEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 008285 408 KVLGHLKHENIVQYYGSEVVD-----DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST--N 477 (571)
Q Consensus 408 ~IL~~L~HpNIVkl~g~~~~~-----~~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~--G 477 (571)
.-|-++.|.|||+++.++.+. .+..++.|||.-|+|..+|++. ...+......+|+.||++||.|||+- -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 344556799999999887654 3578899999999999999752 34588888899999999999999976 6
Q ss_pred ceecCCCCCcEEEcCCCcEEEEecCCcccccC-----CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHH
Q 008285 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552 (571)
Q Consensus 478 IVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-----~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvV 552 (571)
|+|+++..+-|++..+|-+||.--.-...-.. ........+-++|.+||.-. ....+-++|||+||+.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-------~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-------TTNTTGASDIYKFGMC 271 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-------ccccccchhhhhhhHH
Confidence 99999999999999999888753221111000 01111244778899999643 2345668999999999
Q ss_pred HHHHHcCCC
Q 008285 553 VIEMLTGKP 561 (571)
Q Consensus 553 LyELLtGr~ 561 (571)
.+||.-+..
T Consensus 272 AlemailEi 280 (458)
T KOG1266|consen 272 ALEMAILEI 280 (458)
T ss_pred HHHHHHhee
Confidence 999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.6e-07 Score=101.83 Aligned_cols=147 Identities=17% Similarity=0.171 Sum_probs=94.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-------------------------cC----cHHHHHHH------H
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------------------PK----SAECIKQL------E 404 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-------------------------~~----~~~~~k~l------~ 404 (571)
+.|+.++-|.||+|+.+. |+.||||+.+..-.. .. -.+..+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999876 999999998643211 00 11112222 2
Q ss_pred HHHHHHhhcC-----CCCeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 008285 405 QEIKVLGHLK-----HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479 (571)
Q Consensus 405 ~Ei~IL~~L~-----HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIV 479 (571)
+|+.-+.+++ .++|.--.-+++-...-.|+|||++|..+.+...-....++.+.+...+.++. +..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 3444444432 23322111123334566899999999999888543324455444443333221 2333348999
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 480 HRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 480 HRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-06 Score=83.32 Aligned_cols=139 Identities=19% Similarity=0.287 Sum_probs=83.5
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC--CeeEEeeeEE---eCCeEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEV---VDDHLYI 433 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp--NIVkl~g~~~---~~~~lyL 433 (571)
++.|+.|..+.||++.... ..+++|.... ......+..|+.+++.+... .+.+++.... .....++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 5789999999999999765 4899998642 14456778899998888533 3556665332 2345799
Q ss_pred EEeecCCCCHHH----------------HHH---Hhc---CCCCHHH------HHHH---------------HHHHHH-H
Q 008285 434 YLEYVHPGSINR----------------YVR---EHC---RDITESI------VRNF---------------TRHILN-G 469 (571)
Q Consensus 434 VmEy~~GGsL~d----------------~L~---~~~---~~Lse~~------i~~I---------------~~QIa~-g 469 (571)
+|++++|..+.. .+. ... ..+.... ...+ ...+.. .
T Consensus 73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 999999988877 111 110 0001000 0000 111222 2
Q ss_pred HHHHH-------hCCceecCCCCCcEEEc-CCCcEEEEecCCccc
Q 008285 470 LAYLH-------STNTIHRDIKGANLLVD-ASGVVKLADFGMAKH 506 (571)
Q Consensus 470 L~yLH-------s~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~ 506 (571)
+..++ ...++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33333 24699999999999999 666678999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-06 Score=86.16 Aligned_cols=140 Identities=16% Similarity=0.219 Sum_probs=89.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHH------HHHHHHHHhhcCC---CCeeEEee
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKH---ENIVQYYG 423 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~------l~~Ei~IL~~L~H---pNIVkl~g 423 (571)
..+|.+.+++-......|.+... +|+.+++|....... ........ ..+++..+..++- -.+..++-
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45788888888888777776653 578999997653211 11111111 1233333333322 22222221
Q ss_pred e-----EEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEE
Q 008285 424 S-----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (571)
Q Consensus 424 ~-----~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKL 498 (571)
+ +......+++|||++|..|.++.. +++ .+...|..+|.-||+.|++|+|+.|.|++++.++ +++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence 1 222244578999999998876532 333 2445677789999999999999999999998554 999
Q ss_pred EecCCccc
Q 008285 499 ADFGMAKH 506 (571)
Q Consensus 499 iDFGlA~~ 506 (571)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.6e-06 Score=85.27 Aligned_cols=135 Identities=14% Similarity=0.144 Sum_probs=83.5
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC--eeEEeeeEEeCCeEEEEEee
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN--IVkl~g~~~~~~~lyLVmEy 437 (571)
..||.|..+.||+.. |..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence 568999999999842 5567888765211 1234678999998886433 46778777777888999999
Q ss_pred cCCCC-HH--------------HHHHH-----hc---CCCCHHH-HHHHHH----------HHHHH-HHHHH----hCCc
Q 008285 438 VHPGS-IN--------------RYVRE-----HC---RDITESI-VRNFTR----------HILNG-LAYLH----STNT 478 (571)
Q Consensus 438 ~~GGs-L~--------------d~L~~-----~~---~~Lse~~-i~~I~~----------QIa~g-L~yLH----s~GI 478 (571)
++|.. +. ..+.+ +. ....... ...+.. .+... ..+|. ...+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 99863 21 11111 00 0111110 001100 01111 22222 2257
Q ss_pred eecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 479 IHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 479 VHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.3e-06 Score=87.07 Aligned_cols=142 Identities=13% Similarity=0.196 Sum_probs=95.6
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCC------------------c-CcHHHHHHHHHHHHHHhhcC--CCCe
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------------------P-KSAECIKQLEQEIKVLGHLK--HENI 418 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d------------------~-~~~~~~k~l~~Ei~IL~~L~--HpNI 418 (571)
..|..|-.+.||+|.. .++..+|+|+++..... . ...........|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3778899999999985 45899999998653221 0 11111223456777777763 3344
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCH-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcE
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL-~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~v 496 (571)
.+-+.+. .-.|||||+....+ .-.|.+ -.+..+++..+..++++.|.-|-. .|+||+||..-|||+. ++.+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 4444432 33799999953310 001111 123344677888999999998866 8999999999999998 8899
Q ss_pred EEEecCCcccccC
Q 008285 497 KLADFGMAKHLTG 509 (571)
Q Consensus 497 KLiDFGlA~~l~~ 509 (571)
.|||||-+.....
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999998876653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=96.84 Aligned_cols=145 Identities=20% Similarity=0.180 Sum_probs=91.2
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCC--------------------------cCcHHHHHHHHHHHHH----
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------------------------PKSAECIKQLEQEIKV---- 409 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d--------------------------~~~~~~~k~l~~Ei~I---- 409 (571)
+.||.-+.|.||+|+.+. |+.||||+-+..-.+ .-..+..+.+..|++.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999887 999999987542211 0011122222222222
Q ss_pred --H----hhcCCCC------eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008285 410 --L----GHLKHEN------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477 (571)
Q Consensus 410 --L----~~L~HpN------IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G 477 (571)
. +.+.|-+ |.++|. .......|+||||+|..+.|.-.=....++...+..-+.++..-+ |=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 2 2233444 444443 234467899999999876655321123466554444333333222 23468
Q ss_pred ceecCCCCCcEEEc----CCCcEEEEecCCcccccC
Q 008285 478 TIHRDIKGANLLVD----ASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 478 IVHRDIKPsNILLd----~~g~vKLiDFGlA~~l~~ 509 (571)
++|+|-.|.||+++ .++.+.|.|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 367899999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.4e-08 Score=109.29 Aligned_cols=187 Identities=24% Similarity=0.226 Sum_probs=139.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~~~l 431 (571)
...|....-+++|+++++|+.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.++..
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 345666678899999999999877655444 5654321 23445789999999999 77888888888899
Q ss_pred EEEEeecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GG-sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|.|+++.++ +-........-.+.+.+...+.+.-+++|++||+---+|+| ||+..+ +..++.||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999877 22111111112345556667778888999999988778999 777754 78999999999887766
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P 562 (571)
.......+++.|+|||+.+. ..+....|+|++|+-..+|--|-+|
T Consensus 385 ~~~~t~~~~~~~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cccccCCCCCCCCCchhhcc-------cccccCCCccCCCcchhhcCCCCCC
Confidence 55667889999999998873 4577789999999876777666665
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.9e-06 Score=81.43 Aligned_cols=136 Identities=17% Similarity=0.125 Sum_probs=82.9
Q ss_pred EEeecCc-eEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEEEeec
Q 008285 361 LIGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 361 ~LG~G~f-G~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
.|-.|.. ..||++... +..+.+|...... ...+.+|+++++.+. +--+.++++.....+..++|||++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 4555555 788988643 4678888754211 234667888888874 444667787776667789999999
Q ss_pred CCCCHHHHH----------------HH-hcC-----CCCH---HHHHHH---HH----------------HHHHHHHHHH
Q 008285 439 HPGSINRYV----------------RE-HCR-----DITE---SIVRNF---TR----------------HILNGLAYLH 474 (571)
Q Consensus 439 ~GGsL~d~L----------------~~-~~~-----~Lse---~~i~~I---~~----------------QIa~gL~yLH 474 (571)
+|..|.... .. +.. .+.. ...... +. .+...+..|-
T Consensus 75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 154 (244)
T cd05150 75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE 154 (244)
T ss_pred CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence 988766431 00 000 0110 000000 00 0111122221
Q ss_pred -------hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 475 -------STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 475 -------s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23589999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.8e-07 Score=105.15 Aligned_cols=95 Identities=29% Similarity=0.520 Sum_probs=73.3
Q ss_pred HHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cccc---------ccCCCCcccChHHHHHhhh
Q 008285 465 HILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYEL---------SLKGSPNWMAPEVIKAVMQ 533 (571)
Q Consensus 465 QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~~---------~~~GT~~YmAPEvl~~~~~ 533 (571)
+.+.||.|+|+. ++||+.|.|++|.++.++.+||+.|+.+....+. .+.. ...-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence 344899999965 9999999999999999999999999988765441 1111 1224556999999873
Q ss_pred cCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 534 ~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...+.++|+|||||++|.++. |+.-|...
T Consensus 184 ----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 184 ----TTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred ----ccccccccceeeeeEEEEEecCCcchhhcc
Confidence 456789999999999999994 55555544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.1e-06 Score=80.79 Aligned_cols=136 Identities=21% Similarity=0.232 Sum_probs=96.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCee-EEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV-kl~g~~~~~~~ly 432 (571)
...++.+.|++|.+|.||+|.+. |..+|+|+-+.. .....++.|+++|..+.-.++. ++|.+. ..+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~ 88 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDF 88 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEec----hhh
Confidence 35566789999999999999986 568999976521 1235688899999998765554 455442 235
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEcCCCcEEEEecCCcccccCC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK-GANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK-PsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+.|||++|-.|.+..... +- +-+..++..-.-|-..||-|+.|. |..++|-.++.+.|+||.-|+.....
T Consensus 89 i~me~i~G~~L~~~~~~~----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhhhhhcCcchhhhhhcc----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 669999998988765431 22 223445555555778899999998 66666656669999999999854443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.1e-05 Score=92.59 Aligned_cols=80 Identities=15% Similarity=0.201 Sum_probs=55.1
Q ss_pred eeEEeecCceEEEEEEECCCC--cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCe--eEEeeeEEeC---Ce
Q 008285 359 GKLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI--VQYYGSEVVD---DH 430 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG--~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNI--Vkl~g~~~~~---~~ 430 (571)
++.|+.|.+..+|+......+ ..+++|+...... ......+.+|+++|+.+. |.+| .+++.++.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 567899999999998765433 3677776432111 111245779999999995 6654 7777776554 46
Q ss_pred EEEEEeecCCCC
Q 008285 431 LYIYLEYVHPGS 442 (571)
Q Consensus 431 lyLVmEy~~GGs 442 (571)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00013 Score=72.39 Aligned_cols=130 Identities=23% Similarity=0.320 Sum_probs=91.9
Q ss_pred CCeEEeeEEeecCc-eEEEEEEECCCCcEEEEEEeec---CCCC-------cCc------HHHHHHHHHHHHHHhhcC--
Q 008285 354 SQWQKGKLIGRGTF-GSVYIGTNRETGASCAIKEVDI---IPDD-------PKS------AECIKQLEQEIKVLGHLK-- 414 (571)
Q Consensus 354 ~~y~i~k~LG~G~f-G~VYla~~k~tG~~VAIK~i~~---~~~d-------~~~------~~~~k~l~~Ei~IL~~L~-- 414 (571)
..++.++.||.|.. |.||++... |..||||++.. ...+ ... .....-+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 999999864 78999999422 1110 000 123345777888887775
Q ss_pred -CCCe--eEEeeeEEeCC------------------eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 008285 415 -HENI--VQYYGSEVVDD------------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (571)
Q Consensus 415 -HpNI--Vkl~g~~~~~~------------------~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL 473 (571)
+.++ |+++|+..... ...||.||+.... .+.... +.+|++-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHH
Confidence 4456 89999864331 2467888876443 233333 35677778889
Q ss_pred HhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 474 Hs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
|+.||+-+|+++.|.. + -||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C--CEEEecccC
Confidence 9999999999999986 2 389999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.9e-05 Score=78.63 Aligned_cols=72 Identities=10% Similarity=0.127 Sum_probs=44.5
Q ss_pred eEEeecCce-EEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC---CeeEEeeeEEeC---CeEE
Q 008285 360 KLIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE---NIVQYYGSEVVD---DHLY 432 (571)
Q Consensus 360 k~LG~G~fG-~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp---NIVkl~g~~~~~---~~ly 432 (571)
+.|+.|+.. .||+. +..+++|.... . .....+.+|+++|+.+... -+.++++..... +..|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~---~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~ 70 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA---A----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW 70 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc---c----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence 567877776 48876 23467775431 1 1234688899999887532 344555443332 2348
Q ss_pred EEEeecCCCCH
Q 008285 433 IYLEYVHPGSI 443 (571)
Q Consensus 433 LVmEy~~GGsL 443 (571)
++||+++|.+|
T Consensus 71 ~l~~~i~G~~l 81 (235)
T cd05155 71 SVYRWLEGETA 81 (235)
T ss_pred EEEEeecCCCC
Confidence 89999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00012 Score=72.50 Aligned_cols=133 Identities=22% Similarity=0.332 Sum_probs=90.7
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc-----------CcHHHHHHHHHHHHHHhhcC------CCCeeEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQEIKVLGHLK------HENIVQY 421 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~-----------~~~~~~k~l~~Ei~IL~~L~------HpNIVkl 421 (571)
...||+|+.-.||.--+ ....+||+........ ......++..+|+.-...+. +..|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999997543 4457888876433000 00011344445555544444 7889999
Q ss_pred eeeEEeCCeEEEEEeecCCC------CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--C
Q 008285 422 YGSEVVDDHLYIYLEYVHPG------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--S 493 (571)
Q Consensus 422 ~g~~~~~~~lyLVmEy~~GG------sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~ 493 (571)
+|..+++....+|+|.+.+. +|.+++.+. .+++ ++...+.+ -..||-+++|+.+||+|.||++.. +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~---f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDE---FKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHH---HHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99999999999999998532 688888653 4665 44444444 455778899999999999999952 2
Q ss_pred C--cEEEEe
Q 008285 494 G--VVKLAD 500 (571)
Q Consensus 494 g--~vKLiD 500 (571)
+ .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 2 588888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.9e-05 Score=73.25 Aligned_cols=75 Identities=13% Similarity=0.174 Sum_probs=47.5
Q ss_pred eeEEeecCceEEEEEEECC-CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeCCeEEEEEe
Q 008285 359 GKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLYIYLE 436 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~-tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~~~lyLVmE 436 (571)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+ .+++++.+. + .+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 4678888889999997543 357888997542111 1122347888888885333 445554322 2 47999
Q ss_pred ecCCCCH
Q 008285 437 YVHPGSI 443 (571)
Q Consensus 437 y~~GGsL 443 (571)
|++|..|
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00011 Score=71.79 Aligned_cols=99 Identities=21% Similarity=0.192 Sum_probs=79.3
Q ss_pred HHHHHHHhhcCC-CCeeEEeeeEEeCCeEEEEEeecCCCCHHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 008285 404 EQEIKVLGHLKH-ENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS---T 476 (571)
Q Consensus 404 ~~Ei~IL~~L~H-pNIVkl~g~~~~~~~lyLVmEy~~GGsL~d~---L~~~~~~Lse~~i~~I~~QIa~gL~yLHs---~ 476 (571)
..|.-+|+.+++ +++++++|+| ++ ++|.||+..+++... +.. ....+|..+.+|+.+++..+.+|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888875 6999999987 33 568899987766421 112 1346899999999999999999987 4
Q ss_pred CceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 477 GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+...|++++|+-+++++.+|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5889999999999999999999999976544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=3.9e-05 Score=80.92 Aligned_cols=139 Identities=14% Similarity=0.145 Sum_probs=96.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC-----------------CcCcHHHHHHHHHHHHHHhhcCC--
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-----------------DPKSAECIKQLEQEIKVLGHLKH-- 415 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-----------------d~~~~~~~k~l~~Ei~IL~~L~H-- 415 (571)
-+.+++.||-|..+.||.+.+.+ |...++|.-+.... ..|..-..-...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 46778899999999999998654 88899885432110 01111111223468888888842
Q ss_pred CCeeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 416 pNIVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
--+.+.++ .+..++|||+++|..|...-+- ..+..+...+..-|--|-++|+||+|.+--||+|++++.
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 34555554 3566899999998888664321 122345556666677788999999999999999999999
Q ss_pred EEEEecCCcc
Q 008285 496 VKLADFGMAK 505 (571)
Q Consensus 496 vKLiDFGlA~ 505 (571)
+++|||--+.
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997554
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00033 Score=72.64 Aligned_cols=142 Identities=18% Similarity=0.183 Sum_probs=83.1
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC--CeeEEeee------EEe
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVV 427 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp--NIVkl~g~------~~~ 427 (571)
...++.++.|....+|++.. . +..+++|+..... . ...+..|++++..|... .+.+++.. ...
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred ceeccccCCccccceEEEEe-C-CCcEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 44566788888889998864 3 3468888764311 1 13345667777777422 23444431 123
Q ss_pred CCeEEEEEeecCCCCHH-----------HHH---HHhcCCC--------CHH---HH-H-----------HHHHHHHHHH
Q 008285 428 DDHLYIYLEYVHPGSIN-----------RYV---REHCRDI--------TES---IV-R-----------NFTRHILNGL 470 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~-----------d~L---~~~~~~L--------se~---~i-~-----------~I~~QIa~gL 470 (571)
.+..+++|||++|..+. ..+ +.....+ ... .. . .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 46679999999985431 111 1110110 000 00 0 0111233445
Q ss_pred HHHH-------hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 471 AYLH-------STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 471 ~yLH-------s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++|. ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5554 26899999999999999888779999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00072 Score=70.46 Aligned_cols=79 Identities=14% Similarity=0.097 Sum_probs=55.1
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC---CCeeEEeeeEEe---CC
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEVV---DD 429 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H---pNIVkl~g~~~~---~~ 429 (571)
-...+.||.|..+.||...... | .+.+|..+... ....+..|.+.|+.|.. -.+.++++.+.. .+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 3445689999999999986432 3 46677644210 11457789988888853 357788876654 36
Q ss_pred eEEEEEeecCCCCH
Q 008285 430 HLYIYLEYVHPGSI 443 (571)
Q Consensus 430 ~lyLVmEy~~GGsL 443 (571)
..+||||+++|+.+
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 68999999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00034 Score=71.66 Aligned_cols=140 Identities=16% Similarity=0.146 Sum_probs=84.0
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC--CeeEEeee------EEeC
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVVD 428 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp--NIVkl~g~------~~~~ 428 (571)
...+.|..|....+|++... +..+++|+... . . ...+..|++++..+.+. .+.+++.. ....
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEK--V---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred hheecccCccccceEEEEeC--CCcEEEEEcCC--C---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 33567888888899998643 45788897652 1 1 23466677777777432 24444431 2334
Q ss_pred CeEEEEEeecCCCCHHH----H-------H---HHhcCCC----------CHHHH----------HHHHHHHHHHHHHHH
Q 008285 429 DHLYIYLEYVHPGSINR----Y-------V---REHCRDI----------TESIV----------RNFTRHILNGLAYLH 474 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d----~-------L---~~~~~~L----------se~~i----------~~I~~QIa~gL~yLH 474 (571)
+..++||+|++|..+.. . + +.....+ .+... ......+...+.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 56789999999876421 1 1 1110000 10000 001112233444444
Q ss_pred h-------CCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 475 S-------TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 475 s-------~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+ .+++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3 4799999999999999888789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00054 Score=73.55 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=97.7
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCC---C------------------CcCcHHHHHHHHHHHHHHhhcC
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---D------------------DPKSAECIKQLEQEIKVLGHLK 414 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~---~------------------d~~~~~~~k~l~~Ei~IL~~L~ 414 (571)
-.+..+|..|-.+.||.+. ..+|..+|||+++... . ........-..+.|+.-|.+|.
T Consensus 146 ~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 3455688999999999998 5568999999885321 0 0111222333456788888876
Q ss_pred CCCeeEEeeeEEeCCeEEEEEeecCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcC
Q 008285 415 HENIVQYYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDA 492 (571)
Q Consensus 415 HpNIVkl~g~~~~~~~lyLVmEy~~GGs-L~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL-Hs~GIVHRDIKPsNILLd~ 492 (571)
...|.----. .. ....|||+|+.... -.-.|+ ...++...+..+..|++.-|.-| |..++||.||.--|+|+ .
T Consensus 225 ~aGIP~PePI-lL-k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 225 NAGIPCPEPI-LL-KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-H 299 (520)
T ss_pred hcCCCCCCce-ee-ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-E
Confidence 5443321110 11 12368999995221 111122 24578888889999999988888 45699999999999999 6
Q ss_pred CCcEEEEecCCcccc
Q 008285 493 SGVVKLADFGMAKHL 507 (571)
Q Consensus 493 ~g~vKLiDFGlA~~l 507 (571)
+|.+.|||.+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 678999999876543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.001 Score=69.00 Aligned_cols=138 Identities=15% Similarity=0.143 Sum_probs=76.0
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEee------eEEeCCe
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYG------SEVVDDH 430 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g------~~~~~~~ 430 (571)
.+.|+.|....+|+.... +..+++|++.. . . .+.+..|+.+++.|.. -.+.+.+. +....+.
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~-~----~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER-L----T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc-C----C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 456777888899998753 33688897651 1 1 1233345555555531 11333332 1234567
Q ss_pred EEEEEeecCCCCHH-----------HHHH---HhcCC----------CCH-HHHH------------HHHHH-HHHHHHH
Q 008285 431 LYIYLEYVHPGSIN-----------RYVR---EHCRD----------ITE-SIVR------------NFTRH-ILNGLAY 472 (571)
Q Consensus 431 lyLVmEy~~GGsL~-----------d~L~---~~~~~----------Lse-~~i~------------~I~~Q-Ia~gL~y 472 (571)
.+++|||++|..+. ..|. ..... +.+ .... ..+.+ +...+..
T Consensus 97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (319)
T PRK05231 97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF 176 (319)
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence 89999999987431 1111 11000 101 0100 01111 1112222
Q ss_pred HH-------hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 473 LH-------STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 473 LH-------s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+. ..|++|+|+.+.|||++.+..+-|+||+.+..
T Consensus 177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred hhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 22 24899999999999998776678999998864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00022 Score=71.87 Aligned_cols=135 Identities=16% Similarity=0.211 Sum_probs=75.9
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCCeEEEEEeecC
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEYVH 439 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~~lyLVmEy~~ 439 (571)
.+..|-...+|+.. .+|..+++|....... ...-...+|.++++.+...++ .+++... . -++||||++
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK-----ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc-----cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence 35567778899886 3467788886432110 100124678888888864333 3444332 2 368999999
Q ss_pred CCCHHH-----------H---HHH-h-----cCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceec
Q 008285 440 PGSINR-----------Y---VRE-H-----CRDITES-IVRNFTRHI---------LNGLAYLHS--------TNTIHR 481 (571)
Q Consensus 440 GGsL~d-----------~---L~~-~-----~~~Lse~-~i~~I~~QI---------a~gL~yLHs--------~GIVHR 481 (571)
|..+.. + +.+ + ...+... .+..+..++ ...+..+-. ..++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 875532 1 111 1 0111211 112221111 111222221 258999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 482 DIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 482 DIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
|+.+.|||+++++ +.|+||+.+..-
T Consensus 152 Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 152 DVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCCcCcEEEeCCC-CEEEeccccCcC
Confidence 9999999998877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00049 Score=82.04 Aligned_cols=159 Identities=24% Similarity=0.320 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE----EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 008285 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (571)
Q Consensus 398 ~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l----yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL 473 (571)
..+...+.|++.+..+.|+|++.++.+....-.. .+..|+|.+.++...+... ..++...++.+..+++.||+|+
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHH
Confidence 3445566788888888999999999876654332 3456888888999888765 5688899999999999999999
Q ss_pred HhCCceecCCCCC---cEEEcCCCcEEEE--ecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHH
Q 008285 474 HSTNTIHRDIKGA---NLLVDASGVVKLA--DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548 (571)
Q Consensus 474 Hs~GIVHRDIKPs---NILLd~~g~vKLi--DFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWS 548 (571)
|+..+.|.-+... +..++.++.+.+. ||+..+.+..........-...|.++|..... ........|+|.
T Consensus 303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWC 377 (1351)
T ss_pred HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-----cchhhhhhHHHH
Confidence 9996666655555 4445667777777 99998887776666556666678888876531 223344579999
Q ss_pred HHHHHHHHHcCCCC
Q 008285 549 LGCTVIEMLTGKPP 562 (571)
Q Consensus 549 LGvVLyELLtGr~P 562 (571)
+|..+..+..|..+
T Consensus 378 lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHHhhhhhcCcc
Confidence 99999998887643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00053 Score=70.65 Aligned_cols=76 Identities=17% Similarity=0.202 Sum_probs=47.2
Q ss_pred eeEEeecCceEEEEEEECC------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCCeE
Q 008285 359 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHL 431 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~~l 431 (571)
++.|..|-...||++.... .++.+++|+..... .......+|.+++..+...++ .++++.+. +
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~--- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFP-N--- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeC-C---
Confidence 3556677777899887543 25789999864321 112345678888888753333 35554432 2
Q ss_pred EEEEeecCCCCHH
Q 008285 432 YIYLEYVHPGSIN 444 (571)
Q Consensus 432 yLVmEy~~GGsL~ 444 (571)
.+||||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3689999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0019 Score=70.42 Aligned_cols=82 Identities=16% Similarity=0.159 Sum_probs=54.2
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCC-CcCc-HHHHHHHHHHHHHHhhcC---CCCeeEEeeeEEeCCeEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS-AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-d~~~-~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~~~~~lyL 433 (571)
.+.||.|.+..||++.....++.++||.-..... .... ....++...|.+.|+.+. -..+.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3679999999999999864335899997431110 0000 123456667888887763 2457778765 4466789
Q ss_pred EEeecCCCC
Q 008285 434 YLEYVHPGS 442 (571)
Q Consensus 434 VmEy~~GGs 442 (571)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00013 Score=88.36 Aligned_cols=158 Identities=16% Similarity=0.058 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeEEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH
Q 008285 400 IKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH 474 (571)
Q Consensus 400 ~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLH 474 (571)
.+.+..|.+.++...|.++...+.-... ..+.|+.++||.+|.+++.|-+. ...+.+.-+.....+.+....-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3444556666677789888877654332 34568999999999999999653 234555555555555566666666
Q ss_pred hC-----CceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHH
Q 008285 475 ST-----NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548 (571)
Q Consensus 475 s~-----GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWS 548 (571)
.. -.+|++||+-|.+|..+-.+|+.++|+.+...... ......+++.|+.+++.+.. .++.++|+|.
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-------k~t~rsdilr 1425 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-------KFTKRSDILR 1425 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-------hhhhHHHHHH
Confidence 43 36899999999999999999999999998433322 22346688899999988754 3566799999
Q ss_pred HHHHHHHHHcCCCCCC
Q 008285 549 LGCTVIEMLTGKPPWS 564 (571)
Q Consensus 549 LGvVLyELLtGr~PF~ 564 (571)
.|+.+|++.-|..+|-
T Consensus 1426 ~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHhcccHHHH
Confidence 9999999888877763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0033 Score=64.95 Aligned_cols=31 Identities=26% Similarity=0.355 Sum_probs=26.0
Q ss_pred CceecCCCCCcEEEcCCCc-EEEEecCCcccc
Q 008285 477 NTIHRDIKGANLLVDASGV-VKLADFGMAKHL 507 (571)
Q Consensus 477 GIVHRDIKPsNILLd~~g~-vKLiDFGlA~~l 507 (571)
.++|+|+++.|||++.++. +-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999987454 569999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.022 Score=58.60 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=25.7
Q ss_pred CCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 476 ~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.008 Score=63.73 Aligned_cols=147 Identities=13% Similarity=0.157 Sum_probs=83.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeeeEEeCC--e
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDD--H 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~~~~~~--~ 430 (571)
...+++.+-.|..-.+|..... ++.++++ ... ............+|..+|+.+.- --+...++.|.++. .
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~---~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP---RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCC---ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 3444445544444445555443 7778887 221 12233445667788888888743 23445566665555 6
Q ss_pred EEEEEeecCCCCH---------H-HHHH--------Hh-----------c--CCCCHHHHHHHHH--------------H
Q 008285 431 LYIYLEYVHPGSI---------N-RYVR--------EH-----------C--RDITESIVRNFTR--------------H 465 (571)
Q Consensus 431 lyLVmEy~~GGsL---------~-d~L~--------~~-----------~--~~Lse~~i~~I~~--------------Q 465 (571)
.|.||+|++|..+ . .++. .. + ......++..+.. .
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 6999999998321 1 1211 10 0 0001111111111 1
Q ss_pred HHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 466 ILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 466 Ia~gL~yLHs~--------GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+..-..+|+.+ .++|+|+++.||+|+.++.+=|+||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22334555533 5799999999999999888999999998654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0092 Score=64.33 Aligned_cols=85 Identities=9% Similarity=0.046 Sum_probs=51.5
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCC--CcCcHHHHHHHHHHHHHHhhcC--CC-CeeEEeeeEEeCCeEEEEE
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~--d~~~~~~~k~l~~Ei~IL~~L~--Hp-NIVkl~g~~~~~~~lyLVm 435 (571)
.||.|....||++.....++.++||.-...-. ...-.-...+...|.+.|+... -| .+.++|. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999999754346899996421110 0001122345556777776653 23 4666664 3556667999
Q ss_pred eecCCC-CHHHHH
Q 008285 436 EYVHPG-SINRYV 447 (571)
Q Consensus 436 Ey~~GG-sL~d~L 447 (571)
|++... .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999544 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.014 Score=62.18 Aligned_cols=142 Identities=11% Similarity=0.133 Sum_probs=79.6
Q ss_pred eEEeeEEeecCceEEEEEEECC----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCee-EEeeeEEeCCe
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDH 430 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV-kl~g~~~~~~~ 430 (571)
...++.|-.|-.-.+|++.... .++.|++|+..... ...+. ..+|..+++.+..-++. ++++.+ ..+
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~~g- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFFD-RDDEIRTFECMSRHGQGPRLLGRF-PNG- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceeec-hHHHHHHHHHHHHcCCCCceEEEE-CCc-
Confidence 3334456558888999987532 24678888764221 11122 35788888888544433 455544 222
Q ss_pred EEEEEeecCCCCHHHH----------H-------HHhc---C--CCCHHHHHHHHHHH-----------------HHHHH
Q 008285 431 LYIYLEYVHPGSINRY----------V-------REHC---R--DITESIVRNFTRHI-----------------LNGLA 471 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~----------L-------~~~~---~--~Lse~~i~~I~~QI-----------------a~gL~ 471 (571)
.|+||++|..|... + +... . ......+..++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 57899987665321 1 1100 0 01112222222111 11111
Q ss_pred HH----H----hCCceecCCCCCcEEEcC-CCcEEEEecCCcccc
Q 008285 472 YL----H----STNTIHRDIKGANLLVDA-SGVVKLADFGMAKHL 507 (571)
Q Consensus 472 yL----H----s~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l 507 (571)
.| . ...++|+|+++.|||+++ ++.+.|+||..+...
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22 1 236899999999999976 478999999988643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.054 Score=56.38 Aligned_cols=30 Identities=17% Similarity=0.201 Sum_probs=27.9
Q ss_pred CceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 477 GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+++|+|+.+.|||+++++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 899999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.023 Score=60.06 Aligned_cols=139 Identities=15% Similarity=0.192 Sum_probs=77.0
Q ss_pred eeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCee-EEeeeEEeCCeEEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHLYIY 434 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV-kl~g~~~~~~~lyLV 434 (571)
++.|..|=...+|++..... +..|++|+...... ..-.-.+|..+++.+..-++. ++++.+ ..+ +|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~------~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i 88 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD------YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MI 88 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC------eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Ee
Confidence 34555577788998875432 33788887642211 122235788888888654443 455444 222 58
Q ss_pred EeecCCCCHHH-------HH-------HH-hcCC------C-CHHHHHHHHHHH----------------------HHHH
Q 008285 435 LEYVHPGSINR-------YV-------RE-HCRD------I-TESIVRNFTRHI----------------------LNGL 470 (571)
Q Consensus 435 mEy~~GGsL~d-------~L-------~~-~~~~------L-se~~i~~I~~QI----------------------a~gL 470 (571)
.+|++|..|.. .+ ++ +... . -+..+..++.++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 89998765421 11 11 1111 1 122222222221 1112
Q ss_pred HHHH----hC----CceecCCCCCcEEEcC-CCcEEEEecCCcccc
Q 008285 471 AYLH----ST----NTIHRDIKGANLLVDA-SGVVKLADFGMAKHL 507 (571)
Q Consensus 471 ~yLH----s~----GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l 507 (571)
..+. .. -+.|.|+.+.|||+++ ++.++|+||+.|...
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 2221 11 2689999999999974 578999999988643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.047 Score=59.90 Aligned_cols=78 Identities=21% Similarity=0.221 Sum_probs=49.6
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC---CcCcHHHHHHHHHHHHHHhhcC---CCCeeEEeeeEEeCCeE
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHL 431 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~---d~~~~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~~~~~l 431 (571)
..+.||-|....||+..+. +..++||.-..... ..+. ....+...|++.|+.+. -..+.+++.++. +..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wp-l~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWP-MTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCcccc-CCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 3568899999999998863 45688987541111 1000 11333444566666553 247888887654 556
Q ss_pred EEEEeecCC
Q 008285 432 YIYLEYVHP 440 (571)
Q Consensus 432 yLVmEy~~G 440 (571)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999987
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.028 Score=58.77 Aligned_cols=76 Identities=18% Similarity=0.185 Sum_probs=46.8
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC---CCCeeEEeeeEEeCCeEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~~~~~ly 432 (571)
-+..+.|+-|.-..+|... .+++.+.+|+-... ....+..|.+-|+.|. --.+.+++++...++.-|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 4456778989999999987 56788999976521 1234667777777773 455778888888887889
Q ss_pred EEEeecCCC
Q 008285 433 IYLEYVHPG 441 (571)
Q Consensus 433 LVmEy~~GG 441 (571)
|||||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.029 Score=61.27 Aligned_cols=87 Identities=14% Similarity=0.081 Sum_probs=54.5
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCC-CcCcHHHHHHHHHHHHHHhhcC--CC-CeeEEeeeEEeCCeEEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-d~~~~~~~k~l~~Ei~IL~~L~--Hp-NIVkl~g~~~~~~~lyLV 434 (571)
.+.||-|.-.-||++.+...++.|+||.-...-. ...-.-..++...|.++|+.+. -| .+.++|. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5689999999999999854456799986421111 0011123456667777787663 23 4666774 355666789
Q ss_pred EeecCCC-CHHHHH
Q 008285 435 LEYVHPG-SINRYV 447 (571)
Q Consensus 435 mEy~~GG-sL~d~L 447 (571)
||++... .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998643 344443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.16 Score=61.84 Aligned_cols=31 Identities=45% Similarity=0.670 Sum_probs=26.2
Q ss_pred CCceecCCCCCcEEEcCCC--cEE-EEecCCccc
Q 008285 476 TNTIHRDIKGANLLVDASG--VVK-LADFGMAKH 506 (571)
Q Consensus 476 ~GIVHRDIKPsNILLd~~g--~vK-LiDFGlA~~ 506 (571)
+++||+|+++.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5899999999999998775 455 999998764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.038 Score=58.88 Aligned_cols=136 Identities=18% Similarity=0.208 Sum_probs=80.4
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC------eeEEeee--EEeCC--e
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN------IVQYYGS--EVVDD--H 430 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN------IVkl~g~--~~~~~--~ 430 (571)
.|.+ ....||++...+ |. +++|+.... ....++..|+..|++|.-.+ |..+-|. ....+ .
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r 102 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR 102 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC-------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence 4555 667889887554 33 488887642 11245667888888874222 2222221 12234 7
Q ss_pred EEEEEeecCCCCHHH------------HH---HHhcCC-----------CCHH----H---------HHHHHHHHHHHHH
Q 008285 431 LYIYLEYVHPGSINR------------YV---REHCRD-----------ITES----I---------VRNFTRHILNGLA 471 (571)
Q Consensus 431 lyLVmEy~~GGsL~d------------~L---~~~~~~-----------Lse~----~---------i~~I~~QIa~gL~ 471 (571)
.+-+++|++|..+.. ++ +..... +.+. . -.....++...+.
T Consensus 103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~ 182 (331)
T COG2334 103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD 182 (331)
T ss_pred eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence 788999999887762 11 111111 1111 0 0112334445555
Q ss_pred HHHhC--------C--ceecCCCCCcEEEcCCCc-EEEEecCCccc
Q 008285 472 YLHST--------N--TIHRDIKGANLLVDASGV-VKLADFGMAKH 506 (571)
Q Consensus 472 yLHs~--------G--IVHRDIKPsNILLd~~g~-vKLiDFGlA~~ 506 (571)
.+.+. + +||+|+.+.|||++.+.. +.++||+-+..
T Consensus 183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 55532 4 999999999999998874 99999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.032 Score=60.30 Aligned_cols=71 Identities=23% Similarity=0.272 Sum_probs=54.7
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..|++|++- |+.|.. ......+++..|+++.+..|+-+..+ ..=|||+...||||+ +|+|.|+||-+++.-
T Consensus 300 y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 300 YLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred EEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 345666653 455522 23456778889999998888888755 788999999999999 999999999999843
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.051 Score=55.75 Aligned_cols=31 Identities=32% Similarity=0.338 Sum_probs=25.7
Q ss_pred CceecCCCCCcEEEcCC--C---cEEEEecCCcccc
Q 008285 477 NTIHRDIKGANLLVDAS--G---VVKLADFGMAKHL 507 (571)
Q Consensus 477 GIVHRDIKPsNILLd~~--g---~vKLiDFGlA~~l 507 (571)
=++|||++..|||+..+ | .++++||.+++.-
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g 251 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG 251 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccCC
Confidence 38999999999999654 3 6999999988653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.18 Score=54.81 Aligned_cols=78 Identities=15% Similarity=0.155 Sum_probs=45.2
Q ss_pred EEeeEEeecCceEEEEEEECCC-CcE-----EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCC
Q 008285 357 QKGKLIGRGTFGSVYIGTNRET-GAS-----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDD 429 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~t-G~~-----VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~ 429 (571)
..++.|..|-...+|++..... +.. |.++... ...+..-.-.+|+++++.+...++ .++++.+.
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g------~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--- 123 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS------TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--- 123 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc------CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC---
Confidence 3445666688899999975432 222 3333211 111112223578889998865444 45555543
Q ss_pred eEEEEEeecCCCCHH
Q 008285 430 HLYIYLEYVHPGSIN 444 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~ 444 (571)
-++|.||++|..|.
T Consensus 124 -~g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 -DFTIQEWVEGNTMG 137 (383)
T ss_pred -CEEEEEEeccccCC
Confidence 26899999987653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.019 Score=56.16 Aligned_cols=30 Identities=37% Similarity=0.537 Sum_probs=21.5
Q ss_pred CceecCCCCCcEEE-cCCCcEEEEecCCccc
Q 008285 477 NTIHRDIKGANLLV-DASGVVKLADFGMAKH 506 (571)
Q Consensus 477 GIVHRDIKPsNILL-d~~g~vKLiDFGlA~~ 506 (571)
.+.|.||.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57899999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.31 Score=51.47 Aligned_cols=29 Identities=21% Similarity=0.229 Sum_probs=24.7
Q ss_pred CCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 476 ~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+++|+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4799999999999995 4 578999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.29 Score=54.18 Aligned_cols=76 Identities=11% Similarity=0.004 Sum_probs=45.3
Q ss_pred EeeEEeecCceEEEEEEECCC--------CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCee-EEeeeEEeC
Q 008285 358 KGKLIGRGTFGSVYIGTNRET--------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVD 428 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~t--------G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV-kl~g~~~~~ 428 (571)
.++.|..|-.-.+|++..... ++.|.+|+.-... +.+-....|..+++.+...+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t------e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV------DELYNPISEFEVYKTMSKYRIAPQLLNTFS-- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc------cceeCHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence 567777788888998875422 4678888653211 1111334677777777544443 4454432
Q ss_pred CeEEEEEeecCCCCH
Q 008285 429 DHLYIYLEYVHPGSI 443 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL 443 (571)
-+.|.||++|..|
T Consensus 181 --gg~I~efi~g~~l 193 (442)
T PTZ00296 181 --GGRIEEWLYGDPL 193 (442)
T ss_pred --CCEEEEeeCCccC
Confidence 2457899987643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.18 Score=51.40 Aligned_cols=115 Identities=20% Similarity=0.229 Sum_probs=71.1
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEeecCCCCHH
Q 008285 365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN 444 (571)
Q Consensus 365 G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy~~GGsL~ 444 (571)
|+-++.-.++.+- |- ..+|.+...+-. -....+..+.+++.+++ .|+++... ....+-+|+|+|-.-..
T Consensus 73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~----~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCC----INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI- 141 (308)
T ss_pred CCceEEEEecccc-ch-hhhhhccCCCcc----cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-
Confidence 4555555554332 33 344544332211 11244567888888774 58888843 45567899999952211
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 445 RYVREHCRDITESIVRNFTRHILNGLAYLHS--TNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 445 d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs--~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
+. ..++.-=++.|.-.|+ .+.+|+|..|+|||-|..|.+||.|=+.
T Consensus 142 ---------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1111111456667783 4899999999999999999999999664
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.16 E-value=0.22 Score=54.79 Aligned_cols=59 Identities=24% Similarity=0.356 Sum_probs=42.7
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVD 491 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL-Hs~GIVHRDIKPsNILLd 491 (571)
..++-+|+.|.++..++... ..+|+....++.-.++||.-+ --.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 46777899999999999764 345555555555555554443 345899999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 571 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-35 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-35 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-35 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-32 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-32 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-32 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-32 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-32 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-32 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-32 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-32 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-32 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-32 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-31 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-31 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-31 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-31 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-30 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-30 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-30 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-29 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-28 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-28 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-27 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-25 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-25 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-25 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-24 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-24 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-24 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-24 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-23 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-23 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-23 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-23 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-23 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-22 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-22 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-22 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-22 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-22 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-22 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-22 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-22 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-22 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-22 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-22 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-22 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-21 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-21 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-21 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-20 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-110
Identities = 83/227 (36%), Positives = 124/227 (54%), Gaps = 14/227 (6%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
+ + + ++G+GT+G VY G + AIKE+ + + + L
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLH 67
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNF 462
+EI + HLKH+NIVQY GS + + I++E V GS++ +R + E + +
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYELSLKGSP 520
T+ IL GL YLH +HRDIKG N+L++ SGV+K++DFG +K L G+ + G+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+MAPE+I G A DIWSLGCT+IEM TGKPP+ E
Sbjct: 188 QYMAPEIID--KGPRG---YGKAADIWSLGCTIIEMATGKPPFYELG 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 2e-99
Identities = 66/275 (24%), Positives = 111/275 (40%), Gaps = 28/275 (10%)
Query: 303 PQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLI 362
+ L ++ + +A L P +T + P + +
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREEVHWMTHQPRV 66
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRG+FG V+ +++TG CA+K+V + +E+ L IV Y
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPLY 116
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
G+ + I++E + GS+ + ++ + E + L GL YLH+ +H D
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 483 IKGANLLVDASGV-VKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKD 535
+K N+L+ + G L DFG A L + G+ MAPEV+ K
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKP 232
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ K VDIWS C ++ ML G PW+++
Sbjct: 233 CDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGP 263
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 1e-94
Identities = 63/249 (25%), Positives = 118/249 (47%), Gaps = 23/249 (9%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+ + + S + IGRG+F +VY G + ET A E+
Sbjct: 4 RNQQQDDIEELETKAVGM---SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHPGSIN 444
D + ++ ++E ++L L+H NIV++Y S + + E + G++
Sbjct: 61 ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNT--IHRDIKGANLLVDA-SGVVKLADF 501
Y++ + ++R++ R IL GL +LH+ IHRD+K N+ + +G VK+ D
Sbjct: 118 TYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G+A S+ ++ G+P +MAPE+ + K +VD+++ G ++EM T +
Sbjct: 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEY 227
Query: 562 PWSEFEGVS 570
P+SE + +
Sbjct: 228 PYSECQNAA 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 4e-79
Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 35/245 (14%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S +++ + + IG G FGSV+ R G AIK + +E+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREV 61
Query: 408 KVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 463
L +H ++V+Y+ + DDH+ I EY + GS+ + E+ R E+ +++
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMA 504
+ GL Y+HS + +H DIK +N+ + + + K+ D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
++ +G ++A EV++ PK DI++L TV+ +P
Sbjct: 182 TRISSPQ---VEEGDSRFLANEVLQ--ENYTHLPK----ADIFALALTVVCAAGAEPLPR 232
Query: 565 EFEGV 569
+
Sbjct: 233 NGDQW 237
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 2e-78
Identities = 73/239 (30%), Positives = 112/239 (46%), Gaps = 13/239 (5%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
V + + ++ K IGRG F VY G A+K+V
Sbjct: 7 GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
I D A+ +EI +L L H N+++YY S + D+ L I LE G ++R ++
Sbjct: 67 I--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 449 EHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505
+ I E V + + + L ++HS +HRDIK AN+ + A+GVVKL D G+ +
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 506 HLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + SL G+P +M+PE I + N K DIWSLGC + EM + P+
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFK----SDIWSLGCLLYEMAALQSPF 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-77
Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 11/260 (4%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
L + N L P +S + + P S + +Q+ +G G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 370 VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429
V+ ++E G A+K PK + ++L + +H V+ +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 489
LY+ E S+ ++ + E+ V + R L LA+LHS +H D+K AN+
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 490 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549
+ G KL DFG+ L +G P +MAPE++ Q D++SL
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTA----ADVFSL 241
Query: 550 GCTVIEMLTGKPPWSEFEGV 569
G T++E+ EG
Sbjct: 242 GLTILEVACNMELPHGGEGW 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-76
Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 16/226 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K + K IG G V+ N E AIK V++ D ++ + EI L
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLN 62
Query: 412 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
L+ + I++ Y E+ D ++Y+ +E + +N ++++ + I +++ +++L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEA 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPE 526
+ +H +H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 527 VIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
IK + K++ D+WSLGC + M GK P+ +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-76
Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 18/280 (6%)
Query: 298 RHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQ 357
H A + P S K +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFE--RQHMDSPDLGTDDDDKASSSANECISVKGRIYS 59
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-- 415
K IG G V+ N E AIK V++ D ++ + EI L L+
Sbjct: 60 ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHS 115
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ I++ Y E+ D ++Y+ +E + +N ++++ I +++ +++L + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQ 173
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIK--- 529
+H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE IK
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 530 -AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ K++ D+WSLGC + M GK P+ +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 7e-76
Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 16/234 (6%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
+ S S K + K IG G V+ N E AIK V++ + + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSY 73
Query: 404 EQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
EI L L+ + I++ Y E+ D ++Y+ +E + +N ++++ + I ++
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS 131
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKG 518
+ +++L + +H +H D+K AN L+ G++KL DFG+A + T + S G
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 519 SPNWMAPEVIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ N+M PE IK + K++ D+WSLGC + M GK P+ +
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-70
Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 19/267 (7%)
Query: 310 LESNNHLNAHPLPLP-------PGALSPPKSSVTSAVM--PHIMEKPSASPKKSQWQKGK 360
+ +H + H +P GA+ P + + + P + E + + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
IG G+FG+VY + AIK++ E + + +E++ L L+H N +Q
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y G + + ++ +EY GS + + H + + E + T L GLAYLHS N IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+ + + K
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGK- 233
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFE 567
VD+WSLG T IE+ KPP
Sbjct: 234 ---VDVWSLGITCIELAERKPPLFNMN 257
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 9e-70
Identities = 75/216 (34%), Positives = 112/216 (51%), Gaps = 12/216 (5%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W+ +G G FG VY N+ETGA A K ++ ++ ++ EI++L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILAT 72
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H IV+ G+ D L+I +E+ G+++ + E R +TE ++ R +L L +
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 531
LHS IHRD+K N+L+ G ++LADFG++ L S G+P WMAPEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 532 MQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
KD + K DIWSLG T+IEM +PP E
Sbjct: 193 TMKDTPYDYK----ADIWSLGITLIEMAQIEPPHHE 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 6e-68
Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
M S + ++ ++IG G V AIK +++
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---- 56
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
+ +L +EI+ + H NIV YY S VV D L++ ++ + GS+ ++
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 454 -ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+ ES + R +L GL YLH IHRD+K N+L+ G V++ADFG++ L
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 513 ELSLK------GSPNWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
K G+P WMAPEV++ Q G + K DIWS G T IE+ TG P+ +
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVME---QVRGYDFK----ADIWSFGITAIELATGAAPYHK 229
Query: 566 FE 567
+
Sbjct: 230 YP 231
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-67
Identities = 89/225 (39%), Positives = 123/225 (54%), Gaps = 15/225 (6%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
M+ A P++ + K + IG+G+FG V+ G + T AIK +D+ + + I+ +
Sbjct: 13 MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDI 67
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
+QEI VL + +YYGS + D L+I +EY+ GS + + E+ +
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATIL 125
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNW 522
R IL GL YLHS IHRDIK AN+L+ G VKLADFG+A LT + G+P W
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
MAPEVIK Q + K DIWSLG T IE+ G+PP SE
Sbjct: 186 MAPEVIK---QSAYDSK----ADIWSLGITAIELARGEPPHSELH 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-67
Identities = 78/211 (36%), Positives = 121/211 (57%), Gaps = 15/211 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G++GSVY ++ETG AIK+V + D ++++ +EI ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++V+YYGS + L+I +EY GS++ +R + +TE + + L GL YLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQK 534
IHRDIK N+L++ G KLADFG+A LT ++ ++ G+P WMAPEVI+ +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EI 200
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
N DIWSLG T IEM GKPP+++
Sbjct: 201 GYNCV----ADIWSLGITAIEMAEGKPPYAD 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 6e-66
Identities = 79/214 (36%), Positives = 114/214 (53%), Gaps = 15/214 (7%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K ++ + + IG+G G+VY + TG AI+++++ K + EI V+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRE 73
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
K+ NIV Y S +V D L++ +EY+ GS+ V E C + E + R L L +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 531
LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-- 189
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+K PK VDIWSLG IEM+ G+PP+
Sbjct: 190 -RKAYGPK----VDIWSLGIMAIEMIEGEPPYLN 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-65
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 15/219 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ + + IG G+FG + + E G IKE++I S++ ++ +E+ VL ++K
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANMK 81
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
H NIVQY S + LYI ++Y G + + + E + ++ I L ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVM 532
H +HRDIK N+ + G V+L DFG+A+ L + + G+P +++PE+ +
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--- 198
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
K N K DIW+LGC + E+ T K FE S
Sbjct: 199 NKPYNNK----SDIWALGCVLYELCTLKHA---FEAGSM 230
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-64
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 16/255 (6%)
Query: 313 NNHLNAHPLPLPPGALSPPKSSVTSA-VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
++H ++ + L L VT + + IG G+ G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431
+ + +G A+K +D+ + + + L E+ ++ +H N+V+ Y S +V + L
Sbjct: 63 LAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
++ +E++ G++ V + + E + +L LAYLH+ IHRDIK ++L+
Sbjct: 118 WVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 492 ASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 550
G VKL+DFG ++ + SL G+P WMAPEVI + + VDIWSLG
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATE----VDIWSLG 228
Query: 551 CTVIEMLTGKPPWSE 565
VIEM+ G+PP+
Sbjct: 229 IMVIEMVDGEPPYFS 243
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-64
Identities = 78/224 (34%), Positives = 117/224 (52%), Gaps = 21/224 (9%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
++ +L+G GT+G VY G + +TG AIK +D+ D+ ++++QEI +L
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKK 76
Query: 413 L-KHENIVQYYGS------EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTR 464
H NI YYG+ +DD L++ +E+ GS+ ++ + E + R
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM 523
IL GL++LH IHRDIKG N+L+ + VKL DFG++ L + + G+P WM
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 524 APEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
APEVI D + K D+WSLG T IEM G PP +
Sbjct: 197 APEVIACDENPDATYDFK----SDLWSLGITAIEMAEGAPPLCD 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 214 bits (545), Expect = 4e-64
Identities = 50/232 (21%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 348 SASPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
S P+ ++ +IG+G +V + + TG ++ +++ + S E + L+
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQG 75
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
E+ V H NIV Y + + D+ L++ ++ GS + H D + E + +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSL 516
+L L Y+H +HR +K +++L+ G V L+ + +
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 517 KGSPNWMAPEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
W++PEV++ Q + K DI+S+G T E+ G P+ +
Sbjct: 196 VKVLPWLSPEVLQ---QNLQGYDAK----SDIYSVGITACELANGHVPFKDM 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-60
Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W ++G+G +V+ G +++TG AIK + ++ + +E +VL
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
L H+NIV+ + + ++ H + +E+ GS+ + E + ES R +
Sbjct: 64 LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 467 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
+ G+ +L +HR+IK N++ D V KL DFG A+ L +SL G+ +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 523 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ P++ + AV++KD K VD+WS+G T TG P+ FEG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-60
Identities = 70/226 (30%), Positives = 120/226 (53%), Gaps = 21/226 (9%)
Query: 348 SASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLE 404
+ + ++ G L+G+G+F VY + TG AIK +I A +++++
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITESIVRNF 462
E+K+ LKH +I++ Y +D Y+Y LE H G +NRY++ + +E+ R+F
Sbjct: 60 NEVKIHCQLKHPSILELY--NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPN 521
I+ G+ YLHS +HRD+ +NLL+ + +K+ADFG+A L + L G+PN
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+++PE+ + + D+WSLGC +L G+PP F+
Sbjct: 178 YISPEIA---TRSAHGLE----SDVWSLGCMFYTLLIGRPP---FD 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-60
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
MP E ++ IG G++G + G KE+D +
Sbjct: 1 MPSRAED---------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAE 48
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---I 454
+ L E+ +L LKH NIV+YY + + LYI +EY G + + + ++ +
Sbjct: 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 455 TESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT- 508
E V + L H + +HRD+K AN+ +D VKL DFG+A+ L
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
S+ + G+P +M+PE + + N K DIWSLGC + E+ PP F
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMN---RMSYNEK----SDIWSLGCLLYELCALMPP---FTA 218
Query: 569 VS 570
S
Sbjct: 219 FS 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-59
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++ +LIG G FG V+ +R G + IK V + E + E+E+K L L H
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNE---KAEREVKALAKLDHV 64
Query: 417 NIVQYYGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIV 459
NIV Y G L+I +E+ G++ +++ + + + + +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
I G+ Y+HS I+RD+K +N+ + + VK+ DFG+ L KG+
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+M+PE I +D + VD+++LG + E+L E
Sbjct: 185 LRYMSPEQIS---SQDYGKE----VDLYALGLILAELLHVCDTAFE 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-59
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 40/241 (16%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
S +++ ++G+G FG V N AIK++ + E + + E+ +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58
Query: 413 LKHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVREHCRDITESIV 459
L H+ +V+YY + + + L+I +EY G++ + +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 517
R IL L+Y+HS IHRD+K N+ +D S VK+ DFG+AK++ L L
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 518 -------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ ++A EV+ N K +D++SLG EM+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNEK----IDMYSLGIIFFEMIYPFSTGM 232
Query: 565 E 565
E
Sbjct: 233 E 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-59
Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W ++G+G +V+ G +++TG AIK + ++ + +E +VL
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
L H+NIV+ + + ++ H + +E+ GS+ + E + ES R +
Sbjct: 64 LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 467 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
+ G+ +L +HR+IK N++ D V KL DFG A+ L +SL G+ +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 523 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ P++ + AV++KD K VD+WS+G T TG P+ FEG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-58
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 25/224 (11%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K + ++G G G++ A+K + EC ++E+++L
Sbjct: 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--------ECFSFADREVQLLRE 73
Query: 413 L-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H N+++Y+ +E YI +E ++ YV + + +GLA
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 472 YLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELS----LKGSPNW 522
+LHS N +HRD+K N+L+ ++DFG+ K L + S + G+ W
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
+APE++ +D VDI+S GC +++ G P+ +
Sbjct: 193 IAPEMLS----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-57
Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +GRG +G V + +G A+K + + + K+L ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRT 62
Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNG 469
V +YG+ + ++I +E + S + V + + I E I+ I+
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 470 LAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
L +LHS + IHRD+K +N+L++A G VK+ DFG++ +L + G +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
+ + G + DIWSLG T+IE+ + P+ +
Sbjct: 182 NPELNQKGYSVKS---DIWSLGITMIELAILRFPYDSWGTP 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 8e-56
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
IGRG +GSV ++ +G A+K + D+ + KQL ++ V+ IVQ
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQ 85
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 476
+YG+ + +I +E + Y I E I+ T + L +L
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAV 531
IHRDIK +N+L+D SG +KL DFG++ L S+ G +MAPE I
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPS 200
Query: 532 MQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
+ G + + D+WSLG T+ E+ TG+ P+ ++ V
Sbjct: 201 ASRQGYDVR----SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 64/229 (27%), Positives = 115/229 (50%), Gaps = 26/229 (11%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAEC 399
P ++ P + ++ +G+ +G+G F + ++ +T A K I+P
Sbjct: 5 PEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQ 58
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITES 457
+++ EI + L H+++V ++ +D+ +++ LE S+ + +TE
Sbjct: 59 REKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEP 115
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
R + R I+ G YLH IHRD+K NL ++ VK+ DFG+A T + Y+ K
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 172
Query: 518 ----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G+PN++APEV+ +K + + VD+WS+GC + +L GKPP
Sbjct: 173 KVLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-55
Identities = 69/255 (27%), Positives = 122/255 (47%), Gaps = 28/255 (10%)
Query: 320 PLPLPPGA-----LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
P P PG ++ P + + I E + ++ +G+ +G+G F + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 375 NRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
+ +T A K I+P +++ EI + L H+++V ++ +D+ ++
Sbjct: 62 DADTKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFV 116
Query: 434 Y--LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
+ LE S+ + +TE R + R I+ G YLH IHRD+K NL ++
Sbjct: 117 FVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 492 ASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547
VK+ DFG+A T + Y+ K G+PN++APEV+ +K + + VD+W
Sbjct: 176 EDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFE----VDVW 225
Query: 548 SLGCTVIEMLTGKPP 562
S+GC + +L GKPP
Sbjct: 226 SIGCIMYTLLVGKPP 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-54
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 9/210 (4%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
+G GT G V+ R+TG A+K++ + + K++ ++ V+ IVQ
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQ 88
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTI 479
+G+ + + ++I +E + + R I E I+ T I+ L YL I
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+K +N+L+D G +KL DFG++ L + G +MAPE I P
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTKPD 205
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
+ D+WSLG +++E+ TG+ P+ +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTD 235
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-54
Identities = 59/215 (27%), Positives = 111/215 (51%), Gaps = 14/215 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K + + Q+ +E++VL
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLH 86
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 145
Query: 472 YLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL +HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 203
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
++ DIWS+G +++EM G+ P
Sbjct: 204 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-54
Identities = 73/225 (32%), Positives = 119/225 (52%), Gaps = 19/225 (8%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
KK QW + G+ +G+G FG+VY+ +++ A+K + + A QL +E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRRE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+++ HL+H NI++ YG +Y+ LEY G++ R +++ + E + +
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
N L+Y HS IHRDIK NLL+ ++G +K+ADFG + H S L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+I+ + + K VD+WSLG E L GKPP FE +
Sbjct: 178 MIE---GRMHDEK----VDLWSLGVLCYEFLVGKPP---FEANTY 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-54
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ + +GRG FG V+ N+ + AIK + + P +++ +E+K L L+H
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63
Query: 417 NIVQYYGS------------EVVDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNF 462
IV+Y+ + +LYI ++ ++ ++ C + S+ +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 509
I + +LHS +HRD+K +N+ VVK+ DFG+ +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+ G+ +M+PE I + K VDI+SLG + E+L P ++ E
Sbjct: 184 YARHTGQVGTKLYMSPEQIH---GNSYSHK----VDIFSLGLILFELLY--PFSTQME 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-52
Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K+ K++G G+ G+V G A+K + I + EIK+L
Sbjct: 14 KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTE 64
Query: 413 LK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV------REHCRDITESIVRNFTRH 465
H N+++YY SE D LYI LE ++ V E+ + E + R
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------VKLADFGMAKHLTG--L 510
I +G+A+LHS IHRD+K N+LV S + ++DFG+ K L
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 511 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP-WSE 565
S+ +L G+ W APE+++ +L ++DI+S+GC +L+ GK P +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 566 FE 567
+
Sbjct: 244 YS 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-52
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 28/233 (12%)
Query: 346 KPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
+ + P ++ W+ + +G G FG V +++TG AIK+ S + ++
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERW 59
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYV--REHCRD 453
EI+++ L H N+V EV D D + +EY G + +Y+ E+C
Sbjct: 60 CLEIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 510
+ E +R I + L YLH IHRD+K N+++ + K+ D G AK L
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ ++APE++ QK VD WS G E +TG P+
Sbjct: 178 ELCTEFVGTLQYLAPELL---EQKKYTVT----VDYWSFGTLAFECITGFRPF 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-52
Identities = 45/234 (19%), Positives = 87/234 (37%), Gaps = 31/234 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ + +G G F V + G A+K + + ++ ++E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFN 84
Query: 415 HENIVQYYGSEVVDD----HLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHI 466
H NI++ + + ++ L + G+ I R + +TE + I
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGI 143
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----------GLSYELSL 516
GL +H+ HRD+K N+L+ G L D G L +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ + ++ APE+ + + D+WSLGC + M+ G+ P ++ V
Sbjct: 204 RCTISYRAPELFSVQSHCVIDER----TDVWSLGCVLYAMMFGEGP---YDMVF 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 349 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
A K ++ G+ +G+G FG+VY+ ++ A+K + + QL
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQL 61
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
+EI++ HL+H NI++ Y +Y+ LE+ G + + +++H R E F
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFM 120
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ + L Y H IHRDIK NLL+ G +K+ADFG + H ++ G+ +++
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMCGTLDYL 179
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
PE+I+ K + K VD+W G E L G PP F+ S
Sbjct: 180 PPEMIE---GKTHDEK----VDLWCAGVLCYEFLVGMPP---FDSPSH 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-51
Identities = 53/268 (19%), Positives = 113/268 (42%), Gaps = 38/268 (14%)
Query: 324 PPGALSPPKSSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASC 382
P G++ S+ ++ + ++ + K + ++ + + +G F + + +
Sbjct: 2 PLGSMKDILSNYSNLI--YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57
Query: 383 AIKEVD------------IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429
A+K+ + D + E++++ +K+E + ++ +
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE--GIITNY 115
Query: 430 -HLYIYLEYVHPGSINRYVREHCR-------DITESIVRNFTRHILNGLAYLHSTNTI-H 480
+YI EY+ SI ++ I +++ + +LN +Y+H+ I H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K +N+L+D +G VKL+DFG ++++ + +G+ +M PE +G
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNG---- 230
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
VDIWSLG + M P F
Sbjct: 231 -AKVDIWSLGICLYVMFYNVVP---FSL 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---------------------IIPDD 393
Q+ IG+G++G V + N A+K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE 449
+ I+Q+ QEI +L L H N+V+ EV+D DHLY+ E V+ G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVP-T 130
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
++E R + + ++ G+ YLH IHRDIK +NLLV G +K+ADFG++ G
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 510 LSYELSLK-GSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
LS G+P +MAPE + + G A+D+W++G T+ + G+ P+
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCPF 240
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-50
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
A P W + +G G +G V + NR T + A+K I+ D ++ +C + +++EI
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+ L HEN+V++Y + Y++LEY G + + + E + F +
Sbjct: 58 INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
+ G+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
APE++K A VD+WS G + ML G+ PW
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 55/224 (24%), Positives = 108/224 (48%), Gaps = 18/224 (8%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLG 411
++ + K IG+G FG V+ G + + AIK + + + ++ E ++ ++E+ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+L H NIV+ YG ++ + + +E+V G + + + I S+ I G+
Sbjct: 79 NLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 472 YLHSTNT--IHRDIKGANLLVDASG-----VVKLADFGMAKHLTGLSYELSLKGSPNWMA 524
Y+ + N +HRD++ N+ + + K+ADFG+++ L G+ WMA
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMA 194
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
PE I A ++ K D +S + +LTG+ P+ E+
Sbjct: 195 PETIGA-EEESYTEK----ADTYSFAMILYTILTGEGPFDEYSY 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
A P W + +G G +G V + NR T + A+K I+ D ++ +C + +++EI
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+ L HEN+V++Y + Y++LEY G + + + E + F +
Sbjct: 58 INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
+ G+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
APE++K A VD+WS G + ML G+ PW
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+ IG G+FG+VY G A+K ++ + + ++ + E+ VL +H NI
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ + G L I ++ S+ ++ + + R G+ YLH+ +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 479 IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKD 535
IHRD+K N+ + VK+ DFG+A K S++ L GS WMAPEVI+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+ + D+++ G + E++TG+ P+ ++
Sbjct: 202 YSFQ----SDVYAFGIVLYELMTGQLPY---SNINN 230
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++IG G FG VY G A+K PD+ S + I+ + QE K+ LKH NI
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNI 68
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ G + + +L + +E+ G +NR + + I I+ N+ I G+ YLH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 479 ---IHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
IHRD+K +N+L+ ++K+ DFG+A+ + ++S G+ WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEV 185
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGV 569
I+ + D+WS G V+ E+LTG+ P+ +G+
Sbjct: 186 IR---ASMFSKG----SDVWSYG--VLLWELLTGEVPFRGIDGL 220
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-47
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+++G+G FG T+RETG +KE+ E + +E+KV+ L+H N+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+++ G D L EY+ G++ ++ S +F + I +G+AYLHS N
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---------------LSLKGSPNWM 523
IHRD+ N LV + V +ADFG+A+ + + ++ G+P WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 524 APEVIKAVMQKDGNP---KLALAVDIWSLGCTVIEMLTGKPPW 563
APE+I G K VD++S G + E++
Sbjct: 190 APEMIN------GRSYDEK----VDVFSFGIVLCEIIGRVNAD 222
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-47
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + +++GRG FG V R AIK++ +S K E++ L +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-------ESESERKAFIVELRQLSRV 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLA 471
H NIV+ YG + + + +EY GS+ + E T + ++ G+A
Sbjct: 59 NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 472 YLHSTNT---IHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLHS IHRD+K NLL+ A G V+K+ DFG A + + KGS WMAPEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEV 174
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ + + K D++S G + E++T + P+ E G
Sbjct: 175 FE---GSNYSEK----CDVFSWGIILWEVITRRKPFDEIGG 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 17/226 (7%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
P ++ K IG+G F V + + TG AIK II + +++L +E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFRE 64
Query: 407 IKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
++++ L H NIV+ + EV++ LY+ +EY G + Y+ H R + E R+ R
Sbjct: 65 VRIMKILNHPNIVKLF--EVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFR 121
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 524
I++ + Y H +HRD+K NLL+DA +K+ADFG + T + G+P + A
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
PE+ + G VD+WSLG + +++G P F+G +
Sbjct: 182 PELFQ------GKKYDGPEVDVWSLGVILYTLVSGSLP---FDGQN 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKH 415
K +G G G V + R+T AI+ + + A+ +E EI++L L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 416 ENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
I++ D YI LE + G + V + R + E+ + + +L + YLH
Sbjct: 200 PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 256
Query: 475 STNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
IHRD+K N+L+ + ++K+ DFG +K L S +L G+P ++APEV+ +V
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
N VD WSLG + L+G PP+SE
Sbjct: 317 GTAGYNRA----VDCWSLGVILFICLSGYPPFSE 346
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-46
Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG G+FG+V+ G+ A+K I+ + AE + + +E+ ++ L+H NI
Sbjct: 42 KEKIGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHST 476
V + G+ +L I EY+ GS+ R + + + E + + G+ YLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 477 NT--IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYELSLKGSPNWMAPEVIKAVM 532
N +HR++K NLLVD VK+ DFG++ K T LS + S G+P WMAPEV++
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLR--- 212
Query: 533 QKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGV 569
+ N K D++S G VI E+ T + PW
Sbjct: 213 DEPSNEK----SDVYSFG--VILWELATLQQPWGNLNPA 245
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+LIG+G FG VY G AI+ +I + + + +K ++E+ +HEN+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + G+ + HL I ++ VR+ + + R + I+ G+ YLH+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVM 532
+H+D+K N+ D +G V + DFG+ L G +APE+I+ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 533 QKDGNPKLAL--AVDIWSLGCTVIEMLTGKPPWSE 565
KL D+++LG E+ + P+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 80/249 (32%), Positives = 115/249 (46%), Gaps = 50/249 (20%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
S T + MEK ++ L+G G++G V N++TG AIK+
Sbjct: 9 SSGVDLGTENLYFQSMEK---------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 389 IIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSI 443
DD K A ++ EIK+L L+HEN+V EV Y+ E+V +I
Sbjct: 60 ESDDDKMVKKIA--MR----EIKLLKQLRHENLVNLL--EVCKKKKRWYLVFEFVD-HTI 110
Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503
+ + +V+ + I+NG+ + HS N IHRDIK N+LV SGVVKL DFG
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
Query: 504 AKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCT 552
A+ L +P W APE++ G+ K AVD+W++GC
Sbjct: 171 ARTL----------AAPGEVYDDEVATRWYRAPELLV------GDVKYGKAVDVWAIGCL 214
Query: 553 VIEMLTGKP 561
V EM G+P
Sbjct: 215 VTEMFMGEP 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 50/235 (21%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAEC 399
+MEK ++K IG G++G V+ NR+TG AIK+ DD K A
Sbjct: 1 MMEK---------YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-- 49
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITES 457
++ EI++L LKH N+V EV L++ EY ++ + + R + E
Sbjct: 50 LR----EIRMLKQLKHPNLVNLL--EVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEH 102
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
+V++ T L + + H N IHRD+K N+L+ V+KL DFG A+ L
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---------- 152
Query: 518 GSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
P+ W +PE++ G+ + VD+W++GC E+L+G P
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLV------GDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 21/230 (9%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ 402
S PK + ++ K +G G G V + R+T AIK + + A+
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+E EI++L L H I++ D YI LE + G + V + R + E+ +
Sbjct: 62 VETEIEILKKLNHPCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKL 118
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKG 518
+ +L + YLH IHRD+K N+L+ + ++K+ DFG +K L S +L G
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+P ++APEV+ +V N VD WSLG VI L+G PP
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA----VDCWSLG--VILFICLSGYPPFSEH 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 51/242 (21%), Positives = 94/242 (38%), Gaps = 37/242 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ + +++ G F VY + +G A+K + E + + QE+ + L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLS 83
Query: 415 -HENIVQYYGSEVVD-------DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTR 464
H NIVQ+ + + ++ L + G + ++ E ++ V
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 465 HILNGLAYLHSTNT--IHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 509
+ ++H IHRD+K NLL+ G +KL DFG A ++
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGV 569
+ E++ +P + PE+I K DIW+LGC + + + P FE
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEK----QDIWALGCILYLLCFRQHP---FEDG 256
Query: 570 SP 571
+
Sbjct: 257 AK 258
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-45
Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
++ G L+G G++G V + ET A+K I+ + +++EI++L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSIN--RYVREHCRDITESIVRNFTRHI 466
L+H+N++Q +V+ + +Y+ +EY G V E R + +
Sbjct: 63 LRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-R-FPVCQAHGYFCQL 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
++GL YLHS +H+DIK NLL+ G +K++ G+A+ L + + + + GSP +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
PE+ + G VDIWS G T+ + TG P FEG
Sbjct: 179 PPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP---FEG 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 52/254 (20%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IG+G++G V + +T A AIK ++ + + +++++ E++++ L H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI----------------------------------- 443
+ Y + ++ + +E H G +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 444 ----NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVK 497
+ + E ++ N R I + L YLH+ HRDIK N L + S +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 498 LADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
L DFG++K L+ G+P ++APEV+ + G D WS G
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-----KCDAWSAGVL 265
Query: 553 VIEMLTGKPP-WSE 565
+ +L G P
Sbjct: 266 LHLLLMGAVPFPGV 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 65/269 (24%), Positives = 109/269 (40%), Gaps = 28/269 (10%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P + A + P +SQ+Q G L+G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHA--TKLAPGKEKEPLESQYQVGPLLGSGGFGS 58
Query: 370 VYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYG 423
VY G AIK + D ++ E+ +L + +++
Sbjct: 59 VYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL- 114
Query: 424 SEVVD--DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ + D + LE P + ++ E + E + R+F +L + + H+ +H
Sbjct: 115 -DWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 172
Query: 481 RDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
RDIK N+L+D G +KL DFG L Y G+ + PE I+ +
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR------YHRY 225
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ +WSLG + +M+ G P FE
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIP---FEH 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 24/229 (10%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLE 404
K K + G +G GTFG V IG ++ TG A+K I+ +S + + +++
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIK 59
Query: 405 QEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
+EI+ L +H +I++ Y +V+ ++ +EYV G + Y+ +H R + E R
Sbjct: 60 REIQNLKLFRHPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRL 116
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GS 519
+ IL+ + Y H +HRD+K N+L+DA K+ADFG++ ++ + L+ GS
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGS 173
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
PN+ APEVI G VDIWS G + +L G P F+
Sbjct: 174 PNYAAPEVIS------GRLYAGPEVDIWSCGVILYALLCGTLP---FDD 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-44
Identities = 53/240 (22%), Positives = 106/240 (44%), Gaps = 25/240 (10%)
Query: 341 PHIMEKPSASPKKSQ----WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD 393
P +E + + + + +G G FG V+ ++E +K + ++ D
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE---YVHPGSINRYVREH 450
+ ++ EI +L ++H NI++ ++ ++ + L + + ++ H
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
R + E + R +++ + YL + IHRDIK N+++ +KL DFG A +L
Sbjct: 125 PR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 511 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
G+ + APEV+ GNP +++WSLG T+ ++ + P+ E E
Sbjct: 184 KL---FYTFCGTIEYCAPEVLM------GNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----QLEQEIKVLGHLK 414
+++GRG V ++ T A+K +D+ SAE ++ +E+ +L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 415 -HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNG 469
H NI+Q + + + + +L + + G + + + ++E R R +L
Sbjct: 82 GHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEV 136
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
+ LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
M + VD+WS G VI +L G PP W
Sbjct: 197 CSMNDNHPG-YGKEVDMWSTG--VIMYTLLAGSPPFWHR 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 40/286 (13%), Positives = 89/286 (31%), Gaps = 46/286 (16%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
S S V++++ + + +G ++G+ + T++
Sbjct: 36 VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 95
Query: 377 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---------------------- 414
ETG S + + + IKQ+++E+ L L+
Sbjct: 96 ETGESFEVHVPYF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153
Query: 415 ---HENIVQYYGSEVVDDHLYIYLEYVHP--------GSINRYVREHCRDITESIVRNFT 463
+ +++ E L + Y + + H + + T
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLT 212
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
++ LA LH +H ++ ++++D G V L F S +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV---VSSVSRGFE 269
Query: 524 APEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
PE+ +D + + D W+LG + + P ++
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V++ R +G IK I D +S ++Q+E EI+VL L H NI
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIK---TINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYL 473
++ + EV +D+ +Y+ E G + R V R ++E V + ++N LAY
Sbjct: 83 IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
HS + +H+D+K N+L +K+ DFG+A+ + + G+ +MAPEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+D K DIWS G V+ +LTG P
Sbjct: 200 ---RDVTFK----CDIWSAG--VVMYFLLTGCLPFTGT 228
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 35/217 (16%), Positives = 81/217 (37%), Gaps = 22/217 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ G ++ G + G +K ++ S + +E L H N+
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 419 VQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHS 475
+ G H + ++ GS+ + E + +S F + G+A+LH+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 476 TNT--IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ ++++D +++ + +P W+APE ++
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK-KP 184
Query: 534 KDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEG 568
+D N + + D+WS V+ E++T + P+++
Sbjct: 185 EDTNRR---SADMWSFA--VLLWELVTREVPFADLSN 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G+G F V ++ TG A K II SA ++LE+E ++ L+H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHST 476
V+ + S + Y+ + V G + V RE +E+ + + IL +AY HS
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSN 124
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HR++K NLL+ VKLADFG+A + G+P +++PEV+K
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---- 180
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+P + VDIW+ G VI +L G PP W E
Sbjct: 181 --KDP-YSKPVDIWACG--VILYILLVGYPPFWDE 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 25/235 (10%)
Query: 341 PHIMEKPSASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
+ P P ++ K IG G FG + ++ T A+K I
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID 60
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDIT 455
E +++EI L+H NIV++ EV+ HL I +EY G + + R +
Sbjct: 61 E---NVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNAGR-FS 114
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYE 513
E R F + +L+G++Y HS HRD+K N L+D S +K+ DFG +K S
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
S G+P ++APEV+ D+WS G T+ ML G P FE
Sbjct: 175 KSTVGTPAYIAPEVLL------RQEYDGKIADVWSCGVTLYVMLVGAYP---FED 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 68/321 (21%), Positives = 126/321 (39%), Gaps = 36/321 (11%)
Query: 261 SPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHP 320
S N ++ + R N R R+ + Q++ L E+ +A P
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLN-REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 321 LPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA 380
+ + +A ++ +IGRG V +R TG
Sbjct: 67 KGTENLYFQSMGPE------DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 381 SCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL- 435
A+K ++ + E + +E +L + H +I+ + + +++L
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLV 178
Query: 436 -EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487
+ + G +E R+ R +L +++LH+ N +HRD+K N
Sbjct: 179 FDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 488 LLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547
+L+D + ++L+DFG + HL L G+P ++APE++K M + VD+W
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG-YGKEVDLW 289
Query: 548 SLGCTVIE--MLTGKPP-WSE 565
+ G VI +L G PP W
Sbjct: 290 ACG--VILFTLLAGSPPFWHR 308
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHL 413
+ + +G G+FG V + T+ +T A+K I K ++ ++E+EI L L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66
Query: 414 KHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H +I++ Y +V+ + + +EY G + Y+ E R +TE R F + I+ +
Sbjct: 67 RHPHIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVEKKR-MTEDEGRRFFQQIICAIE 122
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVI 528
Y H +HRD+K NLL+D + VK+ADFG++ +T ++ LK GSPN+ APEVI
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVI 179
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G VD+WS G + ML G+ P+
Sbjct: 180 N------GKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-E 416
K +GRG F V ++ TG A K + + +C ++ EI VL K
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
++ + EV ++ I L EY G I + + E ++E+ V + IL G+ YL
Sbjct: 90 RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
H N +H D+K N+L+ G +K+ DFGM++ + + G+P ++APE++
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN- 206
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+P + A D+W++G +I +LT P E
Sbjct: 207 -----YDP-ITTATDMWNIG--IIAYMLLTHTSPFVGE 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
+++G+G+FG V + ++ TG CA+K +I K + L +E+++L L H N
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 418 IVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
I++ Y E +D Y YL E G + + R +E R +L+G+ Y+H
Sbjct: 88 IMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHK 144
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
+HRD+K NLL+ +++ DFG++ H G+ ++APEV+
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--- 201
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSE 565
+ K D+WS G + +L+G PP
Sbjct: 202 -GTYDEK----CDVWSTGVILYILLSGCPPFNGA 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 19/246 (7%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
P + +Q+ K +G G +G V + ++ T
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 382 CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVH 439
AIK II S +L +E+ VL L H NI++ Y + +D YL E
Sbjct: 65 RAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY--DFFEDKRNYYLVMECYK 119
Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 496
G + + + E + +L+G+ YLH N +HRD+K NLL+ + ++
Sbjct: 120 GGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
K+ DFG++ G+ ++APEV++ K + K D+WS+G + +
Sbjct: 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEK----CDVWSIGVILFIL 230
Query: 557 LTGKPP 562
L G PP
Sbjct: 231 LAGYPP 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++G+G+FG V +R T A+K +I + + +E+++L L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
++ + E+++D Y+ E G + + + R +E + + +G+ Y+H
Sbjct: 84 MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N +HRD+K N+L+ + +K+ DFG++ + G+ ++APEV++
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---- 196
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
+ K D+WS G + +L+G PP
Sbjct: 197 GTYDEK----CDVWSAGVILYILLSGTPP 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 51/295 (17%), Positives = 96/295 (32%), Gaps = 53/295 (17%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPHIMEK--------PSASPKKSQWQK------------- 358
P G + P V + ++ K S+ P +WQ
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQL 62
Query: 359 -------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
L+G G F VY T + + ++ + P + Q ++ L
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHIL 467
+++Y + + + + E G+ IN Y + + + +V +F +L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 468 NGLAYLHSTNTIHRDIKGANLLV-----------DASGVVKLADFGMAKHLTGLSYELSL 516
+ +H IH DIK N ++ D S + L D G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 517 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ + E++ K N + +D + + TV ML G + EG
Sbjct: 243 TAKCETSGFQCVEMLS---NKPWNYQ----IDYFGVAATVYCMLFGTYMKVKNEG 290
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++IG+G F V NRETG A+K VD+ + L++E + LKH +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDI-TESIVRNFTRHILNGLAYLHS 475
V+ + D LY+ E++ + V R + +E++ ++ R IL L Y H
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 531
N IHRD+K +L+ + S VKL FG+A L + G+P++MAPEV+K
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK-- 206
Query: 532 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGV 569
P VD+W G VI +L+G P + E +
Sbjct: 207 ----REP-YGKPVDVWGCG--VILFILLSGCLPFYGTKERL 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + +++E+E+ +L ++
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
H NI+ + ++ ++ + L E V G + + +E +TE F + IL+G+
Sbjct: 67 HPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121
Query: 471 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
YLHS H D+K N+++ + +KL DFG+A + + ++ G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
++ P L L D+WS+G VI +L+G P E
Sbjct: 182 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGE 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IGRG++G V I + T A K IP E + + +QEI+++ L H NI
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPK--YFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
++ Y E +D+ IYL E G + V ES + +L+ +AY H
Sbjct: 69 IRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKL 125
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N HRD+K N L +KL DFG+A + G+P +++P+V++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---- 181
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
P+ D WS G V+ +L G PP +
Sbjct: 182 GLYGPE----CDEWSAG--VMMYVLLCGYPPFSAP 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++G+G+FG V +R T A+K +I + + +E+++L L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++ + E+++D Y+ E G + + ++ +E + + +G+ Y+H
Sbjct: 84 MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
N +HRD+K N+L+ + +K+ DFG++ + G+ ++APEV++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR--- 196
Query: 533 QKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+ K D+WS G VI +L+G PP + +
Sbjct: 197 -GTYDEK----CDVWSAG--VILYILLSGTPPFYGK 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 38/293 (12%), Positives = 77/293 (26%), Gaps = 43/293 (14%)
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIG 363
++LL+ L + + +VT+ V P S + + + + +
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71
Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423
G V++ + E A+K S +++L + L E+ +
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKV--FTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 424 SE--------------------------VVDDHLYIYLEYVH-----PGSINRYVREHCR 452
+ + + S +V
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
D + T ++ A L S +H NL + G + L D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
P AP A++ W LG ++ + P+
Sbjct: 250 AS---SVPVTYAPR----EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
++ + IG GT+G VY N G + A+K++ + +D P + I+ EI +L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT--IR----EISILK 55
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV+ Y L + E++ + + + + ++F +LNG+A
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 521
Y H +HRD+K NLL++ G +K+ADFG+A+ G P
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTL 164
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W AP+V+ G+ K + +DIWS+GC EM+ G P
Sbjct: 165 WYRAPDVLM------GSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 39/230 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
+++K + IG GT+G+V+ NRET A+K V + DD P SA ++ EI +L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR----EICLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH+NIV+ + D L + E+ + +Y D+ IV++F +L GL
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 521
+ HS N +HRD+K NLL++ +G +KLA+FG+A+ G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVVTL 165
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
W P+V+ G + ++D+WS GC E+ P F G
Sbjct: 166 WYRPPDVLF------GAKLYSTSIDMWSAGCIFAELANAGRPL--FPGND 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +GRG FG V+ + + K + +++EI +L +H NI
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAK---FVK---VKGTDQVLVKKEISILNIARHRNI 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ + S + L + E++ I R + E + ++ + L +LHS N
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHN 122
Query: 478 TIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
H DI+ N++ S +K+ +FG A+ L L +P + APEV +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ------ 176
Query: 536 GNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
+ ++ A D+WSLG + +L+G P +E
Sbjct: 177 HDV-VSTATDMWSLG--TLVYVLLSGINPFLAE 206
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ +G+G +G V+ G+ + G + A+K I + + E E+ L+HE
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSW---FRETELYNTVMLRHE 62
Query: 417 NIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + S++ H L++ Y GS+ Y++ D + I +GLA+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL--RIVLSIASGLAH 120
Query: 473 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 519
LH HRD+K N+LV +G +AD G+A + + +L + G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+MAPEV+ +Q D VDIW+ G + E+ E
Sbjct: 181 KRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 24/247 (9%)
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASC 382
G + P+ S + P KK ++ GK++G G+F +V + T
Sbjct: 2 DGTAAEPRPGAGS---LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREY 58
Query: 383 AIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439
AIK ++ II + + + E V+ L H V+ Y + D+ LY L Y
Sbjct: 59 AIKILEKRHIIKE--NKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499
G + +Y+R E+ R +T I++ L YLH IHRD+K N+L++ +++
Sbjct: 114 NGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 172
Query: 500 DFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
DFG AK L+ S + S G+ +++PE++ + K + D+W+LGC + ++
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELL----TEKSACK---SSDLWALGCIIYQL 225
Query: 557 LTGKPPW 563
+ G PP+
Sbjct: 226 VAGLPPF 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 47/268 (17%)
Query: 312 SNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
S NA + L P + + ++ + K+IG G+FG V+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ----YYGSEVV 427
E+ AIK+ + D + +E++++ +KH N+V +Y +
Sbjct: 58 QAKLVESD-EVAIKK---VLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 428 DDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRD 482
D +++ L EYV P ++ R R + + + +++ + +L LAY+HS HRD
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 483 IKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQ 533
IK NLL+D SGV+KL DFG AK L G PN + APE+I
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILI--------AGEPNVSYICSRYYRAPELIF---- 214
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G +DIWS GC + E++ G+P
Sbjct: 215 --GATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 72/229 (31%), Positives = 112/229 (48%), Gaps = 42/229 (18%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P++ + K+IG G+FG VY ++G AIK+ + D + +E++++
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKN------RELQIM 101
Query: 411 GHLKHENIVQ----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRN 461
L H NIV+ +Y S D +Y+ L +YV P ++ R R + R + V+
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 520
+ + LAY+HS HRDIK NLL+D + V+KL DFG AK L +G P
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--------RGEP 212
Query: 521 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
N + APE+I G ++D+WS GC + E+L G+P
Sbjct: 213 NVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 51/265 (19%)
Query: 318 AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTN 375
AH G L P M +A S ++++ +G GT+G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQG------PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID 55
Query: 376 RETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432
T + AIK + + ++ P +A I+ E+ +L L+H NI++ + L+
Sbjct: 56 TVTNETVAIKRIRLEHEEEGVPGTA--IR----EVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
+ EY + +Y+ + D++ ++++F ++NG+ + HS +HRD+K NLL+
Sbjct: 110 LIFEYAE-NDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 493 S-----GVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDG 536
S V+K+ DFG+A+ G P W PE++ G
Sbjct: 168 SDASETPVLKIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILL------G 211
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKP 561
+ + +VDIWS+ C EML P
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 46/239 (19%)
Query: 345 EKPSASPKKSQWQKGKL--------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--- 393
+S +++ + +G + +G GT+G VY + G A+K + + +D
Sbjct: 4 HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
P +A I+ EI +L L H NIV + L + E++ + + + E+
Sbjct: 63 PSTA--IR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG 115
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
+ +S ++ + +L G+A+ H +HRD+K NLL+++ G +KLADFG+A+
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-------- 167
Query: 514 LSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G P W AP+V+ G+ K + +VDIWS+GC EM+TGKP
Sbjct: 168 --AFGIPVRSYTHEVVTLWYRAPDVLM------GSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + + +E+E+ +L ++
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
H N++ + EV ++ + L E V G + + +E +TE F + ILNG+
Sbjct: 73 HPNVITLH--EVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127
Query: 471 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
YLHS H D+K N+++ +K+ DFG+A + + ++ G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
++ P L L D+WS+G VI +L+G P +
Sbjct: 188 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGD 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
+ K +G GT+ +VY G ++ T A+KE+ + ++ P +A I+ E+ +L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IR----EVSLLKD 56
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIV + + L + EY+ + +Y+ + I V+ F +L GLAY
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------W 522
H +HRD+K NLL++ G +KLADFG+A+ K P W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165
Query: 523 M-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
P+++ G+ + +D+W +GC EM TG+P
Sbjct: 166 YRPPDILL------GSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + +++E+E+ +L +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
H N++ + + + LE V G + + +E ++E +F + IL+G+ Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 473 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
LH+ H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
P L L D+WS+G VI +L+G P +
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGD 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 61/254 (24%), Positives = 100/254 (39%), Gaps = 35/254 (13%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
PP T P ++ +++++ G L+G+G FG+V+ G AIK
Sbjct: 9 GPPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK--- 62
Query: 389 IIP----DDPKSAECIKQLEQEIKVL----GHLKHENIVQYYGSEVVD--DHLYIYLEYV 438
+IP E+ +L H +++ + + + + LE
Sbjct: 63 VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL--DWFETQEGFMLVLERP 120
Query: 439 HPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVV 496
P + Y+ E + E R F ++ + + HS +HRDIK N+L+D G
Sbjct: 121 LPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI-- 554
KL DFG L Y G+ + PE I + AL +WSLG ++
Sbjct: 180 KLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS------RHQYHALPATVWSLG--ILLY 230
Query: 555 EMLTGKPPWSEFEG 568
+M+ G P FE
Sbjct: 231 DMVCGDIP---FER 241
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + +++G G F V++ R TG A+K I P + LE EI VL
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK---CIKKSPAFRD--SSLENEIAVLKK 62
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
+KHENIV H Y+ ++ V G + +R + R TE + +L+ +
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAV 119
Query: 471 AYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLH +HRD+K NLL + + + + DFG++K + G+P ++APEV
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEV 178
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSE 565
+ + AVD WS+G +L G PP + E
Sbjct: 179 LA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEE 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK 385
G + +++ + + +G+G F V ++ TG A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-N 444
II SA ++LE+E ++ L+H NIV+ + S + Y+ + V G +
Sbjct: 61 ---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117
Query: 445 RYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLAD 500
V RE +E+ + + IL +AY HS +HR++K NLL+ VKLAD
Sbjct: 118 DIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLT 558
FG+A + G+P +++PEV+K + + VDIW+ G VI +L
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKP----VDIWACG--VILYILLV 225
Query: 559 GKPP-WSE 565
G PP W E
Sbjct: 226 GYPPFWDE 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 69/230 (30%), Positives = 117/230 (50%), Gaps = 22/230 (9%)
Query: 341 PHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAE 398
P ++ K + G +G GTFG V +G + TG A+K I+ +S +
Sbjct: 2 PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITE 456
+ ++ +EI+ L +H +I++ Y +V+ +++ +EYV G + Y+ ++ R + E
Sbjct: 59 VVGKIRREIQNLKLFRHPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKNGR-LDE 115
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
R + IL+G+ Y H +HRD+K N+L+DA K+ADFG++ ++ + L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L 172
Query: 517 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ GSPN+ APEVI G VDIWS G + +L G P+
Sbjct: 173 RTSCGSPNYAAPEVIS------GRLYAGPEVDIWSSGVILYALLCGTLPF 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-41
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 38/261 (14%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
+ A+ P + + + K + +G G +G V + + +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 382 CAIK--------EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
AIK + D+ + +++ EI +L L H NI++ + +V +D Y
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYF 121
Query: 434 YL--EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484
YL E+ G + +++ E N + IL+G+ YLH N +HRDIK
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF--------DECDAANIMKQILSGICYLHKHNIVHRDIK 173
Query: 485 GANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541
N+L+ ++ +K+ DFG++ + G+ ++APEV+K K N K
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEK-- 227
Query: 542 LAVDIWSLGCTVIEMLTGKPP 562
D+WS G + +L G PP
Sbjct: 228 --CDVWSCGVIMYILLCGYPP 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 40/227 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ 405
+ +++K +G G F +VY ++ T AIK++ + ++A ++
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR---- 61
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
EIK+L L H NI+ + ++ + +++ + ++++ +T S ++ +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
L GL YLH +HRD+K NLL+D +GV+KLADFG+AK GSPN
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYT 170
Query: 522 ------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W APE++ G + VD+W++GC + E+L P
Sbjct: 171 HQVVTRWYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 32/235 (13%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
M + + ++Q + +G+G F V G A II SA ++L
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKL 57
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI------TES 457
E+E ++ LKH NIV+ + S + H Y+ + V G E DI +E+
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSEA 110
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL 514
+ + IL + + H +HR++K NLL+ VKLADFG+A + G
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 515 S-LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
G+P +++PEV++ + VD+W+ G VI +L G PP W E
Sbjct: 171 FGFAGTPGYLSPEVLR---KDPYGKP----VDLWACG--VILYILLVGYPPFWDE 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 78/229 (34%), Positives = 115/229 (50%), Gaps = 42/229 (18%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q ++ G+GTFG+V +G + TG S AIK+ + DP+ ++L Q ++ L L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPR--FRNREL-QIMQDLAVL 76
Query: 414 KHENIVQ-----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFT 463
H NIVQ Y E +Y+ + EYV P +++R R + R +++ F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 464 RHILNGLAYLH--STNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 520
++ + LH S N HRDIK N+LV+ A G +KL DFG AK L+ P
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--------PSEP 187
Query: 521 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
N + APE+I GN AVDIWS+GC EM+ G+P
Sbjct: 188 NVAYICSRYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 63/303 (20%), Positives = 121/303 (39%), Gaps = 28/303 (9%)
Query: 269 SADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL 328
D + S + R + + + E + + + P
Sbjct: 11 GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+P + + K A K +++G G FG V+ TG A K +
Sbjct: 71 APFDHRI-------VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV 447
+ + ++++ EI V+ L H N++Q Y + + + + +EYV G + +R +
Sbjct: 124 T-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAK 505
E +TE F + I G+ ++H +H D+K N+L + +K+ DFG+A+
Sbjct: 179 DESYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP- 562
G+P ++APEV+ + ++ D+WS+G VI +L+G P
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVVN------YDF-VSFPTDMWSVG--VIAYMLLSGLSPF 288
Query: 563 WSE 565
+
Sbjct: 289 LGD 291
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q K IG+G +G V++G R G A+K + +++ E EI ++HE
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVK---VFFTTEEASW---FRETEIYQTVLMRHE 91
Query: 417 NIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + +++ LY+ +Y GS+ Y++ + + ++GL +
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCH 149
Query: 473 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 519
LH+ HRD+K N+LV +G +AD G+A + E+ + G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+M PEV+ + ++ + D++S G + E+ E
Sbjct: 210 KRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 73/225 (32%), Positives = 118/225 (52%), Gaps = 39/225 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLG 411
SQ+++ + +G GT+ +VY G N+ TG A+KEV + ++ P +A I+ EI ++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IR----EISLMK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVH---PGSI-NRYVREHCRDITESIVRNFTRHIL 467
LKHENIV+ Y ++ L + E++ + +R V R + ++V+ F +L
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 521
GLA+ H +HRD+K NLL++ G +KL DFG+A+ G P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTFSSE 168
Query: 522 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
W AP+V+ G+ + ++DIWS GC + EM+TGKP
Sbjct: 169 VVTLWYRAPDVLM------GSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 314 NHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPK-----------KSQWQKGKLI 362
+H + H + G + S++S S P ++ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRG VY + T A+K + K+ + K + EI VL L H NI++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLK------KTVD-KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 423 GSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ + LE V G + +R V + + +E + + IL +AYLH +H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVH 171
Query: 481 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
RD+K NLL +K+ADFG++K + ++ G+P + APE+++
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR----GCAY 227
Query: 538 PKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
VD+WS+G +I +L G P + E
Sbjct: 228 GP---EVDMWSVG--IITYILLCGFEPFYDE 253
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + C +++E+E+ +L +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
H NI+ + + + LE V G + + +E ++E +F + IL+G+ Y
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 473 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
LH+ H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
P L L D+WS+G VI +L+G P +
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGD 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V+ + TG K ++ ++ EI ++ L H +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKL 110
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + +D + L E++ G + +R E + ++E+ V N+ R GL ++H
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 167
Query: 476 TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ +H DIK N++ + VK+ DFG+A L + + APE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 223
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
P + D+W++G V+ +L+G P E
Sbjct: 224 --REP-VGFYTDMWAIG--VLGYVLLSGLSPFAGE 253
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-39
Identities = 54/285 (18%), Positives = 96/285 (33%), Gaps = 75/285 (26%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIP- 391
AS + ++ + +GRG FG V+ N+ + AIK EV +
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60
Query: 392 ------------------------------------DDPKSAECIKQLEQEIKVLGHLKH 415
S + +I+ +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 473
+N V +LYI ++ ++ ++ R D + + I + +L
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-------------GSP 520
HS +HRD+K +N+ VVK+ DFG+ + E ++ G+
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+M+PE I + + K VDI+SLG + E+L E
Sbjct: 241 LYMSPEQIH---GNNYSHK----VDIFSLGLILFELLYSFSTQME 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDII 390
I+ + + + + + +G G FG V + TG A+K +
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-- 59
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVR 448
I L++EI++L +L HENIV+Y G +E + + + +E++ GS+ Y+
Sbjct: 60 --PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
++ I + I G+ YL S +HRD+ N+LV++ VK+ DFG+ K +
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 509 GLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
Y + SP W APE + K +A D+WS G T+ E+LT
Sbjct: 178 TDKEYYTVKDDRDSPVFWYAPECL-----MQS--KFYIASDVWSFGVTLHELLT 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 34/243 (13%)
Query: 348 SASPKKSQW------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
S P Q + IG+G FG V+ G R G A+K I + +
Sbjct: 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVK---IFSSREERSW--- 81
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITES 457
E EI L+HENI+ + ++ D+ L++ +Y GS+ Y+ + +
Sbjct: 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM 141
Query: 458 IVRNFTRHILNGLAYLHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
I +GLA+LH HRD+K N+LV +G +AD G+A
Sbjct: 142 I--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 510 LSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ + + G+ +MAPEV+ + DI+++G E+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGG 258
Query: 565 EFE 567
E
Sbjct: 259 IHE 261
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
+ IG+G+FG V I +T A+K + +C+++ E +E++++ L+
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLE 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H +V + S ++ +++ ++ + G + RY + E V+ F ++ L YL
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ IHRD+K N+L+D G V + DF +A L + ++ G+ +MAPE+
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF----SS 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD WSLG T E+L G+ P+
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPY 217
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
K K +G G+F ++++ + A+K II K E ++EI L + H
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVK---IIS---KRME--ANTQKEITALKLCEGHP 66
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + H ++ +E ++ G + R ++ +E+ R +++ ++++H
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHD 124
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 531
+HRD+K NLL + + +K+ DFG A+ + L + ++ APE++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-- 182
Query: 532 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGVSP 571
++G + + D+WSLG VI ML+G+ P S ++
Sbjct: 183 --QNGYDE---SCDLWSLG--VILYTMLSGQVPFQSHDRSLTC 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 47/233 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 410
S+++K IG+GTFG V+ +R+TG A+K+V + + P +A +EIK+L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REIKIL 70
Query: 411 GHLKHENIVQYYGSEVV----------DDHLYIYLEYV-HPGSINRYVREHCRDITESIV 459
LKHEN+V E+ +Y+ ++ H + + T S +
Sbjct: 71 QLLKHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
+ + +LNGL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + L+
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQ 181
Query: 520 PNWMAPEVI----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
PN V+ + P+L L +D+W GC + EM T P
Sbjct: 182 PNRYTNRVVTLWYRP-------PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
Q ++ RG FG V+ A+K P + Q E E+ L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF------PIQDKQSWQNEYEVYSLPGM 75
Query: 414 KHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
KHENI+Q+ G+E L++ + GS++ +++ + ++ + + + + G
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARG 133
Query: 470 LAYLHSTNT----------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 517
LAYLH HRDIK N+L+ + +ADFG+A
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 518 -GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ +MAPEV++ + + L +D++++G + E+ +
Sbjct: 194 VGTRRYMAPEVLEGAI--NFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
++ + +G+G FGSV + TGA A+K++ + + ++EI
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREI 75
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
++L L + IV+Y G L + +EY+ G + +++ H + S + ++
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 521
I G+ YL S +HRD+ N+LV++ VK+ADFG+AK L Y + G SP
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
W APE + D + D+WS G + E+ T S
Sbjct: 196 WYAPESL-----SDN--IFSRQSDVWSFGVVLYELFTYCDKSCS 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 68/266 (25%), Positives = 106/266 (39%), Gaps = 40/266 (15%)
Query: 317 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVY 371
LP PP PP P K KK+ +++G G G V
Sbjct: 24 PTPALPHPPAQPPPPPPQQ----FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEV 426
N+ T A+K ++ D + +E+++ + +IV+
Sbjct: 80 QIFNKRTQEKFALK---MLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 427 VDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485
L I +E + G + +R + TE + I + YLHS N HRD+K
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189
Query: 486 ANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
NLL + ++KL DFG AK T + + +P ++APEV+ +K
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYD-----K 242
Query: 543 AVDIWSLGCTVIE--MLTGKPP-WSE 565
+ D+WSLG VI +L G PP +S
Sbjct: 243 SCDMWSLG--VIMYILLCGYPPFYSN 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 9e-38
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 38/307 (12%)
Query: 265 RNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLP 324
N + P+ P + R + K + +N++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI 384
P + V + + +G G FG V+ T R TG + A
Sbjct: 145 PQPVEIKHDHV-----------------LDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI- 443
K V + + +EI+ + L+H +V + + D+ + + E++ G +
Sbjct: 188 KFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADF 501
+ EH + ++E + R + GL ++H N +H D+K N++ S +KL DF
Sbjct: 243 EKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTG 559
G+ HL G+ + APEV + + D+WS+G V+ +L+G
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVG--VLSYILLSG 352
Query: 560 KPP-WSE 565
P E
Sbjct: 353 LSPFGGE 359
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
++ + + +G+G FGSV + TG A+K++ + E ++ E+EI
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREI 62
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
++L L+H+NIV+Y G +L + +EY+ GS+ Y+++H I + +T
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKG-SP-N 521
I G+ YL + IHRD+ N+LV+ VK+ DFG+ K L +++ G SP
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
W APE + + K ++A D+WS G + E+ T
Sbjct: 183 WYAPESL-----TES--KFSVASDVWSFGVVLYELFT 212
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+ IGRG FG V+ G R A+K + + + QE ++L H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRET-LPPDLKAKFLQEARILKQYSHPNI 174
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G +YI +E V G ++R + + G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKD 535
IHRD+ N LV V+K++DFGM++ Y S L+ P W APE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-----NY 289
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPP 562
G + + D+WS G + E + G P
Sbjct: 290 G--RYSSESDVWSFGILLWETFSLGASP 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 38/280 (13%), Positives = 87/280 (31%), Gaps = 43/280 (15%)
Query: 322 PLPPGALSPPKSSVTSAVMP---HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRET 378
S S V++++ + + +G ++G+ + T++ET
Sbjct: 43 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 102
Query: 379 GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL----------------------KHE 416
G S + + + IKQ+++E+ L L K
Sbjct: 103 GESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 417 NIVQYYGSEVVDDHLYIYLEYV-----------HPGSINRYVREHCRDITESIVRNFTRH 465
+ + + +++ + + + H + + T
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQ 219
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWM 523
++ LA LH +H ++ ++++D G V L F + +S P
Sbjct: 220 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
A ++ + + A D W+LG + + P
Sbjct: 280 AERMLP--FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++++K K++G G FG+VY G + AIK + + + L E
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEIL-DEA 68
Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
V+ + + ++ + G + + + + + G + YVREH +I + N+ I
Sbjct: 69 YVMASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 523
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A E I D+WS G TV E++T G P+
Sbjct: 187 ALESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/258 (22%), Positives = 107/258 (41%), Gaps = 74/258 (28%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ GK +G G+FG V + E+G A+K+ + DP+ +E+ ++ L
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKN------RELDIMKVL 57
Query: 414 KHENIVQ--------------------------------------YYGSEVVDDHLYIYL 435
H NI++ + + +L + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 436 EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
EYV P ++++ ++ R I +++ + + + ++HS HRDIK NLLV++
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 493 -SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQKDGNPKLALA 543
+KL DFG AK L P+ + APE++ G + +
Sbjct: 177 KDNTLKLCDFGSAKKLI--------PSEPSVAYICSRFYRAPELML------GATEYTPS 222
Query: 544 VDIWSLGCTVIEMLTGKP 561
+D+WS+GC E++ GKP
Sbjct: 223 IDLWSIGCVFGELILGKP 240
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 53/242 (21%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECI 400
P S S+++ IG G +G+VY + +G A+K V + P S +
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--V 59
Query: 401 KQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVREH 450
+ E+ +L L+ H N+V+ +V + + + E+V + Y+ +
Sbjct: 60 R----EVALLRRLEAFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA 112
Query: 451 -CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
+ +++ R L GL +LH+ +HRD+K N+LV + G VKLADFG+A+
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---- 168
Query: 510 LSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEMLTG 559
+ + P V+ +A P++ L VD+WS+GC EM
Sbjct: 169 ------IYSYQMALTPVVVTLWYRA-------PEVLLQSTYATPVDMWSVGCIFAEMFRR 215
Query: 560 KP 561
KP
Sbjct: 216 KP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 31/226 (13%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
+ ++G G V N T A+K II P ++ +E+++L + H
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPG--HIRSRVFREVEMLYQCQGHR 71
Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
N+++ E ++ YL E + GSI + + E + + + L +L
Sbjct: 72 NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFL 127
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK--------GSPNW 522
H+ HRD+K N+L + VK+ DF + + + GS +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSE 565
MAPEV++A + D+WSLG VI +L+G PP
Sbjct: 188 MAPEVVEA--FSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGR 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 46/242 (19%)
Query: 344 MEKPSASPKKSQWQK-----------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
M+ Q + + IG G++ ++ T A+K II
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IID- 56
Query: 393 DPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV- 447
KS + EI++L +H NI+ +V DD Y+Y+ E + G + ++ +
Sbjct: 57 --KSKRDPTE---EIEILLRYGQHPNIITLK--DVYDDGKYVYVVTELMKGGELLDKILR 109
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 503
++ +E I + YLH+ +HRD+K +N+L +++ DFG
Sbjct: 110 QKF---FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 504 AKHLTGLSYELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGK 560
AK L + L + N++APEV++ Q A DIWSLG V+ MLTG
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPEVLER--QGYD-----AACDIWSLG--VLLYTMLTGY 217
Query: 561 PP 562
P
Sbjct: 218 TP 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 69/255 (27%), Positives = 104/255 (40%), Gaps = 52/255 (20%)
Query: 340 MPHIMEKPSAS----PKKSQWQKG----------KLIGRGTFGSVYIGTNRETGASCAIK 385
M H S+ + + +K +++G G G V +R TG CA+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHP 440
++ D PK QE+ +IV L I +E +
Sbjct: 61 ---LLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110
Query: 441 GSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 496
G + +R + TE R I + +LHS N HRD+K NLL + V+
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 497 KLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
KL DFG AK T + +L+ +P ++APEV+ +K + D+WSLG V
Sbjct: 171 KLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGP--EKYD-----KSCDMWSLG--V 217
Query: 554 IE--MLTGKPP-WSE 565
I +L G PP +S
Sbjct: 218 IMYILLCGFPPFYSN 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK 395
SA + + + +G+G FGSV + TG A+K++
Sbjct: 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HS 81
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+ E ++ E+EI++L L+H+NIV+Y G +L + +EY+ GS+ Y+++H
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLS 511
I + +T I G+ YL + IHRD+ N+LV+ VK+ DFG+ K L
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 512 YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
Y++ G SP W APE + + K ++A D+WS G + E+ T
Sbjct: 202 YKVKEPGESPIFWYAPESL-----TES--KFSVASDVWSFGVVLYELFT 243
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 35/253 (13%)
Query: 344 MEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
ME ++ P + +LIGRG +G+VY G+ E A+K + +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVK---VFSFANRQNF--- 52
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITE 456
E+ I + ++H+NI ++ + + +EY GS+ +Y+ H D
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS 112
Query: 457 SIVRNFTRHILNGLAYLHSTNT---------IHRDIKGANLLVDASGVVKLADFGMAKHL 507
S + GLAYLH+ HRD+ N+LV G ++DFG++ L
Sbjct: 113 SC--RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 508 TGLSYEL---------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
TG S G+ +MAPEV++ + VD+++LG E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 559 GKPPWSEFEGVSP 571
E V
Sbjct: 231 RCTDLFPGESVPE 243
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 65/244 (26%), Positives = 109/244 (44%), Gaps = 53/244 (21%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD---PKSAEC 399
MEK Q++ IG G +G V+ + + G A+K V + + P S
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-- 58
Query: 400 IKQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVRE 449
I+ E+ VL HL+ H N+V+ + +V + L + E+V + Y+ +
Sbjct: 59 IR----EVAVLRHLETFEHPNVVRLF--DVCTVSRTDRETKLTLVFEHVD-QDLTTYL-D 110
Query: 450 HCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
+ + +++ +L GL +LHS +HRD+K N+LV +SG +KLADFG+A+
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-- 168
Query: 508 TGLSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEML 557
+ + V+ +A P++ L VD+WS+GC EM
Sbjct: 169 --------IYSFQMALTSVVVTLWYRA-------PEVLLQSSYATPVDLWSVGCIFAEMF 213
Query: 558 TGKP 561
KP
Sbjct: 214 RRKP 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG FG V + ++ T A+K + ++I + + E ++
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--SDSAFFWE---ERDIMAFANSP 129
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+VQ + + D +LY+ +EY+ G + + D+ E R +T ++ L +HS
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM 187
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+D SG +KLADFG + G+ + G+P++++PEV+K+ +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---Q 244
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ D WS+G + EML G P+
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-NRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIK 408
+ + + +G G+FG V G + +G + A+K + PD E + +E+
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVN 73
Query: 409 VLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
+ L H N+++ YG VV + + E GS+ +R+H + + +
Sbjct: 74 AMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWM 523
G+ YL S IHRD+ NLL+ +VK+ DFG+ + L Y + P W
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
APE +K + A D W G T+ EM T G+ PW G
Sbjct: 192 APESLK-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG F V + ++TG A+K + D++ C ++ E VL +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFRE---ERDVLVNGDRR 121
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I Q + + +++LY+ +EY G + + + I + R + I+ + +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+HRDIK N+L+D G ++LADFG L G L G+P++++PE+++AV
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G D W+LG EM G+ P+
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G+FG V + ++E+G A+K + ++ K E E ++L +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLN---EKRILQAVNFP 101
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V+ S + +LY+ +EYV G + ++R +E R + I+ YLHS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ I+RD+K NLL+D G +++ DFG AK + G ++ +L G+P +APE+I G
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEII----LSKG 214
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPW 563
K AVD W+LG + EM G PP+
Sbjct: 215 YNK---AVDWWALGVLIYEMAAGYPPF 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 56/207 (27%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ +G G+FG V++ +R G A+K + ++ K E E +L + H
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTND---ERLMLSIVTHP 66
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I++ +G+ +++ ++Y+ G + +R + + + + + L YLHS
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ I+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVV----STKP 179
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPW 563
K ++D WS G + EML G P+
Sbjct: 180 YNK---SIDWWSFGILIYEMLAGYTPF 203
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+++G G FG VY G ++ + A+K D K + E ++ +L H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+IV+ G ++++ +I +E G + Y+ + + + ++ I +AYL
Sbjct: 73 PHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVM 532
S N +HRDI N+LV + VKL DFG+++++ Y + P WM+PE I
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI---- 186
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ A D+W + E+L+ GK P+
Sbjct: 187 -NFR--RFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V +G + A+K +I + S + + QE + + L H
Sbjct: 13 LKELGSGQFGVVKLGKWKGQY--DVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPK 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V++YG + +YI EY+ G + Y+R H + + S + + G+A+L S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
IHRD+ N LVD VK++DFGM +++ Y S+ P W APEV
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF-----HY 179
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
K + D+W+ G + E+ + GK P+
Sbjct: 180 F--KYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
L+G G +G V T++ TG AIK+++ D P A + +EIK+L H KHENI+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA---LRTLREIKILKHFKHENII 72
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ S + +YI E + ++R + + +++ ++ F L + LH
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 523
+N IHRD+K +NLL++++ +K+ DFG+A+ + + + S
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APEV+ + A+D+WS GC + E+ +P
Sbjct: 190 APEVMLTSAKYSR------AMDVWSCGCILAELFLRRP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 34/244 (13%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
PH E+P + + K+IG G G V G R G AIK
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--- 83
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ + L E ++G H NI++ G I EY+ GS++ ++R
Sbjct: 84 ALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
H T + R + G+ YL +HRD+ N+LVD++ V K++DFG+++ L
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202
Query: 509 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559
+ ++ W APE I + A D+WS G + E+L G
Sbjct: 203 DDPDAAYTTTGGKIPIR----WTAPEAI-----AFR--TFSSASDVWSFGVVMWEVLAYG 251
Query: 560 KPPW 563
+ P+
Sbjct: 252 ERPY 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 27/233 (11%)
Query: 349 ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
SP +W +G G +G VY G ++ + A+K + +D E
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVR 460
+ +E V+ +KH N+VQ G + YI E++ G++ Y+RE R ++ ++
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 519
I + + YL N IHRD+ N LV + +VK+ADFG+++ +TG +Y
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 520 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGVS 570
P W APE + K ++ D+W+ G + E+ T G P + G+
Sbjct: 175 PIKWTAPESL-----AYN--KFSIKSDVWAFGVLLWEIATYGMSP---YPGID 217
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG G FG V++G AIK I + S E +E +V+ L H +
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD-KVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKL 65
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
VQ YG + + + E++ G ++ Y+R + + G+AYL
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDG 536
IHRD+ N LV + V+K++DFGM + + Y S P W +PEV
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-----SFS 180
Query: 537 NPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + D+WS G + E+ + GK P+
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
G+ IG G FG V+ G N + AIK + + K L QE +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPAL--AVAIK---TCKNCTSDSVREKFL-QEALTMRQF 73
Query: 414 KHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H +IV+ G V+ ++ ++I +E G + +++ + + + + + LAY
Sbjct: 74 DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 530
L S +HRDI N+LV ++ VKL DFG+++++ +Y + KG P WMAPE I
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ A D+W G + E+L G P+
Sbjct: 190 ---NFR--RFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K +K + +G G FG V + TN TG A+K + + +QEI
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEI 84
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
+L L HE+I++Y G + L + +EYV GS+ Y+ H I + + F +
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQ 142
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 521
I G+AYLH+ + IHRD+ N+L+D +VK+ DFG+AK + Y + G SP
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
W APE + K+ K A D+WS G T+ E+LT S
Sbjct: 203 WYAPECL-----KEY--KFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 32/236 (13%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+++ LIG G++G V ++ AIK++ + +D K++ +EI +L L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRL 109
Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
H+++V+ D LY+ LE + R +TE ++ ++L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLV 167
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
G+ Y+HS +HRD+K AN LV+ VK+ DFG+A+ + S +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 529 KAVMQKDGN---------------PKLAL-------AVDIWSLGCTVIEMLTGKPP 562
P+L L A+D+WS+GC E+L
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++ +K K++G G FG+V+ G IK +I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQS-FQAVTDHM 66
Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+G L H +IV+ G + L + +Y+ GS+ +VR+H + ++ N+ I
Sbjct: 67 LAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 523
G+ YL +HR++ N+L+ + V++ADFG+A L +L + P WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A E I G K D+WS G TV E++T G P+
Sbjct: 185 ALESI-----HFG--KYTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G +GSV ++ +G AIK++ A K+ +E+ +L H+
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYRELLLLKHM 80
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
+HEN++ S Y+ + ++ + + + +E ++ +L
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQML 136
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 526
GL Y+HS +HRD+K NL V+ +K+ DFG+A+ E++ W APE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
VI + M + VDIWS+GC + EMLTGK
Sbjct: 194 VILSWMHYNQ------TVDIWSVGCIMAEMLTGKT 222
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++++K K++G G FG+VY G + AIK + + S + K++ E
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT-SPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ + + ++ + G + + + + + G + YVREH +I + N+ I
Sbjct: 69 YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMA 524
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
E I D+WS G TV E++T G P+
Sbjct: 188 LESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + +TG A+K++ A K+ +E+++L H+
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 85
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
KHEN++ S + +Y+ + +N V+ C+ +T+ V+ IL
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQIL 142
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 526
GL Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPE 199
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
++ M + VDIWS+GC + E+LTG+
Sbjct: 200 IMLNWMHYNQ------TVDIWSVGCIMAELLTGRT 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 25/231 (10%)
Query: 344 MEKPS-ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
PS A W K +G G FG V G R AIK + +
Sbjct: 6 KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMI------KE 58
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + +E KV+ +L HE +VQ YG ++I EY+ G + Y+RE
Sbjct: 59 GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
+ + + + YL S +HRD+ N LV+ GVVK++DFG+++++ Y S
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 516 LKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ P W PEV+ K + DIW+ G + E+ + GK P+
Sbjct: 179 VGSKFPVRWSPPEVL-----MYS--KFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 358 KGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ K +G G FG+V G ++ + A+K I+ ++ +L E V+ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDN 77
Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV+ G + + + +E G +N+Y++++ R + + + + G+ YL
Sbjct: 78 PYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE 134
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKA 530
+N +HRD+ N+L+ K++DFG++K L Y+ G P W APE I
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-- 192
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G + E + G+ P+ +G
Sbjct: 193 ---NYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG FG V + + A+K + +++ C ++ E VL + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFRE---ERDVLVNGDSK 134
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I + + D++LY+ ++Y G + + + + E + R + ++ + +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ +HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A +
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA--ME 252
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G + D WSLG + EML G+ P+
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 23/287 (8%)
Query: 287 LRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEK 346
L + F +R + + + + + + ++S
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379
Query: 347 PSASPK---KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECI 400
PS + + + G+ IG G FG V+ G + AIK + +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVRE 436
Query: 401 KQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIV 459
K L QE + H +IV+ G V+ ++ ++I +E G + +++ + + +
Sbjct: 437 KFL-QEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG- 518
+ + LAYL S +HRDI N+LV ++ VKL DFG+++++ +Y + KG
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 519 SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
P WMAPE I + A D+W G + E+L G P+
Sbjct: 554 LPIKWMAPESI-----NFR--RFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
+ + + K W + +G+G FG V++GT T AIK + P
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKP 218
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
+ QE +V+ L+HE +VQ Y V ++ +YI EY+ GS+ +++
Sbjct: 219 GTMSPEAFL----QEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET 273
Query: 452 RD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
+ + + I +G+AY+ N +HRD++ AN+LV + V K+ADFG+A+ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333
Query: 511 SYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
Y P W APE + + D+WS G + E+ T G+ P+
Sbjct: 334 EYTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 341 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
P + KP +K W + K +G G FG V++ T + A+K + P
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKT--MKPGS 224
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CR 452
E V+ L+H+ +V+ + V + +YI E++ GS+ +++
Sbjct: 225 MSVEA----FLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+ +F+ I G+A++ N IHRD++ AN+LV AS V K+ADFG+A+ + Y
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339
Query: 513 ELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562
P W APE I G + D+WS G ++E++T G+ P
Sbjct: 340 TAREGAKFPIKWTAPEAI-----NFG--SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
SP +W +G G +G VY G ++ + A+K + D + E
Sbjct: 206 YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 262
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESI 458
+E V+ +KH N+VQ G + YI E++ G++ Y+RE R ++ +
Sbjct: 263 ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
+ I + + YL N IHR++ N LV + +VK+ADFG+++ +TG +Y
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 519 S-PN-WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562
P W APE + K ++ D+W+ G + E+ T G P
Sbjct: 380 KFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 60/242 (24%), Positives = 92/242 (38%), Gaps = 59/242 (24%)
Query: 341 PHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
PH+ K KK+ +++G G G V N+ T A+K ++ D
Sbjct: 2 PHV--KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--- 53
Query: 396 SAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHPGSI-NRYVRE 449
+ +E+++ + +IV+ L I +E + G + +R
Sbjct: 54 ----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKH 506
+ TE + I + YLHS N HRD+K NLL + ++KL DFG AK
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
Query: 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-W 563
TG Y+ S D+WSLG VI +L G PP +
Sbjct: 170 TTGEKYDKS----------------------------CDMWSLG--VIMYILLCGYPPFY 199
Query: 564 SE 565
S
Sbjct: 200 SN 201
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 35/245 (14%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEV 387
+ P+ + K + K+IG G FG VY G + + AIK
Sbjct: 22 FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-- 79
Query: 388 DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV 447
+ + + L E ++G H NI++ G + I EY+ G++++++
Sbjct: 80 -TLKAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
RE + + + R I G+ YL + N +HRD+ N+LV+++ V K++DFG+++ L
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 508 TGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558
+ ++ W APE I K A D+WS G + E++T
Sbjct: 198 EDDPEATYTTSGGKIPIR----WTAPEAI-----SYR--KFTSASDVWSFGIVMWEVMTY 246
Query: 559 GKPPW 563
G+ P+
Sbjct: 247 GERPY 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+GTFG V + + TG A+K + II D E +VL + +H
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVT---ESRVLQNTRHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + D L +EY + G + ++ R TE R + I++ L YLHS
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 533
+ ++RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV+ +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL----E 178
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + AVD W LG + EM+ G+ P+
Sbjct: 179 DNDYGR---AVDWWGLGVVMYEMMCGRLPF 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 55/249 (22%)
Query: 345 EKPSASPKKSQWQKGKL---IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC 399
K S+ ++ + +GRGT+G VY ++ A+K+++ SA
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR 67
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYV----------HPGSINR 445
EI +L LKH N++ +V H +++ +Y H S
Sbjct: 68 ------EIALLRELKHPNVISLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADF 501
+ +V++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD
Sbjct: 120 KKPVQ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 502 GMAKHLTGLSYELSLKGSPNWM---------APEVIKAVMQKDGNPKLALAVDIWSLGCT 552
G A+ + LK + APE++ G A+DIW++GC
Sbjct: 177 GFAR-----LFNSPLKPLADLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCI 225
Query: 553 VIEMLTGKP 561
E+LT +P
Sbjct: 226 FAELLTSEP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+G G +VY+ + AIK + + E +K+ E+E+ L H+NI
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + DD Y+ +EY+ +++ Y+ H ++ NFT IL+G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRI 132
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+HRDIK N+L+D++ +K+ DFG+AK L T L+ + G+ + +PE Q G
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE------QAKG 186
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
DI+S+G + EML G+PP F G +
Sbjct: 187 EATDE-CTDIYSIGIVLYEMLVGEPP---FNGETA 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 34/244 (13%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
V PH E P+ + + K++G G FG V G + S AIK +
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ + + + E ++G H NI++ G + I EY+ GS++ ++R
Sbjct: 83 VGYTEKQRRD----FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+H T + R I +G+ YL +HRD+ N+L++++ V K++DFG+ + L
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 509 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559
+ ++ W +PE I K A D+WS G + E+++ G
Sbjct: 199 DDPEAAYTTRGGKIPIR----WTSPEAI-----AYR--KFTSASDVWSYGIVLWEVMSYG 247
Query: 560 KPPW 563
+ P+
Sbjct: 248 ERPY 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ IG G +G V + AIK++ + ++ +EIK+L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYC---QRTLREIKILLRF 82
Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+HENI+ + +YI + + + + ++ + ++ + F IL
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILR 139
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 523
GL Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD------PDHDHTGFLTEYVA 193
Query: 524 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ ++DIWS+GC + EML+ +P
Sbjct: 194 TRWYRAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNRP 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+++G+G FG V R TG A K+++ I E ++L +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALN---EKQILEKVNSR 244
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHS 475
+V + D L + L ++ G + ++ + E+ + I GL LH
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
++RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK------ 358
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW 563
N + + D W+LGC + EM+ G+ P+
Sbjct: 359 -NERYTFSPDWWALGCLLYEMIAGQSPF 385
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
LIGRG++G VY+ ++ T + AIK+V+ + +D K++ +EI +L LK + I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYII 88
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ Y + D LYI LE + + + +TE ++ ++L G ++H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH 146
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTGLSYELSLKGSPN 521
+ IHRD+K AN L++ VK+ DFG+A K
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 522 WM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ APE+I ++DIWS GC E+L
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTK------SIDIWSTGCIFAELLNMLQSHIN 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FGSV G R+ AIK ++ +++ +E +++ L + IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQG-TEKADTEEMMREAQIMHQLDNPYIV 73
Query: 420 QYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ G V L + +E G +++++ +I S V + G+ YL N
Sbjct: 74 RLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQK 534
+HRD+ N+L+ K++DFG++K L Y G P W APE I
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----N 186
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G T+ E L+ G+ P+ + +G
Sbjct: 187 FR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQEI 407
S + + I G++G+V G + G AIK V D ++ + K++ +EI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 408 KVLGHLKHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
++L H H NI+ E LY+ E + + + + + I+ ++ F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
HIL GL LH +HRD+ N+L+ + + + DF +A+ T +
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT----------ADAN 189
Query: 523 M----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ VD+WS GC + EM K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRKA 232
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-33
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+++GRG FG V+ + TG A K+++ + + E K+L +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMV---EKKILAKVHSR 245
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAY 472
IV + L + + ++ G I ++ E +T I++GL +
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEH 304
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 529
LH N I+RD+K N+L+D G V+++D G+A + + K G+P +MAPE++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLL 362
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +VD ++LG T+ EM+ + P+
Sbjct: 363 -------GEEYDFSVDYFALGVTLYEMIAARGPF 389
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q K IG G G V + + AIK++ + A K+ +E+ ++ +
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 81
Query: 414 KHENIVQ-------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
H+NI+ E D +YI +E + ++ + ++ ++ + +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQ---MELDHERMSYLLYQM 136
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-AP 525
L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAP 195
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
EVI VDIWS+GC + EM+ G
Sbjct: 196 EVI-------LGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V++G A+K + S + E ++ L+H+ +
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRL 70
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
V+ Y V + +YI EY+ GS+ +++ +T + + + I G+A++ N
Sbjct: 71 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
IHRD++ AN+LV + K+ADFG+A+ + Y P W APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-----NY 184
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPP 562
G + D+WS G + E++T G+ P
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 15/212 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+L+GRG G VY + A+K + ++++E + G L+ ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMS--ETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + +D LY+ + ++ + +R + R I + L H+
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
HRD+K N+LV A L DFG+A L+ + G+ +MAPE +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE------RFSE 209
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
+ DI++L C + E LTG PP ++G
Sbjct: 210 SHATY-RADIYALTCVLYECLTGSPP---YQG 237
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++IG+G FG VY G + + CAIK + + + ++ +E ++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQ-VEAFLREGLLMRGL 79
Query: 414 KHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H N++ G ++ + ++ L Y+ G + +++R R+ T + +F + G+
Sbjct: 80 NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAP 525
YL +HRD+ N ++D S VK+ADFG+A+ + Y + W A
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
E + + + D+WS G + E+LT G PP+
Sbjct: 198 ESL-----QTY--RFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S++ K +G G G V+ + + AIK+ I+ DP+S K +EIK++ L
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSV---KHALREIKIIRRL 65
Query: 414 KHENIV--------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
H+NIV GS + +YI EY+ + + + E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHA 122
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKG 518
R F +L GL Y+HS N +HRD+K ANL ++ V+K+ DFG+A+ +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------PHYS 176
Query: 519 SPNWM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ +P ++ + A+D+W+ GC EMLTGK
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGKT 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+Q + +GRG + V+ N +K + P K + +EIK+L +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIK------REIKILENL 87
Query: 414 K-HENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ NI+ ++V D + E+V+ + + +T+ +R + IL
Sbjct: 88 RGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILK 141
Query: 469 GLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA------KHLTGLSYELSLKGSPN 521
L Y HS +HRD+K N+++D ++L D+G+A + S
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASR----- 194
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
+ PE++ D ++D+WSLGC + M+ K P
Sbjct: 195 YFKGPELLVDYQMYD------YSLDMWSLGCMLASMIFRKEP 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLE 404
+ + +G+GTF ++ G RE G +K +D +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSESFF 60
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
+ ++ L H+++V YG V D + E+V GS++ Y++++ I +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSL 516
+ + +L IH ++ N+L+ +KL+D G++ +
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--- 177
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ W+ PE I ++ L LA D WS G T+ E+ + G P
Sbjct: 178 QERIPWVPPECI-----ENPK-NLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 418
K +G+G +G V+ +R TG A+K++ + A ++ +EI +L L HENI
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREIMILTELSGHENI 71
Query: 419 VQYYGSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V V+ D +Y+ +Y+ ++ +R + + ++ + YLH
Sbjct: 72 VNLL--NVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLH 126
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 523
S +HRD+K +N+L++A VK+ADFG+++ + +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 524 -----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APE++ + +D+WSLGC + E+L GKP
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTK------GIDMWSLGCILGEILCGKP 229
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/319 (21%), Positives = 119/319 (37%), Gaps = 36/319 (11%)
Query: 258 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 317
SP+ P + + H + SP + K+ N +
Sbjct: 2 SPIDPMGHHHHH--HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 318 -AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
A+ + + AL+P V+ ++IGRG FG VY GT
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGP--------SSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 377 ETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDH 430
+ CA+K + E + Q E ++ H N++ G + +
Sbjct: 112 DNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGS 165
Query: 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 490
+ L Y+ G + ++R + T + F + G+ +L S +HRD+ N ++
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 491 DASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVD 545
D VK+ADFG+A+ + ++ + WMA E + + K D
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQ--KFTTKSD 278
Query: 546 IWSLGCTVIEMLT-GKPPW 563
+WS G + E++T G PP+
Sbjct: 279 VWSFGVLLWELMTRGAPPY 297
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++G+G +G V+ T TG A+K + +I + K K E +L +K
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGL 470
H IV + LY+ LEY+ G + R E + I L
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMAL 134
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 527
+LH I+RD+K N++++ G VKL DFG+ K + G+ +MAPE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEI 192
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + G+ + AVD WSLG + +MLTG PP+
Sbjct: 193 L----MRSGHNR---AVDWWSLGALMYDMLTGAPPF 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ +G G +G+V + TGA AIK++ A K+ +E+++L H++HEN++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYRELRLLKHMRHENVI 87
Query: 420 QYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ Y+ + ++ + + ++ + E ++ +L GL Y+
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 144
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 532
H+ IHRD+K NL V+ +K+ DFG+A+ E++ W APEVI M
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWM 201
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ VDIWS+GC + EM+TGK
Sbjct: 202 RYTQ------TVDIWSVGCIMAEMITGKT 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++IGRG FG VY GT + CA+K + E + Q E ++ H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85
Query: 416 ENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
N++ G + + + L Y+ G + ++R + T + F + G+ Y
Sbjct: 86 PNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEV 527
L S +HRD+ N ++D VK+ADFG+A+ + Y + WMA E
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + K D+WS G + E++T G PP+
Sbjct: 204 L-----QTQ--KFTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 69/311 (22%), Positives = 116/311 (37%), Gaps = 28/311 (9%)
Query: 273 SPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPK 332
L SS SN P +L + + N+ P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 333 SSVTSAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASC--A 383
+ ++V P K + +G G FGSV G R A
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367
Query: 384 IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGS 442
IK + K+ +++ +E +++ L + IV+ G V L + +E G
Sbjct: 368 IKV--LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGP 421
Query: 443 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
+++++ +I S V + G+ YL N +HR++ N+L+ K++DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 503 MAKHLTGLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
++K L Y G P W APE I K + D+WS G T+ E L+
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALS 534
Query: 559 -GKPPWSEFEG 568
G+ P+ + +G
Sbjct: 535 YGQKPYKKMKG 545
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 346 KPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
+S W + + IG+G FG V +G R A+K + K+
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-------KNDA 56
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRD-I 454
+ E V+ L+H N+VQ G V+ LYI EY+ GS+ Y+R R +
Sbjct: 57 TAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 455 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514
+ F+ + + YL N +HRD+ N+LV V K++DFG+ K
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SST 170
Query: 515 SLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGVS 570
G P W APE + ++ K + D+WS G + E+ + G+ P + +
Sbjct: 171 QDTGKLPVKWTAPEAL-----REK--KFSTKSDVWSFGILLWEIYSFGRVP---YPRIP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 39/245 (15%)
Query: 335 VTSAVMPHIMEKPSASPK---KSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAI 384
T + P +ME A+ +S W + + IG+G FG V +G R G A+
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAV 221
Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPG 441
K + K+ + E V+ L+H N+VQ G V+ LYI EY+ G
Sbjct: 222 KCI-------KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKG 272
Query: 442 SINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
S+ Y+R R + + F+ + + YL N +HRD+ N+LV V K++D
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 501 FGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
FG+ K + L +K W APE + ++ K + D+WS G + E+ +
Sbjct: 333 FGLTKEASSTQDTGKLPVK----WTAPEAL-----REK--KFSTKSDVWSFGILLWEIYS 381
Query: 559 -GKPP 562
G+ P
Sbjct: 382 FGRVP 386
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 63/276 (22%), Positives = 121/276 (43%), Gaps = 29/276 (10%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKG-------KLI 362
+ +H + H +P + ++ S + + K+ G ++I
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 363 GRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKHENI 418
GRG++ V + ++T A++ V + D+ + ++ E V H +
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQT---EKHVFEQASNHPFL 115
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D+ G +KL D+GM K GL + G+PN++APE++ + +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL----RGE 228
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+VD W+LG + EM+ G+ P+
Sbjct: 229 DYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 73/405 (18%), Positives = 144/405 (35%), Gaps = 27/405 (6%)
Query: 171 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 230
T + + ++ I + + + + + + P
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 231 SSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSP 290
+ +W+ L ++ + + S S+
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 291 RKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSAS 350
+ L + + + + N A + + + K +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 351 PKKSQWQKG-----KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
+ + + ++G+G+FG V + + T A+K + +I DD EC
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV 390
Query: 403 LEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
E +VL K + Q + D LY +EYV+ G + ++ + E
Sbjct: 391 ---EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVF 446
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---G 518
+ I GL +L S I+RD+K N+++D+ G +K+ADFGM K + ++ K G
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCG 504
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+P+++APE+I K +VD W+ G + EML G+ P+
Sbjct: 505 TPDYIAPEII----AYQPYGK---SVDWWAFGVLLYEMLAGQAPF 542
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
++IGRG++ V + ++T A+K V + D+ + ++ E V H
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQT---EKHVFEQASNH 69
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+L+D+ G +KL D+GM K GL + G+PN++APE++
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL---- 182
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+ + +VD W+LG + EM+ G+ P+
Sbjct: 183 RGEDYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+GTFG V + + TG A+K + I+ D E +VL + +H
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLT---ENRVLQNSRHP 208
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 477 -NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
N ++RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE--- 322
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
D AVD W LG + EM+ G+ P+
Sbjct: 323 DNDYGR----AVDWWGLGVVMYEMMCGRLPF 349
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+G+G FG V++GT T AIK + P + QE +V+ L+HE +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKPGTMSPEAFL----QEAQVMKKLRHEKL 324
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
VQ Y V ++ +YI EY+ GS+ +++ + + + I +G+AY+ N
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
+HRD++ AN+LV + V K+ADFG+A+ + Y P W APE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL------ 437
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
+ + D+WS G + E+ T G+ P+
Sbjct: 438 -YGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
K++G G +G V++ + +TG A+K + I K+ E + E +VL H++
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIR 116
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+V + + + L++ L+Y++ G + ++ TE V+ + I+ L +L
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIK 529
H I+RDIK N+L+D++G V L DFG++K ++ E G+ +MAP++++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVR 233
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ K AVD WSLG + E+LTG P+
Sbjct: 234 G--GDSGHDK---AVDWWSLGVLMYELLTGASPF 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
K++G+G+FG V++ ++T AIK + ++ DD EC E +VL +H
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMV---EKRVLSLAWEH 77
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + ++L+ +EY++ G + +++ C S + I+ GL +LHS
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
++RD+K N+L+D G +K+ADFGM K + + G+P+++APE++
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL---- 190
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+VD WS G + EML G+ P+
Sbjct: 191 LGQKYNH---SVDWWSFGVLLYEMLIGQSPF 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
+++G+G+FG V + +ETG A+K + I+ DD EC E ++L H
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMT---EKRILSLARNH 83
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ Q + D L+ +E+V+ G + +++ R E+ R + I++ L +LH
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD 142
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+L+D G KLADFGM K G+ ++ G+P+++APE++
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL---- 196
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
Q+ AVD W++G + EML G P+
Sbjct: 197 QEMLYGP---AVDWWAMGVLLYEMLCGHAPF 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+++G G V++ + A+K + D + + +E + L H I
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 419 VQYY--GSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V Y G Y+ EYV ++ V +T L + H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH 133
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIKA 530
IHRD+K AN+++ A+ VK+ DFG+A+ + + ++ G+ +++PE
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
Q G+ A D++SLGC + E+LTG+PP F G SP
Sbjct: 190 --QARGDSVDA-RSDVYSLGCVLYEVLTGEPP---FTGDSP 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
++G+G+FG V + + T A+K + +I DD EC E +VL K
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV---EKRVLALPGKP 80
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ Q + D LY +EYV+ G + ++ + E + I GL +L S
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+++D+ G +K+ADFGM K + ++ K G+P+++APE+I
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEII---- 193
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
K +VD W+ G + EML G+ P+
Sbjct: 194 AYQPYGK---SVDWWAFGVLLYEMLAGQAPF 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 65/270 (24%), Positives = 102/270 (37%), Gaps = 46/270 (17%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT---- 374
G+ P S + HI+E P +G G FG V++
Sbjct: 6 GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65
Query: 375 -NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
+ A+K + S + ++E ++L L+H++IV+++G L +
Sbjct: 66 LPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 434 YLEYVHPGSINRYVREHCRDITESIVRN--------------FTRHILNGLAYLHSTNTI 479
EY+ G +NR++R H D + G+ YL + +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQK 534
HRD+ N LV VVK+ DFGM++ + Y G WM PE I
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESI-----L 233
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
K D+WS G + E+ T GK PW
Sbjct: 234 YR--KFTTESDVWSFGVVLWEIFTYGKQPW 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q K IG G G V + + AIK++ + A K+ +E+ ++ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 118
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
H+NI+ + +Y+ +E + ++ + ++ ++ + +L
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQML 174
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM---- 523
G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G+ M
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------GTSFMMTPYV 224
Query: 524 ------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
APEVI VDIWS+GC + EM+ K
Sbjct: 225 VTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 38/271 (14%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P ++ + V+ + GK++G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDR-----------NLLILGKILGEGEFGS 49
Query: 370 VYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--- 423
V G T A+K + D S I++ E + H N+++ G
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 424 --SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHST 476
S + L ++ G ++ Y+ + I + F I G+ YL +
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAPEVIKAVMQ 533
N +HRD+ N ++ V +ADFG++K + Y + + P W+A E +
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL----- 221
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
D D+W+ G T+ E+ T G P+
Sbjct: 222 ADR--VYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLG-HLKH 415
K+IG+G+FG V + ++ A+K + I+ + I E VL ++KH
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMS---ERNVLLKNVKH 98
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+V + S D LY L+Y++ G + +++ R E R + I + L YLHS
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS 157
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
N ++RD+K N+L+D+ G + L DFG+ K + + + G+P ++APEV+
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL---- 211
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
K + VD W LG + EML G PP+
Sbjct: 212 HKQPYDR---TVDWWCLGAVLYEMLYGLPPF 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++IGRG FG VY +TG A+K +D I E +L +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALN---ERIMLSLVSTG 249
Query: 417 N---IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ IV + D L L+ ++ G ++ ++ +E+ +R + I+ GL ++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHM 308
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H+ ++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+ +
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL---QK 364
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ D +SLGC + ++L G P+
Sbjct: 365 GVAYDS---SADWFSLGCMLFKLLRGHSPF 391
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G+G+FG V++ + + A+K + + D E +L +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTK----MERDILVEV 83
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNG 469
H IV+ + + + LY+ L+++ G +++ V TE V+ + +
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALA 138
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 526
L +LHS I+RD+K N+L+D G +KL DFG++K + +E G+ +MAPE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
V+ + G+ + + D WS G + EMLTG P+
Sbjct: 197 VV----NRRGHTQ---SADWWSFGVLMFEMLTGTLPF 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 49/223 (21%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+++G+G FGSV ++ S A+K + D ++ I++ +E + H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASSDIEEFLREAACMKEFDH 84
Query: 416 ENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTR 464
++ + G ++ + L ++ G ++ ++ ++ + F
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 521
I G+ YL S N IHRD+ N ++ V +ADFG+++ + Y S P
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
W+A E + D + D+W+ G T+ E++T G+ P+
Sbjct: 205 WLALESL-----ADN--LYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 69/299 (23%), Positives = 105/299 (35%), Gaps = 42/299 (14%)
Query: 293 VYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSS-VTSAVMPHIMEKPSASP 351
Y H + E L L P LS ++S + + P+ S
Sbjct: 3 YYHHHHHHDYDIPTTENL-YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61
Query: 352 KKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAEC 399
+ +G G FG VY G N + A+K + P+ +
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD- 117
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
E ++ H+NIV+ G + +I LE + G + ++RE
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 510
+ + + R I G YL + IHRDI N L+ G V K+ DFGMA+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 511 SYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
Y KG WM PE +G D WS G + E+ + G P+
Sbjct: 238 GYY--RKGGCAMLPVKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 29/223 (13%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G+G+FG VY G E AIK + + E + E V+
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------FTR 464
++V+ G + +E + G + Y+R + + V
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 521
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y P
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WM+PE + KDG D+WS G + E+ T + P+
Sbjct: 206 WMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 44/233 (18%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G FG V++ + A+K + D +A K ++E ++L +L
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAAR--KDFQREAELLTNL 74
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+HE+IV++YG D L + EY+ G +N+++R H D +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 462 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------ 512
I +G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
L ++ WM PE I K D+WS G + E+ T GK PW
Sbjct: 195 TMLPIR----WMPPESI-----MYR--KFTTESDVWSFGVILWEIFTYGKQPW 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 62/251 (24%), Positives = 99/251 (39%), Gaps = 45/251 (17%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
P+ P +W GK +G G FG V T + + A+K ++
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSA 65
Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
E + L E+KVL +L H NIV G+ + + EY G + ++R
Sbjct: 66 HLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 454 ITESIVRN-----------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496
S F+ + G+A+L S N IHRD+ N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 497 KLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
K+ DFG+A+ + +Y + P WMAPE I + D+WS G +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNC--VYTFESDVWSYGIFL 237
Query: 554 IEMLT-GKPPW 563
E+ + G P+
Sbjct: 238 WELFSLGSSPY 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 28/217 (12%)
Query: 361 LIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
I G G +Y+ G +K AE E + L + H +IV
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
Q + D YI +EYV S+ R + + + + IL L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH 199
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S ++ D+K N+++ +KL D G + L G+P + APE
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG---YLYGTPGFQAPE------IV 249
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
P +A DI+++G T+ + P G
Sbjct: 250 RTGP--TVATDIYTVGRTLAALTLDLPT---RNGRYV 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 35/229 (15%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G FG VY G E + AIK + D + + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREE-FRHEAMLRARL 69
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+H N+V G D L + Y G ++ ++ +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 462 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 517
I G+ YL S + +H+D+ N+LV VK++D G+ + + Y+L
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 518 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
P WMAPE I G K ++ DIWS G + E+ + G P+
Sbjct: 190 SLLPIRWMAPEAI-----MYG--KFSIDSDIWSYGVVLWEVFSYGLQPY 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 33/225 (14%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G FG VY G N + A+K + P+ + E ++
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD-ELDFLMEALIISKF 90
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHIL 467
H+NIV+ G + +I +E + G + ++RE + + + R I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGSPN--- 521
G YL + IHRDI N L+ G V K+ DFGMA+ + SY KG
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY--RKGGCAMLP 208
Query: 522 --WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
WM PE +G D WS G + E+ + G P+
Sbjct: 209 VKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE 398
+ +W GK +G G FG V T R + A+K ++ ++ +E
Sbjct: 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE 69
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
++ L E VL + H ++++ YG+ D L + +EY GS+ ++RE + +
Sbjct: 70 -LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 459 VRN-----------------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
F I G+ YL +HRD+ N+LV
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 496 VKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
+K++DFG+++ + SY +G P WMA E + D D+WS G
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-----FDH--IYTTQSDVWSFGVL 241
Query: 553 VIEMLT-GKPPW 563
+ E++T G P+
Sbjct: 242 LWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 49/251 (19%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
P+ P +W Q GK +G G FG V T + A+K ++
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTA 88
Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+ E + L E+K++ HL +HENIV G+ + + EY G + ++R R
Sbjct: 89 HADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 454 ITESIVRNFTRHILN-------------GLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
+ + G+A+L S N IHRD+ N+L+ V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 501 FGMAKHLTGLSY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
FG+A+ + S L +K WMAPE I D + D+WS G +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVK----WMAPESI-----FDC--VYTVQSDVWSYGILL 256
Query: 554 IEMLT-GKPPW 563
E+ + G P+
Sbjct: 257 WEIFSLGLNPY 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 51/260 (19%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKE 386
+ H P S+W + GK +GRG FG V T + A+K
Sbjct: 8 LDEHCERLP---YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 387 VDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---DDHLYIYLEYVHPGS 442
+ + +E + L E+K+L H+ H N+V G L + +E+ G+
Sbjct: 65 L---KEGATHSE-HRALMSELKILIHIGHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGN 118
Query: 443 INRYVREHCRDITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGAN 487
++ Y+R + V ++ + G+ +L S IHRD+ N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 488 LLVDASGVVKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAV 544
+L+ VVK+ DFG+A+ + Y P WMAPE I D +
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDR--VYTIQS 231
Query: 545 DIWSLGCTVIEMLT-GKPPW 563
D+WS G + E+ + G P+
Sbjct: 232 DVWSFGVLLWEIFSLGASPY 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 45/247 (18%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + A+K ++ D
Sbjct: 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATE 115
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y++
Sbjct: 116 KD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
E + G+ YL S IHRD+ N+LV V+K+AD
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 501 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + Y+ + G P WMAPE + D D+WS G + E+
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDR--IYTHQSDVWSFGVLLWEIF 287
Query: 558 T-GKPPW 563
T G P+
Sbjct: 288 TLGGSPY 294
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 45/247 (18%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + + + A+K ++ DD
Sbjct: 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATE 81
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 82 KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
E T + G+ YL S IHRD+ N+LV + V+K+AD
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 501 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + Y+ + G P WMAPE + D D+WS G + E+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMWEIF 253
Query: 558 T-GKPPW 563
T G P+
Sbjct: 254 TLGGSPY 260
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 49/310 (15%)
Query: 288 RSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKP 347
+ P V+ + L + ES++ +N+ PL ++ T +
Sbjct: 12 QDPPAVHKLTKRIPLRRQVTVSAESSSSMNS-NTPLVRITTRLSSTADTPMLAG---VSE 67
Query: 348 SASPKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDD 393
P+ +W GK +G G FG V + + + A+K ++ DD
Sbjct: 68 YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDD 124
Query: 394 PKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 125 ATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 453 DITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 497
E T + G+ YL S IHRD+ N+LV + V+K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 498 LADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
+ADFG+A+ + Y+ + G P WMAPE + D D+WS G +
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMW 296
Query: 555 EMLT-GKPPW 563
E+ T G P+
Sbjct: 297 EIFTLGGSPY 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 43/237 (18%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK++G G FG V T A+K + + S+E + L E+K++ L
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSE-REALMSELKMMTQL 105
Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR------------ 460
HENIV G+ + +Y+ EY G + Y+R +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 461 ----------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 511 SYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
S + + WMAPE + +G + D+WS G + E+ + G P+
Sbjct: 226 SNYVVRGNARLPVKWMAPESL-----FEG--IYTIKSDVWSYGILLWEIFSLGVNPY 275
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 51/241 (21%), Positives = 94/241 (39%), Gaps = 51/241 (21%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ IG G FG V+ E A+K ++ ++ + ++E ++
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+ NIV+ G V + + EY+ G +N ++R S+ +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 462 -----------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
R + G+AYL +HRD+ N LV + VVK+ADFG+++++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 511 SY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562
Y + ++ WM PE I + D+W+ G + E+ + G P
Sbjct: 228 DYYKADGNDAIPIR----WMPPESI-----FYN--RYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 563 W 563
+
Sbjct: 277 Y 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 34/226 (15%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KH 415
+IG G FG V ++ G AIK + + + + E++VL L H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN-------------- 461
NI+ G+ +LY+ +EY G++ ++R+ T+
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 462 -FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 519
F + G+ YL IHRD+ N+LV + V K+ADFG+++ Y G
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 520 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
P WMA E + D+WS G + E+++ G P+
Sbjct: 204 PVRWMAIESL-----NYS--VYTTNSDVWSYGVLLWEIVSLGGTPY 242
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 39/218 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
K+IG+G+FG V + + A+K ++ ++ + +Q +EI++L HL+ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFH---RQAAEEIRILEHLRKQDKD 156
Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
N++ + +H+ + E + S+N Y + + + +VR F IL L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 471 AYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEV 527
LH IH D+K N+L+ +K+ DFG + + + + S + APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFYRAPEV 270
Query: 528 IKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP 561
I L +D+WSLGC + E+LTG P
Sbjct: 271 I-----------LGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
LIG+G+FG V +R AIK II + Q + E+++L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFL---NQAQIEVRLLELMNKHDTE 113
Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
IV + +HL + E + S N Y + R ++ ++ R F + + L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 471 AYLHST--NTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
+L + + IH D+K N+L+ +K+ DFG + L Y S + +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPE 228
Query: 527 VIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP 561
V+ L + A+D+WSLGC ++EM TG+P
Sbjct: 229 VL-----------LGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
LIG G FG VY G R+ GA A+K P+S++ I++ E EI+ L +H ++V
Sbjct: 46 LIGHGVFGKVYKGVLRD-GAKVALKRRT-----PESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----------- 468
G + + IY +Y+ G+ ++ H + ++
Sbjct: 100 LIGFCDERNEMILIY-KYMENGN----LKRHLYG------SDLPTMSMSWEQRLEICIGA 148
Query: 469 --GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSPN 521
GL YLH+ IHRD+K N+L+D + V K+ DFG++K G + + +KG+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLSTVVKGTLG 206
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
++ PE +L D++S G + E+L +
Sbjct: 207 YIDPEYFI-------KGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/240 (20%), Positives = 87/240 (36%), Gaps = 69/240 (28%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 414
+ +G G F +V++ + A+K I+ D E E EIK+L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTE---AAEDEIKLLQRVNDADNT 78
Query: 415 ------HENIVQYYGS---------------EVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+I++ EV+ ++L ++ +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK------YEHRG----- 127
Query: 454 ITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDAS------GVVKLADFGMAKH 506
I V+ ++ +L GL Y+H IH DIK N+L++ +K+AD G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 507 LTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP 561
+ + + + +PEV+ L DIWS C + E++TG
Sbjct: 188 YDEHYTNSIQ---TREYRSPEVL-----------LGAPWGCGADIWSTACLIFELITGDF 233
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 30/222 (13%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ G +G G FG VY G T + A+K++ D + E +Q +QEIKV+
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAA-MVDITTEELKQQFDQEIKVMAK 86
Query: 413 LKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRN-FTRH----- 465
+HEN+V+ G D +Y Y+ GS + + + + + R
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVY-VYMPNGS----LLDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSP 520
NG+ +LH + IHRDIK AN+L+D + K++DFG+A+ + + + G+
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMTSRIVGTT 199
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
+MAPE ++ G ++ DI+S G ++E++TG P
Sbjct: 200 AYMAPEALR------G--EITPKSDIYSFGVVLLEIITGLPA 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 22/211 (10%), Positives = 46/211 (21%), Gaps = 38/211 (18%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
G + + A+ VD P + +++ L + + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ E++ GS+ + + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
+ + V G V LA
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQD----------------------------- 183
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
DI +G ++ +L + P E S
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 56/255 (21%), Positives = 88/255 (34%), Gaps = 91/255 (35%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
+ +G GTFG V + + + A+K ++ + K + E +L ++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTR---SAKIEADILKKIQNDDIN 94
Query: 417 --NIVQYYGS-----------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
NIV+Y+G E + LY + N Y ++ +
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR------NNYNG-----FHIEDIKLYC 143
Query: 464 RHILNGLAYLHSTNTIHRDIKGAN-LLVDASGV------------------------VKL 498
IL L YL + H D+K N LL D +KL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 499 ADFGMA-----KHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDI 546
DFG A H + ++ Y APEVI L L + D+
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYR----------APEVI-----------LNLGWDVSSDM 242
Query: 547 WSLGCTVIEMLTGKP 561
WS GC + E+ TG
Sbjct: 243 WSFGCVLAELYTGSL 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GT+ G AIK + + QL E K+ ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKH-PQLHIESKIYKMMQ 62
Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I +++ G+E D+ + +E + P S+ R + V +++ +
Sbjct: 63 GGVGIPTIRWCGAE--GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 472 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 520
Y+HS N IHRD+K N L+ +V + DFG+AK +L G+
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 521 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + + Q +D D+ SLG ++ G PW
Sbjct: 180 RYASINTHLGIEQSRRD---------DLESLGYVLMYFNLGSLPW 215
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/243 (24%), Positives = 85/243 (34%), Gaps = 71/243 (29%)
Query: 360 KLIGRGTFGSVYIGTNRETGA-SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
+G G FG V + + G A+K I+ + + E EI+VL HL
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK---IVKNVDRYCE---AARSEIQVLEHLNTTDP 73
Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
VQ H+ I E + ++ Y ++E+ +R I
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 470 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 505
+ +LHS H D+K N L V + +K+ DFG A
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 506 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 558
H T +S Y APEVI LAL D+WS+GC +IE
Sbjct: 191 HSTLVSTRHYR----------APEVI-----------LALGWSQPCDVWSIGCILIEYYL 229
Query: 559 GKP 561
G
Sbjct: 230 GFT 232
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ G+ IG G+FG ++ GTN AIK +P+ ++ QL E + L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDA-PQLRDEYRTYKLLA 63
Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I V Y+G E H + ++ + P S+ + R + V + +L +
Sbjct: 64 GCTGIPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 472 YLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTG--LSYE--LSLKG 518
+H + ++RDIK N L+ ++ + DFGM K +T + Y +L G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 519 SPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +M+ Q +D D+ +LG + L G PW
Sbjct: 181 TARYMSINTHLGREQSRRD---------DLEALGHVFMYFLRGSLPW 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 55/243 (22%), Positives = 85/243 (34%), Gaps = 71/243 (29%)
Query: 360 KLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
+G GTFG V + G + A+K II + K + EI VL +K +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK---IIRNVGKYR---EAARLEINVLKKIKEKDK 78
Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
V H+ I E + N + ++E+ + VR+ + +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 470 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 505
L +LH H D+K N L V++ +++ADFG A
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 506 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 558
H T ++ Y PEVI L L D+WS+GC + E
Sbjct: 196 HTTIVATRHYR----------PPEVI-----------LELGWAQPCDVWSIGCILFEYYR 234
Query: 559 GKP 561
G
Sbjct: 235 GFT 237
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 39/228 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ GK IG G FG + +G N T AIK E P + QL E + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-------PMKSRA-PQLHLEYRFYKQL 61
Query: 414 KH-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
+ I V Y+G + + LE + P S+ R + V +++ +
Sbjct: 62 GSGDGIPQVYYFGPC--GKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 471 AYLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTGLSYE----LSLK 517
Y+HS N I+RD+K N L+ G V+ + DF +AK T SL
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 518 GSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ +M+ Q +D D+ +LG + L G PW
Sbjct: 179 GTARYMSINTHLGKEQSRRD---------DLEALGHMFMYFLRGSLPW 217
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++GRG FG VY G G A+K + + ++ Q + E++++ H N+++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH-----ILNGLAYLH 474
G + L +Y Y+ GS+ +RE + + R GLAYLH
Sbjct: 92 LRGFCMTPTERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLH 148
Query: 475 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIK 529
IHRD+K AN+L+D + DFG+AK + ++ ++G+ +APE +
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G K + D++ G ++E++TG+
Sbjct: 209 T-----G--KSSEKTDVFGYGVMLLELITGQRA 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 48/257 (18%), Positives = 78/257 (30%), Gaps = 78/257 (30%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+QW GK IG G FG +Y+ A ++ + + L E+K
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH---VVKVEYQEN---GPLFSELKFYQR 89
Query: 413 LKHENIVQYYGSEVVDDHLYI-YLEY--VHPGSINRY--------------VREHCRDIT 455
+ ++ ++ + D+L I + Y +
Sbjct: 90 VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK 149
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKH------- 506
+S V +L+ L Y+H +H DIK ANLL+ V LAD+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 507 ----------LTG----------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546
G LS + D+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRS--------------------------DV 243
Query: 547 WSLGCTVIEMLTGKPPW 563
LG ++ L GK PW
Sbjct: 244 EILGYCMLRWLCGKLPW 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GTN +T AIK ++ P QL E K+ L+
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQ 60
Query: 415 -HENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I V+++G E D+ + ++ + P S+ R ++ V ++N +
Sbjct: 61 GGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 472 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 520
++HS + +HRDIK N L+ + V + DFG+AK S +L G+
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 521 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + + Q +D D+ SLG ++ L G PW
Sbjct: 178 RYASVNTHLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 45/242 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ W+ G IG+G FG +Y+ + + S ++ +P L E+K
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQR 89
Query: 413 LKHENIVQ-----------------YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRD 453
+Q G + Y ++ + + + + +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR 148
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAK----HL 507
+ V + IL+ L Y+H +H DIK +NLL++ V L D+G+A
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 508 TGLSYEL----SLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+Y G+ + + + V + D+ LG +I+ LTG
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG---------DLEILGYCMIQWLTGHL 259
Query: 562 PW 563
PW
Sbjct: 260 PW 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 4e-14
Identities = 40/204 (19%), Positives = 64/204 (31%), Gaps = 47/204 (23%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-- 405
S + Q+ + IG G FG V+ T AIK + I D + K E+
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 406 -EIKVLGHL---------KHENIVQYYGSEVV---------------------------- 427
EI + L + E + V
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 428 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIK 484
DD L+I LE+ G +R + ++ + LA ++ HRD+
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 485 GANLLVDASGVVKLADFGMAKHLT 508
N+L+ + + KL K T
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST 213
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 45/242 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------ASCAIKEVDIIPDDPKSAECIKQLE 404
QW+ R G +Y T ++K + D + +
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ 97
Query: 405 QEIKV--------LGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHC--RD 453
+ K L I G V D + ++ L + S+ +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHV 155
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKH----L 507
++E V +L+ L +LH +H ++ N+ VD V LA +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 561
++Y +G +++ ++ K + D+ SLG +++ L G
Sbjct: 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS---------DLQSLGYCMLKWLYGFL 266
Query: 562 PW 563
PW
Sbjct: 267 PW 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 30/131 (22%), Positives = 54/131 (41%), Gaps = 11/131 (8%)
Query: 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496
+ +T + ++ + G+ +L S IHRD+ N+L+ VV
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 497 KLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
K+ DFG+A+ + + + WMAPE I + + D+WS G +
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLL 285
Query: 554 IEMLT-GKPPW 563
E+ + G P+
Sbjct: 286 WEIFSLGASPY 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK +GRG FG V T + A+K + + +E + L E+K+L H+
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSE-HRALMSELKILIHI 82
Query: 414 -KHENIVQYYG-SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
H N+V G L + +E+ G+++ Y+R + + G
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA--RFRQGKD 140
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
Y+ I D+K + +S + F K L+ + E
Sbjct: 141 YV---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 41/263 (15%), Positives = 83/263 (31%), Gaps = 61/263 (23%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 414
+ +G G F +V++ + + A+K ++ E EI++L ++
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTE---TALDEIRLLKSVRNSDPN 96
Query: 415 ---HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHI 466
E +VQ + H+ + E + + +++ + + + + V+ + +
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 467 LNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADF-------GMAKHLTGLSYELSLKG 518
L GL YLH+ IH DIK N+L+ + S +
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 519 SPNWMAPEVIKAVMQKDGNPKLA---------------------------------LAVD 545
+ ++ + K+A D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 546 IWSLGCTVIEMLTGKPPWSEFEG 568
IWS C E+ TG + G
Sbjct: 276 IWSTACMAFELATGDYLFEPHSG 298
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 48/384 (12%), Positives = 103/384 (26%), Gaps = 106/384 (27%)
Query: 133 LNIESVKNDLRPSVPVRSTPTSL-------SSSHA-----------VSPQRSN---LQNP 171
L I S++ +LR + + L ++ + + L
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 172 TPLHNPKSISTRRRGFSHDLNIE-CANY-SSRADIIPKSAPTSVFSSPAVSPQSSKTGNV 229
T H S+ + D Y R +P+ T +P+
Sbjct: 285 TTTH--ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-------TNPR------R 329
Query: 230 FSSFWA-----PKEIQDWSTAEVPDLGRFVG-CTSPVSPFK-RNVYSA-----DHSPLPS 277
S +W L + + + P + R ++ + +P+
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
Query: 278 PPRQS--SQSNLRSPRKVYFPLRHKSL-PQNSKE------------LLESNNHLNAH--- 319
V L SL + KE ++ N H
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 320 ------PLPLPPGALSPPKSS--VTSAVMPHIM-----EKPSASPKKSQ---WQKGKLIG 363
P L PP S + H+ E+ + + + K+
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR- 508
Query: 364 RGTFGSVYIGTNRETGASCA--IKEVD-----IIPDDPKSAECIKQLEQEIKVLG-HL-- 413
+ T S ++++ I +DPK + + + + +L
Sbjct: 509 -------HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC 561
Query: 414 -KHENIVQYYGSEVVDDHLYIYLE 436
K+ ++++ ++ + I+ E
Sbjct: 562 SKYTDLLR---IALMAEDEAIFEE 582
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 571 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.65 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 86.58 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.47 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=417.03 Aligned_cols=203 Identities=28% Similarity=0.536 Sum_probs=181.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+++|+.++|||||+++++|.+++.+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 479999999999999999999999999999999863210 011224678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC---
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~--- 510 (571)
|||||+||+|.++|.+. +.++|.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999875 57999999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCcccCcccCCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23346789999999999974 35789999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=419.20 Aligned_cols=204 Identities=29% Similarity=0.505 Sum_probs=177.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|++|+|||||++++++.+++.+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 3589999999999999999999999999999999875332 3445678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
||||||+||+|.++|... ...+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999999764 3457999999999999999999999999999999999999999999999999998775432
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|||||++. +..|+.++||||||||||||++|+.||.+.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~-------~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICE-------NKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 234567999999999987 346899999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=415.62 Aligned_cols=200 Identities=35% Similarity=0.601 Sum_probs=180.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+++|+.++|||||+++++|.+++.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45799999999999999999999999999999999754322 1345789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
||||||+||+|.+++.+ ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 148 ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999999999976 46999999999999999999999999999999999999999999999999999987553 3
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|||||++. +..|+.++||||||||+|||++|+.||.+.
T Consensus 226 ~~~~~~GTp~YmAPEvl~-------~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCcCcCCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 445688999999999986 346899999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=400.85 Aligned_cols=203 Identities=30% Similarity=0.520 Sum_probs=165.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+++.+|+++|+.++|||||++++++.+++.+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 589999999999999999999999999999999864321 122345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||| +|+|.++|.+. +.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+........
T Consensus 91 vmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 99999 68999999775 57999999999999999999999999999999999999999999999999999987766656
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...+||+.|||||++.+ ...++.++|||||||++|||++|+.||.+.
T Consensus 169 ~~~~GT~~Y~APE~~~~------~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------CTTSCHHHHSS------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCeeECcccCChhhhcC------CCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 67889999999999863 334568999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=419.43 Aligned_cols=200 Identities=35% Similarity=0.601 Sum_probs=180.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.+.|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 45799999999999999999999999999999999754322 1345789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
||||||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 225 iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999999999975 46999999999999999999999999999999999999999999999999999987553 3
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|||||++. +..|+.++||||||||+|||++|+.||.+.
T Consensus 303 ~~~~~~GTp~YmAPEvl~-------~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CBCCCEECTTTCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCcCcCCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 445678999999999986 346899999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=404.75 Aligned_cols=197 Identities=29% Similarity=0.509 Sum_probs=174.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4579999999999999999999999999999999874211 236999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccccCCc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l~~~~ 511 (571)
||||||+||+|.++|++. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 127 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999999875 5699999999999999999999999999999999999999887 69999999998775432
Q ss_pred c------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 Y------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ....+||+.|||||++. +..|+.++|||||||+||||++|+.||.+..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVM-------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp --------CCCCCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred cccceecCCccccCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 1 12367999999999997 3468899999999999999999999997643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=393.38 Aligned_cols=199 Identities=31% Similarity=0.566 Sum_probs=175.2
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----CCeE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHL 431 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----~~~l 431 (571)
|++.+.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+++|++|+|||||+++++|.+ ++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 478889999999999999999999999999986432 234456789999999999999999999999875 3568
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd-~~g~vKLiDFGlA~~l~ 508 (571)
|||||||+||+|.++|.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|+...
T Consensus 105 ~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999875 57999999999999999999999998 99999999999997 47999999999998654
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ......+||+.|||||++.. .|+.++|||||||+||||++|+.||.+..
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~~--------~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred C-CccCCcccCccccCHHHcCC--------CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 3 33446789999999998752 48899999999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=402.88 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=171.5
Q ss_pred CCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
++|++++.||+|+||+||+|++. .+++.||||++........ ...++.+|+++|++++|||||++++++.+++.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 58999999999999999999874 4688999999864221111 12357789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG- 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~- 509 (571)
+|||||||+||+|.++|.+. +.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999875 5799999999999999999999999999999999999999999999999999987544
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVN-------RRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHH-------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccccCcccCCHHHhc-------cCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 33345678999999999997 346889999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=395.92 Aligned_cols=208 Identities=29% Similarity=0.489 Sum_probs=177.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
++...+++++++.||+|+||+||+|+++. .||||+++... ...+..+.+.+|+++|++++|||||++++++. +
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~ 103 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K 103 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C
Confidence 55667799999999999999999998653 59999986433 23456788999999999999999999999875 5
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|||||||+||+|.++|......+++.++..|+.||+.||+|||++|||||||||+||||++++.+||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 67899999999999999998776789999999999999999999999999999999999999999999999999998764
Q ss_pred CCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... .....+||+.|||||++... ....|+.++|||||||+||||++|+.||.+..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCcceeecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 322 23356899999999999731 13468999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=394.99 Aligned_cols=205 Identities=32% Similarity=0.588 Sum_probs=177.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
..+++|.+.+.||+|+||+||+|++. .+|..||||+++. ......+.+.+|+++|++++|||||++++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 34568999999999999999999875 4688999999863 2345567899999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
.+.+.+|||||||+||+|.++|++.+ ..+++.++..|+.||++||+|||+++||||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999997642 469999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+.+||+|||+++........ ....||+.|||||++.. ..|+.++|||||||+||||+| |+.||.+..
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999876543322 23468999999999974 368999999999999999998 999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=392.77 Aligned_cols=205 Identities=28% Similarity=0.530 Sum_probs=172.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
....+|.+.+.||+|+||+||+|+++ .+++.||||+++. ......+.+.+|+++|++++|||||+++++|
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34568999999999999999999865 4688999999863 2345567899999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~--------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd 491 (571)
.+.+.+|||||||++|+|.++|++.. ..+++.++..|+.||++||+|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 99999999999999999999997642 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 492 ASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 492 ~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.++.+||+|||+++.+..... .....||+.|||||++. +..|+.++|||||||+||||+| |+.||.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-------~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhc-------CCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999999999987644322 23467999999999987 4468999999999999999999 999997653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=387.76 Aligned_cols=206 Identities=24% Similarity=0.398 Sum_probs=177.2
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
....++++.+.||+|+||+||+|.+. .+++.||||+++.... ....+.+.+|+.+|++++|||||+++|++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 34568999999999999999999864 4678999999863322 23346789999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 490 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~---------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL 490 (571)
.+++.+|||||||++|+|.++|... ...+++.++..|+.||++||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999753 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 491 DASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 491 d~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
++++.+||+|||+++.+.... .....+||+.|||||++.. ..|+.++|||||||+||||+| |+.||.+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-------CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999998765432 2234679999999999974 368999999999999999998 89999865
Q ss_pred C
Q 008285 567 E 567 (571)
Q Consensus 567 e 567 (571)
.
T Consensus 252 ~ 252 (308)
T 4gt4_A 252 S 252 (308)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=381.89 Aligned_cols=197 Identities=27% Similarity=0.509 Sum_probs=162.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC-----
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----- 429 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~----- 429 (571)
+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 6999999999999999999999999999999987532 2345577899999999999999999999987655
Q ss_pred -------eEEEEEeecCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEe
Q 008285 430 -------HLYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (571)
Q Consensus 430 -------~lyLVmEy~~GGsL~d~L~~~~~--~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiD 500 (571)
.+|||||||.||+|.+++..... ...+..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999986432 345677889999999999999999999999999999999999999999
Q ss_pred cCCcccccCCcc-------------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 501 FGMAKHLTGLSY-------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 501 FGlA~~l~~~~~-------------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||+|+.+..... ....+||+.|||||++. +..|+.++|||||||++|||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-------GNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHc-------CCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999987654321 12357999999999986 3468999999999999999996 7753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=394.74 Aligned_cols=203 Identities=30% Similarity=0.490 Sum_probs=177.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----- 427 (571)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ......+++.+|+++|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF---DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc---cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 358999999999999999999999999999999986432 234456778899999999999999999998764
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+.+|||||||+ |+|.++|.+. +.+++.+++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+++.
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 367899999996 7799999764 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCC-----ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGL-----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~-----~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+... ......+||+.|||||++.+ ...|+.++||||||||+|||++|+.||.+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~------~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLS------LHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccCccccccccccceeChHhcCHHHhcC------CCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 6432 22345789999999999863 345789999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=384.41 Aligned_cols=207 Identities=26% Similarity=0.461 Sum_probs=177.4
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIVkl~g 423 (571)
+...++|++++.||+|+||+||+|.+..+ ++.||||.+... ......+.+.+|+++|.++.| ||||++++
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~----~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45567999999999999999999997654 357999987632 233456779999999999965 89999999
Q ss_pred eEEeC-CeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008285 424 SEVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487 (571)
Q Consensus 424 ~~~~~-~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsN 487 (571)
+|... +.+|||||||++|+|.++|++.. ..+++.++..|+.||++||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98764 56899999999999999997632 348999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008285 488 LLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563 (571)
Q Consensus 488 ILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF 563 (571)
|||++++.+||+|||+|+.+..... ....+||+.|||||++.. ..|+.++|||||||+||||++ |+.||
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-------CCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 9999999999999999987654332 234679999999999974 468999999999999999998 99999
Q ss_pred CCCC
Q 008285 564 SEFE 567 (571)
Q Consensus 564 ~~~e 567 (571)
.+..
T Consensus 289 ~~~~ 292 (353)
T 4ase_A 289 PGVK 292 (353)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 8754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=409.29 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=180.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC-CcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
...++|++++.||+|+||+||+|+++.+|+.||||++..... .............++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 345689999999999999999999999999999999863210 0112233334455677888889999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|||||||.||+|.++|.+. +.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999999876 5699999999999999999999999999999999999999999999999999988765
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ....+||+.|||||++.. +..|+.++||||||||||||++|+.||.+.
T Consensus 345 ~~-~~t~~GTp~YmAPEvl~~------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 KK-PHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CC-CCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CC-CCCccCCcCccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43 346789999999999862 346889999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=401.52 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=183.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++|+.|+|||||+++++|.+++.+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 5899999999999999999999999999999998642 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEEecCCcccccCCc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||+||+|.++|.+....+++.+++.++.||+.||.|||++||+||||||+||||+. .+.+||+|||+++.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999999766678999999999999999999999999999999999999974 4899999999999887766
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|||||++. +..|+.++|||||||+||||++|+.||.+.
T Consensus 312 ~~~~~~GT~~y~APEv~~-------~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp EEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ceeeeEECccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 666788999999999987 346899999999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=372.58 Aligned_cols=201 Identities=26% Similarity=0.359 Sum_probs=164.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
++|.+.+.||+|+||+||+|++ +|+.||||++... .......+.|+.++.+++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 4789999999999999999987 5899999998531 111223345677777889999999999998764
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEEEec
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~--------GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
.+|||||||+||+|.++|+. ..+++..+..++.||+.||+|||++ |||||||||+||||+.++.+||+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 58999999999999999976 4699999999999999999999987 9999999999999999999999999
Q ss_pred CCcccccCCccc-----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 502 GMAKHLTGLSYE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 502 GlA~~l~~~~~~-----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
|+++........ ...+||+.|||||++.+..... ...++.++|||||||+||||++|+.||..
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~-~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTT-CHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhccccccc-CCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 999876543221 2357999999999996421110 12467799999999999999999877653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=377.04 Aligned_cols=196 Identities=25% Similarity=0.435 Sum_probs=169.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~ 428 (571)
.++|++++.||+|+||+||+|+++ .+++.||||.+.... ...++.+|+++|+.+ .|+|||+++++|.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 458999999999999999999875 467899999875321 124577899999998 599999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA~~l 507 (571)
+.+|||||||+||+|.+++. .+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+..
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999999983 49999999999999999999999999999999999999876 89999999999765
Q ss_pred cCCc-----------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc
Q 008285 508 TGLS-----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 508 ~~~~-----------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
.... .....+||+.|||||++.+ ...|+.++||||+|||+|||++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK------CPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC------CCCCCCccchhhhHHHHHHHHH
Confidence 4321 1123579999999999863 3458899999999999999999
Q ss_pred CCCCCCC
Q 008285 559 GKPPWSE 565 (571)
Q Consensus 559 Gr~PF~~ 565 (571)
|+.||..
T Consensus 243 G~~Pf~~ 249 (361)
T 4f9c_A 243 GRYPFYK 249 (361)
T ss_dssp TCSSSSC
T ss_pred CCCCCCC
Confidence 9999954
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.53 Aligned_cols=205 Identities=29% Similarity=0.517 Sum_probs=184.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+++|+.++|+||+++++++...+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3458999999999999999999999999999999986432 2345567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999999775 569999999999999999999999999999999999999999999999999998776665
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQG------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHT------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCcceeCcccccC------CCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 5667789999999999873 233458999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.07 Aligned_cols=206 Identities=30% Similarity=0.540 Sum_probs=178.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+.+|+.++++++|+||+++++++...+.+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3568999999999999999999999999999999986433 23456678899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999999875 569999999999999999999999999999999999999999999999999998765432
Q ss_pred --cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 --~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAK-------GEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ---------CCSSCCHHHHH-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccCccccCccccCHhHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223456999999999987 3457889999999999999999999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=342.45 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=181.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|.+..+|+.||+|.+... ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 46899999999999999999999999999999998632 123456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEEecCCcccccCC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~l~~~ 510 (571)
+|||||.|++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999999776667999999999999999999999999999999999999986 789999999999987665
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CccccccCChhhcCcHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 55556779999999999863 35788999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.81 Aligned_cols=203 Identities=31% Similarity=0.526 Sum_probs=181.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|.+..+|+.||+|.+.. ......+.+.+|+++++.++|+||+++++++.+++..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34689999999999999999999999999999998743 2345668899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
++||||+.|++|.+++......+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999998764432
Q ss_pred cc---------------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YE---------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~---------------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ....||+.|+|||++. +..++.++|||||||++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-------GRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 21 1457999999999986 346789999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.33 Aligned_cols=206 Identities=28% Similarity=0.473 Sum_probs=174.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
...++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.+ .|+||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 345689999999999999999999999999999999863110 1122346678899999988 6999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999986432
Q ss_pred -CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 -~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++... .++.++|||||||++|||++|+.||.+.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEM-------LYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ---------CCGGGCCHHHHHHH-------HCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccccCCCcCeEChhhcCCC-------CcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 3334467899999999998743 4678999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.89 Aligned_cols=204 Identities=28% Similarity=0.482 Sum_probs=181.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34589999999999999999999999999999999874322 2345567788999999988 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-C
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-G 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~-~ 509 (571)
+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++... .
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999875 569999999999999999999999999999999999999999999999999998643 2
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccCCCccccCccccC-------CCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 33344678999999999986 34578999999999999999999999965
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.37 Aligned_cols=201 Identities=36% Similarity=0.629 Sum_probs=179.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++|+||+++++++...+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 345899999999999999999999999999999998743322 135678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+|||||.||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999999999764 69999999999999999999999999999999999999999999999999998765433
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHH-------CSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccCCccCCcCccChhhhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233567999999999987 346789999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=347.78 Aligned_cols=204 Identities=29% Similarity=0.472 Sum_probs=179.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4589999999999999999999999999999999863110 01112456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Cc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~ 511 (571)
+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999999999765 5799999999999999999999999999999999999999999999999999986432 33
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CBCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccChhhCChhhhc-------CCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 344678999999999986 345788999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.57 Aligned_cols=207 Identities=25% Similarity=0.471 Sum_probs=182.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
..++|++++.||+|+||+||+|+++.+|+.||||++........ .....+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34689999999999999999999999999999999875432211 11124678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKH 506 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~ 506 (571)
+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999764 5799999999999999999999999999999999999998776 799999999998
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.........+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCCCCccccCCCCccEECchHHc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 76655555678999999999986 346789999999999999999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=358.27 Aligned_cols=214 Identities=26% Similarity=0.410 Sum_probs=184.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|..++|+||+++++++.+.+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345689999999999999999999999999999999863110 011123447789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|||||||.||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999887668999999999999999999999999999999999999999999999999999876543
Q ss_pred cc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ....+||+.|+|||++...........|+.++|||||||++|||++|+.||.+.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 32 234689999999999975433333446889999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.80 Aligned_cols=205 Identities=27% Similarity=0.477 Sum_probs=179.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
...++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+.+|..+|.++ +||||+++++++.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 345689999999999999999999999999999999874322 1223345678899999887 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc-c
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-T 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l-~ 508 (571)
.+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.. .
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999999875 56999999999999999999999999999999999999999999999999999863 3
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
........+||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~-------~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCccccccCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 344455678999999999987 34678999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.78 Aligned_cols=203 Identities=29% Similarity=0.479 Sum_probs=181.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999874332 3445677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~l~~ 509 (571)
+|||||.||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999999764 569999999999999999999999999999999999999754 4599999999988766
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccCCCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 55555678999999999986 346889999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.59 Aligned_cols=206 Identities=32% Similarity=0.493 Sum_probs=172.0
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHH-HhhcCCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~I-L~~L~HpNIVkl~g~~~~~~ 429 (571)
...++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+..|..+ ++.++|+||+++++++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3456899999999999999999999999999999998643211 12234556677776 57789999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999986433
Q ss_pred -CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 -~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCccccccCCccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 33445678999999999986 345889999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=354.36 Aligned_cols=211 Identities=25% Similarity=0.413 Sum_probs=181.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+.+|+.++..++|+||+++++++.+.+.+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 456899999999999999999999999999999998631100 000122377899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||||.||+|.+++.+....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999999998766789999999999999999999999999999999999999999999999999998765433
Q ss_pred c--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ....+||+.|||||++..... +...++.++|||||||++|||++|+.||.+.
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~--~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEG--GKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHT--SCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CcccccccCCcCeeChHHHhhccc--CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 2 234679999999999974321 2345788999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.28 Aligned_cols=208 Identities=29% Similarity=0.469 Sum_probs=177.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||+||+|.++.+|+.||||++.............+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34589999999999999999999999999999999864211000011246688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEEecCCcc
Q 008285 432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAK 505 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~---vKLiDFGlA~ 505 (571)
|+|||||+|++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999988653 235899999999999999999999999999999999999976554 9999999998
Q ss_pred cccCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 506 HLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....... ....+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVK-------REPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EecCCCeeecCCcCCcCccCHHHHc-------CCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 7755332 33567999999999986 335789999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=333.39 Aligned_cols=213 Identities=30% Similarity=0.503 Sum_probs=182.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~-- 429 (571)
...+|++.+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+++|++++|+||+++++++...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 456899999999999999999999999999999998642211 12456779999999999999999999988765
Q ss_pred eEEEEEeecCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEEecCC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 503 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~--~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL----d~~g~vKLiDFGl 503 (571)
.+|+||||+.|++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999986433 39999999999999999999999999999999999999 7888899999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhh-cCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQ-KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~-~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
++............||+.|+|||++..... ......++.++|||||||++|||++|+.||...++
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 998776665566789999999999874321 11235688999999999999999999999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.50 Aligned_cols=202 Identities=26% Similarity=0.519 Sum_probs=178.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 4589999999999999999999999999999999863110 00112456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999999875 56999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 160 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVS-------TKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp BCCCCSCTTTCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCccccCHhHhc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 33567999999999986 345788999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.52 Aligned_cols=206 Identities=27% Similarity=0.466 Sum_probs=178.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
...++|++.+.||+|+||+||+|+++.+|+.||||+++.... ......+.+..|..++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh--hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345699999999999999999999999999999999863210 0011235577899999877 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999986432
Q ss_pred -CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 -~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcccCCCCCcccCChhhhc-------CCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 33345678999999999986 345789999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=335.15 Aligned_cols=206 Identities=26% Similarity=0.460 Sum_probs=181.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.++|++.+.||+|+||.||+|.++.+|+.||||++........ .....+.+.+|+.+|+.++|+||+++++++...+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999875433211 111246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCcccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHL 507 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~l 507 (571)
|+||||+.|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999764 5799999999999999999999999999999999999998877 8999999999887
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCCccccccCCcCcCCceeec-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 6554455677999999999986 346789999999999999999999999653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=340.25 Aligned_cols=202 Identities=17% Similarity=0.236 Sum_probs=172.0
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEE-----EECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC---CCCeeE
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQ 420 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla-----~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~---HpNIVk 420 (571)
......+|++.+.||+|+||+||+| .+..+++.||||++... . ...+..|+++++.++ |+||++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~---~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----N---PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----C---HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----C---hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 3445678999999999999999999 46778999999998632 1 245667777777776 999999
Q ss_pred EeeeEEeCCeEEEEEeecCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----
Q 008285 421 YYGSEVVDDHLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---- 492 (571)
Q Consensus 421 l~g~~~~~~~lyLVmEy~~GGsL~d~L~~----~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---- 492 (571)
+++++...+..|||||||.||+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999975 2456999999999999999999999999999999999999988
Q ss_pred -------CCcEEEEecCCccccc---CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008285 493 -------SGVVKLADFGMAKHLT---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (571)
Q Consensus 493 -------~g~vKLiDFGlA~~l~---~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P 562 (571)
++.+||+|||+++.+. ........+||+.|||||++. +..++.++|||||||++|||++|+.|
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-------NKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-------TCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-------CCCCCccccHHHHHHHHHHHHhCCCc
Confidence 8999999999997543 233344577999999999986 33588999999999999999999999
Q ss_pred CCC
Q 008285 563 WSE 565 (571)
Q Consensus 563 F~~ 565 (571)
|..
T Consensus 285 f~~ 287 (365)
T 3e7e_A 285 KVK 287 (365)
T ss_dssp CEE
T ss_pred ccc
Confidence 853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.96 Aligned_cols=205 Identities=24% Similarity=0.455 Sum_probs=172.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH- 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~- 430 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+.+|+.+++.++|+||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 4568999999999999999999999999999999986432 2345566788999999999999999999999876543
Q ss_pred ---EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 431 ---LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 ---lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.|+||||++|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999875 56999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ---------------CCTTCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCcCcccCCHHHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 44321 22356999999999987 346889999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.90 Aligned_cols=211 Identities=25% Similarity=0.451 Sum_probs=184.8
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3445689999999999999999999999999999999863210 01112466889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999999764 5699999999999999999999999999999999999999999999999999998776
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......+||+.|+|||++... .+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSR----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCC----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCceeccCCCccccCCeeeccC----CCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 6666678899999999998631 12357889999999999999999999997543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.75 Aligned_cols=201 Identities=31% Similarity=0.509 Sum_probs=175.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||+||+|.++.+|+.||||++...... ....+.+.+|+.++++++|+||+++++++.+++.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 4899999999999999999999999999999998754322 2345677899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~ 512 (571)
||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 79 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999997 4676777665678999999999999999999999999999999999999999999999999999876532 22
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.....||+.|+|||++.+ ...++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ccCCccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 335678999999999863 3347899999999999999999888863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.72 Aligned_cols=206 Identities=27% Similarity=0.412 Sum_probs=178.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
....+|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+..|..+|..+ +|+||+++++++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 345699999999999999999999999999999999864210 0011245678899999988 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999986432
Q ss_pred -CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 -~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHT-------TCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccccCCccccChhhhc-------CCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 33344678999999999986 345789999999999999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=335.00 Aligned_cols=206 Identities=28% Similarity=0.426 Sum_probs=169.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..++|++.+.||+|+||.||+|++. .+|+.||||++...... ........+.+|+.+|+.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4568999999999999999999985 68999999998643211 1123345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|+|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999999775 569999999999999999999999999999999999999999999999999998643
Q ss_pred C-CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 G-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~-~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ........||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILM-------RSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ------CTTSSCCTTSCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCccccccCCCcCccCHhhCc-------CCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 3 22334567999999999986 335788999999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=334.62 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=177.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
...+|++.+.||+|+||.||+|++..+|+.||||++...... +.+.+|+++++.+ +|+||+++++++...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 346899999999999999999999999999999998643221 3477899999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----EEEEecCCcc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-----VKLADFGMAK 505 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~-----vKLiDFGlA~ 505 (571)
.|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 99999999876678999999999999999999999999999999999999998887 9999999998
Q ss_pred cccCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.+..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHL-------GKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHc-------CCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 7644322 23567999999999987 3467899999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=349.15 Aligned_cols=208 Identities=29% Similarity=0.449 Sum_probs=178.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|+++.+|+.||+|++...... .....+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 456899999999999999999999999999999998631100 000113467899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||||.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999999999976 469999999999999999999999999999999999999999999999999998765543
Q ss_pred c--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ....+||+.|+|||++.... ....++.++|||||||+||||++|+.||.+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTT---TTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCcCCccccCHHHhhccC---CCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 2 23578999999999997421 1123778999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=330.98 Aligned_cols=208 Identities=27% Similarity=0.465 Sum_probs=173.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV 427 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~ 427 (571)
...++|++.+.||+|+||+||+|++..+|+.||||++...............+.+|+++++.+ +|+||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 345699999999999999999999999999999999875432221111223455666666665 49999999999887
Q ss_pred CC-----eEEEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 428 DD-----HLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 428 ~~-----~lyLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
.. .+++||||+. ++|.+++..... .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999997 699999986532 3999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+++............||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHH-------TSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred ccccccCCCcccCCccccccccCchHHc-------CCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998776655555678999999999987 345788999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.19 Aligned_cols=203 Identities=32% Similarity=0.506 Sum_probs=179.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|+||+++++++.+.+.+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34689999999999999999999999999999999863210 0111246678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 195 -~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp -BCCCEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -cccccCCccccCHHHhc-------CCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 23567999999999986 345788999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.19 Aligned_cols=206 Identities=29% Similarity=0.495 Sum_probs=176.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|+++|+.++|+||+++++++.+.+.+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 4469999999999999999999986 489999999864322 223346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|+||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999998 5888888877677999999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+...
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp C---CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred ccccCCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 22334678999999999863 34578999999999999999999999976543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=318.69 Aligned_cols=204 Identities=28% Similarity=0.468 Sum_probs=182.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++|+||+++++++...+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 45699999999999999999999999999999999874332 344567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~---vKLiDFGlA~~l~ 508 (571)
|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999999775 56999999999999999999999999999999999999976655 9999999998876
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.........||+.|+|||++. ...++.++||||||+++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCccccCCCCCcCCcCchhhc-------CCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 655555678999999999986 345788999999999999999999999654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.20 Aligned_cols=203 Identities=21% Similarity=0.380 Sum_probs=181.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||+|.++.+|+.||+|++... .......+.+|+++|+.++|+||+++++++.+.+.+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 35899999999999999999999999999999998632 1233457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEEecCCcccccCC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~l~~~ 510 (571)
+|||||.||+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+...
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999999876667999999999999999999999999999999999999974 578999999999987665
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 205 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp SCEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cceeeeccCCCccCchhcc-------CCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 5555567999999999986 3457899999999999999999999997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.52 Aligned_cols=205 Identities=31% Similarity=0.574 Sum_probs=176.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 45699999999999999999999999999999999864322 22335678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+|||||.|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999999998654 469999999999999999999999999999999999999999999999999998654322
Q ss_pred ---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccccCCCccCcCccCcHHhcc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2235679999999999873 2334778999999999999999999997644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=345.77 Aligned_cols=199 Identities=27% Similarity=0.412 Sum_probs=165.1
Q ss_pred CCCeEEe-eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhh-cCCCCeeEEeeeEEe---
Q 008285 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV--- 427 (571)
Q Consensus 353 ~~~y~i~-k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~-L~HpNIVkl~g~~~~--- 427 (571)
..+|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|++++.+ ++|+||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3578776 7999999999999999999999999998621 345678888744 579999999998876
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecC
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG 502 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFG 502 (571)
.+.+|||||||.||+|.++|.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999998643 35999999999999999999999999999999999999987 7899999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
+++...........+||+.|+|||++. ...++.++|||||||++|||++|+.||.+..+
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TCEECC-----------CTTCCGGGSC-------CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcC-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 998776555455678999999999885 34688999999999999999999999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.40 Aligned_cols=207 Identities=28% Similarity=0.537 Sum_probs=179.4
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeE
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k-------~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVk 420 (571)
.....++|++++.||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+++|+.+ +|+||++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCC
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 4445679999999999999999999874 34567999987632 2345567899999999999 8999999
Q ss_pred EeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008285 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485 (571)
Q Consensus 421 l~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKP 485 (571)
+++++...+.+|+||||+.||+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999999999999999999999999998653 2489999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008285 486 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 561 (571)
Q Consensus 486 sNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~ 561 (571)
+||||+.++.+||+|||+++.+..... .....|++.|+|||++. +..++.++|||||||++|||++ |+.
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt~g~~ 304 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGS 304 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-------CCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999987654322 23355788999999987 3468999999999999999999 999
Q ss_pred CCCCC
Q 008285 562 PWSEF 566 (571)
Q Consensus 562 PF~~~ 566 (571)
||.+.
T Consensus 305 p~~~~ 309 (370)
T 2psq_A 305 PYPGI 309 (370)
T ss_dssp SSTTC
T ss_pred CCCCC
Confidence 99764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.77 Aligned_cols=210 Identities=22% Similarity=0.428 Sum_probs=182.8
Q ss_pred CCCCCeEEeeEEeec--CceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 351 PKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G--~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
...++|++++.||+| +||+||+|+++.+|+.||||++.... ......+.+.+|+.+|+.++|+||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 345689999999999 99999999999999999999987532 2345677888999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|+|||||.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999999764 356999999999999999999999999999999999999999999999999988654
Q ss_pred cCC--------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 508 TGL--------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 508 ~~~--------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
... .......||+.|+|||++... ...++.++|||||||++|||++|+.||.+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhcc-----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 221 112234789999999998631 24578899999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.86 Aligned_cols=203 Identities=33% Similarity=0.589 Sum_probs=163.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++++.||+|+||+||+|.++.+|+.||||++....... ..+.+.+|+++|+.++|+||+++++++..++.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 458999999999999999999999999999999987543222 1245778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 433 IYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~-----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999998 69999997643 35899999999999999999999999999999999999999999999999999876
Q ss_pred cCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcccCCCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 532 22335679999999999863 335789999999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.52 Aligned_cols=202 Identities=29% Similarity=0.520 Sum_probs=172.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|.+ .+|+.||||++.....+ ....+.+.+|+++++.++|+||+++++++...+.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 4899999999999999999998 67999999998643322 1223567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~ 512 (571)
||||+.+ +|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 9999984 999999876677999999999999999999999999999999999999999999999999999876432 22
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999863 345789999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.37 Aligned_cols=199 Identities=26% Similarity=0.451 Sum_probs=173.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVm 435 (571)
|...+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+++|++++|+||+++++++...+.+||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34477899999999999999999999999998742 2344577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCcEEEEecCCcccccCCccc
Q 008285 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 436 Ey~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL--d~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||+|++|.+++......+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999999999998766679999999999999999999999999999999999999 56789999999999987665555
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.
T Consensus 246 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVN-------YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCCSSCTTCCHHHHT-------TCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCCCcEeChhhcc-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 5667999999999986 346789999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.40 Aligned_cols=204 Identities=30% Similarity=0.439 Sum_probs=166.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||+||+|+++.+|+.||||++...... .+.+.+|+.+++.++|+||+++++++...+.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 3456999999999999999999999999999999998743221 2457799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEEecCCccccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLT 508 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~--vKLiDFGlA~~l~ 508 (571)
+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++...
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999999765 56999999999999999999999999999999999999987665 9999999998655
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.........||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+..
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLR------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -----------CTTSCHHHHHC------SSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ccCCCCCCcCCCCcCChhhhcC------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 4444456779999999999873 2223445999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=350.70 Aligned_cols=206 Identities=29% Similarity=0.465 Sum_probs=171.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++++.||+|+||.||+|.+..+|+.||||++..... ........+.+|+.+|+.++|+||+++++++...+.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 345689999999999999999999999999999999863211 112334567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|||||||.||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999999775 579999999999999999999998 9999999999999999999999999999986433
Q ss_pred -CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 -LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 -~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++. +..++.++|||||||+||||++|+.||.+.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp -----CCSSSCGGGCCHHHHH-------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccccCCccccCHhhcC-------CCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 33344578999999999986 346889999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=326.08 Aligned_cols=200 Identities=26% Similarity=0.470 Sum_probs=170.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
++|++++.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+++|++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 479999999999999999999999999999999874332 234567889999999999999999999886643
Q ss_pred -----------------------------------------------------eEEEEEeecCCCCHHHHHHHhc--CCC
Q 008285 430 -----------------------------------------------------HLYIYLEYVHPGSINRYVREHC--RDI 454 (571)
Q Consensus 430 -----------------------------------------------------~lyLVmEy~~GGsL~d~L~~~~--~~L 454 (571)
.+|+|||||+|++|.+++.... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 3899999999999999998642 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-------------cccccCCCCc
Q 008285 455 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-------------YELSLKGSPN 521 (571)
Q Consensus 455 se~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-------------~~~~~~GT~~ 521 (571)
.+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 667789999999999999999999999999999999999999999999998765532 2234579999
Q ss_pred ccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 522 YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
|+|||++. +..++.++|||||||++|||++|..|+.
T Consensus 242 y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIH-------GNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHH-------CCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhc-------CCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999987 3467899999999999999999988763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.65 Aligned_cols=207 Identities=29% Similarity=0.461 Sum_probs=177.8
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
.....+|++.+.||+|+||.||+|.+..+|. .||||++... ......+.+.+|+.+|+.++|+||+++++++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456799999999999999999999986655 4999998632 23455677899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+.+.+|+||||++|++|.+++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999999999987767899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... .....+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF-------RTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCccceeeccCCCCcccccCHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 654321 123446778999999874 357889999999999999999 999997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.50 Aligned_cols=203 Identities=27% Similarity=0.446 Sum_probs=178.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 458999999999999999999999999999999987432 23345677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~l~~ 509 (571)
+|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 87 lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999999875 5699999999999999999999999999999999999998 467899999999987755
Q ss_pred Cc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLR-------KDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCceeecccCCcccCCHHHhc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 33 234567999999999986 346788999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=341.08 Aligned_cols=204 Identities=31% Similarity=0.516 Sum_probs=179.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+|+.++|+||+++++++...+.+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4589999999999999999999999999999999863110 00111346889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+||||+ +|+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 999999 78999999775 5699999999999999999999999999999999999999999999999999988776666
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+.
T Consensus 164 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVING------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TCCCTTSTTTSCGGGSCC------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cccccCCcCcCCHHHHcC------CCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 667789999999999863 222368999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=323.35 Aligned_cols=204 Identities=31% Similarity=0.532 Sum_probs=174.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 58999999999999999999999999999999875432 334556778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~ 512 (571)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999999988654 56999999999999999999999999999999999999999999999999999876542 22
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -------GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 345679999999999863 3467889999999999999999999997653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.15 Aligned_cols=206 Identities=29% Similarity=0.514 Sum_probs=182.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
....+|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 345689999999999999999999999999999999864321 234556778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999999998765 57999999999999999999999999999999999999999999999999999876532
Q ss_pred -ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 -SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 -~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......|++.|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccccCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 23345679999999999863 35788999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.70 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=163.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++|++++|+||+++++++...+.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 3468999999999999999999999999999999987421 235677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFGlA~~l~ 508 (571)
|+||||+.|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999999764 56999999999999999999999999999999999999975 8899999999998776
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||.+..
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILR-------GCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ----------CGGGSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cccccccccCCCCccCHHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 554445677999999999986 3357899999999999999999999997544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=318.78 Aligned_cols=201 Identities=23% Similarity=0.339 Sum_probs=177.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~ 430 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 45689999999999999999999999999999998864322 13467899999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----EEEEecCCcc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-----VKLADFGMAK 505 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~-----vKLiDFGlA~ 505 (571)
.|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 99999999877667999999999999999999999999999999999999987765 9999999998
Q ss_pred cccCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 7654322 23467999999999986 3457899999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.04 Aligned_cols=200 Identities=28% Similarity=0.472 Sum_probs=179.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||+|.+..++..||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 35799999999999999999999999999999998643221 2466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l~~ 509 (571)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999999999775 569999999999999999999999999999999999999 7889999999999988766
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........||+.|+|||++.+ .++.++||||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEG--------LYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTT--------CBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccchhccCCCCCccChHHhcc--------cCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 655566789999999998752 3788999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=336.76 Aligned_cols=202 Identities=27% Similarity=0.507 Sum_probs=167.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC--e
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD--H 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~--~ 430 (571)
++|++++.||+|+||+||+|.+..+|+.||||++.... ......+++.+|+.+|+.+. |+||+++++++...+ .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 58999999999999999999999999999999875322 23455677889999999997 999999999987654 6
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
+|+|||||. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 899999997 689999976 46999999999999999999999999999999999999999999999999999865321
Q ss_pred ----------------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 ----------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ----------------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234679999999999863 3468899999999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.19 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=177.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-----CCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-----HpNIVkl~g~~ 425 (571)
...++|++++.||+|+||+||+|++..+|+.||||++.. .....+.+..|+++++.+. |+||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 345699999999999999999999999999999999862 2345566788999999986 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC------------
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA------------ 492 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~------------ 492 (571)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 899999998653 35999999999999999999999999999999999999975
Q ss_pred -------------CCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC
Q 008285 493 -------------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (571)
Q Consensus 493 -------------~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG 559 (571)
++.+||+|||+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL-------NLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc-------CCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999865442 23567999999999987 34688999999999999999999
Q ss_pred CCCCCCCC
Q 008285 560 KPPWSEFE 567 (571)
Q Consensus 560 r~PF~~~e 567 (571)
+.||...+
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.30 Aligned_cols=207 Identities=29% Similarity=0.500 Sum_probs=170.8
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.......+|++.+.||+|+||+||+|++ +|..||||++.... ......+.+.+|+++|++++|+||+++++++..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD---FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC---CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3445567999999999999999999987 58899999986432 234556788999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
.+.+++||||+.||+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999999997642 23999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLR-------DEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ----------------CCTTSCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CccccccccccccCCCCccccChhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 97654432 223467999999999986 345788999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.60 Aligned_cols=208 Identities=30% Similarity=0.501 Sum_probs=171.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---------------------CcHHHHHHHHHHHHHHh
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------------------KSAECIKQLEQEIKVLG 411 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---------------------~~~~~~k~l~~Ei~IL~ 411 (571)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... ......+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 458999999999999999999999999999999986432110 01123466889999999
Q ss_pred hcCCCCeeEEeeeEEe--CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 008285 412 HLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 489 (571)
Q Consensus 412 ~L~HpNIVkl~g~~~~--~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNIL 489 (571)
.++|+||+++++++.+ .+.+|+||||+++++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999887 5789999999999999886533 56999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 490 VDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 490 Ld~~g~vKLiDFGlA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|+.++.+||+|||+++...... ......||+.|+|||++... ....++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET----RKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT----CCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999998765432 23356799999999988631 0112477899999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=324.37 Aligned_cols=200 Identities=25% Similarity=0.352 Sum_probs=169.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~l 431 (571)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ..........|+..+..+ +|+||+++++++.+.+.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR---GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC---SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc---ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 3589999999999999999999999999999998753322 223334444555555554 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999 689999998877789999999999999999999999999999999999999999999999999998876655
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG--------SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--------CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CCcccCCCccccCHhHhcC--------CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 5556779999999998752 47889999999999999999976654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=325.67 Aligned_cols=206 Identities=24% Similarity=0.458 Sum_probs=181.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.++|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999875432211 111246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCcccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHL 507 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~l 507 (571)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999999764 5699999999999999999999999999999999999999887 7999999999887
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CccccccccCCCCCccCccccc-------CCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 6655445667999999999986 346788999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.83 Aligned_cols=213 Identities=26% Similarity=0.468 Sum_probs=186.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC----cHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK----SAECIKQLEQEIKVLGHLK-HENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~----~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~ 426 (571)
..++|++.+.||+|+||.||+|.++.+|+.||||++........ .....+.+.+|+++++++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45699999999999999999999999999999999875432211 1234567889999999996 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999999875 5699999999999999999999999999999999999999999999999999988
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...........|++.|+|||++...... ....++.++||||||+++|+|++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcccccccCCccccCHHHhcccccc-ccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 7665555567799999999998754322 2446788999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.79 Aligned_cols=202 Identities=28% Similarity=0.499 Sum_probs=172.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||+||+|.++.+|..||+|++...... ...+.+.+|+++|+.++|+||+++++++.+.+..|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 35899999999999999999999999999999998753322 12467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCccc
Q 008285 433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKH 506 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~ 506 (571)
+||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 4679999999999999999999999999999999999999 4567899999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...........||+.|+|||++.. .++.++|||||||++|||++|+.||.+.
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKR--------DVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--------CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcccCcCcccccCcCChHHhcc--------CCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 766555556779999999998742 4788999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.91 Aligned_cols=205 Identities=29% Similarity=0.520 Sum_probs=181.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 45689999999999999999999999999999999864322 2345567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|+||||+++++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999999998765 56999999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......|++.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLS-------KKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHT-------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccccCCCCcCCcchhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2233467999999999986 335788999999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.22 Aligned_cols=213 Identities=28% Similarity=0.483 Sum_probs=182.2
Q ss_pred ccCCCCCCCCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC
Q 008285 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417 (571)
Q Consensus 343 ~~~~p~~~~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN 417 (571)
+.+.+......++|++.+.||+|+||.||+|.+ ..++..||||++... ......+.+.+|+++|+.++|+|
T Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 12 ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp --CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTT
T ss_pred ccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCc
Confidence 444556667778999999999999999999987 345689999987632 23455678899999999999999
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLH 474 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~-----------------------~~Lse~~i~~I~~QIa~gL~yLH 474 (571)
|+++++++.+.+.+|+||||+.|++|.+++.... ..+++.+++.++.||+.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998643 23899999999999999999999
Q ss_pred hCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHH
Q 008285 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGC 551 (571)
Q Consensus 475 s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGv 551 (571)
++||+||||||+||||+.++.+||+|||++........ .....+++.|+|||++.. ..++.++|||||||
T Consensus 168 ~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~ 240 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-------HIYTTQSDVWSFGV 240 (314)
T ss_dssp HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-------CEECHHHHHHHHHH
T ss_pred HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-------CCcCchhhHHHHHH
Confidence 99999999999999999999999999999987644322 223457888999999874 35788999999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 008285 552 TVIEMLT-GKPPWSEF 566 (571)
Q Consensus 552 VLyELLt-Gr~PF~~~ 566 (571)
++|||++ |+.||.+.
T Consensus 241 il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 241 LLWEIVTLGGNPYPGI 256 (314)
T ss_dssp HHHHHHTTSCCSSTTC
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999 99999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.05 Aligned_cols=203 Identities=30% Similarity=0.524 Sum_probs=173.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....+|++++.||+|+||+||+|+ +..+|+.||||++.. ......+.+.+|+++|+.++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345799999999999999999998 567899999998863 23455678899999999999999999999886
Q ss_pred eC--CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 427 VD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 427 ~~--~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
.. ..+++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 54 5689999999999999999887667999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 505 KHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 505 ~~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
........ .....|+..|+|||++.. ..++.++|||||||++|||++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcC-------CCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 87654321 223457778999999874 3578999999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=315.87 Aligned_cols=203 Identities=27% Similarity=0.444 Sum_probs=177.7
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++.+.||+|+||.||+|.+.. ++.||+|++..... . .+.+.+|++++++++|+||+++++++.+.+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM---S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB---C---HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc---C---HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3455689999999999999999999874 77899999864221 1 256889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..|+||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999987777799999999999999999999999999999999999999999999999999987654
Q ss_pred Cc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.. ......|++.|+|||++.. ..++.++||||||+++|+|++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCcccccccCCHHHhcC-------CCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 32 2223557788999999863 357899999999999999999 99999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.74 Aligned_cols=206 Identities=25% Similarity=0.442 Sum_probs=178.3
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS 424 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~ 424 (571)
....++|++++.||+|+||.||+|++. .+++.||||++... ......+.+.+|+.+++.++|+||++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344579999999999999999999987 45689999988632 234556789999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008285 425 EVVDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR 481 (571)
Q Consensus 425 ~~~~~~lyLVmEy~~GGsL~d~L~~~~-----------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHR 481 (571)
+.+.+.+|+||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999999999999998642 569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc
Q 008285 482 DIKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 482 DIKPsNILLd~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
||||+||||+.++.+||+|||+++.+.... ......||+.|+|||++.. ..++.++|||||||++|||++
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-------CCcCcccccHHHHHHHHHHHh
Confidence 999999999999999999999998664322 2224568889999999873 357899999999999999999
Q ss_pred -CCCCCCCC
Q 008285 559 -GKPPWSEF 566 (571)
Q Consensus 559 -Gr~PF~~~ 566 (571)
|+.||.+.
T Consensus 272 ~g~~p~~~~ 280 (343)
T 1luf_A 272 YGLQPYYGM 280 (343)
T ss_dssp TTCCTTTTS
T ss_pred cCCCcCCCC
Confidence 99999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.86 Aligned_cols=209 Identities=26% Similarity=0.468 Sum_probs=181.8
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.+....++|++.+.||+|+||.||+|.++.+|+.||||.+... ......+.+.+|+++|+.++|+||+++++++..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 3455667999999999999999999999999999999987632 234455678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+.+|+||||++||+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999999999887677999999999999999999999999999999999999999999999999999865
Q ss_pred cCCcccc---ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~---~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
....... ...+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNY-------GRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4432221 1224677999999874 357889999999999999998 999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.43 Aligned_cols=205 Identities=26% Similarity=0.475 Sum_probs=176.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+.+|+.++++++|+||+++++++...+..|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 479999999999999999999999999999999875432211 1112467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCccccc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLT 508 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~l~ 508 (571)
+||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999999765 5699999999999999999999999999999999999998776 89999999998776
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.........|++.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp --------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCcccccCCCcCccCcceec-------CCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 554445567999999999886 345788999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=343.77 Aligned_cols=203 Identities=28% Similarity=0.463 Sum_probs=162.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++++.||+|+||+||+|.++.+|+.||||++.... ......+++.+|+++|++++|+||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 468999999999999999999999999999999886432 3345567889999999999999999999988543
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|+||||+. ++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred CceEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 56899999984 7999999764 56999999999999999999999999999999999999999999999999999876
Q ss_pred cCCc----------------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-
Q 008285 508 TGLS----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558 (571)
Q Consensus 508 ~~~~----------------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt- 558 (571)
.... .....+||+.|+|||++.. ...|+.++||||||||||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL------QENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC------CCCCCcHhHHHHHHHHHHHHHHh
Confidence 4321 1234678999999998753 4468999999999999999999
Q ss_pred ----------CCCCCCCC
Q 008285 559 ----------GKPPWSEF 566 (571)
Q Consensus 559 ----------Gr~PF~~~ 566 (571)
|+++|.+.
T Consensus 281 ~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGS 298 (458)
T ss_dssp STTTCSSGGGCCCSCC--
T ss_pred ccccccccccccccCCCC
Confidence 66666543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.17 Aligned_cols=211 Identities=27% Similarity=0.527 Sum_probs=184.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC---cHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~---~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
.+|++.+.||+|+||.||+|.++.+|+.||||++........ ..+..+.+.+|+.+++.+ .|+||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 479999999999999999999999999999999875432211 223456788999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999999999999865 5699999999999999999999999999999999999999999999999999988776
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........||+.|+|||++.+.... ....++.++|||||||++|+|++|+.||.+.
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDE-THPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCT-TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccCCCCCCccChhhccccccc-cCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 5555567899999999998753221 2345788999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.45 Aligned_cols=208 Identities=26% Similarity=0.467 Sum_probs=173.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+.+|+++++.++|+||+++++++...+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 35689999999999999999999999999999999864332222222335678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999985 8999998766779999999999999999999999999999999999999999999999999998764432
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......||+.|+|||++.+ ...++.++|||||||++|||++|..||.+.
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 3345679999999999863 345789999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.81 Aligned_cols=198 Identities=34% Similarity=0.605 Sum_probs=176.5
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|...+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 588899999999999999999999999999998743321 235678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-cc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~~ 513 (571)
|||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 121 ~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp ECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 999999999999865 469999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 199 ~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 199 KSLVGTPYWMAPEVIS-------RSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCCccccCHhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4567999999999986 346788999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.09 Aligned_cols=207 Identities=27% Similarity=0.479 Sum_probs=176.5
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~-----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g 423 (571)
....++|++++.||+|+||.||+|. +..+++.||||++... ......+.+.+|++++.++ +|+||+++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3456799999999999999999998 5567789999998632 2344567789999999999 7999999999
Q ss_pred eEEeCCe-EEEEEeecCCCCHHHHHHHhcC--------------------------------------------------
Q 008285 424 SEVVDDH-LYIYLEYVHPGSINRYVREHCR-------------------------------------------------- 452 (571)
Q Consensus 424 ~~~~~~~-lyLVmEy~~GGsL~d~L~~~~~-------------------------------------------------- 452 (571)
++.+.+. +++|||||.||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9887654 8999999999999999976432
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc---ccc
Q 008285 453 ---------------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---YEL 514 (571)
Q Consensus 453 ---------------~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~---~~~ 514 (571)
.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 18999999999999999999999999999999999999999999999999998664322 222
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 254 ~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp -CEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccCCCceeEChhhhcC-------CCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 4568889999999873 357899999999999999998 999997654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.65 Aligned_cols=205 Identities=29% Similarity=0.490 Sum_probs=175.8
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++|++.+.||+|+||+||+|.+. ++..||||++...... .+.+.+|+++++.++|+||+++++++.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 4456679999999999999999999877 5778999998643211 25578999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999998766779999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 509 GLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 509 ~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... .....+|+.|+|||++.. ..++.++||||||+++|+|++ |+.||....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccccccCCccCcccCCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 4322 223457788999999873 357899999999999999998 999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.10 Aligned_cols=203 Identities=31% Similarity=0.506 Sum_probs=168.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEE----EEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~V----AIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||+||+|++..+|+.+ |+|.+.. .......+.+.+|+.++++++|+||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 4568999999999999999999998888765 6665532 1222345778899999999999999999999886
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
. ..++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 478999999999999999887778999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc---cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~---~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... ....||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCcccccccCCCccccccChHHhcc-------CCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 543222 23457889999999874 357899999999999999999 99999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.53 Aligned_cols=202 Identities=29% Similarity=0.495 Sum_probs=176.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|++++++++|+||+++++++...+.
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 45679999999999999999999876 4778999998643211 2557899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.|+||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999999887677999999999999999999999999999999999999999999999999999876543
Q ss_pred ccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
... ....+++.|+|||++.. ..++.++||||||+++|+|++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHY-------FKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHH-------SEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhhcccCCCcCcccCCHHHHhc-------cCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 322 23456778999999874 246779999999999999999 99999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=319.40 Aligned_cols=205 Identities=33% Similarity=0.642 Sum_probs=161.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3589999999999999999999999999999999863110 01112467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999999877678999999999999999999999999999999999999999999999999999876532 2
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATR-------SAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cceeccCCCCcCCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 2234679999999998863 35678999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.28 Aligned_cols=210 Identities=26% Similarity=0.452 Sum_probs=173.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||+||+|.+..+++.||||++.............+.+.+|+++|+.++|+||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 35899999999999999999999999999999998642211112234577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 008285 433 IYLEYVHPGSINRYVREH---------------------------------------CRDITESIVRNFTRHILNGLAYL 473 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~---------------------------------------~~~Lse~~i~~I~~QIa~gL~yL 473 (571)
+|||||+||+|.+++... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 11246778899999999999999
Q ss_pred HhCCceecCCCCCcEEEcCCC--cEEEEecCCcccccCCc-----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhH
Q 008285 474 HSTNTIHRDIKGANLLVDASG--VVKLADFGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546 (571)
Q Consensus 474 Hs~GIVHRDIKPsNILLd~~g--~vKLiDFGlA~~l~~~~-----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDV 546 (571)
|++||+||||||+||||+.++ .+||+|||++..+.... ......||+.|+|||++... ...++.++||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Di 259 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-----NESYGPKCDA 259 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-----SSCCCTHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-----CCCCCcHHHH
Confidence 999999999999999998766 89999999998653321 12356799999999998631 3467889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 008285 547 WSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 547 WSLGvVLyELLtGr~PF~~~e 567 (571)
|||||++|||++|+.||.+..
T Consensus 260 wslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.32 Aligned_cols=202 Identities=30% Similarity=0.490 Sum_probs=172.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
..++|++.+.||+|+||+||+|.++.+|+.||||++.... ......+++.+|+++|++++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3568999999999999999999999999999999986432 3345567889999999999999999999998776
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 57999999996 6999999764 5699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCc-----------------------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 507 LTGLS-----------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 507 l~~~~-----------------------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
..... .....+||+.|+|||++.. ...++.++||||||||+|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL------QENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc------CCCCCcccccchHHHHHHHHHhccccc
Confidence 65432 1245779999999998753 446899999999999999999865554
Q ss_pred C
Q 008285 564 S 564 (571)
Q Consensus 564 ~ 564 (571)
.
T Consensus 253 ~ 253 (432)
T 3n9x_A 253 I 253 (432)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=346.40 Aligned_cols=201 Identities=24% Similarity=0.378 Sum_probs=169.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+++.+|+.+|+.++|+||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 358999999999999999999999999999999986432 2345567888999999999999999999998654
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+||||||+++ +|.+++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred cCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 457999999975 4666664 3499999999999999999999999999999999999999999999999999988
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcccCCCcccccccCHHHHcC-------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 766555566789999999999973 368889999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.37 Aligned_cols=208 Identities=26% Similarity=0.503 Sum_probs=180.4
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCee
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIV 419 (571)
.+....++|++++.||+|+||.||+|++.. .+..||||++... ......+.+.+|+++++.+ +|+||+
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 445566799999999999999999999754 3357999988632 2345567889999999999 899999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
++++++...+.+|+||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999998753 359999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr 560 (571)
|+||||+.++.+||+|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++ |+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999998765432 223455788999999986 3468899999999999999999 99
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||.+.
T Consensus 292 ~p~~~~ 297 (382)
T 3tt0_A 292 SPYPGV 297 (382)
T ss_dssp CSSTTC
T ss_pred CCCCCC
Confidence 999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.88 Aligned_cols=208 Identities=24% Similarity=0.431 Sum_probs=180.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC---cHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~---~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++|++.+.||+|+||+||+|.++.+|+.||||++........ .....+.+.+|+.+|+.++|+||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3589999999999999999999999999999999875432111 1112345678999999999999999999999999
Q ss_pred eEEEEEeecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GG-sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 999999999766 999999764 569999999999999999999999999999999999999999999999999999877
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.........||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMG------NPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred CCCceeccCCCccccChhhhcC------CCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 6665566789999999999863 2334789999999999999999999997643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.76 Aligned_cols=206 Identities=29% Similarity=0.473 Sum_probs=172.7
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcE----EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~----VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
.....+|++.+.||+|+||+||+|.+..+|+. ||+|.+...... ...+.+.+|+.+++.++|+||+++++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR----QSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC----SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 34567999999999999999999999988876 666665422211 1224567899999999999999999987
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
. ++..++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 5 567899999999999999998766679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 506 HLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.+..... .....|+..|+|||++.. ..++.++|||||||++|+|++ |+.||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHF-------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccCcccccccccCCCCcccccChHHhcc-------CCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 7654322 234568889999999974 358899999999999999999 999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.03 Aligned_cols=202 Identities=28% Similarity=0.486 Sum_probs=170.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+++|+.++|+||+++++++...+.+|+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 4799999999999999999999999999999998643211 111234579999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 999997 69999998877779999999999999999999999999999999999999999999999999998654322 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ------CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999999863 346789999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.17 Aligned_cols=203 Identities=36% Similarity=0.621 Sum_probs=179.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
..|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+.+|+++|+.++|+||+++++++...+..|+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 46999999999999999999999999999999986432 2334556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 999997 6888888776678999999999999999999999999999999999999999999999999999876542
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|+|||++... ....++.++|||||||++|||++|+.||.+.
T Consensus 208 ~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp CCCCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 346799999999998632 1345788999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.14 Aligned_cols=206 Identities=26% Similarity=0.463 Sum_probs=178.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc--------CcHHHHHHHHHHHHHHhhcCCCCeeEEee
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP--------KSAECIKQLEQEIKVLGHLKHENIVQYYG 423 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~--------~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g 423 (571)
...+|++++.||+|+||+||+|.++.+++.||||++....... ......+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568999999999999999999999999999999987432211 01123567889999999999999999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEEe
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLAD 500 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g---~vKLiD 500 (571)
++.+.+.+|||||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999999775 5699999999999999999999999999999999999998765 699999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||++.............||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--------KYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT--------CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc--------CCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999988766555556789999999998752 4788999999999999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.96 Aligned_cols=204 Identities=29% Similarity=0.486 Sum_probs=175.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----- 427 (571)
.++|++++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 458999999999999999999999999999999886433222 123456789999999999999999999887
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 ---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 ---~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
.+.+|+||||+. ++|.+++......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 456899999997 5888888776677999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-----ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGL-----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~-----~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.+... .......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 876421 12234678999999999863 345789999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=317.12 Aligned_cols=204 Identities=32% Similarity=0.573 Sum_probs=175.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|.+..++..||+|++..... ......+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34689999999999999999999999999999999853110 1112245688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999999875 569999999999999999999999999999999999999999999999999986554332
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|++.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus 164 -~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp -----CCCCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -ccccCCCCCccCHhHhc-------cCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 23467999999999986 345788999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.17 Aligned_cols=206 Identities=31% Similarity=0.544 Sum_probs=182.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|++..+|+.||||++..... ......+.+.+|+.+|+.++|+||+++++++...+.+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34689999999999999999999999999999999863210 0112346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+|||||.||+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999999876655
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISG------RLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCcCeEChhhccC------CCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 5566789999999999873 233478999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=319.18 Aligned_cols=196 Identities=24% Similarity=0.416 Sum_probs=174.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEe--C
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV--D 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~--~ 428 (571)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .+.+.+|+++|+.++ |+||+++++++.+ .
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 3568999999999999999999999999999999986311 356889999999997 9999999999987 6
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA~~l 507 (571)
...++||||+.+++|.+++. .+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 77899999999999999874 389999999999999999999999999999999999999766 8999999999877
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
..........|+..|+|||++.. ...++.++|||||||++|+|++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCccccccccccccChhhhcC------CCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 66555556789999999999863 34688999999999999999999999953
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=327.26 Aligned_cols=205 Identities=25% Similarity=0.471 Sum_probs=168.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+++|+.++|+||+++++++...+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3458999999999999999999999999999999986432 2233456677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-----cCCCcEEEEecCCccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKH 506 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL-----d~~g~vKLiDFGlA~~ 506 (571)
||||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 109 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99999998 5999999775 569999999999999999999999999999999999999 4555699999999987
Q ss_pred ccCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||....
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HC-----------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCcccccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 6532 22334568999999999863 3457899999999999999999999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.90 Aligned_cols=209 Identities=27% Similarity=0.436 Sum_probs=165.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.++..+++.++|+||+++++++.+.+.
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 45579999999999999999999999999999999986422 223334445566666888899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 431 LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999997 588887754 356799999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...........||+.|+|||++.... ....++.++|||||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPEL---NQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCT---TC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccccccccCCCccccChhhcChhh---cCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 76655555567999999999974211 1446889999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=357.26 Aligned_cols=207 Identities=25% Similarity=0.419 Sum_probs=182.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|+++.+|+.||||++..... ........+.+|+++|+.++|+||+++++++.+.+.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh--hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 445689999999999999999999999999999999863210 001123557889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|||||||.||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999999997643 3499999999999999999999999999999999999999999999999999988766
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~-------~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTT-------CEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CccccccCCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 555556789999999999863 35788999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.14 Aligned_cols=203 Identities=38% Similarity=0.685 Sum_probs=174.4
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++.+.||+|+||.||+|.+..+|+.||||.+..... .+.+.+|+.+++.++|+||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 3446689999999999999999999999999999999874221 256788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999999999986667899999999999999999999999999999999999999999999999999987654
Q ss_pred Cc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ......|++.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQ-------EIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHS-------SSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hccccCccCCCCCccChhhcC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 32 233467999999999986 335788999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.44 Aligned_cols=198 Identities=22% Similarity=0.395 Sum_probs=156.7
Q ss_pred CCeEEe---eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCC
Q 008285 354 SQWQKG---KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (571)
Q Consensus 354 ~~y~i~---k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~ 429 (571)
.+|++. +.||+|+||+||+|.++.+|+.||||++.. .....+.+|+.+++.+. |+||+++++++.+.+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG--------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh--------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 357765 789999999999999999999999999863 12356778999999997 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEEecCCccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH 506 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g---~vKLiDFGlA~~ 506 (571)
..|+|||||+||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999999999875 6799999999999999999999999999999999999997665 899999999986
Q ss_pred ccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLN-------QNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCCCcccccCCCcCccCHHHhc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 64432 233567899999999986 3458899999999999999999999997643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=315.74 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=177.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHH---HHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI---KQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~---k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...++|++.+.||+|+||+||+|.+..+++.||||++....... ..... +.+.+|++++++++|+||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 44579999999999999999999999999999999986533322 22222 678899999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCc-----EEEEe
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGV-----VKLAD 500 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~-----vKLiD 500 (571)
.. ++||||+.+++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 7999999999999999887778999999999999999999999999 999999999999987776 99999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
||+++.... ......||+.|+|||++... ...++.++|||||||++|||++|+.||....
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAE-----EESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCS-----SCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCccccccc--cccccCCCccccCchhhccC-----CCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999985543 23346799999999987421 3457889999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.06 Aligned_cols=207 Identities=27% Similarity=0.469 Sum_probs=167.4
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
.....++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+++.++|+||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 344567999999999999999999998654 456999987532 2345567889999999999999999999987
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
.++..|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 4567899999999999999998776679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 506 HLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
....... .....+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp --------------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcccccccccCCCcccccChhhccc-------CCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 7654332 223457788999999873 357889999999999999996 999997653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=332.36 Aligned_cols=207 Identities=22% Similarity=0.385 Sum_probs=169.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCC-----CcEEEEEEeecCCCCcCc-HHHH-----HHHHHHHHHHhhcCCCCee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKS-AECI-----KQLEQEIKVLGHLKHENIV 419 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~t-----G~~VAIK~i~~~~~d~~~-~~~~-----k~l~~Ei~IL~~L~HpNIV 419 (571)
...++|++++.||+|+||.||+|.+..+ ++.||||++......... .... ..+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998765 588999998642210000 0001 1233466677888999999
Q ss_pred EEeeeEEeC----CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CC
Q 008285 420 QYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--AS 493 (571)
Q Consensus 420 kl~g~~~~~----~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd--~~ 493 (571)
++++++... ...||||||| |++|.+++......+++.+++.|+.||+.||+|||++||+||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998775 4589999999 9999999988767899999999999999999999999999999999999998 88
Q ss_pred CcEEEEecCCcccccCCccc--------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~~--------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
+.+||+|||+++.+...... ....||+.|+|||++. +..++.++|||||||++|||++|+.||.+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-------GVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999876443211 2355999999999986 34589999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=338.53 Aligned_cols=213 Identities=29% Similarity=0.497 Sum_probs=180.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC--
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~-- 429 (571)
...+|++.+.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+++|++++|+||+++++++...+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 45689999999999999999999999999999999864221 112456678999999999999999999988765
Q ss_pred eEEEEEeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEEecCC
Q 008285 430 HLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 503 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL----d~~g~vKLiDFGl 503 (571)
..|+|||||.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997543 239999999999999999999999999999999999999 7788899999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD-GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d-~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
++............||+.|+|||++....... ....++.++|||||||++|||++|+.||...++
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 99877665555678999999999986421100 012467799999999999999999999976544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.03 Aligned_cols=207 Identities=26% Similarity=0.401 Sum_probs=180.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|+||+++++++.+.+.
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 345689999999999999999999999999999999863110 001123567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999764 246999999999999999999999999999999999999999999999999999877
Q ss_pred cCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred cCCCcccccccCCccccChhhhc-------CCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 55433 33468999999999986 346889999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=318.67 Aligned_cols=208 Identities=25% Similarity=0.403 Sum_probs=171.7
Q ss_pred CCCCeEEe-eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~-k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
..+.|++. +.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+++|.++ +|+||+++++++.+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 45689995 789999999999999999999999999874321 1235678999999885 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEEecCCccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKH 506 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~---vKLiDFGlA~~ 506 (571)
.+|+||||+.|++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999875 56999999999999999999999999999999999999987765 99999999876
Q ss_pred ccCCc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... ......||+.|+|||++...... ...++.++|||||||++|||++|+.||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE--ASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHH--HHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhccccc--ccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 53211 11235699999999998742110 1235678999999999999999999997653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=309.31 Aligned_cols=201 Identities=25% Similarity=0.409 Sum_probs=173.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~l 431 (571)
..+|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +|+||+++++++.+.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 35899999999999999999999999999999998743322 23356778899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---------------
Q 008285 432 YIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--------------- 493 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~---~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~--------------- 493 (571)
++||||++|++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999997642 569999999999999999999999999999999999999844
Q ss_pred ----CcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 494 ----GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 494 ----g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
..+||+|||++....... ...||+.|+|||++.. ...++.++|||||||++|+|++|..+|..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765433 3459999999999863 33566899999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.25 Aligned_cols=208 Identities=27% Similarity=0.461 Sum_probs=179.6
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~ 422 (571)
.....++|++.+.||+|+||.||+|.+ ..+++.||||++... ......+.+.+|+.+++++ +|+||++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 344567999999999999999999985 457889999998632 2234457789999999999 899999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCR-----------------DITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~-----------------~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKP 485 (571)
+++...+..++||||+.+|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999986543 489999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008285 486 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 561 (571)
Q Consensus 486 sNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~ 561 (571)
+|||++.++.+||+|||++........ .....|++.|+|||++.. ..++.++|||||||++|+|++ |+.
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~ 246 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSS 246 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999987654332 223457788999999873 357899999999999999998 999
Q ss_pred CCCCCC
Q 008285 562 PWSEFE 567 (571)
Q Consensus 562 PF~~~e 567 (571)
||.+..
T Consensus 247 p~~~~~ 252 (313)
T 1t46_A 247 PYPGMP 252 (313)
T ss_dssp SSTTCC
T ss_pred CCCccc
Confidence 997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.86 Aligned_cols=202 Identities=27% Similarity=0.485 Sum_probs=174.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
..+|++++.||+|+||+||+|+++.++..||||++....... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 347999999999999999999999999999999987533221 12356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFGlA~~l~~ 509 (571)
+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 113 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999999775 56999999999999999999999999999999999999975 45599999999988776
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRK--------KYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTT--------CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccCCCcCeeCHHHHcc--------cCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 655566789999999998752 4788999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.90 Aligned_cols=206 Identities=31% Similarity=0.547 Sum_probs=170.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.++|+||+++++++...+..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34689999999999999999999999999999999863210 0112245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999999875 569999999999999999999999999999999999999999999999999998776655
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++.. ....+.++||||||+++|+|++|+.||.+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISG------RLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp -----------CCTGGGTT------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccCCccccCHHHHcC------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4455679999999999863 223468999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.21 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=171.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~l 431 (571)
.++|++.+.||+|+||+||+|.++.+|+.||||++...... ..+|++++.++ +||||+++++++.+.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 45899999999999999999999999999999998743321 34678888887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CcEEEEecCCcccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMAKHL 507 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~----g~vKLiDFGlA~~l 507 (571)
|+|||||.||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++..
T Consensus 92 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999999765 569999999999999999999999999999999999998433 35999999999876
Q ss_pred cCC-ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~-~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... ......+||+.|+|||++... .++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQ-------GYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHH-------HHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCCceeccCCCccccCHHHhcCC-------CCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 543 233456799999999998752 3567999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.18 Aligned_cols=201 Identities=24% Similarity=0.435 Sum_probs=174.0
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCC-------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG-------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g 423 (571)
...++|++.+.||+|+||+||+|.+..++ ..||+|++... .....+.+.+|++++++++|+||+++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 34568999999999999999999998877 46999988532 2233467889999999999999999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--------
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------- 495 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~-------- 495 (571)
++.+.+..|+||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999999887666999999999999999999999999999999999999988877
Q ss_pred EEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 008285 496 VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSE 565 (571)
Q Consensus 496 vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG-r~PF~~ 565 (571)
+||+|||++....... ...|++.|+|||++.. ...++.++|||||||++|||++| .+||..
T Consensus 160 ~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD---ILQERIPWVPPECIEN------PKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp EEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eeeccCcccccccCcc---ccCCcCcccCHHHhCC------CCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9999999997654422 3457889999999873 23578899999999999999995 555544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.86 Aligned_cols=206 Identities=29% Similarity=0.530 Sum_probs=179.5
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+.+|+++++.++|+||+++++++.+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 3445689999999999999999999999999999999863110 00112356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999999875 5699999999999999999999999999999999999999999999999999976644
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. .....|++.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 167 LR-RRTMCGTLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SC-BCCCCSCGGGCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cc-cccccCCCCcCCHHHhc-------cCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 32 23467999999999986 335788999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.91 Aligned_cols=204 Identities=28% Similarity=0.509 Sum_probs=179.8
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
....++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.+|+.++|+||+++++++...+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 34456899999999999999999999999999999998743 23455678899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.+|+||||++|++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999999875 5699999999999999999999986 99999999999999999999999999997653
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 184 DS-MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HH-C----CCCCTTCCHHHHT-------TCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cc-cccCCCCCCCeECHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 223467999999999986 346889999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.59 Aligned_cols=206 Identities=32% Similarity=0.511 Sum_probs=176.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++...+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 4568999999999999999999999999999999886432 3345567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 100 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999999898887553 56999999999999999999999999999999999999999999999999999866442
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......|++.|+|||++.. ...++.++|||||||++|+|++|+.||....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp -----CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334679999999999863 3357889999999999999999999997653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.61 Aligned_cols=204 Identities=25% Similarity=0.497 Sum_probs=181.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.++.+|+.||||++....... ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3458999999999999999999999999999999986433221 12346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l~ 508 (571)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999999765 569999999999999999999999999999999999999 467899999999998876
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG--------TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCCCccccCceeecC--------CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 6555556789999999999863 4788999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.40 Aligned_cols=200 Identities=29% Similarity=0.493 Sum_probs=172.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
...+|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 456899999999999999999999999999999988643211 23799999999999999999988543
Q ss_pred -----------------------------------CeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHH
Q 008285 429 -----------------------------------DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGL 470 (571)
Q Consensus 429 -----------------------------------~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL 470 (571)
..+++||||+. ++|.+++.. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 34899999998 588777753 346799999999999999999
Q ss_pred HHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHH
Q 008285 471 AYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549 (571)
Q Consensus 471 ~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSL 549 (571)
+|||++||+||||||+||||+ .++.+||+|||+++.+..........||+.|+|||++.+ ...++.++|||||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG------ATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT------CSSCCTHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC------CCCCCcchhhhhH
Confidence 999999999999999999997 689999999999998766666667789999999999863 3458899999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 008285 550 GCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 550 GvVLyELLtGr~PF~~~e 567 (571)
||++|||++|+.||.+..
T Consensus 229 G~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=327.41 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=166.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 358999999999999999999999999999999987432 23455677889999999999999999999987665
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+|+||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999997 57888875 3599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
...........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -------------CTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccCCceecCCccCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 765444455779999999999863 357889999999999999999999997653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.48 Aligned_cols=202 Identities=30% Similarity=0.500 Sum_probs=174.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...+|++++.||+|+||.||+|+ +..+|+.||||++..... ....+.+.+|+++|+.++|+||+++++++..
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 45679999999999999999999 567899999999864322 1234678899999999999999999999987
Q ss_pred C--CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 428 D--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 428 ~--~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
. +.+++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 66899999999999999998777789999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 506 HLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 506 ~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
....... .....||..|+|||++.. ..++.++|||||||++|+|++|+.||.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQ-------SKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecC-------CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 7654332 224568888999999874 346789999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.95 Aligned_cols=205 Identities=30% Similarity=0.489 Sum_probs=168.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEE----EEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASC----AIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~V----AIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....+|++++.||+|+||+||+|.+..+|+.+ |+|.+.... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 34579999999999999999999999888866 555443211 1223467889999999999999999999987
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+ .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 654 7899999999999999988777899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... .....||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -------------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCccccccccCCCccccccCHHHHcC-------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 644322 223457888999999973 357899999999999999999 999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.50 Aligned_cols=210 Identities=28% Similarity=0.540 Sum_probs=179.0
Q ss_pred CCCCCCCCCCeEEeeEEeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCC
Q 008285 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417 (571)
Q Consensus 346 ~p~~~~~~~~y~i~k~LG~G~fG~VYla~~k-------~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpN 417 (571)
.+.+....++|++++.||+|+||.||+|.+. .++..||||++... ......+.+.+|+++++.+ +|+|
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCC
Confidence 3445566789999999999999999999976 45788999987632 2345567889999999999 8999
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRD 482 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRD 482 (571)
|+++++++...+.+|+||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999999999999999999999999999998643 2489999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-
Q 008285 483 IKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558 (571)
Q Consensus 483 IKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt- 558 (571)
|||+||||+.++.+||+|||+++....... .....+++.|+|||++.. ..++.++|||||||++|||++
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-------CCcChHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999987654322 223457889999999874 347889999999999999999
Q ss_pred CCCCCCCC
Q 008285 559 GKPPWSEF 566 (571)
Q Consensus 559 Gr~PF~~~ 566 (571)
|+.||.+.
T Consensus 256 g~~p~~~~ 263 (334)
T 2pvf_A 256 GGSPYPGI 263 (334)
T ss_dssp SCCSSTTC
T ss_pred CCCCcCcC
Confidence 99999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.05 Aligned_cols=208 Identities=32% Similarity=0.510 Sum_probs=173.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC---cCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d---~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
++|++.+.||+|+||.||+|.+..+|+.||||++...... .........+.+|+++|+.++|+||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5899999999999999999999999999999998643211 111223456789999999999999999999886654
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~---vKLiDFGlA~~l 507 (571)
+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 89999999999999999764 57999999999999999999999999999999999999986654 999999999877
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..........||+.|+|||++... ....++.++|||||||++|+|++|+.||....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHT----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred ccccccccccCCcCccCchhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 654444456799999999998532 13457889999999999999999999997643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.49 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=172.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee-EEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~-~~~~~~l 431 (571)
.++|++.+.||+|+||.||+|++..+|+.||||++...... +.+.+|+.+++.++|++++..+.. +...+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 46899999999999999999999999999999998643221 347789999999998776655554 4667788
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l~ 508 (571)
++||||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 899999998766789999999999999999999999999999999999999 488999999999998765
Q ss_pred CCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccCChhhhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 4322 23467999999999986 3458899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.98 Aligned_cols=205 Identities=26% Similarity=0.431 Sum_probs=174.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~-----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
...++|++++.||+|+||+||+|. +..+++.||||++... ........+.+|+.++++++|+||+++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 445689999999999999999999 4457889999987532 2344556788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VV 496 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g---~v 496 (571)
...+..|+|||||.||+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999998754 3589999999999999999999999999999999999998554 59
Q ss_pred EEEecCCcccccCC---ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 497 KLADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~---~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
||+|||+++.+... .......||+.|+|||++.. ..++.++|||||||++|||++ |+.||...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999865322 22234568999999999874 358899999999999999998 99999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=326.18 Aligned_cols=201 Identities=23% Similarity=0.383 Sum_probs=172.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC--------CCCeeEEee
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--------HENIVQYYG 423 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~--------HpNIVkl~g 423 (571)
..++|++.+.||+|+||+||+|++..+|+.||||++.. .....+.+.+|+.+|+.++ |+||+++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34689999999999999999999999999999999862 2345677889999999985 788999999
Q ss_pred eEE----eCCeEEEEEeecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCC---
Q 008285 424 SEV----VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASG--- 494 (571)
Q Consensus 424 ~~~----~~~~lyLVmEy~~GGsL~d~L~~-~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g--- 494 (571)
++. ....+|+||||+ +++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 456799999999 5666666654 346799999999999999999999999 999999999999998775
Q ss_pred ----------------------------------------------cEEEEecCCcccccCCccccccCCCCcccChHHH
Q 008285 495 ----------------------------------------------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528 (571)
Q Consensus 495 ----------------------------------------------~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl 528 (571)
.+||+|||++...... .....||+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence 7999999999876543 2345799999999998
Q ss_pred HHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 529 ~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
.. ..++.++|||||||+||||++|+.||....+
T Consensus 266 ~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 266 IG-------SGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cC-------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 73 3578899999999999999999999976543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.37 Aligned_cols=201 Identities=28% Similarity=0.513 Sum_probs=171.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+++|+.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 468999999999999999999999999999999875322 23455678899999999999999999999987653
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 7999999976 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... ....+||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+
T Consensus 178 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 178 ADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc--cCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6542 334679999999999873 2468889999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=311.24 Aligned_cols=195 Identities=28% Similarity=0.502 Sum_probs=173.9
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe------
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV------ 427 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~------ 427 (571)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+.... +.+.+|+++++.++|+||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 47999999999999999999999999999999987422 246689999999999999999998764
Q ss_pred ----------CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 428 ----------DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 428 ----------~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999764 3579999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
||+|||++.............|++.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS-------SQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH-------CSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EECcchhheeccccccccccCCcccccChhhhc-------cCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999998876655555667999999999986 3457889999999999999999998874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.84 Aligned_cols=202 Identities=24% Similarity=0.461 Sum_probs=176.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|.++.+|+.||||++........ ....+.+|+++|++++||||+++++++.+.+.+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch---HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 4589999999999999999999999999999999864221111 2366789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~l~~ 509 (571)
+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++....
T Consensus 98 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999999999775 5699999999999999999999999999999999999995 456899999999987766
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp C----CCTTGGGGCCGGGGGS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccCCCcCCCCCCCHHHhCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 555556789999999999852 4789999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.49 Aligned_cols=206 Identities=25% Similarity=0.367 Sum_probs=172.9
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
......+|++.+.||+|+||+||+|++. ++.||||++... ........+|+.+|++++|+||+++++++...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 3345569999999999999999999876 789999998632 22334556799999999999999999998875
Q ss_pred C----eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEcCCC
Q 008285 429 D----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST----------NTIHRDIKGANLLVDASG 494 (571)
Q Consensus 429 ~----~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~----------GIVHRDIKPsNILLd~~g 494 (571)
. .+|+|||||.+|+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 4 47999999999999999976 3599999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 495 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 495 ~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.+||+|||+++.+..... .....||+.|+|||++...... ...++.++|||||||++|||++|+.||.+.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF--QRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCC--CHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhccccccc--CcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999987654322 2336799999999998642110 123566899999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.42 Aligned_cols=206 Identities=27% Similarity=0.419 Sum_probs=179.2
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
....+|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+..|..+|..+ +|+||+++++++.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345689999999999999999999999999999999863110 0011235677899999988 6999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc-
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT- 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~- 508 (571)
.+||||||+.||+|.++|... +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999999876 569999999999999999999999999999999999999999999999999998643
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........+||+.|||||++. ...|+.++|||||||+||||++|+.||.+.
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHT-------CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccccCCCcccCHhhhc-------CCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 333445678999999999986 346899999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.33 Aligned_cols=208 Identities=23% Similarity=0.438 Sum_probs=160.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....++|++++.||+|+||+||+|.+..++. .||||++..... .....+.+.+|+++++.++|+||+++++++.
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3445689999999999999999999887765 899998864221 2234677899999999999999999999998
Q ss_pred eCCeE------EEEEeecCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 008285 427 VDDHL------YIYLEYVHPGSINRYVREHC-----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (571)
Q Consensus 427 ~~~~l------yLVmEy~~GGsL~d~L~~~~-----~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~ 495 (571)
..+.. ++||||+.+|+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77655 99999999999999996542 25999999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 496 VKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 496 vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+||+|||+++....... .....+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcC-------CCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999987644322 223457788999999874 357899999999999999999 999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.97 Aligned_cols=208 Identities=27% Similarity=0.475 Sum_probs=176.1
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~ 422 (571)
+....++|++++.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|+++ +|+||++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 344567999999999999999999997 3456789999986322 223346788999999999 899999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCR----------------------DITESIVRNFTRHILNGLAYLHSTNTIH 480 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~----------------------~Lse~~i~~I~~QIa~gL~yLHs~GIVH 480 (571)
+++...+.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 999999999999999999999999986532 3789999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH
Q 008285 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (571)
Q Consensus 481 RDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL 557 (571)
|||||+||||+.++.+||+|||++........ .....||+.|+|||++.. ..++.++|||||||++|+|+
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHT
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-------CCCChhHhHHHHHHHHHHHH
Confidence 99999999999999999999999986644322 223457889999999873 35789999999999999999
Q ss_pred c-CCCCCCCCC
Q 008285 558 T-GKPPWSEFE 567 (571)
Q Consensus 558 t-Gr~PF~~~e 567 (571)
+ |+.||.+..
T Consensus 269 t~g~~p~~~~~ 279 (344)
T 1rjb_A 269 SLGVNPYPGIP 279 (344)
T ss_dssp TTSCCSSTTCC
T ss_pred cCCCCCcccCC
Confidence 8 999997653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=311.28 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=170.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeee-EEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~-~~~~~~ 430 (571)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|++++..+.. +...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 34689999999999999999999999999999998654322 1347789999999998776666554 466788
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l 507 (571)
.++||||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 89999999 899999998766789999999999999999999999999999999999999 78899999999999876
Q ss_pred cCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 508 TGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 508 ~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhc-------CCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 54322 22467999999999987 34588999999999999999999999986543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.57 Aligned_cols=206 Identities=27% Similarity=0.486 Sum_probs=168.1
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
.....+|++.+.||+|+||.||+|+++ .++..||||.++.. ......+.+.+|+.+|++++|+||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 344568999999999999999999987 56778999998642 23445678999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+.+|+||||++||+|.+++.+....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999999999988767899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 507 LTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 507 l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... .....+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY-------RKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp -----------------CTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cccCCccceeccCCCcCCCccChhhhcc-------CCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 654321 112345778999999873 357899999999999999998 99999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.66 Aligned_cols=204 Identities=29% Similarity=0.538 Sum_probs=177.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe---
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--- 427 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--- 427 (571)
.....|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+.+|+.+|+.++|+||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 34557999999999999999999999999999999987432 234556788999999999999999999998876
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEEecCC
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGM 503 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd-~~g~vKLiDFGl 503 (571)
...+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 35689999999999999999875 56999999999999999999999999 99999999999997 789999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+...... ......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+..
T Consensus 179 ~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 179 ATLKRAS-FAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp GGGCCTT-SBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ccccccc-ccccccCCcCcCCHHHHhc--------cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9765443 2334679999999998752 47889999999999999999999997643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.37 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=177.0
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+. ++..||+|.+..... . .+.+.+|+++++.++|+||+++++++...+.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---C---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---C---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34568999999999999999999987 578899999864321 1 2568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999887677999999999999999999999999999999999999999999999999999876442
Q ss_pred c--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 511 ~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
. ......|+..|+|||++.. ..++.++||||||+++|+|++ |+.||.+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccccccChhhhcC-------CCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 2 1223457888999999873 357889999999999999999 99999764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.63 Aligned_cols=205 Identities=24% Similarity=0.405 Sum_probs=170.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+.+|+.+++.++|+||+++++++..++.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 3468999999999999999999999999999999986422 22345567889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|+||||++|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999999875 569999999999999999999999999999999999999999999999999998765432
Q ss_pred c--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 Y--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. .....|++.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFS-------ESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp --------CCGGGCCGGGTC-------C----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccccCCCcCccCHHHHc-------CCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 1 22456999999999885 335778999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.10 Aligned_cols=209 Identities=27% Similarity=0.490 Sum_probs=172.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeeeEEeC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVD 428 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~~~~~ 428 (571)
....+|++++.||+|+||.||+|.+. +++.||||++.... ......+.+.+|+.+|+.++| +||+++++++...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 45668999999999999999999974 58999999987533 234556788999999999976 9999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|+||| +.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+.
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CEEEEEEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99999999 5578999999875 6799999999999999999999999999999999999996 6789999999998765
Q ss_pred CCcc---ccccCCCCcccChHHHHHhhhcC----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSY---ELSLKGSPNWMAPEVIKAVMQKD----GNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~---~~~~~GT~~YmAPEvl~~~~~~d----~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... .....||+.|+|||++....... ....++.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 4322 23467999999999987421110 1246889999999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.89 Aligned_cols=206 Identities=27% Similarity=0.517 Sum_probs=180.8
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+.....+|++.+.||+|+||+||+|.+..++..||||.+... ....+.+.+|+++++.++|+||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 445677999999999999999999999999999999998632 12356788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999864 345999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCccccccCCccccCcCChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 54332 223457888999999873 357899999999999999999 999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=318.94 Aligned_cols=208 Identities=32% Similarity=0.599 Sum_probs=159.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.....++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3455679999999999999999999999999999999875322 123356688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 429 DHLYIYLEYVHPGSINRYVRE-------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~-------~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
+..|+||||+.|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999999975 2355999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCc------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 502 GMAKHLTGLS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++....... ......||+.|+|||++... ..++.++|||||||++|+|++|+.||...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV------RGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH------HCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc------cCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 9987654321 12345699999999998642 24678999999999999999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.20 Aligned_cols=206 Identities=34% Similarity=0.575 Sum_probs=168.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+.+|+.+++.++|+||+++++++...+..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS--SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 3458999999999999999999999999999999986422 23345667889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999975 34569999999999999999999999999999999999999999999999999998664
Q ss_pred CCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... ......|++.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 432 223456999999999986 346789999999999999999999999653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=333.35 Aligned_cols=200 Identities=32% Similarity=0.489 Sum_probs=169.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
...+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+++|+.++|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 34579999999999999999999999999999998863221 133699999999999999999987542
Q ss_pred ---CeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEec
Q 008285 429 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADF 501 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDF 501 (571)
..+++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+||
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence 236799999985 66666543 34679999999999999999999999999999999999999955 67899999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|+++.+.........+||+.|+|||++.+ ...++.++||||||||||||++|+.||.+..
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99998766555556789999999999863 3358899999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.50 Aligned_cols=209 Identities=35% Similarity=0.592 Sum_probs=176.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+++++.++|+||+++++++...+.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3568999999999999999999999999999999986422 12346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~- 510 (571)
|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999999999877778999999999999999999999999999999999999999999999999987643221
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.......|++.|+|||++...... ...++.++|||||||++|+|++|+.||....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMK--DTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTT--STTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCChhhcCCeeeccccCC--CCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 122345699999999998643211 3457889999999999999999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.05 Aligned_cols=201 Identities=42% Similarity=0.702 Sum_probs=178.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
...|++++.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++|+||+++++++...+.+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 35799999999999999999999999999999998753322 23567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 97 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999999865 569999999999999999999999999999999999999999999999999998765433
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 175 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIK-------QSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccCccCCCcCccCHHHHh-------cCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 223467999999999986 345788999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=311.41 Aligned_cols=203 Identities=31% Similarity=0.587 Sum_probs=177.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 479999999999999999999999999999999864322 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999998653 569999999999999999999999999999999999999999999999999998654321
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......|++.|+|||++.. ...++.++|||||||++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTC------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred hcccCCccccCccChHHHhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2234679999999999863 2234778999999999999999999997644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.81 Aligned_cols=203 Identities=33% Similarity=0.602 Sum_probs=164.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
...+|++.+.||+|+||.||+|.+. |..||||++...... ......+.+.+|+++++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4569999999999999999999975 889999988643221 2233457788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcC--------CCcEEEEe
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDA--------SGVVKLAD 500 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G---IVHRDIKPsNILLd~--------~g~vKLiD 500 (571)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999853 57999999999999999999999999 899999999999985 77899999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
||++........ ....||+.|+|||++.. ..++.++||||||+++|+|++|+.||.+.+
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRA-------SMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHH-------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCcccccccccc-cCCCCccceeCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986654332 24579999999999874 357899999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=317.43 Aligned_cols=208 Identities=25% Similarity=0.428 Sum_probs=178.7
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~ 422 (571)
.+....++|++.+.||+|+||.||+|.++ .+++.||||.+... ........+.+|+.+++.++|+||++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----cCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 34555679999999999999999999876 45788999987632 2334556788999999999999999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+++...+..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 99999999999999999999999997642 457999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+.+||+|||++........ .....|++.|+|||++.. ..++.++|||||||++|+|++ |+.||.+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhcc-------CCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999986644321 223457889999999873 357899999999999999999 89999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=314.40 Aligned_cols=208 Identities=27% Similarity=0.496 Sum_probs=166.9
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.....++|++.+.||+|+||+||+|++.. .||+|+++... ......+.+.+|+++|++++|+||++++++ ...
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~ 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence 45567799999999999999999998643 59999986533 234556788999999999999999999985 456
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+++||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 77899999999999999997766779999999999999999999999999999999999999999999999999997654
Q ss_pred C---CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 G---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~---~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
. ........||+.|+|||++... ....++.++|||||||++|+|++|+.||.+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQ----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ------------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccCCCccccCchhhccc----CCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 3 1222345799999999998631 13457889999999999999999999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=310.68 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=175.9
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDH 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~ 430 (571)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+++++.++|+||+++++++.. .+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 458999999999999999999999999999999987432 234556788999999999999999999998754 578
Q ss_pred EEEEEeecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCcEEEEecC
Q 008285 431 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~---~~~Lse~~i~~I~~QIa~gL~yLHs~G-----IVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999999754 234999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCcc-ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~-~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++........ .....|++.|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHH-------CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hheeeccccccccccCCCccccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 9987654322 22456899999999986 3357899999999999999999999997653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.11 Aligned_cols=204 Identities=26% Similarity=0.464 Sum_probs=173.4
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEE--EEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~V--AIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~ 428 (571)
..++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+++++++ +|+||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 3468999999999999999999999888866 888876322 223456688999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+.+|+||||+++++|.+++.+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999997643 369999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+.+||+|||+++............+++.|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhcc-------ccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999975544333344567889999999863 346889999999999999998 99999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=319.74 Aligned_cols=203 Identities=27% Similarity=0.464 Sum_probs=177.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....+|++.+.||+|+||.||+|+ +..+|+.||||++.. ......+.+.+|++++++++|+||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-----SGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc-----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 345699999999999999999999 567899999999863 23455677899999999999999999999886
Q ss_pred --eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 427 --VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 427 --~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
..+.+|+||||++|++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 456689999999999999999876667999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 505 KHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 505 ~~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
........ .....||..|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSD-------NIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred eecccCCccceeeccCCccccccCHHHhcc-------CCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 87654321 223558888999999874 3468899999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.71 Aligned_cols=209 Identities=36% Similarity=0.668 Sum_probs=171.3
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe-
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV- 427 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~- 427 (571)
....++|++++.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++++ +|+||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34567999999999999999999999999999999998743221 25678899999999 79999999999987
Q ss_pred -----CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 428 -----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 428 -----~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
.+.+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999864 356999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 502 GMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++....... ......|++.|+|||++..... ....++.++|||||||++|+|++|+.||.+.
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCceecCcCccccccccCCccccChhhhccccc--cCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9998764322 2234579999999999863211 1345788999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.52 Aligned_cols=209 Identities=31% Similarity=0.508 Sum_probs=167.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC---cCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d---~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++|++.+.||+|+||+||+|.+..+++.||||++...... .........+.+|+++|++++|+||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45899999999999999999999999999999998643211 112223345789999999999999999999874 56
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKH 506 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~ 506 (571)
.+|+|||||.+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 689999999999999988654 569999999999999999999999999999999999999654 4599999999998
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..........+||+.|+|||++... ....++.++|||||||++|+|++|+.||.+..
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CC-----------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cCCCccccccCCCCCccCceeeecC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 7665555567899999999998531 13457889999999999999999999997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.82 Aligned_cols=206 Identities=29% Similarity=0.492 Sum_probs=172.0
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCC----cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG----~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
.....+|++.+.||+|+||+||+|.+..++ ..||||.+... ........+.+|+.+++.++|+||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 445679999999999999999999987653 35999988632 2334556788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
...+..||||||+.+++|.+++......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999998876789999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 506 HLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
....... .....+++.|+|||++. ...++.++|||||||++|||++ |+.||.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ---------------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhccccccccccCCCCccccccCchhcc-------cCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 7654321 12234678899999986 3468899999999999999999 99999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=329.21 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=174.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC---CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k---~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~ 427 (571)
...+|++.+.||+|+||+||+|++. .+|+.||||+++..... ......+.+.+|+++|+++ +|+||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 3468999999999999999999984 58999999998532110 0011224466799999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+.+||||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999875 56999999999999999999999999999999999999999999999999999865
Q ss_pred cCCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... .....+||+.|+|||++... ...++.++|||||||++|||++|+.||...
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 4322 22346799999999998631 234678999999999999999999999743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=314.56 Aligned_cols=200 Identities=31% Similarity=0.482 Sum_probs=175.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 4589999999999999999999999999999999874321 22356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l~~ 509 (571)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999999999775 569999999999999999999999999999999999999 7889999999999976543
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ......|++.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBS-------SCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C-ccccccCCCCccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2 223456999999999875 346789999999999999999999999653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.12 Aligned_cols=204 Identities=13% Similarity=0.133 Sum_probs=159.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc--CCCCeeEEe-------e
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL--KHENIVQYY-------G 423 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L--~HpNIVkl~-------g 423 (571)
...|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.| +||||++++ +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--THHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 3469999999999999999999999999999999875332 2345566777885555444 699988865 4
Q ss_pred eEEeC-----------------CeEEEEEeecCCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHHHhCCcee
Q 008285 424 SEVVD-----------------DHLYIYLEYVHPGSINRYVREHCRDITESIV------RNFTRHILNGLAYLHSTNTIH 480 (571)
Q Consensus 424 ~~~~~-----------------~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i------~~I~~QIa~gL~yLHs~GIVH 480 (571)
++... ..+|||||||+ |+|.+++......+.+..+ ..++.||+.||+|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 44433 33899999998 8999999876555666555 677899999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCC
Q 008285 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560 (571)
Q Consensus 481 RDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr 560 (571)
|||||+||||+.++.+||+|||+++...... ....||+.|+|||++.. ....++.++|||||||++|||++|+
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA-----STATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC-----SEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccC-----CCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998765422 13457799999999852 1145789999999999999999999
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
.||.+.
T Consensus 291 ~Pf~~~ 296 (371)
T 3q60_A 291 LPFGLV 296 (371)
T ss_dssp CSTTBC
T ss_pred CCCCCc
Confidence 999765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.88 Aligned_cols=202 Identities=26% Similarity=0.473 Sum_probs=176.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~---- 428 (571)
..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+.+|+++|++++|+||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 45899999999999999999999999999999998632 2345567788999999999999999999988765
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+|+||||+. ++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 36899999997 699999976 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHT------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCccccccccccccCCCCCHHhcC------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 54322 234579999999998763 3357889999999999999999999997654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=318.29 Aligned_cols=208 Identities=29% Similarity=0.483 Sum_probs=178.5
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~-----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~ 422 (571)
.....++|++.+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.+|+.+ +|+||++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----AHADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----cChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34456799999999999999999999987665 7999988632 2344567789999999999 899999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREH-------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 489 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~-------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNIL 489 (571)
+++...+.+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999754 235899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008285 490 VDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565 (571)
Q Consensus 490 Ld~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~ 565 (571)
|+.++.+||+|||++........ .....|++.|+|||++.. ..++.++|||||||++|||++ |..||.+
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-------CCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999986543321 223456788999999873 357899999999999999998 9999976
Q ss_pred CC
Q 008285 566 FE 567 (571)
Q Consensus 566 ~e 567 (571)
..
T Consensus 270 ~~ 271 (333)
T 2i1m_A 270 IL 271 (333)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.33 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=175.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||+||+|.+. +|+.||||.+.... ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34568999999999999999999965 68999999875322 1235678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~---~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986532 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK-------GRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH-------CBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccCCCccccCHHHhcC-------CCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 4322 2234558999999999874 35788999999999999999999999643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.23 Aligned_cols=206 Identities=25% Similarity=0.449 Sum_probs=173.7
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
.....++|++.+.||+|+||+||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++|+||+++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 44556799999999999999999998654 3446999987632 2344567889999999999999999999987
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
.. +..|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 64 56789999999999999998877779999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 506 HLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
....... .....+++.|+|||++.. ..++.++|||||||++|+|++ |+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINF-------RRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccccccccCCCCcceeCchhhcc-------CCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 7654322 223457889999999863 357889999999999999998 99999654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.91 Aligned_cols=203 Identities=29% Similarity=0.540 Sum_probs=175.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC---
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~--- 428 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+++++.++|+||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 456999999999999999999999999999999998532 2345566788999999999999999999987654
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 689999876 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc-----------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSY-----------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~-----------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+..... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHS------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCccccccchhhccccccccCCeeecc------CCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 643211 123578999999998863 3468899999999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.08 Aligned_cols=208 Identities=27% Similarity=0.495 Sum_probs=172.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC--CCCeeEEeeeEEeCC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVDD 429 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g~~~~~~ 429 (571)
...+|++++.||+|+||+||+|.+.. |+.||||++.... ......+.+.+|+.+|+.++ |+||+++++++...+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc---ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34579999999999999999999865 9999999987533 23456678899999999996 599999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+||||| +.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+..
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999999 5679999999875 5799999999999999999999999999999999999995 58999999999987654
Q ss_pred Ccc---ccccCCCCcccChHHHHHhhhc----CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSY---ELSLKGSPNWMAPEVIKAVMQK----DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~---~~~~~GT~~YmAPEvl~~~~~~----d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... ....+||+.|+|||++...... .....++.++||||||||||||++|+.||.+.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 321 2356799999999998642110 01235889999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.45 Aligned_cols=209 Identities=16% Similarity=0.242 Sum_probs=166.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHH---HHHhhcCCCCeeEEe------
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI---KVLGHLKHENIVQYY------ 422 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei---~IL~~L~HpNIVkl~------ 422 (571)
..++|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+.+|+ ++|+.++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C--CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc--chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 356899999999999999999999999999999998743222 223457788999 455556799999998
Q ss_pred -eeEEeCC-----------------eEEEEEeecCCCCHHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 008285 423 -GSEVVDD-----------------HLYIYLEYVHPGSINRYVREHCRDITE-------SIVRNFTRHILNGLAYLHSTN 477 (571)
Q Consensus 423 -g~~~~~~-----------------~lyLVmEy~~GGsL~d~L~~~~~~Lse-------~~i~~I~~QIa~gL~yLHs~G 477 (571)
+++.+.+ ..||||||+ +|+|.+++.... .+++ ..++.|+.||+.||+|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 6655543 279999999 689999998653 2444 788889999999999999999
Q ss_pred ceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHh----hhcCCCCCCCchhhHHHHHHHH
Q 008285 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV----MQKDGNPKLALAVDIWSLGCTV 553 (571)
Q Consensus 478 IVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~----~~~d~~~~~s~ksDVWSLGvVL 553 (571)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++... ...+....++.++|||||||++
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999999986443 2335567 999999999753 1111122578999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 008285 554 IEMLTGKPPWSEFE 567 (571)
Q Consensus 554 yELLtGr~PF~~~e 567 (571)
|||++|+.||.+..
T Consensus 304 ~elltg~~Pf~~~~ 317 (377)
T 3byv_A 304 YWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHSSCCC----
T ss_pred HHHHHCCCCCcccc
Confidence 99999999997643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=312.19 Aligned_cols=202 Identities=28% Similarity=0.452 Sum_probs=165.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhh--cCCCCeeEEeeeEEeC-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVD- 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~--L~HpNIVkl~g~~~~~- 428 (571)
..++|++.+.||+|+||+||+|++ +|+.||||++... ..+.+..|.+++.. ++|+||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 456899999999999999999987 5899999998531 12344556666666 7899999999986553
Q ss_pred ---CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCcEE
Q 008285 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHRDIKGANLLVDASGVVK 497 (571)
Q Consensus 429 ---~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH--------s~GIVHRDIKPsNILLd~~g~vK 497 (571)
..+|+||||+.+|+|.++++. ..+++..++.++.||+.||+||| ++||+||||||+||||+.++.+|
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 458999999999999999954 46999999999999999999999 99999999999999999999999
Q ss_pred EEecCCcccccCCccc-----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC----------CCC
Q 008285 498 LADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPP 562 (571)
Q Consensus 498 LiDFGlA~~l~~~~~~-----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG----------r~P 562 (571)
|+|||+++........ ....||+.|+|||++......+ ...++.++|||||||++|||++| +.|
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCC-cccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 9999999766443222 2347999999999987421110 00345789999999999999999 888
Q ss_pred CCCC
Q 008285 563 WSEF 566 (571)
Q Consensus 563 F~~~ 566 (571)
|.+.
T Consensus 233 f~~~ 236 (301)
T 3q4u_A 233 FYDV 236 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 8654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=311.49 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=174.2
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEE-CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC------CeeEEee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE------NIVQYYG 423 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~-k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp------NIVkl~g 423 (571)
...++|++.+.||+|+||.||+|.+ ..+|+.||||++.. .....+.+.+|+++++.++|+ +|+++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 3456999999999999999999998 56889999999862 234557788999999988765 4999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----------
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---------- 492 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---------- 492 (571)
++...+.+|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 899999997653 36899999999999999999999999999999999999987
Q ss_pred ---------CCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 493 ---------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 493 ---------~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
++.+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL-------ALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhh-------CCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999865432 23467999999999986 345789999999999999999999999
Q ss_pred CCCC
Q 008285 564 SEFE 567 (571)
Q Consensus 564 ~~~e 567 (571)
...+
T Consensus 235 ~~~~ 238 (339)
T 1z57_A 235 PTHD 238 (339)
T ss_dssp CCSC
T ss_pred CCCC
Confidence 7643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.85 Aligned_cols=203 Identities=16% Similarity=0.294 Sum_probs=174.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC--
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-- 428 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~-- 428 (571)
...++|++.+.||+|+||.||+|++. |..||||++.... ......+.+.+|+.++++++|+||+++++++.+.
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD---WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT---CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 34568999999999999999999985 8899999987532 2345567799999999999999999999999877
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
+..++||||++||+|.+++..... .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 788999999999999999987533 5899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... ....||+.|+|||++.... ...++.++|||||||++|||++|+.||.+.
T Consensus 162 ~~~~----~~~~~t~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 162 SFQS----PGRMYAPAWVAPEALQKKP----EDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp TTSC----TTCBSCGGGSCHHHHHSCG----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred eecc----cCccCCccccChhhhccCC----CCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 5332 2356899999999987421 123455899999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.33 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=169.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc------CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP------KSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~------~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
..++|++.+.||+|+||.||+|.+.. |..||||++....... ......+.+.+|+++|++++|+||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35689999999999999999999865 9999999985433221 2344567899999999999999999999998
Q ss_pred EeC-----CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEe
Q 008285 426 VVD-----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (571)
Q Consensus 426 ~~~-----~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiD 500 (571)
... ..+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 543 36899999998 789998887667899999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||++.............||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp TTC---------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccccccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999987665555556779999999999863 245789999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.00 Aligned_cols=204 Identities=26% Similarity=0.447 Sum_probs=173.0
Q ss_pred CCCeEEe-eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCe
Q 008285 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH 430 (571)
Q Consensus 353 ~~~y~i~-k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ 430 (571)
.++|.+. +.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3468887 89999999999999999999999999987533222 22456789999999995 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecCCccc
Q 008285 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKH 506 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFGlA~~ 506 (571)
+|+||||+.||+|.+++... ...+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999998542 356999999999999999999999999999999999999987 78999999999988
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...........||+.|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILN-------YDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp C---------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCccccccccCCcCccCCeeec-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76655455677999999999986 346788999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.24 Aligned_cols=193 Identities=29% Similarity=0.505 Sum_probs=165.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe------
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV------ 427 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~------ 427 (571)
++|++++.||+|+||.||+|++..+|+.||||++.. .....+.+.+|+.+++.++|+||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 479999999999999999999999999999999863 34556788999999999999999999998765
Q ss_pred -------CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEe
Q 008285 428 -------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (571)
Q Consensus 428 -------~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiD 500 (571)
.+.+|+||||++|++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4568999999999999999987666789999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCC---------------ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc
Q 008285 501 FGMAKHLTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 501 FGlA~~l~~~---------------~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
||++...... .......|++.|+|||++.. ...++.++|||||||++|+|++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh
Confidence 9999865421 11234568999999999862 3357899999999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.51 Aligned_cols=204 Identities=29% Similarity=0.492 Sum_probs=172.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEE-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEV- 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~- 426 (571)
..++|++.+.||+|+||.||+|.+. .+|+.||||++......... ...+.+|+.+++.+ .|+||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 4468999999999999999999995 67899999998653322111 12344666666665 8999999999987
Q ss_pred ----eCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 427 ----VDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 427 ----~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999998 69999998653 34999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
|++.............|++.|+|||++. ...++.++|||||||++|+|++|+.||.+.
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCCccccccccceeCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9998766544445677999999999986 335788999999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.69 Aligned_cols=206 Identities=27% Similarity=0.489 Sum_probs=175.7
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS 424 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~-----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~ 424 (571)
...++|++.+.||+|+||+||+|.+ ..+++.||||++... ......+.+.+|+.++.++ +|+||++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3456999999999999999999985 456789999998632 2344557789999999999 69999999999
Q ss_pred EEeCC-eEEEEEeecCCCCHHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008285 425 EVVDD-HLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 488 (571)
Q Consensus 425 ~~~~~-~lyLVmEy~~GGsL~d~L~~~~~~---------------Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNI 488 (571)
+...+ .+|+||||+.|++|.+++...... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87755 489999999999999999865332 89999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008285 489 LVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564 (571)
Q Consensus 489 LLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~ 564 (571)
||+.++.+||+|||+++....... .....||+.|+|||++.. ..++.++|||||||++|+|++ |+.||.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-------ccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999986644322 223557889999999873 357899999999999999998 999997
Q ss_pred CCC
Q 008285 565 EFE 567 (571)
Q Consensus 565 ~~e 567 (571)
+..
T Consensus 253 ~~~ 255 (316)
T 2xir_A 253 GVK 255 (316)
T ss_dssp TCC
T ss_pred ccc
Confidence 643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=315.26 Aligned_cols=207 Identities=23% Similarity=0.398 Sum_probs=160.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEE--
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEV-- 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~-- 426 (571)
.....+|++.+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+++++. |+||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34456899999999999999999999999999999988532 3455677889999999996 999999999984
Q ss_pred ------eCCeEEEEEeecCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcE
Q 008285 427 ------VDDHLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 427 ------~~~~lyLVmEy~~GGsL~d~L~~--~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd~~g~v 496 (571)
....+++||||+. |+|.+++.. ....+++.+++.++.||+.||.|||++| |+||||||+||||+.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3345899999996 799998865 3456999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCccc-------------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 497 KLADFGMAKHLTGLSYE-------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 497 KLiDFGlA~~l~~~~~~-------------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
||+|||+++........ ....||+.|+|||++... ....++.++|||||||++|+|++|+.||
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY----SNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CC----TTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc----ccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 99999999876543211 135589999999998421 1446788999999999999999999999
Q ss_pred CCC
Q 008285 564 SEF 566 (571)
Q Consensus 564 ~~~ 566 (571)
.+.
T Consensus 254 ~~~ 256 (337)
T 3ll6_A 254 EDG 256 (337)
T ss_dssp ---
T ss_pred cch
Confidence 754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=330.19 Aligned_cols=201 Identities=29% Similarity=0.542 Sum_probs=173.5
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++|+||+++++++...
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 4556679999999999999999999885 7899999986321 235688999999999999999999998776
Q ss_pred C-eEEEEEeecCCCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 D-HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 ~-~lyLVmEy~~GGsL~d~L~~~~~~-Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+ .+|||||||.+|+|.+++...... +++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 5 799999999999999999876443 79999999999999999999999999999999999999999999999999986
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... ....++..|+|||++. ...++.++|||||||+||||++ |+.||.+..
T Consensus 339 ~~~~~--~~~~~~~~y~aPE~~~-------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 339 ASSTQ--DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp CC--------CCCTTTSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ccccc--cCCCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 54322 2346788999999987 3468999999999999999998 999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=310.18 Aligned_cols=201 Identities=28% Similarity=0.484 Sum_probs=167.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE------
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV------ 426 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~------ 426 (571)
.++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+++++.++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 46899999999999999999999999999999988632 2455678899999999999999999998873
Q ss_pred --------eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEE
Q 008285 427 --------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVK 497 (571)
Q Consensus 427 --------~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vK 497 (571)
..+.+|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699999864 5699999999999999999999999999999999999997 567999
Q ss_pred EEecCCcccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 498 LADFGMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 498 LiDFGlA~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|+|||+++...... ......|+..|+|||++.. ...++.++|||||||++|||++|+.||.+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcC------cccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99999998764321 1223557999999999863 2467899999999999999999999997653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.52 Aligned_cols=205 Identities=28% Similarity=0.535 Sum_probs=171.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE-e
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-V 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~-~ 427 (571)
...+|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.++++++|+||+++++++. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3457999999999999999999976433 35888887632 23455678899999999999999999999854 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++..|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 56789999999999999999877777999999999999999999999999999999999999999999999999999866
Q ss_pred cCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... .....||+.|+|||.+.. ..++.++|||||||++|+|++ |.+||.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cccchhccccccCCCCCccccChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 44321 223557888999999874 357899999999999999999 667776544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=308.52 Aligned_cols=205 Identities=26% Similarity=0.442 Sum_probs=175.9
Q ss_pred CCCCCeEEee-EEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 351 PKKSQWQKGK-LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 351 ~~~~~y~i~k-~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
...++|.+.+ .||+|+||.||+|.+. .++..||||++... ......+.+.+|+++++.++|+||+++++++ .
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 3456788877 9999999999999864 46788999998642 2345667899999999999999999999998 5
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 66799999999999999999876677999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... .....||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcceeeccccccccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 54322 123456889999999863 357889999999999999998 999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=327.50 Aligned_cols=200 Identities=30% Similarity=0.511 Sum_probs=158.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
.+|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++|+||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 58999999999999999999999999999999876422 2345567788999999999999999999998654
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 6899999875 56999999999999999999999999999999999999999999999999999875
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... .....||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 183 ADE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc--CCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 234679999999999863 3467889999999999999999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.56 Aligned_cols=205 Identities=20% Similarity=0.320 Sum_probs=173.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---- 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~---- 427 (571)
..++|++.+.||+|+||.||+|.+..+|+.||||++.. ......+.+.+|+++++.++|+||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 45689999999999999999999999999999998864 234556778899999999999999999998873
Q ss_pred CCeEEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
....|+||||+.+++|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 3478999999999999999976 3467999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcc----------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 505 KHLTGLSY----------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 505 ~~l~~~~~----------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
........ .....||+.|+|||++... ....++.++|||||||++|+|++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ----SHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC----SEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccC----CCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 76532111 1134579999999987531 112367899999999999999999999953
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=322.11 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=166.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCc-HHH-----HHHHHHHHHHHhhcCCCCeeEEe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKS-AEC-----IKQLEQEIKVLGHLKHENIVQYY 422 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~-~~~-----~k~l~~Ei~IL~~L~HpNIVkl~ 422 (571)
..++|++++.||+|+||.||+|.+.. ++..||||++......... ... .+.+.+|+.+++.++|+||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45689999999999999999999987 7889999998743211000 011 12356788999999999999999
Q ss_pred eeEEe----CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--cE
Q 008285 423 GSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG--VV 496 (571)
Q Consensus 423 g~~~~----~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g--~v 496 (571)
+++.. .+.+|+||||+ |++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 99988 67899999999 999999997654 799999999999999999999999999999999999998777 99
Q ss_pred EEEecCCcccccCCc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 497 KLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 497 KLiDFGlA~~l~~~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
||+|||+++.+.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-------GVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999998764321 113457999999999987 33689999999999999999999999954
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=306.82 Aligned_cols=202 Identities=26% Similarity=0.487 Sum_probs=172.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
...|.+.+.||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.+++.++|+||+++++++.+.+
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 4478889999999999999999765554 7999987632 23455678899999999999999999999998766
Q ss_pred eE-EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 HL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~l-yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.. ++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 65 99999999999999998877789999999999999999999999999999999999999999999999999998654
Q ss_pred CCc-----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCC
Q 008285 509 GLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSE 565 (571)
Q Consensus 509 ~~~-----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P-F~~ 565 (571)
... ......|++.|+|||.+. ...++.++|||||||++|+|++|..| |..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQ-------TYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCcccccccCcCCCCCccccChhhhc-------cCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 322 222356788999999986 34678999999999999999995554 543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.11 Aligned_cols=206 Identities=27% Similarity=0.510 Sum_probs=180.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+.....+|++.+.||+|+||.||+|.++.++..||||.++.... ..+.+.+|+.+|++++|+||+++++++...
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 45566789999999999999999999999999999999863221 246788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|||||||.+|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999864 345899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... ....+++.|+|||++.. ..++.++|||||||+||||++ |+.||.+.+
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhc-------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 543322 23446788999999874 357889999999999999999 999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.92 Aligned_cols=200 Identities=28% Similarity=0.475 Sum_probs=174.6
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc------CCCCeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL------KHENIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L------~HpNIVkl~g~~ 425 (571)
...+|++++.||+|+||+||+|.+..+|+.||||++.. .....+.+.+|+.+++.+ .|+||+++++.+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 34589999999999999999999999999999999862 234456677888888877 467999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEEecC
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFG 502 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~--vKLiDFG 502 (571)
...+.+++||||+. ++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 79999987653 45999999999999999999999999999999999999998887 9999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+++..... ....+||+.|+|||++.. ..++.++|||||||+||||++|+.||.+.+
T Consensus 248 ~a~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR--VYTYIQSRFYRAPEVILG-------ARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC--CCSSCSCGGGCCHHHHHT-------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc--ccccCCCCCccChHHHhC-------CCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765432 234679999999999973 357899999999999999999999997653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.73 Aligned_cols=200 Identities=32% Similarity=0.485 Sum_probs=168.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH- 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~- 430 (571)
...+|++.+.||+|+||+||+|++..+++ ||+|.+..... ...+|+++|+.++|+||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 34589999999999999999999987665 88887753221 12369999999999999999999866443
Q ss_pred -----EEEEEeecCCCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecC
Q 008285 431 -----LYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFG 502 (571)
Q Consensus 431 -----lyLVmEy~~GGsL~d~L~--~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFG 502 (571)
+|+|||||.++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 889999998654433332 2356799999999999999999999999999999999999998 79999999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+++.+..........||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+..
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccCCCCCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998766666667789999999999863 3458899999999999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.44 Aligned_cols=202 Identities=25% Similarity=0.437 Sum_probs=173.6
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+++++.++|+||+++++++...+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 34568999999999999999999854 6899999998643221 112357899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 431 LYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~---~~Lse~~i~~I~~QIa~gL~yLHs~---GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
.++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999998642 3499999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 505 KHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 505 ~~l~~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
....... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH-------SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccCcccccccccccCCcCccCHHHhcc-------CCCCccccchhHHHHHHHHHhCCCccc
Confidence 8764322 2334569999999999864 247889999999999999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.94 Aligned_cols=206 Identities=24% Similarity=0.429 Sum_probs=173.3
Q ss_pred CCCCCCeEEee-EEeecCceEEEEEE--ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGK-LIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k-~LG~G~fG~VYla~--~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
.....+|++.+ .||+|+||+||+|. ...+++.||||++.... ......+.+.+|+++++.++|+||+++++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 33456899998 99999999999995 45678899999986432 2223467789999999999999999999988
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
..+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 667889999999999999999874 5699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
....... ....|++.|+|||++.. ..++.++||||||+++|+|++ |+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhcc-------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 6543221 22446788999999874 246789999999999999999 999997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.57 Aligned_cols=201 Identities=23% Similarity=0.462 Sum_probs=176.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|++++++++|+||+++++++...+.+|+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 48999999999999999999999999999999986433222 224668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEEecCCcccccCC
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGL 510 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---g~vKLiDFGlA~~l~~~ 510 (571)
||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999999765 569999999999999999999999999999999999999754 47999999999877654
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......|++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccccCcccccChHHhcC--------CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 44445568899999998852 3788999999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=307.31 Aligned_cols=202 Identities=41% Similarity=0.704 Sum_probs=171.5
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
+|....+||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3444458999999999999999999999999987432 13346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCcccccCCc
Q 008285 435 LEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~--~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~l~~~~ 511 (571)
|||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999999987533 4678899999999999999999999999999999999987 8999999999998765432
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......|++.|+|||++.... ..++.++|||||||++|+|++|+.||.+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGP-----RGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGG-----GGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CcccccCCCccccChhhhcCCC-----CCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 233567999999999987421 23678999999999999999999999653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.87 Aligned_cols=203 Identities=26% Similarity=0.505 Sum_probs=173.6
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++|++++.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+++++.++|+||+++++++. .
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 4455679999999999999999999976 467899998864221 1356889999999999999999999875 5
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+..|+||||+.|++|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 66899999999999999996532 36999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... ....++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCcccccccCCCCccCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 543322 23457889999999863 357889999999999999999 99999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.06 Aligned_cols=202 Identities=35% Similarity=0.516 Sum_probs=161.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe--
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-- 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~-- 430 (571)
.++|++.+.||+|+||+||+|++..+|+.||||++...... .....+|++.+..++|+||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 35899999999999999999999999999999988643221 1345567888888999999999999876543
Q ss_pred -----EEEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEcC-CCcEEEE
Q 008285 431 -----LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLH--STNTIHRDIKGANLLVDA-SGVVKLA 499 (571)
Q Consensus 431 -----lyLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLH--s~GIVHRDIKPsNILLd~-~g~vKLi 499 (571)
+++||||+.+ +|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999985 55554432 3456899999999999999999999 999999999999999996 8999999
Q ss_pred ecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 500 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 500 DFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|||+++.+..........||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999998776665666789999999999853 3457899999999999999999999997643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.33 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=167.7
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhc----CCCCeeEEeee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHL----KHENIVQYYGS 424 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L----~HpNIVkl~g~ 424 (571)
....++|++.+.||+|+||.||+|.+..+|+.||||++........ .......+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3445689999999999999999999999999999999864332111 112234456789999888 89999999999
Q ss_pred EEeCCeEEEEEee-cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecC
Q 008285 425 EVVDDHLYIYLEY-VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFG 502 (571)
Q Consensus 425 ~~~~~~lyLVmEy-~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFG 502 (571)
+...+..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9999999999999 7899999999875 5699999999999999999999999999999999999998 88999999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
++....... .....|+..|+|||++.. ....+.++|||||||++|+|++|+.||..
T Consensus 186 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 186 SGALLHDEP-YTDFDGTRVYSPPEWISR------HQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SCEECCSSC-BCCCCSCTTTSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhhhcccCc-ccccCCcccccCceeeec------CCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 998775533 335679999999999874 22345689999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.65 Aligned_cols=205 Identities=27% Similarity=0.517 Sum_probs=176.0
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.+....++|++.+.||+|+||.||+|.+.. +..||||.++... . ..+.+.+|+.+|+.++|+||+++++++.
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~---~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---M---SVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS---B---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC---c---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 345566799999999999999999999864 7889999986422 1 2467889999999999999999999875
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+.+|||||||.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 67789999999999999999754 24689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
....... ....+++.|+|||++.. ..++.++|||||||+||||++ |+.||.+..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCceeccCCCcccccccCHHHhcc-------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 6543221 23446788999999873 358899999999999999999 999997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.49 Aligned_cols=208 Identities=24% Similarity=0.423 Sum_probs=167.4
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECC---CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~---tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....++|++++.||+|+||.||+|.+.. ++..||+|.+.... ......+.+.+|+.++++++|+||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---SSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3456789999999999999999998765 45689999876432 23455678899999999999999999999988
Q ss_pred eCC-----eEEEEEeecCCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 008285 427 VDD-----HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (571)
Q Consensus 427 ~~~-----~lyLVmEy~~GGsL~d~L~~~-----~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~v 496 (571)
+.+ ..|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 765 359999999999999999542 3569999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 497 KLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 497 KLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
||+|||++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |+.||....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhc-------CCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 999999998764432 122345788999999986 3468899999999999999999 999997643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.45 Aligned_cols=196 Identities=20% Similarity=0.288 Sum_probs=169.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC--------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeE----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE--------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ---- 420 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~--------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVk---- 420 (571)
.++|++.+.||+|+||.||+|++.. +++.||||++... +.+.+|++++++++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 5699999999999999999999987 4889999998632 35778999999999999887
Q ss_pred -----------EeeeEEe-CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008285 421 -----------YYGSEVV-DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487 (571)
Q Consensus 421 -----------l~g~~~~-~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsN 487 (571)
+++++.. ++.+|+||||+ +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 5667766 67899999999 99999999864 3679999999999999999999999999999999999
Q ss_pred EEEcCCC--cEEEEecCCcccccCCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHH
Q 008285 488 LLVDASG--VVKLADFGMAKHLTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (571)
Q Consensus 488 ILLd~~g--~vKLiDFGlA~~l~~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELL 557 (571)
|||+.++ .+||+|||+++.+..... .....||+.|+|||++. +..++.++|||||||++|||+
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-------GCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHH
Confidence 9999988 999999999986643221 12357999999999986 346889999999999999999
Q ss_pred cCCCCCCCC
Q 008285 558 TGKPPWSEF 566 (571)
Q Consensus 558 tGr~PF~~~ 566 (571)
+|+.||...
T Consensus 263 ~g~~pf~~~ 271 (352)
T 2jii_A 263 YGFLPWTNC 271 (352)
T ss_dssp HSCCTTGGG
T ss_pred hCCCCcccC
Confidence 999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=310.72 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=172.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCC-cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC------eeEEeee
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN------IVQYYGS 424 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG-~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN------IVkl~g~ 424 (571)
..++|++.+.||+|+||+||+|.+..++ +.||||++.. .....+.+.+|+.+++.++|++ |+.++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3569999999999999999999998877 6899999862 2344567888999999987655 9999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-------------
Q 008285 425 EVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV------------- 490 (571)
Q Consensus 425 ~~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL------------- 490 (571)
+...+.+||||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 577777776543 569999999999999999999999999999999999999
Q ss_pred ------cCCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 491 ------DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 491 ------d~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
+.++.+||+|||+++..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVIL-------ELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeee-------cCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999865433 23467999999999986 3467899999999999999999999997
Q ss_pred CCC
Q 008285 565 EFE 567 (571)
Q Consensus 565 ~~e 567 (571)
...
T Consensus 241 ~~~ 243 (355)
T 2eu9_A 241 THE 243 (355)
T ss_dssp CSS
T ss_pred CCC
Confidence 643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.30 Aligned_cols=202 Identities=30% Similarity=0.521 Sum_probs=173.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|..++.||+|+||+||+|.+ +++.||||++..... ....+..+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 455568999999999999986 588999999864322 12234567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 435 LEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~--~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 9999999999999743 3459999999999999999999999999999999999999999999999999998664422
Q ss_pred --cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 --~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG--------EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT--------EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cccccccCCCcCcCChHHhcC--------CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 1234579999999998752 36789999999999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.58 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=170.9
Q ss_pred CCCCCeEEeeEEeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~-----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~ 425 (571)
...++|++++.||+|+||.||+|+ +..++..||||.+... ........+.+|+.+++.++|+||+++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 455699999999999999999999 5567889999998532 2344556788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcE
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVV 496 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~v 496 (571)
...+..|+||||++|++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998754 34899999999999999999999999999999999999984 4569
Q ss_pred EEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 497 KLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
||+|||++....... ......|++.|+|||++.. ..++.++|||||||++|+|++ |+.||...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 999999997653322 1223568899999999873 357899999999999999998 99999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.79 Aligned_cols=201 Identities=25% Similarity=0.479 Sum_probs=162.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc--CCCCeeEEeeeEEeC--
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL--KHENIVQYYGSEVVD-- 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L--~HpNIVkl~g~~~~~-- 428 (571)
.++|++.+.||+|+||.||+|++. |+.||||++... .......|.+++..+ +|+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT--------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG--------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc--------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 358999999999999999999885 899999998531 113344555565554 899999999999887
Q ss_pred --CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEE
Q 008285 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--------NTIHRDIKGANLLVDASGVVKL 498 (571)
Q Consensus 429 --~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~--------GIVHRDIKPsNILLd~~g~vKL 498 (571)
..+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 3699999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCccc-----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC----------CCCC
Q 008285 499 ADFGMAKHLTGLSYE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPW 563 (571)
Q Consensus 499 iDFGlA~~l~~~~~~-----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG----------r~PF 563 (571)
+|||++..+...... ....||+.|+|||++....... ...++.++|||||||++|||++| +.||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999999766443222 2457999999999986421110 00111259999999999999999 7777
Q ss_pred CCC
Q 008285 564 SEF 566 (571)
Q Consensus 564 ~~~ 566 (571)
.+.
T Consensus 263 ~~~ 265 (337)
T 3mdy_A 263 HDL 265 (337)
T ss_dssp TTT
T ss_pred hhh
Confidence 654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=311.08 Aligned_cols=210 Identities=29% Similarity=0.454 Sum_probs=157.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHH-HHhhcCCCCeeEEeeeEEe
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~-IL~~L~HpNIVkl~g~~~~ 427 (571)
+....++|++.+.||+|+||.||+|.++.+|+.||||++.... ......++..|+. +++.++|+||+++++++..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4455679999999999999999999999999999999987432 2233445555555 7788899999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecC
Q 008285 428 DDHLYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~----~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
.+..|+||||+.| +|.+++.. ....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999984 88887763 246799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+++............||+.|+|||++.... ....++.++|||||||++|+|++|+.||.+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSA---SRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred CceecccccccccCCCCccccCceeecccc---CcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 998776554444557999999999984311 1335788999999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=306.92 Aligned_cols=210 Identities=28% Similarity=0.444 Sum_probs=160.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.++.+|+.||||++.... ......+.+..+..+++.++|+||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34568999999999999999999999999999999987432 223334445556667888899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|+||||+ ++.+..++......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5677777666567899999999999999999999995 999999999999999999999999999987765
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........|++.|+|||++..... ....++.++|||||||++|+|++|+.||...
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDP--TKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ---------CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccccccCCCccccChhhcccccc--cccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 544455679999999999853211 1345788999999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.50 Aligned_cols=199 Identities=28% Similarity=0.497 Sum_probs=156.0
Q ss_pred CCeEE-eeEEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--C
Q 008285 354 SQWQK-GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--D 428 (571)
Q Consensus 354 ~~y~i-~k~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~ 428 (571)
+.|++ +++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.++|+||+++++++.. .
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 35776 558999999999999976 5688999998863221 1357789999999999999999999965 6
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcE
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVV 496 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~--------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL----d~~g~v 496 (571)
..+||||||+. ++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 78999999997 68888875321 249999999999999999999999999999999999999 677899
Q ss_pred EEEecCCcccccCC----ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 497 KLADFGMAKHLTGL----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 497 KLiDFGlA~~l~~~----~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
||+|||+++.+... ......+||+.|+|||++.. ...++.++||||||||+|||++|+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999876542 22234679999999999863 345899999999999999999999999654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=313.05 Aligned_cols=205 Identities=26% Similarity=0.416 Sum_probs=162.4
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHH--HhhcCCCCeeEEeeeEEe
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV--LGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~I--L~~L~HpNIVkl~g~~~~ 427 (571)
....++|++++.||+|+||.||+|++ +|+.||||++.... ...+..|.++ +..++|+||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN--------RQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 34567999999999999999999976 58999999986321 1223334444 455899999999985543
Q ss_pred -----CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCC
Q 008285 428 -----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---------NTIHRDIKGANLLVDAS 493 (571)
Q Consensus 428 -----~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~---------GIVHRDIKPsNILLd~~ 493 (571)
...+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+||||+.+
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 23578999999999999999764 468999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccCCc---------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLS---------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~---------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
+.+||+|||+++.+.... ......||+.|+|||++.+.........++.++|||||||++|||++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999998764321 12245699999999998642111111245678999999999999999987764
Q ss_pred CC
Q 008285 565 EF 566 (571)
Q Consensus 565 ~~ 566 (571)
..
T Consensus 237 ~~ 238 (336)
T 3g2f_A 237 PG 238 (336)
T ss_dssp TT
T ss_pred Cc
Confidence 43
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=318.07 Aligned_cols=200 Identities=29% Similarity=0.505 Sum_probs=171.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL- 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l- 431 (571)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 458999999999999999999999999999999986422 3345567888999999999999999999999877655
Q ss_pred -----EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 432 -----YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 432 -----yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred cceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 68888773 4599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 194 ADAE--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp --------CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccC--cCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6443 234678999999999863 2467889999999999999999999997653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=310.63 Aligned_cols=207 Identities=26% Similarity=0.460 Sum_probs=171.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE--eCCe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV--VDDH 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~--~~~~ 430 (571)
.++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+.+|+++++.++|+||+++++++. ..+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 35899999999999999999999999999999998632110 00123567889999999999999999999884 4567
Q ss_pred EEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
+|+||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999876 77777653 45699999999999999999999999999999999999999999999999999987643
Q ss_pred ---CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 ---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ---~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........|++.|+|||++... ...++.++|||||||++|||++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGL-----DTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCC-----SCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCCCCCcChhhccCc-----ccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 2222346699999999998631 223477999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.65 Aligned_cols=202 Identities=30% Similarity=0.524 Sum_probs=174.8
Q ss_pred CCCCCeEEeeEEeecCceEEEEEE----ECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~----~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
....+|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+++++.++|+||+++++++.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 345689999999999999999998 4668999999998642 2345677899999999999999999999886
Q ss_pred eCC--eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 427 VDD--HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 427 ~~~--~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
..+ .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999887667999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 505 KHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 505 ~~l~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
........ .....++..|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hhccccccccccccCCCCceeEECchhhcC-------CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 87654322 123457788999999874 246789999999999999999999885
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.56 Aligned_cols=200 Identities=26% Similarity=0.407 Sum_probs=174.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIVkl~g~~~~~~~l 431 (571)
.++|+++++||+|+||.||+|++..+|+.||||++...... ..+.+|+++++.++| ++|..+..++...+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 46899999999999999999999999999999987643322 236789999999986 6666677777788899
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEEecCCccccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLT 508 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILL---d~~g~vKLiDFGlA~~l~ 508 (571)
||||||+ +++|.+++......+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 899999998766789999999999999999999999999999999999999 688999999999998765
Q ss_pred CCcc--------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~--------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||+.|+|||++. +..++.++||||||||||||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCccccccccccccccCCCccccCHHHhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 4332 12567999999999987 3468899999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=306.82 Aligned_cols=205 Identities=27% Similarity=0.480 Sum_probs=165.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECC-CCc--EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~-tG~--~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..++|++.+.||+|+||+||+|++.. ++. .||||++..... ...+..+.+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 45689999999999999999998643 333 689998763221 1234567889999999999999999999988765
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+ .++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 4 899999999999999998876779999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... .....++..|+|||++.. ..++.++||||||+++|+|++ |+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccchhhhccCCCCceeeCchhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 4322 123457888999999874 246789999999999999999 99999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.28 Aligned_cols=205 Identities=27% Similarity=0.525 Sum_probs=165.2
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~- 427 (571)
....|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+|++++|+||+++++++..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 3457899999999999999999876433 45888887532 223456788999999999999999999998654
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++..|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 56789999999999999999877777999999999999999999999999999999999999999999999999999866
Q ss_pred cCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... .....+++.|+|||++.. ..++.++|||||||++|||++ |.+||.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp ---------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccccccccccCCCCCcccccChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 43221 123457889999999873 357899999999999999999 788887654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=314.27 Aligned_cols=200 Identities=24% Similarity=0.392 Sum_probs=170.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-----------CCCeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQ 420 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-----------HpNIVk 420 (571)
...+|++.+.||+|+||+||+|++..+|+.||||++.. .....+.+.+|+++++++. |+||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 45689999999999999999999999999999999862 2344567788999998886 789999
Q ss_pred EeeeEEeCC----eEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEc---
Q 008285 421 YYGSEVVDD----HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVD--- 491 (571)
Q Consensus 421 l~g~~~~~~----~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~-GIVHRDIKPsNILLd--- 491 (571)
+++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||||+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999988754 789999999 89999999864 34599999999999999999999998 999999999999994
Q ss_pred ---CCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 492 ---ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 492 ---~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..+.+||+|||+++..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH-------TCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHh-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3448999999999876543 23457999999999987 3457899999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=303.85 Aligned_cols=200 Identities=30% Similarity=0.538 Sum_probs=165.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4455679999999999999999999874 8899999876321 246788999999999999999999987554
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~-~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+.+|+||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence 478999999999999999976532 389999999999999999999999999999999999999999999999999986
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
..... ....+++.|+|||++.. ..++.++||||||+++|+|++ |+.||...
T Consensus 167 ~~~~~--~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 167 ASSTQ--DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -----------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccc--cCCCccccccCHHHhCC-------CCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 54432 23457889999999873 357889999999999999998 99999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=311.29 Aligned_cols=199 Identities=33% Similarity=0.499 Sum_probs=170.5
Q ss_pred CCeEEeeEEeecCceEEEEEEE----CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~----k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~- 428 (571)
..|++++.||+|+||+||+|.+ ..+|+.||||++... ......+.+.+|+++|+.++|+||+++++++.+.
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3459999999999999988754 457899999998642 2345567789999999999999999999999884
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6789999999999999999763 4999999999999999999999999999999999999999999999999999877
Q ss_pred cCCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 508 ~~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
..... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE-------YKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 54321 224568888999999974 3467899999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.89 Aligned_cols=200 Identities=28% Similarity=0.474 Sum_probs=173.5
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CC-----CeeEEeeeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE-----NIVQYYGSE 425 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-Hp-----NIVkl~g~~ 425 (571)
..++|++.+.||+|+||+||+|.+..+|+.||||++.. .......+..|+.+++.+. |+ +|+++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 35699999999999999999999999999999999862 2345567788999988885 55 499999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEc--CCCcEEEEe
Q 008285 426 VVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLH--STNTIHRDIKGANLLVD--ASGVVKLAD 500 (571)
Q Consensus 426 ~~~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLH--s~GIVHRDIKPsNILLd--~~g~vKLiD 500 (571)
...+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999996 59999998653 56999999999999999999999 57999999999999994 578899999
Q ss_pred cCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 501 FGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
||+++..... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLG-------MPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTCC--CCSSCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceecccc--cccccCCccccChHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876542 234679999999999873 358899999999999999999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.00 Aligned_cols=208 Identities=27% Similarity=0.449 Sum_probs=176.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC-cHHHHHHHHHHHHHHhhcC--CCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLK--HENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~-~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g~~~ 426 (571)
....++|++++.||+|+||.||+|++..+|+.||||++........ .....+.+.+|+.+++++. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456799999999999999999999999999999999875332210 0011234667999999996 599999999999
Q ss_pred eCCeEEEEEeecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEEecCCc
Q 008285 427 VDDHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMA 504 (571)
Q Consensus 427 ~~~~lyLVmEy~~G-GsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd-~~g~vKLiDFGlA 504 (571)
..+.+++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 99999999999987 8999999875 5699999999999999999999999999999999999998 7899999999999
Q ss_pred ccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 505 ~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
....... .....||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 198 ~~~~~~~-~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 198 ALLKDTV-YTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EECCSSC-BCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccccc-ccCCCCCccCCChHHhcc------CCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 8775433 334679999999999874 23346789999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.46 Aligned_cols=196 Identities=31% Similarity=0.519 Sum_probs=162.8
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++.+.||+|+||+||+|++. ++.||||.+.. ....+.+.+|+++|++++|+||+++++++. +..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 74 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence 3468999999999999999999875 78899998752 123467889999999999999999999875 458
Q ss_pred EEEEeecCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEcCCCc-EEEEecCCcc
Q 008285 432 YIYLEYVHPGSINRYVREHCR--DITESIVRNFTRHILNGLAYLHS---TNTIHRDIKGANLLVDASGV-VKLADFGMAK 505 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~--~Lse~~i~~I~~QIa~gL~yLHs---~GIVHRDIKPsNILLd~~g~-vKLiDFGlA~ 505 (571)
|+||||++|++|.+++..... .+++..+..++.||++||+|||+ +||+||||||+||||+.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 999999999999999976432 47899999999999999999999 89999999999999988876 7999999997
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFE-------GSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------------CCTTSSCHHHHT-------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccc--cccCCCCCceEChhhhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 65432 22346999999999986 3467899999999999999999999998653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.19 Aligned_cols=205 Identities=26% Similarity=0.438 Sum_probs=170.8
Q ss_pred CCCCCeEEee-EEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 351 PKKSQWQKGK-LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 351 ~~~~~y~i~k-~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
....++.+.+ .||+|+||.||+|.++ .++..||||+++.... ....+.+.+|+++|++++|+|||++++++..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3455677766 8999999999999876 3566799999864321 1235678899999999999999999999875
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|||||||.+|+|.+++......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 6699999999999999999876677999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
...... ....+++.|+|||++.. ..++.++|||||||+||||++ |+.||.+..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp C--------------CCTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 433211 12345688999999873 368899999999999999998 999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.06 Aligned_cols=203 Identities=29% Similarity=0.512 Sum_probs=169.7
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
+....++|++.+.||+|+||.||+|.+.. +..||||+++.... . .+.+.+|+++|++++|+||+++++++..
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 45566789999999999999999999875 56799998864221 1 3568899999999999999999998765
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|||||||.+|+|.+++... ...+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 7789999999999999999753 356999999999999999999999999999999999999999999999999999876
Q ss_pred cCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
..... .....++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCceecccCCcccccccCHhHHhc-------CCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 54322 123457788999999873 358899999999999999999 99999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.68 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=170.7
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe--
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-- 430 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~-- 430 (571)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 358999999999999999999999999999999986422 334556788899999999999999999999887654
Q ss_pred ----EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 431 ----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 431 ----lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred cceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 68888764 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 176 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 176 ADAE--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ----------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCC--ccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 234578999999999863 2467889999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.48 Aligned_cols=207 Identities=24% Similarity=0.413 Sum_probs=176.1
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcC------------cHHHHHHHHHHHHHHhhcCCCCee
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK------------SAECIKQLEQEIKVLGHLKHENIV 419 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~------------~~~~~k~l~~Ei~IL~~L~HpNIV 419 (571)
..++|++++.||+|+||.||+|.+ +|+.||||++........ .....+.+.+|+.+++.++|+||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 346999999999999999999998 899999999864211100 011126788999999999999999
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHH------HHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEc
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRY------VREH-CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVD 491 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~------L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd 491 (571)
++++++.+.+.+|+||||++|++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 5442 4679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 492 ASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-AVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 492 ~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~-ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.++.+||+|||++...... ......|+..|+|||++.. ...++. ++|||||||++|||++|+.||....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcC------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999876543 3345679999999999863 223444 8999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.59 Aligned_cols=204 Identities=29% Similarity=0.512 Sum_probs=175.2
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.+....++|++.+.||+|+||.||+|.+.. +..||||+++.... . .+.+.+|+++|++++|+||+++++++..
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~---~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---C---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---C---HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 355567799999999999999999999875 56799999864221 1 3568899999999999999999998765
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+.+|||||||.+|+|.++|... ...+++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 7789999999999999999753 35699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 507 LTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 507 l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+..... .....++..|+|||++.. ..++.++|||||||+||||++ |+.||.+.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred cCCCceecccCCcCcccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654321 123457788999999873 358899999999999999999 99999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.54 Aligned_cols=200 Identities=26% Similarity=0.416 Sum_probs=168.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhh--cCCCCeeEEeeeEEeCC--
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH--LKHENIVQYYGSEVVDD-- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~--L~HpNIVkl~g~~~~~~-- 429 (571)
++|++.+.||+|+||.||+|++ +|+.||||++... ..+.+.+|++++.. ++|+||+++++++...+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4899999999999999999998 4899999998531 13456788888887 78999999999998876
Q ss_pred --eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCcEEEE
Q 008285 430 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH--------STNTIHRDIKGANLLVDASGVVKLA 499 (571)
Q Consensus 430 --~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH--------s~GIVHRDIKPsNILLd~~g~vKLi 499 (571)
.+|+||||+.+|+|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred cceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 79999999999999999976 36999999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC----------CCCCC
Q 008285 500 DFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWS 564 (571)
Q Consensus 500 DFGlA~~l~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG----------r~PF~ 564 (571)
|||++........ .....||+.|+|||++....... ...++.++|||||||++|||++| +.||.
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhccccccc-ccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999987654332 23457999999999986421100 00233689999999999999999 78987
Q ss_pred CC
Q 008285 565 EF 566 (571)
Q Consensus 565 ~~ 566 (571)
..
T Consensus 269 ~~ 270 (342)
T 1b6c_B 269 DL 270 (342)
T ss_dssp TT
T ss_pred cc
Confidence 64
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=300.69 Aligned_cols=210 Identities=28% Similarity=0.490 Sum_probs=171.0
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC--CCCeeEEeeeEEe
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVV 427 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g~~~~ 427 (571)
.....+|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+.+|+++++.++ |+||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc---ccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 344568999999999999999999985 48999999987433 23455678899999999997 5999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+.+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 999999999 5679999999875 5799999999999999999999999999999999999996 489999999999876
Q ss_pred cCCcc---ccccCCCCcccChHHHHHhhhc----CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSY---ELSLKGSPNWMAPEVIKAVMQK----DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~---~~~~~GT~~YmAPEvl~~~~~~----d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..... .....|++.|+|||++...... .....++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 54322 2245699999999998642111 01246889999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.93 Aligned_cols=199 Identities=30% Similarity=0.409 Sum_probs=147.8
Q ss_pred CCCCeEEee-EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe---
Q 008285 352 KKSQWQKGK-LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--- 427 (571)
Q Consensus 352 ~~~~y~i~k-~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--- 427 (571)
..++|++.+ +||+|+||+||+|.++.+|+.||||++.. .....+ .....++.+.|+||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ---EVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES------SHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC------cHHHHH---HHHHHHHhcCCCChHHHHHHHhhccC
Confidence 445899965 69999999999999999999999999863 112222 22334566789999999999876
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecC
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG 502 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFG 502 (571)
...+|||||||.||+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 455899999999999999998653 36999999999999999999999999999999999999975 4569999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+++...... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||....
T Consensus 177 ~~~~~~~~~-~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 177 FAKETTQNA-LQTPCYTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp TCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceeccccc-cccCCCCcCccChhhhC-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 998765432 23467899999999985 3356789999999999999999999996543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=308.87 Aligned_cols=211 Identities=26% Similarity=0.417 Sum_probs=172.4
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.....++|++.+.||+|+||.||+|.+.. .||+|++........ ..+.+.+|+.+++.++|+||+++++++...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 45566799999999999999999999864 499998865432211 224567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+++||||+.|++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999999987666799999999999999999999999999999999999998 6799999999987543
Q ss_pred C------CccccccCCCCcccChHHHHHhhhc--CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 G------LSYELSLKGSPNWMAPEVIKAVMQK--DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~------~~~~~~~~GT~~YmAPEvl~~~~~~--d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
. ........|++.|+|||++...... .....++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 1122235589999999998642111 01345789999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=335.07 Aligned_cols=202 Identities=25% Similarity=0.455 Sum_probs=167.4
Q ss_pred CCeEE-eeEEeecCceEEEEEEE--CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 354 SQWQK-GKLIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i-~k~LG~G~fG~VYla~~--k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
..+.+ .+.||+|+||.||+|.+ +.+++.||||+++.... .....+.+.+|+++|++++|+|||++++++. .+.
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~ 443 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICE-AES 443 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG---CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCC
Confidence 34544 35899999999999955 45678999999864322 2233577899999999999999999999886 556
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
++||||||.+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 89999999999999999764 67999999999999999999999999999999999999999999999999999876543
Q ss_pred cc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 511 SY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 511 ~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.. .....||+.|+|||++.. ..++.++|||||||+||||++ |+.||.+..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ------------CGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCCCCceeeeChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 21 223456788999999963 358899999999999999998 999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=332.75 Aligned_cols=195 Identities=26% Similarity=0.416 Sum_probs=169.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECC-CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~-tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
..++|++.+.||+|+||+||+|.+.. +|+.||||++... ......+.+.+|+++|++++|+||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 34699999999999999999999976 7899999987532 234556778899999999999999999999988765
Q ss_pred -----EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 431 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 431 -----lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
.||||||++|++|.+++.. .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999998754 69999999999999999999999999999999999999875 89999999998
Q ss_pred cccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 506 ~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
..... ....||+.|+|||++.. .++.++|||||||++|+|++|..||.+
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~--------~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRT--------GPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHH--------CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC---CccCCCccccCHHHHcC--------CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 76543 34679999999999864 237899999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=293.75 Aligned_cols=179 Identities=12% Similarity=0.069 Sum_probs=157.4
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ 430 (571)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+..+.+.+|+.++..++|+||+++++++.+.+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG--VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC--CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc--ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 34468999999999999999999999999999999986432 2335567888999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
.|+||||++|++|.+++.. .....++..|+.||+.||+|||++||+||||||+||||+.+|.+||++++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999999954 24666788999999999999999999999999999999999999997443
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
|++ .++.++|||||||++|||++|+.||.+..
T Consensus 175 -----------~~~--------------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 -----------TMP--------------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp -----------CCT--------------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred -----------ccC--------------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 25678999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=329.75 Aligned_cols=204 Identities=27% Similarity=0.472 Sum_probs=173.1
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCC---CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~t---G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
....+|++++.||+|+||.||+|.+..+ +..||||.+... ......+.+.+|+.+|++++|+||+++++++ .
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~ 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-e
Confidence 3456899999999999999999998654 457899987532 2345567889999999999999999999987 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 56789999999999999999877667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 508 TGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
...... ....|++.|+|||++.. ..++.++|||||||++|||++ |..||.+.
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CC----------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceeccCCCCCcceeCHHHhcC-------CCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 543322 23457789999999863 357899999999999999997 99999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.93 Aligned_cols=206 Identities=31% Similarity=0.467 Sum_probs=161.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
...+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+++|+.+ +||||+++++++.+.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345578888999999999998754 457999999988631 134567899999886 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----------
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---------- 493 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~------Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~---------- 493 (571)
.+|||||||. |+|.+++...... ..+..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 6999999764221 1333457899999999999999999999999999999654
Q ss_pred ---CcEEEEecCCcccccCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008285 494 ---GVVKLADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564 (571)
Q Consensus 494 ---g~vKLiDFGlA~~l~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~ 564 (571)
+.+||+|||+++.+..... .....||+.|+|||++...........++.++|||||||++|||++ |+.||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 4899999999987755322 1235799999999998643222223568999999999999999999 999997
Q ss_pred CC
Q 008285 565 EF 566 (571)
Q Consensus 565 ~~ 566 (571)
+.
T Consensus 242 ~~ 243 (434)
T 2rio_A 242 DK 243 (434)
T ss_dssp ST
T ss_pred Cc
Confidence 53
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=314.29 Aligned_cols=197 Identities=20% Similarity=0.258 Sum_probs=161.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC---cCcHHHHHHHHHHHHHHhhcC---------CCCeeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLK---------HENIVQ 420 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d---~~~~~~~k~l~~Ei~IL~~L~---------HpNIVk 420 (571)
.++|++++.||+|+||+||+|++ +|+.||||++...... .......+.+.+|+.+|+.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45899999999999999999998 6899999999764321 111223466778888888885 777777
Q ss_pred EeeeEE------------------------------eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 008285 421 YYGSEV------------------------------VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470 (571)
Q Consensus 421 l~g~~~------------------------------~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL 470 (571)
+++.+. ..+.+|||||||.+|+|.+.+.+ ..+++.+++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776543 26789999999999976666643 5689999999999999999
Q ss_pred HHHH-hCCceecCCCCCcEEEcCCC--------------------cEEEEecCCcccccCCccccccCCCCcccChHHHH
Q 008285 471 AYLH-STNTIHRDIKGANLLVDASG--------------------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529 (571)
Q Consensus 471 ~yLH-s~GIVHRDIKPsNILLd~~g--------------------~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~ 529 (571)
+||| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|||||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 9999999999876543 347999999999986
Q ss_pred HhhhcCCCCCCCchhhHHHHHHH-HHHHHcCCCCCCC
Q 008285 530 AVMQKDGNPKLALAVDIWSLGCT-VIEMLTGKPPWSE 565 (571)
Q Consensus 530 ~~~~~d~~~~~s~ksDVWSLGvV-LyELLtGr~PF~~ 565 (571)
+ ..+.++||||||++ .++++.|..||.+
T Consensus 251 g--------~~~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 G--------DGDYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp C--------CSSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred C--------CCccceehhhhhCCCCcccccccCCCcc
Confidence 3 12789999998777 7778889999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.31 Aligned_cols=202 Identities=24% Similarity=0.406 Sum_probs=162.3
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCC
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~ 429 (571)
....+|++.+.||+|+||+||. ....+|+.||||++.... ...+.+|+++|+.+ +|+|||++++++.+.+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--------FSFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--------EEECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 3445799999999999999764 334578999999885321 12245799999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCcEEEEecCCc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMA 504 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-----~g~vKLiDFGlA 504 (571)
.+|||||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+||||+. ...+||+|||++
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 6999999876666777778899999999999999999999999999999943 236889999999
Q ss_pred ccccCCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 505 KHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
+.+.... ......||+.|+|||++... ....++.++|||||||++|||++ |..||...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 8765432 22346799999999998631 12356789999999999999999 99999643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=286.12 Aligned_cols=177 Identities=28% Similarity=0.434 Sum_probs=153.5
Q ss_pred CCCeEEe-eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHH-hhcCCCCeeEEeeeEEe---
Q 008285 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVV--- 427 (571)
Q Consensus 353 ~~~y~i~-k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL-~~L~HpNIVkl~g~~~~--- 427 (571)
..+|.+. +.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++ +.++|+||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 3478877 889999999999999999999999999862 13466788887 55689999999999887
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecC
Q 008285 428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG 502 (571)
Q Consensus 428 -~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFG 502 (571)
...+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999998753 36999999999999999999999999999999999999987 7899999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++....+ ..++.++|||||||++|||++|+.||.+..
T Consensus 166 ~a~~~~~----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 166 FAKETTG----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp TCEECTT----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccccc----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 9875432 135668999999999999999999997543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.08 Aligned_cols=208 Identities=17% Similarity=0.240 Sum_probs=159.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCee------------
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV------------ 419 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIV------------ 419 (571)
...|.++++||+|+||+||+|++..+|+.||||++..... ......+.+.+|+.+++.+.| .|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3469999999999999999999999999999998863322 222335778899999999977 3211
Q ss_pred ---E------EeeeEEe-----CCeEEEEEeecCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 008285 420 ---Q------YYGSEVV-----DDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTI 479 (571)
Q Consensus 420 ---k------l~g~~~~-----~~~lyLVmEy~~GGsL~d~L~~~------~~~Lse~~i~~I~~QIa~gL~yLHs~GIV 479 (571)
. ++..+.. ...++++|+++ +++|.+++... ...+++..+..|+.||+.||+|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1 1111111 12457777776 58999998521 34478889999999999999999999999
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCCCcccChHHHHHhh--hcC-CCCCCCchhhHHHHHHHHHHH
Q 008285 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM--QKD-GNPKLALAVDIWSLGCTVIEM 556 (571)
Q Consensus 480 HRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~--~~d-~~~~~s~ksDVWSLGvVLyEL 556 (571)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++.... ... ....++.++|||||||++|||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999998865443 344668 9999999996431 000 244578899999999999999
Q ss_pred HcCCCCCCCC
Q 008285 557 LTGKPPWSEF 566 (571)
Q Consensus 557 LtGr~PF~~~ 566 (571)
++|+.||...
T Consensus 311 ltg~~Pf~~~ 320 (413)
T 3dzo_A 311 WCADLPNTDD 320 (413)
T ss_dssp HHSSCCCCTT
T ss_pred HHCCCCCCCc
Confidence 9999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=328.84 Aligned_cols=201 Identities=28% Similarity=0.478 Sum_probs=175.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe------
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV------ 427 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~------ 427 (571)
++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+++|+.++|+||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 5899999999999999999999999999999987532 234556778999999999999999999998765
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEEecC
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV---VKLADFG 502 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~--~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~---vKLiDFG 502 (571)
.+..|+|||||.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999998643 25899999999999999999999999999999999999986664 9999999
Q ss_pred CcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
++.............||+.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSC-------CSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccccccCCcccCChHHhc-------cCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999877665556678999999999875 34688899999999999999999999964
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-33 Score=308.25 Aligned_cols=189 Identities=16% Similarity=0.055 Sum_probs=136.3
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeecCCCC-----cCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeCCeEEEE
Q 008285 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 361 ~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-----~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~~~lyLV 434 (571)
.++.|++|.+..++....|+.|+||++...... .......+++.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467888888888887778999999998753321 12234457799999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-ccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYE 513 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~ 513 (571)
||||+|++|.++|.+. +.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 9999999999999875 567764 57899999999999999999999999999999999999999999876543 233
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~ 561 (571)
...+||+.|||||++.+ .+..++|+|++|+++++|+++..
T Consensus 397 ~t~vGTp~YmAPE~l~g--------~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--------NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------------CCCCTTHH
T ss_pred cCceechhhccHHHhCC--------CCCCcccccccccchhhhccccc
Confidence 45779999999999864 35667999999999887655543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=271.86 Aligned_cols=190 Identities=16% Similarity=0.179 Sum_probs=148.0
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc---CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~---~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
...+.||+|+||+||+|.. .+..+++|.+....... ......+++.+|+++|++++|+||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467899999999999943 47889999865422211 112234668999999999999999966666667788899
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
|||||+|++|.+++.+ +..++.||++||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999999865 5689999999999999999999999999999988 999999999998765322
Q ss_pred -------ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 513 -------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 513 -------~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.....||+.|||||++..... .|+...|+|+..+-.++.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~-----~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLE-----GYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHH-----HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHH-----HHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999986432 25667899999999999988888875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=219.05 Aligned_cols=150 Identities=19% Similarity=0.230 Sum_probs=119.3
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC----cCcH---------HHHHHHHHHHHHHhhcCCCCeeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD----PKSA---------ECIKQLEQEIKVLGHLKHENIVQY 421 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d----~~~~---------~~~k~l~~Ei~IL~~L~HpNIVkl 421 (571)
.|.+++.||+|+||.||+|.+ .+|+.||||++...... .... .....+.+|+++|++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 455669999999999999999 88999999998632211 0001 24567889999999998 5 666
Q ss_pred eeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEec
Q 008285 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 422 ~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
++.+.. +..|+|||||+|++|.+ +. + .....++.||+.||.|||++||+||||||+||||+ ++.+||+||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 665433 56699999999999987 41 1 23457999999999999999999999999999999 999999999
Q ss_pred CCcccccCCccccccCCCCcccChHHHHH
Q 008285 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKA 530 (571)
Q Consensus 502 GlA~~l~~~~~~~~~~GT~~YmAPEvl~~ 530 (571)
|+++.. ..|+|||.+..
T Consensus 237 G~a~~~------------~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVEV------------GEEGWREILER 253 (282)
T ss_dssp TTCEET------------TSTTHHHHHHH
T ss_pred CCCeEC------------CCCCHHHHHHH
Confidence 999743 34789999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9e-22 Score=196.21 Aligned_cols=144 Identities=19% Similarity=0.242 Sum_probs=111.1
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcE--EEEEEeecCCCCcC-------------------cHHHHHHHHHHHHHHhhc
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGHL 413 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~--VAIK~i~~~~~d~~-------------------~~~~~k~l~~Ei~IL~~L 413 (571)
-|++.+.||+|+||.||+|.+..+|+. ||||+++....... .......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778999 99998754211100 112234678999999999
Q ss_pred CCCCe--eEEeeeEEeCCeEEEEEeecCC-C----CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCC
Q 008285 414 KHENI--VQYYGSEVVDDHLYIYLEYVHP-G----SINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKG 485 (571)
Q Consensus 414 ~HpNI--Vkl~g~~~~~~~lyLVmEy~~G-G----sL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLH-s~GIVHRDIKP 485 (571)
.|++| ..+++. +..+|||||+.+ | .|.+++.. +++..+..++.||+.||.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88764 344432 356899999942 3 67665432 235567889999999999999 99999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccc
Q 008285 486 ANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 486 sNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+|||++. .++|+|||++....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999988 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=178.30 Aligned_cols=141 Identities=13% Similarity=0.145 Sum_probs=102.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-------------cCcHHHH----HHHHHHHHHHhhcCCCC
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECI----KQLEQEIKVLGHLKHEN 417 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-------------~~~~~~~----k~l~~Ei~IL~~L~HpN 417 (571)
-|.+++.||.|+||.||+|.+. +|+.||||+++..... ....... ....+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999975 6999999987532100 0111111 11245777777775444
Q ss_pred ee--EEeeeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-
Q 008285 418 IV--QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG- 494 (571)
Q Consensus 418 IV--kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g- 494 (571)
+. ..++ . ...+|||||++|+.|.++. .......++.||+.+|.+||++|||||||||.||||+++|
T Consensus 175 v~vp~p~~---~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIA---Q-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEE---E-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCeeee---c-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 32 2222 1 2237999999998886542 1224567889999999999999999999999999998776
Q ss_pred ---------cEEEEecCCcccc
Q 008285 495 ---------VVKLADFGMAKHL 507 (571)
Q Consensus 495 ---------~vKLiDFGlA~~l 507 (571)
.+.||||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=128.85 Aligned_cols=139 Identities=14% Similarity=0.094 Sum_probs=110.6
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyL 433 (571)
.|++...++.|+++.||++... |..+++|+........ ...+.+|+++|+.+. +..+.++++++...+..|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 6888899999999999999743 6889999876321111 124778999999885 6778899998888899999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 475 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-------------------------------------- 475 (571)
||||++|.+|.+.+. +......++.+++.+|+.||+
T Consensus 88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999877531 122334778899999999998
Q ss_pred ---------------------CCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 476 ---------------------TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 476 ---------------------~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+++|+|+++.|||+++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766678999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.6e-11 Score=118.93 Aligned_cols=135 Identities=12% Similarity=0.077 Sum_probs=98.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC--eeEEeeeEEeCCeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHLY 432 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN--IVkl~g~~~~~~~ly 432 (571)
.|.+..+.+.|..+.||++.. .+|..+++|+.... . ...+.+|+.+++.+.+.+ +.++++++...+..|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--A------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--T------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--c------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 455544444566699999964 56788999986532 1 134678999998886444 566888887778899
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN----------------------------------- 477 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G----------------------------------- 477 (571)
+||||++|..|. +. .... ..++.+++..|+.||+..
T Consensus 92 ~v~e~i~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEECCSSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEecCCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999999998884 11 1221 245667777777777643
Q ss_pred -----------------------ceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 478 -----------------------TIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 478 -----------------------IVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++|+|++|.|||+++++.+.|+|||.+...
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987777789999997643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=6e-11 Score=119.84 Aligned_cols=186 Identities=15% Similarity=0.182 Sum_probs=124.0
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCC--eeEEeeeEEeCC---eEEE
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HEN--IVQYYGSEVVDD---HLYI 433 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpN--IVkl~g~~~~~~---~lyL 433 (571)
+.++.|....||++. ..+++|+... ......+.+|+++|+.+. +.. +.+++......+ ..|+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 469999999999863 4688887531 234567889999998884 332 344554433332 3488
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 475 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-------------------------------------- 475 (571)
|||+++|..|.+... ..++.++...++.+++..|+.||+
T Consensus 94 vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988876433 247788888888888888888886
Q ss_pred --------------------CCceecCCCCCcEEEcC--CCcEEEEecCCcccccCCccccccCCCCcc---cChHHHHH
Q 008285 476 --------------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNW---MAPEVIKA 530 (571)
Q Consensus 476 --------------------~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~l~~~~~~~~~~GT~~Y---mAPEvl~~ 530 (571)
..++|+|+++.|||++. ++.+.|+||+.+...... .... ....+ ..++....
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~--~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI--SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH--TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH--HHHhhccccCHHHHHH
Confidence 24699999999999987 567899999998654321 1111 11111 33443322
Q ss_pred hhhcCCCC-------CCCchhhHHHHHHHHHHHHcCCCCC
Q 008285 531 VMQKDGNP-------KLALAVDIWSLGCTVIEMLTGKPPW 563 (571)
Q Consensus 531 ~~~~d~~~-------~~s~ksDVWSLGvVLyELLtGr~PF 563 (571)
....-+.. ....-.++|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 21110000 0112368999999999999999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.9e-11 Score=121.99 Aligned_cols=141 Identities=13% Similarity=0.194 Sum_probs=105.1
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEee--cCCCCcCcHHHHHHHHHHHHHHhhcC--CCCeeEEeeeEEeC---C
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD---D 429 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~--~~~~d~~~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g~~~~~---~ 429 (571)
..++.|+.|.++.||++... +..+++|+.. ... .......+.+|+.+|+.|. +..+.+++..+.+. +
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~----~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK----LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC----CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 34678999999999998754 4678888654 211 1112346778999999997 45578888877665 4
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS---------------------------------- 475 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs---------------------------------- 475 (571)
..|+||||++|..|.+. ....++..+...++.+++..|+.||+
T Consensus 115 ~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 58999999998877542 12347788888999999999999997
Q ss_pred ------------------------CCceecCCCCCcEEEcCCC--cEEEEecCCccc
Q 008285 476 ------------------------TNTIHRDIKGANLLVDASG--VVKLADFGMAKH 506 (571)
Q Consensus 476 ------------------------~GIVHRDIKPsNILLd~~g--~vKLiDFGlA~~ 506 (571)
.+++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 4699999999999998765 369999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=8.1e-08 Score=97.66 Aligned_cols=182 Identities=16% Similarity=0.123 Sum_probs=111.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCC---CeeEEeeeEE-eCCeEEEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE---NIVQYYGSEV-VDDHLYIY 434 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~Hp---NIVkl~g~~~-~~~~lyLV 434 (571)
++.++.|....||+. |..+++|+.. .......+.+|+++|+.|.+. .|.+++.++. ..+..|+|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence 356889999999988 5678888742 124457789999999999742 3556666654 34567899
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-------------------------------------- 476 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~-------------------------------------- 476 (571)
|||++|..|.+..- ..++..+...++.++...|+.||+.
T Consensus 92 ~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 92 YRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99999988866321 1234444444555555555555432
Q ss_pred ----------------------CceecCCCCCcEEEcC---CCc-EEEEecCCcccccCCccccccCCCCcccChHHHHH
Q 008285 477 ----------------------NTIHRDIKGANLLVDA---SGV-VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530 (571)
Q Consensus 477 ----------------------GIVHRDIKPsNILLd~---~g~-vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~ 530 (571)
.++|+|+++.|||++. ++. +.|+||+.+..-.... .... ......++....
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~-Dla~--~~~~~~~~~~~~ 245 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDY-DYVY--LLEDCGELFTRQ 245 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGG-GGHH--HHHHTCHHHHHH
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHH-HHHH--HHHhcCHHHHHH
Confidence 4599999999999987 344 5899999886543211 1110 001123443322
Q ss_pred hhhcCCCCCC---CchhhHHHHHHHHHHHHc
Q 008285 531 VMQKDGNPKL---ALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 531 ~~~~d~~~~~---s~ksDVWSLGvVLyELLt 558 (571)
...+...... -....+|++..+++.++.
T Consensus 246 ~~~Y~~~~~~~~~~~r~~~~~~~~~l~~~~~ 276 (306)
T 3tdw_A 246 VMAYRGEVDLDTHIRKVSLFVTFDQVSYLLE 276 (306)
T ss_dssp HHHHTTCSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 2221101111 246788888877666543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-07 Score=93.50 Aligned_cols=134 Identities=16% Similarity=0.113 Sum_probs=97.4
Q ss_pred EEeecCce-EEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEEEEeec
Q 008285 361 LIGRGTFG-SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYV 438 (571)
Q Consensus 361 ~LG~G~fG-~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyLVmEy~ 438 (571)
.+..|..| .||+......+..+.+|+... .....+.+|..+|+.+. +--+.+++.++.+.+..|+|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 44556555 699988777788899997642 23456788999999885 334678888888899999999999
Q ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 008285 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST------------------------------------------ 476 (571)
Q Consensus 439 ~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~------------------------------------------ 476 (571)
+|..+.+..... ......+..++...|+.||..
T Consensus 103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 998887765431 112233445555555555531
Q ss_pred ----------------CceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 477 ----------------NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 477 ----------------GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 2689999999999998877889999988643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=6.7e-07 Score=93.48 Aligned_cols=82 Identities=15% Similarity=0.066 Sum_probs=49.9
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC--CcCcHHHHHHHHHHHHHHhhcCC--C-CeeEEeeeEEeCCeEE
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKH--E-NIVQYYGSEVVDDHLY 432 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~--d~~~~~~~k~l~~Ei~IL~~L~H--p-NIVkl~g~~~~~~~ly 432 (571)
..+.||.|..+.||++....+++.++||....... .........++..|.++|+.+.. + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999998766678999997642111 00000012345678888887742 3 34456643 455668
Q ss_pred EEEeecCCC
Q 008285 433 IYLEYVHPG 441 (571)
Q Consensus 433 LVmEy~~GG 441 (571)
+||||+.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=5.4e-07 Score=92.43 Aligned_cols=86 Identities=13% Similarity=0.084 Sum_probs=53.8
Q ss_pred eEEeeEE-eecCceEEEEEEEC--C----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-C--CCeeEEeeeE
Q 008285 356 WQKGKLI-GRGTFGSVYIGTNR--E----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-H--ENIVQYYGSE 425 (571)
Q Consensus 356 y~i~k~L-G~G~fG~VYla~~k--~----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-H--pNIVkl~g~~ 425 (571)
....+.| +.|....+|++... . +|..+++|........... ....+.+|+.+|+.|. + -.+.+++.++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 4456778 88989999988753 1 1567888875421100000 0134567888887774 2 3466777765
Q ss_pred EeC---CeEEEEEeecCCCCH
Q 008285 426 VVD---DHLYIYLEYVHPGSI 443 (571)
Q Consensus 426 ~~~---~~lyLVmEy~~GGsL 443 (571)
.+. +..|+||||++|..|
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 544 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=1.2e-05 Score=80.94 Aligned_cols=137 Identities=13% Similarity=0.118 Sum_probs=78.8
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC--CCCeeEEee------eEEeCCe
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYG------SEVVDDH 430 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g------~~~~~~~ 430 (571)
.+.|+.|..+.||++... +..+++|+... .. ..+..|+.+++.|. .-.+.+++. +....+.
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~------~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~ 105 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR------PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF 105 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECS------CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCC------CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence 456766778999998753 34589998753 11 22334555555543 112333332 1235677
Q ss_pred EEEEEeecCCCCHH-----------H---HHHHhcCCC-------------CHHH-------------------------
Q 008285 431 LYIYLEYVHPGSIN-----------R---YVREHCRDI-------------TESI------------------------- 458 (571)
Q Consensus 431 lyLVmEy~~GGsL~-----------d---~L~~~~~~L-------------se~~------------------------- 458 (571)
.+++|||++|..+. . .++.....+ .+..
T Consensus 106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 185 (346)
T 2q83_A 106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS 185 (346)
T ss_dssp EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence 89999999986442 1 112111111 1110
Q ss_pred ------HHHHHHHHHHHHHHHH-------------hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 459 ------VRNFTRHILNGLAYLH-------------STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 459 ------i~~I~~QIa~gL~yLH-------------s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+..+..++..++.+|+ ..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112223344566665 36899999999999998888999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=7.9e-05 Score=78.69 Aligned_cols=33 Identities=15% Similarity=0.220 Sum_probs=28.4
Q ss_pred HhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 474 Hs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+...++|+|+++.|||++.++ ++|+||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356899999999999998776 999999988643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=9.3e-05 Score=76.14 Aligned_cols=76 Identities=14% Similarity=0.188 Sum_probs=59.3
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC---CCCeeEEeeeEEeCCeEEEE
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~---HpNIVkl~g~~~~~~~lyLV 434 (571)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++......+..|+|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 456789999999999875 4678889976521 1456778988888884 35678888888778899999
Q ss_pred EeecCCCCH
Q 008285 435 LEYVHPGSI 443 (571)
Q Consensus 435 mEy~~GGsL 443 (571)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.67 E-value=8.2e-05 Score=74.71 Aligned_cols=134 Identities=7% Similarity=0.030 Sum_probs=74.3
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCCeEEEEEee
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~~lyLVmEy 437 (571)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .++++. +.+.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEee
Confidence 678999999999998 45888876532111 1123457777777642222 355543 34445789999
Q ss_pred c-CCCCHHHH---------------H---HHhcCCC----C-HHHHHHHHHH--------------HHHHHHHH----H-
Q 008285 438 V-HPGSINRY---------------V---REHCRDI----T-ESIVRNFTRH--------------ILNGLAYL----H- 474 (571)
Q Consensus 438 ~-~GGsL~d~---------------L---~~~~~~L----s-e~~i~~I~~Q--------------Ia~gL~yL----H- 474 (571)
+ +|..|... | +.....+ . ...+..+... +...+..| .
T Consensus 89 i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~ 168 (301)
T 3dxq_A 89 IAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA 168 (301)
T ss_dssp CTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred cCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence 9 65544210 1 1111001 1 1111111111 11111111 1
Q ss_pred ---hCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 475 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 475 ---s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
...++|+|+.+.||| ..++.+.|+||+.+..-
T Consensus 169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred cCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 56667899999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00015 Score=73.61 Aligned_cols=33 Identities=33% Similarity=0.309 Sum_probs=28.2
Q ss_pred hCCceecCCCCCcEEEcCC----CcEEEEecCCcccc
Q 008285 475 STNTIHRDIKGANLLVDAS----GVVKLADFGMAKHL 507 (571)
Q Consensus 475 s~GIVHRDIKPsNILLd~~----g~vKLiDFGlA~~l 507 (571)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999874 78999999988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00041 Score=69.69 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=81.2
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC--eeEEee------eEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYG------SEV 426 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN--IVkl~g------~~~ 426 (571)
.....+.|+.|....+|++.... | .+++|+..... ....+..|+.+++.|...+ +.+++. +..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~ 93 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 93 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred cceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence 34556778889999999987542 3 68899875311 1133556777777764212 233332 123
Q ss_pred eCCeEEEEEeecCCCCHH-----H------H---HHHhcCC--------CC---HHHHH-H-----------HHHHHHHH
Q 008285 427 VDDHLYIYLEYVHPGSIN-----R------Y---VREHCRD--------IT---ESIVR-N-----------FTRHILNG 469 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~-----d------~---L~~~~~~--------Ls---e~~i~-~-----------I~~QIa~g 469 (571)
..+..+++|+|++|..+. . . ++..... .. +.... . +...+...
T Consensus 94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~ 173 (322)
T 2ppq_A 94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 173 (322)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence 356789999999986431 1 1 1211111 11 11100 0 00113444
Q ss_pred HHHHHh-------CCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 470 LAYLHS-------TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 470 L~yLHs-------~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+..|.. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 174 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 555552 4799999999999998876678999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.001 Score=66.16 Aligned_cols=80 Identities=15% Similarity=0.028 Sum_probs=54.7
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC---CCeeEEeeeEEeCCe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEVVDDH 430 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H---pNIVkl~g~~~~~~~ 430 (571)
.+..-++.+|.|..+.||+.+. .+|+.|.+|+...... .. ...+..|+..|+.|.- --+.+++.. +.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--AL---DGLFRAEALGLDWLGRSFGSPVPQVAGW----DD 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ET
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--ch---hhHHHHHHHHHHHHHhhCCCCcceEEec----cC
Confidence 3567788999999999999985 4689999997542211 11 1346788888888742 234555543 22
Q ss_pred EEEEEeecCCCCH
Q 008285 431 LYIYLEYVHPGSI 443 (571)
Q Consensus 431 lyLVmEy~~GGsL 443 (571)
-++||||++++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3789999987743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00058 Score=68.73 Aligned_cols=137 Identities=12% Similarity=0.068 Sum_probs=78.4
Q ss_pred eEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeee-----EEeCCeEE
Q 008285 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGS-----EVVDDHLY 432 (571)
Q Consensus 360 k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~-----~~~~~~ly 432 (571)
+.|+ |....||++.. .+|+.+++|...... .. ...+..|+.+++.+.. -.+++++.. ....+..+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 4566 88889998764 346789999875221 11 2345667777777742 123444432 23356778
Q ss_pred EEEeecCCCCHH-----HH---------HHHhcC--------CCCHHHH----------------------HHHHHHHHH
Q 008285 433 IYLEYVHPGSIN-----RY---------VREHCR--------DITESIV----------------------RNFTRHILN 468 (571)
Q Consensus 433 LVmEy~~GGsL~-----d~---------L~~~~~--------~Lse~~i----------------------~~I~~QIa~ 468 (571)
++|||++|..+. .+ ++.... .++.... ..++.+++.
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 999999875431 11 111100 1111110 011112222
Q ss_pred HHHHH----HhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 469 GLAYL----HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 469 gL~yL----Hs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+..+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222 234689999999999998 4 899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00026 Score=73.09 Aligned_cols=75 Identities=12% Similarity=0.001 Sum_probs=43.4
Q ss_pred EeeEEeecCceEEEEEEECC--------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeC
Q 008285 358 KGKLIGRGTFGSVYIGTNRE--------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVD 428 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~--------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~ 428 (571)
..+.|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ +.++++.+ .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD------ELYNTISEFEVYKTMSKYKIAPQLLNTF--N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG------GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc------ceecHHHHHHHHHHHHhcCCCCceEEec--C
Confidence 45678888889999998653 136788887542111 1112356788888775333 34666543 2
Q ss_pred CeEEEEEeecCCCC
Q 008285 429 DHLYIYLEYVHPGS 442 (571)
Q Consensus 429 ~~lyLVmEy~~GGs 442 (571)
-++||||++|..
T Consensus 109 --~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 --GGRIEEWLYGDP 120 (369)
T ss_dssp --TEEEEECCCSEE
T ss_pred --CcEEEEEecCCc
Confidence 268999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00068 Score=72.37 Aligned_cols=75 Identities=13% Similarity=0.099 Sum_probs=48.9
Q ss_pred EEeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeC
Q 008285 357 QKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVD 428 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~ 428 (571)
..++.|+.|-...||++.... ++..+++|+.... .. ...+.+|..+++.|...+| .++++.+.
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~-- 146 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFS-- 146 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--
Confidence 345678889999999998653 3578999987321 11 1234468888888753333 56665443
Q ss_pred CeEEEEEeecCCCC
Q 008285 429 DHLYIYLEYVHPGS 442 (571)
Q Consensus 429 ~~lyLVmEy~~GGs 442 (571)
+ .+||||++|..
T Consensus 147 ~--g~v~e~l~G~~ 158 (429)
T 1nw1_A 147 G--GRLEEYIPSRP 158 (429)
T ss_dssp T--EEEECCCCEEE
T ss_pred C--CEEEEEeCCcc
Confidence 2 38999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00095 Score=70.47 Aligned_cols=138 Identities=14% Similarity=0.170 Sum_probs=80.0
Q ss_pred eeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCe
Q 008285 359 GKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH 430 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~ 430 (571)
++.|.-|-...+|++.... ++..+++|+.-.. .. ....+.+|..+++.|. +.-..++++.+. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQ---GVDSLVLESVMFAILAERSLGPQLYGVFP--E- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------C---CHHHHHHHHHHHHHHHHTTSSCCEEEEET--T-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C-
Confidence 3567778888899988642 3578899975211 11 1344558888888875 222355665543 2
Q ss_pred EEEEEeecCCCCHHH-----------H---HH---Hh----cCCCC--HHHHHHHHHHHHH-------------------
Q 008285 431 LYIYLEYVHPGSINR-----------Y---VR---EH----CRDIT--ESIVRNFTRHILN------------------- 468 (571)
Q Consensus 431 lyLVmEy~~GGsL~d-----------~---L~---~~----~~~Ls--e~~i~~I~~QIa~------------------- 468 (571)
.+||||++|..|.. + |. .. ..... +.++..++.++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 28999999764421 1 11 11 11112 3455555544322
Q ss_pred HHHHHH----h----CCceecCCCCCcEEEcCC----CcEEEEecCCccc
Q 008285 469 GLAYLH----S----TNTIHRDIKGANLLVDAS----GVVKLADFGMAKH 506 (571)
Q Consensus 469 gL~yLH----s----~GIVHRDIKPsNILLd~~----g~vKLiDFGlA~~ 506 (571)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 2 268999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0047 Score=66.70 Aligned_cols=77 Identities=17% Similarity=0.077 Sum_probs=48.8
Q ss_pred EEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCCeEEEEE
Q 008285 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYL 435 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~~lyLVm 435 (571)
..++.|+.|-...+|++.....+..+++|+......... ...+|..+++.|...++ .++++.+ .+ .+||
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~ 180 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFF--TN--GRIE 180 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEE
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEE
Confidence 345678889999999998765457888997642211111 12478888888865444 4666655 22 3599
Q ss_pred eecCCCCH
Q 008285 436 EYVHPGSI 443 (571)
Q Consensus 436 Ey~~GGsL 443 (571)
||++|..|
T Consensus 181 e~I~G~~l 188 (458)
T 2qg7_A 181 EFMDGYAL 188 (458)
T ss_dssp ECCCSEEC
T ss_pred EeeCCccC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0062 Score=62.51 Aligned_cols=32 Identities=22% Similarity=0.273 Sum_probs=28.3
Q ss_pred CCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 476 ~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
.+++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.028 Score=55.45 Aligned_cols=102 Identities=21% Similarity=0.117 Sum_probs=69.2
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccccccCCC
Q 008285 441 GSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519 (571)
Q Consensus 441 GsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yL-Hs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~~~~GT 519 (571)
.+|.+.|...+.+|+|+++|.++.|.+..|.-+ +++.-..+=+.+..|+|..+|.|-+.+ ..+. ...
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 489999999999999999999999999998776 222222333457999999999988764 2111 012
Q ss_pred CcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008285 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (571)
Q Consensus 520 ~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~P 562 (571)
..+.+||... ...+.+.-|||||++||..+--..|
T Consensus 101 ~~~~~pe~~~--------~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 101 PPPVAGKLGY--------SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------CCSS--------SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCChhhcc--------ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 2356777642 2346789999999999998864443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.033 Score=59.56 Aligned_cols=77 Identities=10% Similarity=0.032 Sum_probs=47.1
Q ss_pred EEeeEEeecCceEEEEEEECCC-------CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeC
Q 008285 357 QKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVD 428 (571)
Q Consensus 357 ~i~k~LG~G~fG~VYla~~k~t-------G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~ 428 (571)
..++.|.-|-...+|++..... +..+++|+....... .-...+|..+++.+...+ ..++++.+ .
T Consensus 73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~------~idR~~E~~~l~~L~~~gi~P~l~~~~--~ 144 (424)
T 3mes_A 73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK------FYDSKVELDVFRYLSNINIAPNIIADF--P 144 (424)
T ss_dssp EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C------CCCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch------hcCHHHHHHHHHHHHhcCCCCCEEEEc--C
Confidence 3456777788889999987521 578899875321111 112346777777774222 34555432 2
Q ss_pred CeEEEEEeecCCCCH
Q 008285 429 DHLYIYLEYVHPGSI 443 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL 443 (571)
+ ++||||++|..|
T Consensus 145 ~--~~I~efI~G~~l 157 (424)
T 3mes_A 145 E--GRIEEFIDGEPL 157 (424)
T ss_dssp T--EEEEECCCSEEC
T ss_pred C--CEEEEEeCCccC
Confidence 2 789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.094 Score=54.99 Aligned_cols=29 Identities=24% Similarity=0.362 Sum_probs=25.3
Q ss_pred ceecCCCCCcEEE------cCCCcEEEEecCCccc
Q 008285 478 TIHRDIKGANLLV------DASGVVKLADFGMAKH 506 (571)
Q Consensus 478 IVHRDIKPsNILL------d~~g~vKLiDFGlA~~ 506 (571)
++|+|+.+.|||+ ++++.+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=86.58 E-value=4.4 Score=45.98 Aligned_cols=81 Identities=17% Similarity=0.255 Sum_probs=48.1
Q ss_pred EEeeeEEeCCeEEEEEeecCCCCHHHHHHHh----------cCCC------CHHHHHHHHHHHH--HHHHHHHhCCceec
Q 008285 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREH----------CRDI------TESIVRNFTRHIL--NGLAYLHSTNTIHR 481 (571)
Q Consensus 420 kl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~----------~~~L------se~~i~~I~~QIa--~gL~yLHs~GIVHR 481 (571)
..|.+.......- ++|+++..+|.+++.+. .... .......+++.++ +.+.|+ .|| +
T Consensus 477 ~~Y~Vipls~~~G-LIE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YI--LGl--G 551 (696)
T 2x6h_A 477 TPYKVLATSSKHG-FLQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYL--LGV--G 551 (696)
T ss_dssp CCCCEEESSTTCE-EEECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHH--HTC--C
T ss_pred eccEEEeccCCCC-eeeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHH--ccC--C
Confidence 3444444444433 34777655666655432 1111 1233444555443 345555 233 7
Q ss_pred CCCCCcEEEcCCCcEEEEecCCcc
Q 008285 482 DIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 482 DIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
|-.++||||+.+|++.=+|||.+-
T Consensus 552 DRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 552 DRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCcceEEeCCCCEEEEeehhhh
Confidence 999999999999999999999874
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.47 E-value=35 Score=38.12 Aligned_cols=82 Identities=15% Similarity=0.295 Sum_probs=49.8
Q ss_pred eEEeeeEEeCCeEEEEEeecCCCCHHHHH----------HHhcCC------CCHHHHHHHHHHHH--HHHHHHHhCCcee
Q 008285 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYV----------REHCRD------ITESIVRNFTRHIL--NGLAYLHSTNTIH 480 (571)
Q Consensus 419 Vkl~g~~~~~~~lyLVmEy~~GGsL~d~L----------~~~~~~------Lse~~i~~I~~QIa--~gL~yLHs~GIVH 480 (571)
+..|.+.......- ++|++++.++.+.+ .+.... ..++....+++.++ +.+.|+= ||
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--Gi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--GV-- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--TC--
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--ec--
Confidence 34455544444444 45787765555544 332211 12334445555543 3455553 44
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCcc
Q 008285 481 RDIKGANLLVDASGVVKLADFGMAK 505 (571)
Q Consensus 481 RDIKPsNILLd~~g~vKLiDFGlA~ 505 (571)
+|=.++||||+.+|++.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 6889999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 571 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-27 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-63
Identities = 75/211 (35%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ET A K +D KS E ++ EI +L H
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 68
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + +++L+I +E+ G+++ + E R +TES ++ + L+ L YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L G +KLADFG++ T S G+P WMAPEV+ K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
D D+WSLG T+IEM +PP E
Sbjct: 189 DR--PYDYKADVWSLGITLIEMAEIEPPHHE 217
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-60
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P W + +G G +G V + NR T + A+K VD+ ++ +C + +++EI +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 57
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L HEN+V++YG + Y++LEY G + + + E + F ++ G+
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 527
YLH HRDIK NLL+D +K++DFG+A + E L G+ ++APE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+K A VD+WS G + ML G+ PW +
Sbjct: 177 LK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-59
Identities = 60/213 (28%), Positives = 112/213 (52%), Gaps = 14/213 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K + + Q+ +E++VL
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLH 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 472 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL + I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
++ DIWS+G +++EM G+ P
Sbjct: 177 ------GTHYSVQSDIWSMGLSLVEMAVGRYPI 203
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-59
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 11/211 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ G+ +G+G FG+VY+ +++ A+K + + A QL +E+++ HL
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 63
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+H NI++ YG +Y+ LEY G++ R ++ E + + N L+Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS IHRDIK NLL+ ++G +K+ADFG + H S +L G+ +++ PE+I+
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIE---- 177
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
VD+WSLG E L GKPP+
Sbjct: 178 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-58
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 14/217 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
Q G+ IG G+FG+VY G A+K ++ + + ++ + E+ VL
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLR 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H NI+ + G L I ++ S+ ++ + + R G+
Sbjct: 60 KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 528
YLH+ + IHRD+K N+ + VK+ DFG+A + S L GS WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + + + D+++ G + E++TG+ P+S
Sbjct: 179 RMQDKNPYSFQ----SDVYAFGIVLYELMTGQLPYSN 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 1e-57
Identities = 75/213 (35%), Positives = 113/213 (53%), Gaps = 10/213 (4%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + + IG G+FG+VY + AIK++ +S E + + +E++ L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQK 71
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L+H N +QY G + + ++ +EY GS + + H + + E + T L GLAY
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LHS N IHRD+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMD 187
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + K VD+WSLG T IE+ KPP
Sbjct: 188 EGQYDGK----VDVWSLGITCIELAERKPPLFN 216
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 189 bits (480), Expect = 2e-56
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 7/216 (3%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVL 410
++ +++GRG V ++ T A+K +D+ SAE +++L + E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 411 GHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+ H NI+Q + + ++ + + G + Y+ E ++E R R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
+ LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
D +P VD+WS G + +L G PP+
Sbjct: 183 C-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (473), Expect = 1e-54
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 342 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
H+++ + + +G G FG V+ T R TG + A K V +
Sbjct: 23 HVLDH---------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKE 68
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+ +EI+ + L+H +V + + D+ + + E++ G + V + ++E
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGS 519
+ R + GL ++H N +H D+K N++ S +KL DFG+ HL G+
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ APEV + + D+WS+G +L+G P+
Sbjct: 189 AEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPF 225
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-54
Identities = 80/228 (35%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
I+EK S K ++ + + IG+G G+VY + TG AI+++++ +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQP 59
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
+ + EI V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQ 117
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LK 517
+ R L L +LHS IHRDIK N+L+ G VKL DFG +T + S +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
G+P WMAPEV+ VDIWSLG IEM+ G+PP+
Sbjct: 178 GTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-53
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 20/215 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IGRG+F +VY G + ET A + D + ++ ++E ++L L+H NI
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 419 VQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V++Y S + + E + G++ Y++ + ++R++ R IL GL +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129
Query: 475 STNT--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
+ IHRD+K N+ + +G VK+ D G+A S+ ++ G+P +MAPE+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE- 187
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
K +VD+++ G ++EM T + P+SE
Sbjct: 188 -------KYDESVDVYAFGMCMLEMATSEYPYSEC 215
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-53
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 351 PKK---SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
P+K ++ GK++G G+F +V + T AIK ++ + + +E
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRER 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ L H V+ Y + D+ LY L Y G + +Y+R E+ R +T I+
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIV 118
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMA 524
+ L YLH IHRD+K N+L++ +++ DFG AK L+ S + S G+ +++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
PE++ + D+W+LGC + +++ G PP+
Sbjct: 179 PELLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRA 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-53
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +GRG FG V+ + + K V + D +++EI +L +H
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NI+ + S + L + E++ I + ++ E + ++ + L +LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 476 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N H DI+ N++ S +K+ +FG A+ L L +P + APEV +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---- 176
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ ++ A D+WSLG V +L+G P+
Sbjct: 177 ---HDVVSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 9e-53
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 21/223 (9%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ IG G++G + G K + + + L E+ +L LKH
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGL 470
NIV+YY + + LYI +EY G + + + ++ + E V + L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 471 AYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMA 524
H + +HRD+K AN+ +D VKL DFG+A+ L S+ + G+P +M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
PE + DIWSLGC + E+ PP++ F
Sbjct: 183 PEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 3e-52
Identities = 43/214 (20%), Positives = 91/214 (42%), Gaps = 14/214 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G FG V+ + TG K ++ ++ EI ++ L H
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++ + + + + LE++ G + + ++E+ V N+ R GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 476 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ +H DIK N++ + + VK+ DFG+A L + + APE++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 201
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+ D+W++G +L+G P++ +
Sbjct: 202 ---REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 3e-51
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 15/216 (6%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + ++G G F V + ++ T AIK + + K +E EI VL
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHK 63
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+KH NIV HLY+ ++ V G + + E TE +L+ + Y
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKY 122
Query: 473 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
LH +HRD+K NLL D + ++DFG++K S + G+P ++APEV+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ AVD WS+G +L G PP+ +
Sbjct: 183 -------QKPYSKAVDCWSIGVIAYILLCGYPPFYD 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-51
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 11/221 (4%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKV 409
P +SQ+Q G L+G G FGSVY G AIK V+ D ++ E+ +
Sbjct: 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 410 LGHLK--HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
L + +++ D + LE P + E + R+F +L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
+ + H+ +HRDIK N+L+D + G +KL DFG L + G+ + PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
I+ + + +WSLG + +M+ G P+ E
Sbjct: 180 WIR------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-49
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + + IG+G FG V +G R G A+K + K+ + E V+ L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQL 57
Query: 414 KHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
+H N+VQ G V + LYI EY+ GS+ Y+R R + + F+ + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
YL N +HRD+ N+LV V K++DFG+ K + S + + K W APE ++
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-- 173
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K + D+WS G + E+ + G+ P+
Sbjct: 174 -----EKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-49
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+ + IG G FG V++G AIK + + A + +E +V+ L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H +VQ YG + + + E++ G ++ Y+R + + G+AYL
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAV 531
IHRD+ N LV + V+K++DFGM + + + K W +PEV
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-- 175
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
+ + D+WS G + E+ + GK P+
Sbjct: 176 -----FSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (432), Expect = 4e-49
Identities = 53/212 (25%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+Q + +G G+FG V++ +R G A+K + + + ++ E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 61
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H I++ +G+ +++ ++Y+ G + + + + + + L YL
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS + I+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVS---- 174
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
++D WS G + EML G P+ +
Sbjct: 175 ---TKPYNKSIDWWSFGILIYEMLAGYTPFYD 203
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (434), Expect = 7e-49
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLK 414
+ ++IGRG FG VY +TG A+K +D K E + E + ++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV + D L L+ ++ G ++ ++ +H E+ +R + I+ GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMH 124
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ ++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL------ 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ D +SLGC + ++L G P+
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 7e-49
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 3/213 (1%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + ++IG G FG V G + G + + + + + E ++G
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF 84
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H N++ G + I E++ GS++ ++R++ T + R I G+ YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N +HRD+ N+LV+++ V K++DFG+++ L + + + + P A
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
K A D+WS G + E+++ G+ P+ +
Sbjct: 205 IQYR-KFTSASDVWSYGIVMWEVMSYGERPYWD 236
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-48
Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 12/211 (5%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LK 414
+ K++G+G+FG V++ ++T AIK + D + ++ E +VL +
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H + + + ++L+ +EY++ G + +++ + S + I+ GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQ 533
S ++RD+K N+L+D G +K+ADFGM K G + + G+P+++APE++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---- 176
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
K +VD WS G + EML G+ P+
Sbjct: 177 ---GQKYNHSVDWWSFGVLLYEMLIGQSPFH 204
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-48
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 8/206 (3%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G F +VY ++ T AIK++ + + +EIK+L L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ ++ + +++ + ++++ +T S ++ + L GL YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
HRD+K NLL+D +GV+KLADFG+AK + + + APE++
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG--- 179
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWS 564
+ VD+W++GC + E+L P
Sbjct: 180 ---VGVDMWAVGCILAELLLRVPFLP 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-48
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK + IG GT+G VY N+ TG A+K I D ++ +EI +L L H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ ++ LY+ E++H I +++++ +L GLA+ HS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+HRD+K NLL++ G +KLADFG+A+ + + + APE++
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G + AVDIWSLGC EM+T + +
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALF 203
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 1e-47
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+++G G V++ + A+K + D + + +E + L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 65
Query: 415 HENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H IV Y + + YI +EYV ++ V +T L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPE 526
+ H IHRD+K AN+++ A+ VK+ DFG+A+ + ++ ++ G+ +++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+ + D++SLGC + E+LTG+PP++
Sbjct: 185 QAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-47
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG+V G + + + A+K I+ ++ +L E V+ L +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ G + + +E G +N+Y++++ + + + + G+ YL +N
Sbjct: 70 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN 127
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQ 533
+HRD+ N+L+ K++DFG++K L + K W APE I
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---- 183
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G + E + G+ P+ +G
Sbjct: 184 ---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-47
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K +G G FG V G R AIK + + + + +E KV+ +L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK------EGSMSEDEFIEEAKVMMNL 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
HE +VQ YG ++I EY+ G + Y+RE + + + + YL
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAV 531
S +HRD+ N LV+ GVVK++DFG+++++ Y S K W PEV+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
K + DIW+ G + E+ + GK P+ F
Sbjct: 175 -----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-47
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + +G G+FG V G S A+K + PD E + +E+ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H N+++ YG V+ + + E GS+ +R+H + + + G+ Y
Sbjct: 68 LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----KGSPNWMAPEVI 528
L S IHRD+ NLL+ +VK+ DFG+ + L + K W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGV 569
K + A D W G T+ EM T G+ PW G
Sbjct: 187 K-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLK 414
+ G+ +G G F V + TG A K + + + +E+E+ +L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H N++ + + + LE V G + ++ E +TE F + ILNG+ YLH
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH 130
Query: 475 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
S H D+K N+++ V +K+ DFG+A + + ++ G+P ++APE++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
L L D+WS+G +L+G P+
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPF 216
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++++K K++G G FG+VY G G I + S + K++ E V+
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + ++ + G + + + + + G + YVREH +I + N+ I G+
Sbjct: 67 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL---KGSPNWMAPEVI 528
YL +HRD+ N+LV VK+ DFG+AK L E K WMA E I
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
+ D+WS G TV E++T G P+
Sbjct: 186 L-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-46
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
++ + + G+ IG G FG V+ G + AIK D ++ QE
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEAL 60
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ H +IV+ G + ++ ++I +E G + +++ + + + + +
Sbjct: 61 TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPE 526
LAYL S +HRDI N+LV ++ VKL DFG+++++ +Y + K WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
I + A D+W G + E+L G P+
Sbjct: 180 SIN-------FRRFTSASDVWMFGVCMWEILMHGVKPF 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-46
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + + +G G FG V++G A+K + + + E ++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK------QGSMSPDAFLAEANLMKQ 64
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 471
L+H+ +V+ Y V + +YI EY+ GS+ +++ +T + + + I G+A
Sbjct: 65 LQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIK 529
++ N IHRD++ AN+LV + K+ADFG+A+ + Y K W APE I
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
+ D+WS G + E++T G+ P+
Sbjct: 184 -------YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417
+++G G G V N+ T A+K + + +E+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPH 66
Query: 418 IVQYYG----SEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAY 472
IV+ L I +E + G + +++ TE + I + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 473 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
LHS N HRD+K NLL + + ++KL DFG AK T + + +P ++APEV+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 185
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
G K + D+WSLG + +L G PP+ G++
Sbjct: 186 ------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-45
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKV 409
S + K+IG G FG VY G + + AIK + + + E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGI 62
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+G H NI++ G + I EY+ G++++++RE + + + R I G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAP 525
+ YL + N +HRD+ N+LV+++ V K++DFG+++ L K W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
E I K A D+WS G + E++T
Sbjct: 183 EAIS-------YRKFTSASDVWSFGIVMWEVMTYGERP 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-45
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 362 IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FGSV G R AIK + +++ +E +++ L + IV
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ G + L + +E G +++++ +I S V + G+ YL N +
Sbjct: 73 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQKD 535
HRD+ N+L+ K++DFG++K L + + K W APE I
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN------ 185
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568
K + D+WS G T+ E L+ G+ P+ + +G
Sbjct: 186 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-45
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 13/216 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
Q++ IG G +G V+ + + G A+K V + + + ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 414 KHENIVQYYGSEVV-----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+H N+V+ + V + L + E+V + + +++ +L
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
GL +LHS +HRD+K N+LV +SG +KLADFG+A+ + S+ + + APEV+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
A VD+WS+GC EM KP +
Sbjct: 188 L-------QSSYATPVDLWSVGCIFAEMFRRKPLFR 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-45
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+++K IG+GTFG V+ +R+TG A+K + + + +EIK+L L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLL 66
Query: 414 KHENIVQYYGS--------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
KHEN+V +Y+ ++ + T S ++ +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQM 125
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSP 520
+LNGL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + + + +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ PE++ G +D+W GC + EM T P
Sbjct: 186 WYRPPELLL------GERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ IG G +G V + AIK++ ++ +EIK+L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRF 63
Query: 414 KHENIVQYYG---SEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+HENI+ + ++ +YL ++ + + ++ + ++ + F IL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRG 121
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAP 525
L Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ + + AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
E++ + ++DIWS+GC + EML+ +P +
Sbjct: 182 EIM------LNSKGYTKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-45
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ KL+G+GTFG V + + TG A+K + + + + + E +VL + +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H + + D L +EY + G + ++ TE R + I++ L YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQ 533
S + ++RDIK NL++D G +K+ DFG+ K + G+P ++APEV++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ AVD W LG + EM+ G+ P+
Sbjct: 179 ---DNDYGRAVDWWGLGVVMYEMMCGRLPF 205
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 8e-45
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+++ +G G +G VY G ++ + A+K + + +++ +E V+
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMK 68
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
+KH N+VQ G + YI E++ G++ Y+RE R +++ ++ I + +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 528
YL N IHRD+ N LV + +VK+ADFG+++ +TG +Y K W APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
K ++ D+W+ G + E+ T + G+
Sbjct: 189 A-------YNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDL 222
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (399), Expect = 9e-45
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 12/211 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ + IG GT+G VY N G + A+K I + + +EI +L LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKELK 58
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NIV+ Y L + E++ + ++F +LNG+AY H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HRD+K NLL++ G +K+ADFG+A+ + + + AP+V+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM---- 173
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ K + +DIWS+GC EM+ G P +
Sbjct: 174 --GSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 35/243 (14%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLG 411
+ + GK++G G FG V T + +V + + + + + L E+K++
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----------------- 453
L HENIV G+ + +Y+ EY G + Y+R
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 454 -----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+T + F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 509 GLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
S + + + WMAPE + + D+WS G + E+ + G P+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 565 EFE 567
Sbjct: 269 GIP 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-44
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+ + +G+G FG V++GT T AIK + + QE +V+
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK------PGTMSPEAFLQEAQVMK 67
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGL 470
L+HE +VQ Y V ++ +YI EY+ GS+ +++ E + + + + I +G+
Sbjct: 68 KLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVI 528
AY+ N +HRD++ AN+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
+ + D+WS G + E+ T + G+
Sbjct: 187 L-------YGRFTIKSDVWSFGILLTELTTKGRVP--YPGMVN 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (393), Expect = 9e-44
Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ G+ IG G+FG ++ GTN AIK P A ++ + K+L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRR-SDAPQLRDEYRTYKLLAGCTG 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
V Y+G E H + ++ + P S+ + R + V + +L + +H
Sbjct: 63 IPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 476 TNTIHRDIKGANLLVDA-----SGVVKLADFGMAKHL--------TGLSYELSLKGSPNW 522
+ ++RDIK N L+ + ++ + DFGM K + +L G+ +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
M+ + ++ + + D+ +LG + L G PW
Sbjct: 180 MSINTH---LGREQSRR----DDLEALGHVFMYFLRGSLPW 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-43
Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GT+ G AIK + P QL E K+ ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQ 60
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
I D+ + +E + S+ R + V +++ + Y+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNW 522
HS N IHRD+K N L+ +V + DFG+AK +L G+ +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ + + D+ SLG ++ G PW
Sbjct: 180 ASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQ 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-42
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 337 SAVMPHIMEKPSA---SPKKSQWQKGKLIGRGTFGSVYIGT---NRETGASCAIKEVDII 390
SA+ P +++ P ++IGRG FG VY GT N CA+K ++ I
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVRE 449
D + Q E ++ H N++ G + + + L Y+ G + ++R
Sbjct: 67 TDI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
+ T + F + G+ +L S +HRD+ N ++D VK+ADFG+A+ +
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 510 LSYEL-----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
++ K WMA E ++ K D+WS G + E++T G PP+
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 564 SE 565
+
Sbjct: 236 PD 237
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 73/242 (30%), Positives = 115/242 (47%), Gaps = 28/242 (11%)
Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
S VT+ V + P++ + K+IG G+FG VY ++G AIK +
Sbjct: 1 SKVTTVVA--TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQ 55
Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRY 446
D + +E++++ L H NIV+ G + + +L + L+YV P ++ R
Sbjct: 56 DK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV 108
Query: 447 VREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFG 502
R + R + V+ + + LAY+HS HRDIK NLL+D V+KL DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
AK L +S S + APE+I G ++D+WS GC + E+L G+P
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPI 222
Query: 563 WS 564
+
Sbjct: 223 FP 224
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
++ ++ + +G G +G+V + TGA AIK + +S K+ +E+++L H
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKH 73
Query: 413 LKHENIVQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
++HEN++ E +DD YL G+ + +H + + E ++ +L
Sbjct: 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLK 132
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
GL Y+H+ IHRD+K NL V+ +K+ DFG+A+ + + APEVI
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVI 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ VDIWS+GC + EM+TGK +
Sbjct: 191 L------NWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 2e-42
Identities = 68/222 (30%), Positives = 115/222 (51%), Gaps = 13/222 (5%)
Query: 344 MEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
E PS + + Q+ + K +G G+FG V + ++E+G A+K +D + I+
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEH 87
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
E ++L + +V+ S + +LY+ +EYV G + ++R R +E R +
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFY 146
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
I+ YLHS + I+RD+K NLL+D G +++ DFG AK + G ++ +L G+P
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEA 204
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+APE+I + AVD W+LG + EM G PP+
Sbjct: 205 LAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFF 239
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++K + IG GT+G+V+ NRET A+K + D +EI +L LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELK 59
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H+NIV+ + D L + E+ + +Y D+ IV++F +L GL + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S N +HRD+K NLL++ +G +KLA+FG+A+ S + W P + +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
++D+WS GC E+ P
Sbjct: 179 YST-----SIDMWSAGCIFAELANAGRPL 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-42
Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 28/226 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG+G FG V+ G + G A+K E E EI L+HENI
Sbjct: 8 QESIGKGRFGEVWRG--KWRGEEVAVKIFS------SREERSWFREAEIYQTVMLRHENI 59
Query: 419 VQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ + ++ D+ L++ +Y GS+ Y+ + +T + +GLA+LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 475 S--------TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPN 521
HRD+K N+LV +G +AD G+A + + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
+MAPEV+ + + + DI+++G E+ E
Sbjct: 178 YMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 6e-42
Identities = 53/259 (20%), Positives = 99/259 (38%), Gaps = 49/259 (18%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE 398
+E P ++ + + IG G FG V+ E A+K + + SA+
Sbjct: 8 LEYP-----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASAD 58
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----- 453
++E ++ + NIV+ G V + + EY+ G +N ++R
Sbjct: 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 454 ------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
++ + R + G+AYL +HRD+ N LV + V
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178
Query: 496 VKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
VK+ADFG+++++ Y + WM PE I + D+W+ G
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVV 231
Query: 553 VIEMLTGKPPWSEFEGVSP 571
+ E+ + + G++
Sbjct: 232 LWEIFSYGLQP--YYGMAH 248
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 59/216 (27%), Positives = 111/216 (51%), Gaps = 13/216 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
++ K++G G +G V++ + +TG A+K + + A+ + E +VL
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLE 83
Query: 412 HLKHE-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H++ +V + + + L++ L+Y++ G + ++ + R TE V+ + I+ L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLAL 142
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 528
+LH I+RDIK N+L+D++G V L DFG++K E + G+ +MAP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ AVD WSLG + E+LTG P++
Sbjct: 203 RGGDSGHDK-----AVDWWSLGVLMYELLTGASPFT 233
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 8e-41
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 30/231 (12%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+ + +IG G FG V ++ G AIK + + S + + E++VL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLC 65
Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------IT 455
L H NI+ G+ +LY+ +EY G++ ++R+ ++
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
+ +F + G+ YL IHRD+ N+LV + V K+ADFG+++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565
+ WMA E + D+WS G + E+++ G P+
Sbjct: 186 GRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 58/255 (22%), Positives = 97/255 (38%), Gaps = 44/255 (17%)
Query: 342 HIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDI 389
++ P+ P +W GK +G G FG V T + + A+K +
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK- 62
Query: 390 IPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ L E+KVL +L H NIV G+ + + EY G + ++R
Sbjct: 63 ---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 449 EHCRD-----------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
+ + +F+ + G+A+L S N IHRD+ N+L+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179
Query: 492 ASGVVKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+ K+ DFG+A+ + S + + WMAPE I N D+WS
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWS 232
Query: 549 LGCTVIEMLTGKPPW 563
G + E+ +
Sbjct: 233 YGIFLWELFSLGSSP 247
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 146 bits (368), Expect = 5e-40
Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
+Q + +GRG + V+ N +K + K++++EIK+L +L+
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88
Query: 415 HENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + V + E+V+ ++ + +T+ +R + IL L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDY 144
Query: 473 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
HS +HRD+K N+++D ++L D+G+A+ S + PE
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE----- 199
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
++D+WSLGC + M+ K P+
Sbjct: 200 -LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-39
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 20/213 (9%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q K IG G G V + + AIK + ++ K+ +E+ ++ + H+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 417 NIVQYYGSEVVDD------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
NI+ +Y+ +E + + ++ + +L G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
+LHS IHRD+K +N++V + +K+ DFG+A+ + + APEVI
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 191
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VDIWS+GC + EM+ K +
Sbjct: 192 ------GMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q +G G +GSV + +TG A+K + +S K+ +E+++L H+KHE
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 417 NIVQYYGS-----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
N++ + + + + ++ +N V+ C+ +T+ V+ IL GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y+HS + IHRD+K +NL V+ +K+ DFG+A+H + + APE++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML-- 191
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
VDIWS+GC + E+LTG+ +
Sbjct: 192 ----NWMHYNQTVDIWSVGCIMAELLTGRTLF 219
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-37
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 22/233 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
+ + + +G+G+FG VY G + V I ++ S + E V+
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRN 461
++V+ G + +E + G + Y+R + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKG 518
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVSP 571
WM+PE +K + D+WS G + E+ T ++G+S
Sbjct: 198 PVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN 241
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 45/249 (18%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + A+K + +
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDAT 58
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-- 453
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y++
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 454 -------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
++ + + + G+ YL S IHRD+ N+LV V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 501 FGMAKHLTGLSYELSL---KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + + Y + WMAPE + + D+WS G + E+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIF 231
Query: 558 T-GKPPWSE 565
T G P+
Sbjct: 232 TLGGSPYPG 240
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 30/241 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
+ + + GK +GRG FG V + + V + + + + + L E+K+L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 411 GHLKHENIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD--------------- 453
H+ H V L + +E+ G+++ Y+R +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
+T + ++ + G+ +L S IHRD+ N+L+ VVK+ DFG+A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 514 L---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ + WMAPE I + + D+WS G + E+ + + GV
Sbjct: 191 VRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVK 241
Query: 571 P 571
Sbjct: 242 I 242
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 2e-29
Identities = 46/237 (19%), Positives = 89/237 (37%), Gaps = 37/237 (15%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G F +V++ + A+K V + E EIK+L +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVND 68
Query: 416 ENIVQ-------------YYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVR 460
+ + + + + +++ + + G + + R I V+
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 461 NFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGV------VKLADFGMAKHLTGLSYE 513
++ +L GL Y+ IH DIK N+L++ +K+AD G A +
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 186
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGVS 570
+ + + +PEV+ DIWS C + E++TG + EG S
Sbjct: 187 TNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 105 bits (263), Expect = 7e-27
Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDI-------------IPDDPKSAECIKQLEQ 405
GKL+G G +V+ + E C +K + D S I+
Sbjct: 5 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E + L L+ + + Y + + + +E + + R E+ ++
Sbjct: 64 EFRALQKLQGLAVPKVYA---WEGN-AVLMELIDAKELYRVRVENPDEVL--------DM 111
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525
IL +A + +H D+ N+LV G + + DF + + + L+
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE-----RDV 165
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
I + + DI S +++
Sbjct: 166 RNIITYFSRTYRTE----KDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 571 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=391.31 Aligned_cols=204 Identities=31% Similarity=0.584 Sum_probs=177.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ..+..+.+.+|+++|++++|||||++++++.+++.+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 458999999999999999999999999999999987432 1233466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~- 511 (571)
||||||+||+|.++|... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 80 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999999654 569999999999999999999999999999999999999999999999999998764332
Q ss_pred --cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 --~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....+||+.|||||++.. ...++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccccceeeCcCccCHhHhcC------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 2345789999999999873 2335678999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=386.05 Aligned_cols=202 Identities=32% Similarity=0.584 Sum_probs=179.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+++|+.++|||||++++++.+++.+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 479999999999999999999999999999999863210 011224668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||||+||+|.+++.+. ..+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...... .
T Consensus 84 vmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R 161 (263)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-C
T ss_pred EEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-c
Confidence 99999999999999875 569999999999999999999999999999999999999999999999999998775543 3
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 162 ~~~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp EETTEEGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCCCcccCHHHHc-------CCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 3567999999999997 345788999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=387.49 Aligned_cols=201 Identities=37% Similarity=0.635 Sum_probs=180.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 45899999999999999999999999999999998753322 1356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
||||||.||+|.+++.+ ..+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+... .
T Consensus 94 ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp EEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999999999998876 46999999999999999999999999999999999999999999999999999987543 3
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CBCCCCSCGGGCCHHHHS-------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCCCccChhhhc-------CCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 344677999999999986 3467899999999999999999999997643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=388.86 Aligned_cols=207 Identities=34% Similarity=0.581 Sum_probs=182.8
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
+.|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 479999999999999999999999999999999874321 234668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
|||||+||+|.+++.+....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999999999999998777789999999999999999999999999999999999999999999999999998664422 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....+||+.|||||++..... ....|+.++|||||||++|||++|+.||.+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~--~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCST--TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccccCCHHHHhhccc--CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 335779999999999864221 24468899999999999999999999997653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=393.24 Aligned_cols=203 Identities=28% Similarity=0.518 Sum_probs=179.9
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
..++|++++.||+|+||+||+|+++.+|+.||+|+++.... ....+++.+|+.+|++++|||||+++++|.+++.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45689999999999999999999999999999999875322 23346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEEecCCcccccCC
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~ 510 (571)
|||||||.||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999999999875 569999999999999999999997 59999999999999999999999999999876442
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....+||+.|||||++. +..|+.++|||||||++|||++|+.||...+
T Consensus 159 -~~~~~~GT~~Y~APEvl~-------~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHH-------CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHc-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 233578999999999997 3468999999999999999999999997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=387.62 Aligned_cols=203 Identities=29% Similarity=0.539 Sum_probs=177.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+++|++++||||+++++++.+++.+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 479999999999999999999999999999999863110 011224678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc--
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-- 511 (571)
|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||++++.+||+|||+++.+....
T Consensus 86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999775 579999999999999999999999999999999999999999999999999998775422
Q ss_pred -cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 -~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp -----CCCCGGGCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCccccCceeec-------cCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 233567999999999997 346899999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-46 Score=391.33 Aligned_cols=201 Identities=25% Similarity=0.427 Sum_probs=183.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++.+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4899999999999999999999999999999998632 23445778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCcEEEEecCCcccccCCc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd--~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||+||+|.++|.+..+.+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999999976667799999999999999999999999999999999999995 46889999999999887766
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 181 ~~~~~~gT~~Y~aPEv~~-------~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp CEEEECSCTTTCCHHHHH-------TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceecCcccccCHHHHc-------CCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 666788999999999987 346789999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-46 Score=391.81 Aligned_cols=202 Identities=21% Similarity=0.384 Sum_probs=183.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4799999999999999999999999999999998642 22334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCcEEEEecCCcccccCCc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd--~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||+||+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.+....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999999999877666799999999999999999999999999999999999997 67899999999999887766
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
......||+.|||||++. +..|+.++|||||||++|||++|+.||.+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp CEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ceeeccCcccccCHHHHc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 666778999999999986 3468999999999999999999999997643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=379.39 Aligned_cols=203 Identities=30% Similarity=0.515 Sum_probs=168.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe--CCeE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHL 431 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~--~~~l 431 (571)
++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|++++|||||++++++.+ ++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 589999999999999999999999999999999865332 34456778999999999999999999998865 4568
Q ss_pred EEEEeecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~---~~~~Lse~~i~~I~~QIa~gL~yLHs~G-----IVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
|||||||+||+|.+++.+ ....+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999964 3467999999999999999999999876 99999999999999999999999999
Q ss_pred cccccCCc-cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~-~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++.+.... .....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeecccCCCccccCCCCcccCCHHHHc-------CCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 98875433 334578999999999986 346899999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=377.72 Aligned_cols=206 Identities=26% Similarity=0.464 Sum_probs=183.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc-CcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~-~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++....... ......+.+.+|+++|++++|||||++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457999999999999999999999999999999986533221 2222356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEEecCCcccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHL 507 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g----~vKLiDFGlA~~l 507 (571)
|||||||+||+|.++|.+. ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||++..+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999875 5799999999999999999999999999999999999998766 5999999999988
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
..........||+.|||||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCccccccCCCCcccCHHHHc-------CCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 7666666778999999999996 346789999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-47 Score=386.55 Aligned_cols=202 Identities=29% Similarity=0.447 Sum_probs=163.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.+.|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+++|+.++|||||++++++.+++.+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45799999999999999999999999999999998743221 22356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~l~~ 509 (571)
||||||+||+|.++|.+. ..+++.+++.++.||+.||+|||++|||||||||+|||+. +++.+||+|||+++....
T Consensus 84 lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999999764 6799999999999999999999999999999999999994 578999999999998766
Q ss_pred CccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp ----------CTTSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCeeeeeeeCccccCcHHHc-------CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 66566778999999999986 346889999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-46 Score=381.49 Aligned_cols=202 Identities=35% Similarity=0.591 Sum_probs=179.9
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLV 434 (571)
.|++++.||+|+||+||+|+++.+|+.||||++.... ....+..+.+.+|+++|++++|||||++++++.+++.+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh--ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 5999999999999999999999999999999987432 23345667899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcccc
Q 008285 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (571)
Q Consensus 435 mEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~~ 514 (571)
||||.||+|..++... ..+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++..... .
T Consensus 94 ~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~ 169 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (309)
T ss_dssp EECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred EEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---C
Confidence 9999999998776554 67999999999999999999999999999999999999999999999999999876543 3
Q ss_pred ccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 515 ~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...||+.|||||++.+.. ...|+.++|||||||++|||++|+.||.+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~----~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp CCCSCGGGCCHHHHTTTT----SCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCccccCHHHHhccC----CCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 467999999999986421 335888999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=371.81 Aligned_cols=200 Identities=30% Similarity=0.549 Sum_probs=174.7
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe----CCe
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDH 430 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----~~~ 430 (571)
.|++.+.||+|+||+||+|+++.+++.||+|.+..... .....+.+.+|+++|++++|||||++++++.+ ...
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 34778899999999999999999999999999864322 23456778999999999999999999999875 356
Q ss_pred EEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEEecCCcccc
Q 008285 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAKHL 507 (571)
Q Consensus 431 lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~G--IVHRDIKPsNILLd-~~g~vKLiDFGlA~~l 507 (571)
+|||||||+||+|.+++.+. ..+++.+++.++.||+.||+|||++| |+||||||+||||+ +++.+||+|||+++..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 89999999999999999875 57999999999999999999999998 99999999999996 5789999999999865
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... .....+||+.|||||++.. .|+.++|||||||++|||++|+.||.+..
T Consensus 166 ~~~-~~~~~~GT~~Y~aPE~~~~--------~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 166 RAS-FAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CTT-SBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCC-ccCCcccCccccCHHHhCC--------CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 443 3345789999999998752 47899999999999999999999997653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=389.06 Aligned_cols=205 Identities=29% Similarity=0.474 Sum_probs=181.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3589999999999999999999999999999999863210 01123567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Cc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~ 511 (571)
+|||||.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999987644 33
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.....+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~-------~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CBCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccceeCHHHhhhhhcc-------CCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 445678999999999986 3468899999999999999999999997643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-45 Score=369.11 Aligned_cols=213 Identities=26% Similarity=0.480 Sum_probs=189.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCc----HHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEe
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLK-HENIVQYYGSEVV 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~----~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~ 427 (571)
.++|++.+.||+|+||+||+|+++.+|+.||||++......... ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999998765443322 234456889999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
++.+|||||||+||+|.++|... +.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999875 57999999999999999999999999999999999999999999999999999988
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
..........||+.|+|||++...... ....++.++||||+||++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~-~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCceeeeeccCCCCCHHHhhccccc-cCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 765555667899999999999865332 35568899999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-46 Score=383.09 Aligned_cols=201 Identities=26% Similarity=0.528 Sum_probs=179.1
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 479999999999999999999999999999999863110 011224678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
|||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+....
T Consensus 82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred EeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 99999999999998775 568999999999999999999999999999999999999999999999999998875533
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
...+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~Gt~~Y~APE~l~-------~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVS-------TKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCCCSCTTTCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccCcccccCHHHHc-------CCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 3578999999999986 345788999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=375.17 Aligned_cols=208 Identities=27% Similarity=0.482 Sum_probs=175.0
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
++...++|++++.||+|+||+||+|+++ ..||||+++....+ ....+.+.+|+++|++++|||||++++++. +
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence 3455678999999999999999999864 35999998654332 234678899999999999999999999764 5
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|||||||+||+|.++|......+++..+..|+.||++||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 67899999999999999998776779999999999999999999999999999999999999999999999999998765
Q ss_pred CCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... ......||+.|||||++... ....|+.++|||||||+||||++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCcccccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 422 22356799999999998631 13358999999999999999999999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=377.54 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=181.3
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++|+.++|||||++++++.+++.+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 458999999999999999999999999999999986421 22355789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEEecCCcccccCC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGL 510 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~--~g~vKLiDFGlA~~l~~~ 510 (571)
||||||.||+|.++|.+....+++.+++.|+.||+.||.|||++||+||||||+||||+. ...+||+|||+++.....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999999876667999999999999999999999999999999999999974 458999999999988766
Q ss_pred ccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 511 ~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.......||+.|+|||.+. +..|+.++|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~~~~~t~~y~ape~~~-------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CEEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Ccccccccccccccchhcc-------CCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 6666678999999999986 346789999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-45 Score=383.83 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=178.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCC-CcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~-d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~l 431 (571)
.++|+++++||+|+||+||+|+++.+|+.||||++..... .............|+++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3589999999999999999999999999999999853110 011122233344567888888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
|||||||.||+|.++|.+. ..+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999999999999876 569999999999999999999999999999999999999999999999999998776543
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
....+||+.|||||++.. +..|+.++|||||||+||||++|+.||.+..
T Consensus 162 -~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 162 -PHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp -CCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred -ccccccccccchhHHhhc------CCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 335679999999999863 3457899999999999999999999997654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-45 Score=365.46 Aligned_cols=204 Identities=24% Similarity=0.457 Sum_probs=173.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+++|+.++|||||++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 458999999999999999999999999999999986432 234556678999999999999999999999988754
Q ss_pred -eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 430 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 430 -~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
.+|||||||+|++|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred ceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 389999999999999999775 579999999999999999999999999999999999999999999999999987654
Q ss_pred CCc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
... .....+||+.|||||++. +..++.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp ----------------TTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCcccccCHHHHc-------CCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 322 233567999999999986 346889999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=373.29 Aligned_cols=204 Identities=28% Similarity=0.492 Sum_probs=167.3
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCc---EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~---~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..++|++.++||+|+||+||+|.++.+|+ .||||.+... ......+.+.+|+++|++++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 34689999999999999999999987765 4777776422 2345567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|+|||||+||+|.+++......+++.++..++.||++||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999999999998877789999999999999999999999999999999999999999999999999998765
Q ss_pred CCccc------cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLSYE------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~~~------~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
..... ....||+.|||||++. ...++.++|||||||+||||++ |+.||.+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp ----------------CGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHh-------cCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 43221 1245789999999987 3468999999999999999998 89999765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-45 Score=372.24 Aligned_cols=203 Identities=27% Similarity=0.467 Sum_probs=178.6
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
++...++|++.+.||+|+||+||+|+++.+|+.||||+++... . ..+++.+|+++|++++|||||++++++.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---M---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---S---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---c---hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 5556679999999999999999999999999999999876322 1 135688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|||||||.+|+|.+++.+. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999753 456999999999999999999999999999999999999999999999999999877
Q ss_pred cCCccc--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 508 TGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 508 ~~~~~~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
...... ....|++.|||||++.. ..|+.++|||||||++|||++|..||.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCceeeccccccccccChHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 554322 23458899999999874 368999999999999999999776654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-45 Score=382.18 Aligned_cols=201 Identities=32% Similarity=0.515 Sum_probs=179.6
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+++|+.++|||||++++++.+.+.+|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 589999999999999999999999999999999863110 011224668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~~ 513 (571)
||||+.||+|..++.+. +.+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+....
T Consensus 119 v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred ccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 99999999999999876 569999999999999999999999999999999999999999999999999999876533
Q ss_pred cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 514 ~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
....||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 196 ~~~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CCCEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCccccCCHHHHc-------CCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 3567999999999987 345788999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=371.88 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=170.6
Q ss_pred EeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEEEEee
Q 008285 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyLVmEy 437 (571)
.+++||+|+||+||+|+++.+|+.||||+++............+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 56899999999999999999999999999865433322233346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-cccccc
Q 008285 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSL 516 (571)
Q Consensus 438 ~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~~~~~~ 516 (571)
|.|+++..++ .....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9987766555 44567999999999999999999999999999999999999999999999999999876543 233456
Q ss_pred CCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 517 ~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+||+.|||||++.. ...|+.++|||||||++|||++|+.||.+.
T Consensus 161 ~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 161 VVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecChhhccHHHHcc------CCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 79999999999863 346799999999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=360.89 Aligned_cols=199 Identities=28% Similarity=0.479 Sum_probs=165.4
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
.++|++++.||+|+||+||+|.++ +++.||||++.... .. .+++.+|++++++++|||||++++++..++.+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---Cc---HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 358999999999999999999986 47789999876322 22 256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
+|||||.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999999999988777899999999999999999999999999999999999999999999999999987654332
Q ss_pred c--cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008285 513 E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSE 565 (571)
Q Consensus 513 ~--~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~ 565 (571)
. ....||+.|||||++. ...|+.++|||||||++|||++ |++||..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~-------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFS-------FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------CTTSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eeecceecCcccCChHHhc-------CCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 2 2456899999999986 3468999999999999999999 5666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=364.66 Aligned_cols=204 Identities=26% Similarity=0.448 Sum_probs=175.9
Q ss_pred CCCCeEEeeE-EeecCceEEEEEEECC--CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKL-IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~-LG~G~fG~VYla~~k~--tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.+++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+++|++++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 4467888885 9999999999998764 3557999998632 234556789999999999999999999998864
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+|||||||+||+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 56899999999999999987766789999999999999999999999999999999999999999999999999998775
Q ss_pred CCccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 509 GLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
..... ....||+.|||||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccCccccChHHHhC-------CCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 43322 23568999999999874 357899999999999999998 999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=370.89 Aligned_cols=203 Identities=27% Similarity=0.476 Sum_probs=176.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHh-hcCCCCeeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~-~L~HpNIVkl~g~~~~~~~ly 432 (571)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+..|+.++. .++|||||++++++.+++.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 479999999999999999999999999999999863110 00112345566666654 689999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCC-c
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~-~ 511 (571)
||||||+||+|.++|... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999999875 56999999999999999999999999999999999999999999999999999876543 3
Q ss_pred cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 512 ~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
......||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCCCcCCHHHHc-------CCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 334577999999999997 346889999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=371.39 Aligned_cols=207 Identities=28% Similarity=0.487 Sum_probs=175.0
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCc-----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEee
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~-----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g 423 (571)
+...++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|.++ +|||||++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC----HHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 3455789999999999999999999876543 689998753221 23346688999999998 8999999999
Q ss_pred eEEeCCeEEEEEeecCCCCHHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008285 424 SEVVDDHLYIYLEYVHPGSINRYVREHC----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHR 481 (571)
Q Consensus 424 ~~~~~~~lyLVmEy~~GGsL~d~L~~~~----------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHR 481 (571)
++.+.+.+|||||||+||+|.++|.... ..+++.+++.|+.||++||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997642 248999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc
Q 008285 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558 (571)
Q Consensus 482 DIKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt 558 (571)
||||+|||++.++.+||+|||+|+....... .....||+.|||||++.. ..|+.++|||||||++|||++
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTT
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-------CCCCcceeccchhHHHHHHHh
Confidence 9999999999999999999999987654332 224568999999999873 368999999999999999997
Q ss_pred -CCCCCCCCC
Q 008285 559 -GKPPWSEFE 567 (571)
Q Consensus 559 -Gr~PF~~~e 567 (571)
|+.||.+..
T Consensus 262 ~g~~Pf~~~~ 271 (325)
T d1rjba_ 262 LGVNPYPGIP 271 (325)
T ss_dssp TSCCSSTTCC
T ss_pred CCCCCCCCCC
Confidence 899997653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=363.87 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=175.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+++|++++|||||++++++.+.+.+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 489999999999999999999999999999999864321 12234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC-Ccc
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~-~~~ 512 (571)
|||||.++.+..........+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.... ...
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9999975544444445566799999999999999999999999999999999999999999999999999987654 334
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.
T Consensus 159 ~~~~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp TTCCBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceeecccceeeehhhhcc------ccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 445679999999999863 345688999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=360.93 Aligned_cols=207 Identities=27% Similarity=0.433 Sum_probs=175.7
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCc-CcHHHHHHHHHHHHHHhhcC--CCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~-~~~~~~k~l~~Ei~IL~~L~--HpNIVkl~g~~~~~ 428 (571)
..++|+++++||+|+||+||+|+++.+|+.||||++....... ......+++.+|+.+|++++ |+|||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3568999999999999999999999999999999986432111 11111234668999999996 89999999999999
Q ss_pred CeEEEEEeecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEEecCCccc
Q 008285 429 DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKH 506 (571)
Q Consensus 429 ~~lyLVmEy~~G-GsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-~g~vKLiDFGlA~~ 506 (571)
+.+|+||||+.+ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999999986 5788888765 57999999999999999999999999999999999999985 47999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.... ......||+.|||||++.. ...++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~-~~~~~~GT~~y~aPE~~~~------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 161 LKDT-VYTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccc-cccccccCCCcCCHHHHcC------CCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 6543 3345789999999999974 334567899999999999999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=357.68 Aligned_cols=203 Identities=26% Similarity=0.489 Sum_probs=172.4
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~ 427 (571)
.++...++|++++.||+|+||+||+|+++ ++..||||+++... .. .+.+.+|+++|++++|||||++++++.
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~- 78 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MS---PDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CC---HHHHHHHHHHHHhCCCCCEeEEEeeec-
Confidence 34556679999999999999999999976 57889999886322 11 356889999999999999999999764
Q ss_pred CCeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++.+|||||||++|+|.+++... ...+++.++..|+.||++||.|||++||+||||||+||||++++.+||+|||+++.
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 56789999999999999987533 34699999999999999999999999999999999999999999999999999998
Q ss_pred ccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCC-CCCC
Q 008285 507 LTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP-PWSE 565 (571)
Q Consensus 507 l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~-PF~~ 565 (571)
+..... .....||+.|||||++.. ..++.++|||||||++|||++|.. ||..
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccCCccccccccCCcccccChHHHhC-------CCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 765432 234679999999999874 357899999999999999999554 4543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=356.40 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=168.1
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCC----cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG----~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
.++|++.++||+|+||.||+|.++.++ ..||||.+.... .....+.+.+|+++|++++|+|||++++++.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 358999999999999999999987655 469999886322 234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+++|||||.+++|.+++.+....+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 509 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 509 ~~~~----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.... .....||+.|||||++. ...++.++|||||||++|||++|..||.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp ------------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCccceEeccCCCCccccCHHHHc-------cCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 4321 22356899999999987 3468999999999999999999655543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=371.70 Aligned_cols=197 Identities=27% Similarity=0.410 Sum_probs=172.9
Q ss_pred CCeEEee-EEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEe----
Q 008285 354 SQWQKGK-LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV---- 427 (571)
Q Consensus 354 ~~y~i~k-~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~---- 427 (571)
++|++.+ .||+|+||+||+|+++.+|+.||||+++. ...+.+|++++.++ +|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4798874 69999999999999999999999999862 14567899887654 89999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEEecCC
Q 008285 428 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGM 503 (571)
Q Consensus 428 ~~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~---~g~vKLiDFGl 503 (571)
+..+|||||||+||+|.++|.+.+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 466899999999999999998653 46999999999999999999999999999999999999974 56799999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
++...........+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+..
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCG-------GGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeeccCCCccccccCCcccCCcHHHcC-------CCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 998877666667889999999999863 357889999999999999999999996543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=352.61 Aligned_cols=199 Identities=31% Similarity=0.518 Sum_probs=177.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++ ++..||||+++.... . .+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---C---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 58899999999999999999985 688999999874322 1 2568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc-
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~- 512 (571)
||||+.+|+|.+++......+++..++.++.||++||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999999887777899999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 513 -~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.....||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~-------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred eecccCCCCCcCCcHHhcC-------CCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 224669999999999974 358899999999999999998 89999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=358.07 Aligned_cols=200 Identities=25% Similarity=0.450 Sum_probs=167.5
Q ss_pred eEEe-eEEeecCceEEEEEEEC--CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEE
Q 008285 356 WQKG-KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 356 y~i~-k~LG~G~fG~VYla~~k--~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~ly 432 (571)
+.+. +.||+|+||+||+|.++ .+++.||||+++... ......+.+.+|+++|++++|||||++++++.. +.+|
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~ 83 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 83 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEE
Confidence 4443 57999999999999865 356789999986422 223445778999999999999999999998854 5679
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCcc
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~~ 512 (571)
||||||++|+|.+++.+. ..+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....
T Consensus 84 lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999999999999764 5699999999999999999999999999999999999999999999999999987654322
Q ss_pred c----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 513 E----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 513 ~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
. ....||+.|||||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCCCceecCchhhcC-------CCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 1 23568999999999974 357889999999999999998 999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=353.52 Aligned_cols=206 Identities=27% Similarity=0.473 Sum_probs=167.0
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
+...++|++++.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+++|++++|||||++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 344568999999999999999999987543 46788876432 23455678999999999999999999999885
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
++.+|+|||||.+|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 5778999999999999999888777899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCcc--ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 507 LTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~--~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
+..... .....||+.|+|||++.. ..++.++|||||||++|||++ |++||.+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp -------------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcceeccceecCcccchhhHhcc-------CCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 654322 234568999999999973 368899999999999999998 899997653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=361.75 Aligned_cols=202 Identities=30% Similarity=0.496 Sum_probs=169.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCc----EEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~----~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
..+|++++.||+|+||+||+|.+..+|+ .||+|.++... .....+.+.+|+++|++++|||||++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLT- 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3579999999999999999999988876 47777665321 22335678999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+..+++|||+.+|+|.+++......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 45678899999999999998887889999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 509 GLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 509 ~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... .....||+.|||||++.. ..|+.++|||||||++|||++ |+.||.+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccccccccCccccChHHHhc-------CCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 4332 223568999999999974 368999999999999999998 89999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=354.48 Aligned_cols=204 Identities=29% Similarity=0.475 Sum_probs=172.5
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCC-CcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc---CCCCeeEEeeeEEe-
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~t-G~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L---~HpNIVkl~g~~~~- 427 (571)
.++|++++.||+|+||+||+|++..+ ++.||||++......... ...+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 35899999999999999999999765 567999998653322111 12344666666655 79999999998864
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCC
Q 008285 428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (571)
Q Consensus 428 ----~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGl 503 (571)
...+|++||||.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 3468999999998877766666667799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 504 A~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
++............||+.|||||++. +..|+.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~-------~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhcccccCCCcccChhhcCcchhc-------CCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 98776666666788999999999986 346899999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-42 Score=347.91 Aligned_cols=202 Identities=29% Similarity=0.487 Sum_probs=172.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++ +|+.||||++.....+ ....+.+.+|+.+|++++|+|||++++.+..++..|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 48999999999999999999986 6899999998653322 2234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
+|||+.++.|..+... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... .
T Consensus 78 ~~e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9999987666666543 4779999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.....|++.|+|||++.. ...++.++|||||||++|||++|+.||.+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceecccchhhhHHHHhC------CCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 334569999999999863 346789999999999999999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-42 Score=354.15 Aligned_cols=199 Identities=31% Similarity=0.451 Sum_probs=170.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
.+|+++++||+|+||+||+|+++.+|+.||||++..... ...+|+++|++++|+||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 379999999999999999999999999999999864321 124799999999999999999988643
Q ss_pred -CeEEEEEeecCCCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEEecCCc
Q 008285 429 -DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMA 504 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~--~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g-~vKLiDFGlA 504 (571)
..+|||||||.++.+..+.. .....+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 34799999998664443332 2345699999999999999999999999999999999999999765 8999999999
Q ss_pred ccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 505 ~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+.+.........+||..|+|||++.. ...|+.++|||||||++|||++|+.||....
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred hhccCCcccccccccccccChHHhhc------ccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 98877666667889999999999863 3468899999999999999999999997543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=347.14 Aligned_cols=201 Identities=28% Similarity=0.464 Sum_probs=166.3
Q ss_pred CCCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC
Q 008285 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (571)
Q Consensus 349 ~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~ 428 (571)
++...++|++++.||+|+||+||+|+++.+ +.||||+++... .. .+.+.+|+.+|++++|+|||++++++. +
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CC---HHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 445567999999999999999999998764 679999986322 12 256889999999999999999999884 5
Q ss_pred CeEEEEEeecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~-~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|+|||||.+|+|..++... ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 6789999999999999988643 356999999999999999999999999999999999999999999999999999876
Q ss_pred cCCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008285 508 TGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (571)
Q Consensus 508 ~~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~ 564 (571)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|..||.
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cCCCceeeccccccccccChHHHhC-------CCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 4432 2234669999999999973 368899999999999999999655554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=347.17 Aligned_cols=206 Identities=26% Similarity=0.454 Sum_probs=164.5
Q ss_pred CCCCCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeee
Q 008285 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGS 424 (571)
Q Consensus 351 ~~~~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~ 424 (571)
...++|++++.||+|+||.||+|.+.. +++.||||+++.. ......+.+.+|+.++.++ +|+||+.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc----cCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 445689999999999999999999754 4568999987532 2234456677888888777 68999999998
Q ss_pred EEeC-CeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008285 425 EVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANL 488 (571)
Q Consensus 425 ~~~~-~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNI 488 (571)
+... +.+++|||||++|+|.++|.... ..+++.+++.++.||++||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 7664 46899999999999999997542 3489999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC-CCCCC
Q 008285 489 LVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWS 564 (571)
Q Consensus 489 LLd~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG-r~PF~ 564 (571)
||+.++.+||+|||+++...... ......||+.|||||++.. ..++.++|||||||++|||++| ..||.
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-------CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999998764432 2234679999999999974 3688999999999999999986 56887
Q ss_pred CCC
Q 008285 565 EFE 567 (571)
Q Consensus 565 ~~e 567 (571)
+..
T Consensus 239 ~~~ 241 (299)
T d1ywna1 239 GVK 241 (299)
T ss_dssp TCC
T ss_pred CCC
Confidence 653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-42 Score=347.83 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=175.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEE
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~ 426 (571)
..++|++++.||+|+||+||+|+++ .+++.||||+++.. ......+++.+|+++|++++|+||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh----cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3568999999999999999999975 35678999987532 23455678999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008285 427 VDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d~L~~~~-----------------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDI 483 (571)
..+..++||||+.+|+|.++|.... ..+++..+..|+.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999996532 24889999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCcccccCCc---cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCC
Q 008285 484 KGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560 (571)
Q Consensus 484 KPsNILLd~~g~vKLiDFGlA~~l~~~~---~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr 560 (571)
||+||||+.++.+||+|||+++.+.... ......|++.|||||++.. ..|+.++|||||||++|||++|.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-------CCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999998664432 2224668899999999974 46899999999999999999985
Q ss_pred -CCCCCC
Q 008285 561 -PPWSEF 566 (571)
Q Consensus 561 -~PF~~~ 566 (571)
+||.+.
T Consensus 240 ~~p~~~~ 246 (301)
T d1lufa_ 240 LQPYYGM 246 (301)
T ss_dssp CCTTTTS
T ss_pred CCCCCCC
Confidence 677654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=347.41 Aligned_cols=210 Identities=27% Similarity=0.526 Sum_probs=174.7
Q ss_pred CCCCCCCCCCeEEeeEEeecCceEEEEEEECCCC-------cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCC
Q 008285 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417 (571)
Q Consensus 346 ~p~~~~~~~~y~i~k~LG~G~fG~VYla~~k~tG-------~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpN 417 (571)
.+.+....++|++++.||+|+||.||+|++..++ ..||||+++.. .......++.+|+.++.++ +|+|
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----cChHHHHHHHHHHHHHHHhcCCCe
Confidence 3446667789999999999999999999876554 47999987532 2334457788899888888 7999
Q ss_pred eeEEeeeEEeCCeEEEEEeecCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008285 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRD 482 (571)
Q Consensus 418 IVkl~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRD 482 (571)
||++++++.+++.+|+|||||++|+|.++|.... ..+++.+++.++.||+.||+|||++||||||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 9999999999999999999999999999997543 3589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-
Q 008285 483 IKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558 (571)
Q Consensus 483 IKPsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt- 558 (571)
|||+|||++.++.+||+|||+++....... .....|++.|+|||.+.. ..|+.++|||||||++|||++
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-------CCCCchhhhHHhHHHHHHhccC
Confidence 999999999999999999999987755332 234678999999999974 368999999999999999998
Q ss_pred CCCCCCCC
Q 008285 559 GKPPWSEF 566 (571)
Q Consensus 559 Gr~PF~~~ 566 (571)
|+.||.+.
T Consensus 234 g~~p~~~~ 241 (299)
T d1fgka_ 234 GGSPYPGV 241 (299)
T ss_dssp SCCSSTTC
T ss_pred CCCCCCCC
Confidence 78998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=347.29 Aligned_cols=204 Identities=27% Similarity=0.482 Sum_probs=166.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECC-CC--cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRE-TG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~-tG--~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~ 429 (571)
.++|++.+.||+|+||.||+|++.. ++ ..||||++..... ...+..+.+.+|+++|++++|+|||++++++.+ +
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4689999999999999999998653 33 3689998753222 233456789999999999999999999999865 5
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
.+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 77999999999999999988777899999999999999999999999999999999999999999999999999998755
Q ss_pred Cccc----cccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008285 510 LSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566 (571)
Q Consensus 510 ~~~~----~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~ 566 (571)
.... ....|+..|+|||++.. ..++.++|||||||++|||++ |+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceecCccccCcccCCHHHHhC-------CCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 3322 23457889999999974 357889999999999999998 89999765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=351.77 Aligned_cols=201 Identities=28% Similarity=0.513 Sum_probs=171.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC---
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~--- 429 (571)
.++|++++.||+|+||+||+|.++.+|+.||||+++.. .......+.+.+|+++|++++|+|||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 56899999999999999999999999999999998632 233456678899999999999999999999987665
Q ss_pred ---eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 430 ---~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
.+|+||||| |.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 579999999 6778887754 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+
T Consensus 171 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 171 ADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc--cccccccccccCHHHHcC------CCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 6543 235679999999999874 3457889999999999999999999997653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-41 Score=341.22 Aligned_cols=200 Identities=23% Similarity=0.350 Sum_probs=174.6
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCeeEEeeeEEeCCeE
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHL 431 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIVkl~g~~~~~~~l 431 (571)
.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.+.| +||+.+++++......
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 45899999999999999999999999999999987643322 235678888988875 8999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCcEEEEecCCccc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMAKH 506 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~-----~g~vKLiDFGlA~~ 506 (571)
|+||||+ |++|.+++......+++.++..++.|++.||+|||++||+||||||+||||+. ++.+||+|||+++.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 69999999887778999999999999999999999999999999999999964 57899999999987
Q ss_pred ccCCc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 507 LTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 507 l~~~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
+.... .....+||+.|||||++. +..++.++|||||||++|||++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhc-------CCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 64321 223467999999999987 3468999999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=337.48 Aligned_cols=202 Identities=30% Similarity=0.472 Sum_probs=178.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCCeEEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~~lyL 433 (571)
++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+++.+|+.+|++++|+||+++++++.+.+..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 489999999999999999999999999999999875432 23456788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc-c
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~-~ 512 (571)
|||++.|++|..++... +.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||.++...... .
T Consensus 79 v~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred Eeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999999988887654 679999999999999999999999999999999999999999999999999998775533 3
Q ss_pred ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 513 ~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
.....++..|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ceeeccccchhhhhHhcc------CCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 334567889999998863 33568899999999999999999999743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=350.85 Aligned_cols=201 Identities=25% Similarity=0.455 Sum_probs=170.3
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
.+|++++.||+|+||+||+|+++.+|+.||||++... ......+.+.+|+++|++++|+||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4799999999999999999999999999999998642 23455678899999999999999999999987653
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccC
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~ 509 (571)
..+++|||+.||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 23455566778999999976 4699999999999999999999999999999999999999999999999999986644
Q ss_pred Cc----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 510 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 510 ~~----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.. .....+||+.|+|||++.. ...++.++||||+||++|||++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccceeeccccccceechHHHhhc------CCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 32 2234679999999999863 345788999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-41 Score=345.88 Aligned_cols=196 Identities=24% Similarity=0.404 Sum_probs=173.2
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeC--C
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--D 429 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~--~ 429 (571)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+++.+|+++|+.+. |+||+++++++... .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 458999999999999999999999999999999986321 356789999999995 99999999998754 5
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEEecCCccccc
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLT 508 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~-g~vKLiDFGlA~~l~ 508 (571)
.+++|||||.+++|..+. +.+++.+++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+++...
T Consensus 106 ~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp SEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred ceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 699999999999997653 469999999999999999999999999999999999999865 469999999999887
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
........+||+.|+|||++.. ...++.++|||||||++|||++|+.||...
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCcccccccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 6666667789999999999864 345789999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=345.26 Aligned_cols=204 Identities=29% Similarity=0.473 Sum_probs=170.0
Q ss_pred CCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-----
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----- 427 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~----- 427 (571)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 46899999999999999999999999999999987643322 1233567799999999999999999998755
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCc
Q 008285 428 ---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (571)
Q Consensus 428 ---~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA 504 (571)
++.+|+|||||.++.+..+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -----CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 3468999999986665544 444567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCc-----cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 505 KHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 505 ~~l~~~~-----~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
+.+.... .....+||+.|+|||++.. ...|+.++|||||||++|||++|+.||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccccccccccccceecCHHHhhHHHHcC------CCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 7654322 2234679999999999863 345789999999999999999999999754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=347.31 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=172.0
Q ss_pred CCCCeEEeeEEeecCceEEEEEEECCCCcE--EEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEEeeeEEeC
Q 008285 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (571)
Q Consensus 352 ~~~~y~i~k~LG~G~fG~VYla~~k~tG~~--VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl~g~~~~~ 428 (571)
..++|++.++||+|+||+||+|+++.+|.. ||||.+.... ..+..+.+.+|+++|.++ +|||||++++++.++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 346899999999999999999999988875 5666654322 123356789999999998 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 429 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~---------------~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+.+|+|||||+||+|.++|+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999753 3569999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEF 566 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr-~PF~~~ 566 (571)
+.+||+|||+++............||..|+|||.+.. ..++.++|||||||++|||++|. +||.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CceEEccccccccccccccccceecCCcccchHHhcc-------CCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 9999999999987665544455679999999999973 35789999999999999999965 567653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=340.31 Aligned_cols=200 Identities=29% Similarity=0.531 Sum_probs=164.9
Q ss_pred CCCCCCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-C
Q 008285 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-D 428 (571)
Q Consensus 350 ~~~~~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-~ 428 (571)
....++|++++.||+|+||.||+|+++ |..||||+++.. ...+.+.+|+++|++++||||+++++++.+ .
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 345568999999999999999999984 789999987521 123568899999999999999999998865 4
Q ss_pred CeEEEEEeecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~-~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
+.+|+||||+.+|+|.++|.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 66899999999999999997643 35899999999999999999999999999999999999999999999999999876
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr~PF~~~e 567 (571)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |++||....
T Consensus 154 ~~~~--~~~~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 154 SSTQ--DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp ----------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CCCC--ccccccccCCChHHHhC-------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 5432 34568999999999974 358999999999999999998 788887643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-40 Score=336.67 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=169.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCC-eeEEeeeEEeCCeEE
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLY 432 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpN-IVkl~g~~~~~~~ly 432 (571)
++|++++.||+|+||+||+|++..+|+.||||++...... +++..|+++++.++|+| |+.+.+++.+.+..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 5799999999999999999999999999999987753322 23678999999998665 555666677888999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEEecCCcccccC
Q 008285 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTG 509 (571)
Q Consensus 433 LVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd---~~g~vKLiDFGlA~~l~~ 509 (571)
+||||+ +++|.+++......+++..+..++.||+.||+|||++|||||||||+|||++ .+..+||+|||+++.+..
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999999 5777777777677899999999999999999999999999999999999985 455799999999997654
Q ss_pred Cc--------cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 510 LS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 510 ~~--------~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
.. .....+||+.|||||++. +..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHT-------TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cccccceeccccCCcCCCccccCHHHHh-------CCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 32 123467999999999986 34589999999999999999999999976543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=340.91 Aligned_cols=208 Identities=27% Similarity=0.458 Sum_probs=177.9
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhc-CCCCeeEE
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY 421 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k-----~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L-~HpNIVkl 421 (571)
.++...++|++++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.++.++ +|+|||++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 35556679999999999999999999863 467789999986422 234456788999999999 69999999
Q ss_pred eeeEEeCCeEEEEEeecCCCCHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008285 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (571)
Q Consensus 422 ~g~~~~~~~lyLVmEy~~GGsL~d~L~~~~-----------------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIK 484 (571)
++++.+.+.+|+|||||.+|+|.++|.... ..+++..+..++.||+.||+|||++||||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999997642 258999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 008285 485 GANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (571)
Q Consensus 485 PsNILLd~~g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLt-Gr 560 (571)
|+|||++.++.+||+|||+++....... .....||+.|+|||++.. ..++.++|||||||++|||++ |.
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-------CCCCCcccccchHHHHHHHHhCCC
Confidence 9999999999999999999987754322 234578999999999973 368899999999999999999 55
Q ss_pred CCCCCC
Q 008285 561 PPWSEF 566 (571)
Q Consensus 561 ~PF~~~ 566 (571)
+||...
T Consensus 246 p~~~~~ 251 (311)
T d1t46a_ 246 SPYPGM 251 (311)
T ss_dssp CSSTTC
T ss_pred CCCCCC
Confidence 556543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=339.39 Aligned_cols=208 Identities=24% Similarity=0.414 Sum_probs=178.0
Q ss_pred CCCCCCCCeEEeeEEeecCceEEEEEEECC-----CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEe
Q 008285 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422 (571)
Q Consensus 348 ~~~~~~~~y~i~k~LG~G~fG~VYla~~k~-----tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~ 422 (571)
.++...++|++++.||+|+||+||+|.++. ++..||||+++.. ........+.+|++++++++|+|||+++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 355666899999999999999999998752 4578999987532 2344556789999999999999999999
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~---------~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~ 493 (571)
+++..++..++|||||.+|+|.+++.... ..+++..+..++.||++||.|||+++|+||||||+||||+.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 99999999999999999999999986431 347899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccCCcc---ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 008285 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEF 566 (571)
Q Consensus 494 g~vKLiDFGlA~~l~~~~~---~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtG-r~PF~~~ 566 (571)
+.+||+|||+++.+..... .....||+.|+|||.+.. ..++.++|||||||++|||++| +.||.+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-------CCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 9999999999987654332 234568999999999974 3678899999999999999997 5778654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=346.17 Aligned_cols=208 Identities=27% Similarity=0.453 Sum_probs=175.8
Q ss_pred CCCeEEeeEEeecCceEEEEEEE---CCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-CCeeEEeeeEEeC
Q 008285 353 KSQWQKGKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD 428 (571)
Q Consensus 353 ~~~y~i~k~LG~G~fG~VYla~~---k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-pNIVkl~g~~~~~ 428 (571)
.++|++++.||+|+||+||+|++ +.+|+.||||+++..... ......+.+.+|+++|++++| +||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-cchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 46899999999999999999987 457899999998532211 011123557789999999976 8999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
+.+++||||+.||+|.+++... ..+.+..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999999999876 568899999999999999999999999999999999999999999999999998764
Q ss_pred CCc--cccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~--~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
... ......|++.|+|||.+... ...++.++|||||||+||||++|+.||.+..
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~-----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ccccccccccccccccchhHHhhcC-----CcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 432 23456799999999998642 3357889999999999999999999997654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=336.52 Aligned_cols=199 Identities=27% Similarity=0.495 Sum_probs=170.3
Q ss_pred eEEeeEEeecCceEEEEEEECCCC---cEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEe-CCeE
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHL 431 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG---~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~-~~~l 431 (571)
++..++||+|+||+||+|++..++ ..||||.++.. ......+++.+|+++|++++|||||++++++.. ++.+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 344688999999999999987643 36899987532 235567889999999999999999999999876 4689
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccccCCc
Q 008285 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (571)
Q Consensus 432 yLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~~~~ 511 (571)
++|||||.+|+|.+++......+++..+..++.||+.||.|||+.||+||||||+||||++++.+||+|||+++.+....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999999998877788999999999999999999999999999999999999999999999999998765432
Q ss_pred c-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 512 Y-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 512 ~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
. .....||+.|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cccceecccccccccccChHHHhc-------CCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2 223568999999999874 3589999999999999999997777754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=340.23 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=163.5
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeCC----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~~---- 429 (571)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.. .......+.|+..+.+++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4789999999999999999986 5899999988531 111122334555666789999999999988764
Q ss_pred eEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEcCCCcEEEEec
Q 008285 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVKLADF 501 (571)
Q Consensus 430 ~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs--------~GIVHRDIKPsNILLd~~g~vKLiDF 501 (571)
.+|+|||||.+|+|.++|++. .+++..+..++.|++.||+|||. +|||||||||+||||+.++.+||+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 589999999999999999864 69999999999999999999996 69999999999999999999999999
Q ss_pred CCcccccCCcc-----ccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008285 502 GMAKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (571)
Q Consensus 502 GlA~~l~~~~~-----~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~ 565 (571)
|+++....... .....||+.|||||++...... ....++.++|||||||+||||++|..||..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT-TCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccc-cCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99987754321 2246799999999998642111 112357789999999999999999988753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=343.31 Aligned_cols=201 Identities=29% Similarity=0.469 Sum_probs=170.4
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
++|++++.||+|+||+||+|+++.+|+.||||++.... ......+++.+|+++|++++|+|||++++++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 47999999999999999999999999999999986422 3345567788999999999999999999988643
Q ss_pred CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCccccc
Q 008285 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (571)
Q Consensus 429 ~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l~ 508 (571)
...+++|||+.||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred CceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 344667788889999999854 469999999999999999999999999999999999999999999999999997654
Q ss_pred CCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008285 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (571)
Q Consensus 509 ~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~e 567 (571)
.. .....|++.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~--~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 173 DE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp GG--GSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc--cccccccccccCchhhcC------CccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 32 335678999999998763 3456889999999999999999999997643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=342.12 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=162.2
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCeeEEeeeEEeC-----
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~g~~~~~----- 428 (571)
++|++++.||+|+||+||+|.++.+|+.||||++.... ......+++.+|+.+|++++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh---cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 57999999999999999999999999999999987432 2345567889999999999999999999998643
Q ss_pred -CeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecCCcccc
Q 008285 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (571)
Q Consensus 429 -~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~l 507 (571)
..+|+|||||.|+.| +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 678999999976544 444 246999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008285 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566 (571)
Q Consensus 508 ~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~ 566 (571)
.........+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~-------~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------CCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccccccccChhhhc-------CCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 7666666778999999999986 346788999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-35 Score=304.46 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=161.0
Q ss_pred CCeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-----------CCCeeEEe
Q 008285 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQYY 422 (571)
Q Consensus 354 ~~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-----------HpNIVkl~ 422 (571)
++|++++.||+|+||+||+|+++.+|+.||||+++. .....+.+.+|+++|+.+. |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 469999999999999999999999999999999862 2233466778998888875 47899999
Q ss_pred eeEEe--CCeEEEEEeecCCCCHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC---
Q 008285 423 GSEVV--DDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG--- 494 (571)
Q Consensus 423 g~~~~--~~~lyLVmEy~~GGsL~d~L--~~~~~~Lse~~i~~I~~QIa~gL~yLHs-~GIVHRDIKPsNILLd~~g--- 494 (571)
+++.. ....+++|+++..+...... ......+++..++.++.||+.||+|||+ +||+||||||+||||+.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88754 35667777777655433332 3344679999999999999999999997 8999999999999997655
Q ss_pred ---cEEEEecCCcccccCCccccccCCCCcccChHHHHHhhhcCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 008285 495 ---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (571)
Q Consensus 495 ---~vKLiDFGlA~~l~~~~~~~~~~GT~~YmAPEvl~~~~~~d~~~~~s~ksDVWSLGvVLyELLtGr~PF~~~eg 568 (571)
.++|+|||.+...... ....+||+.|+|||++. ...++.++|||||||++++|++|+.||...++
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH-------TCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccceeeEeecccccccccc--cccccccccccChhhcc-------ccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 4999999999865443 34567999999999987 34578899999999999999999999986554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.1e-25 Score=209.17 Aligned_cols=173 Identities=17% Similarity=0.199 Sum_probs=123.4
Q ss_pred eEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCC-------------cCcHHHHHHHHHHHHHHhhcCCCCeeEEe
Q 008285 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQEIKVLGHLKHENIVQYY 422 (571)
Q Consensus 356 y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d-------------~~~~~~~k~l~~Ei~IL~~L~HpNIVkl~ 422 (571)
+.+++.||+|+||+||+|++. +|+.||||+++..... ............|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999985 6899999987532110 01112234456789999999999999888
Q ss_pred eeEEeCCeEEEEEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEEecC
Q 008285 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (571)
Q Consensus 423 g~~~~~~~lyLVmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs~GIVHRDIKPsNILLd~~g~vKLiDFG 502 (571)
+.. ..+++|||+++..+. .+++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+|||
T Consensus 81 ~~~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EEE----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred Eec----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 652 237999999876553 25556677899999999999999999999999999999865 48999999
Q ss_pred CcccccCCccccccCCCCcccChH--HHHHhhhcCCCCCCCchhhHHHHHHHH
Q 008285 503 MAKHLTGLSYELSLKGSPNWMAPE--VIKAVMQKDGNPKLALAVDIWSLGCTV 553 (571)
Q Consensus 503 lA~~l~~~~~~~~~~GT~~YmAPE--vl~~~~~~d~~~~~s~ksDVWSLGvVL 553 (571)
+|+........ .|.... .+.... ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~-------~~l~rd~~~~~~~f----~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR-------EILERDVRNIITYF----SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH-------HHHHHHHHHHHHHH----HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH-------HHHHHHHHHHHHHH----cCCCCCcccHHHHHHHH
Confidence 99766432211 122111 111111 12467789999985444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=3.5e-07 Score=86.97 Aligned_cols=139 Identities=14% Similarity=0.086 Sum_probs=90.0
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcC-CCCeeEEeeeEEeCCeEEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~-HpNIVkl~g~~~~~~~lyL 433 (571)
.|+..+..+-++.+.||+.. .+++.+.+|......... ...+.+|..+++.+. +--+.+++.++..++..|+
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 56766654444457899875 346678888765322211 224667888887774 4336677877788899999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 008285 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 475 (571)
Q Consensus 434 VmEy~~GGsL~d~L~~~~~~Lse~~i~~I~~QIa~gL~yLHs-------------------------------------- 475 (571)
|||+++|..+...+... . ....++.++...|+.||+
T Consensus 88 v~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 99999988775432110 0 111222333333333332
Q ss_pred ---------------C------CceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 476 ---------------T------NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 476 ---------------~------GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
. .++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 368999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=7e-06 Score=77.31 Aligned_cols=137 Identities=13% Similarity=0.032 Sum_probs=82.6
Q ss_pred EEeecCc-eEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC--CCeeEEeeeEEeCCeEEEEEee
Q 008285 361 LIGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEY 437 (571)
Q Consensus 361 ~LG~G~f-G~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H--pNIVkl~g~~~~~~~lyLVmEy 437 (571)
.+..|.. +.||+... ..|..+.+|...... ...+..|+.+|+.+.. -.+.+++....+.+..++|||+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 4555554 68898875 346678888764321 1235677777777642 3366778777788889999999
Q ss_pred cCCCCHHH--------------HHHHh------cCCC--CHHHHH-H----H---------------HHHHHHHHHHHHh
Q 008285 438 VHPGSINR--------------YVREH------CRDI--TESIVR-N----F---------------TRHILNGLAYLHS 475 (571)
Q Consensus 438 ~~GGsL~d--------------~L~~~------~~~L--se~~i~-~----I---------------~~QIa~gL~yLHs 475 (571)
++|..+.. .+.+. ...+ ...... . + ...+...+..+..
T Consensus 88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 98765532 11110 0000 000000 0 0 0011223333433
Q ss_pred C-------CceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 476 T-------NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 476 ~-------GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
+ .++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2 379999999999998877788999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.95 E-value=8.7e-06 Score=83.38 Aligned_cols=81 Identities=16% Similarity=0.097 Sum_probs=48.9
Q ss_pred eeEEeecCceEEEEEEECCCCcEEEEEEeecC---CCCcCcHHHHHHHHHHHHHHhhcC-C--CCeeEEeeeEEeCCeEE
Q 008285 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDII---PDDPKSAECIKQLEQEIKVLGHLK-H--ENIVQYYGSEVVDDHLY 432 (571)
Q Consensus 359 ~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~---~~d~~~~~~~k~l~~Ei~IL~~L~-H--pNIVkl~g~~~~~~~ly 432 (571)
.+.||.|....||++.+..+|+.+++|.-... ..+... ....+...|.+.|+.+. + ..+.+++.+ +.+..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 45789999999999998777889999964321 011000 01233456777777663 2 345666643 455668
Q ss_pred EEEeecCCCC
Q 008285 433 IYLEYVHPGS 442 (571)
Q Consensus 433 LVmEy~~GGs 442 (571)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00037 Score=68.81 Aligned_cols=133 Identities=12% Similarity=0.105 Sum_probs=75.7
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCee-----EEe--eeEEeCCeEEEEEee
Q 008285 365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-----QYY--GSEVVDDHLYIYLEY 437 (571)
Q Consensus 365 G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNIV-----kl~--g~~~~~~~lyLVmEy 437 (571)
+..-.||++.. ++|..|++|+.+... .. .+++..|++.|..|...+|. ..- ..+..++..+.++++
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~---~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~ 105 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 105 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCC---CC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence 44568999985 568999999876321 11 34566788888777532221 111 133456778999999
Q ss_pred cCCCCH-----HHH------H---HHhc--------CCCC-------------------HH---HHHHHHHHHHHHHHHH
Q 008285 438 VHPGSI-----NRY------V---REHC--------RDIT-------------------ES---IVRNFTRHILNGLAYL 473 (571)
Q Consensus 438 ~~GGsL-----~d~------L---~~~~--------~~Ls-------------------e~---~i~~I~~QIa~gL~yL 473 (571)
+.|..+ ..+ + +... ..++ .. ....++.+++..+.-+
T Consensus 106 ~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 185 (325)
T d1zyla1 106 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 185 (325)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHh
Confidence 986532 111 1 1100 0111 11 1112223333322222
Q ss_pred H----hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 474 H----STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 474 H----s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
- ..++||+|+.+.|||++++ ..|+||+.+..
T Consensus 186 ~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 186 WREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1 2379999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.76 E-value=0.0017 Score=62.84 Aligned_cols=143 Identities=13% Similarity=0.067 Sum_probs=77.8
Q ss_pred CeEEeeEEeecCceEEEEEEECCCCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCC-----CCeeEEe---eeEE
Q 008285 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-----ENIVQYY---GSEV 426 (571)
Q Consensus 355 ~y~i~k~LG~G~fG~VYla~~k~tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~H-----pNIVkl~---g~~~ 426 (571)
...-.+.|..|---+.|+.+... ..+++|++.... ..+.+..|+++|.+|.. |..+... ....
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~-------~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS--CCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC-------CHHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 45556667788888999987543 458999875311 12345567777777642 2222211 1233
Q ss_pred eCCeEEEEEeecCCCCHHH-----------HH---HHhcCC--------CCH------------------HHHHHHHHHH
Q 008285 427 VDDHLYIYLEYVHPGSINR-----------YV---REHCRD--------ITE------------------SIVRNFTRHI 466 (571)
Q Consensus 427 ~~~~lyLVmEy~~GGsL~d-----------~L---~~~~~~--------Lse------------------~~i~~I~~QI 466 (571)
..+..+.++.++.|..... .+ +..... ... ......+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 4566677777776642211 01 100000 000 0111222223
Q ss_pred HHHHHHHH----hCCceecCCCCCcEEEcCCCcEEEEecCCccc
Q 008285 467 LNGLAYLH----STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (571)
Q Consensus 467 a~gL~yLH----s~GIVHRDIKPsNILLd~~g~vKLiDFGlA~~ 506 (571)
...+...+ ..|+||+|+.++||+++.+...-|+||+.+..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 33333332 24899999999999999888889999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0022 Score=64.59 Aligned_cols=75 Identities=15% Similarity=0.176 Sum_probs=48.0
Q ss_pred EeeEEeecCceEEEEEEECC-------CCcEEEEEEeecCCCCcCcHHHHHHHHHHHHHHhhcCCCCe-eEEeeeEEeCC
Q 008285 358 KGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDD 429 (571)
Q Consensus 358 i~k~LG~G~fG~VYla~~k~-------tG~~VAIK~i~~~~~d~~~~~~~k~l~~Ei~IL~~L~HpNI-Vkl~g~~~~~~ 429 (571)
.++.|+-|-.-.+|++.... ....|.+++.- .. ... ....+|..+++.+.-.+| .++++.+. +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--~ 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETE---SHLVAESVIFTLLSERHLGPKLYGIFS--G 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chh---hHHHHHHHHHHHHHhCCCCCeEEEEcC--C
Confidence 34678889999999998653 23556776643 11 111 234578888888753343 46776553 2
Q ss_pred eEEEEEeecCCCCH
Q 008285 430 HLYIYLEYVHPGSI 443 (571)
Q Consensus 430 ~lyLVmEy~~GGsL 443 (571)
.+||||++|..|
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 689999987543
|